
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
      
      
      <link rel="icon" href="../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.17">
    
    
      
        <title>Migrate ncit - Mondo Disease Ontology Ingest</title>
      
    
    
      <link rel="stylesheet" href="../../assets/stylesheets/main.bcfcd587.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
    <script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    <body dir="ltr">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#ncit" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../.." title="Mondo Disease Ontology Ingest" class="md-header__button md-logo" aria-label="Mondo Disease Ontology Ingest" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54Z"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Mondo Disease Ontology Ingest
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Migrate ncit
            
          </span>
        </div>
      </div>
    </div>
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../.." title="Mondo Disease Ontology Ingest" class="md-nav__button md-logo" aria-label="Mondo Disease Ontology Ingest" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54Z"/></svg>

    </a>
    Mondo Disease Ontology Ingest
  </label>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../.." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Getting started
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../cite/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Cite
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../history/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    History
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_4" >
        
          
          <label class="md-nav__link" for="__nav_4" id="__nav_4_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    How-to guides
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_4">
            <span class="md-nav__icon md-icon"></span>
            How-to guides
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_4_1" >
        
          
          <label class="md-nav__link" for="__nav_4_1" id="__nav_4_1_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Standard ODK workflows
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_4_1_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_4_1">
            <span class="md-nav__icon md-icon"></span>
            Standard ODK workflows
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../odk-workflows/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Overview
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../odk-workflows/EditorsWorkflow/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Editors Workflow
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../odk-workflows/ReleaseWorkflow/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Release Workflow
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../odk-workflows/RepoManagement/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Manage your ODK Repository
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../odk-workflows/SettingUpDockerForODK/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Setting up Docker for ODK
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../odk-workflows/UpdateImports/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Imports management
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../odk-workflows/ManageDocumentation/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Managing the documentation
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../odk-workflows/ContinuousIntegration/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Continuous Integration
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../odk-workflows/RepositoryFileStructure/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Your ODK Repository Overview
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../contributing/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Contributing
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../unmapped/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Mapping progress report
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_6" >
        
          
          <label class="md-nav__link" for="__nav_6" id="__nav_6_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Reference
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_6_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_6">
            <span class="md-nav__icon md-icon"></span>
            Reference
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_6_1" >
        
          
          <label class="md-nav__link" for="__nav_6_1" id="__nav_6_1_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Developers
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_6_1_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_6_1">
            <span class="md-nav__icon md-icon"></span>
            Developers
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../developer/workflows/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Workflows
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../unmapped/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Mondo sources: Mapping progress report
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../mapped_deprecated/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Mondo sources: Deprecated terms w/ Mondo xrefs
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_6_4" >
        
          
          <label class="md-nav__link" for="__nav_6_4" id="__nav_6_4_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Mondo sources
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_6_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_6_4">
            <span class="md-nav__icon md-icon"></span>
            Mondo sources
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../sources/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Overview
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../sources/doid/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    DO
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../sources/icd10cm/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    ICD10CM
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../sources/icd10who/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    ICD10WHO
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../sources/icd11foundation/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    ICD11Foundation
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../sources/ncit/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    NCIT
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../sources/omim/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    OMIM
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../sources/ordo/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    ORDO
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_6_5" >
        
          
          <label class="md-nav__link" for="__nav_6_5" id="__nav_6_5_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Externally managed content
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_6_5_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_6_5">
            <span class="md-nav__icon md-icon"></span>
            Externally managed content
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../externally-managed-content/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Overview
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../external/nord/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    NORD
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_6_6" >
        
          
          <label class="md-nav__link" for="__nav_6_6" id="__nav_6_6_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Mondo source metrics
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_6_6_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_6_6">
            <span class="md-nav__icon md-icon"></span>
            Mondo source metrics
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../metrics/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Overview
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../metrics/doid/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    DO
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../metrics/icd10cm/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    ICD10CM
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../metrics/icd10who/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    ICD10WHO
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../metrics/icd11foundation/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    ICD11Foundation
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../metrics/ncit/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    NCIT
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../metrics/omim/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    OMIM
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../metrics/ordo/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    ORDO
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#ncit" class="md-nav__link">
    <span class="md-ellipsis">
      NCIT
    </span>
  </a>
  
    <nav class="md-nav" aria-label="NCIT">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#migratable-terms" class="md-nav__link">
    <span class="md-ellipsis">
      Migratable terms
    </span>
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  


  <h1>Migrate ncit</h1>

<h2 id="ncit">NCIT</h2>
<p><a href="https://flatgithub.com/monarch-initiative/mondo-ingest?filename=src/ontology/slurp/ncit.tsv">Interactive FlatGithub table</a></p>
<h3 id="migratable-terms">Migratable terms</h3>
<table>
<thead>
<tr>
<th style="text-align: left;">mondo_id</th>
<th style="text-align: left;">mondo_label</th>
<th style="text-align: left;">xref</th>
<th style="text-align: left;">xref_source</th>
<th style="text-align: left;">original_label</th>
<th style="text-align: left;">definition</th>
<th style="text-align: left;">parents</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align: left;">ID</td>
<td style="text-align: left;">LABEL</td>
<td style="text-align: left;">A oboInOwl:hasDbXref</td>
<td style="text-align: left;">&gt;A oboInOwl:source SPLIT=</td>
<td style="text-align: left;"></td>
<td style="text-align: left;"></td>
<td style="text-align: left;">A IAO:0000115</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853241</td>
<td style="text-align: left;">primary central nervous system neoplasm</td>
<td style="text-align: left;">NCIT:C102871</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Central Nervous System Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that arises from the brain or the spinal cord.</td>
<td style="text-align: left;">MONDO:0006130</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853254</td>
<td style="text-align: left;">adrenal cortical carcinoma by ensat stage</td>
<td style="text-align: left;">NCIT:C104030</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Carcinoma by ENSAT Stage</td>
<td style="text-align: left;">A term that refers to the staging of adrenal cortical carcinoma according to the European Network for the Study of Adrenal Tumors (ENSAT).</td>
<td style="text-align: left;">MONDO:0006639</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853260</td>
<td style="text-align: left;">uveal melanoma by gene expression profile</td>
<td style="text-align: left;">NCIT:C111030</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uveal Melanoma by Gene Expression Profile</td>
<td style="text-align: left;">Classification of uveal melanoma into molecular subtypes as defined by gene expression profiling.</td>
<td style="text-align: left;">MONDO:0006486</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853262</td>
<td style="text-align: left;">glioblastoma by gene expression profile</td>
<td style="text-align: left;">NCIT:C111691</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Glioblastoma by Gene Expression Profile</td>
<td style="text-align: left;">Classification of glioblastoma into molecular subtypes as defined by gene expression profiling.</td>
<td style="text-align: left;">MONDO:0018177</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853267</td>
<td style="text-align: left;">thymoma by masaoka-koga stage</td>
<td style="text-align: left;">NCIT:C112006</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thymoma by Masaoka-Koga Stage</td>
<td style="text-align: left;">A staging system for thymoma based on the anatomic extent of disease at the time of surgery.</td>
<td style="text-align: left;">MONDO:0006456</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853279</td>
<td style="text-align: left;">uterine carcinosarcoma, homologous type</td>
<td style="text-align: left;">NCIT:C113238</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Carcinosarcoma, Homologous Type</td>
<td style="text-align: left;">A carcinosarcoma of the uterus characterized by the presence of sarcomatous elements that arise from the tissues of the uterus.</td>
<td style="text-align: left;">MONDO:0006485</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853280</td>
<td style="text-align: left;">uterine carcinosarcoma, heterologous type</td>
<td style="text-align: left;">NCIT:C113239</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Carcinosarcoma, Heterologous Type</td>
<td style="text-align: left;">A carcinosarcoma of the uterus characterized by the presence of sarcomatous elements composed of tissues that are not found in the uterus (e.g., bone, cartilage, skeletal muscle).</td>
<td style="text-align: left;">MONDO:0006485</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853284</td>
<td style="text-align: left;">main duct pancreatic intraductal papillary-mucinous neoplasm</td>
<td style="text-align: left;">NCIT:C113664</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm</td>
<td style="text-align: left;">An intraductal papillary-mucinous neoplasm of the pancreas that arises from the main pancreatic duct.</td>
<td style="text-align: left;">MONDO:0004286</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853285</td>
<td style="text-align: left;">branch duct pancreatic intraductal papillary-mucinous neoplasm</td>
<td style="text-align: left;">NCIT:C113665</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm</td>
<td style="text-align: left;">An intraductal papillary-mucinous neoplasm of the pancreas that arises in one of the branches of the main pancreatic duct.  It usually has an indolent behavior.</td>
<td style="text-align: left;">MONDO:0004286</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853286</td>
<td style="text-align: left;">mixed type pancreatic intraductal papillary-mucinous neoplasm</td>
<td style="text-align: left;">NCIT:C113667</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm</td>
<td style="text-align: left;">An intraductal papillary-mucinous neoplasm of the pancreas that arises primarily from the main pancreatic duct and extends to the branch ducts.</td>
<td style="text-align: left;">MONDO:0004286</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853303</td>
<td style="text-align: left;">adult undifferentiated high grade pleomorphic sarcoma of bone</td>
<td style="text-align: left;">NCIT:C114782</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone</td>
<td style="text-align: left;">An undifferentiated high grade pleomorphic sarcoma that arises from the bone and occurs during adulthood.</td>
<td style="text-align: left;">MONDO:0002618</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853306</td>
<td style="text-align: left;">metastatic malignant neoplasm in the soft tissue</td>
<td style="text-align: left;">NCIT:C114831</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Soft Tissue</td>
<td style="text-align: left;">A malignant neoplasm that has spread from its original site of growth to the soft tissue.</td>
<td style="text-align: left;">MONDO:0024637,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853313</td>
<td style="text-align: left;">adult epithelioid hemangioendothelioma</td>
<td style="text-align: left;">NCIT:C114923</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Epithelioid Hemangioendothelioma</td>
<td style="text-align: left;">An epithelioid hemangioendothelioma that occurs during adulthood.</td>
<td style="text-align: left;">MONDO:0015523</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853316</td>
<td style="text-align: left;">primary central nervous system hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C114951</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Central Nervous System Hodgkin Lymphoma</td>
<td style="text-align: left;">A Hodgkin lymphoma that arises from the central nervous system.</td>
<td style="text-align: left;">MONDO:0004952,MONDO:0002571</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853326</td>
<td style="text-align: left;">adult fibrolamellar carcinoma</td>
<td style="text-align: left;">NCIT:C114992</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Fibrolamellar Carcinoma</td>
<td style="text-align: left;">A fibrolamellar carcinoma that occurs during adulthood.</td>
<td style="text-align: left;">MONDO:0016216,MONDO:0006210</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853331</td>
<td style="text-align: left;">hepatocellular carcinoma by bclc stage</td>
<td style="text-align: left;">NCIT:C115132</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatocellular Carcinoma by BCLC Stage</td>
<td style="text-align: left;">A staging classification system for hepatocellular carcinoma that uses variables related to tumor stage, liver functional status, physical status, and cancer-related symptoms, and links the stages with a treatment algorithm. (HPB (Oxford) 2005; 7(1):35-41)</td>
<td style="text-align: left;">MONDO:0007256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853337</td>
<td style="text-align: left;">adult myelodysplastic syndrome</td>
<td style="text-align: left;">NCIT:C115153</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Myelodysplastic Syndrome</td>
<td style="text-align: left;">Myelodysplastic syndrome that occurs in adulthood.</td>
<td style="text-align: left;">MONDO:0018881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853343</td>
<td style="text-align: left;">distal urethral carcinoma</td>
<td style="text-align: left;">NCIT:C115210</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Distal Urethral Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the distal part of the urethra.</td>
<td style="text-align: left;">MONDO:0021327</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853344</td>
<td style="text-align: left;">familial testicular germ cell tumor</td>
<td style="text-align: left;">NCIT:C115211</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Familial Testicular Germ Cell Tumor</td>
<td style="text-align: left;">Germ cell tumor that arises from the testis and is diagnosed in at least two relatives.</td>
<td style="text-align: left;">MONDO:0010108</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853348</td>
<td style="text-align: left;">proximal urethral carcinoma</td>
<td style="text-align: left;">NCIT:C115334</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Proximal Urethral Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the proximal part of the urethra.</td>
<td style="text-align: left;">MONDO:0021327</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853359</td>
<td style="text-align: left;">invasive bladder urothelial carcinoma associated with urethral carcinoma</td>
<td style="text-align: left;">NCIT:C115966</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Bladder Urothelial Carcinoma Associated with Urethral Carcinoma</td>
<td style="text-align: left;">Invasive urothelial carcinoma of the bladder which is associated with the presence of in situ or infiltrating urethral carcinoma.</td>
<td style="text-align: left;">MONDO:0003890</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853405</td>
<td style="text-align: left;">anaplastic plasmacytoma</td>
<td style="text-align: left;">NCIT:C118421</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Plasmacytoma</td>
<td style="text-align: left;">A plasmacytoma characterized by the presence of malignant plasma cells with anaplastic features.</td>
<td style="text-align: left;">MONDO:0005615,MONDO:0020633</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853427</td>
<td style="text-align: left;">adult penile carcinoma</td>
<td style="text-align: left;">NCIT:C118820</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Penile Carcinoma</td>
<td style="text-align: left;">A carcinoma of the penis that occurs during adulthood.</td>
<td style="text-align: left;">MONDO:0006360</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853431</td>
<td style="text-align: left;">adult salivary gland carcinoma</td>
<td style="text-align: left;">NCIT:C118825</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Salivary Gland Carcinoma</td>
<td style="text-align: left;">A carcinoma of the salivary gland that occurs during adulthood.</td>
<td style="text-align: left;">MONDO:0000521</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853434</td>
<td style="text-align: left;">orbital melanoma</td>
<td style="text-align: left;">NCIT:C118828</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Orbital Melanoma</td>
<td style="text-align: left;">A melanoma that arises from the structures of the orbit.</td>
<td style="text-align: left;">MONDO:0002889,MONDO:0005105</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853464</td>
<td style="text-align: left;">malignant kidney neoplasm except renal pelvis</td>
<td style="text-align: left;">NCIT:C120456</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Kidney Neoplasm Except Renal Pelvis</td>
<td style="text-align: left;">A malignant neoplasm that affects the renal parenchyma but not the renal pelvis.</td>
<td style="text-align: left;">MONDO:0002367</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853467</td>
<td style="text-align: left;">mammary-type myofibroblastoma</td>
<td style="text-align: left;">NCIT:C121181</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mammary-Type Myofibroblastoma</td>
<td style="text-align: left;">A benign mesenchymal neoplasm characterized by the presence of spindle shaped myofibroblasts and mast cells in a collagenous stroma.  It is histologically identical to the myofibroblastoma of breast.  It usually arises from the subcutaneous tissue and the most common sites of involvement are the inguinal/groin, paratesticular, and vulvovaginal areas.</td>
<td style="text-align: left;">MONDO:0040675</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853473</td>
<td style="text-align: left;">leiomyosarcoma of deep soft tissue</td>
<td style="text-align: left;">NCIT:C121571</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Leiomyosarcoma of Deep Soft Tissue</td>
<td style="text-align: left;">A rare leiomyosarcoma that arises from the deep soft tissue in the retroperitoneum or abdominal cavity.</td>
<td style="text-align: left;">MONDO:0018078,MONDO:0005058</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853476</td>
<td style="text-align: left;">spindle cell/sclerosing rhabdomyosarcoma</td>
<td style="text-align: left;">NCIT:C121654</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Spindle Cell/Sclerosing Rhabdomyosarcoma</td>
<td style="text-align: left;">An uncommon variant of rhabdomyosarcoma with spindle cell or sclerosing morphology. It affects both children and adults and it is more common in males.</td>
<td style="text-align: left;">MONDO:0005212</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853478</td>
<td style="text-align: left;">soft tissue angiosarcoma</td>
<td style="text-align: left;">NCIT:C121671</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Soft Tissue Angiosarcoma</td>
<td style="text-align: left;">An angiosarcoma that arises from the soft tissues, usually in the deep muscles of the lower extremities, retroperitoneum, mediastinum, and mesentery.</td>
<td style="text-align: left;">MONDO:0018078,MONDO:0016982</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853479</td>
<td style="text-align: left;">conventional schwannoma</td>
<td style="text-align: left;">NCIT:C121677</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conventional Schwannoma</td>
<td style="text-align: left;">A common, usually encapsulated benign nerve sheath tumor composed of well-differentiated Schwann cells.</td>
<td style="text-align: left;">MONDO:0002546</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853481</td>
<td style="text-align: left;">solitary circumscribed neuroma</td>
<td style="text-align: left;">NCIT:C121681</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Solitary Circumscribed Neuroma</td>
<td style="text-align: left;">A benign peripheral nerve sheath tumor characterized by the presence of Schwann cells, axons, and perineurial fibroblasts.  It usually arises from the skin of the head and neck or the oral mucosa.  It presents as a solitary and painless nodular mass.</td>
<td style="text-align: left;">MONDO:0002547,MONDO:0000648</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853483</td>
<td style="text-align: left;">hybrid nerve sheath tumor</td>
<td style="text-align: left;">NCIT:C121686</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hybrid Nerve Sheath Tumor</td>
<td style="text-align: left;">A benign nerve sheath tumor characterized by the combination of histologic features seen in schwannomas, neurofibromas, and perineuriomas.</td>
<td style="text-align: left;">MONDO:0002547,MONDO:0000648,MONDO:0021043</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853491</td>
<td style="text-align: left;">malignant mixed tumor, not otherwise specified</td>
<td style="text-align: left;">NCIT:C121787</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Mixed Tumor, Not Otherwise Specified</td>
<td style="text-align: left;">A malignant myoepithelioma characterized by the presence of a minor ductal component.</td>
<td style="text-align: left;">MONDO:0003158,MONDO:0005853</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853492</td>
<td style="text-align: left;">benign phosphaturic mesenchymal tumor</td>
<td style="text-align: left;">NCIT:C121788</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Phosphaturic Mesenchymal Tumor</td>
<td style="text-align: left;">A phosphaturic mesenchymal tumor with benign histologic features.  It may recur locally but does not metastasize.  Complete excision is curative.</td>
<td style="text-align: left;">MONDO:0006368,MONDO:0000654</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853493</td>
<td style="text-align: left;">malignant phosphaturic mesenchymal tumor</td>
<td style="text-align: left;">NCIT:C121789</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Phosphaturic Mesenchymal Tumor</td>
<td style="text-align: left;">A phosphaturic mesenchymal tumor characterized by the presence of nuclear atypia, high mitotic activity, increased cellularity, marked pleomorphism, and necrosis. It usually develops in lesions that have recurred locally and metastasizes to other sites.</td>
<td style="text-align: left;">MONDO:0006368,MONDO:0002927</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853494</td>
<td style="text-align: left;">sclerosing pecoma</td>
<td style="text-align: left;">NCIT:C121790</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sclerosing PEComa</td>
<td style="text-align: left;">A tumor with perivascular epithelioid cell differentiation characterized by the presence of cords of neoplastic cells in a densely collagenous stroma.</td>
<td style="text-align: left;">MONDO:0006359</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853495</td>
<td style="text-align: left;">undifferentiated soft tissue sarcoma</td>
<td style="text-align: left;">NCIT:C121793</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Undifferentiated Soft Tissue Sarcoma</td>
<td style="text-align: left;">A term that refers to a heterogeneous group of uncommon soft tissue sarcomas that do not show an identifiable line of differentiation using currently available technologies.  This is a diagnosis of exclusion and includes undifferentiated pleomorphic sarcoma (also known as malignant fibrous histiocytoma), undifferentiated spindle cell sarcoma, undifferentiated round cell sarcoma, and undifferentiated epithelioid sarcoma.</td>
<td style="text-align: left;">MONDO:0018078</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853498</td>
<td style="text-align: left;">osteochondromyxoma</td>
<td style="text-align: left;">NCIT:C121842</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Osteochondromyxoma</td>
<td style="text-align: left;">A rare benign chondroid and osteoid matrix-producing neoplasm of bone characterized by extensive myxoid changes.  It may be a locally destructive neoplasm and has been reported in patients with Carney complex.</td>
<td style="text-align: left;">MONDO:0000631,MONDO:0024470</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853499</td>
<td style="text-align: left;">subungual exostosis</td>
<td style="text-align: left;">NCIT:C121844</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Subungual Exostosis</td>
<td style="text-align: left;">A benign tumor that affects the distal phalanx, most often the great toe. Grossly it consists of a cartilage cap and a bony stalk. Microscopically it is characterized by an osteochondromatous proliferation with a gradual transition of a peripheral spindle-cell proliferation to hyaline cartilage to trabecular bone. Pain and swelling are present. Simple resection is usually curative.</td>
<td style="text-align: left;">MONDO:0024470</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853500</td>
<td style="text-align: left;">bizarre parosteal osteochondromatous proliferation</td>
<td style="text-align: left;">NCIT:C121845</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bizarre Parosteal Osteochondromatous Proliferation</td>
<td style="text-align: left;">A benign lesion that usually affects the proximal small bones of the hands or feet.  Grossly it consists of a cartilage cap and a bony stalk.  Microscopically it is characterized by the presence of spindle cells, cartilage, and bone, usually in a disorganized pattern compared to subungual exostosis.  Enlarged (bizarre) chondrocytes are present in the cartilage.  Swelling with or without pain is present.  Recurrences following resection have been reported in approximately half of cases.</td>
<td style="text-align: left;">MONDO:0024470</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853501</td>
<td style="text-align: left;">intermediate chondrogenic neoplasm</td>
<td style="text-align: left;">NCIT:C121846</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intermediate Chondrogenic Neoplasm</td>
<td style="text-align: left;">A locally aggressive or rarely metastasizing cartilaginous matrix-producing neoplasm characterized by the presence of neoplastic chondrocytes.</td>
<td style="text-align: left;">MONDO:0024469</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853502</td>
<td style="text-align: left;">chondrosarcoma, grade 2</td>
<td style="text-align: left;">NCIT:C121870</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chondrosarcoma, Grade 2</td>
<td style="text-align: left;">An intermediate-grade chondrosarcoma arising in the medulla of bone or within the cartilaginous cap of a pre-existing osteochondroma. It is characterized by the presence of increased cellularity and a greater degree of nuclear atypia and hyperchromasia as compared to grade 1 chondrosarcoma. Mitotic activity is present.</td>
<td style="text-align: left;">MONDO:0008977</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853504</td>
<td style="text-align: left;">benign notochordal cell tumor</td>
<td style="text-align: left;">NCIT:C121901</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Notochordal Cell Tumor</td>
<td style="text-align: left;">An intraosseous benign tumor of notochord origin that arises in the bones of the base of the skull, vertebral bodies, sacrum or coccyx.  It contains vacuolated tumor cells without atypia, but lacks myxoid matrix, necrosis, and lobular architecture, which are features that characterize its malignant counterpart, chordoma.  Most lesions are incidental findings.</td>
<td style="text-align: left;">MONDO:0002597,MONDO:0000631</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853507</td>
<td style="text-align: left;">intermediate osteogenic neoplasm</td>
<td style="text-align: left;">NCIT:C121925</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intermediate Osteogenic Neoplasm</td>
<td style="text-align: left;">A non-metastasizing, locally aggressive, bone-forming neoplasm.</td>
<td style="text-align: left;">MONDO:0045053</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853508</td>
<td style="text-align: left;">intermediate bone neoplasm</td>
<td style="text-align: left;">NCIT:C121926</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intermediate Bone Neoplasm</td>
<td style="text-align: left;">A locally aggressive or rarely metastasizing neoplasm that arises from the bone.</td>
<td style="text-align: left;">MONDO:0019060</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853510</td>
<td style="text-align: left;">primary bone non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C121930</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Bone Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A non-Hodgkin lymphoma that arises from the bone, without lymph node or other extranodal involvement.  The femur, spine, and pelvic bones are the most frequently affected areas.  The majority of cases are diffuse large B-cell lymphomas.  Most patients present with pain in the affected area.  Systemic symptoms are rare.</td>
<td style="text-align: left;">MONDO:0017814,MONDO:0018908</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853512</td>
<td style="text-align: left;">bone epithelioid hemangioendothelioma</td>
<td style="text-align: left;">NCIT:C121941</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Epithelioid Hemangioendothelioma</td>
<td style="text-align: left;">A low-grade malignant blood vessel neoplasm arising from the bone.  It is characterized by the presence of epithelioid endothelial cells.  The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma.</td>
<td style="text-align: left;">MONDO:0024499,MONDO:0002129,MONDO:0015523</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853515</td>
<td style="text-align: left;">acute lymphoblastic leukemia by gene expression profile</td>
<td style="text-align: left;">NCIT:C121973</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Lymphoblastic Leukemia by Gene Expression Profile</td>
<td style="text-align: left;">Gene expression-based patient cluster groups in acute lymphoblastic leukemia.</td>
<td style="text-align: left;">MONDO:0004967</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853523</td>
<td style="text-align: left;">borderline ovarian serous tumor/atypical proliferative ovarian serous tumor</td>
<td style="text-align: left;">NCIT:C122584</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor</td>
<td style="text-align: left;">A non-invasive serous neoplasm that arises from the ovary and shows greater cellular proliferation and cytologic atypia as compared to benign ovarian serous tumors, but less as compared to low-grade ovarian serous carcinoma.</td>
<td style="text-align: left;">MONDO:0020662</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853524</td>
<td style="text-align: left;">borderline ovarian serous tumor-micropapillary variant/non-invasive low grade ovarian serous carcinoma</td>
<td style="text-align: left;">NCIT:C122585</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma</td>
<td style="text-align: left;">A non-invasive serous neoplasm that arises from the ovary and shows micropapillary and/or cribriform architectural patterns.  It is composed of round epithelial cells with scant cytoplasm and moderate nuclear atypia.</td>
<td style="text-align: left;">MONDO:0020662</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853525</td>
<td style="text-align: left;">infant leukemia</td>
<td style="text-align: left;">NCIT:C122603</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Infant Leukemia</td>
<td style="text-align: left;">An acute lymphoblastic or acute myeloid leukemia that occurs in infancy.</td>
<td style="text-align: left;">MONDO:0004355</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853528</td>
<td style="text-align: left;">childhood acute myeloid leukemia not otherwise specified</td>
<td style="text-align: left;">NCIT:C122625</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Acute Myeloid Leukemia Not Otherwise Specified</td>
<td style="text-align: left;">Acute myeloid leukemias that occur in children and do not fulfill the criteria for inclusion in the group of acute myeloid leukemias with recurrent genetic abnormalities or myelodysplastic changes, or are therapy-related. This category includes entities classified according to the French-American-British classification scheme.</td>
<td style="text-align: left;">MONDO:0015667,MONDO:0004996</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853529</td>
<td style="text-align: left;">hypoplastic myelodysplastic syndrome</td>
<td style="text-align: left;">NCIT:C122686</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hypoplastic Myelodysplastic Syndrome</td>
<td style="text-align: left;">Myelodysplastic syndrome characterized by decreased cellularity in the bone marrow.</td>
<td style="text-align: left;">MONDO:0018881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853530</td>
<td style="text-align: left;">cytogenetically normal acute myeloid leukemia</td>
<td style="text-align: left;">NCIT:C122687</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cytogenetically Normal Acute Myeloid Leukemia</td>
<td style="text-align: left;">Acute myeloid leukemia that is not associated with cytogenetic abnormalities.</td>
<td style="text-align: left;">MONDO:0018874</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853532</td>
<td style="text-align: left;">childhood acute myeloid leukemia with abnormalities of chromosome 5q</td>
<td style="text-align: left;">NCIT:C122725</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q</td>
<td style="text-align: left;">A rare acute myeloid leukemia that occurs in children and is characterized primarily by deletions of 5q.</td>
<td style="text-align: left;">MONDO:0004996</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853533</td>
<td style="text-align: left;">childhood acute myeloid leukemia with abnormalities of chromosome 7</td>
<td style="text-align: left;">NCIT:C122726</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7</td>
<td style="text-align: left;">A rare acute myeloid leukemia that occurs in childhood and is characterized by deletion of chromosome 7.</td>
<td style="text-align: left;">MONDO:0004996</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853659</td>
<td style="text-align: left;">childhood lymphomatoid granulomatosis</td>
<td style="text-align: left;">NCIT:C123392</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Lymphomatoid Granulomatosis</td>
<td style="text-align: left;">Lymphomatoid granulomatosis that occurs during childhood.</td>
<td style="text-align: left;">MONDO:0019466</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853660</td>
<td style="text-align: left;">childhood langerhans cell histiocytosis with risk organ involvement</td>
<td style="text-align: left;">NCIT:C123395</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement</td>
<td style="text-align: left;">Langerhans cell histiocytosis that occurs during childhood and involves the bone marrow, spleen, liver, or lung.</td>
<td style="text-align: left;">MONDO:0017025</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853661</td>
<td style="text-align: left;">childhood langerhans cell histiocytosis without risk organ involvement</td>
<td style="text-align: left;">NCIT:C123396</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement</td>
<td style="text-align: left;">Langerhans cell histiocytosis that occurs during childhood and does not involve the bone marrow, spleen, liver, or lung.</td>
<td style="text-align: left;">MONDO:0017025</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853668</td>
<td style="text-align: left;">fusion-positive rhabdomyosarcoma</td>
<td style="text-align: left;">NCIT:C123735</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fusion-Positive Rhabdomyosarcoma</td>
<td style="text-align: left;">A rhabdomyosarcoma characterized by the presence of chromosomal translocation t(1;13)(p36;q14) that results in PAX7-FOXO1 gene fusion; or translocation t(2;13)(q35;q14) that results in PAX3-FOXO1 gene fusion.</td>
<td style="text-align: left;">MONDO:0005212</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853669</td>
<td style="text-align: left;">fusion-negative rhabdomyosarcoma</td>
<td style="text-align: left;">NCIT:C123736</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fusion-Negative Rhabdomyosarcoma</td>
<td style="text-align: left;">A rhabdomyosarcoma characterized by the absence of chromosomal translocation t(1;13)(p36;q14) or t(2;13)(q35;q14) and therefore the absence of PAX7-FOXO1 or PAX3-FOXO1 gene fusion.</td>
<td style="text-align: left;">MONDO:0005212</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853671</td>
<td style="text-align: left;">refractory malignant germ cell tumor</td>
<td style="text-align: left;">NCIT:C123739</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Germ Cell Tumor</td>
<td style="text-align: left;">A malignant germ cell tumor that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0006290,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853673</td>
<td style="text-align: left;">childhood germinomatous germ cell tumor</td>
<td style="text-align: left;">NCIT:C123838</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Germinomatous Germ Cell Tumor</td>
<td style="text-align: left;">A germinomatous germ cell tumor occurring in children.</td>
<td style="text-align: left;">MONDO:0020580,MONDO:0003751</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853675</td>
<td style="text-align: left;">childhood nongerminomatous germ cell tumor</td>
<td style="text-align: left;">NCIT:C123841</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Nongerminomatous Germ Cell Tumor</td>
<td style="text-align: left;">A nongerminomatous germ cell tumor occurring in children.</td>
<td style="text-align: left;">MONDO:0021656,MONDO:0003751</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853680</td>
<td style="text-align: left;">childhood mixed germ cell tumor</td>
<td style="text-align: left;">NCIT:C123848</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Mixed Germ Cell Tumor</td>
<td style="text-align: left;">A mixed germ cell tumor occurring in children.</td>
<td style="text-align: left;">MONDO:0015864,MONDO:0004479,MONDO:0005853</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853693</td>
<td style="text-align: left;">childhood astrocytoma</td>
<td style="text-align: left;">NCIT:C124275</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Astrocytoma</td>
<td style="text-align: left;">An astrocytoma that occurs during childhood.</td>
<td style="text-align: left;">MONDO:0019781,MONDO:0002505</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853694</td>
<td style="text-align: left;">childhood atypical choroid plexus papilloma</td>
<td style="text-align: left;">NCIT:C124291</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Atypical Choroid Plexus Papilloma</td>
<td style="text-align: left;">An atypical choroid plexus papilloma that occurs during childhood.</td>
<td style="text-align: left;">MONDO:0002684,MONDO:0024744</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853721</td>
<td style="text-align: left;">ovarian adenomatoid tumor</td>
<td style="text-align: left;">NCIT:C126331</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Adenomatoid Tumor</td>
<td style="text-align: left;">A rare benign mesothelial tumor that arises from the ovary. It is characterized by the presence of gland-like structures.</td>
<td style="text-align: left;">MONDO:0004230,MONDO:0000646</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853728</td>
<td style="text-align: left;">chronic eosinophilic leukemia with fip1l1-pdgfra</td>
<td style="text-align: left;">NCIT:C126351</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA</td>
<td style="text-align: left;">Chronic eosinophilic leukemia characterized by the rearrangement of the PDGFRA gene, most often resulting in the formation of FIP1L1-PDGFRA fusion transcripts.</td>
<td style="text-align: left;">MONDO:0015689,MONDO:0001014</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853731</td>
<td style="text-align: left;">peritoneal desmoplastic small round cell tumor</td>
<td style="text-align: left;">NCIT:C126356</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Peritoneal Desmoplastic Small Round Cell Tumor</td>
<td style="text-align: left;">A desmoplastic small round cell tumor that occurs in the abdominal and/or pelvic peritoneum.</td>
<td style="text-align: left;">MONDO:0019373,MONDO:0002087</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853732</td>
<td style="text-align: left;">pelvic fibromatosis</td>
<td style="text-align: left;">NCIT:C126358</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pelvic Fibromatosis</td>
<td style="text-align: left;">Fibromatosis that occurs in the pelvis. It affects almost always females. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It recurs if incompletely resected but lacks metastatic potential.</td>
<td style="text-align: left;">MONDO:0007608</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853733</td>
<td style="text-align: left;">abdominal inflammatory myofibroblastic tumor</td>
<td style="text-align: left;">NCIT:C126359</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Abdominal Inflammatory Myofibroblastic Tumor</td>
<td style="text-align: left;">An inflammatory myofibroblastic tumor that arises from the abdominal cavity.</td>
<td style="text-align: left;">MONDO:0015798</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853734</td>
<td style="text-align: left;">thyroid gland cribriform morular carcinoma</td>
<td style="text-align: left;">NCIT:C126408</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Cribriform Morular Carcinoma</td>
<td style="text-align: left;">A thyroid gland carcinoma characterized by the presence of cribriform, trabecular, follicular, papillary, and solid growth patterns and squamoid morulae formation. It may occur with familial adenomatous polyposis or sporadically.</td>
<td style="text-align: left;">MONDO:0015075</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853735</td>
<td style="text-align: left;">thyroid gland papillary carcinoma with fibromatosis/fasciitis-like/desmoid-type stroma</td>
<td style="text-align: left;">NCIT:C126410</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like/Desmoid-Type Stroma</td>
<td style="text-align: left;">A rare morphologic variant of papillary thyroid gland carcinoma characterized by the presence of abundant and cellular stroma resembling nodular fasciitis, fibromatosis, or other proliferative myofibroblastic processes. (WHO)</td>
<td style="text-align: left;">MONDO:0005075</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853742</td>
<td style="text-align: left;">broad ligament serous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C126479</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Broad Ligament Serous Adenocarcinoma</td>
<td style="text-align: left;">A rare serous adenocarcinoma that arises from the broad ligament.</td>
<td style="text-align: left;">MONDO:0002741,MONDO:0005278</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853743</td>
<td style="text-align: left;">oropharyngeal poorly differentiated carcinoma</td>
<td style="text-align: left;">NCIT:C126750</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oropharyngeal Poorly Differentiated Carcinoma</td>
<td style="text-align: left;">A high-grade carcinoma that arises from the oropharynx. It is characterized by the presence of malignant cells which bear minimal resemblance to the cells from which they arose.</td>
<td style="text-align: left;">MONDO:0044704</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853745</td>
<td style="text-align: left;">endometrial dedifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C126769</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endometrial Dedifferentiated Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the endometrium and is characterized by the presence of an undifferentiated carcinomatous component and a second component of either FIGO grade 1 or 2 endometrioid carcinoma.</td>
<td style="text-align: left;">MONDO:0002447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853748</td>
<td style="text-align: left;">uterine corpus hydropic leiomyoma</td>
<td style="text-align: left;">NCIT:C126975</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Hydropic Leiomyoma</td>
<td style="text-align: left;">A variant of leiomyoma arising from the uterine corpus. It is characterized by conspicuous zonal edema. Hyalinization may also be present.</td>
<td style="text-align: left;">MONDO:0007886</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853749</td>
<td style="text-align: left;">uterine corpus high grade endometrial stromal sarcoma</td>
<td style="text-align: left;">NCIT:C126998</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus High Grade Endometrial Stromal Sarcoma</td>
<td style="text-align: left;">A rare, high-grade sarcoma that arises from the endometrial stroma. It is characterized by round cell morphology. It was previously also known as undifferentiated uterine sarcoma. In 2014, high grade endometrial stromal sarcoma was reclassified and is currently considered a distinct and rare neoplasm. It appears to have a prognosis that falls between low grade endometrial stromal sarcoma and undifferentiated sarcoma.</td>
<td style="text-align: left;">MONDO:0002923</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853751</td>
<td style="text-align: left;">benign uterine corpus pecoma</td>
<td style="text-align: left;">NCIT:C127071</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Uterine Corpus PEComa</td>
<td style="text-align: left;">A benign neoplasm with perivascular epithelioid cell differentiation arising from the uterine corpus. It is characterized by the absence of pleomorphism and scarcity or absence of mitotic figures. It usually affects perimenopausal women. Patients present with a pelvic mass or abnormal bleeding.</td>
<td style="text-align: left;">MONDO:0004221,MONDO:0020581,MONDO:0021525</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853753</td>
<td style="text-align: left;">uterine corpus germ cell tumor</td>
<td style="text-align: left;">NCIT:C127077</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Germ Cell Tumor</td>
<td style="text-align: left;">A benign or malignant germ cell tumor that arises from the uterine corpus. Representative examples include teratoma and yolk sac tumor.</td>
<td style="text-align: left;">MONDO:0021254,MONDO:0018201</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853764</td>
<td style="text-align: left;">cervical neuroendocrine neoplasm</td>
<td style="text-align: left;">NCIT:C128041</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Neuroendocrine Neoplasm</td>
<td style="text-align: left;">A neuroendocrine neoplasm that arises from the cervix. This category includes neuroendocrine tumor grade 1, neuroendocrine tumor grade 2, and neuroendocrine carcinoma (small cell and large cell neuroendocrine carcinoma).</td>
<td style="text-align: left;">MONDO:0019496,MONDO:0021230</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853771</td>
<td style="text-align: left;">vaginal papillary carcinoma</td>
<td style="text-align: left;">NCIT:C128060</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Papillary Carcinoma</td>
<td style="text-align: left;">A rare squamous cell carcinoma that arises from the vagina resembling transitional cell carcinoma of the urinary tract.</td>
<td style="text-align: left;">MONDO:0002979,MONDO:0006490</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853775</td>
<td style="text-align: left;">ovarian cancer by figo stage 2014</td>
<td style="text-align: left;">NCIT:C128081</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Cancer by FIGO Stage 2014</td>
<td style="text-align: left;">A category of staging terms for ovarian cancer according to the International Federation of Gynecology and Obstetrics (FIGO), 2014. AJCC ovarian cancer stage terms from the 6th and 7th editions that are synonymous to the FIGO ovarian cancer staging classification of 2014 are included as preferred terms.</td>
<td style="text-align: left;">MONDO:0005140</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853776</td>
<td style="text-align: left;">ovarian cancer by ajcc v6 and v7 stage</td>
<td style="text-align: left;">NCIT:C128106</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Cancer by AJCC v6 and v7 Stage</td>
<td style="text-align: left;">A category of staging terms for ovarian cancer according to the American Joint Committee on cancer (AJCC) 6th and 7th editions. International Federation of Gynecology and Obstetrics (FIGO) ovarian cancer staging terms prior to 2014 are included in this category if synonymous with the AJCC terms.</td>
<td style="text-align: left;">MONDO:0005140</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853779</td>
<td style="text-align: left;">vaginal germ cell tumor</td>
<td style="text-align: left;">NCIT:C128112</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Germ Cell Tumor</td>
<td style="text-align: left;">A germ tumor that arises from the vagina.</td>
<td style="text-align: left;">MONDO:0005040,MONDO:0021050</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853781</td>
<td style="text-align: left;">vulvar squamous intraepithelial lesion, hpv-associated</td>
<td style="text-align: left;">NCIT:C128142</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Squamous Intraepithelial Lesion, HPV-Associated</td>
<td style="text-align: left;">An intraepithelial lesion of the vulvar squamous epithelium associated with HPV infection. It is characterized by maturation abnormalities and nuclear hyperchromasia that are confined to the basement membrane.</td>
<td style="text-align: left;">MONDO:0005198</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853784</td>
<td style="text-align: left;">vulvar adenocarcinoma of mammary gland type</td>
<td style="text-align: left;">NCIT:C128162</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Adenocarcinoma of Mammary Gland Type</td>
<td style="text-align: left;">A rare adenocarcinoma that arises from the vulva and is characterized by the presence of morphological features identical to those seen in breast adenocarcinomas.</td>
<td style="text-align: left;">MONDO:0024336</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853787</td>
<td style="text-align: left;">vulvar mucinous adenocarcinoma, intestinal-type</td>
<td style="text-align: left;">NCIT:C128166</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Mucinous Adenocarcinoma, Intestinal-Type</td>
<td style="text-align: left;">A rare vulvar mucinous adenocarcinoma that resembles a large intestinal adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0004957,MONDO:0024336,MONDO:0006254</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853835</td>
<td style="text-align: left;">b acute lymphoblastic leukemia, philadelphia chromosome negative</td>
<td style="text-align: left;">NCIT:C128629</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative</td>
<td style="text-align: left;">A B acute lymphoblastic leukemia (B-ALL) that does not have the cytogenetic abnormality t(9;22)(q34;q11.2). Most cases of B-ALL do not have this translocation.</td>
<td style="text-align: left;">MONDO:0020511</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853837</td>
<td style="text-align: left;">nk-cell lymphoma, unclassifiable</td>
<td style="text-align: left;">NCIT:C128697</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">NK-Cell Lymphoma, Unclassifiable</td>
<td style="text-align: left;">A very rare NK-cell lymphoma with pathologic and clinical features posing difficulty in its exact diagnosis and classification.</td>
<td style="text-align: left;">MONDO:0000430</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853840</td>
<td style="text-align: left;">hereditary melanoma with cdkn2a mutation</td>
<td style="text-align: left;">NCIT:C128801</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hereditary Melanoma with CDKN2A Mutation</td>
<td style="text-align: left;">A hereditary cutaneous melanoma caused by germline mutation(s) in the CDKN2A gene.</td>
<td style="text-align: left;">MONDO:0018961</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853846</td>
<td style="text-align: left;">glioblastoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C129295</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Glioblastoma, Not Otherwise Specified</td>
<td style="text-align: left;">A central nervous system tumor with morphological features of glioblastoma in which there is insufficient information on the IDH genes status.</td>
<td style="text-align: left;">MONDO:0018177</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853850</td>
<td style="text-align: left;">oligodendroglioma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C129319</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oligodendroglioma, Not Otherwise Specified</td>
<td style="text-align: left;">A central nervous system tumor with morphological features of oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.</td>
<td style="text-align: left;">MONDO:0016695</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853851</td>
<td style="text-align: left;">anaplastic oligodendroglioma, idh-mutant and 1p/19q-codeleted</td>
<td style="text-align: left;">NCIT:C129321</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted</td>
<td style="text-align: left;">An anaplastic oligodendroglioma carrying IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion).</td>
<td style="text-align: left;">MONDO:0016696</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853852</td>
<td style="text-align: left;">anaplastic oligodendroglioma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C129322</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Oligodendroglioma, Not Otherwise Specified</td>
<td style="text-align: left;">A central nervous system tumor with morphological features of anaplastic oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.</td>
<td style="text-align: left;">MONDO:0016696</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853853</td>
<td style="text-align: left;">oligoastrocytoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C129323</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oligoastrocytoma, Not Otherwise Specified</td>
<td style="text-align: left;">A central nervous system tumor with morphological features of oligoastrocytoma in which there is insufficient information on the IDH genes status.</td>
<td style="text-align: left;">MONDO:0016702</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853854</td>
<td style="text-align: left;">anaplastic oligoastrocytoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C129324</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Oligoastrocytoma, Not Otherwise Specified</td>
<td style="text-align: left;">A central nervous system tumor with morphological features of anaplastic oligoastrocytoma in which there is insufficient information on the IDH genes status.</td>
<td style="text-align: left;">MONDO:0016703</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853855</td>
<td style="text-align: left;">diffuse glioma</td>
<td style="text-align: left;">NCIT:C129325</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Glioma</td>
<td style="text-align: left;">A glioma that has diffusely infiltrated the surrounding central nervous system tissues.</td>
<td style="text-align: left;">MONDO:0021042</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853859</td>
<td style="text-align: left;">medulloblastoma molecular subtypes</td>
<td style="text-align: left;">NCIT:C129439</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Medulloblastoma Molecular Subtypes</td>
<td style="text-align: left;">A term that refers to the classification of medulloblastomas based on their molecular characteristics.</td>
<td style="text-align: left;">MONDO:0007959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853860</td>
<td style="text-align: left;">medulloblastoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C129447</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Medulloblastoma, Not Otherwise Specified</td>
<td style="text-align: left;">A medulloblastoma which has not been further characterized.</td>
<td style="text-align: left;">MONDO:0007959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853861</td>
<td style="text-align: left;">small cell adenocarcinoma</td>
<td style="text-align: left;">NCIT:C129449</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Cell Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma composed of small malignant cells.</td>
<td style="text-align: left;">MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853862</td>
<td style="text-align: left;">central nervous system solitary fibrous tumor</td>
<td style="text-align: left;">NCIT:C129526</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Solitary Fibrous Tumor</td>
<td style="text-align: left;">A mesenchymal, non-meningothelial neoplasm arising from the central nervous system. It is characterized by a collagenous and low cellularity spindle cell and/or hemangiopericytomatous histopathological pattern, recurrent intrachromosomal rearrangement on chromosome 12q that results in the fusion of the NAB2 and STAT6 genes, high recurrence rates, and long-term risk of systemic metastasis.</td>
<td style="text-align: left;">MONDO:0003244,MONDO:0016238</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853863</td>
<td style="text-align: left;">central nervous system mesenchymal chondrosarcoma</td>
<td style="text-align: left;">NCIT:C129534</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Mesenchymal Chondrosarcoma</td>
<td style="text-align: left;">A mesenchymal chondrosarcoma that arises from the central nervous system.</td>
<td style="text-align: left;">MONDO:0002217,MONDO:0006853</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853864</td>
<td style="text-align: left;">central nervous system epithelioid hemangioendothelioma</td>
<td style="text-align: left;">NCIT:C129536</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Epithelioid Hemangioendothelioma</td>
<td style="text-align: left;">A low-grade malignant blood vessel neoplasm that arises from the central nervous system.  It is characterized by the presence of epithelioid endothelial cells.</td>
<td style="text-align: left;">MONDO:0037740,MONDO:0015523</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853865</td>
<td style="text-align: left;">central nervous system angiolipoma</td>
<td style="text-align: left;">NCIT:C129538</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Angiolipoma</td>
<td style="text-align: left;">An angiolipoma that arises from the central nervous system.</td>
<td style="text-align: left;">MONDO:0003844,MONDO:0006085</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853866</td>
<td style="text-align: left;">central nervous system undifferentiated pleomorphic sarcoma</td>
<td style="text-align: left;">NCIT:C129566</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Undifferentiated Pleomorphic Sarcoma</td>
<td style="text-align: left;">A rare undifferentiated pleomorphic sarcoma (formerly known as malignant fibrous histiocytoma) involving the central nervous system.</td>
<td style="text-align: left;">MONDO:0002217,MONDO:0002142</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853868</td>
<td style="text-align: left;">primary central nervous system anaplastic large cell lymphoma, alk-positive</td>
<td style="text-align: left;">NCIT:C129598</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive</td>
<td style="text-align: left;">An anaplastic large cell lymphoma, ALK-positive, arising from the central nervous system.</td>
<td style="text-align: left;">MONDO:0006128,MONDO:0017602</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853869</td>
<td style="text-align: left;">primary central nervous system anaplastic large cell lymphoma, alk-negative</td>
<td style="text-align: left;">NCIT:C129599</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative</td>
<td style="text-align: left;">An anaplastic large cell lymphoma, ALK-negative, arising from the central nervous system.</td>
<td style="text-align: left;">MONDO:0006128,MONDO:0017603</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853870</td>
<td style="text-align: left;">central nervous system intravascular large b-cell lymphoma</td>
<td style="text-align: left;">NCIT:C129602</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Intravascular Large B-Cell Lymphoma</td>
<td style="text-align: left;">A rare extranodal B-cell non-Hodgkin lymphoma that affects the central nervous system.  It is characterized by the presence of lymphoma cells exclusively in the lumina of small vessels, particularly capillaries.</td>
<td style="text-align: left;">MONDO:0017596,MONDO:0020324</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853882</td>
<td style="text-align: left;">acute myeloid leukemia with monoallelic cebpa mutation</td>
<td style="text-align: left;">NCIT:C129783</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia with Monoallelic CEBPA Mutation</td>
<td style="text-align: left;">An acute myeloid leukemia with single mutations of the CEBPA gene.</td>
<td style="text-align: left;">MONDO:0017894</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853887</td>
<td style="text-align: left;">metastatic transitional cell carcinoma</td>
<td style="text-align: left;">NCIT:C129828</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Transitional Cell Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from transitional cells and has spread from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0024879,MONDO:0006474</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853888</td>
<td style="text-align: left;">chronic myelomonocytic leukemia with eosinophilia associated with t(5;12)(q31;p12)</td>
<td style="text-align: left;">NCIT:C129852</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12)(q31;p12)</td>
<td style="text-align: left;">Chronic myelomonocytic leukemia characterized by the presence of eosinophilia, PDGFRB gene rearrangement, and t(5;12)(q31;p12).</td>
<td style="text-align: left;">MONDO:0015690</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853892</td>
<td style="text-align: left;">chronic myelomonocytic leukemia-0</td>
<td style="text-align: left;">NCIT:C130035</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Myelomonocytic Leukemia-0</td>
<td style="text-align: left;">A chronic myelomonocytic leukemia characterized by the presence of less than 5 percent blasts in the bone marrow and less than 2 percent blasts in the peripheral blood.</td>
<td style="text-align: left;">MONDO:0020311</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853893</td>
<td style="text-align: left;">myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia</td>
<td style="text-align: left;">NCIT:C130037</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia</td>
<td style="text-align: left;">A myelodysplastic syndrome with ring sideroblasts and dysplastic changes involving only one myeloid cell lineage in the bone marrow.</td>
<td style="text-align: left;">MONDO:0019157</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853943</td>
<td style="text-align: left;">anastomosing hemangioma</td>
<td style="text-align: left;">NCIT:C131760</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anastomosing Hemangioma</td>
<td style="text-align: left;">An unusual variant of capillary hemangioma. It is characterized by a unique anastomosing sinusoidal-like architecture which may mimic angiosarcoma. It was originally described in the kidney but rare cases have been reported in other sites.</td>
<td style="text-align: left;">MONDO:0002407</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853956</td>
<td style="text-align: left;">acute megakaryoblastic leukemia with cbfa2t3-glis2</td>
<td style="text-align: left;">NCIT:C132109</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2</td>
<td style="text-align: left;">A non-Down syndrome acute megakaryoblastic leukemia that occurs in children. It is associated with CBFA2T3-GLIS2 chimeric oncogene and has an unfavorable prognosis.</td>
<td style="text-align: left;">MONDO:0004996</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853961</td>
<td style="text-align: left;">atypical pituitary neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C132296</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Pituitary Neuroendocrine Tumor</td>
<td style="text-align: left;">A usually aggressive and invasive pituitary neuroendocrine tumor characterized by excessive p53 immunoreactivity, increased mitotic activity, and MIB-1 proliferative index greater than 3%.</td>
<td style="text-align: left;">MONDO:0006373</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853963</td>
<td style="text-align: left;">lip and oral cavity cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C132728</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lip and Oral Cavity Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of lip and oral cavity carcinoma according to the American Joint Committee on Cancer, 8th edition.</td>
<td style="text-align: left;">MONDO:0023644</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853964</td>
<td style="text-align: left;">lip and oral cavity cancer by ajcc v6 and v7 stage</td>
<td style="text-align: left;">NCIT:C132736</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of lip and oral cavity carcinoma according to the American Joint Committee on Cancer, 6th and 7th editions.</td>
<td style="text-align: left;">MONDO:0023644</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853965</td>
<td style="text-align: left;">major salivary gland cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C132778</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Major Salivary Gland Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of major salivary gland cancer according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0006284</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853966</td>
<td style="text-align: left;">major salivary gland cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C132779</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Major Salivary Gland Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of major salivary gland cancer according to the American Joint Committee on Cancer, 8th edition.</td>
<td style="text-align: left;">MONDO:0006284</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853968</td>
<td style="text-align: left;">pharyngeal carcinoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C132814</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pharyngeal Carcinoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of pharyngeal carcinoma according to the American Joint Committee on Cancer, 8th edition.</td>
<td style="text-align: left;">MONDO:0021345</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853973</td>
<td style="text-align: left;">metastatic malignant germ cell tumor</td>
<td style="text-align: left;">NCIT:C132854</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Germ Cell Tumor</td>
<td style="text-align: left;">A malignant germ cell tumor that has spread from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0006290</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853979</td>
<td style="text-align: left;">sinonasal cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C133074</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sinonasal Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of nasal cavity and paranasal sinus carcinoma according to the American Joint Committee on Cancer, 8th edition.</td>
<td style="text-align: left;">MONDO:0056819</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853980</td>
<td style="text-align: left;">lung adenofibroma</td>
<td style="text-align: left;">NCIT:C133091</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Adenofibroma</td>
<td style="text-align: left;">A very rare benign neoplasm that arises from the lung. It is characterized by the presence of a stromal and an epithelial component. It resembles the adenofibromas that arise from the organs of the female reproductive system.</td>
<td style="text-align: left;">MONDO:0021043,MONDO:0002732</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853981</td>
<td style="text-align: left;">laryngeal cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C133156</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Laryngeal Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of laryngeal carcinoma according to the American Joint Committee on Cancer, 8th edition.</td>
<td style="text-align: left;">MONDO:0002358</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853986</td>
<td style="text-align: left;">esophageal cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C133399</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of esophageal carcinoma according to the American Joint Committee on Cancer, 8th edition.</td>
<td style="text-align: left;">MONDO:0019086</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853991</td>
<td style="text-align: left;">gastroesophageal junction adenocarcinoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C133548</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of gastroesophageal junction adenocarcinoma according to the American Joint Committee on Cancer, 8th edition.</td>
<td style="text-align: left;">MONDO:0003219</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853993</td>
<td style="text-align: left;">gastric cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C133638</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of gastric cancer according to the American Joint Committee on Cancer, 8th edition.</td>
<td style="text-align: left;">MONDO:0004950</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853994</td>
<td style="text-align: left;">small intestinal cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C133716</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of small intestinal cancer according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0005522</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853996</td>
<td style="text-align: left;">appendix carcinoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C133733</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Carcinoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of appendiceal carcinoma according to the American Joint Committee on Cancer, 7th edition. Carcinoid tumors are staged separately. (from AJCC 7th Ed.)</td>
<td style="text-align: left;">MONDO:0003196</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853997</td>
<td style="text-align: left;">anal canal cancer by ajcc v6 and v7 stage</td>
<td style="text-align: left;">NCIT:C133787</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anal Canal Cancer by AJCC v6 and v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of anal canal cancer according to the American Joint Committee on Cancer, 6th and 7th editions. This staging system applies to carcinomas arising in the anal canal only; melanomas, carcinoid tumors, sarcomas, and perianal tumors are not included. (from AJCC 6th and 7th Eds.)</td>
<td style="text-align: left;">MONDO:0007108</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0853998</td>
<td style="text-align: left;">anal cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C133794</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anal Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of anal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to all carcinomas arising in the anal canal, including carcinomas that arise within anorectal fistulas and those arising in the perianal area (anal margin). High-grade neuroendocrine carcinomas (small cell neuroendocrine carcinoma and large cell neuroendocrine carcinoma) are staged using this system. There is no AJCC staging system for anal mucosal melanomas and anal well-differentiated neuroendocrine tumors. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0003199</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854000</td>
<td style="text-align: left;">small intestinal adenocarcinoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C133893</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Adenocarcinoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of small intestinal adenocarcinoma according to the American Joint Committee on Cancer, 8th edition. Nonadenocarcinomas arising in the small intestine should have a TNM assigned but are not assigned a stage classification. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0003198</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854002</td>
<td style="text-align: left;">appendix carcinoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C134117</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Carcinoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of appendiceal carcinoma according to the American Joint Committee on Cancer, 8th edition. This staging system applies to carcinomas of the appendix, including high-grade neuroendocrine carcinomas, mixed adenoneuroendocrine carcinomas, and goblet cell carcinoids. Well-differentiated neuroendocrine tumors (carcinoids) are staged according to the classification for neuroendocrine tumors of the appendix. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0003196</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854009</td>
<td style="text-align: left;">colorectal cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C134180</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of colorectal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to adenocarcinomas, high-grade neuroendocrine carcinomas, and squamous cell carcinomas of the colon and rectum. Appendiceal carcinomas, anal carcinomas, and well-differentiated neuroendocrine tumors (carcinoids) are not covered by this staging system. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0024331</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854013</td>
<td style="text-align: left;">intrahepatic cholangiocarcinoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C134514</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intrahepatic Cholangiocarcinoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of intrahepatic cholangiocarcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0003210</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854014</td>
<td style="text-align: left;">hepatocellular carcinoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C134515</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatocellular Carcinoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of hepatocellular carcinoma according to the American Joint Committee on Cancer, 8th edition. This staging system applies to hepatocellular carcinomas and fibrolamellar carcinomas (fibrolamellar variant of hepatocellular carcinoma). Intrahepatic cholangiocarcinomas, combined hepatocellular-cholangiocarcinomas, and sarcomas of the liver are not staged using this staging system. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0007256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854017</td>
<td style="text-align: left;">intrahepatic bile duct cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C134604</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intrahepatic Bile Duct Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of intrahepatic bile duct cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to intrahepatic cholangiocarcinomas, combined hepatocellular-cholangiocarcinomas (mixed hepatocholangiocarcinomas), and primary neuroendocrine tumors of the liver. Primary sarcomas of the liver, pure hepatocellular carcinomas, hilar cholangiocarcinomas, and gallbladder carcinomas are not staged using this staging system. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0018531</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854018</td>
<td style="text-align: left;">gallbladder cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C134660</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of gallbladder cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to gallbladder carcinomas. Well-differentiated neuroendocrine tumors and sarcomas are not staged using this staging system. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0003220</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854019</td>
<td style="text-align: left;">hilar cholangiocarcinoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C134742</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hilar Cholangiocarcinoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of hilar cholangiocarcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0003345</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854020</td>
<td style="text-align: left;">hilar cholangiocarcinoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C134743</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hilar Cholangiocarcinoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of hilar cholangiocarcinoma according to the American Joint Committee on Cancer, 8th edition. Hilar well-differentiated neuroendocrine tumors and sarcomas are not staged using this staging system. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0003345</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854022</td>
<td style="text-align: left;">distal bile duct cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C134810</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Distal Bile Duct Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of distal bile duct cancer according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0003707</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854023</td>
<td style="text-align: left;">distal bile duct cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C134811</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Distal Bile Duct Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of distal bile duct cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to bile duct adenocarcinomas, biliary intraepithelial neoplasia, high-grade neuroendocrine carcinomas, and papillary carcinomas that arise from the distal bile duct. Tumors arising in the ampulla of Vater, sarcomas, and well-differentiated neuroendocrine tumors (carcinoids) are not staged using this staging system. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0003707</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854025</td>
<td style="text-align: left;">ampulla of vater cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C134864</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ampulla of Vater Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of ampulla of Vater cancer according to the American Joint Committee on Cancer, 8th edition. This staging system does not apply to well-differentiated neuroendocrine (carcinoid) tumors but does apply to high-grade neuroendocrine carcinomas, such as small cell carcinoma and large cell neuroendocrine carcinoma. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0017590</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854029</td>
<td style="text-align: left;">lung non-squamous non-small cell carcinoma</td>
<td style="text-align: left;">NCIT:C135017</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Non-Squamous Non-Small Cell Carcinoma</td>
<td style="text-align: left;">A non-small cell lung carcinoma without evidence of squamous differentiation.</td>
<td style="text-align: left;">MONDO:0005233</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854030</td>
<td style="text-align: left;">gastric neuroendocrine tumor by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C135045</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Neuroendocrine Tumor by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of a gastric neuroendocrine tumor according to the American Joint Committee on Cancer, 8th edition. This staging system applies to gastric "carcinoid" tumors (NET G1 and G2, and rare well-differentiated G3). Gastric high-grade neuroendocrine carcinoma and gastric mixed adenoneuroendocrine carcinoma are not included in this staging system. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0015062</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854031</td>
<td style="text-align: left;">duodenal neuroendocrine tumor by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C135075</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Duodenal Neuroendocrine Tumor by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of a duodenal neuroendocrine tumor according to the American Joint Committee on Cancer, 8th edition. This staging system applies to well-differentiated neuroendocrine tumors of the duodenum. Carcinomas of the duodenum, including high-grade (grade 3), poorly differentiated neuroendocrine carcinomas are not included in this staging system. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0015063</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854032</td>
<td style="text-align: left;">jejunal neuroendocrine tumor by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C135119</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Jejunal Neuroendocrine Tumor by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of a jejunal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This classification system applies to small bowel "carcinoid" tumors (NET G1 and G2, and rare well-differentiated G3) arising in the jejunum. This classification system does not apply to high-grade neuroendocrine carcinomas, mixed adenoneuroendocrine carcinomas, and neuroendocrine tumors of the duodenum. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0015064</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854033</td>
<td style="text-align: left;">ileal neuroendocrine tumor by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C135124</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ileal Neuroendocrine Tumor by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of an ileal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This classification system applies to small bowel "carcinoid" tumors (NET G1 and G2, and rare well-differentiated G3) arising in the ileum. This classification system does not apply to high-grade neuroendocrine carcinomas, mixed adenoneuroendocrine carcinomas, and neuroendocrine tumors of the duodenum. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0015065</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854034</td>
<td style="text-align: left;">digestive system neuroendocrine tumor by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C135129</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Digestive System Neuroendocrine Tumor by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of a digestive system neuroendocrine tumor, following the rules of the TNM AJCC v7 classification system.</td>
<td style="text-align: left;">MONDO:0000386</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854036</td>
<td style="text-align: left;">appendix neuroendocrine tumor by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C135156</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Neuroendocrine Tumor by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of an appendiceal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This staging system applies to appendiceal NETs (carcinoid tumors) (NET G1 and G2, and rare well-differentiated G3). High-grade neuroendocrine carcinomas (NEC), goblet cell carcinoids, mixed adenocarcinomas, and adenocarcinomas of the appendix are not staged using this staging system. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0015066</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854042</td>
<td style="text-align: left;">pancreatic neuroendocrine tumor by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C135560</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Neuroendocrine Tumor by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of a pancreatic neuroendocrine tumor, following the American Joint Committee on Cancer (AJCC) v8 staging guidelines. This staging system applies to well-differentiated neuroendocrine tumors arising in the pancreas. Carcinomas of the pancreas, including high-grade (grade 3), poorly differentiated neuroendocrine carcinomas are not staged using this staging system. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0019954</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854043</td>
<td style="text-align: left;">thymus epithelial neoplasm by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C136320</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thymus Epithelial Neoplasm by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of a thymus epithelial neoplasm, following the rules of the TNM AJCC v8 classification system. This staging system applies to thymomas, thymus carcinomas, thymus neuroendocrine tumors, and combined thymus carcinomas. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0018079</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854045</td>
<td style="text-align: left;">pleural malignant mesothelioma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C136374</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pleural Malignant Mesothelioma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of pleural malignant mesothelioma, following the rules of the TNM AJCC v7 classification system.</td>
<td style="text-align: left;">MONDO:0005112</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854046</td>
<td style="text-align: left;">pleural malignant mesothelioma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C136399</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pleural Malignant Mesothelioma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of pleural malignant mesothelioma, following the rules of the TNM AJCC v8 classification system. This staging system applies to pleural diffuse malignant mesothelioma only. Localized pleural malignant mesotheliomas and other primary tumors of the pleura are not staged using this staging system. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0005112</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854048</td>
<td style="text-align: left;">lung cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C136467</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of lung cancer, following the rules of the TNM AJCC v8 classification system. This staging system derives from analyses of the new retrospective and prospective databases of the International Association for the Study of Lung Cancer (IASLC). These databases contain information on patients diagnosed with lung cancer from 1999 to 2010 originating from 35 different databases in 16 countries around the world. This staging system applies to carcinomas of the lung, including non-small cell and small cell carcinomas, and bronchopulmonary carcinoid tumors. It does not apply to sarcomas or other rare tumors of the lung. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0005138</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854057</td>
<td style="text-align: left;">bone cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C136610</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of bone cancer, following the rules of the TNM AJCC v7 classification system.</td>
<td style="text-align: left;">MONDO:0002129</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854058</td>
<td style="text-align: left;">bone cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C136612</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of appendicular skeleton, trunk, skull, and facial bones cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to osteosarcoma, chondrosarcoma, Ewing sarcoma, spindle cell sarcoma, hemangioendothelioma, angiosarcoma, fibrosarcoma/myofibroid sarcoma, chordoma, adamantinoma, and other cancers arising in the bone. It does not apply to primary malignant lymphoma of the bone and multiple myeloma. There are no AJCC prognostic stage groupings for spine and pelvis. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0002129</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854060</td>
<td style="text-align: left;">soft tissue sarcoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C136693</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Soft Tissue Sarcoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of soft tissue sarcoma, following the rules of the TNM AJCC v8 classification system.</td>
<td style="text-align: left;">MONDO:0018078</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854061</td>
<td style="text-align: left;">soft tissue sarcoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C136707</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Soft Tissue Sarcoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system.</td>
<td style="text-align: left;">MONDO:0018078</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854062</td>
<td style="text-align: left;">uterine corpus sarcoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C136708</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Sarcoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of uterine corpus sarcoma, following the rules of the TNM AJCC v7 classification system.</td>
<td style="text-align: left;">MONDO:0005210</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854063</td>
<td style="text-align: left;">invasive lung mucinous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C136709</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Lung Mucinous Adenocarcinoma</td>
<td style="text-align: left;">An invasive adenocarcinoma that arises from the lung. It is characterized by the presence of tall columnar cells and mucin production. This category refers to cases formerly classified as mucinous bronchioloalveolar carcinoma, excluding cases that meet the criteria for adenocarcinoma in situ or mucinous minimally invasive adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0040677,MONDO:0005061,MONDO:0004957</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854064</td>
<td style="text-align: left;">lung enteric adenocarcinoma</td>
<td style="text-align: left;">NCIT:C136710</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Enteric Adenocarcinoma</td>
<td style="text-align: left;">A well-differentiated adenocarcinoma located in the lung periphery. It resembles colorectal adenocarcinoma with acinar and/or cribriform architecture and papillotubular structures.</td>
<td style="text-align: left;">MONDO:0006254,MONDO:0005061</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854065</td>
<td style="text-align: left;">lung keratinizing squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C136713</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Keratinizing Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell lung carcinoma characterized by the presence of keratinization, pearl formation, and/or intercellular bridges.</td>
<td style="text-align: left;">MONDO:0005097</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854067</td>
<td style="text-align: left;">lung non-mucinous adenocarcinoma in situ</td>
<td style="text-align: left;">NCIT:C136716</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Non-Mucinous Adenocarcinoma In Situ</td>
<td style="text-align: left;">Lung adenocarcinoma in situ characterized by the presence of type II pneumocyte and/or Clara cell differentiation. Almost all cases of lung adenocarcinoma in situ are non-mucinous.</td>
<td style="text-align: left;">MONDO:0000503</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854068</td>
<td style="text-align: left;">lung mucinous adenocarcinoma in situ</td>
<td style="text-align: left;">NCIT:C136717</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Mucinous Adenocarcinoma In Situ</td>
<td style="text-align: left;">A very rare lung adenocarcinoma in situ variant characterized by the presence of tall columnar cells with basal nuclei and abundant cytoplasmic mucin.</td>
<td style="text-align: left;">MONDO:0000503</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854069</td>
<td style="text-align: left;">lung squamous cell carcinoma in situ</td>
<td style="text-align: left;">NCIT:C136719</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Squamous Cell Carcinoma In Situ</td>
<td style="text-align: left;">A preinvasive bronchial neoplastic lesion affecting the squamous epithelium. It is characterized by the absence of progression of maturation from base to luminal surface, basilar zone expansion with cellular crowding throughout the epithelium, absence of the intermediate zone, and surface flattening confined to the most superficial cells. The nuclear-to-cytoplasmic ratio is often high and variable, the chromatin is coarse and uneven, and mitotic figures are present through full thickness. The cell size may be markedly increased. Anisocytosis and pleomorphism may be present. (Adapted from WHO, 2015)</td>
<td style="text-align: left;">MONDO:0005097,MONDO:0004693</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854075</td>
<td style="text-align: left;">cutaneous melanoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C137645</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Melanoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system. This staging system does not apply to melanoma of the conjunctiva, melanoma of the uvea, mucosal melanoma arising in the head and neck, and mucosal melanoma of the urethra, vagina, rectum, and anus. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854076</td>
<td style="text-align: left;">occult breast carcinoma</td>
<td style="text-align: left;">NCIT:C137674</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Occult Breast Carcinoma</td>
<td style="text-align: left;">Breast carcinoma presenting with isolated axillary lymphadenopathy, without clinical or mammographic evidence of breast tumor.</td>
<td style="text-align: left;">MONDO:0004989</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854077</td>
<td style="text-align: left;">breast pleomorphic lobular carcinoma in situ</td>
<td style="text-align: left;">NCIT:C137839</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Pleomorphic Lobular Carcinoma In Situ</td>
<td style="text-align: left;">Breast lobular carcinoma in situ characterized by the presence of neoplastic large cells with marked nuclear pleomorphism.</td>
<td style="text-align: left;">MONDO:0006270</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854089</td>
<td style="text-align: left;">prostate carcinoma by gene expression profile</td>
<td style="text-align: left;">NCIT:C138167</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Carcinoma by Gene Expression Profile</td>
<td style="text-align: left;">A header term that includes the following prostate carcinoma subtypes determined by gene expression profiling: luminal A prostate carcinoma, luminal B prostate carcinoma, and basal-like prostate carcinoma.</td>
<td style="text-align: left;">MONDO:0005159</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854092</td>
<td style="text-align: left;">high grade b-cell lymphoma with myc and bcl2 and/or bcl6 rearrangements</td>
<td style="text-align: left;">NCIT:C138195</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements</td>
<td style="text-align: left;">High-grade B-cell lymphoma characterized by the abnormal rearrangement of MYC gene, BCL2 gene, and/or BCL6 gene. Patients with this type of lymphoma usually respond poorly to standard treatments and have a poor prognosis.</td>
<td style="text-align: left;">MONDO:0044889</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854094</td>
<td style="text-align: left;">double-expressor lymphoma</td>
<td style="text-align: left;">NCIT:C138899</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Double-Expressor Lymphoma</td>
<td style="text-align: left;">A diffuse large B-cell lymphoma characterized by double expression of MYC and BCL2 proteins without MYC and BCL2 gene aberrations. These lymphomas may have a worse prognosis than other diffuse large B-cell lymphomas, not otherwise specified, but they are not as aggressive as the high-grade B-cell lymphomas, with rearrangements of MYC and BCL2 and/or BCL6 genes.</td>
<td style="text-align: left;">MONDO:0018905</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854097</td>
<td style="text-align: left;">follicular helper t-cell lymphoma</td>
<td style="text-align: left;">NCIT:C139005</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Follicular Helper T-Cell Lymphoma</td>
<td style="text-align: left;">A group of node-based peripheral T-cell lymphomas with phenotypic features of T follicular helper (TFH) cells. This category includes the following: follicular helper T-cell lymphoma, angioimmunoblastic-type; follicular helper T-cell lymphoma, follicular-type; and follicular helper T-cell lymphoma, not otherwise specified.</td>
<td style="text-align: left;">MONDO:0000430</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854098</td>
<td style="text-align: left;">multiple myeloma myeloma by ds stage</td>
<td style="text-align: left;">NCIT:C139008</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multiple Myeloma Myeloma by DS Stage</td>
<td style="text-align: left;">A header term that refers to the staging of multiple myeloma according to the Durie/Salmon staging system.</td>
<td style="text-align: left;">MONDO:0009693</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854099</td>
<td style="text-align: left;">multiple myeloma by iss stage</td>
<td style="text-align: left;">NCIT:C139009</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multiple Myeloma by ISS Stage</td>
<td style="text-align: left;">A header term that refers to the staging of multiple myeloma according to the International Staging System.</td>
<td style="text-align: left;">MONDO:0009693</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854100</td>
<td style="text-align: left;">type d lymphomatoid papulosis</td>
<td style="text-align: left;">NCIT:C139014</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Type D Lymphomatoid Papulosis</td>
<td style="text-align: left;">A variant of lymphomatoid papulosis which mimics primary cutaneous aggressive epidermotropic CD8-positive cytotoxic T-cell lymphoma.</td>
<td style="text-align: left;">MONDO:0020326</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854101</td>
<td style="text-align: left;">type e lymphomatoid papulosis</td>
<td style="text-align: left;">NCIT:C139015</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Type E Lymphomatoid Papulosis</td>
<td style="text-align: left;">A variant of lymphomatoid papulosis characterized by the presence of atypical lymphocytes which exhibited distinct angioinvasion.</td>
<td style="text-align: left;">MONDO:0020326</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854102</td>
<td style="text-align: left;">lymphomatoid papulosis with dusp22-irf4 gene rearrangement</td>
<td style="text-align: left;">NCIT:C139017</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lymphomatoid Papulosis with DUSP22-IRF4 Gene Rearrangement</td>
<td style="text-align: left;">A variant of lymphomatoid papulosis associated with chromosomal rearrangements involving the DUSP22-IRF4 locus at 6p25.3.</td>
<td style="text-align: left;">MONDO:0020326</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854105</td>
<td style="text-align: left;">breast cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C139532</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of breast cancer, following the rules of the TNM AJCC v8 classification system. It applies to invasive (infiltrating) carcinoma of the breast and ductal carcinoma in situ of the breast. It does not apply to breast sarcoma, phyllodes tumor, and breast lymphoma. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0004989</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854108</td>
<td style="text-align: left;">fibroadenoma of anogenital mammary-type glands</td>
<td style="text-align: left;">NCIT:C139547</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fibroadenoma of Anogenital Mammary-Type Glands</td>
<td style="text-align: left;">A benign epithelial-stromal neoplasm that arises from the perineum and resembles the breast fibroadenoma.</td>
<td style="text-align: left;">MONDO:0000383,MONDO:0021045</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854109</td>
<td style="text-align: left;">vulvar composite hidradenoma papilliferum and fibroadenoma</td>
<td style="text-align: left;">NCIT:C139548</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Composite Hidradenoma Papilliferum and Fibroadenoma</td>
<td style="text-align: left;">A benign composite neoplasm that arises from the vulva and is characterized by mixed histopathologic features of hidradenoma papilliferum and fibroadenoma.</td>
<td style="text-align: left;">MONDO:0021043,MONDO:0000643</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854111</td>
<td style="text-align: left;">vulvar cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C139618</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of vulvar cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to all carcinomas of the vulva. Melanoma of the vulva is staged according to the classification for melanoma of the skin. (AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0005215</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854112</td>
<td style="text-align: left;">vaginal cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C139657</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of vaginal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to all carcinomas of the vagina. There is no AJCC staging system for mucosal melanoma of the vagina. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0015867</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854113</td>
<td style="text-align: left;">cervical cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C139733</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 8th edition.</td>
<td style="text-align: left;">MONDO:0005131</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854114</td>
<td style="text-align: left;">uterine corpus carcinoma or carcinosarcoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C139801</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of uterine corpus cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to carcinomas and carcinosarcomas. It does not apply to uterine corpus sarcomas: leiomyosarcomas, endometrial stromal sarcomas, and adenosarcomas. These sarcomas are staged according to the classification for uterine corpus sarcomas. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0006003</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854115</td>
<td style="text-align: left;">uterine corpus sarcoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C139869</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Sarcoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of uterine corpus sarcoma according to the American Joint Committee on Cancer, 8th edition. This staging system applies to leiomyosarcomas, endometrial stromal sarcomas, and adenosarcomas of the uterine corpus. It does not apply to carcinosarcomas which are staged according to the carcinomas and carcinosarcomas of the uterine corpus. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0005210</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854119</td>
<td style="text-align: left;">ovarian cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C139963</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of ovarian cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to ovarian carcinomas. Nonepithelial primary ovarian cancers may be staged using this classification but should be reported separately. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0005140</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854120</td>
<td style="text-align: left;">fallopian tube cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C139983</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fallopian Tube Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of fallopian tube cancer according to the American Joint Committee on Cancer, 8th edition.</td>
<td style="text-align: left;">MONDO:0006206</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854121</td>
<td style="text-align: left;">primary peritoneal cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C140003</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Peritoneal Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of primary peritoneal cancer according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0015686</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854122</td>
<td style="text-align: left;">primary peritoneal cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C140004</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Peritoneal Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of primary peritoneal cancer according to the American Joint Committee on Cancer, 8th edition.</td>
<td style="text-align: left;">MONDO:0015686</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854123</td>
<td style="text-align: left;">gestational trophoblastic tumor by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C140032</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gestational Trophoblastic Tumor by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of gestational trophoblastic tumor according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0018944</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854124</td>
<td style="text-align: left;">penile cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C140075</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of penile cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to penile squamous cell carcinoma and associated histologic subtypes. It does not apply to urethral carcinomas, sarcomas, and melanomas. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0006360</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854125</td>
<td style="text-align: left;">prostate cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C140163</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of prostate cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to adenocarcinomas and squamous cell carcinomas of the prostate gland. It does not apply to sarcomas, urothelial cell carcinomas, and urothelial carcinoma of bladder involving prostate. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0005159</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854126</td>
<td style="text-align: left;">testicular cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C140225</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of testicular cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to postpubertal germ cell tumors of the testis and malignant sex cord-stromal tumors of the testis. It does not apply to spermatocytic tumors (no AJCC staging system), nonmalignant sex cord-/gonadal -stromal tumors (no AJCC staging system), prepubertal germ cell tumors (no AJCC staging system), hematolymphoid tumors (hematologic malignancies staging system), and paratesticular neoplasms (no AJCC staging system).  (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0005447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854127</td>
<td style="text-align: left;">testicular cancer by ajcc v6 and v7 stage</td>
<td style="text-align: left;">NCIT:C140241</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Cancer by AJCC v6 and v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of testicular cancer according to the American Joint Committee on Cancer, 6th and 7th editions.</td>
<td style="text-align: left;">MONDO:0005447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854128</td>
<td style="text-align: left;">renal cell cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C140322</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renal Cell Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of kidney cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to carcinomas arising in the kidney. It does not apply to urothelial carcinomas (are staged according to the classification for renal pelvis and ureter), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), sarcomas (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs), and Wilms tumor (no AJCC staging system). (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0005549</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854130</td>
<td style="text-align: left;">renal pelvis and ureter cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C140355</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renal Pelvis and Ureter Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of renal pelvis and ureter cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to renal pelvis and ureter urothelial (transitional cell) carcinoma, including histologic variants micropapillary and nested subtypes. It does not apply to renal cell carcinomas (are staged according to the classification for kidney), renal medullary carcinomas (are staged according to the classification for kidney), collecting duct carcinomas (are staged according to the classification for kidney),  lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and mesenchymal tumors (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs). (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0020654</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854134</td>
<td style="text-align: left;">renal pelvis and ureter cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C140376</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renal Pelvis and Ureter Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of renal pelvis and ureter cancer according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0020654</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854137</td>
<td style="text-align: left;">bladder cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C140416</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of bladder cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to carcinomas arising in the bladder. The typical carcinoma of the bladder is urothelial carcinoma. These carcinomas may include other histologic elements, including adenocarcinoma, squamous cell carcinoma, and small cell neuroendocrine carcinoma, but should be classified as urothelial unless the cancer is composed entirely of the alternative histology. All histologic cell types that are derived primarily from the urinary bladder epithelium should follow this staging system. It does not apply to prostatic urothelial carcinomas (are staged according to the classification for urethra), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and sarcomas (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs).  (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0004986</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854139</td>
<td style="text-align: left;">urethral cancer by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C140457</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Urethral Cancer by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of urethral cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to urothelial (transitional cell), squamous, and glandular carcinomas of the urethra and to urothelial (transitional cell) carcinomas of the prostate and prostatic urethra. It does not apply to squamous cell carcinomas of the penile foreskin (are staged according to the classification for penis), primary urothelial carcinomas of the bladder with transmural involvement of the prostate (are staged according to the classification for urinary bladder), prostatic adenocarcinomas (are staged according to the classification for prostate), mucosal melanomas of the urethra (no AJCC staging system), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and sarcomas (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs).  (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0021327</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854141</td>
<td style="text-align: left;">urethral cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C140464</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Urethral Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of urethral cancer according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0021327</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854142</td>
<td style="text-align: left;">eyelid carcinoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C140511</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Carcinoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of eyelid carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0003876</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854143</td>
<td style="text-align: left;">eyelid carcinoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C140513</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Carcinoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of eyelid carcinoma according to the American Joint Committee on Cancer, 8th edition. This staging system applies to all primary carcinomas of the eyelid, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), sebaceous carcinoma, and other rare carcinomas, such as all varieties of sweat gland carcinoma (e.g., eccrine carcinoma). It does not apply to carcinomas of the head and neck with direct extension to eyelid (are staged according to the cutaneous squamous cell carcinomas of the head and neck), Merkel cell carcinomas of the eyelid (are staged according to the classification for Merkel cell carcinomas), and melanomas of the eyelid (are staged according to the classification for melanomas of the skin).  (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0003876</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854144</td>
<td style="text-align: left;">choroidal and ciliary body melanoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C140659</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Choroidal and Ciliary Body Melanoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of choroidal and ciliary body melanoma, following the rules of the TNM AJCC v8 classification system.</td>
<td style="text-align: left;">MONDO:0006486</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854145</td>
<td style="text-align: left;">uveal melanoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C140672</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uveal Melanoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of uveal melanoma, following the rules of the TNM AJCC v7 classification system.</td>
<td style="text-align: left;">MONDO:0006486</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854146</td>
<td style="text-align: left;">retinoblastoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C140750</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Retinoblastoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of retinoblastoma according to the American Joint Committee on Cancer, 8th edition. This staging system does not apply to central nervous system component of "trilateral retinoblastoma" (is staged according to the classification for brain and spinal cord), retinoma (or retinocytoma) (no AJCC staging system), and medulloepithelioma (no AJCC staging system). (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0008380</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854148</td>
<td style="text-align: left;">differentiated thyroid gland carcinoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C140959</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of differentiated thyroid gland carcinoma, following the rules of the TNM AJCC v7 classification system.</td>
<td style="text-align: left;">MONDO:0015447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854150</td>
<td style="text-align: left;">differentiated thyroid gland carcinoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C140965</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of differentiated thyroid gland carcinoma, following the rules of the TNM AJCC v8 classification system.</td>
<td style="text-align: left;">MONDO:0015447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854153</td>
<td style="text-align: left;">thyroid gland anaplastic carcinoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C140999</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of thyroid gland anaplastic carcinoma, following the rules of the TNM AJCC v7 classification system.</td>
<td style="text-align: left;">MONDO:0006468</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854154</td>
<td style="text-align: left;">thyroid gland anaplastic carcinoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C141000</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of thyroid gland anaplastic carcinoma, following the rules of the TNM AJCC v8 classification system.</td>
<td style="text-align: left;">MONDO:0006468</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854155</td>
<td style="text-align: left;">thyroid gland medullary carcinoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C141041</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Medullary Carcinoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of thyroid gland medullary carcinoma, following the rules of the TNM AJCC v7 classification system.</td>
<td style="text-align: left;">MONDO:0015277</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854156</td>
<td style="text-align: left;">thyroid gland medullary carcinoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C141042</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Medullary Carcinoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of thyroid gland medullary carcinoma, following the rules of the TNM AJCC v8 classification system. Differentiated and anaplastic thyroid gland carcinomas are staged according to the classification for thyroid-differentiated and anaplastic carcinoma. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0015277</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854157</td>
<td style="text-align: left;">adrenal cortical carcinoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C141098</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Carcinoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of adrenal cortical carcinoma, following the rules of the TNM AJCC v7 classification system.</td>
<td style="text-align: left;">MONDO:0006639</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854158</td>
<td style="text-align: left;">adrenal cortical carcinoma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C141100</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Carcinoma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of adrenal cortical carcinoma, following the rules of the TNM AJCC v8 classification system. Adrenal medullary pheochromocytoma is staged according to the classification for adrenal neuroendocrine tumors. There is no AJCC staging system for neuroblastic tumors of the adrenal gland. (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0006639</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854159</td>
<td style="text-align: left;">adrenal gland pheochromocytoma and sympathetic paraganglioma by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C141128</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of adrenal gland pheochromocytoma and sympathetic paraganglioma, following the rules of the TNM AJCC v8 classification system. Parasympathetic paragangliomas are not staged because they are largely benign. This staging system does not apply to neuroendocrine tumors of the pancreas (are staged according to the classification for neuroendocrine tumors of the pancreas) and carotid body tumors (not staged). (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0021072</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854166</td>
<td style="text-align: left;">chronic lymphocytic leukemia- modified rai staging system</td>
<td style="text-align: left;">NCIT:C141206</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Lymphocytic Leukemia- Modified Rai Staging System</td>
<td style="text-align: left;">A term that refers to the staging of chronic lymphocytic leukemia according to modified Rai staging system. This system is mainly used in North America.</td>
<td style="text-align: left;">MONDO:0004948</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854167</td>
<td style="text-align: left;">chronic lymphocytic leukemia- binet staging system</td>
<td style="text-align: left;">NCIT:C141208</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Lymphocytic Leukemia- Binet Staging System</td>
<td style="text-align: left;">A term that refers to the staging of chronic lymphocytic leukemia according to Binet staging system. This system is in wide use outside the United States.</td>
<td style="text-align: left;">MONDO:0004948</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854189</td>
<td style="text-align: left;">multiple myeloma by riss stage</td>
<td style="text-align: left;">NCIT:C141393</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multiple Myeloma by RISS Stage</td>
<td style="text-align: left;">A staging system for multiple myeloma based on the Revised International Staging System (RISS) criteria. This staging system does not apply to smoldering multiple myeloma (no AJCC staging system), monoclonal gammopathy of undetermined significance (no AJCC staging system), and Waldenstrom macroglobulinemia (no AJCC staging system). (from AJCC 8th Ed.)</td>
<td style="text-align: left;">MONDO:0009693</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854192</td>
<td style="text-align: left;">thoracic nut carcinoma</td>
<td style="text-align: left;">NCIT:C142781</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thoracic NUT Carcinoma</td>
<td style="text-align: left;">A highly aggressive, poorly differentiated carcinoma that arises from the thoracic structures. It is characterized by mutations and rearrangement of the NUT gene. It usually presents at an advanced stage with pleuritic chest pain and pleural effusion, non-productive cough, shortness of breath, and weigh loss.</td>
<td style="text-align: left;">MONDO:0005563,MONDO:0003274</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854193</td>
<td style="text-align: left;">benign lung pecoma</td>
<td style="text-align: left;">NCIT:C142784</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Lung PEComa</td>
<td style="text-align: left;">A benign lung tumor that arises from perivascular epithelioid cells (PECs).</td>
<td style="text-align: left;">MONDO:0002732,MONDO:0020588,MONDO:0020581</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854200</td>
<td style="text-align: left;">pulmonary artery intimal sarcoma</td>
<td style="text-align: left;">NCIT:C142825</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pulmonary Artery Intimal Sarcoma</td>
<td style="text-align: left;">A sarcoma arising from the arterial intima of pulmonary arteries.</td>
<td style="text-align: left;">MONDO:0006255,MONDO:0002426</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854201</td>
<td style="text-align: left;">primary pulmonary myxoid sarcoma with ewsr1-creb1 fusion</td>
<td style="text-align: left;">NCIT:C142827</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Pulmonary Myxoid Sarcoma with EWSR1-CREB1 Fusion</td>
<td style="text-align: left;">A sarcoma that arises from the lung. It is related to a bronchus and is often predominantly endobronchial. It is characterized by the proliferation of round and spindle cells within a myxoid stroma. It is associated with the presence of an EWSR1::CREB1 fusion gene.</td>
<td style="text-align: left;">MONDO:0002426</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854212</td>
<td style="text-align: left;">refractory rhabdoid tumor</td>
<td style="text-align: left;">NCIT:C142858</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Rhabdoid Tumor</td>
<td style="text-align: left;">Rhabdoid tumor that does not respond to treatment.</td>
<td style="text-align: left;">MONDO:0002728,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854225</td>
<td style="text-align: left;">atypical type a thymoma</td>
<td style="text-align: left;">NCIT:C146640</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Type A Thymoma</td>
<td style="text-align: left;">A rare type A thymoma displaying atypical features (hypercellularity, increased mitotic activity, and focal necrosis).</td>
<td style="text-align: left;">MONDO:0002588</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854227</td>
<td style="text-align: left;">thymus hepatoid adenocarcinoma</td>
<td style="text-align: left;">NCIT:C146717</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thymus Hepatoid Adenocarcinoma</td>
<td style="text-align: left;">A very rare adenocarcinoma that arises from the thymus. It is characterized by the presence of malignant polygonal cells resembling hepatocytes.</td>
<td style="text-align: left;">MONDO:0006243,MONDO:0003209</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854229</td>
<td style="text-align: left;">malignant mediastinal germ cell tumor stage grouping of the pediatric study group</td>
<td style="text-align: left;">NCIT:C146848</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group</td>
<td style="text-align: left;">A term that refers to the staging of mediastinal malignant germ cell tumors according to the Pediatric Study Group staging criteria. This staging system is not an official UICC TNM classification. (WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart, 2015)</td>
<td style="text-align: left;">MONDO:0006298</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854230</td>
<td style="text-align: left;">metastatic epithelioid hemangioendothelioma</td>
<td style="text-align: left;">NCIT:C146858</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Epithelioid Hemangioendothelioma</td>
<td style="text-align: left;">An epithelioid hemangioendothelioma that has spread from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0015523,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854231</td>
<td style="text-align: left;">mediastinal mixed germ cell tumor</td>
<td style="text-align: left;">NCIT:C146861</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Mixed Germ Cell Tumor</td>
<td style="text-align: left;">A malignant germ cell tumor that arises from the mediastinum. It is characterized by the presence of at least two different germ cell tumor components. The different germ cell tumor components include choriocarcinoma, embryonal carcinoma, yolk sac tumor, teratoma, and seminoma.</td>
<td style="text-align: left;">MONDO:0006298,MONDO:0015864,MONDO:0005853</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854234</td>
<td style="text-align: left;">mediastinal epithelioid hemangioendothelioma</td>
<td style="text-align: left;">NCIT:C146988</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Epithelioid Hemangioendothelioma</td>
<td style="text-align: left;">An epithelioid hemangioendothelioma that arises from the mediastinum.</td>
<td style="text-align: left;">MONDO:0037743,MONDO:0015523</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854235</td>
<td style="text-align: left;">cardiac extraskeletal osteosarcoma</td>
<td style="text-align: left;">NCIT:C147003</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Extraskeletal Osteosarcoma</td>
<td style="text-align: left;">An extraskeletal osteosarcoma that arises from the heart. It produces osteoid and bone, and occasionally shows chondroblastic differentiation.</td>
<td style="text-align: left;">MONDO:0002621,MONDO:0003354</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854236</td>
<td style="text-align: left;">cardiac myxofibrosarcoma</td>
<td style="text-align: left;">NCIT:C147004</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Myxofibrosarcoma</td>
<td style="text-align: left;">A low-grade sarcoma that arises from the heart. It is composed of spindle or rounded cells in a myxoid stroma. The most common location is the left atrium.</td>
<td style="text-align: left;">MONDO:0019202,MONDO:0003742</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854237</td>
<td style="text-align: left;">cardiac yolk sac tumor</td>
<td style="text-align: left;">NCIT:C147006</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Yolk Sac Tumor</td>
<td style="text-align: left;">A yolk sac tumor that arises within the myocardium or cardiac chambers.</td>
<td style="text-align: left;">MONDO:0001991,MONDO:0005744</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854242</td>
<td style="text-align: left;">pericardial sarcoma</td>
<td style="text-align: left;">NCIT:C147098</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pericardial Sarcoma</td>
<td style="text-align: left;">A rare sarcoma that arises from the pericardium. The two most common types are angiosarcoma and synovial sarcoma. Patients present with symptoms related to pericardial effusion.</td>
<td style="text-align: left;">MONDO:0018078,MONDO:0001322</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854249</td>
<td style="text-align: left;">recurrent lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C147861</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Recurrent Lymphoproliferative Disorder</td>
<td style="text-align: left;">The reemergence of a lymphoproliferative disorder after a period of remission.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854250</td>
<td style="text-align: left;">oropharyngeal p16ink4a-negative squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C147906</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma</td>
<td style="text-align: left;">An oropharyngeal squamous cell carcinoma which is negative for p16INK4a by immunohistochemistry. This negative immunohistochemistry result does not exclude human papillomavirus infection.</td>
<td style="text-align: left;">MONDO:0044704</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854251</td>
<td style="text-align: left;">primary central nervous system b-cell non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C147948</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Central Nervous System B-Cell Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A B-cell non-Hodgkin lymphoma that arises from the brain, meninges, or spinal cord.</td>
<td style="text-align: left;">MONDO:0015759,MONDO:0044887</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854253</td>
<td style="text-align: left;">refractory melanoma</td>
<td style="text-align: left;">NCIT:C147983</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Melanoma</td>
<td style="text-align: left;">Melanoma that does not respond to treatment.</td>
<td style="text-align: left;">MONDO:0036501,MONDO:0005105</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854268</td>
<td style="text-align: left;">refractory round cell liposarcoma</td>
<td style="text-align: left;">NCIT:C148299</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Round Cell Liposarcoma</td>
<td style="text-align: left;">Round cell liposarcoma that does not respond to treatment.</td>
<td style="text-align: left;">MONDO:0005238</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854269</td>
<td style="text-align: left;">metastatic round cell liposarcoma</td>
<td style="text-align: left;">NCIT:C148300</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Round Cell Liposarcoma</td>
<td style="text-align: left;">Round cell liposarcoma that has spread to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0005238</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854270</td>
<td style="text-align: left;">refractory sarcoma</td>
<td style="text-align: left;">NCIT:C148301</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Sarcoma</td>
<td style="text-align: left;">A sarcoma that does not respond to treatment.</td>
<td style="text-align: left;">MONDO:0036501,MONDO:0005089</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854284</td>
<td style="text-align: left;">refractory leukemia</td>
<td style="text-align: left;">NCIT:C148426</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Leukemia</td>
<td style="text-align: left;">Leukemia that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0005059,MONDO:0004111</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854293</td>
<td style="text-align: left;">castration-naive prostate carcinoma</td>
<td style="text-align: left;">NCIT:C148536</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Castration-Naive Prostate Carcinoma</td>
<td style="text-align: left;">Advanced prostatic carcinoma which was not previously treated with androgen-deprivation therapy.</td>
<td style="text-align: left;">MONDO:0004956</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854294</td>
<td style="text-align: left;">thoracic esophagus adenocarcinoma</td>
<td style="text-align: left;">NCIT:C150027</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thoracic Esophagus Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma that arises from the thoracic esophagus.</td>
<td style="text-align: left;">MONDO:0005028,MONDO:0021325</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854295</td>
<td style="text-align: left;">thoracic esophagus squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C150029</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thoracic Esophagus Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the thoracic esophagus.</td>
<td style="text-align: left;">MONDO:0005580,MONDO:0021325</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854296</td>
<td style="text-align: left;">cervical esophagus adenocarcinoma</td>
<td style="text-align: left;">NCIT:C150031</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Esophagus Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma that arises from the cervical esophagus.</td>
<td style="text-align: left;">MONDO:0021326,MONDO:0005028</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854297</td>
<td style="text-align: left;">cervical esophagus squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C150032</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Esophagus Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the cervical esophagus.</td>
<td style="text-align: left;">MONDO:0021326,MONDO:0005580</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854298</td>
<td style="text-align: left;">gastric cardia squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C150034</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Cardia Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the gastric cardia.</td>
<td style="text-align: left;">MONDO:0003834,MONDO:0006230</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854317</td>
<td style="text-align: left;">high risk neuroblastoma</td>
<td style="text-align: left;">NCIT:C150281</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">High Risk Neuroblastoma</td>
<td style="text-align: left;">Neuroblastoma usually presenting with metastatic disease and MYCN gene amplifications.</td>
<td style="text-align: left;">MONDO:0005072</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854322</td>
<td style="text-align: left;">hhv8-related lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C150399</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">HHV8-Related Lymphoproliferative Disorder</td>
<td style="text-align: left;">A lymphoproliferative disorder caused by the human herpesvirus 8 (HHV8). This category includes the following: HHV8-positive multicentric Castleman disease; HHV8-positive diffuse large B-cell lymphoma, not otherwise specified; primary effusion lymphoma; and germinotropic lymphoproliferative disorders.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854323</td>
<td style="text-align: left;">hhv8-positive multicentric castleman disease</td>
<td style="text-align: left;">NCIT:C150404</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">HHV8-Positive Multicentric Castleman Disease</td>
<td style="text-align: left;">Multicentric Castleman disease associated with HHV8 infection.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854324</td>
<td style="text-align: left;">extracavitary primary effusion lymphoma</td>
<td style="text-align: left;">NCIT:C150406</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extracavitary Primary Effusion Lymphoma</td>
<td style="text-align: left;">A rare HHV8-positive B-cell lymphoma indistinguishable from primary effusion lymphoma presenting as solid tumor mass. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0018842</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854325</td>
<td style="text-align: left;">body cavity primary effusion lymphoma</td>
<td style="text-align: left;">NCIT:C150407</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Body Cavity Primary Effusion Lymphoma</td>
<td style="text-align: left;">A large B-cell lymphoma presenting as a serous effusion without detectable tumor masses. It is universally associated with human herpes virus 8 (HHV8), also called Kaposi sarcoma-associated herpesvirus.  It mostly occurs in the setting of immunodeficiency. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0018842</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854332</td>
<td style="text-align: left;">refractory malignant bone neoplasm</td>
<td style="text-align: left;">NCIT:C150525</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Bone Neoplasm</td>
<td style="text-align: left;">Malignant bone neoplasm that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0002129,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854334</td>
<td style="text-align: left;">refractory malignant female reproductive system neoplasm</td>
<td style="text-align: left;">NCIT:C150527</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Female Reproductive System Neoplasm</td>
<td style="text-align: left;">Malignant female reproductive system neoplasm that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0001416,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854335</td>
<td style="text-align: left;">refractory malignant neoplasm of multiple primary sites</td>
<td style="text-align: left;">NCIT:C150529</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Neoplasm of Multiple Primary Sites</td>
<td style="text-align: left;">Malignant neoplasm of multiple primary sites that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854339</td>
<td style="text-align: left;">refractory malignant male reproductive system neoplasm</td>
<td style="text-align: left;">NCIT:C150534</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Male Reproductive System Neoplasm</td>
<td style="text-align: left;">Malignant male reproductive system neoplasm that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0005836,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854340</td>
<td style="text-align: left;">refractory malignant mesothelioma</td>
<td style="text-align: left;">NCIT:C150535</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Mesothelioma</td>
<td style="text-align: left;">Malignant mesothelioma that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0006292,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854342</td>
<td style="text-align: left;">refractory malignant soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C150537</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Soft Tissue Neoplasm</td>
<td style="text-align: left;">Malignant soft tissue neoplasm that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0024637,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854347</td>
<td style="text-align: left;">refractory malignant urinary system neoplasm</td>
<td style="text-align: left;">NCIT:C150543</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Urinary System Neoplasm</td>
<td style="text-align: left;">Malignant urinary system neoplasm that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0006295,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854349</td>
<td style="text-align: left;">refractory malignant skin neoplasm</td>
<td style="text-align: left;">NCIT:C150546</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Skin Neoplasm</td>
<td style="text-align: left;">Malignant skin neoplasm that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0002898,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854350</td>
<td style="text-align: left;">prostate adenocarcinoma without neuroendocrine differentiation</td>
<td style="text-align: left;">NCIT:C150557</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Adenocarcinoma without Neuroendocrine Differentiation</td>
<td style="text-align: left;">A prostate adenocarcinoma characterized by the absence of focal or diffuse neuroendocrine differentiation.</td>
<td style="text-align: left;">MONDO:0005082</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854351</td>
<td style="text-align: left;">igm monoclonal gammopathy of undetermined significance</td>
<td style="text-align: left;">NCIT:C150566</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">IgM Monoclonal Gammopathy of Undetermined Significance</td>
<td style="text-align: left;">Monoclonal gammopathy of undetermined significance defined by a serum IgM paraprotein concentration less than 30g/L; bone marrow lymphoplasmacytic infiltration of less than 10%; and no evidence of anemia, constitutional symptoms, hyperviscocity, lymphadenopathy, hepatosplenomegaly, or other end-organ damage that can be attributed to the underlying lymphoproliferative disorder. It is a precursor condition that may progress to lymphoplasmacytic lymphoma/ Waldenstrom macroglobulinemia, other B-cell neoplasms, or primary amyloidosis. Progression to plasma cell myeloma occurs rarely, if at all. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0004225</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854352</td>
<td style="text-align: left;">invasive bladder carcinoma</td>
<td style="text-align: left;">NCIT:C150570</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Bladder Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the bladder mucosa and invades the bladder wall.</td>
<td style="text-align: left;">MONDO:0004986,MONDO:0040677</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854353</td>
<td style="text-align: left;">localized cerebral neoplasm</td>
<td style="text-align: left;">NCIT:C150573</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Localized Cerebral Neoplasm</td>
<td style="text-align: left;">A cerebral neoplasm that is confined to a specific site without evidence of spread to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0021632,MONDO:0021374</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854358</td>
<td style="text-align: left;">non-igm monoclonal gammopathy of undetermined significance</td>
<td style="text-align: left;">NCIT:C150588</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-IgM Monoclonal Gammopathy of Undetermined Significance</td>
<td style="text-align: left;">Monoclonal gammopathy of undetermined significance defined by the presence in the serum of an IgG, IgA, or (rarely) IgD paraprotein at a concentration of less than 30g/L; clonal bone marrow plasma cells less than 10%; and absence of end-organ damage such as hypercalcemia, renal insufficiency, anemia, bone marrow lesions, and amyloidosis attributable to the plasma cell proliferative disorder. The risk of progression to plasma cell myeloma, light-chain amyloidosis, or a related disorder is 1% per year. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0004225</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854359</td>
<td style="text-align: left;">testicular follicular lymphoma</td>
<td style="text-align: left;">NCIT:C150589</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Follicular Lymphoma</td>
<td style="text-align: left;">A distinctive variant of follicular lymphoma arising from the testis. It has been reported with higher frequency in children, but is also seen rarely in adults. It differs biologically from nodal follicular lymphoma because it lacks evidence of the BCL2 translocation. It is usually of high cytological grade, usually grade 3A, but has a good prognosis, even without additional therapy beyond surgical excision. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0001472,MONDO:0018906</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854363</td>
<td style="text-align: left;">metastatic malignant neoplasm in the viscera</td>
<td style="text-align: left;">NCIT:C150597</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Viscera</td>
<td style="text-align: left;">A malignant neoplasm which has spread from its original site of growth to any visceral site.</td>
<td style="text-align: left;">MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854376</td>
<td style="text-align: left;">tumors derived from langerhans cells</td>
<td style="text-align: left;">NCIT:C150692</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tumors Derived from Langerhans Cells</td>
<td style="text-align: left;">This category includes two main sub-groups, according to the degree of cytological atypia and clinical aggressiveness: Langerhans cell histiocytosis and Langerhans cell sarcoma. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0006247</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854377</td>
<td style="text-align: left;">langerhans cell histiocytosis, monostotic</td>
<td style="text-align: left;">NCIT:C150701</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Langerhans Cell Histiocytosis, Monostotic</td>
<td style="text-align: left;">Langerhans cell histiocytosis presenting as a solitary lesion.</td>
<td style="text-align: left;">MONDO:0018310</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854378</td>
<td style="text-align: left;">langerhans cell histiocytosis, polyostotic</td>
<td style="text-align: left;">NCIT:C150702</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Langerhans Cell Histiocytosis, Polyostotic</td>
<td style="text-align: left;">Langerhans cell histiocytosis presenting with multiple sites of involvement.</td>
<td style="text-align: left;">MONDO:0018310</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854379</td>
<td style="text-align: left;">langerhans cell histiocytosis, disseminated</td>
<td style="text-align: left;">NCIT:C150703</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Langerhans Cell Histiocytosis, Disseminated</td>
<td style="text-align: left;">Langerhans cell histiocytosis presenting with disseminated disease.</td>
<td style="text-align: left;">MONDO:0018310</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854381</td>
<td style="text-align: left;">transformed non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C151957</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Transformed Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">Histologic transformation of a usually indolent non-Hodgkin lymphoma to an aggressive non-Hodgkin lymphoma.</td>
<td style="text-align: left;">MONDO:0018908</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854382</td>
<td style="text-align: left;">acute leukemia of ambiguous lineage, not otherwise specified</td>
<td style="text-align: left;">NCIT:C151975</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified</td>
<td style="text-align: left;">Acute leukemia of ambiguous lineage, expressing combinations of markers that do not allow for its classification as either acute undifferentiated leukemia or mixed phenotype acute leukemia, and definitive classification along a single lineage is difficult. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0019460</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854389</td>
<td style="text-align: left;">mixed phenotype acute leukemia, rare types</td>
<td style="text-align: left;">NCIT:C151990</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mixed Phenotype Acute Leukemia, Rare Types</td>
<td style="text-align: left;">A very rare mixed phenotype acute leukemia in which the blasts express combinations of B, T, myeloid, and megakaryocytic lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.</td>
<td style="text-align: left;">MONDO:0020743</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854394</td>
<td style="text-align: left;">metastatic sarcoma</td>
<td style="text-align: left;">NCIT:C152076</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Sarcoma</td>
<td style="text-align: left;">A sarcoma that has spread from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0005089,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854395</td>
<td style="text-align: left;">refractory malignant head and neck neoplasm</td>
<td style="text-align: left;">NCIT:C152078</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Head and Neck Neoplasm</td>
<td style="text-align: left;">A malignant head and neck neoplasm that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0005627,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854414</td>
<td style="text-align: left;">refractory ewing sarcoma/peripheral primitive neuroectodermal tumor</td>
<td style="text-align: left;">NCIT:C153286</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor</td>
<td style="text-align: left;">A malignant small round cell tumor with or without neural differentiation that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0021038,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854420</td>
<td style="text-align: left;">metastatic chordoma</td>
<td style="text-align: left;">NCIT:C153323</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Chordoma</td>
<td style="text-align: left;">A chordoma that has spread from its original site of growth to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0008978</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854422</td>
<td style="text-align: left;">castration-sensitive prostate carcinoma</td>
<td style="text-align: left;">NCIT:C153336</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Castration-Sensitive Prostate Carcinoma</td>
<td style="text-align: left;">A prostate carcinoma that is sensitive to castration therapy.</td>
<td style="text-align: left;">MONDO:0005159</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854468</td>
<td style="text-align: left;">sinonasal poorly differentiated carcinoma</td>
<td style="text-align: left;">NCIT:C154324</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sinonasal Poorly Differentiated Carcinoma</td>
<td style="text-align: left;">A poorly differentiated carcinoma that arises from the nasal cavity and/or paranasal sinuses.</td>
<td style="text-align: left;">MONDO:0056819</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854469</td>
<td style="text-align: left;">densely granulated corticotroph pituitary neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C154339</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Densely Granulated Corticotroph Pituitary Neuroendocrine Tumor</td>
<td style="text-align: left;">A corticotroph pituitary neuroendocrine tumor composed of basophilic PAS-positive cells that are diffusely and strongly positive for ACTH, consistent with the abundance of secretory granules seen at the ultrastructural level. (WHO)</td>
<td style="text-align: left;">MONDO:0006068</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854470</td>
<td style="text-align: left;">sparsely granulated corticotroph pituitary neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C154340</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sparsely Granulated Corticotroph Pituitary Neuroendocrine Tumor</td>
<td style="text-align: left;">A corticotroph pituitary neuroendocrine tumor composed of faintly basophilic or chromophobic PAS-positive cells with weak or patchy positivity for ACTH, consistent with the scant, small secretory granules seen ultrastructurally. (WHO)</td>
<td style="text-align: left;">MONDO:0006068</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854471</td>
<td style="text-align: left;">crooke cell tumor</td>
<td style="text-align: left;">NCIT:C154342</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Crooke Cell Tumor</td>
<td style="text-align: left;">A corticotroph pituitary tumor composed of cells with Crooke hyaline change. Ring-like cytokeratin expression is typical of these neoplasms. ACTH expression is dislocated to the cell periphery and juxtanuclear region. Ultrastructurally, intermediate filaments are arranged in a ring-like pattern. (WHO)</td>
<td style="text-align: left;">MONDO:0006068</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854472</td>
<td style="text-align: left;">non-functioning corticotroph pituitary neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C154429</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Functioning Corticotroph Pituitary Neuroendocrine Tumor</td>
<td style="text-align: left;">Corticotroph pituitary neuroendocrine tumor not associated with a hormonal syndrome.</td>
<td style="text-align: left;">MONDO:0019613,MONDO:0006068</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854480</td>
<td style="text-align: left;">multiple synchronous pituitary neuroendocrine tumors of distinct lineages</td>
<td style="text-align: left;">NCIT:C154520</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multiple Synchronous Pituitary Neuroendocrine Tumors of Distinct Lineages</td>
<td style="text-align: left;">Multiple pituitary neuroendocrine tumors composed of adenohypopheseal cells of two or more lineages or a null cell tumor in combination with a lineage-specific pituitary neuroendocrine tumor in the same gland.</td>
<td style="text-align: left;">MONDO:0006373</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854485</td>
<td style="text-align: left;">cutaneous melanoma of the extremity</td>
<td style="text-align: left;">NCIT:C155305</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Melanoma of the Extremity</td>
<td style="text-align: left;">A cutaneous melanoma that arises from the upper or lower extremity.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854489</td>
<td style="text-align: left;">sarcoma of the extremity</td>
<td style="text-align: left;">NCIT:C155647</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sarcoma of the Extremity</td>
<td style="text-align: left;">A sarcoma that arises from the soft tissues or bones of the upper or lower extremity.</td>
<td style="text-align: left;">MONDO:0005089</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854492</td>
<td style="text-align: left;">mixed gangliocytoma-pituitary neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C155767</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mixed Gangliocytoma-Pituitary Neuroendocrine Tumor</td>
<td style="text-align: left;">A pituitary neoplasm composed of mature ganglionic cells admixed with pituitary neoplastic neuroendocrine cells.</td>
<td style="text-align: left;">MONDO:0021043,MONDO:0006373</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854495</td>
<td style="text-align: left;">ependymal pituicytoma</td>
<td style="text-align: left;">NCIT:C155774</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ependymal Pituicytoma</td>
<td style="text-align: left;">A very rare, low-grade neoplasm that arises from the posterior pituitary. It is composed of epithelioid and oncocytic cells forming sheets and fascicles. It shows histopathological features reminiscent of ependymomas, including perivascular pseudorosettes and true rosettes. There is no evidence of necrosis or increased mitotic activity. Despite the presence of ependymal histopathological features, these neoplasms probably are not related to ependymomas. Their prognosis is unknown.</td>
<td style="text-align: left;">MONDO:0003257</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854496</td>
<td style="text-align: left;">sellar meningioma</td>
<td style="text-align: left;">NCIT:C155776</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sellar Meningioma</td>
<td style="text-align: left;">A rare meningioma that arises from the sellar region.</td>
<td style="text-align: left;">MONDO:0002720,MONDO:0850302</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854500</td>
<td style="text-align: left;">sellar solitary fibrous tumor</td>
<td style="text-align: left;">NCIT:C155784</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sellar Solitary Fibrous Tumor</td>
<td style="text-align: left;">An extremely rare meningeal solitary fibrous tumor that arises from the sellar region.</td>
<td style="text-align: left;">MONDO:0002720,MONDO:0003223</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854518</td>
<td style="text-align: left;">metastatic malignant pancreatic neoplasm</td>
<td style="text-align: left;">NCIT:C155852</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Pancreatic Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that arises from the pancreas and has metastasized to another anatomic site.</td>
<td style="text-align: left;">MONDO:0009831,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854521</td>
<td style="text-align: left;">chest wall sarcoma</td>
<td style="text-align: left;">NCIT:C155873</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chest Wall Sarcoma</td>
<td style="text-align: left;">A sarcoma that arises from the anatomic structures that surround the lungs and the pleura.</td>
<td style="text-align: left;">MONDO:0005089,MONDO:0021323</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854523</td>
<td style="text-align: left;">unresectable desmoid fibromatosis</td>
<td style="text-align: left;">NCIT:C155877</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Unresectable Desmoid Fibromatosis</td>
<td style="text-align: left;">Desmoid fibromatosis that is not amenable to surgical resection.</td>
<td style="text-align: left;">MONDO:0007608</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854527</td>
<td style="text-align: left;">smoldering waldenstrom macroglobulinemia</td>
<td style="text-align: left;">NCIT:C155910</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Smoldering Waldenstrom Macroglobulinemia</td>
<td style="text-align: left;">Waldenstrom macroglobulinemia with serum IgM monoclonal protein equal or more than 3 g/dL and/or at least 10% bone marrow lymphoplasmacytic infiltration but no evidence of constitutional symptoms, symptomatic anemia, or hyperviscosity. (Blood 2008, 112:2709)</td>
<td style="text-align: left;">MONDO:0100280</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854528</td>
<td style="text-align: left;">metastatic malignant neoplasm in the thoracic cavity</td>
<td style="text-align: left;">NCIT:C155919</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Thoracic Cavity</td>
<td style="text-align: left;">A malignant neoplasm that has spread to the thoracic cavity from another anatomic site.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0003274</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854529</td>
<td style="text-align: left;">medullary hemangioblastoma</td>
<td style="text-align: left;">NCIT:C155949</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Medullary Hemangioblastoma</td>
<td style="text-align: left;">A hemangioblastoma that arises from the medulla oblongata.</td>
<td style="text-align: left;">MONDO:0003902</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854530</td>
<td style="text-align: left;">chromophobe renal cell carcinoma associated with birt-hogg-dube syndrome</td>
<td style="text-align: left;">NCIT:C155951</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome</td>
<td style="text-align: left;">Chromophobe renal cell carcinoma that develops in a patient with Birt-Hogg-Dube syndrome.</td>
<td style="text-align: left;">MONDO:0017885</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854531</td>
<td style="text-align: left;">uterine ligament papillary cystadenoma</td>
<td style="text-align: left;">NCIT:C155952</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Ligament Papillary Cystadenoma</td>
<td style="text-align: left;">A cystadenoma that arises from the broad or other uterine ligaments. It is characterized by the presence of small papillary projections in the inner surface of the cysts. It may be sporadic or associated with von Hippel-Lindau disease.</td>
<td style="text-align: left;">MONDO:0021091,MONDO:0020582</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854533</td>
<td style="text-align: left;">thyroid gland spindle cell follicular adenoma</td>
<td style="text-align: left;">NCIT:C155957</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Spindle Cell Follicular Adenoma</td>
<td style="text-align: left;">A rare thyroid gland follicular adenoma composed predominantly of spindle cells.</td>
<td style="text-align: left;">MONDO:0005032</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854534</td>
<td style="text-align: left;">thyroid gland black follicular adenoma</td>
<td style="text-align: left;">NCIT:C155958</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Black Follicular Adenoma</td>
<td style="text-align: left;">A thyroid gland follicular adenoma seen in patients treated with minocycline. The tumors have black discoloration visible on macroscopic examination and cytoplasmic accumulation of black pigment. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0005032</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854545</td>
<td style="text-align: left;">hypothalamic-chiasmatic pilomyxoid astrocytoma</td>
<td style="text-align: left;">NCIT:C156038</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hypothalamic-Chiasmatic Pilomyxoid Astrocytoma</td>
<td style="text-align: left;">A pilomyxoid astrocytoma occurring in the hypothalamic-chiasmatic region.</td>
<td style="text-align: left;">MONDO:0016692</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854546</td>
<td style="text-align: left;">fourth ventricle medulloblastoma</td>
<td style="text-align: left;">NCIT:C156039</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fourth Ventricle Medulloblastoma</td>
<td style="text-align: left;">A medulloblastoma occurring in the fourth ventricle.</td>
<td style="text-align: left;">MONDO:0007959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854547</td>
<td style="text-align: left;">third ventricle germinoma</td>
<td style="text-align: left;">NCIT:C156040</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Third Ventricle Germinoma</td>
<td style="text-align: left;">A germinoma that arises from the third ventricle.</td>
<td style="text-align: left;">MONDO:0002214</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854549</td>
<td style="text-align: left;">temporal lobe pleomorphic xanthoastrocytoma</td>
<td style="text-align: left;">NCIT:C156042</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Temporal Lobe Pleomorphic Xanthoastrocytoma</td>
<td style="text-align: left;">A pleomorphic xanthoastrocytoma that arises from the temporal lobe of the brain.</td>
<td style="text-align: left;">MONDO:0016690</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854550</td>
<td style="text-align: left;">spindle cell variant thyroid gland papillary carcinoma</td>
<td style="text-align: left;">NCIT:C156045</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Spindle Cell Variant Thyroid Gland Papillary Carcinoma</td>
<td style="text-align: left;">Papillary carcinoma of the thyroid gland with focal areas of spindle cell metaplasia.</td>
<td style="text-align: left;">MONDO:0005075</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854551</td>
<td style="text-align: left;">hobnail variant thyroid gland papillary carcinoma</td>
<td style="text-align: left;">NCIT:C156050</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hobnail Variant Thyroid Gland Papillary Carcinoma</td>
<td style="text-align: left;">A rare variant of papillary thyroid gland carcinoma in which more than 30% of cells have hobnail features. (WHO)</td>
<td style="text-align: left;">MONDO:0005075</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854584</td>
<td style="text-align: left;">metastatic neuroblastoma</td>
<td style="text-align: left;">NCIT:C156101</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Neuroblastoma</td>
<td style="text-align: left;">A neuroblastoma that has metastasized from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0005072</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854588</td>
<td style="text-align: left;">thyroid gland follicular carcinoma, encapsulated angioinvasive</td>
<td style="text-align: left;">NCIT:C156122</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive</td>
<td style="text-align: left;">An encapsulated follicular carcinoma of the thyroid gland which shows angioinvasion.</td>
<td style="text-align: left;">MONDO:0005034</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854589</td>
<td style="text-align: left;">thyroid gland follicular carcinoma, widely invasive</td>
<td style="text-align: left;">NCIT:C156123</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Follicular Carcinoma, Widely Invasive</td>
<td style="text-align: left;">A follicular carcinoma of the thyroid gland with extension into surrounding thyroid or extrathyroid tissues.</td>
<td style="text-align: left;">MONDO:0040677,MONDO:0005034</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854594</td>
<td style="text-align: left;">thyroid gland mucinous carcinoma</td>
<td style="text-align: left;">NCIT:C156267</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Mucinous Carcinoma</td>
<td style="text-align: left;">A rare primary carcinoma of the thyroid gland characterized by the presence of clusters of malignant epithelial cells associated with abundant extracellular mucin deposition.</td>
<td style="text-align: left;">MONDO:0015075</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854595</td>
<td style="text-align: left;">intrathyroidal thymoma</td>
<td style="text-align: left;">NCIT:C156268</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intrathyroidal Thymoma</td>
<td style="text-align: left;">A rare thymoma arising within or is attached to the thyroid gland.</td>
<td style="text-align: left;">MONDO:0015074,MONDO:0006456</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854598</td>
<td style="text-align: left;">orbital alveolar soft part sarcoma</td>
<td style="text-align: left;">NCIT:C156276</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Orbital Alveolar Soft Part Sarcoma</td>
<td style="text-align: left;">An alveolar soft part sarcoma involving the orbit. It usually occurs in children.</td>
<td style="text-align: left;">MONDO:0004943,MONDO:0011655</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854599</td>
<td style="text-align: left;">bladder alveolar soft part sarcoma</td>
<td style="text-align: left;">NCIT:C156277</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Alveolar Soft Part Sarcoma</td>
<td style="text-align: left;">An alveolar soft part sarcoma involving the bladder.</td>
<td style="text-align: left;">MONDO:0001374,MONDO:0011655</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854601</td>
<td style="text-align: left;">colon liposarcoma</td>
<td style="text-align: left;">NCIT:C156279</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colon Liposarcoma</td>
<td style="text-align: left;">A liposarcoma that arises from the colon.</td>
<td style="text-align: left;">MONDO:0003352,MONDO:0005060</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854608</td>
<td style="text-align: left;">thyroid gland schwannoma</td>
<td style="text-align: left;">NCIT:C156340</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Schwannoma</td>
<td style="text-align: left;">A rare schwannoma that arises from the thyroid gland.</td>
<td style="text-align: left;">MONDO:0004820,MONDO:0006107</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854616</td>
<td style="text-align: left;">thyroid gland solitary fibrous tumor</td>
<td style="text-align: left;">NCIT:C156349</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Solitary Fibrous Tumor</td>
<td style="text-align: left;">A rare solitary fibrous tumor that arises from the thyroid gland.</td>
<td style="text-align: left;">MONDO:0016238,MONDO:0015074</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854639</td>
<td style="text-align: left;">malignant abdominal neoplasm</td>
<td style="text-align: left;">NCIT:C156714</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Abdominal Neoplasm</td>
<td style="text-align: left;">A primary or metastatic malignant neoplasm that affects the organs and structures of the abdomen.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854640</td>
<td style="text-align: left;">malignant pelvic neoplasm</td>
<td style="text-align: left;">NCIT:C156715</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Pelvic Neoplasm</td>
<td style="text-align: left;">A primary or metastatic malignant neoplasm that affects the organs and structures of the pelvis.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854647</td>
<td style="text-align: left;">metastatic basal cell carcinoma</td>
<td style="text-align: left;">NCIT:C156769</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Basal Cell Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the basal cells and has metastasized to another anatomic site.</td>
<td style="text-align: left;">MONDO:0024879,MONDO:0020804</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854656</td>
<td style="text-align: left;">adrenal cortical sex cord-stromal tumor</td>
<td style="text-align: left;">NCIT:C156943</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Sex Cord-Stromal Tumor</td>
<td style="text-align: left;">An extremely rare sex cord-stromal tumor that arises from the adrenal cortex. The reported cases were solitary and unilateral.</td>
<td style="text-align: left;">MONDO:0006055,MONDO:0036591</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854657</td>
<td style="text-align: left;">adrenal gland schwannoma</td>
<td style="text-align: left;">NCIT:C156944</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Gland Schwannoma</td>
<td style="text-align: left;">A rare schwannoma that arises from the adrenal medulla.</td>
<td style="text-align: left;">MONDO:0021468,MONDO:0004820</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854658</td>
<td style="text-align: left;">adrenal gland lymphoma</td>
<td style="text-align: left;">NCIT:C156945</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Gland Lymphoma</td>
<td style="text-align: left;">A rare lymphoma that arises from the adrenal gland.</td>
<td style="text-align: left;">MONDO:0002817,MONDO:0001499</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854659</td>
<td style="text-align: left;">adrenal gland sarcoma</td>
<td style="text-align: left;">NCIT:C156956</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Gland Sarcoma</td>
<td style="text-align: left;">A rare sarcoma that arises from the adrenal gland.</td>
<td style="text-align: left;">MONDO:0002817,MONDO:0001501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854660</td>
<td style="text-align: left;">primary vitreoretinal non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C157065</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Vitreoretinal Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">An uncommon and potentially fatal intraocular non-Hodgkin lymphoma that involves the uvea, retina, vitreous body, and optic nerve. It is a subset of primary central nervous system non-Hodgkin lymphoma. The majority of cases are diffuse large B-cell lymphomas.</td>
<td style="text-align: left;">MONDO:0004351,MONDO:0044887</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854663</td>
<td style="text-align: left;">unresectable paraganglioma</td>
<td style="text-align: left;">NCIT:C157126</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Unresectable Paraganglioma</td>
<td style="text-align: left;">Paraganglioma that is not amenable to surgical resection.</td>
<td style="text-align: left;">MONDO:0000448</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854669</td>
<td style="text-align: left;">breast histiocytoid carcinoma</td>
<td style="text-align: left;">NCIT:C157235</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Histiocytoid Carcinoma</td>
<td style="text-align: left;">A rare variant of invasive lobular breast carcinoma characterized by the presence of histiocyte-like malignant cells with pale cytoplasm forming sheets or linear patterns. Apocrine differentiation may be present. It usually has an aggressive clinical course.</td>
<td style="text-align: left;">MONDO:0005051</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854670</td>
<td style="text-align: left;">adrenal gland ganglioneuroblastoma, intermixed</td>
<td style="text-align: left;">NCIT:C157243</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Gland Ganglioneuroblastoma, Intermixed</td>
<td style="text-align: left;">An intermixed ganglioneuroblastoma arising from the adrenal gland.</td>
<td style="text-align: left;">MONDO:0004477,MONDO:0003326</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854671</td>
<td style="text-align: left;">adrenal gland ganglioneuroblastoma, nodular</td>
<td style="text-align: left;">NCIT:C157244</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Gland Ganglioneuroblastoma, Nodular</td>
<td style="text-align: left;">A nodular ganglioneuroblastoma arising from the adrenal gland.</td>
<td style="text-align: left;">MONDO:0004477,MONDO:0003325</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854672</td>
<td style="text-align: left;">composite paraganglioma</td>
<td style="text-align: left;">NCIT:C157246</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Composite Paraganglioma</td>
<td style="text-align: left;">A neoplasm that combines morphologic characteristics of paraganglioma and neuroectodermal tumors such as neuroblastoma, ganglioneuroma, ganglioneuroblastoma, or peripheral nerve sheath tumor.</td>
<td style="text-align: left;">MONDO:0000448</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854679</td>
<td style="text-align: left;">peripheral hemangioblastoma</td>
<td style="text-align: left;">NCIT:C157450</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Peripheral Hemangioblastoma</td>
<td style="text-align: left;">A hemangioblastoma that arises from peripheral nerves or extraneural tissues.</td>
<td style="text-align: left;">MONDO:0016748</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854688</td>
<td style="text-align: left;">bap1-mutated clear cell renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C157614</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">BAP1-Mutated Clear Cell Renal Cell Carcinoma</td>
<td style="text-align: left;">A clear cell renal cell carcinoma that is associated with a mutation in BAP1 gene. These tumors are typically high grade and associated with poor outcome.</td>
<td style="text-align: left;">MONDO:0018492</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854691</td>
<td style="text-align: left;">transformed chronic lymphocytic leukemia to diffuse large b-cell lymphoma</td>
<td style="text-align: left;">NCIT:C157624</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma</td>
<td style="text-align: left;">Histologic transformation of an indolent chronic lymphocytic leukemia to an aggressive diffuse large B-cell lymphoma.</td>
<td style="text-align: left;">MONDO:0004948</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854692</td>
<td style="text-align: left;">metastatic adenoid cystic carcinoma</td>
<td style="text-align: left;">NCIT:C157638</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Adenoid Cystic Carcinoma</td>
<td style="text-align: left;">An adenoid cystic carcinoma that has spread from the original site of growth to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0004971,MONDO:0024879</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854698</td>
<td style="text-align: left;">refractory lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C157686</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Lymphoproliferative Disorder</td>
<td style="text-align: left;">Lymphoproliferative disorder that is resistant to treatment.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854705</td>
<td style="text-align: left;">kidney synovial sarcoma</td>
<td style="text-align: left;">NCIT:C157737</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Synovial Sarcoma</td>
<td style="text-align: left;">A rare synovial sarcoma that arises from the kidney.</td>
<td style="text-align: left;">MONDO:0002930,MONDO:0010434</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854706</td>
<td style="text-align: left;">kidney neuroendocrine neoplasm</td>
<td style="text-align: left;">NCIT:C157743</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Neuroendocrine Neoplasm</td>
<td style="text-align: left;">An epithelial neoplasm with neuroendocrine differentiation that arises from the kidney.  It includes neuroendocrine tumor, small cell neuroendocrine carcinoma, large cell neuroendocrine carcinoma, and paraganglioma.</td>
<td style="text-align: left;">MONDO:0019496,MONDO:0021163</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854714</td>
<td style="text-align: left;">bladder neuroendocrine neoplasm</td>
<td style="text-align: left;">NCIT:C157758</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Neuroendocrine Neoplasm</td>
<td style="text-align: left;">An epithelial neoplasm with neuroendocrine differentiation that arises from the bladder. This category includes neuroendocrine tumors, neuroendocrine carcinomas, and paragangliomas.</td>
<td style="text-align: left;">MONDO:0019496,MONDO:0004987</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854748</td>
<td style="text-align: left;">subcutaneous disorder</td>
<td style="text-align: left;">NCIT:C157995</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Subcutaneous Disorder</td>
<td style="text-align: left;">A disorder of the subcutaneous tissue.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854749</td>
<td style="text-align: left;">kidney epithelioid angiomyolipoma</td>
<td style="text-align: left;">NCIT:C158032</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Epithelioid Angiomyolipoma</td>
<td style="text-align: left;">An angiomyolipoma that arises from the kidney and is composed exclusively or predominantly of epithelioid cells. It is often associated with cytologic atypia and may recur or metastasize.</td>
<td style="text-align: left;">MONDO:0004555,MONDO:0002606</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854750</td>
<td style="text-align: left;">kidney mixed epithelial and stromal tumor family</td>
<td style="text-align: left;">NCIT:C158046</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Mixed Epithelial and Stromal Tumor Family</td>
<td style="text-align: left;">A family of tumors ranging from predominantly cystic tumors (adult cystic nephromas) to tumors that are variably solid (mixed epithelial and stromal tumors) and contain biphasic epithelial and stromal components with spindle stroma, glands, and cysts. Most of these tumors are benign. (WHO 2016).</td>
<td style="text-align: left;">MONDO:0021163</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854756</td>
<td style="text-align: left;">non-invasive bladder urothelial neoplasm</td>
<td style="text-align: left;">NCIT:C158374</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Invasive Bladder Urothelial Neoplasm</td>
<td style="text-align: left;">A non-invasive neoplasm that arises from the urothelial lining of the bladder.</td>
<td style="text-align: left;">MONDO:0003755,MONDO:0004987</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854773</td>
<td style="text-align: left;">platinum-sensitive lung small cell carcinoma</td>
<td style="text-align: left;">NCIT:C158495</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Platinum-Sensitive Lung Small Cell Carcinoma</td>
<td style="text-align: left;">Lung small cell carcinoma that is sensitive to platinum therapy.</td>
<td style="text-align: left;">MONDO:0008433</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854780</td>
<td style="text-align: left;">borderline ovarian mixed epithelial tumor/atypical proliferative ovarian mixed epithelial tumor</td>
<td style="text-align: left;">NCIT:C158616</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Borderline Ovarian Mixed Epithelial Tumor/Atypical Proliferative Ovarian Mixed Epithelial Tumor</td>
<td style="text-align: left;">A low grade, non-invasive mixed epithelial proliferative neoplasm that arises from the ovary. In most cases is composed of serous and endocervical-type mucinous cells.</td>
<td style="text-align: left;">MONDO:0021043,MONDO:0016093</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854781</td>
<td style="text-align: left;">endometrioid tumor, variant with squamous differentiation</td>
<td style="text-align: left;">NCIT:C158620</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endometrioid Tumor, Variant with Squamous Differentiation</td>
<td style="text-align: left;">An endometrioid tumor exhibiting squamous differentiation.</td>
<td style="text-align: left;">MONDO:0002480</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854783</td>
<td style="text-align: left;">bladder soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C158636</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Soft Tissue Neoplasm</td>
<td style="text-align: left;">A mesenchymal neoplasm that arises from the bladder.</td>
<td style="text-align: left;">MONDO:0006424,MONDO:0004987</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854795</td>
<td style="text-align: left;">early stage pancreatic ductal adenocarcinoma</td>
<td style="text-align: left;">NCIT:C158961</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early Stage Pancreatic Ductal Adenocarcinoma</td>
<td style="text-align: left;">Pancreatic ductal adenocarcinoma that has not spread beyond the pancreas.</td>
<td style="text-align: left;">MONDO:0005184</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854804</td>
<td style="text-align: left;">kidney ewing sarcoma</td>
<td style="text-align: left;">NCIT:C159208</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Ewing Sarcoma</td>
<td style="text-align: left;">A rare Ewing sarcoma arising from the kidney.</td>
<td style="text-align: left;">MONDO:0018270,MONDO:0002930</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854806</td>
<td style="text-align: left;">kidney hemangioma</td>
<td style="text-align: left;">NCIT:C159211</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Hemangioma</td>
<td style="text-align: left;">A rare hemangioma arising from the kidney.</td>
<td style="text-align: left;">MONDO:0002513,MONDO:0006500</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854807</td>
<td style="text-align: left;">kidney lymphangioma</td>
<td style="text-align: left;">NCIT:C159214</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Lymphangioma</td>
<td style="text-align: left;">A rare lymphangioma arising from the kidney.</td>
<td style="text-align: left;">MONDO:0002013,MONDO:0002513</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854808</td>
<td style="text-align: left;">kidney schwannoma</td>
<td style="text-align: left;">NCIT:C159221</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Schwannoma</td>
<td style="text-align: left;">A rare schwannoma arising from the kidney.</td>
<td style="text-align: left;">MONDO:0002513,MONDO:0004820</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854809</td>
<td style="text-align: left;">kidney solitary fibrous tumor</td>
<td style="text-align: left;">NCIT:C159222</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Solitary Fibrous Tumor</td>
<td style="text-align: left;">A rare solitary fibrous tumor arising from the kidney.</td>
<td style="text-align: left;">MONDO:0016238,MONDO:0021163</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854812</td>
<td style="text-align: left;">kidney germ cell tumor</td>
<td style="text-align: left;">NCIT:C159227</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Germ Cell Tumor</td>
<td style="text-align: left;">A rare benign or malignant germ cell tumor that arises from the kidney.</td>
<td style="text-align: left;">MONDO:0018201,MONDO:0021163</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854813</td>
<td style="text-align: left;">human papillomavirus-independent penile squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C159244</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Human Papillomavirus-Independent Penile Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the penis and is not caused by human papillomavirus infection. Morphologic variants include pseudohyperplastic, pseudoglandular, verrucous, papillary, and sarcomatoid carcinoma.</td>
<td style="text-align: left;">MONDO:0018352</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854815</td>
<td style="text-align: left;">penile carcinoma cuniculatum</td>
<td style="text-align: left;">NCIT:C159247</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Carcinoma Cuniculatum</td>
<td style="text-align: left;">A variant of verrucous carcinoma of the penis characterized by a labyrinthine growth pattern.</td>
<td style="text-align: left;">MONDO:0003698</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854817</td>
<td style="text-align: left;">penile papillary-basaloid carcinoma</td>
<td style="text-align: left;">NCIT:C159249</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Papillary-Basaloid Carcinoma</td>
<td style="text-align: left;">A variant of penile basaloid squamous cell carcinoma. It is characterized by a papillary exophytic or endophytic growth pattern.</td>
<td style="text-align: left;">MONDO:0004089</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854818</td>
<td style="text-align: left;">penile warty-basaloid carcinoma</td>
<td style="text-align: left;">NCIT:C159250</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Warty-Basaloid Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the penis. It is characterized by warty (condylomatous) and basaloid features.</td>
<td style="text-align: left;">MONDO:0004430,MONDO:0020656</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854819</td>
<td style="text-align: left;">penile lymphoepithelioma-like carcinoma</td>
<td style="text-align: left;">NCIT:C159252</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Lymphoepithelioma-Like Carcinoma</td>
<td style="text-align: left;">A variant of penile squamous cell carcinoma characterized by the presence of islands of malignant cells with uniform vesicular nuclei and prominent nucleoli, and a dense lymphocytic infiltrate.</td>
<td style="text-align: left;">MONDO:0003572,MONDO:0020656</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854820</td>
<td style="text-align: left;">borderline ovarian mucinous tumor/atypical proliferative ovarian mucinous tumor with microinvasion</td>
<td style="text-align: left;">NCIT:C159311</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Microinvasion</td>
<td style="text-align: left;">A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic mucinous epithelial cells, atypia, and microinvasion of the ovarian stroma.</td>
<td style="text-align: left;">MONDO:0003756</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854831</td>
<td style="text-align: left;">bladder leiomyosarcoma</td>
<td style="text-align: left;">NCIT:C159670</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Leiomyosarcoma</td>
<td style="text-align: left;">A leiomyosarcoma that arises from the bladder. It is the most common type of bladder sarcoma in adults.</td>
<td style="text-align: left;">MONDO:0001374,MONDO:0005058</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854838</td>
<td style="text-align: left;">bladder hemangioma</td>
<td style="text-align: left;">NCIT:C159680</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Hemangioma</td>
<td style="text-align: left;">A hemangioma that arises from the bladder. Most tumors occur in adults.</td>
<td style="text-align: left;">MONDO:0000384,MONDO:0006500</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854839</td>
<td style="text-align: left;">bladder granular cell tumor</td>
<td style="text-align: left;">NCIT:C159681</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Granular Cell Tumor</td>
<td style="text-align: left;">A rare granular cell tumor arising from the bladder. Most tumors are benign.</td>
<td style="text-align: left;">MONDO:0006235,MONDO:0004987</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854840</td>
<td style="text-align: left;">bladder neurofibroma</td>
<td style="text-align: left;">NCIT:C159682</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Neurofibroma</td>
<td style="text-align: left;">A plexiform or diffuse neurofibroma arising from the bladder.</td>
<td style="text-align: left;">MONDO:0000384,MONDO:0016755</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854841</td>
<td style="text-align: left;">ebv-related lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C159717</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">EBV-Related Lymphoproliferative Disorder</td>
<td style="text-align: left;">A lymphoproliferative disorder associated with Epstein-Barr virus. This category includes, but is not limited to, Burkitt lymphoma, classic Hodgkin lymphoma, and lymphomas arising in immunocompromised individuals.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854843</td>
<td style="text-align: left;">platinum-sensitive ovarian carcinoma</td>
<td style="text-align: left;">NCIT:C159902</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Platinum-Sensitive Ovarian Carcinoma</td>
<td style="text-align: left;">An ovarian carcinoma that has a documented response to platinum-based chemotherapy.</td>
<td style="text-align: left;">MONDO:0005140</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854847</td>
<td style="text-align: left;">metastatic nut carcinoma</td>
<td style="text-align: left;">NCIT:C160297</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic NUT Carcinoma</td>
<td style="text-align: left;">NUT carcinoma that has spread from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0024879,MONDO:0005563</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854850</td>
<td style="text-align: left;">hematologic malignancy-associated skin squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C160666</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hematologic Malignancy-Associated Skin Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the skin in a patient with a history of hematologic malignancy, usually non-Hodgkin lymphoma or chronic lymphocytic leukemia.</td>
<td style="text-align: left;">MONDO:0002529</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854854</td>
<td style="text-align: left;">prostate acinar microcystic adenocarcinoma</td>
<td style="text-align: left;">NCIT:C160817</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Acinar Microcystic Adenocarcinoma</td>
<td style="text-align: left;">Acinar prostate adenocarcinoma characterized by the presence of microcystic foci.</td>
<td style="text-align: left;">MONDO:0002493</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854859</td>
<td style="text-align: left;">platinum-sensitive primary peritoneal carcinoma</td>
<td style="text-align: left;">NCIT:C160872</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Platinum-Sensitive Primary Peritoneal Carcinoma</td>
<td style="text-align: left;">Primary peritoneal carcinoma that has a documented response to platinum-based chemotherapy.</td>
<td style="text-align: left;">MONDO:0015686</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854860</td>
<td style="text-align: left;">platinum-sensitive fallopian tube carcinoma</td>
<td style="text-align: left;">NCIT:C160873</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Platinum-Sensitive Fallopian Tube Carcinoma</td>
<td style="text-align: left;">Fallopian tube carcinoma that has a documented response to platinum-based chemotherapy.</td>
<td style="text-align: left;">MONDO:0006206</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854866</td>
<td style="text-align: left;">cribriform adenocarcinoma of minor salivary gland</td>
<td style="text-align: left;">NCIT:C160974</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cribriform Adenocarcinoma of Minor Salivary Gland</td>
<td style="text-align: left;">A minor salivary gland adenocarcinoma characterized by a cribriform pattern. It often metastasizes to the neck lymph nodes.</td>
<td style="text-align: left;">MONDO:0006304,MONDO:0006176</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854873</td>
<td style="text-align: left;">prostate synovial sarcoma</td>
<td style="text-align: left;">NCIT:C161034</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Synovial Sarcoma</td>
<td style="text-align: left;">A rare synovial sarcoma that arises from the prostate gland.</td>
<td style="text-align: left;">MONDO:0002854,MONDO:0010434</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854874</td>
<td style="text-align: left;">prostate osteosarcoma</td>
<td style="text-align: left;">NCIT:C161035</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Osteosarcoma</td>
<td style="text-align: left;">A rare osteosarcoma that arises from the prostate gland.</td>
<td style="text-align: left;">MONDO:0002621,MONDO:0002854</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854875</td>
<td style="text-align: left;">prostate undifferentiated pleomorphic sarcoma</td>
<td style="text-align: left;">NCIT:C161038</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Undifferentiated Pleomorphic Sarcoma</td>
<td style="text-align: left;">A rare undifferentiated pleomorphic sarcoma that arises from the prostate gland.</td>
<td style="text-align: left;">MONDO:0002854,MONDO:0002142</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854877</td>
<td style="text-align: left;">prostate soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C161045</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Soft Tissue Neoplasm</td>
<td style="text-align: left;">A mesenchymal neoplasm that arises from the prostate gland.</td>
<td style="text-align: left;">MONDO:0006424,MONDO:0021259</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854881</td>
<td style="text-align: left;">prostate hemangioma</td>
<td style="text-align: left;">NCIT:C161581</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Hemangioma</td>
<td style="text-align: left;">A rare hemangioma that arises from the prostate gland.</td>
<td style="text-align: left;">MONDO:0021510,MONDO:0006500</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854888</td>
<td style="text-align: left;">prostate cystadenoma</td>
<td style="text-align: left;">NCIT:C161606</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Cystadenoma</td>
<td style="text-align: left;">A rare cystadenoma affecting the prostate gland. It is characterized by the presence of multilocular prostatic cysts.</td>
<td style="text-align: left;">MONDO:0021510,MONDO:0002369</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854889</td>
<td style="text-align: left;">prostate wilms tumor</td>
<td style="text-align: left;">NCIT:C161607</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Wilms Tumor</td>
<td style="text-align: left;">A rare Wilms tumor affecting the prostate gland.</td>
<td style="text-align: left;">MONDO:0008315,MONDO:0006058</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854891</td>
<td style="text-align: left;">prostate melanoma</td>
<td style="text-align: left;">NCIT:C161611</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Melanoma</td>
<td style="text-align: left;">An exceptionally rare melanoma arising from the prostate gland.</td>
<td style="text-align: left;">MONDO:0006320,MONDO:0008315</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854893</td>
<td style="text-align: left;">seminal vesicle mixed epithelial and stromal tumor</td>
<td style="text-align: left;">NCIT:C161636</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Seminal Vesicle Mixed Epithelial and Stromal Tumor</td>
<td style="text-align: left;">A rare biphasic neoplasm that arises from the seminal vesicle. It is characterized by the presence of stromal and benign epithelial components. Rarely, the stromal component may display atypia and mitotic activity and the tumor may behave in a malignant clinical course.</td>
<td style="text-align: left;">MONDO:0021043,MONDO:0002790</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854895</td>
<td style="text-align: left;">benign seminal vesicle neoplasm</td>
<td style="text-align: left;">NCIT:C161643</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Seminal Vesicle Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the seminal vesicle and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0000625,MONDO:0002790</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854896</td>
<td style="text-align: left;">malignant seminal vesicle neoplasm</td>
<td style="text-align: left;">NCIT:C161644</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Seminal Vesicle Neoplasm</td>
<td style="text-align: left;">A primary or metastatic malignant neoplasm that affects the seminal vesicle.</td>
<td style="text-align: left;">MONDO:0005836,MONDO:0002790</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854902</td>
<td style="text-align: left;">regressed testicular germ cell tumor</td>
<td style="text-align: left;">NCIT:C162139</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Regressed Testicular Germ Cell Tumor</td>
<td style="text-align: left;">A testicular germ cell tumor that has undergone either partial or complete regression, resulting in the creation of a fibrotic nodule in the testis.</td>
<td style="text-align: left;">MONDO:0010108</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854909</td>
<td style="text-align: left;">cervical cancer by figo stage 2018</td>
<td style="text-align: left;">NCIT:C162225</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Cancer by FIGO Stage 2018</td>
<td style="text-align: left;">A term that refers to the staging of cervical cancer according to the International Federation of Gynecology and Obstetrics (FIGO) staging, 2018.</td>
<td style="text-align: left;">MONDO:0005131</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854911</td>
<td style="text-align: left;">metastatic malignant digestive system neoplasm</td>
<td style="text-align: left;">NCIT:C162255</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Digestive System Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that arises in the digestive system and has spread from its original site of growth to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0002516,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854912</td>
<td style="text-align: left;">hypermutated colorectal carcinoma</td>
<td style="text-align: left;">NCIT:C162256</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hypermutated Colorectal Carcinoma</td>
<td style="text-align: left;">A colorectal carcinoma characterized by a high mutational rate caused by DNA mismatch repair deficiency or POLE/POLD1 driver mutations.</td>
<td style="text-align: left;">MONDO:0024331</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854925</td>
<td style="text-align: left;">thymus neuroendocrine neoplasm</td>
<td style="text-align: left;">NCIT:C162460</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thymus Neuroendocrine Neoplasm</td>
<td style="text-align: left;">An epithelial neoplasm with neuroendocrine differentiation that arises from the thymus. This category includes neuroendocrine tumors (carcinoid tumors) and neuroendocrine carcinomas.</td>
<td style="text-align: left;">MONDO:0018079,MONDO:0019496</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854927</td>
<td style="text-align: left;">intratubular large cell hyalinizing sertoli cell neoplasia</td>
<td style="text-align: left;">NCIT:C162466</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intratubular Large Cell Hyalinizing Sertoli Cell Neoplasia</td>
<td style="text-align: left;">A clinically benign intratubular neoplastic proliferation of large Sertoli cells in the testis. It is associated with prominent basement membrane deposits. It occurs almost exclusively in patients with Peutz-Jeghers syndrome.</td>
<td style="text-align: left;">MONDO:0003125</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854928</td>
<td style="text-align: left;">testicular diffuse large b-cell lymphoma</td>
<td style="text-align: left;">NCIT:C162467</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Diffuse Large B-Cell Lymphoma</td>
<td style="text-align: left;">A diffuse large B-cell lymphoma that arises from the testis. It predominantly affects older men. Patients usually present with a unilateral hard painless mass. Bilateral masses have been described in a minority of patients.</td>
<td style="text-align: left;">MONDO:0001472,MONDO:0018905</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854929</td>
<td style="text-align: left;">testicular nasal type extranodal nk/t-cell lymphoma</td>
<td style="text-align: left;">NCIT:C162468</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Nasal Type Extranodal NK/T-Cell Lymphoma</td>
<td style="text-align: left;">A nasal type extranodal NK/T-cell lymphoma affecting the testis. Patients usually present with unilateral testicular enlargement. Bilateral involvement is rare. The prognosis is poor.</td>
<td style="text-align: left;">MONDO:0001472,MONDO:0019472</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854930</td>
<td style="text-align: left;">testicular myeloid sarcoma</td>
<td style="text-align: left;">NCIT:C162469</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Myeloid Sarcoma</td>
<td style="text-align: left;">A rare myeloid sarcoma that arises from the testis. At presentation the involvement is usually unilateral.</td>
<td style="text-align: left;">MONDO:0005447,MONDO:0006861</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854931</td>
<td style="text-align: left;">testicular plasmacytoma</td>
<td style="text-align: left;">NCIT:C162470</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Plasmacytoma</td>
<td style="text-align: left;">A rare plasmacytoma that arises in the testis. At presentation the involvement is usually unilateral.</td>
<td style="text-align: left;">MONDO:0005447,MONDO:0002754</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854936</td>
<td style="text-align: left;">paratesticular neoplasm</td>
<td style="text-align: left;">NCIT:C162485</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Paratesticular Neoplasm</td>
<td style="text-align: left;">A benign, borderline, or malignant neoplasm that affects the paratesticular structures.</td>
<td style="text-align: left;">MONDO:0024582</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854952</td>
<td style="text-align: left;">penile melanoma</td>
<td style="text-align: left;">NCIT:C162547</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Melanoma</td>
<td style="text-align: left;">A melanoma that arises from the penis. It may be cutaneous or mucosal. The most common site of involvement is glans penis.</td>
<td style="text-align: left;">MONDO:0001325,MONDO:0005105</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854953</td>
<td style="text-align: left;">penile lymphoma</td>
<td style="text-align: left;">NCIT:C162548</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Lymphoma</td>
<td style="text-align: left;">A lymphoma that arises from penile skin, subcutis, corpora cavernosa, and spongiosum. Diffuse large B-cell lymphoma is the most common primary penile lymphoma. (WHO 2016)</td>
<td style="text-align: left;">MONDO:0001325,MONDO:0017207</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854955</td>
<td style="text-align: left;">primary peritoneal undifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C162562</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Peritoneal Undifferentiated Carcinoma</td>
<td style="text-align: left;">An extremely rare carcinoma arising from the peritoneum. It is characterized by the presence of a diffuse malignant infiltrate that is composed of epithelial cells without evidence of glandular or squamous differentiation.</td>
<td style="text-align: left;">MONDO:0015686,MONDO:0005617</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854956</td>
<td style="text-align: left;">primary peritoneal transitional cell carcinoma</td>
<td style="text-align: left;">NCIT:C162564</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Peritoneal Transitional Cell Carcinoma</td>
<td style="text-align: left;">An extremely rare transitional cell carcinoma that arises from the peritoneum.</td>
<td style="text-align: left;">MONDO:0015686,MONDO:0006474</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854959</td>
<td style="text-align: left;">penile soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C162574</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Soft Tissue Neoplasm</td>
<td style="text-align: left;">A rare mesenchymal neoplasm that arises from the penis.</td>
<td style="text-align: left;">MONDO:0006424,MONDO:0006895</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854966</td>
<td style="text-align: left;">penile malignant peripheral nerve sheath tumor</td>
<td style="text-align: left;">NCIT:C162584</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Malignant Peripheral Nerve Sheath Tumor</td>
<td style="text-align: left;">A rare malignant peripheral nerve sheath tumor that occurs in the penis.</td>
<td style="text-align: left;">MONDO:0001387,MONDO:0017827</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854967</td>
<td style="text-align: left;">penile leiomyosarcoma</td>
<td style="text-align: left;">NCIT:C162585</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Leiomyosarcoma</td>
<td style="text-align: left;">A leiomyosarcoma that occurs in the penis.</td>
<td style="text-align: left;">MONDO:0001387,MONDO:0005058</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854968</td>
<td style="text-align: left;">penile schwannoma</td>
<td style="text-align: left;">NCIT:C162586</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Schwannoma</td>
<td style="text-align: left;">A schwannoma that occurs in the penis.</td>
<td style="text-align: left;">MONDO:0004820,MONDO:0021458</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854969</td>
<td style="text-align: left;">penile neurofibroma</td>
<td style="text-align: left;">NCIT:C162587</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Neurofibroma</td>
<td style="text-align: left;">A neurofibroma that occurs in the penis.</td>
<td style="text-align: left;">MONDO:0021458,MONDO:0016755</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854971</td>
<td style="text-align: left;">penile undifferentiated pleomorphic sarcoma</td>
<td style="text-align: left;">NCIT:C162589</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Undifferentiated Pleomorphic Sarcoma</td>
<td style="text-align: left;">A rare undifferentiated pleomorphic sarcoma that occurs in the penis.</td>
<td style="text-align: left;">MONDO:0001387,MONDO:0002142</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854974</td>
<td style="text-align: left;">metastatic malignant neoplasm in the head and neck</td>
<td style="text-align: left;">NCIT:C162594</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Head and Neck</td>
<td style="text-align: left;">The spread of a malignant neoplasm to the head and neck.  This may be from a primary head and neck malignant neoplasm, or from a malignant neoplasm at a distant site.</td>
<td style="text-align: left;">MONDO:0005627,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854984</td>
<td style="text-align: left;">refractory childhood malignant neoplasm</td>
<td style="text-align: left;">NCIT:C162703</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Childhood Malignant Neoplasm</td>
<td style="text-align: left;">A childhood malignant neoplasm that does not respond to treatment.</td>
<td style="text-align: left;">MONDO:0006517,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0854998</td>
<td style="text-align: left;">asph-positive head and neck squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C162770</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">ASPH-Positive Head and Neck Squamous Cell Carcinoma</td>
<td style="text-align: left;">A head and neck squamous cell carcinoma in which the malignant cells are positive for ASPH gene.</td>
<td style="text-align: left;">MONDO:0010150</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855003</td>
<td style="text-align: left;">parapharyngeal neoplasm</td>
<td style="text-align: left;">NCIT:C162820</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Parapharyngeal Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the parapharyngeal space.</td>
<td style="text-align: left;">MONDO:0021351</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855006</td>
<td style="text-align: left;">retropharyngeal neoplasm</td>
<td style="text-align: left;">NCIT:C162825</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Retropharyngeal Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the retropharyngeal space.</td>
<td style="text-align: left;">MONDO:0021351</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855015</td>
<td style="text-align: left;">non-invasive cribriform carcinoma</td>
<td style="text-align: left;">NCIT:C162973</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Invasive Cribriform Carcinoma</td>
<td style="text-align: left;">A carcinoma characterized by the presence of a cribriform architectural pattern. There is no evidence of surrounding stromal invasion by the malignant cells.</td>
<td style="text-align: left;">MONDO:0006176</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855028</td>
<td style="text-align: left;">micropapillary carcinoma</td>
<td style="text-align: left;">NCIT:C164144</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Micropapillary Carcinoma</td>
<td style="text-align: left;">A carcinoma characterized by the presence of a predominant micropapillary pattern.</td>
<td style="text-align: left;">MONDO:0006509</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855034</td>
<td style="text-align: left;">aggressive prostate adenocarcinoma</td>
<td style="text-align: left;">NCIT:C164185</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Aggressive Prostate Adenocarcinoma</td>
<td style="text-align: left;">Prostate adenocarcinoma that metastasizes quickly to other anatomic sites. It usually has a Gleason score between 8 and 10, a PSA level higher than 20 ng/ml, and is classified as T3b or T4.</td>
<td style="text-align: left;">MONDO:0005082</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855035</td>
<td style="text-align: left;">head and neck sarcoma</td>
<td style="text-align: left;">NCIT:C164198</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Sarcoma</td>
<td style="text-align: left;">A sarcoma that arises from the head and neck region.</td>
<td style="text-align: left;">MONDO:0005089,MONDO:0005627</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855040</td>
<td style="text-align: left;">warty carcinoma</td>
<td style="text-align: left;">NCIT:C164248</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Warty Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma characterized by a papillary growth pattern, hyperkeratosis, and koilocytosis.</td>
<td style="text-align: left;">MONDO:0002979</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855041</td>
<td style="text-align: left;">differentiated intraepithelial neoplasia</td>
<td style="text-align: left;">NCIT:C164249</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Differentiated Intraepithelial Neoplasia</td>
<td style="text-align: left;">Intraepithelial neoplasia of the penis or vulva. It usually presents as a solitary white or pink macule or plaque that may be slightly elevated. A background of long-standing lichen sclerosus is often present.</td>
<td style="text-align: left;">MONDO:0024474</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855042</td>
<td style="text-align: left;">human papillomavirus-independent squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C164250</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Human Papillomavirus-Independent Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma not associated with human papilloma virus infection.</td>
<td style="text-align: left;">MONDO:0005096</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855043</td>
<td style="text-align: left;">invasive sarcomatoid urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C164252</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Sarcomatoid Urothelial Carcinoma</td>
<td style="text-align: left;">An invasive urothelial carcinoma that exhibits spindle cell sarcomatoid features.</td>
<td style="text-align: left;">MONDO:0040678,MONDO:0002837</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855044</td>
<td style="text-align: left;">mixed neuroendocrine non-neuroendocrine neoplasm</td>
<td style="text-align: left;">NCIT:C164255</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mixed Neuroendocrine Non-Neuroendocrine Neoplasm</td>
<td style="text-align: left;">A rare neoplasm that consists of neuroendocrine and non-neuroendocrine cellular components. At least 30% of either component should be present for the diagnosis to be made.</td>
<td style="text-align: left;">MONDO:0021043,MONDO:0005626</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855047</td>
<td style="text-align: left;">nf1-associated malignant peripheral nerve sheath tumor</td>
<td style="text-align: left;">NCIT:C164313</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">NF1-Associated Malignant Peripheral Nerve Sheath Tumor</td>
<td style="text-align: left;">A malignant peripheral nerve sheath tumor that is associated with NF1 gene inactivation and a history of neurofibromatosis type 1.</td>
<td style="text-align: left;">MONDO:0017827</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855048</td>
<td style="text-align: left;">sporadic malignant peripheral nerve sheath tumor</td>
<td style="text-align: left;">NCIT:C164314</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sporadic Malignant Peripheral Nerve Sheath Tumor</td>
<td style="text-align: left;">A malignant peripheral nerve sheath tumor that is not caused by inherited genetic mutations.</td>
<td style="text-align: left;">MONDO:0017827</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855049</td>
<td style="text-align: left;">radiation-induced malignant peripheral nerve sheath tumor</td>
<td style="text-align: left;">NCIT:C164316</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Radiation-Induced Malignant Peripheral Nerve Sheath Tumor</td>
<td style="text-align: left;">A malignant peripheral nerve sheath tumor that is the result of exposure to ionizing radiation.</td>
<td style="text-align: left;">MONDO:0017827</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855058</td>
<td style="text-align: left;">soft tissue sarcoma of the trunk and extremities</td>
<td style="text-align: left;">NCIT:C165190</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Soft Tissue Sarcoma of the Trunk and Extremities</td>
<td style="text-align: left;">A soft tissue sarcoma that arises from the trunk or the extremities.</td>
<td style="text-align: left;">MONDO:0018078</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855059</td>
<td style="text-align: left;">metastatic malignant mesothelioma</td>
<td style="text-align: left;">NCIT:C165252</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Mesothelioma</td>
<td style="text-align: left;">Malignant mesothelioma that has spread from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0006292,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855079</td>
<td style="text-align: left;">skin verrucous carcinoma</td>
<td style="text-align: left;">NCIT:C165465</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Verrucous Carcinoma</td>
<td style="text-align: left;">A verrucous carcinoma that arises from the skin. It usually affects the palms, soles, and distal digits.</td>
<td style="text-align: left;">MONDO:0002529,MONDO:0006006</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855080</td>
<td style="text-align: left;">skin squamous cell carcinoma with osteoclast-like giant cells</td>
<td style="text-align: left;">NCIT:C165466</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Squamous Cell Carcinoma with Osteoclast-Like Giant Cells</td>
<td style="text-align: left;">A rare squamous cell carcinoma of the skin characterized by the presence of multinucleated non-neoplastic giant cells that resemble osteoclasts.</td>
<td style="text-align: left;">MONDO:0002529</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855081</td>
<td style="text-align: left;">skin lymphoepithelial carcinoma</td>
<td style="text-align: left;">NCIT:C165467</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Lymphoepithelial Carcinoma</td>
<td style="text-align: left;">A rare, poorly differentiated squamous cell carcinoma of the skin. It is characterized by the presence of tumor cells islands surrounded and infiltrated by lymphocytes and plasma cells.</td>
<td style="text-align: left;">MONDO:0002529,MONDO:0003572</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855082</td>
<td style="text-align: left;">skin squamous cell carcinoma with sarcomatoid differentiation</td>
<td style="text-align: left;">NCIT:C165468</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation</td>
<td style="text-align: left;">A rare carcinoma of the skin characterized by the presence of squamous cell carcinomatous and sarcomatous components.</td>
<td style="text-align: left;">MONDO:0002529,MONDO:0002928</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855085</td>
<td style="text-align: left;">lichen planus-like keratosis</td>
<td style="text-align: left;">NCIT:C165485</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lichen Planus-Like Keratosis</td>
<td style="text-align: left;">A benign intraepidermal squamoproliferative neoplasm characterized by irregular acanthosis, hyperkeratosis, parakeratosis, and prominent chronic inflammation.</td>
<td style="text-align: left;">MONDO:0002093</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855094</td>
<td style="text-align: left;">combined nevus</td>
<td style="text-align: left;">NCIT:C165529</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Combined Nevus</td>
<td style="text-align: left;">A melanocytic nevus that arises from the skin or conjunctiva and is characterized by the presence of two or more morphologically distinct melanocytic nevus components in a single lesion. One component is a conventional nevus component, and the other(s) are usually blue nevus, deep penetrating nevus, Spitz nevus, or balloon cell nevus components.</td>
<td style="text-align: left;">MONDO:0005073</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855104</td>
<td style="text-align: left;">proximal gastric adenocarcinoma</td>
<td style="text-align: left;">NCIT:C165628</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Proximal Gastric Adenocarcinoma</td>
<td style="text-align: left;">A gastric adenocarcinoma that arises from the proximal part of the stomach.</td>
<td style="text-align: left;">MONDO:0005036</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855113</td>
<td style="text-align: left;">mixed carcinoma</td>
<td style="text-align: left;">NCIT:C165723</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mixed Carcinoma</td>
<td style="text-align: left;">A carcinoma characterized by the presence of more than one malignant epithelial histologic pattern.</td>
<td style="text-align: left;">MONDO:0005853,MONDO:0004993</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855116</td>
<td style="text-align: left;">hormone receptor-negative breast carcinoma</td>
<td style="text-align: left;">NCIT:C165743</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hormone Receptor-Negative Breast Carcinoma</td>
<td style="text-align: left;">Breast adenocarcinoma that is negative for hormone receptors.</td>
<td style="text-align: left;">MONDO:0004988</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855127</td>
<td style="text-align: left;">musculoskeletal neoplasm</td>
<td style="text-align: left;">NCIT:C166354</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Musculoskeletal Neoplasm</td>
<td style="text-align: left;">A benign, intermediate, or malignant neoplasm that affects muscles and bones.</td>
<td style="text-align: left;">MONDO:0002081,MONDO:0044334</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855139</td>
<td style="text-align: left;">acute myeloid leukemia with ram immunophenotype</td>
<td style="text-align: left;">NCIT:C167089</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia with RAM Immunophenotype</td>
<td style="text-align: left;">A high risk pediatric acute myeloid leukemia with an extremely poor prognosis. The blasts show bright CD56 expression, dim-to-negative expression of CD45 and CD38, and lack of HLA-DR expression. This immunophenotype was named after one of the pediatric patient's initials (RAM), from Children's Oncology Group (COG) clinical trial AAML0531.</td>
<td style="text-align: left;">MONDO:0004996</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855140</td>
<td style="text-align: left;">obesity-related malignant neoplasm</td>
<td style="text-align: left;">NCIT:C167168</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Obesity-Related Malignant Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that occurs in the context of obesity.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855143</td>
<td style="text-align: left;">metastatic primary peritoneal carcinoma</td>
<td style="text-align: left;">NCIT:C167203</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Primary Peritoneal Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the peritoneum and has metastasized to another anatomic site.</td>
<td style="text-align: left;">MONDO:0015686,MONDO:0024879</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855150</td>
<td style="text-align: left;">midgut neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C167327</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Midgut Neuroendocrine Tumor</td>
<td style="text-align: left;">A neuroendocrine tumor that arises from the jejunum, ileum, proximal colon, or appendix.</td>
<td style="text-align: left;">MONDO:0000386</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855151</td>
<td style="text-align: left;">adnexal adenocarcinoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C167341</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adnexal Adenocarcinoma, Not Otherwise Specified</td>
<td style="text-align: left;">An adenocarcinoma that arises from the sweat glands and is characterized by the absence of specific morphological features to allow further classification.</td>
<td style="text-align: left;">MONDO:0005524</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855152</td>
<td style="text-align: left;">spiradenocylindroma</td>
<td style="text-align: left;">NCIT:C167342</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Spiradenocylindroma</td>
<td style="text-align: left;">A benign adnexal neoplasm with histological features of both spiradenoma and cylindroma in a single nodular lesion.</td>
<td style="text-align: left;">MONDO:0021489</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855153</td>
<td style="text-align: left;">carcinoma arising from spiradenocylindroma</td>
<td style="text-align: left;">NCIT:C167344</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Carcinoma Arising from Spiradenocylindroma</td>
<td style="text-align: left;">A carcinoma that arises from a spiradenocylindroma.</td>
<td style="text-align: left;">MONDO:0005524,MONDO:0024878</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855154</td>
<td style="text-align: left;">malignant mixed tumor of the skin</td>
<td style="text-align: left;">NCIT:C167346</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Mixed Tumor of the Skin</td>
<td style="text-align: left;">A rare malignant skin neoplasm that arises from a benign mixed tumor of the skin.</td>
<td style="text-align: left;">MONDO:0002206,MONDO:0005853</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855157</td>
<td style="text-align: left;">syringocystadenocarcinoma papilliferum</td>
<td style="text-align: left;">NCIT:C167365</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Syringocystadenocarcinoma Papilliferum</td>
<td style="text-align: left;">A sweat gland carcinoma usually arising from a pre-existing syringocystadenoma papilliferum.</td>
<td style="text-align: left;">MONDO:0005524</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855159</td>
<td style="text-align: left;">adnexal secretory carcinoma</td>
<td style="text-align: left;">NCIT:C167368</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adnexal Secretory Carcinoma</td>
<td style="text-align: left;">A rare adnexal carcinoma characterized by the presence of morphological features identical to those seen in salivary gland and breast secretory carcinomas.</td>
<td style="text-align: left;">MONDO:0005524</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855160</td>
<td style="text-align: left;">signet ring cell/histiocytoid carcinoma</td>
<td style="text-align: left;">NCIT:C167369</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Signet Ring Cell/Histiocytoid Carcinoma</td>
<td style="text-align: left;">A rare aggressive adnexal carcinoma that affects the eyelid and rarely the axilla. Morphologically, it is characterized by the presence of signet ring cells or histiocytoid epithelial cells with eosinophilic cytoplasm infiltrating the dermis and subcutis, often in a single file pattern.</td>
<td style="text-align: left;">MONDO:0005524</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855173</td>
<td style="text-align: left;">resectable glioma</td>
<td style="text-align: left;">NCIT:C168573</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Resectable Glioma</td>
<td style="text-align: left;">A glioma that is amenable to surgical resection.</td>
<td style="text-align: left;">MONDO:0021042</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855181</td>
<td style="text-align: left;">phyllodes tumor of anogenital mammary-type glands</td>
<td style="text-align: left;">NCIT:C168602</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Phyllodes Tumor of Anogenital Mammary-Type Glands</td>
<td style="text-align: left;">A rare phyllodes tumor that arises from mammary-like glands in the anogenital region.</td>
<td style="text-align: left;">MONDO:0005078</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855182</td>
<td style="text-align: left;">metastatic malignant neoplasm in the digestive system</td>
<td style="text-align: left;">NCIT:C168669</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Digestive System</td>
<td style="text-align: left;">A malignant neoplasm that has spread to the digestive system from another anatomic site.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0002516</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855187</td>
<td style="text-align: left;">unresectable round cell liposarcoma</td>
<td style="text-align: left;">NCIT:C168724</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Unresectable Round Cell Liposarcoma</td>
<td style="text-align: left;">A round cell liposarcoma that is not amenable to surgical resection.</td>
<td style="text-align: left;">MONDO:0005238</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855221</td>
<td style="text-align: left;">skin soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C169100</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Soft Tissue Neoplasm</td>
<td style="text-align: left;">A mesenchymal neoplasm that arises from the skin.</td>
<td style="text-align: left;">MONDO:0006424,MONDO:0002531</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855230</td>
<td style="text-align: left;">metastatic malignant head and neck neoplasm</td>
<td style="text-align: left;">NCIT:C170467</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Head and Neck Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that arises from the head and neck region and has spread to another anatomic site.</td>
<td style="text-align: left;">MONDO:0005627,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855232</td>
<td style="text-align: left;">skin pleomorphic liposarcoma</td>
<td style="text-align: left;">NCIT:C170473</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Pleomorphic Liposarcoma</td>
<td style="text-align: left;">A rare pleomorphic liposarcoma arising from the skin.</td>
<td style="text-align: left;">MONDO:0003600,MONDO:0020562</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855235</td>
<td style="text-align: left;">skin angiolipoma</td>
<td style="text-align: left;">NCIT:C170478</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Angiolipoma</td>
<td style="text-align: left;">An angiolipoma arising from the skin.</td>
<td style="text-align: left;">MONDO:0000964,MONDO:0006085</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855238</td>
<td style="text-align: left;">benign periampullary neoplasm</td>
<td style="text-align: left;">NCIT:C170725</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Periampullary Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the periampullary region and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential..</td>
<td style="text-align: left;">MONDO:0006734</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855241</td>
<td style="text-align: left;">metastatic malignant breast neoplasm</td>
<td style="text-align: left;">NCIT:C170728</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Breast Neoplasm</td>
<td style="text-align: left;">A malignant breast neoplasm that has metastasized to another anatomic site.</td>
<td style="text-align: left;">MONDO:0007254,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855243</td>
<td style="text-align: left;">primary peritoneal adenocarcinoma</td>
<td style="text-align: left;">NCIT:C170733</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Peritoneal Adenocarcinoma</td>
<td style="text-align: left;">A rare adenocarcinoma that arises from the lining of the peritoneum.</td>
<td style="text-align: left;">MONDO:0015686,MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855244</td>
<td style="text-align: left;">appendix mucinous neoplasm</td>
<td style="text-align: left;">NCIT:C170734</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Mucinous Neoplasm</td>
<td style="text-align: left;">An appendiceal neoplasm characterized by mucinous epithelial proliferation with extracellular mucin and pushing tumour margins. (WHO 2019)</td>
<td style="text-align: left;">MONDO:0024338,MONDO:0001236</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855250</td>
<td style="text-align: left;">alveolar ridge squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C170774</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Alveolar Ridge Squamous Cell Carcinoma</td>
<td style="text-align: left;">Squamous cell carcinoma arising from the upper or lower alveolar ridge.</td>
<td style="text-align: left;">MONDO:0004958</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855252</td>
<td style="text-align: left;">metastatic malignant skin neoplasm</td>
<td style="text-align: left;">NCIT:C170811</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Skin Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm of the skin that has spread to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0002898</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855256</td>
<td style="text-align: left;">metastatic rhabdoid tumor</td>
<td style="text-align: left;">NCIT:C170828</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Rhabdoid Tumor</td>
<td style="text-align: left;">A rhabdoid tumor that has spread from the original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0002728,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855263</td>
<td style="text-align: left;">metastatic carcinosarcoma</td>
<td style="text-align: left;">NCIT:C170924</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Carcinosarcoma</td>
<td style="text-align: left;">A carcinosarcoma that has spread from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0002928</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855266</td>
<td style="text-align: left;">malignant fundus neoplasm</td>
<td style="text-align: left;">NCIT:C170940</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Fundus Neoplasm</td>
<td style="text-align: left;">A primary or metastatic malignant neoplasm that affects the gastric fundus.</td>
<td style="text-align: left;">MONDO:0001056</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855285</td>
<td style="text-align: left;">mediastinal non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C171037</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A non-Hodgkin lymphoma that arises from the mediastinum.</td>
<td style="text-align: left;">MONDO:0004021,MONDO:0018908</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855297</td>
<td style="text-align: left;">oligometastatic prostate carcinoma</td>
<td style="text-align: left;">NCIT:C171265</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oligometastatic Prostate Carcinoma</td>
<td style="text-align: left;">Prostate carcinoma that has metastasized to a limited number of sites.</td>
<td style="text-align: left;">MONDO:0004956</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855330</td>
<td style="text-align: left;">acute myeloid leukemia arising from previous myeloproliferative neoplasm</td>
<td style="text-align: left;">NCIT:C172129</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia Arising from Previous Myeloproliferative Neoplasm</td>
<td style="text-align: left;">An acute myeloid leukemia that develops in patients with a prior history of myeloproliferative neoplasm.</td>
<td style="text-align: left;">MONDO:0019457</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855331</td>
<td style="text-align: left;">acute myeloid leukemia arising from previous myelodysplastic/myeloproliferative neoplasm</td>
<td style="text-align: left;">NCIT:C172130</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm</td>
<td style="text-align: left;">An acute myeloid leukemia that develops in patients with a prior history of myelodysplastic/myeloproliferative neoplasm.</td>
<td style="text-align: left;">MONDO:0019457</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855335</td>
<td style="text-align: left;">progesterone receptor-positive malignant neoplasm</td>
<td style="text-align: left;">NCIT:C172183</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Progesterone Receptor-Positive Malignant Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that is positive for progesterone receptors.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855346</td>
<td style="text-align: left;">refractory myeloid neoplasm</td>
<td style="text-align: left;">NCIT:C172281</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Myeloid Neoplasm</td>
<td style="text-align: left;">A myeloid neoplasm that does not respond to treatment.</td>
<td style="text-align: left;">MONDO:0005170,MONDO:0004111</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855368</td>
<td style="text-align: left;">skin ewing sarcoma</td>
<td style="text-align: left;">NCIT:C172634</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Ewing Sarcoma</td>
<td style="text-align: left;">A rare Ewing sarcoma that arises from the skin.</td>
<td style="text-align: left;">MONDO:0018270,MONDO:0006414</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855377</td>
<td style="text-align: left;">oxyntic gland adenoma</td>
<td style="text-align: left;">NCIT:C172655</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oxyntic Gland Adenoma</td>
<td style="text-align: left;">A benign epithelial neoplasm composed of columnar cells with differentiation to chief cells, parietal cells, or both, with a high rate of progression to adenocarcinoma (submucosal invasion). (WHO 2019)</td>
<td style="text-align: left;">MONDO:0006221</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855378</td>
<td style="text-align: left;">gastroblastoma</td>
<td style="text-align: left;">NCIT:C172659</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastroblastoma</td>
<td style="text-align: left;">A very rare biphasic tumor arising in the gastric muscularis propria (usually of the antrum), generally in boys and young men. It is associated with MALAT1-GLI1 gene fusion. (WHO 2019)</td>
<td style="text-align: left;">MONDO:0001056</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855386</td>
<td style="text-align: left;">colorectal conventional adenoma</td>
<td style="text-align: left;">NCIT:C172680</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Conventional Adenoma</td>
<td style="text-align: left;">A premalignant colorectal neoplasm composed of dysplastic epithelium. The descriptor "conventional" distinguishes this from lesions in the serrated pathway. (WHO 2019)</td>
<td style="text-align: left;">MONDO:0005484</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855389</td>
<td style="text-align: left;">colorectal poorly cohesive adenocarcinoma</td>
<td style="text-align: left;">NCIT:C172694</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Poorly Cohesive Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma that arises from the colorectal mucosa and is characterized by the presence of isolated malignant cells or malignant cells that form small aggregates.</td>
<td style="text-align: left;">MONDO:0005008</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855390</td>
<td style="text-align: left;">colorectal adenoma-like adenocarcinoma</td>
<td style="text-align: left;">NCIT:C172699</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Adenoma-Like Adenocarcinoma</td>
<td style="text-align: left;">A well differentiated colorectal adenocarcinoma with good prognosis. It resembles a villous adenoma on the surface.</td>
<td style="text-align: left;">MONDO:0005008,MONDO:0003204</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855391</td>
<td style="text-align: left;">inflammatory bowel disease-associated colorectal adenocarcinoma</td>
<td style="text-align: left;">NCIT:C172700</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Inflammatory Bowel Disease-Associated Colorectal Adenocarcinoma</td>
<td style="text-align: left;">A colorectal adenocarcinoma that develops in patients with a history of inflammatory bowel disease.</td>
<td style="text-align: left;">MONDO:0005008</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855393</td>
<td style="text-align: left;">steatohepatitic hepatocellular carcinoma</td>
<td style="text-align: left;">NCIT:C172709</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Steatohepatitic Hepatocellular Carcinoma</td>
<td style="text-align: left;">Hepatocellular carcinoma characterized by the presence of steatohepatitis features, including macrovesicular steatosis, fibrosis, ballooning of malignant hepatocytes, Mallory bodies, and inflammation.</td>
<td style="text-align: left;">MONDO:0007256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855394</td>
<td style="text-align: left;">hepatocellular macrotrabecular massive carcinoma</td>
<td style="text-align: left;">NCIT:C172710</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatocellular Macrotrabecular Massive Carcinoma</td>
<td style="text-align: left;">Hepatocellular carcinoma characterized by more than 50% growth of macrotrabecular pattern (equal to or more than 6 to 10 cells thick). It presents with higher grade and stage compared to conventional hepatocellular carcinoma. It has poor prognosis with early recurrence and poor overall survival.</td>
<td style="text-align: left;">MONDO:0007256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855395</td>
<td style="text-align: left;">hepatocellular chromophobe carcinoma</td>
<td style="text-align: left;">NCIT:C172712</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatocellular Chromophobe Carcinoma</td>
<td style="text-align: left;">Hepatocellular carcinoma characterized by the presence of malignant cells with smooth chromophobic cytoplasm, abrupt focal nuclear anaplasia, and scattered microscopic pseudocysts.</td>
<td style="text-align: left;">MONDO:0007256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855396</td>
<td style="text-align: left;">hepatocellular neutrophil-rich carcinoma</td>
<td style="text-align: left;">NCIT:C172713</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatocellular Neutrophil-Rich Carcinoma</td>
<td style="text-align: left;">Hepatocellular carcinoma characterized by the presence of diffuse neutrophil infiltrates within the tumor.</td>
<td style="text-align: left;">MONDO:0007256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855397</td>
<td style="text-align: left;">small hepatocellular carcinoma</td>
<td style="text-align: left;">NCIT:C172714</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Hepatocellular Carcinoma</td>
<td style="text-align: left;">Hepatocellular carcinoma measuring equal to or less than 2 cm in diameter. It includes early hepatocellular carcinoma and small progressed hepatocellular carcinoma.</td>
<td style="text-align: left;">MONDO:0007256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855398</td>
<td style="text-align: left;">liver mixed adenoneuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C172718</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Liver Mixed Adenoneuroendocrine Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the liver and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.</td>
<td style="text-align: left;">MONDO:0006182,MONDO:0018531</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855401</td>
<td style="text-align: left;">gallbladder pyloric gland adenoma</td>
<td style="text-align: left;">NCIT:C172731</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Pyloric Gland Adenoma</td>
<td style="text-align: left;">A grossly visible non-invasive neoplasm of the gallbladder composed of uniform back-to-back mucinous glands arranged in a tubular configuration. (WHO 2019)</td>
<td style="text-align: left;">MONDO:0006216</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855408</td>
<td style="text-align: left;">pancreatic poorly cohesive adenocarcinoma</td>
<td style="text-align: left;">NCIT:C172811</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Poorly Cohesive Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma that arises from the pancreas and is characterized by the presence of isolated malignant cells or malignant cells that form small aggregates.</td>
<td style="text-align: left;">MONDO:0005184</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855409</td>
<td style="text-align: left;">pancreatic undifferentiated carcinoma with rhabdoid cells</td>
<td style="text-align: left;">NCIT:C172812</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Undifferentiated Carcinoma with Rhabdoid Cells</td>
<td style="text-align: left;">An undifferentiated carcinoma that arises from the pancreas. It is characterized by the presence of rhabdoid cells.</td>
<td style="text-align: left;">MONDO:0006478</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855413</td>
<td style="text-align: left;">conventional follicular dendritic cell sarcoma</td>
<td style="text-align: left;">NCIT:C172846</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conventional Follicular Dendritic Cell Sarcoma</td>
<td style="text-align: left;">Follicular dendritic cell sarcoma that is not associated with Epstein-Barr virus.</td>
<td style="text-align: left;">MONDO:0005764</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855418</td>
<td style="text-align: left;">digestive system soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C172852</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Digestive System Soft Tissue Neoplasm</td>
<td style="text-align: left;">A benign, intermediate, or malignant mesenchymal neoplasm that arises from the digestive system.</td>
<td style="text-align: left;">MONDO:0006424,MONDO:0021223</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855432</td>
<td style="text-align: left;">sinonasal spindle cell squamous carcinoma</td>
<td style="text-align: left;">NCIT:C173079</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sinonasal Spindle Cell Squamous Carcinoma</td>
<td style="text-align: left;">A poorly differentiated squamous cell carcinoma arising from the sinonasal tract. It is characterized by the presence of malignant cells with spindle cell features.</td>
<td style="text-align: left;">MONDO:0021663,MONDO:0044787</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855433</td>
<td style="text-align: left;">sinonasal lymphoepithelial carcinoma</td>
<td style="text-align: left;">NCIT:C173080</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sinonasal Lymphoepithelial Carcinoma</td>
<td style="text-align: left;">A nonkeratinizing squamous cell carcinoma arising from the sinonasal tract. It is characterized by the presence of large cells with vesicular nuclei and prominent nucleoli, a syncytial growth pattern, and a lymphoplasmacytic infiltrate.</td>
<td style="text-align: left;">MONDO:0002831</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855435</td>
<td style="text-align: left;">head and neck nut carcinoma</td>
<td style="text-align: left;">NCIT:C173087</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck NUT Carcinoma</td>
<td style="text-align: left;">A highly aggressive, poorly differentiated carcinoma that arises from the head and neck. Most cases are in the nasal cavity and paranasal sinuses. It is characterized by mutations and rearrangement of the NUT gene.</td>
<td style="text-align: left;">MONDO:0005563,MONDO:0002038</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855439</td>
<td style="text-align: left;">malignant sinonasal neoplasm</td>
<td style="text-align: left;">NCIT:C173097</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Sinonasal Neoplasm</td>
<td style="text-align: left;">A primary or metastatic malignant neoplasm involving the nasal cavity and paranasal sinuses.</td>
<td style="text-align: left;">MONDO:0056820,MONDO:0005627</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855471</td>
<td style="text-align: left;">peritoneal implant</td>
<td style="text-align: left;">NCIT:C173164</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Peritoneal Implant</td>
<td style="text-align: left;">Deposits of borderline, malignant, and rarely benign tumors, usually from the ovary, on the peritoneal surface.</td>
<td style="text-align: left;">MONDO:0006901</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855472</td>
<td style="text-align: left;">sinonasal ameloblastoma</td>
<td style="text-align: left;">NCIT:C173166</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sinonasal Ameloblastoma</td>
<td style="text-align: left;">A locally aggressive, primarily gnathic (jaw) tumor with a high propensity for recurrence. It originates wholly within the sinonasal tract, without connection to gnathic sites, arising from sinonasal epithelium and showing histological features identical to those of its counterpart originating in the jaw. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0056820</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855481</td>
<td style="text-align: left;">microsatellite stable colorectal carcinoma</td>
<td style="text-align: left;">NCIT:C173324</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Microsatellite Stable Colorectal Carcinoma</td>
<td style="text-align: left;">A colorectal carcinoma characterized by the absence of microsatellite instability.</td>
<td style="text-align: left;">MONDO:0024331</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855487</td>
<td style="text-align: left;">nasopharyngeal adenoid cystic carcinoma</td>
<td style="text-align: left;">NCIT:C173340</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nasopharyngeal Adenoid Cystic Carcinoma</td>
<td style="text-align: left;">An adenoid cystic carcinoma that arises from the nasopharynx.</td>
<td style="text-align: left;">MONDO:0006367,MONDO:0015459</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855489</td>
<td style="text-align: left;">ectopic pituitary neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C173345</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ectopic Pituitary Neuroendocrine Tumor</td>
<td style="text-align: left;">A pituitary neuroendocrine tumor that does not involve the sella turcica.</td>
<td style="text-align: left;">MONDO:0006373</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855495</td>
<td style="text-align: left;">cutaneous merkel cell carcinoma</td>
<td style="text-align: left;">NCIT:C173385</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Merkel Cell Carcinoma</td>
<td style="text-align: left;">A rare aggressive neuroendocrine carcinoma that arises from the skin and most often affects older individuals. It is usually located in the head, neck, and extremities. The tumor is composed of small round cells with scanty cytoplasm. Merkel cell polyomavirus is implicated in the majority of cases.</td>
<td style="text-align: left;">MONDO:0002656,MONDO:0019210</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855506</td>
<td style="text-align: left;">laryngeal chondroma</td>
<td style="text-align: left;">NCIT:C173406</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Laryngeal Chondroma</td>
<td style="text-align: left;">A benign neoplasm arising from hyaline cartilage of the larynx. It is characterized by the presence of chondrocytes, a lobulated growth pattern, and calcification.</td>
<td style="text-align: left;">MONDO:0002360,MONDO:0002354</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855507</td>
<td style="text-align: left;">laryngeal chondrosarcoma</td>
<td style="text-align: left;">NCIT:C173407</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Laryngeal Chondrosarcoma</td>
<td style="text-align: left;">A chondrosarcoma that arises from hyaline cartilage of the larynx.</td>
<td style="text-align: left;">MONDO:0002448,MONDO:0008977</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855526</td>
<td style="text-align: left;">head and neck melanocytic neoplasm</td>
<td style="text-align: left;">NCIT:C173488</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Melanocytic Neoplasm</td>
<td style="text-align: left;">A melanocytic neoplasm that arises from the skin or mucosal sites in the head and neck region.</td>
<td style="text-align: left;">MONDO:0021143,MONDO:0005586</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855532</td>
<td style="text-align: left;">refractory primitive neuroectodermal tumor</td>
<td style="text-align: left;">NCIT:C173565</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Primitive Neuroectodermal Tumor</td>
<td style="text-align: left;">Primitive neuroectodermal tumor that does not respond to treatment.</td>
<td style="text-align: left;">MONDO:0005462,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855540</td>
<td style="text-align: left;">head and neck heterotopia-associated carcinoma</td>
<td style="text-align: left;">NCIT:C173588</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Heterotopia-Associated Carcinoma</td>
<td style="text-align: left;">A head and neck carcinoma arising from heterotopic tissue elements (i.e. histologically normal tissue of a particular type that is present at an abnormal anatomical site). (WHO 2017)</td>
<td style="text-align: left;">MONDO:0002038</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855551</td>
<td style="text-align: left;">salivary gland poorly differentiated carcinoma</td>
<td style="text-align: left;">NCIT:C173649</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Salivary Gland Poorly Differentiated Carcinoma</td>
<td style="text-align: left;">A high-grade carcinoma that arises from the salivary glands. This category includes large and small cell types with or without neuroendocrine differentiation.</td>
<td style="text-align: left;">MONDO:0000521</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855553</td>
<td style="text-align: left;">salivary gland lymphadenoma</td>
<td style="text-align: left;">NCIT:C173659</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Salivary Gland Lymphadenoma</td>
<td style="text-align: left;">A rare benign salivary gland tumor that consists of a well-circumscribed biphasic proliferation of epithelial cells and reactive lymphoid tissue. Sebaceous and non-sebaceous forms can be distinguished. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0021460</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855558</td>
<td style="text-align: left;">sialolipoma</td>
<td style="text-align: left;">NCIT:C173682</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sialolipoma</td>
<td style="text-align: left;">A benign salivary gland neoplasm composed of mature adipose tissue and epithelial tissue. It usually occurs in the parotid gland.</td>
<td style="text-align: left;">MONDO:0021460</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855575</td>
<td style="text-align: left;">appendix disorder</td>
<td style="text-align: left;">NCIT:C173799</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the appendix.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855576</td>
<td style="text-align: left;">retroperitoneal undifferentiated pleomorphic sarcoma</td>
<td style="text-align: left;">NCIT:C173808</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Retroperitoneal Undifferentiated Pleomorphic Sarcoma</td>
<td style="text-align: left;">A rare undifferentiated pleomorphic sarcoma that arises from the retroperitoneum.</td>
<td style="text-align: left;">MONDO:0001501,MONDO:0002142</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855577</td>
<td style="text-align: left;">lung alveolar soft part sarcoma</td>
<td style="text-align: left;">NCIT:C173809</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Alveolar Soft Part Sarcoma</td>
<td style="text-align: left;">An exceptionally rare alveolar soft part sarcoma that arises from the lung.</td>
<td style="text-align: left;">MONDO:0002426,MONDO:0011655</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855584</td>
<td style="text-align: left;">maxillofacial neoplasm</td>
<td style="text-align: left;">NCIT:C173845</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Maxillofacial Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects a maxillofacial bone.</td>
<td style="text-align: left;">MONDO:0024653</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855590</td>
<td style="text-align: left;">craniofacial fibrous dysplasia</td>
<td style="text-align: left;">NCIT:C173926</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Craniofacial Fibrous Dysplasia</td>
<td style="text-align: left;">Fibrous dysplasia affecting the craniofacial bones.</td>
<td style="text-align: left;">MONDO:0000845</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855591</td>
<td style="text-align: left;">benign head and neck neoplasm</td>
<td style="text-align: left;">NCIT:C173932</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Head and Neck Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the head and neck and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0005165,MONDO:0005586</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855593</td>
<td style="text-align: left;">aggressive papillary tumor</td>
<td style="text-align: left;">NCIT:C174022</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Aggressive Papillary Tumor</td>
<td style="text-align: left;">A locally invasive, papillary epithelial neoplasm arising in any area of the middle ear, including the mastoid process and air cells, and may fill the tympanic cavity. It is characterized by the presence of a papillary glandular pattern, with complex interdigitating papillae lying loosely or infiltrating fibrous connective tissue. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0021366,MONDO:0021096</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855594</td>
<td style="text-align: left;">benign inner ear neoplasm</td>
<td style="text-align: left;">NCIT:C174023</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Inner Ear Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the inner ear and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include vestibular schwannoma and lipoma.</td>
<td style="text-align: left;">MONDO:0021474,MONDO:0024320</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855597</td>
<td style="text-align: left;">malignant inner ear neoplasm</td>
<td style="text-align: left;">NCIT:C174026</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Inner Ear Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that affects the inner ear.</td>
<td style="text-align: left;">MONDO:0003277,MONDO:0024320</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855616</td>
<td style="text-align: left;">conjunctival oncocytoma</td>
<td style="text-align: left;">NCIT:C174388</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Oncocytoma</td>
<td style="text-align: left;">A benign epithelial neoplasm that arises from the conjunctiva. It is characterized by the presence of oncocytic cells with abundant eosinophilic and granular cytoplasm.</td>
<td style="text-align: left;">MONDO:0010795,MONDO:0006105</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855618</td>
<td style="text-align: left;">conjunctival spindle cell carcinoma</td>
<td style="text-align: left;">NCIT:C174398</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Spindle Cell Carcinoma</td>
<td style="text-align: left;">A conjunctival squamous cell carcinoma characterized by the presence of pleomorphic spindle cells.</td>
<td style="text-align: left;">MONDO:0006173,MONDO:0021663</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855620</td>
<td style="text-align: left;">conjunctival carcinoma</td>
<td style="text-align: left;">NCIT:C174403</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the conjunctiva.</td>
<td style="text-align: left;">MONDO:0002466,MONDO:0003454</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855625</td>
<td style="text-align: left;">conjunctival subepithelial (stromal) nevus</td>
<td style="text-align: left;">NCIT:C174426</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Subepithelial (Stromal) Nevus</td>
<td style="text-align: left;">A conjunctival nevus characterized by an intrastromal proliferation of predominantly type B nevus cells.</td>
<td style="text-align: left;">MONDO:0006172</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855630</td>
<td style="text-align: left;">conjunctival blue nevus</td>
<td style="text-align: left;">NCIT:C174452</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Blue Nevus</td>
<td style="text-align: left;">A benign melanocytic neoplasm that arises from the conjunctiva. It is characterized by the presence of dendritic and spindle-shaped melanocytes in the subepithelial connective tissue. It presents as a dark brown or black, slightly elevated conjunctival lesion.</td>
<td style="text-align: left;">MONDO:0006172,MONDO:0006680</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855631</td>
<td style="text-align: left;">atypical ewing sarcoma</td>
<td style="text-align: left;">NCIT:C174456</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Ewing Sarcoma</td>
<td style="text-align: left;">Ewing sarcoma characterized by the presence of large malignant cells with prominent nucleoli and irregular contours.</td>
<td style="text-align: left;">MONDO:0012817</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855634</td>
<td style="text-align: left;">metastatic malignant neoplasm in the conjunctiva</td>
<td style="text-align: left;">NCIT:C174496</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Conjunctiva</td>
<td style="text-align: left;">A malignant neoplasm that has spread to the conjunctiva from another anatomic site.</td>
<td style="text-align: left;">MONDO:0044913,MONDO:0003454</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855635</td>
<td style="text-align: left;">iris epithelioid cell melanoma</td>
<td style="text-align: left;">NCIT:C174498</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Iris Epithelioid Cell Melanoma</td>
<td style="text-align: left;">An iris melanoma characterized by the presence of malignant large epithelioid melanocytes.</td>
<td style="text-align: left;">MONDO:0004064,MONDO:0006200</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855640</td>
<td style="text-align: left;">iris mixed epithelioid and spindle cell melanoma</td>
<td style="text-align: left;">NCIT:C174506</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Iris Mixed Epithelioid and Spindle Cell Melanoma</td>
<td style="text-align: left;">A melanoma that arises from the iris and is characterized by the presence of a mixture of spindle A melanoma cells, spindle B melanoma cells, and epithelioid melanoma cells.</td>
<td style="text-align: left;">MONDO:0004064,MONDO:0003910</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855641</td>
<td style="text-align: left;">metastatic malignant neoplasm in the uvea</td>
<td style="text-align: left;">NCIT:C174507</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Uvea</td>
<td style="text-align: left;">A malignant neoplasm that has spread to the uvea from another anatomic site.</td>
<td style="text-align: left;">MONDO:0002659,MONDO:0044913</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855646</td>
<td style="text-align: left;">retinal astrocytoma</td>
<td style="text-align: left;">NCIT:C174539</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Retinal Astrocytoma</td>
<td style="text-align: left;">An astrocytoma that arises from the neurosensory retina. It is often found in association with the tuberous sclerosis complex.</td>
<td style="text-align: left;">MONDO:0021231,MONDO:0024649</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855649</td>
<td style="text-align: left;">adenoma of the retinal pigment epithelium</td>
<td style="text-align: left;">NCIT:C174550</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adenoma of the Retinal Pigment Epithelium</td>
<td style="text-align: left;">A benign neoplasm that arises from the retinal pigment epithelium. It consists of cords and tubules of variably pigmented proliferating retinal pigment epithelium cells, separated by fibrous stroma. Malignant transformation is rare. (WHO 2018)</td>
<td style="text-align: left;">MONDO:0021453,MONDO:0004972</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855650</td>
<td style="text-align: left;">retinal pigment epithelium adenocarcinoma</td>
<td style="text-align: left;">NCIT:C174551</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Retinal Pigment Epithelium Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma that arises from the retinal pigment epithelium. The prognosis is good if the tumor has not extended extraocularly.</td>
<td style="text-align: left;">MONDO:0002466,MONDO:0003072,MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855653</td>
<td style="text-align: left;">ciliary body adenoma</td>
<td style="text-align: left;">NCIT:C174560</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ciliary Body Adenoma</td>
<td style="text-align: left;">A benign neoplasm of the pigmented ciliary epithelium (pigmented epithelial adenoma) and/or the non-pigmented ciliary epithelium (non-pigmented epithelial adenoma). (WHO 2018)</td>
<td style="text-align: left;">MONDO:0021486,MONDO:0004972</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855654</td>
<td style="text-align: left;">ciliary body adenocarcinoma</td>
<td style="text-align: left;">NCIT:C174561</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ciliary Body Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma that arises from the pigmented or non-pigmented ciliary epithelium.</td>
<td style="text-align: left;">MONDO:0002466,MONDO:0002969,MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855667</td>
<td style="text-align: left;">incidental gallbladder carcinoma</td>
<td style="text-align: left;">NCIT:C175214</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Incidental Gallbladder Carcinoma</td>
<td style="text-align: left;">Gallbladder carcinoma that is discovered incidental to gallbladder surgery for another indication.</td>
<td style="text-align: left;">MONDO:0003220</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855668</td>
<td style="text-align: left;">metastatic malignant neoplasm in the regional lymph nodes</td>
<td style="text-align: left;">NCIT:C175222</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Regional Lymph Nodes</td>
<td style="text-align: left;">The spread of a malignant neoplasm from its original site of growth to nearby lymph nodes.</td>
<td style="text-align: left;">MONDO:0005438</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855669</td>
<td style="text-align: left;">lacrimal gland oncocytoma</td>
<td style="text-align: left;">NCIT:C175264</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lacrimal Gland Oncocytoma</td>
<td style="text-align: left;">A benign epithelial neoplasm that arises from the lacrimal gland and is characterized by the presence of oncocytic cells with abundant eosinophilic and granular cytoplasm.</td>
<td style="text-align: left;">MONDO:0010795,MONDO:0021488</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855671</td>
<td style="text-align: left;">lacrimal gland myoepithelial carcinoma</td>
<td style="text-align: left;">NCIT:C175274</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lacrimal Gland Myoepithelial Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the lacrimal gland and is characterized by the presence of a malignant cellular infiltrate exhibiting myoepithelial differentiation.</td>
<td style="text-align: left;">MONDO:0003158,MONDO:0002463</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855672</td>
<td style="text-align: left;">lacrimal gland carcinosarcoma</td>
<td style="text-align: left;">NCIT:C175279</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lacrimal Gland Carcinosarcoma</td>
<td style="text-align: left;">An aggressive high grade malignant neoplasm that arises from the lacrimal gland and is characterized by the presence of a malignant epithelial and a sarcomatous component.</td>
<td style="text-align: left;">MONDO:0002464,MONDO:0002928</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855673</td>
<td style="text-align: left;">lacrimal gland epithelial-myoepithelial carcinoma</td>
<td style="text-align: left;">NCIT:C175288</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lacrimal Gland Epithelial-Myoepithelial Carcinoma</td>
<td style="text-align: left;">A rare slow-growing carcinoma that arises from the lacrimal gland and is characterized by the presence of duct-like structures lined by two layers of cells; an inner layer composed of epithelial-type cells and an outer layer composed of clear, myoepithelial-type cells.</td>
<td style="text-align: left;">MONDO:0002463,MONDO:0003389</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855674</td>
<td style="text-align: left;">lacrimal gland acinic cell carcinoma</td>
<td style="text-align: left;">NCIT:C175290</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lacrimal Gland Acinic Cell Carcinoma</td>
<td style="text-align: left;">An extremely rare low-grade salivary gland-type carcinoma that arises from the lacrimal gland and exhibits acinar differentiation.</td>
<td style="text-align: left;">MONDO:0002475,MONDO:0004965</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855675</td>
<td style="text-align: left;">lacrimal gland warthin tumor</td>
<td style="text-align: left;">NCIT:C175291</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lacrimal Gland Warthin Tumor</td>
<td style="text-align: left;">A rare benign tumor that arises from the lacrimal gland and is characterized by the presence of an oncocytic epithelial component and dense lymphoid stroma.</td>
<td style="text-align: left;">MONDO:0021488,MONDO:0006493</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855679</td>
<td style="text-align: left;">lacrimal drainage system neoplasm</td>
<td style="text-align: left;">NCIT:C175316</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lacrimal Drainage System Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the lacrimal drainage system.</td>
<td style="text-align: left;">MONDO:0002460</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855700</td>
<td style="text-align: left;">primary uveal non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C175451</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Uveal Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">An indolent, low-grade B-cell non-Hodgkin lymphoma that arises from the choroid, iris, or ciliary body. It is characterized by the presence of a diffuse infiltrate of small, round lymphocytes. Lymphoid follicles with germinal centers may be present. In the past these tumors were termed 'reactive lymphoid hyperplasia'. Now they are considered low-grade B-cell lymphomas, most commonly extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue.</td>
<td style="text-align: left;">MONDO:0004351,MONDO:0002659,MONDO:0017594</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855708</td>
<td style="text-align: left;">conjunctival myxoma</td>
<td style="text-align: left;">NCIT:C175495</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Myxoma</td>
<td style="text-align: left;">A rare myxoma arising from the bulbar conjunctiva.</td>
<td style="text-align: left;">MONDO:0044784,MONDO:0006105</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855710</td>
<td style="text-align: left;">conjunctival hemangioma</td>
<td style="text-align: left;">NCIT:C175497</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Hemangioma</td>
<td style="text-align: left;">A hemangioma that arises from the conjunctiva.</td>
<td style="text-align: left;">MONDO:0006105,MONDO:0006500</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855711</td>
<td style="text-align: left;">conjunctival lymphangioma</td>
<td style="text-align: left;">NCIT:C175498</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Lymphangioma</td>
<td style="text-align: left;">A lymphangioma that arises from the conjunctiva.</td>
<td style="text-align: left;">MONDO:0002013,MONDO:0006105</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855718</td>
<td style="text-align: left;">malignant hypothalamic neoplasm</td>
<td style="text-align: left;">NCIT:C175539</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Hypothalamic Neoplasm</td>
<td style="text-align: left;">A primary or metastatic malignant neoplasm that affects the hypothalamus.</td>
<td style="text-align: left;">MONDO:0002786,MONDO:0006799</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855721</td>
<td style="text-align: left;">breast polymorphous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C175604</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Polymorphous Adenocarcinoma</td>
<td style="text-align: left;">A rare, low grade malignant epithelial neoplasm arising from the breast. It is characterized by the presence of uniform, small to medium size malignant epithelial cells and an infiltrating pattern.</td>
<td style="text-align: left;">MONDO:0006256,MONDO:0004988</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855722</td>
<td style="text-align: left;">breast tall cell carcinoma with reversed polarity</td>
<td style="text-align: left;">NCIT:C175607</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Tall Cell Carcinoma with Reversed Polarity</td>
<td style="text-align: left;">A rare subtype of invasive breast carcinoma characterized by tall columnar cells with reversed nuclear polarity, arranged in solid and solid papillary patterns, most commonly associated with IDH2 p.Arg172 hotspot mutations. (WHO 2019)</td>
<td style="text-align: left;">MONDO:0006256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855727</td>
<td style="text-align: left;">locally invasive desmoid-type fibromatosis</td>
<td style="text-align: left;">NCIT:C175667</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Locally Invasive Desmoid-Type Fibromatosis</td>
<td style="text-align: left;">Desmoid-type fibromatosis that has invaded the surrounding tissues.</td>
<td style="text-align: left;">MONDO:0007608</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855734</td>
<td style="text-align: left;">metastatic malignant neoplasm in the supraclavicular lymph nodes</td>
<td style="text-align: left;">NCIT:C175934</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Supraclavicular Lymph Nodes</td>
<td style="text-align: left;">The spread of a malignant neoplasm from its original site of growth to supraclavicular lymph nodes.</td>
<td style="text-align: left;">MONDO:0005438</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855737</td>
<td style="text-align: left;">breast classic lobular carcinoma in situ</td>
<td style="text-align: left;">NCIT:C175949</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Classic Lobular Carcinoma In Situ</td>
<td style="text-align: left;">Breast lobular carcinoma in situ characterized by the presence of dyscohesive proliferations of type A and/or type B epithelial cells. Type A cells are small cells with uniform hyperchromatic nuclei, whereas type B cells have slightly larger vesicular nuclei, with mild variability in size and shape and with small nucleoli. The cell populations may be mixed in individual proliferations. (WHO 2019)</td>
<td style="text-align: left;">MONDO:0006270</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855738</td>
<td style="text-align: left;">breast florid lobular carcinoma in situ</td>
<td style="text-align: left;">NCIT:C175950</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Florid Lobular Carcinoma In Situ</td>
<td style="text-align: left;">Breast lobular carcinoma in situ characterized by the presence of neoplastic cells with cytological features identical to classic lobular carcinoma in situ, but with marked distention of terminal ductal lobular units or ducts.</td>
<td style="text-align: left;">MONDO:0006270</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855740</td>
<td style="text-align: left;">breast ductal carcinoma in situ, comedo type</td>
<td style="text-align: left;">NCIT:C176005</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Ductal Carcinoma In Situ, Comedo Type</td>
<td style="text-align: left;">Breast ductal carcinoma in situ characterized by the presence of sheets of tumor cells with evidence of central necrosis and associated karyorrhectic/nuclear debris.</td>
<td style="text-align: left;">MONDO:0003575,MONDO:0005023</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855747</td>
<td style="text-align: left;">ocular surface squamous neoplasia</td>
<td style="text-align: left;">NCIT:C176043</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ocular Surface Squamous Neoplasia</td>
<td style="text-align: left;">A clinical term that refers to neoplastic lesions that arise from the conjunctival squamous epithelium and includes squamous intraepithelial neoplasia and squamous cell carcinoma.</td>
<td style="text-align: left;">MONDO:0020204</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855748</td>
<td style="text-align: left;">breast cellular fibroadenoma</td>
<td style="text-align: left;">NCIT:C176045</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Cellular Fibroadenoma</td>
<td style="text-align: left;">A fibroadenoma characterized by the presence of a pericanalicular growth pattern, increased stromal cellularity, and less than 2 mitoses per 10 high-power fields.</td>
<td style="text-align: left;">MONDO:0002056</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855749</td>
<td style="text-align: left;">primary breast angiosarcoma</td>
<td style="text-align: left;">NCIT:C176251</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Breast Angiosarcoma</td>
<td style="text-align: left;">An angiosarcoma that arises from the breast parenchyma and is not associated with radiation exposure.</td>
<td style="text-align: left;">MONDO:0003024</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855751</td>
<td style="text-align: left;">breast angiolipoma</td>
<td style="text-align: left;">NCIT:C176255</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Angiolipoma</td>
<td style="text-align: left;">An angiolipoma that arises from the breast. The majority are located in the subcutaneous tissue overlying the breast parenchyma, rather than in breast parenchyma.</td>
<td style="text-align: left;">MONDO:0000970,MONDO:0006085</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855753</td>
<td style="text-align: left;">breast schwannoma</td>
<td style="text-align: left;">NCIT:C176414</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Schwannoma</td>
<td style="text-align: left;">A schwannoma that arises from the breast.</td>
<td style="text-align: left;">MONDO:0000620,MONDO:0004820</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855754</td>
<td style="text-align: left;">breast neurofibroma</td>
<td style="text-align: left;">NCIT:C176415</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Neurofibroma</td>
<td style="text-align: left;">A neurofibroma that arises from the breast.</td>
<td style="text-align: left;">MONDO:0000620,MONDO:0016755</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855756</td>
<td style="text-align: left;">synovial chondrosarcoma</td>
<td style="text-align: left;">NCIT:C176467</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Synovial Chondrosarcoma</td>
<td style="text-align: left;">An extremely rare chondrosarcoma arising from the synovium either as a de novo neoplasm or secondary to synovial chondromatosis.</td>
<td style="text-align: left;">MONDO:0018078,MONDO:0002403,MONDO:0008977</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855757</td>
<td style="text-align: left;">male breast carcinoma in situ</td>
<td style="text-align: left;">NCIT:C176503</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Male Breast Carcinoma In Situ</td>
<td style="text-align: left;">A proliferation of atypical neoplastic epithelial cells confined to the mammary ducts of the male breast. It includes the entire spectrum of carcinoma in situ observed in the female breast. It usually develops in the retroareolar region.</td>
<td style="text-align: left;">MONDO:0005628,MONDO:0004658</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855758</td>
<td style="text-align: left;">invasive male breast carcinoma</td>
<td style="text-align: left;">NCIT:C176504</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Male Breast Carcinoma</td>
<td style="text-align: left;">A rare invasive carcinoma that arises from the male breast. Morphologically, it is similar to the invasive carcinomas that arise from the female breast. It usually develops in the retroareolar region.</td>
<td style="text-align: left;">MONDO:0006256,MONDO:0005628</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855763</td>
<td style="text-align: left;">invasive female breast carcinoma</td>
<td style="text-align: left;">NCIT:C176579</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Female Breast Carcinoma</td>
<td style="text-align: left;">An invasive carcinoma that arises from the breast in females.</td>
<td style="text-align: left;">MONDO:0006256,MONDO:0004379</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855764</td>
<td style="text-align: left;">female breast carcinoma in situ</td>
<td style="text-align: left;">NCIT:C176580</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Female Breast Carcinoma In Situ</td>
<td style="text-align: left;">A proliferation of atypical neoplastic epithelial cells confined to the mammary ducts of the female breast.</td>
<td style="text-align: left;">MONDO:0004658,MONDO:0004379</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855783</td>
<td style="text-align: left;">functioning lung neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C176705</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Functioning Lung Neuroendocrine Tumor</td>
<td style="text-align: left;">A lung neuroendocrine tumor that is associated with carcinoid syndrome.</td>
<td style="text-align: left;">MONDO:0021120,MONDO:0006041</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855784</td>
<td style="text-align: left;">non-functioning lung neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C176706</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Functioning Lung Neuroendocrine Tumor</td>
<td style="text-align: left;">A lung neuroendocrine tumor that is not associated with carcinoid syndrome.</td>
<td style="text-align: left;">MONDO:0021119,MONDO:0006041</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855809</td>
<td style="text-align: left;">metastatic malignant thoracic neoplasm</td>
<td style="text-align: left;">NCIT:C176862</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Thoracic Neoplasm</td>
<td style="text-align: left;">A malignant thoracic neoplasm that has spread from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0003274</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855811</td>
<td style="text-align: left;">psammocarcinoma</td>
<td style="text-align: left;">NCIT:C176887</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Psammocarcinoma</td>
<td style="text-align: left;">An extremely rare variant of serous carcinoma arising from the ovary or peritoneum. It is characterized by extensive formation of psammoma bodies, low-grade cytological features, and invasion of surrounding structures.</td>
<td style="text-align: left;">MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855861</td>
<td style="text-align: left;">lipoma-like atypical lipomatous tumor/well differentiated liposarcoma</td>
<td style="text-align: left;">NCIT:C176979</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lipoma-Like Atypical Lipomatous Tumor/Well Differentiated Liposarcoma</td>
<td style="text-align: left;">An atypical lipomatous tumor/well differentiated liposarcoma composed of mature adipocytes in which, unlike in benign lipoma, substantial variation in cell size is appreciated alongside nuclear atypia in fat cells or stromal spindle cells. (WHO 2020)</td>
<td style="text-align: left;">MONDO:0006097</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855862</td>
<td style="text-align: left;">superficial atypical lipomatous tumor</td>
<td style="text-align: left;">NCIT:C176980</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Superficial Atypical Lipomatous Tumor</td>
<td style="text-align: left;">A locally aggressive mesenchymal neoplasm of a superficial body structure that is characterized by the presence of an adipocytic proliferation exhibiting at least focal nuclear atypia in both adipocytes and stromal cells. Amplification of MDM2 and/or CDK4 is almost always present.</td>
<td style="text-align: left;">MONDO:0006097</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855863</td>
<td style="text-align: left;">atypical lipomatous tumor/well differentiated liposarcoma of deep soft tissue</td>
<td style="text-align: left;">NCIT:C176981</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Lipomatous Tumor/Well Differentiated Liposarcoma of Deep Soft Tissue</td>
<td style="text-align: left;">An atypical lipomatous tumor/well differentiated liposarcoma that occurs in deep soft tissue.</td>
<td style="text-align: left;">MONDO:0006097</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855864</td>
<td style="text-align: left;">myxoid pleomorphic liposarcoma</td>
<td style="text-align: left;">NCIT:C176989</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myxoid Pleomorphic Liposarcoma</td>
<td style="text-align: left;">An exceptionally rare, aggressive adipocytic neoplasm, typically occurring in children and adolescents. Myxoid pleomorphic liposarcoma shows mixed histological features of conventional myxoid liposarcoma and pleomorphic liposarcoma and lacks the gene fusions and amplifications of myxoid liposarcoma, atypical lipomatous tumor, and dedifferentiated liposarcoma. (WHO 2020)</td>
<td style="text-align: left;">MONDO:0005060</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855883</td>
<td style="text-align: left;">plaque-like dermatofibrosarcoma protuberans</td>
<td style="text-align: left;">NCIT:C177325</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Plaque-Like Dermatofibrosarcoma Protuberans</td>
<td style="text-align: left;">A rare variant of dermatofibrosarcoma protuberans characterized by plaque-like growth, resembling plaque-like CD34-positive dermal fibroma.</td>
<td style="text-align: left;">MONDO:0011934</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855884</td>
<td style="text-align: left;">somatic-type malignancy</td>
<td style="text-align: left;">NCIT:C177364</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Somatic-Type Malignancy</td>
<td style="text-align: left;">A malignant non-germ cell component that typically develops secondarily within a germ cell tumor. The malignant cellular component is usually sarcomatous or carcinomatous.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855885</td>
<td style="text-align: left;">epithelioid myxofibrosarcoma</td>
<td style="text-align: left;">NCIT:C177414</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Epithelioid Myxofibrosarcoma</td>
<td style="text-align: left;">A rare subtype of myxofibrosarcoma composed predominantly of malignant epithelioid cells with abundant eosinophilic cytoplasm.</td>
<td style="text-align: left;">MONDO:0019202</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855891</td>
<td style="text-align: left;">bladder flat urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C177531</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Flat Urothelial Carcinoma</td>
<td style="text-align: left;">An in situ or invasive urothelial carcinoma that arises from the bladder wall and does not grow toward the hollow part of the bladder.</td>
<td style="text-align: left;">MONDO:0005611</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855897</td>
<td style="text-align: left;">epithelioid hemangioendothelioma with wwtr1-camta1 gene fusion</td>
<td style="text-align: left;">NCIT:C177552</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Epithelioid Hemangioendothelioma with WWTR1-CAMTA1 Gene Fusion</td>
<td style="text-align: left;">Epithelioid hemangioendothelioma characterized by a t(1;3)(p36;q23-q25) translocation, resulting in a WWTR1-CAMTA1 gene fusion. This translocation and associated gene fusion occur in more than 90% of epithelioid hemangioendotheliomas.</td>
<td style="text-align: left;">MONDO:0015523</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855898</td>
<td style="text-align: left;">epithelioid hemangioendothelioma with yap1-tfe3 gene fusion</td>
<td style="text-align: left;">NCIT:C177553</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Epithelioid Hemangioendothelioma with YAP1-TFE3 Gene Fusion</td>
<td style="text-align: left;">Epithelioid hemangioendothelioma characterized by a YAP1-TFE3 gene fusion. This gene fusion occurs in a subset of epithelioid hemangioendotheliomas characterized by the presence of well-formed vessels lined by epithelioid endothelial cells with abundant eosinophilic cytoplasm. Patients with YAP1-TFE3 gene fusion tumors tend to be younger than those with a WWTR1-CAMTA1 gene fusion.</td>
<td style="text-align: left;">MONDO:0015523</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855909</td>
<td style="text-align: left;">who grade 1 glioma</td>
<td style="text-align: left;">NCIT:C177797</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">WHO Grade 1 Glioma</td>
<td style="text-align: left;">A category of low-grade gliomas that includes subependymal giant cell astrocytoma, pilocytic astrocytoma, angiocentric glioma, and subependymoma.</td>
<td style="text-align: left;">MONDO:0021637</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855914</td>
<td style="text-align: left;">ebv-associated smooth muscle tumor</td>
<td style="text-align: left;">NCIT:C178217</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">EBV-Associated Smooth Muscle Tumor</td>
<td style="text-align: left;">A rare smooth muscle neoplasm of uncertain biological potential. It is associated with Epstein-Barr virus infection and seen in patients with immunodeficiency, including primary immunodeficiency, HIV/AIDS infection, and post-transplant immunosuppression.</td>
<td style="text-align: left;">MONDO:0006975</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855915</td>
<td style="text-align: left;">pleomorphic leiomyosarcoma</td>
<td style="text-align: left;">NCIT:C178220</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pleomorphic Leiomyosarcoma</td>
<td style="text-align: left;">A leiomyosarcoma characterized by the presence of poorly differentiated areas with pleomorphic appearance, in addition to areas with typical morphologic features.</td>
<td style="text-align: left;">MONDO:0005058</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855916</td>
<td style="text-align: left;">epithelioid schwannoma</td>
<td style="text-align: left;">NCIT:C178245</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Epithelioid Schwannoma</td>
<td style="text-align: left;">A schwannoma characterized by the presence of epithelioid cells with eosinophilic cytoplasm, within a myxoid and/or hyalinized stroma.</td>
<td style="text-align: left;">MONDO:0002546</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855935</td>
<td style="text-align: left;">gastric melanoma</td>
<td style="text-align: left;">NCIT:C178519</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Melanoma</td>
<td style="text-align: left;">A melanoma that arises from mucosa of the stomach.</td>
<td style="text-align: left;">MONDO:0001056,MONDO:0045070</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855938</td>
<td style="text-align: left;">yolk sac tumor with somatic-type malignancy</td>
<td style="text-align: left;">NCIT:C178523</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Yolk Sac Tumor with Somatic-Type Malignancy</td>
<td style="text-align: left;">A yolk sac tumor that is characterized by morphologic transformation to somatic-type malignancy. The somatic-type malignant component most often is sarcomatous or carcinomatous.</td>
<td style="text-align: left;">MONDO:0005744</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855939</td>
<td style="text-align: left;">conventional chordoma</td>
<td style="text-align: left;">NCIT:C178563</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conventional Chordoma</td>
<td style="text-align: left;">A malignant bone tumor arising from the remnants of the fetal notochord. It is characterized by the presence of large epithelioid cells with clear to light eosinophilic cytoplasm. Some of the cells are large with bubbly, vacuolated cytoplasm (physaliphorous cells). The cells form cords and nests that are embedded within an extracellular myxoid matrix.</td>
<td style="text-align: left;">MONDO:0008978</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855941</td>
<td style="text-align: left;">bone langerhans cell histiocytosis</td>
<td style="text-align: left;">NCIT:C178607</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Langerhans Cell Histiocytosis</td>
<td style="text-align: left;">Langerhans cell histiocytosis that affects the bone.</td>
<td style="text-align: left;">MONDO:0019060,MONDO:0018310</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855942</td>
<td style="text-align: left;">bone erdheim-chester disease</td>
<td style="text-align: left;">NCIT:C178609</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Erdheim-Chester Disease</td>
<td style="text-align: left;">Erdheim-Chester disease affecting the bone.</td>
<td style="text-align: left;">MONDO:0019060,MONDO:0018153</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855961</td>
<td style="text-align: left;">b-cell lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C179052</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">B-Cell Lymphoproliferative Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic proliferation of B-lymphocytes.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855962</td>
<td style="text-align: left;">t/nk-cell lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C179053</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">T/NK-Cell Lymphoproliferative Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic proliferation of T-lymphocytes and/or NK-cells.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855976</td>
<td style="text-align: left;">ovarian signet ring cell adenocarcinoma</td>
<td style="text-align: left;">NCIT:C179208</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Signet Ring Cell Adenocarcinoma</td>
<td style="text-align: left;">An extremely rare adenocarcinoma that arises from the ovary. It is characterized by the presence of signet ring malignant epithelial cells.</td>
<td style="text-align: left;">MONDO:0005092,MONDO:0002752</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855983</td>
<td style="text-align: left;">borderline ovarian seromucinous tumor</td>
<td style="text-align: left;">NCIT:C179259</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Borderline Ovarian Seromucinous Tumor</td>
<td style="text-align: left;">A low grade ovarian epithelial neoplasm characterized by the presence of atypical neoplastic serous and mucinous cells.</td>
<td style="text-align: left;">MONDO:0016093,MONDO:0003811</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855987</td>
<td style="text-align: left;">mesonephric-like adenocarcinoma</td>
<td style="text-align: left;">NCIT:C179320</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mesonephric-Like Adenocarcinoma</td>
<td style="text-align: left;">An exceedingly rare adenocarcinoma that arises from the uterine corpus and ovary and displays mesonephric differentiation. Some tumors are thought to derive from mesonephric duct (Wolffian duct) remnants. Others may have a Mullerian duct lineage.</td>
<td style="text-align: left;">MONDO:0001416,MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855990</td>
<td style="text-align: left;">ovarian dedifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C179334</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Dedifferentiated Carcinoma</td>
<td style="text-align: left;">An aggressive carcinoma arising from the ovary.  Most patients present with advanced disease.  Microscopically, it is characterized by the presence of an undifferentiated carcinomatous component and a second component of either endometrioid carcinoma or, rarely, serous carcinoma.</td>
<td style="text-align: left;">MONDO:0005140</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855991</td>
<td style="text-align: left;">ovarian mixed cell adenocarcinoma</td>
<td style="text-align: left;">NCIT:C179339</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Mixed Cell Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma that arises from the ovary and is characterized by the presence of two or more adenocarcinoma components, most often endometrioid and clear cell.</td>
<td style="text-align: left;">MONDO:0002752</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855993</td>
<td style="text-align: left;">giant cell-rich osteosarcoma</td>
<td style="text-align: left;">NCIT:C179410</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Giant Cell-Rich Osteosarcoma</td>
<td style="text-align: left;">An exceedingly rare, high-grade variant of conventional osteosarcoma characterized by the presence of numerous osteoclast-like giant cells and variable amount of tumor osteoid.</td>
<td style="text-align: left;">MONDO:0002631</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855995</td>
<td style="text-align: left;">unresectable plexiform neurofibroma</td>
<td style="text-align: left;">NCIT:C179423</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Unresectable Plexiform Neurofibroma</td>
<td style="text-align: left;">Plexiform neurofibroma that is not amenable to surgical resection.</td>
<td style="text-align: left;">MONDO:0003304</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0855999</td>
<td style="text-align: left;">ovarian neuroectodermal-type tumor</td>
<td style="text-align: left;">NCIT:C179474</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Neuroectodermal-Type Tumor</td>
<td style="text-align: left;">A rare ovarian malignant tumor with neuroectodermal differentiation. It is characterized either by a small round cell proliferation or by neuronal or glial differentiation.</td>
<td style="text-align: left;">MONDO:0008170</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856000</td>
<td style="text-align: left;">ovarian wolffian tumor</td>
<td style="text-align: left;">NCIT:C179548</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Wolffian Tumor</td>
<td style="text-align: left;">An epithelial neoplasm of Wolffian (mesonephric) origin arising from the ovarian hilum. Most tumors behave in a benign fashion.</td>
<td style="text-align: left;">MONDO:0002229,MONDO:0004255</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856002</td>
<td style="text-align: left;">her2-low breast carcinoma</td>
<td style="text-align: left;">NCIT:C179553</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">HER2-Low Breast Carcinoma</td>
<td style="text-align: left;">A breast adenocarcinoma defined by low expression of HER2 (IHC1+ or IHC2+; FISH negative).</td>
<td style="text-align: left;">MONDO:0004988</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856003</td>
<td style="text-align: left;">peritoneal calcifying fibrous tumor</td>
<td style="text-align: left;">NCIT:C179560</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Peritoneal Calcifying Fibrous Tumor</td>
<td style="text-align: left;">A benign well-circumscribed lesion arising from the mesentery. It is characterized by the presence of fibroblasts, lymphoplasmacytic infiltrates, collagenous stroma formation, psammoma bodies, and dystrophic calcifications.</td>
<td style="text-align: left;">MONDO:0000650,MONDO:0006121</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856016</td>
<td style="text-align: left;">basal ganglia neoplasm</td>
<td style="text-align: left;">NCIT:C179882</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Basal Ganglia Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the basal ganglia.</td>
<td style="text-align: left;">MONDO:0021374</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856017</td>
<td style="text-align: left;">cerebellar peduncle neoplasm</td>
<td style="text-align: left;">NCIT:C179883</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cerebellar Peduncle Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the cerebellar peduncle.</td>
<td style="text-align: left;">MONDO:0002913</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856018</td>
<td style="text-align: left;">corpus callosum neoplasm</td>
<td style="text-align: left;">NCIT:C179884</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Corpus Callosum Neoplasm</td>
<td style="text-align: left;">A primary or metastatic neoplasm that affects the corpus callosum.</td>
<td style="text-align: left;">MONDO:0021374</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856019</td>
<td style="text-align: left;">oral cavity carcinoma cuniculatum</td>
<td style="text-align: left;">NCIT:C179894</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oral Cavity Carcinoma Cuniculatum</td>
<td style="text-align: left;">A variant of well-differentiated squamous cell carcinoma arising from the oral cavity. It is characterized by the presence of minimal cytological atypia, multiple keratin-filled crypts, and intraepithelial neutrophils.</td>
<td style="text-align: left;">MONDO:0021538</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856021</td>
<td style="text-align: left;">uterine ligament leiomyoma</td>
<td style="text-align: left;">NCIT:C179923</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Ligament Leiomyoma</td>
<td style="text-align: left;">A leiomyoma that arises from the broad or other uterine ligaments.</td>
<td style="text-align: left;">MONDO:0006106,MONDO:0020582</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856022</td>
<td style="text-align: left;">uterine ligament adenomyoma</td>
<td style="text-align: left;">NCIT:C179925</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Ligament Adenomyoma</td>
<td style="text-align: left;">A benign neoplasm that arises from the broad or other uterine ligaments. It is characterized by the presence of a glandular and a mesenchymal component.</td>
<td style="text-align: left;">MONDO:0005635,MONDO:0020582</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856024</td>
<td style="text-align: left;">uterine ligament wolffian tumor</td>
<td style="text-align: left;">NCIT:C179927</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Ligament Wolffian Tumor</td>
<td style="text-align: left;">An epithelial neoplasm of Wolffian (mesonephric) origin arising from a uterine ligament. Most tumors behave in a benign fashion.</td>
<td style="text-align: left;">MONDO:0004255,MONDO:0021629</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856025</td>
<td style="text-align: left;">uterine ligament ependymoma</td>
<td style="text-align: left;">NCIT:C179928</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Ligament Ependymoma</td>
<td style="text-align: left;">A rare neoplasm that arises from the broad or other uterine ligaments and shows ependymal differentiation.</td>
<td style="text-align: left;">MONDO:0021629</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856026</td>
<td style="text-align: left;">broad ligament neoplasm</td>
<td style="text-align: left;">NCIT:C179931</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Broad Ligament Neoplasm</td>
<td style="text-align: left;">A benign, borderline, or malignant neoplasm that affects the broad ligament.</td>
<td style="text-align: left;">MONDO:0021629</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856027</td>
<td style="text-align: left;">microsatellite stable ovarian carcinoma</td>
<td style="text-align: left;">NCIT:C180332</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Microsatellite Stable Ovarian Carcinoma</td>
<td style="text-align: left;">Ovarian carcinoma characterized by the absence of microsatellite instability.</td>
<td style="text-align: left;">MONDO:0005140</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856028</td>
<td style="text-align: left;">microsatellite stable endometrial carcinoma</td>
<td style="text-align: left;">NCIT:C180335</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Microsatellite Stable Endometrial Carcinoma</td>
<td style="text-align: left;">Endometrial carcinoma characterized by the absence of microsatellite instability.</td>
<td style="text-align: left;">MONDO:0002447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856033</td>
<td style="text-align: left;">tectal glioma</td>
<td style="text-align: left;">NCIT:C180407</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tectal Glioma</td>
<td style="text-align: left;">A glioma that arises from the tectum mesenchephali.</td>
<td style="text-align: left;">MONDO:0021042</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856038</td>
<td style="text-align: left;">no specific molecular profile endometrial endometrioid adenocarcinoma</td>
<td style="text-align: left;">NCIT:C180516</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">No Specific Molecular Profile Endometrial Endometrioid Adenocarcinoma</td>
<td style="text-align: left;">An endometrial endometrioid adenocarcinoma characterized by the absence of POLE gene mutations, mismatch repair (MMR) deficiency, and p53 gene mutations.</td>
<td style="text-align: left;">MONDO:0006192</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856040</td>
<td style="text-align: left;">dysembryoplastic neuroepithelial-like tumor of the septum pellucidum</td>
<td style="text-align: left;">NCIT:C180532</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Dysembryoplastic Neuroepithelial-Like Tumor of the Septum Pellucidum</td>
<td style="text-align: left;">A very rare, low-grade midline brain neoplasm that affects the septum pellucidum. It is characterized by similar histological features to those found in dysembryoplastic neuroepithelial tumor, but does not display multinodularity. It usually manifests with symptoms related to increased intracranial pressure. Epilepsy has been reported in approximately one third of patients. PDGFRA gene mutations have been identified in the majority of patients. Alterations in FGFR1 and NF1 genes have also been reported. BRAF mutations which represent the most common molecular alteration found in cortical dysembryoplastic neuroepithelial tumor, were absent in this rare group of midline tumors.</td>
<td style="text-align: left;">MONDO:0016729</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856041</td>
<td style="text-align: left;">endometrial mucinous adenocarcinoma, intestinal-type</td>
<td style="text-align: left;">NCIT:C180536</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endometrial Mucinous Adenocarcinoma, Intestinal-Type</td>
<td style="text-align: left;">A rare mucinous adenocarcinoma arising from intestinal metaplasia of the endometrium.</td>
<td style="text-align: left;">MONDO:0005461,MONDO:0006254</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856044</td>
<td style="text-align: left;">uterine corpus central primitive neuroectodermal tumor</td>
<td style="text-align: left;">NCIT:C180546</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Central Primitive Neuroectodermal Tumor</td>
<td style="text-align: left;">A rare uterine corpus malignant small round cell tumor with neuroglial differentiation. The prognosis is poor.</td>
<td style="text-align: left;">MONDO:0005210,MONDO:0006974</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856048</td>
<td style="text-align: left;">urothelial carcinoma, high grade</td>
<td style="text-align: left;">NCIT:C180606</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Urothelial Carcinoma, High Grade</td>
<td style="text-align: left;">Urothelial carcinoma characterized by the presence of neoplastic epithelial cells with high grade features.</td>
<td style="text-align: left;">MONDO:0040679</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856052</td>
<td style="text-align: left;">gestational trophoblastic disorder</td>
<td style="text-align: left;">NCIT:C180633</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gestational Trophoblastic Disorder</td>
<td style="text-align: left;">A group of pregnancy-related proliferative disorders. It includes non-neoplastic disorders (complete hydatidiform mole, partial hydatidiform mole, placental site nodule and plaque, and exaggerated placental site reaction) and neoplasms (invasive hydatidiform mole and trophoblastic tumors). Trophoblastic tumors include gestational choriocarcinoma, epithelioid trophoblastic tumor, placental-site trophoblastic tumor, and mixed trophoblastic tumor.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856053</td>
<td style="text-align: left;">mixed trophoblastic tumor</td>
<td style="text-align: left;">NCIT:C180634</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mixed Trophoblastic Tumor</td>
<td style="text-align: left;">A gestational trophoblastic tumor characterized by the presence of two or three histological types of gestational trophoblastic tumor, including choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor.</td>
<td style="text-align: left;">MONDO:0018944</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856054</td>
<td style="text-align: left;">metastatic hydatidiform mole</td>
<td style="text-align: left;">NCIT:C180635</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Hydatidiform Mole</td>
<td style="text-align: left;">The spread of abnormal molar chorionic villi from an invasive hydatidiform mole in the uterine cavity to other anatomic sites, usually the vaginal wall and pelvis.</td>
<td style="text-align: left;">MONDO:0020549</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856055</td>
<td style="text-align: left;">low grade papillary schneiderian carcinoma</td>
<td style="text-align: left;">NCIT:C180670</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Low Grade Papillary Schneiderian Carcinoma</td>
<td style="text-align: left;">A rare sinonasal carcinoma characterized by the presence of a papillary architecture and bland morphological features similar to the Schneiderian papilloma, a pushing pattern of stromal invasion, and an increased risk of local recurrence.</td>
<td style="text-align: left;">MONDO:0056819</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856057</td>
<td style="text-align: left;">cervical squamous cell carcinoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C180839</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Squamous Cell Carcinoma, Not Otherwise Specified</td>
<td style="text-align: left;">Cervical squamous cell carcinoma in which information on the p16 immunohistochemistry or HPV testing status is not available.</td>
<td style="text-align: left;">MONDO:0006143</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856060</td>
<td style="text-align: left;">human papillomavirus-independent cervical adenocarcinoma</td>
<td style="text-align: left;">NCIT:C180848</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Human Papillomavirus-Independent Cervical Adenocarcinoma</td>
<td style="text-align: left;">Cervical adenocarcinoma not associated with human papillomavirus infection.</td>
<td style="text-align: left;">MONDO:0005153</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856067</td>
<td style="text-align: left;">cervical adenocarcinoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C180870</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Adenocarcinoma, Not Otherwise Specified</td>
<td style="text-align: left;">A cervical adenocarcinoma that cannot be classified by WHO criteria or International Endocervical Adenocarcinoma Criteria and Classification (IECC).</td>
<td style="text-align: left;">MONDO:0005153</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856071</td>
<td style="text-align: left;">cervical germ cell tumor</td>
<td style="text-align: left;">NCIT:C180879</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Germ Cell Tumor</td>
<td style="text-align: left;">A rare germ cell tumor that arises from the cervix. Examples include mature cystic teratoma, yolk sac tumor, and choriocarcinoma.</td>
<td style="text-align: left;">MONDO:0005040,MONDO:0021230</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856072</td>
<td style="text-align: left;">minor salivary gland intraductal papillary neoplasm</td>
<td style="text-align: left;">NCIT:C180880</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Minor Salivary Gland Intraductal Papillary Neoplasm</td>
<td style="text-align: left;">A rare papillary neoplasm that grows within and is limited to the duct system of the minor salivary glands. This category includes papillary cystadenoma, ductal papilloma (including the intraductal and inverted variants), sialadenoma papilliferum, and intraductal papillary mucinous neoplasm.</td>
<td style="text-align: left;">MONDO:0021370</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856074</td>
<td style="text-align: left;">adult myofibroma</td>
<td style="text-align: left;">NCIT:C180888</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Myofibroma</td>
<td style="text-align: left;">A rare myofibroma that occurs in adults.</td>
<td style="text-align: left;">MONDO:0006312</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856077</td>
<td style="text-align: left;">human papillomavirus-related vaginal squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C180917</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Human Papillomavirus-Related Vaginal Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the vagina and is caused by human papillomavirus infection.</td>
<td style="text-align: left;">MONDO:0020657,MONDO:0006490</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856083</td>
<td style="text-align: left;">vaginal adenocarcinoma of skene gland origin</td>
<td style="text-align: left;">NCIT:C180947</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Adenocarcinoma of Skene Gland Origin</td>
<td style="text-align: left;">A rare vaginal adenocarcinoma arising from the Skene gland. It is characterized by morphological and immunohistochemical features similar to prostate adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0020653,MONDO:0004173</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856100</td>
<td style="text-align: left;">hybrid salivary gland tumor</td>
<td style="text-align: left;">NCIT:C181078</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hybrid Salivary Gland Tumor</td>
<td style="text-align: left;">A rare neoplasm that arises from the salivary gland and consists of at least two histologically distinct types of tumor within the same topographic location. The tumor components can be either benign or malignant.</td>
<td style="text-align: left;">MONDO:0021043,MONDO:0021357</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856104</td>
<td style="text-align: left;">eyelid basal cell carcinoma</td>
<td style="text-align: left;">NCIT:C181159</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Basal Cell Carcinoma</td>
<td style="text-align: left;">A basal cell carcinoma that arises from the eyelid.</td>
<td style="text-align: left;">MONDO:0003876,MONDO:0005341</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856106</td>
<td style="text-align: left;">major salivary gland squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C181161</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Major Salivary Gland Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the parotid or submandibular gland.</td>
<td style="text-align: left;">MONDO:0044740,MONDO:0006284</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856111</td>
<td style="text-align: left;">lung hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C181205</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Hodgkin Lymphoma</td>
<td style="text-align: left;">A rare Hodgkin lymphoma that arises in and is confined to the lung at the time of diagnosis.</td>
<td style="text-align: left;">MONDO:0003987,MONDO:0004952</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856112</td>
<td style="text-align: left;">primary bone hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C181207</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Bone Hodgkin Lymphoma</td>
<td style="text-align: left;">An exceedingly rare Hodgkin lymphoma that arises from the bone, without lymph node or other extranodal involvement.</td>
<td style="text-align: left;">MONDO:0004952,MONDO:0017814</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856114</td>
<td style="text-align: left;">cervical cancer by ajcc v9 stage</td>
<td style="text-align: left;">NCIT:C181562</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Cancer by AJCC v9 Stage</td>
<td style="text-align: left;">A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 9th edition. This staging system applies to carcinomas and carcinosarcomas. It does not apply to sarcomas, lymphomas, and melanomas. Sarcomas are staged according to the corpus uteri classification for sarcomas. Lymphomas are staged according to Hodgkin and non-Hodgkin lymphoma classification. Melanomas are not staged. (from AJCC 9th Ed.)</td>
<td style="text-align: left;">MONDO:0005131</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856117</td>
<td style="text-align: left;">epiglottic squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C181714</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Epiglottic Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma of the larynx that arises from the epiglottis.</td>
<td style="text-align: left;">MONDO:0004293,MONDO:0004473</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856124</td>
<td style="text-align: left;">vulvar squamous cell carcinoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C181902</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Squamous Cell Carcinoma, Not Otherwise Specified</td>
<td style="text-align: left;">Vulvar squamous cell carcinoma in which information on the p16 immunohistochemistry or HPV testing status is not available.</td>
<td style="text-align: left;">MONDO:0024609</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856134</td>
<td style="text-align: left;">vulvar kaposi sarcoma</td>
<td style="text-align: left;">NCIT:C181938</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Kaposi Sarcoma</td>
<td style="text-align: left;">A Kaposi sarcoma arising from the vulva.</td>
<td style="text-align: left;">MONDO:0005055,MONDO:0005214</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856137</td>
<td style="text-align: left;">vulvar epithelioid sarcoma</td>
<td style="text-align: left;">NCIT:C181971</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Epithelioid Sarcoma</td>
<td style="text-align: left;">An epithelioid sarcoma that arises from the vulva.</td>
<td style="text-align: left;">MONDO:0005214,MONDO:0017387</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856139</td>
<td style="text-align: left;">vulvar ewing sarcoma</td>
<td style="text-align: left;">NCIT:C181977</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Ewing Sarcoma</td>
<td style="text-align: left;">Ewing sarcoma arising from the vulva.</td>
<td style="text-align: left;">MONDO:0018270,MONDO:0005214</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856154</td>
<td style="text-align: left;">bronchiolar adenoma/ciliated muconodular papillary tumor</td>
<td style="text-align: left;">NCIT:C183045</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor</td>
<td style="text-align: left;">A rare, benign, circumscribed nodule arising from the bronchioles. It is usually seen in middle-aged to elderly patients. It is characterized by the presence a two-layer cellular structure composed of a basal and luminal layer.</td>
<td style="text-align: left;">MONDO:0003422</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856155</td>
<td style="text-align: left;">invasive lung non-mucinous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C183109</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Lung Non-Mucinous Adenocarcinoma</td>
<td style="text-align: left;">An invasive adenocarcinoma that arises from the lung. It is characterized by the absence of tall columnar cells and mucin production. This category includes lepidic adenocarcinoma, acinar adenocarcinoma, papillary adenocarcinoma, micropapillary adenocarcinoma, and solid adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0040677,MONDO:0005061</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856158</td>
<td style="text-align: left;">lung intravascular large b-cell lymphoma</td>
<td style="text-align: left;">NCIT:C183121</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Intravascular Large B-Cell Lymphoma</td>
<td style="text-align: left;">An aggressive extranodal B-cell non-Hodgkin lymphoma that affects the lung.  It is characterized by the presence of large neoplastic lymphocytes exclusively in the lumina of small vessels, particularly capillaries.</td>
<td style="text-align: left;">MONDO:0020324,MONDO:0006387</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856161</td>
<td style="text-align: left;">pleural mesothelioma in situ</td>
<td style="text-align: left;">NCIT:C183134</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pleural Mesothelioma In Situ</td>
<td style="text-align: left;">A non-invasive mesothelial neoplasm that arises from the pleura. It is characterized by the proliferation of a single-layer of flat or cuboidal neoplastic mesothelial cells. Cytological atypia is absent or minimal. Mitoses are absent. BAP1 gene inactivation and/or CDKN2A gene homozygous deletion are present. Patients present with non-resolving pleural effusion. It may progress to invasive epithelioid mesothelioma.</td>
<td style="text-align: left;">MONDO:0003308</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856165</td>
<td style="text-align: left;">cardiac diffuse large b-cell lymphoma</td>
<td style="text-align: left;">NCIT:C183146</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Diffuse Large B-Cell Lymphoma</td>
<td style="text-align: left;">A diffuse large B-cell lymphoma that arises from the heart.</td>
<td style="text-align: left;">MONDO:0003917,MONDO:0018905</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856172</td>
<td style="text-align: left;">pleural calcifying fibrous tumor</td>
<td style="text-align: left;">NCIT:C183277</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pleural Calcifying Fibrous Tumor</td>
<td style="text-align: left;">A rare, benign, well-circumscribed lesion arising from the pleura. It is characterized by the presence of fibroblasts, lymphoplasmacytic infiltrates, collagenous stroma formation, and dystrophic calcifications. Patients may present with chest pain, dyspnea, cough, or may be asymptomatic.</td>
<td style="text-align: left;">MONDO:0006121,MONDO:0021457</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856178</td>
<td style="text-align: left;">thymus carcinoma with adenoid cystic carcinoma-like features</td>
<td style="text-align: left;">NCIT:C183313</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thymus Carcinoma with Adenoid Cystic Carcinoma-Like Features</td>
<td style="text-align: left;">A very rare primary thymus carcinoma that resembles adenoid cystic carcinoma of the salivary gland.</td>
<td style="text-align: left;">MONDO:0006451</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856179</td>
<td style="text-align: left;">thymus enteric-type adenocarcinoma</td>
<td style="text-align: left;">NCIT:C183314</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thymus Enteric-Type Adenocarcinoma</td>
<td style="text-align: left;">A primary thymus adenocarcinoma characterized by morphological and immunohistochemical features seen in colorectal adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0003209,MONDO:0006254</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856180</td>
<td style="text-align: left;">thymus adenocarcinoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C183315</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thymus Adenocarcinoma, Not Otherwise Specified</td>
<td style="text-align: left;">A primary thymus adenocarcinoma that does not conform to either low-grade papillary adenocarcinoma or enteric-type adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0003209</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856181</td>
<td style="text-align: left;">thymus carcinoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C183316</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thymus Carcinoma, Not Otherwise Specified</td>
<td style="text-align: left;">A primary thymus carcinoma that cannot be defined as one of the thymic carcinomas with specific morphologic characteristics.</td>
<td style="text-align: left;">MONDO:0006451</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856182</td>
<td style="text-align: left;">mediastinal follicular dendritic cell sarcoma</td>
<td style="text-align: left;">NCIT:C183374</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Follicular Dendritic Cell Sarcoma</td>
<td style="text-align: left;">A rare follicular dendritic cell sarcoma that affects the structures of the mediastinum.</td>
<td style="text-align: left;">MONDO:0005764,MONDO:0005843</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856183</td>
<td style="text-align: left;">metastatic malignant neoplasm in the mediastinal lymph nodes</td>
<td style="text-align: left;">NCIT:C183510</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Mediastinal Lymph Nodes</td>
<td style="text-align: left;">The spread of a malignant neoplasm to the mediastinal lymph nodes from an adjacent or distant anatomic site.</td>
<td style="text-align: left;">MONDO:0005438</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856191</td>
<td style="text-align: left;">salivary gland adenoma</td>
<td style="text-align: left;">NCIT:C184295</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Salivary Gland Adenoma</td>
<td style="text-align: left;">A benign adenoma that arises from the salivary gland. This group includes pleomorphic adenoma, canalicular adenoma, basal cell adenoma, and sebaceous adenoma.</td>
<td style="text-align: left;">MONDO:0021460,MONDO:0004972</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856197</td>
<td style="text-align: left;">multiple solitary plasmacytoma of bone</td>
<td style="text-align: left;">NCIT:C185035</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multiple Solitary Plasmacytoma of Bone</td>
<td style="text-align: left;">The presence of more than one plasmacytoma arising in the bone, concurrently or sequentially, in the absence of bone marrow involvement by plasma cell myeloma.</td>
<td style="text-align: left;">MONDO:0002755</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856199</td>
<td style="text-align: left;">splenic plasmacytoma</td>
<td style="text-align: left;">NCIT:C185041</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Splenic Plasmacytoma</td>
<td style="text-align: left;">A plasmacytoma that arises in the spleen.</td>
<td style="text-align: left;">MONDO:0002754,MONDO:0005966</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856204</td>
<td style="text-align: left;">extramedullary disease in multiple myeloma</td>
<td style="text-align: left;">NCIT:C185149</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extramedullary Disease in Multiple Myeloma</td>
<td style="text-align: left;">Infiltration of organs and soft tissues by malignant (clonal) plasma cells in patients with history of multiple myeloma. Skin, liver, lymph nodes, pleura, and central nervous system are the most frequently affected sites.</td>
<td style="text-align: left;">MONDO:0009693</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856206</td>
<td style="text-align: left;">astrocytoma, idh-mutant</td>
<td style="text-align: left;">NCIT:C185167</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Astrocytoma, IDH-Mutant</td>
<td style="text-align: left;">An astrocytoma associated with IDH1 or IDH2 gene mutations and absence of 1p/19q codeletion. It is classified as grade 2, 3, or 4.</td>
<td style="text-align: left;">MONDO:0019781</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856207</td>
<td style="text-align: left;">astrocytoma, idh-wildtype</td>
<td style="text-align: left;">NCIT:C185184</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Astrocytoma, IDH-Wildtype</td>
<td style="text-align: left;">Astrocytoma lacking mutations in IDH1 or IDH2 genes. It includes diffuse astrocytoma, IDH-wildtype and anaplastic astrocytoma, IDH-wildtype.</td>
<td style="text-align: left;">MONDO:0019781</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856208</td>
<td style="text-align: left;">astrocytoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C185185</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Astrocytoma, Not Otherwise Specified</td>
<td style="text-align: left;">A central nervous system tumor with morphological features of astrocytoma in which there is insufficient information on the IDH genes status.</td>
<td style="text-align: left;">MONDO:0019781</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856216</td>
<td style="text-align: left;">extranodal lymphoma</td>
<td style="text-align: left;">NCIT:C185752</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extranodal Lymphoma</td>
<td style="text-align: left;">A non-Hodgkin or Hodgkin lymphoma that arises from an anatomic site other than a lymph node.</td>
<td style="text-align: left;">MONDO:0017207</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856233</td>
<td style="text-align: left;">childhood spinal cord ependymoma</td>
<td style="text-align: left;">NCIT:C186495</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Spinal Cord Ependymoma</td>
<td style="text-align: left;">An ependymoma of the spinal cord not associated with MYCN amplification and occurring in children.</td>
<td style="text-align: left;">MONDO:0002716,MONDO:0003478,MONDO:0003473</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856239</td>
<td style="text-align: left;">central nervous system ewing sarcoma</td>
<td style="text-align: left;">NCIT:C186611</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Ewing Sarcoma</td>
<td style="text-align: left;">Ewing sarcoma that arises in the central nervous system.</td>
<td style="text-align: left;">MONDO:0018270,MONDO:0002217,MONDO:0016713</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856240</td>
<td style="text-align: left;">intracranial mesenchymal tumor, fet-creb fusion-positive</td>
<td style="text-align: left;">NCIT:C186614</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intracranial Mesenchymal Tumor, FET-CREB Fusion-Positive</td>
<td style="text-align: left;">A provisional entity that refers to a group of neoplasms with a broad morphological spectrum, characterized by fusion of a FET family gene (usually EWSR1 and rarely FUS) with a member of the CREB family of transcription factors (CREB1, ATF1, or CREM). It includes entities previously termed intracranial angiomatoid fibrous histiocytoma or intracranial myxoid mesenchymal tumor. It is usually located in the supratentorial brain and mostly affects children and young adults. There is a spectrum of clinical behaviors ranging from slowly growing tumors to rapid recurrences, and rarely metastases.</td>
<td style="text-align: left;">MONDO:0003244,MONDO:0021632</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856241</td>
<td style="text-align: left;">cervical cancer by figo stage 2009</td>
<td style="text-align: left;">NCIT:C186619</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Cancer by FIGO Stage 2009</td>
<td style="text-align: left;">A term that refers to the staging of cervical cancer according to the International Federation of Gynecology and Obstetrics (FIGO) staging, 2009.</td>
<td style="text-align: left;">MONDO:0005131</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856244</td>
<td style="text-align: left;">central nervous system lymphomatoid granulomatosis</td>
<td style="text-align: left;">NCIT:C186662</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Lymphomatoid Granulomatosis</td>
<td style="text-align: left;">Lymphomatoid granulomatosis that affects the brain, spinal cord, and leptomeninges.</td>
<td style="text-align: left;">MONDO:0019466,MONDO:0003641</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856253</td>
<td style="text-align: left;">childhood acute leukemia</td>
<td style="text-align: left;">NCIT:C187056</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Acute Leukemia</td>
<td style="text-align: left;">An acute leukemia that occurs during childhood.</td>
<td style="text-align: left;">MONDO:0010643,MONDO:0004355</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856254</td>
<td style="text-align: left;">pituitary neuroendocrine tumor of pit1-lineage</td>
<td style="text-align: left;">NCIT:C187086</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pituitary Neuroendocrine Tumor of PIT1-Lineage</td>
<td style="text-align: left;">A pituitary neuroendocrine tumor arising from PIT1-lineage adenohypophysial cells.</td>
<td style="text-align: left;">MONDO:0006373</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856255</td>
<td style="text-align: left;">pituitary neuroendocrine tumor of tpit-lineage</td>
<td style="text-align: left;">NCIT:C187087</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pituitary Neuroendocrine Tumor of TPIT-Lineage</td>
<td style="text-align: left;">A pituitary neuroendocrine tumor arising from TPIT-lineage adenohypophysial cells.</td>
<td style="text-align: left;">MONDO:0006373</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856256</td>
<td style="text-align: left;">pituitary neuroendocrine tumor of sf1-lineage</td>
<td style="text-align: left;">NCIT:C187088</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pituitary Neuroendocrine Tumor of SF1-Lineage</td>
<td style="text-align: left;">A pituitary neuroendocrine tumor arising from SF1-lineage adenohypophysial cells.</td>
<td style="text-align: left;">MONDO:0006373</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856257</td>
<td style="text-align: left;">pituitary neuroendocrine tumor without distinct lineage differentiation</td>
<td style="text-align: left;">NCIT:C187096</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pituitary Neuroendocrine Tumor without Distinct Lineage Differentiation</td>
<td style="text-align: left;">A pituitary neuroendocrine tumor that belongs to more than one adenohypophysial cell lineage or does not show evidence of adenohypophysial hormonal immunoreactivity and specific adenohypophysial cell derivation.</td>
<td style="text-align: left;">MONDO:0006373</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856258</td>
<td style="text-align: left;">pituitary neuroendocrine tumor, not otherwise specified</td>
<td style="text-align: left;">NCIT:C187135</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pituitary Neuroendocrine Tumor, Not Otherwise Specified</td>
<td style="text-align: left;">A pituitary neuroendocrine tumor in which further characterization regarding subtyping is not available.</td>
<td style="text-align: left;">MONDO:0006373</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856267</td>
<td style="text-align: left;">thyroid gland follicular adenoma with papillary architecture</td>
<td style="text-align: left;">NCIT:C187261</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Follicular Adenoma with Papillary Architecture</td>
<td style="text-align: left;">A benign, encapsulated thyroid gland neoplasm characterized by the presence of large follicles with intrafollicular papillary architecture. The cells lining the papillae are usually columnar. It is usually a cystic neoplasm and lacks nuclear atypia and capsular invasion. Psammoma bodies are not present. Activating TSHR mutations have been described in the majority of cases. In a small number of cases GNAS mutations have been identified.</td>
<td style="text-align: left;">MONDO:0005032</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856268</td>
<td style="text-align: left;">low risk thyroid gland neoplasm</td>
<td style="text-align: left;">NCIT:C187273</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Low Risk Thyroid Gland Neoplasm</td>
<td style="text-align: left;">A thyroid gland neoplasm in which the incidence of metastatic spread is extremely low. This category includes thyroid gland noninvasive follicular neoplasm with papillary-like nuclear features, thyroid gland hyalinizing trabecular tumor, and thyroid gland tumors of uncertain malignant potential.</td>
<td style="text-align: left;">MONDO:0015074</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856272</td>
<td style="text-align: left;">invasive breast lobular carcinoma with extracellular mucin</td>
<td style="text-align: left;">NCIT:C187405</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Breast Lobular Carcinoma with Extracellular Mucin</td>
<td style="text-align: left;">A rare variant of invasive breast lobular carcinoma characterized by the presence of pools of extracellular mucin in which groups of floating lobular carcinoma cells are identified.</td>
<td style="text-align: left;">MONDO:0005051</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856275</td>
<td style="text-align: left;">thyroid gland follicular carcinoma, signet ring cell variant</td>
<td style="text-align: left;">NCIT:C187643</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Follicular Carcinoma, Signet Ring Cell Variant</td>
<td style="text-align: left;">A morphologic variant of follicular carcinoma of the thyroid gland characterized by the presence of malignant follicular cells with cytoplasmic vacuoles and eccentrically placed nuclei.</td>
<td style="text-align: left;">MONDO:0005034</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856276</td>
<td style="text-align: left;">classic thyroid gland papillary carcinoma</td>
<td style="text-align: left;">NCIT:C187644</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Classic Thyroid Gland Papillary Carcinoma</td>
<td style="text-align: left;">A thyroid gland papillary carcinoma characterized by the presence of thin cores of fibrovascular tissue lined by one or occasionally several layers of malignant cells with distinct nuclear features that include nuclear pseudoinclusions, nuclear grooves, and ground glass nuclear inclusions.</td>
<td style="text-align: left;">MONDO:0005075</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856277</td>
<td style="text-align: left;">high grade follicular cell-derived non-anaplastic thyroid gland carcinoma</td>
<td style="text-align: left;">NCIT:C187645</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">High Grade Follicular Cell-Derived Non-Anaplastic Thyroid Gland Carcinoma</td>
<td style="text-align: left;">A thyroid gland carcinoma that arises from follicular cells and is characterized by the presence of high mitotic activity and necrotic changes in the absence of anaplastic histological features. This category includes poorly differentiated thyroid gland carcinoma and differentiated high-grade thyroid gland carcinoma.</td>
<td style="text-align: left;">MONDO:0024622</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856285</td>
<td style="text-align: left;">thyroid gland secretory carcinoma</td>
<td style="text-align: left;">NCIT:C187994</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Secretory Carcinoma</td>
<td style="text-align: left;">An invasive adenocarcinoma of the thyroid gland characterized by the presence of cells that secrete eosinophilic material. It is composed of cystic spaces, tubular structures, and solid areas. ETV6 translocations and ETV6-NTRK3 fusion are present.</td>
<td style="text-align: left;">MONDO:0024622</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856286</td>
<td style="text-align: left;">thyroblastoma</td>
<td style="text-align: left;">NCIT:C187995</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroblastoma</td>
<td style="text-align: left;">A high-grade, rapidly growing malignant embryonal neoplasm that arises from the thyroid gland. It is characterized by the presence of primitive follicular-like structures surrounded by primitive small cells and primitive spindle cell mesenchymal stroma. It is associated with DICER1 gene mutations. The prognosis is poor.</td>
<td style="text-align: left;">MONDO:0002108,MONDO:0005564</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856287</td>
<td style="text-align: left;">teratoma with endocrine differentiation</td>
<td style="text-align: left;">NCIT:C188013</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Teratoma with Endocrine Differentiation</td>
<td style="text-align: left;">A teratoma that arises outside an endocrine organ and shows endocrine differentiation. The endocrine component ranges from benign endocrine tissue to malignant endocrine neoplasms. This category includes struma ovarii, thyroid carcinoma arising in struma ovarii, and carcinoid tumor arising in ovarian teratoma.</td>
<td style="text-align: left;">MONDO:0002601</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856289</td>
<td style="text-align: left;">b-cell malignant neoplasm</td>
<td style="text-align: left;">NCIT:C188021</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">B-Cell Malignant Neoplasm</td>
<td style="text-align: left;">A clonal lymphoproliferative disorder composed of neoplastic B-cells. It includes B-cell non-Hodgkin lymphomas, B-cell leukemias, and plasma cell myeloma.</td>
<td style="text-align: left;">MONDO:0004992,MONDO:0004095</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856293</td>
<td style="text-align: left;">mast cell leukemia with an associated myeloid neoplasm</td>
<td style="text-align: left;">NCIT:C188031</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mast Cell Leukemia with an Associated Myeloid Neoplasm</td>
<td style="text-align: left;">Mast cell leukemia associated with another clonal non-mast cell myeloid neoplasm (e.g., myelodysplastic syndrome, myeloproliferative neoplasm, and acute myeloid leukemia).</td>
<td style="text-align: left;">MONDO:0020332,MONDO:0020334</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856298</td>
<td style="text-align: left;">refractory wilms tumor</td>
<td style="text-align: left;">NCIT:C188038</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Wilms Tumor</td>
<td style="text-align: left;">Wilms tumor that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0006058,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856302</td>
<td style="text-align: left;">pleural proximal-type epithelioid sarcoma</td>
<td style="text-align: left;">NCIT:C188055</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pleural Proximal-Type Epithelioid Sarcoma</td>
<td style="text-align: left;">A rare epithelioid sarcoma of the proximal type that arises from the pleura.</td>
<td style="text-align: left;">MONDO:0004244,MONDO:0006294</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856303</td>
<td style="text-align: left;">lung osteosarcoma</td>
<td style="text-align: left;">NCIT:C188061</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Osteosarcoma</td>
<td style="text-align: left;">A rare extraskeletal osteosarcoma that arises from the lung parenchyma.</td>
<td style="text-align: left;">MONDO:0002621,MONDO:0002426</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856304</td>
<td style="text-align: left;">pleural leiomyosarcoma</td>
<td style="text-align: left;">NCIT:C188063</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pleural Leiomyosarcoma</td>
<td style="text-align: left;">A rare leiomyosarcoma that arises from the pleural cavity.</td>
<td style="text-align: left;">MONDO:0006294,MONDO:0005058</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856305</td>
<td style="text-align: left;">bone malignant peripheral nerve sheath tumor</td>
<td style="text-align: left;">NCIT:C188064</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Malignant Peripheral Nerve Sheath Tumor</td>
<td style="text-align: left;">An exceedingly rare malignant peripheral nerve sheath tumor that arises from the bone.</td>
<td style="text-align: left;">MONDO:0021054,MONDO:0017827</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856308</td>
<td style="text-align: left;">lung secretory carcinoma</td>
<td style="text-align: left;">NCIT:C188068</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Secretory Carcinoma</td>
<td style="text-align: left;">A rare carcinoma that arises from the lung and has histopathological, immunohistochemical, and genetic features identical to those described in breast and salivary gland secretory carcinomas.</td>
<td style="text-align: left;">MONDO:0005138</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856309</td>
<td style="text-align: left;">prostate alveolar rhabdomyosarcoma</td>
<td style="text-align: left;">NCIT:C188070</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Alveolar Rhabdomyosarcoma</td>
<td style="text-align: left;">A rare alveolar rhabdomyosarcoma arising from the prostate gland.</td>
<td style="text-align: left;">MONDO:0006389,MONDO:0009994</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856312</td>
<td style="text-align: left;">retroperitoneal malignant peripheral nerve sheath tumor</td>
<td style="text-align: left;">NCIT:C188073</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Retroperitoneal Malignant Peripheral Nerve Sheath Tumor</td>
<td style="text-align: left;">Malignant peripheral nerve sheath tumor that arises in the retroperitoneum.</td>
<td style="text-align: left;">MONDO:0001501,MONDO:0017827</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856313</td>
<td style="text-align: left;">rectal epithelioid cell melanoma</td>
<td style="text-align: left;">NCIT:C188079</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Rectal Epithelioid Cell Melanoma</td>
<td style="text-align: left;">An epithelioid cell melanoma arising from the rectum.</td>
<td style="text-align: left;">MONDO:0002167,MONDO:0002973</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856316</td>
<td style="text-align: left;">lung anaplastic large cell lymphoma</td>
<td style="text-align: left;">NCIT:C188082</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Anaplastic Large Cell Lymphoma</td>
<td style="text-align: left;">A rare anaplastic large cell lymphoma that arises in the lung parenchyma.</td>
<td style="text-align: left;">MONDO:0020644,MONDO:0020325</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856325</td>
<td style="text-align: left;">adrenal cortical myxoid carcinoma</td>
<td style="text-align: left;">NCIT:C188182</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Myxoid Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the adrenal cortex and is characterized by the presence of abundant extracellular connective tissue mucin.</td>
<td style="text-align: left;">MONDO:0006639</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856326</td>
<td style="text-align: left;">adrenal cortical high grade carcinoma</td>
<td style="text-align: left;">NCIT:C188183</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical High Grade Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the adrenal cortex and is characterized by the presence of more than twenty mitoses per ten square millimeters.</td>
<td style="text-align: left;">MONDO:0006639</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856327</td>
<td style="text-align: left;">adrenal cortical melanoma</td>
<td style="text-align: left;">NCIT:C188185</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Melanoma</td>
<td style="text-align: left;">A rare melanoma that arises within the adrenal cortex.</td>
<td style="text-align: left;">MONDO:0021312,MONDO:0006320</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856336</td>
<td style="text-align: left;">head and neck neuroendocrine neoplasm</td>
<td style="text-align: left;">NCIT:C188222</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Neuroendocrine Neoplasm</td>
<td style="text-align: left;">A neoplasm with neuroendocrine differentiation that arises from the head and neck. This category includes neuroendocrine tumors, neuroendocrine carcinomas, and paragangliomas.</td>
<td style="text-align: left;">MONDO:0019496,MONDO:0005586</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856338</td>
<td style="text-align: left;">adrenal gland lipoma</td>
<td style="text-align: left;">NCIT:C188250</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Gland Lipoma</td>
<td style="text-align: left;">A rare lipoma that arises from the adrenal gland.</td>
<td style="text-align: left;">MONDO:0021511,MONDO:0005106</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856339</td>
<td style="text-align: left;">adrenal gland hemangioma</td>
<td style="text-align: left;">NCIT:C188251</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Gland Hemangioma</td>
<td style="text-align: left;">A rare hemangioma that arises from the adrenal gland.</td>
<td style="text-align: left;">MONDO:0021511,MONDO:0006500</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856340</td>
<td style="text-align: left;">adrenal gland lymphangioma</td>
<td style="text-align: left;">NCIT:C188252</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Gland Lymphangioma</td>
<td style="text-align: left;">A rare lymphangioma that arises from the adrenal gland.</td>
<td style="text-align: left;">MONDO:0002013,MONDO:0021511</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856341</td>
<td style="text-align: left;">adrenal gland leiomyoma</td>
<td style="text-align: left;">NCIT:C188253</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Gland Leiomyoma</td>
<td style="text-align: left;">A rare leiomyoma that arises from the adrenal gland.</td>
<td style="text-align: left;">MONDO:0006106,MONDO:0021511</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856343</td>
<td style="text-align: left;">multiple endocrine neoplasia type 5</td>
<td style="text-align: left;">NCIT:C188257</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multiple Endocrine Neoplasia Type 5</td>
<td style="text-align: left;">An inherited neoplastic syndrome caused by mutations in the MYC-associated factor X (MAX) gene. It is associated with the development of paragangliomas/pheochromocytomas, pituitary neuroendocrine tumors, and parathyroid adenomas. Renal cell carcinomas, squamous cell carcinomas, breast carcinomas, lung carcinomas, and endometrial carcinomas have also been reported.</td>
<td style="text-align: left;">MONDO:0017169</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856349</td>
<td style="text-align: left;">chronic phase primary myelofibrosis</td>
<td style="text-align: left;">NCIT:C188314</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Phase Primary Myelofibrosis</td>
<td style="text-align: left;">Primary myelofibrosis characterized by the presence of less than 10% blasts in the peripheral blood or bone marrow.</td>
<td style="text-align: left;">MONDO:0009692</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856357</td>
<td style="text-align: left;">intraductal hyperplasia</td>
<td style="text-align: left;">NCIT:C26458</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intraductal Hyperplasia</td>
<td style="text-align: left;">A hyperplasia of the intraductal cells.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856375</td>
<td style="text-align: left;">reticulosarcoma involving spleen</td>
<td style="text-align: left;">NCIT:C26959</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Reticulosarcoma Involving Spleen</td>
<td style="text-align: left;">An antiquated term that refers to a non-Hodgkin lymphoma composed of diffuse infiltrates of large, often anaplastic lymphocytes affecting the spleen.</td>
<td style="text-align: left;">MONDO:0009975</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856376</td>
<td style="text-align: left;">lymphosarcoma involving spleen</td>
<td style="text-align: left;">NCIT:C26960</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lymphosarcoma Involving Spleen</td>
<td style="text-align: left;">An antiquated term that refers to a non-Hodgkin lymphoma composed of small and medium sized lymphocytes affecting the spleen.</td>
<td style="text-align: left;">MONDO:0004638</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856398</td>
<td style="text-align: left;">cutaneous nonpigmented nevus</td>
<td style="text-align: left;">NCIT:C27095</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Nonpigmented Nevus</td>
<td style="text-align: left;">A cutaneous nevus characterized by the absence of melanin pigment in the melanocytes.</td>
<td style="text-align: left;">MONDO:0044794</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856421</td>
<td style="text-align: left;">transplant-related disorder</td>
<td style="text-align: left;">NCIT:C27233</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Transplant-Related Disorder</td>
<td style="text-align: left;">A disorder associated with an individual having received a tissue or organ transplant.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856422</td>
<td style="text-align: left;">familial adenomatous polyposis associated medulloblastoma</td>
<td style="text-align: left;">NCIT:C27237</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Familial Adenomatous Polyposis Associated Medulloblastoma</td>
<td style="text-align: left;">A medulloblastoma developing in patients with familiar adenomatous polyposis syndrome.  It is observed in patients with Turcot syndrome, type 2.</td>
<td style="text-align: left;">MONDO:0007959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856423</td>
<td style="text-align: left;">lymphoma by stage</td>
<td style="text-align: left;">NCIT:C27268</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lymphoma by Stage</td>
<td style="text-align: left;">A term that refers to the staging of a lymphoma according to specific classification guidelines.</td>
<td style="text-align: left;">MONDO:0005062</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856424</td>
<td style="text-align: left;">glandular cell intraepithelial neoplasia</td>
<td style="text-align: left;">NCIT:C27269</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Glandular Cell Intraepithelial Neoplasia</td>
<td style="text-align: left;">A precancerous neoplastic intraepithelial process involving the glandular epithelium.</td>
<td style="text-align: left;">MONDO:0024474,MONDO:0024276</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856425</td>
<td style="text-align: left;">secondary myelodysplastic syndrome</td>
<td style="text-align: left;">NCIT:C27280</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Secondary Myelodysplastic Syndrome</td>
<td style="text-align: left;">A myelodysplastic syndrome resulting from chemotherapy or radiation therapy for cancer or exposure to certain chemicals.</td>
<td style="text-align: left;">MONDO:0018881,MONDO:0024881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856428</td>
<td style="text-align: left;">metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor</td>
<td style="text-align: left;">NCIT:C27292</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor</td>
<td style="text-align: left;">A small round cell tumor with or without neural differentiation that has spread from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0021038,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856443</td>
<td style="text-align: left;">unresectable malignant neoplasm</td>
<td style="text-align: left;">NCIT:C27359</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Unresectable Malignant Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that is not amenable to surgical resection.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856447</td>
<td style="text-align: left;">mucin-producing adenocarcinoma</td>
<td style="text-align: left;">NCIT:C27379</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mucin-Producing Adenocarcinoma</td>
<td style="text-align: left;">An invasive adenocarcinoma composed of malignant glandular cells which produce mucin.</td>
<td style="text-align: left;">MONDO:0020596,MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856451</td>
<td style="text-align: left;">extraosseous/peripheral ameloblastoma</td>
<td style="text-align: left;">NCIT:C27396</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extraosseous/Peripheral Ameloblastoma</td>
<td style="text-align: left;">An ameloblastoma that arises from the soft tissues in the gingiva or alveolar mucosa.  It presents as a painless exophytic mass.</td>
<td style="text-align: left;">MONDO:0017795</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856452</td>
<td style="text-align: left;">ampulla of vater intestinal-type adenocarcinoma</td>
<td style="text-align: left;">NCIT:C27415</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ampulla of Vater Intestinal-Type Adenocarcinoma</td>
<td style="text-align: left;">An invasive adenocarcinoma arising from the ampulla of Vater. Morphologically, it is characterized by the presence of intestinal-type malignant epithelial cells.</td>
<td style="text-align: left;">MONDO:0002670,MONDO:0006254</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856456</td>
<td style="text-align: left;">small intestinal gastrin-producing neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C27450</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Gastrin-Producing Neuroendocrine Tumor</td>
<td style="text-align: left;">A gastrin-producing neuroendocrine tumor that arises from the small intestine.  It is characterized by the presence of uniform cells that form pseudorosettes.  The neoplastic cells have uniform nuclei and small amount of eosinophilic cytoplasm.</td>
<td style="text-align: left;">MONDO:0002995,MONDO:0003523</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856457</td>
<td style="text-align: left;">small intestinal enterochromaffin cell serotonin-producing neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C27451</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor</td>
<td style="text-align: left;">A well-differentiated neuroendocrine tumor that arises from the small intestine and produces serotonin.</td>
<td style="text-align: left;">MONDO:0002995</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856458</td>
<td style="text-align: left;">small intestinal somatostatin-producing neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C27453</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Somatostatin-Producing Neuroendocrine Tumor</td>
<td style="text-align: left;">A somatostatin-producing neuroendocrine tumor that arises from the small intestine.</td>
<td style="text-align: left;">MONDO:0002995,MONDO:0006976</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856460</td>
<td style="text-align: left;">colorectal adenoma with moderate dysplasia</td>
<td style="text-align: left;">NCIT:C27457</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Adenoma with Moderate Dysplasia</td>
<td style="text-align: left;">An adenoma that arises from the colon or rectum.  It is characterized by the presence of moderate epithelial dysplasia.</td>
<td style="text-align: left;">MONDO:0005484</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856461</td>
<td style="text-align: left;">colorectal adenoma with mild dysplasia</td>
<td style="text-align: left;">NCIT:C27458</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Adenoma with Mild Dysplasia</td>
<td style="text-align: left;">An adenoma that arises from the colon or rectum.  It is characterized by the presence of mild epithelial dysplasia.</td>
<td style="text-align: left;">MONDO:0005484</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856463</td>
<td style="text-align: left;">disseminated malignant neoplasm</td>
<td style="text-align: left;">NCIT:C27470</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Disseminated Malignant Neoplasm</td>
<td style="text-align: left;">Cancer that is spread throughout the body, a metastatic phenomenon.</td>
<td style="text-align: left;">MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856464</td>
<td style="text-align: left;">bone lipoma</td>
<td style="text-align: left;">NCIT:C27475</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Lipoma</td>
<td style="text-align: left;">A benign neoplasm which is composed of adipocytes and arises from the surface of the bone or the medullary cavity.</td>
<td style="text-align: left;">MONDO:0000631,MONDO:0005106</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856465</td>
<td style="text-align: left;">bone schwannoma</td>
<td style="text-align: left;">NCIT:C27476</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Schwannoma</td>
<td style="text-align: left;">A very rare schwannoma of the bone. It is often located in the mandible and is well circumscribed.</td>
<td style="text-align: left;">MONDO:0004820,MONDO:0000631</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856468</td>
<td style="text-align: left;">secondary chondrosarcoma</td>
<td style="text-align: left;">NCIT:C27482</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Secondary Chondrosarcoma</td>
<td style="text-align: left;">A chondrosarcoma that arises either in a pre-existing enchondroma or within the cartilaginous cap of a pre-existing osteochondroma.</td>
<td style="text-align: left;">MONDO:0021054,MONDO:0024881,MONDO:0008977</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856469</td>
<td style="text-align: left;">conventional alveolar rhabdomyosarcoma</td>
<td style="text-align: left;">NCIT:C27492</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conventional Alveolar Rhabdomyosarcoma</td>
<td style="text-align: left;">An alveolar rhabdomyosarcoma characterized by the presence of large striated muscle cells with clear cytoplasm, giant cells with myoblastic differentiation, and fibrovascular septa.</td>
<td style="text-align: left;">MONDO:0009994</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856470</td>
<td style="text-align: left;">solid alveolar rhabdomyosarcoma</td>
<td style="text-align: left;">NCIT:C27493</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Solid Alveolar Rhabdomyosarcoma</td>
<td style="text-align: left;">A morphologic variant of alveolar rhabdomyosarcoma.  It is characterized by the presence of a solid growth pattern and the absence of fibrovascular stroma.</td>
<td style="text-align: left;">MONDO:0009994</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856471</td>
<td style="text-align: left;">lymphadenopathic kaposi sarcoma</td>
<td style="text-align: left;">NCIT:C27500</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lymphadenopathic Kaposi Sarcoma</td>
<td style="text-align: left;">A Kaposi sarcoma affecting the lymph nodes.</td>
<td style="text-align: left;">MONDO:0001082,MONDO:0005055</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856472</td>
<td style="text-align: left;">conventional extraskeletal myxoid chondrosarcoma</td>
<td style="text-align: left;">NCIT:C27501</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conventional Extraskeletal Myxoid Chondrosarcoma</td>
<td style="text-align: left;">A well differentiated extraskeletal myxoid chondrosarcoma.</td>
<td style="text-align: left;">MONDO:0012825</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856474</td>
<td style="text-align: left;">angiosarcoma associated with lymphedema</td>
<td style="text-align: left;">NCIT:C27512</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Angiosarcoma Associated with Lymphedema</td>
<td style="text-align: left;">An angiosarcoma that develops in association with long standing lymphedema.</td>
<td style="text-align: left;">MONDO:0016982</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856475</td>
<td style="text-align: left;">desmoplastic fibroblastoma</td>
<td style="text-align: left;">NCIT:C27515</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Desmoplastic Fibroblastoma</td>
<td style="text-align: left;">A rare benign soft tissue neoplasm characterized by the presence of an abundant collagenous or myxocollagenous matrix, spindle-shaped, and stellate-shaped fibroblasts.  It usually presents as an asymptomatic, slowly growing subcutaneous mass. The most common sites of involvement are the upper arm, shoulder, and lower limb.</td>
<td style="text-align: left;">MONDO:0005167</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856477</td>
<td style="text-align: left;">columnar trichoblastoma</td>
<td style="text-align: left;">NCIT:C27524</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Columnar Trichoblastoma</td>
<td style="text-align: left;">A benign adnexal tumor occurring in the face of young female subjects. It is characterized by the presence of epithelial neoplastic cells and keratinous cysts in a desmoplastic stroma.</td>
<td style="text-align: left;">MONDO:0020593</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856479</td>
<td style="text-align: left;">primary cutaneous mucinous carcinoma</td>
<td style="text-align: left;">NCIT:C27533</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Cutaneous Mucinous Carcinoma</td>
<td style="text-align: left;">A rare low-grade carcinoma of the sweat glands. The most common sites are eyelids, scalp, axilla, face and trunk. It is histologically characterized by proliferating ducts until the overproduction of mucin creates islands of tumor cells, essentially floating in mucinous pools (Rosai J. Ackerman's Surgical Pathology).</td>
<td style="text-align: left;">MONDO:0005524,MONDO:0004957</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856501</td>
<td style="text-align: left;">oral cavity disorder</td>
<td style="text-align: left;">NCIT:C27641</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oral Cavity Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder affecting the oral cavity.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856504</td>
<td style="text-align: left;">sinonasal disorder</td>
<td style="text-align: left;">NCIT:C27647</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sinonasal Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the nasal cavity or paranasal sinuses.  Representative examples include inflammatory disorders, papillomas, and carcinomas.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856509</td>
<td style="text-align: left;">human papillomavirus-related verrucous carcinoma</td>
<td style="text-align: left;">NCIT:C27678</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Human Papillomavirus-Related Verrucous Carcinoma</td>
<td style="text-align: left;">A verrucous carcinoma that is associated with human papillomavirus infection.</td>
<td style="text-align: left;">MONDO:0020657,MONDO:0006006</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856510</td>
<td style="text-align: left;">human papillomavirus-related vulvar squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C27679</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the vulva and is caused by human papillomavirus infection.</td>
<td style="text-align: left;">MONDO:0020657,MONDO:0024609</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856511</td>
<td style="text-align: left;">human papillomavirus-related esophageal squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C27680</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma</td>
<td style="text-align: left;">An esophageal squamous cell carcinoma that arises from squamous epithelial cells infected with human papillomavirus.</td>
<td style="text-align: left;">MONDO:0005580,MONDO:0020657</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856512</td>
<td style="text-align: left;">human papillomavirus-related anal squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C27681</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Human Papillomavirus-Related Anal Squamous Cell Carcinoma</td>
<td style="text-align: left;">An anal squamous cell carcinoma related to infection with sexually transmittable human papillomavirus.</td>
<td style="text-align: left;">MONDO:0020657,MONDO:0006082</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856518</td>
<td style="text-align: left;">ebv-related post-transplant lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C27696</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">EBV-Related Post-Transplant Lymphoproliferative Disorder</td>
<td style="text-align: left;">A lymphoproliferative disorder that develops following organ transplantation and is associated with Epstein-Barr virus infection.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856523</td>
<td style="text-align: left;">extragastrointestinal gastrointestinal stromal tumor</td>
<td style="text-align: left;">NCIT:C27716</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extragastrointestinal Gastrointestinal Stromal Tumor</td>
<td style="text-align: left;">A rare gastrointestinal stromal tumor that presents as a solitary mass outside the gastrointestinal tract.</td>
<td style="text-align: left;">MONDO:0011719</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856526</td>
<td style="text-align: left;">myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia</td>
<td style="text-align: left;">NCIT:C27726</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia</td>
<td style="text-align: left;">A myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia, dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines, and 15% or more ring sideroblasts in the bone marrow.  (WHO, 2001)</td>
<td style="text-align: left;">MONDO:0019157</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856539</td>
<td style="text-align: left;">myelodysplastic/myeloproliferative neoplasm, not otherwise specified</td>
<td style="text-align: left;">NCIT:C27780</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified</td>
<td style="text-align: left;">A myelodysplastic/myeloproliferative neoplasm that does not meet the criteria of other myelodysplastic/myeloproliferative neoplasms, myelodysplastic syndromes, and myeloproliferative neoplasms. It is associated with cytopenia, blasts less than 20% in bone marrow and peripheral blood, thrombocytosis, and absence of genetic abnormalities associated with myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions.</td>
<td style="text-align: left;">MONDO:0006311</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856541</td>
<td style="text-align: left;">spindle cell type gastrointestinal stromal tumor</td>
<td style="text-align: left;">NCIT:C27792</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Spindle Cell Type Gastrointestinal Stromal Tumor</td>
<td style="text-align: left;">A gastrointestinal stromal tumor composed of neoplastic spindle cells.</td>
<td style="text-align: left;">MONDO:0011719</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856542</td>
<td style="text-align: left;">mixed cell type gastrointestinal stromal tumor</td>
<td style="text-align: left;">NCIT:C27793</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mixed Cell Type Gastrointestinal Stromal Tumor</td>
<td style="text-align: left;">A gastrointestinal stromal tumor composed of a mixture of neoplastic epithelioid and spindle cells.</td>
<td style="text-align: left;">MONDO:0011719</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856545</td>
<td style="text-align: left;">nodular sclerosis classic hodgkin lymphoma, syncytial variant</td>
<td style="text-align: left;">NCIT:C27807</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nodular Sclerosis Classic Hodgkin Lymphoma, Syncytial Variant</td>
<td style="text-align: left;">Nodular sclerosis classic Hodgkin lymphoma characterized by the presence of large numbers of Hodgkin and Reed-Sternberg cells forming confluent sheets.</td>
<td style="text-align: left;">MONDO:0004665</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856546</td>
<td style="text-align: left;">pigmented nevus</td>
<td style="text-align: left;">NCIT:C27816</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pigmented Nevus</td>
<td style="text-align: left;">A nevus characterised by the presence of excessive pigment.</td>
<td style="text-align: left;">MONDO:0005073</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856549</td>
<td style="text-align: left;">invasive breast carcinoma by histologic grade</td>
<td style="text-align: left;">NCIT:C27829</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Breast Carcinoma by Histologic Grade</td>
<td style="text-align: left;">A term that refers to the classification of invasive breast carcinomas according to their histologic grade.</td>
<td style="text-align: left;">MONDO:0006256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856551</td>
<td style="text-align: left;">endometrial endometrioid adenocarcinoma with clear cell change</td>
<td style="text-align: left;">NCIT:C27843</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endometrial Endometrioid Adenocarcinoma with Clear Cell Change</td>
<td style="text-align: left;">A morphologic variant of endometrioid adenocarcinoma characterized by the presence of large multinucleated clear cells.</td>
<td style="text-align: left;">MONDO:0006192,MONDO:0005004</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856552</td>
<td style="text-align: left;">endometrial endometrioid adenocarcinoma with a poorly differentiated carcinomatous component</td>
<td style="text-align: left;">NCIT:C27844</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component</td>
<td style="text-align: left;">A primary endometrioid adenocarcinoma of the endometrium characterized by the presence of a component with poorly differentiated carcinoma cells.</td>
<td style="text-align: left;">MONDO:0006192</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856553</td>
<td style="text-align: left;">endometrial endometrioid adenocarcinoma with an undifferentiated carcinomatous component</td>
<td style="text-align: left;">NCIT:C27845</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component</td>
<td style="text-align: left;">A primary endometrioid adenocarcinoma of the endometrium characterized by the presence of a component with undifferentiated malignant cells.</td>
<td style="text-align: left;">MONDO:0006192</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856554</td>
<td style="text-align: left;">endometrial endometrioid adenocarcinoma, ciliated variant</td>
<td style="text-align: left;">NCIT:C27848</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endometrial Endometrioid Adenocarcinoma, Ciliated Variant</td>
<td style="text-align: left;">An endometrioid adenocarcinoma arising from the endometrium, in which ciliated cells line the majority of the malignant glands.</td>
<td style="text-align: left;">MONDO:0006192</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856569</td>
<td style="text-align: left;">type 1 papillary renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C27886</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Type 1 Papillary Renal Cell Carcinoma</td>
<td style="text-align: left;">A papillary renal cell carcinoma characterized by the presence of papillae covered by small cells with scant amount of cytoplasm. The cells are arranged in a single layer on the basement membrane of the papillae.</td>
<td style="text-align: left;">MONDO:0017884</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856570</td>
<td style="text-align: left;">type 2 papillary renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C27887</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Type 2 Papillary Renal Cell Carcinoma</td>
<td style="text-align: left;">A papillary renal cell carcinoma characterized by the presence of papillae covered by cells of a higher nuclear grade as compared to type 1 papillary renal cell carcinoma. The cells have eosinophilic cytoplasm and pseudostratified nuclei.</td>
<td style="text-align: left;">MONDO:0017884</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856571</td>
<td style="text-align: left;">sporadic papillary renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C27890</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sporadic Papillary Renal Cell Carcinoma</td>
<td style="text-align: left;">A papillary renal cell carcinoma that occurs in a patient who does not have a family history of papillary renal cell carcinoma nor is a carrier of an inherited DNA change that would increase the risk of developing this carcinoma.</td>
<td style="text-align: left;">MONDO:0017884</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856580</td>
<td style="text-align: left;">sporadic burkitt lymphoma</td>
<td style="text-align: left;">NCIT:C27914</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sporadic Burkitt Lymphoma</td>
<td style="text-align: left;">A clinical variant of Burkitt lymphoma that occurs throughout the world.  It affects both children and adults and is more frequently seen in males.</td>
<td style="text-align: left;">MONDO:0007243</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856592</td>
<td style="text-align: left;">metaplastic carcinoma</td>
<td style="text-align: left;">NCIT:C27949</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metaplastic Carcinoma</td>
<td style="text-align: left;">A general term used to describe carcinomas arising from epithelial cells that have been transformed into another cell type (metaplastic epithelial cells). A representative example is the adenocarcinoma arising in Barrett esophagus. This term is also used to describe carcinomas in which the malignant epithelial cells show differentiation towards another cell type. A representative example of the latter is the metaplastic breast carcinoma in which the malignant glandular cells show squamous, spindle cell, or chondroid/osseous differentiation.</td>
<td style="text-align: left;">MONDO:0004993</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856593</td>
<td style="text-align: left;">nipple squamous cell carcinoma in situ</td>
<td style="text-align: left;">NCIT:C28292</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nipple Squamous Cell Carcinoma In Situ</td>
<td style="text-align: left;">An intraepidermal squamous cell carcinoma involving the area of the nipple.</td>
<td style="text-align: left;">MONDO:0004693,MONDO:0003950</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856599</td>
<td style="text-align: left;">biliary system disorder</td>
<td style="text-align: left;">NCIT:C2899</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Biliary System Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the intrahepatic or extrahepatic bile ducts or the gallbladder. Representative examples of non-neoplastic disorders include cholangitis and cholecystitis. Representative examples of neoplastic disorders include extrahepatic bile duct adenoma, intrahepatic and extrahepatic cholangiocarcinoma, and gallbladder carcinoma.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856602</td>
<td style="text-align: left;">enchondroma</td>
<td style="text-align: left;">NCIT:C3007</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Enchondroma</td>
<td style="text-align: left;">A common benign hyaline cartilage neoplasm arising in the intramedullary bone.  It is characterized by the presence of chondrocytes, low mitotic activity, and in some cases, a nodular pattern and calcification. The small bones of the hands and feet are the most frequently affected sites.</td>
<td style="text-align: left;">MONDO:0000631,MONDO:0002360</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856604</td>
<td style="text-align: left;">pancreatic glucagon-producing neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C3062</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Glucagon-Producing Neuroendocrine Tumor</td>
<td style="text-align: left;">A usually malignant, glucagon-producing neuroendocrine tumor arising from the pancreatic alpha cells.  It may or may not be associated with inappropriate secretion of glucagon and an associated clinical syndrome.</td>
<td style="text-align: left;">MONDO:0019954</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856606</td>
<td style="text-align: left;">chronic phase chronic myeloid leukemia, bcr-abl1 positive</td>
<td style="text-align: left;">NCIT:C3175</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive</td>
<td style="text-align: left;">A phase of chronic myeloid leukemia, BCR-ABL1 positive in which the peripheral blood smear shows leukocytosis with neutrophils in different stages of maturation, less than 2% blasts, and normal or increased platelet count. Most patients have mild anemia. The bone marrow is hypercellular due to increased numbers of neutrophils and their precursors, and blasts usually account for fewer than 5% of the marrow cells. Megakaryocytes are smaller than normal and have hypolobated nuclei. The spleen is enlarged due to infiltration of the cords of the red pulp by granulocytes.</td>
<td style="text-align: left;">MONDO:0001014,MONDO:0011996</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856607</td>
<td style="text-align: left;">myeloid leukemia, philadelphia-negative</td>
<td style="text-align: left;">NCIT:C3176</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myeloid Leukemia, Philadelphia-Negative</td>
<td style="text-align: left;">Myeloid leukemia characterized by the absence of Philadelphia chromosome.</td>
<td style="text-align: left;">MONDO:0004643</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856608</td>
<td style="text-align: left;">neoplasm by site</td>
<td style="text-align: left;">NCIT:C3263</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neoplasm by Site</td>
<td style="text-align: left;">A term that refers to the classification of a neoplastic process according to the anatomic site that is involved.</td>
<td style="text-align: left;">MONDO:0005070</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856610</td>
<td style="text-align: left;">osteochondroma</td>
<td style="text-align: left;">NCIT:C3295</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Osteochondroma</td>
<td style="text-align: left;">A common, benign cartiliginous neoplasm arising from the metaphysis of bone. The tumor grows on the surface of the bone; it may be pedunculated or sessile. It is characterized by the presence of chondrocytes, a cartilage cap, and a fibrous perichondrium that extends to the periosteum of the bone. In some cases, there is deletion of 8q24.1 chromosome locus.</td>
<td style="text-align: left;">MONDO:0000631,MONDO:0024470</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856611</td>
<td style="text-align: left;">extra-adrenal paraganglioma</td>
<td style="text-align: left;">NCIT:C3309</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extra-Adrenal Paraganglioma</td>
<td style="text-align: left;">A paraganglioma arising from sympathetic or parasympathetic paraganglia outside the adrenal gland.</td>
<td style="text-align: left;">MONDO:0000448</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856614</td>
<td style="text-align: left;">supratentorial neoplasm</td>
<td style="text-align: left;">NCIT:C3397</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Supratentorial Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that occurs within the intracranial cavity above the tentorium cerebelli.</td>
<td style="text-align: left;">MONDO:0021211</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856615</td>
<td style="text-align: left;">thyroid gland nodule</td>
<td style="text-align: left;">NCIT:C3415</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Nodule</td>
<td style="text-align: left;">A nodular lesion that develops in the thyroid gland.  Causes include adenoma, thyroiditis, fluid-filled cyst, multinodular goiter, and carcinoma.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856638</td>
<td style="text-align: left;">grade 3 follicular lymphoma</td>
<td style="text-align: left;">NCIT:C3460</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Grade 3 Follicular Lymphoma</td>
<td style="text-align: left;">A follicular lymphoma which contains more than 15 centroblasts per 40X high-power microscopic field.</td>
<td style="text-align: left;">MONDO:0018906,MONDO:0017595</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856661</td>
<td style="text-align: left;">epithelioid cell type gastrointestinal stromal tumor</td>
<td style="text-align: left;">NCIT:C3486</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Epithelioid Cell Type Gastrointestinal Stromal Tumor</td>
<td style="text-align: left;">A benign or malignant gastrointestinal stromal tumor with epithelioid morphology.</td>
<td style="text-align: left;">MONDO:0011719</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856691</td>
<td style="text-align: left;">uterine corpus degenerated leiomyoma</td>
<td style="text-align: left;">NCIT:C3511</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Degenerated Leiomyoma</td>
<td style="text-align: left;">A morphologic variant of uterine corpus leiomyoma characterized by the presence of hyalinized or myxoid stroma, edema, cystic changes, hemorrhage, and calcifications.</td>
<td style="text-align: left;">MONDO:0007886</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856703</td>
<td style="text-align: left;">eyelid vascular disorder</td>
<td style="text-align: left;">NCIT:C35198</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Vascular Disorder</td>
<td style="text-align: left;">Any non-neoplastic or neoplastic disorder affecting the arteries, veins, or lymphatic vessels of the eyelid.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856706</td>
<td style="text-align: left;">placental polyp</td>
<td style="text-align: left;">NCIT:C3521</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Placental Polyp</td>
<td style="text-align: left;">A polyp in the uterine cavity that is formed by placenta remnants.</td>
<td style="text-align: left;">MONDO:0021498,MONDO:0005079</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856715</td>
<td style="text-align: left;">chondromatosis</td>
<td style="text-align: left;">NCIT:C35259</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chondromatosis</td>
<td style="text-align: left;">A multifocal benign neoplasm arising from bone or soft tissue.  It is characterized by the presence of chondrocytes and is composed of hyaline cartilage.</td>
<td style="text-align: left;">MONDO:0024470</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856723</td>
<td style="text-align: left;">malignant palate neoplasm</td>
<td style="text-align: left;">NCIT:C3530</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Palate Neoplasm</td>
<td style="text-align: left;">A primary or metastatic malignant neoplasm that affects the hard palate, soft palate, or uvula.</td>
<td style="text-align: left;">MONDO:0005515,MONDO:0005286</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856758</td>
<td style="text-align: left;">malignant neoplasm of multiple primary sites</td>
<td style="text-align: left;">NCIT:C35427</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Neoplasm of Multiple Primary Sites</td>
<td style="text-align: left;">A malignant neoplasm arising in multiple primary sites.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856764</td>
<td style="text-align: left;">behavioral disorder</td>
<td style="text-align: left;">NCIT:C35470</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Behavioral Disorder</td>
<td style="text-align: left;">A specific behavioral problem that occurs in persistent patterns and characteristic clusters and that causes clinically significant impairment.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856772</td>
<td style="text-align: left;">lung kaposi sarcoma</td>
<td style="text-align: left;">NCIT:C3551</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Kaposi Sarcoma</td>
<td style="text-align: left;">A Kaposi sarcoma arising from the lung.</td>
<td style="text-align: left;">MONDO:0002426,MONDO:0005055</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856784</td>
<td style="text-align: left;">malignant exocervical neoplasm</td>
<td style="text-align: left;">NCIT:C3554</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Exocervical Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that affects the exocervix.</td>
<td style="text-align: left;">MONDO:0002974</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856787</td>
<td style="text-align: left;">complex endometrial hyperplasia with atypia</td>
<td style="text-align: left;">NCIT:C35560</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Complex Endometrial Hyperplasia with Atypia</td>
<td style="text-align: left;">A hyperplasia characterized by excessive proliferation of endometrial cells, resulting in the formation of complex epithelial structures.  It is associated with cytologic atypia and an increased risk of endometrial adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0006169</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856810</td>
<td style="text-align: left;">mixed tumor of the salivary gland</td>
<td style="text-align: left;">NCIT:C35691</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mixed Tumor of the Salivary Gland</td>
<td style="text-align: left;">A benign or malignant neoplasm that arises from the salivary glands.  It is characterized by the presence of epithelial and mesenchymal elements.  This category includes pleomorphic adenoma, carcinoma ex pleomorphic adenoma, and carcinosarcoma.</td>
<td style="text-align: left;">MONDO:0021043,MONDO:0021357</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856811</td>
<td style="text-align: left;">posterior pharyngeal wall carcinoma</td>
<td style="text-align: left;">NCIT:C35692</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Posterior Pharyngeal Wall Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the posterior wall of the pharynx.</td>
<td style="text-align: left;">MONDO:0021345</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856812</td>
<td style="text-align: left;">benign uvula neoplasm</td>
<td style="text-align: left;">NCIT:C35698</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Uvula Neoplasm</td>
<td style="text-align: left;">A non-metastasizing neoplasm that arises from the uvula.</td>
<td style="text-align: left;">MONDO:0021480</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856814</td>
<td style="text-align: left;">testicular teratoma with somatic-type malignancy</td>
<td style="text-align: left;">NCIT:C35711</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Teratoma with Somatic-Type Malignancy</td>
<td style="text-align: left;">A testicular teratoma associated with a distinct secondary component that resembles a somatic-type malignant neoplasm (e.g., carcinoma or sarcoma).</td>
<td style="text-align: left;">MONDO:0003403,MONDO:0006444,MONDO:0018193</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856818</td>
<td style="text-align: left;">salivary gland lymphoepithelial carcinoma</td>
<td style="text-align: left;">NCIT:C35736</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Salivary Gland Lymphoepithelial Carcinoma</td>
<td style="text-align: left;">A rare carcinoma that arises from the salivary glands, most often the parotid gland.  It is characterized by the presence of an undifferentiated carcinomatous component associated with a prominent reactive lymphoplasmacytic infiltrate.</td>
<td style="text-align: left;">MONDO:0000521,MONDO:0003572</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856830</td>
<td style="text-align: left;">metastatic malignant neoplasm in the bone</td>
<td style="text-align: left;">NCIT:C3580</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Bone</td>
<td style="text-align: left;">A malignant neoplasm that has spread to the bone from another anatomic site.</td>
<td style="text-align: left;">MONDO:0002129,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856835</td>
<td style="text-align: left;">monoblastic sarcoma</td>
<td style="text-align: left;">NCIT:C35816</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Monoblastic Sarcoma</td>
<td style="text-align: left;">A less common form of myeloid sarcoma composed of monoblasts.  Monoblastic sarcoma may precede or occur simultaneously with acute monoblastic leukemia. (WHO 2001)</td>
<td style="text-align: left;">MONDO:0006861</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856836</td>
<td style="text-align: left;">blastic granulocytic sarcoma</td>
<td style="text-align: left;">NCIT:C35817</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Blastic Granulocytic Sarcoma</td>
<td style="text-align: left;">A granulocytic sarcoma composed primarily of myeloblasts (WHO 2001).</td>
<td style="text-align: left;">MONDO:0006237</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856837</td>
<td style="text-align: left;">immature granulocytic sarcoma</td>
<td style="text-align: left;">NCIT:C35818</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Immature Granulocytic Sarcoma</td>
<td style="text-align: left;">A granulocytic sarcoma composed of myeloblasts and promyelocytes (WHO 2001).</td>
<td style="text-align: left;">MONDO:0006237</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856838</td>
<td style="text-align: left;">differentiated granulocytic sarcoma</td>
<td style="text-align: left;">NCIT:C35819</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Differentiated Granulocytic Sarcoma</td>
<td style="text-align: left;">A granulocytic sarcoma composed of promyelocytes and more mature neutrophils (WHO 2001).</td>
<td style="text-align: left;">MONDO:0006237</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856840</td>
<td style="text-align: left;">salivary gland cystadenoma</td>
<td style="text-align: left;">NCIT:C35833</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Salivary Gland Cystadenoma</td>
<td style="text-align: left;">An uncommon benign epithelial tumor, characterized by predominantly unicystic or multicystic growth; there is focal intraluminal papillary proliferation of the lining epithelium. Nearly half occur in the parotid gland.  In the minor salivary glands, women are affected more than men. In the major salivary glands, cystadenomas present as slowly enlarging, asymptomatic masses that may be slightly compressible. Cystadenocarcinoma is the malignant counterpart.</td>
<td style="text-align: left;">MONDO:0021460,MONDO:0036976,MONDO:0002369</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856844</td>
<td style="text-align: left;">salivary gland ductal papilloma</td>
<td style="text-align: left;">NCIT:C35839</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Salivary Gland Ductal Papilloma</td>
<td style="text-align: left;">A benign papillary neoplasm that arises from the salivary glands.  This category includes intraductal papilloma, inverted ductal papilloma, and sialadenoma papilliferum.</td>
<td style="text-align: left;">MONDO:0002363,MONDO:0021460</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856847</td>
<td style="text-align: left;">grade 1 clear cell renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C35851</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Grade 1 Clear Cell Renal Cell Carcinoma</td>
<td style="text-align: left;">A clear cell renal cell carcinoma characterized by absent or inconspicuous and basophilic nucleoli at x 400 magnification. (WHO 1982 /ISUP 2014)</td>
<td style="text-align: left;">MONDO:0005005</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856848</td>
<td style="text-align: left;">grade 2 clear cell renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C35852</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Grade 2 Clear Cell Renal Cell Carcinoma</td>
<td style="text-align: left;">A clear cell renal cell carcinoma characterized by nucleoli conspicuous and eosinophilic at x 400 magnification, and visible but not prominent at x 100 magnification. (WHO 1982 /ISUP 2014)</td>
<td style="text-align: left;">MONDO:0005005</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856849</td>
<td style="text-align: left;">grade 3 clear cell renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C35853</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Grade 3 Clear Cell Renal Cell Carcinoma</td>
<td style="text-align: left;">A clear cell renal cell carcinoma characterized by nucleoli conspicuous and eosinophilic at x 100 magnification. (WHO 1982 /ISUP 2014)</td>
<td style="text-align: left;">MONDO:0005005</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856850</td>
<td style="text-align: left;">grade 4 clear cell renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C35854</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Grade 4 Clear Cell Renal Cell Carcinoma</td>
<td style="text-align: left;">A clear cell renal cell carcinoma characterized by extreme nuclear pleomorphism and/or sarcomatoid and/or rhabdoid differentiation and/or tumor giant cells. (WHO, 1982 /ISUP 2014)</td>
<td style="text-align: left;">MONDO:0005005</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856855</td>
<td style="text-align: left;">endemic african kaposi sarcoma</td>
<td style="text-align: left;">NCIT:C35874</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endemic African Kaposi Sarcoma</td>
<td style="text-align: left;">A Kaposi sarcoma that occurs in adults and children in Equatorial Africa.</td>
<td style="text-align: left;">MONDO:0005055</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856856</td>
<td style="text-align: left;">distantly metastatic malignant neoplasm</td>
<td style="text-align: left;">NCIT:C35933</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Distantly Metastatic Malignant Neoplasm</td>
<td style="text-align: left;">A malignant tumor that has spread from its original (primary) site of growth to another site distant from the primary site.</td>
<td style="text-align: left;">MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856857</td>
<td style="text-align: left;">malignant neoplasm by grade</td>
<td style="text-align: left;">NCIT:C36041</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Neoplasm by Grade</td>
<td style="text-align: left;">A term that refers to the categorization of malignant neoplasm by histologic grade.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856858</td>
<td style="text-align: left;">moderately differentiated malignant neoplasm</td>
<td style="text-align: left;">NCIT:C36049</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Moderately Differentiated Malignant Neoplasm</td>
<td style="text-align: left;">A neoplasm whose histologic characteristics are intermediate between poorly differentiated and well differentiated.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856859</td>
<td style="text-align: left;">poorly differentiated malignant neoplasm</td>
<td style="text-align: left;">NCIT:C36050</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Poorly Differentiated Malignant Neoplasm</td>
<td style="text-align: left;">A neoplasm whose histologic characteristics have regressed and are more similar to stem cells.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856860</td>
<td style="text-align: left;">undifferentiated malignant neoplasm</td>
<td style="text-align: left;">NCIT:C36051</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Undifferentiated Malignant Neoplasm</td>
<td style="text-align: left;">A neoplasm that has minimal to no differentiating features.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856861</td>
<td style="text-align: left;">well differentiated malignant neoplasm</td>
<td style="text-align: left;">NCIT:C36052</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Well Differentiated Malignant Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm with morphological features reminiscent of the tissue from which it arose.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856862</td>
<td style="text-align: left;">acute promyelocytic leukemia with t(11;17)(q23;q21); zbtb16-rara</td>
<td style="text-align: left;">NCIT:C36056</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA</td>
<td style="text-align: left;">Acute promyelocytic leukemia with a variant RARA rearrangement associated with t(11;17)(q23;q21) that results in the expression of ZBTB16-RARA fusion protein. It lacks differentiation response to retinoids treatment.</td>
<td style="text-align: left;">MONDO:0100375</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856863</td>
<td style="text-align: left;">acute promyelocytic leukemia with t(5;17)(q35;q21); npm1-rara</td>
<td style="text-align: left;">NCIT:C36057</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Promyelocytic Leukemia with t(5;17)(q35;q21); NPM1-RARA</td>
<td style="text-align: left;">Acute promyelocytic leukemia with a variant RARA rearrangement associated with t(5;17)(q35;q21) that results in the expression of NPM1-RARA fusion protein.</td>
<td style="text-align: left;">MONDO:0100375</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856864</td>
<td style="text-align: left;">acute promyelocytic leukemia with t(11;17)(q13;q21); numa1-rara</td>
<td style="text-align: left;">NCIT:C36058</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA</td>
<td style="text-align: left;">Acute promyelocytic leukemia with a variant RARA rearrangement associated with t(11;17)(q13;q21) that results in the expression of NUMA1-RARA fusion protein.</td>
<td style="text-align: left;">MONDO:0100375</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856865</td>
<td style="text-align: left;">chronic myelomonocytic leukemia with eosinophilia</td>
<td style="text-align: left;">NCIT:C36060</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Myelomonocytic Leukemia with Eosinophilia</td>
<td style="text-align: left;">A chronic myelomonocytic leukemia characterized by a peripheral blood eosinophil count of equal or greater than 1.5x10E9/L, and absence of PDGFRA or PDGFRB gene abnormalities.</td>
<td style="text-align: left;">MONDO:0020311</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856866</td>
<td style="text-align: left;">chronic myelomonocytic leukemia-1</td>
<td style="text-align: left;">NCIT:C36061</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Myelomonocytic Leukemia-1</td>
<td style="text-align: left;">A chronic myelomonocytic leukemia characterized by the presence of less than 10 percent blasts in the bone marrow and less than 5 percent blasts in the peripheral blood.</td>
<td style="text-align: left;">MONDO:0020311</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856867</td>
<td style="text-align: left;">chronic myelomonocytic leukemia-2</td>
<td style="text-align: left;">NCIT:C36062</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Myelomonocytic Leukemia-2</td>
<td style="text-align: left;">A chronic myelomonocytic leukemia characterized by the presence of 10-19 percent blasts in the bone marrow and 5-19 percent blasts in the peripheral blood or by the presence of Auer rods regardless of the blasts count.</td>
<td style="text-align: left;">MONDO:0020311</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856875</td>
<td style="text-align: left;">hereditary male breast carcinoma</td>
<td style="text-align: left;">NCIT:C36106</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hereditary Male Breast Carcinoma</td>
<td style="text-align: left;">Breast carcinoma that has developed in male relatives of patients with history of breast carcinoma.</td>
<td style="text-align: left;">MONDO:0016419,MONDO:0005628</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856876</td>
<td style="text-align: left;">hereditary female breast carcinoma</td>
<td style="text-align: left;">NCIT:C36107</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hereditary Female Breast Carcinoma</td>
<td style="text-align: left;">Breast carcinoma that has developed in female relatives of patients with history of breast carcinoma.</td>
<td style="text-align: left;">MONDO:0016419,MONDO:0004379</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856880</td>
<td style="text-align: left;">non-hereditary clear cell renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C36261</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Hereditary Clear Cell Renal Cell Carcinoma</td>
<td style="text-align: left;">The most common type of renal cell carcinoma, characterized by a loss of genetic material of the short arm of chromosome 3.  The most common symptom at the time of diagnosis is hematuria.  The tumor has a golden-yellow color because of the abundance of intracytoplasmic lipid.  This is a clinically aggressive type of renal cell carcinoma.  The tumor usually metastasizes to unusual sites and late metastasis is common.</td>
<td style="text-align: left;">MONDO:0005005</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856882</td>
<td style="text-align: left;">metastatic benign neoplasm</td>
<td style="text-align: left;">NCIT:C36264</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Benign Neoplasm</td>
<td style="text-align: left;">A very rare benign neoplasm that metastasizes inexplicably. This category includes metastasizing pleomorphic adenoma of the salivary gland and uterine corpus metastasizing leiomyoma.</td>
<td style="text-align: left;">MONDO:0005165,MONDO:0024883</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856883</td>
<td style="text-align: left;">lymphomatous adult t-cell leukemia/lymphoma</td>
<td style="text-align: left;">NCIT:C36266</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lymphomatous Adult T-Cell Leukemia/Lymphoma</td>
<td style="text-align: left;">An adult T-cell leukemia/lymphoma characterized by generalized lymphadenopathy without peripheral blood involvement.  Most patients have advanced disease, however hypercalcemia is not frequently present.</td>
<td style="text-align: left;">MONDO:0019471</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856884</td>
<td style="text-align: left;">hodgkin-like adult t-cell leukemia/lymphoma</td>
<td style="text-align: left;">NCIT:C36268</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hodgkin-Like Adult T-Cell Leukemia/Lymphoma</td>
<td style="text-align: left;">A rare morphologic variant of adult T-cell leukemia/lymphoma characterized by the presence of Hodgkin-like and Reed-Sternberg-like cells.</td>
<td style="text-align: left;">MONDO:0019471</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856885</td>
<td style="text-align: left;">t-cell prolymphocytic leukemia, small cell variant</td>
<td style="text-align: left;">NCIT:C36270</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">T-Cell Prolymphocytic Leukemia, Small Cell Variant</td>
<td style="text-align: left;">A T-cell prolymphocytic leukemia characterized by the presence of small neoplastic prolymphocytes often with invisible nucleolus by light microscopy.</td>
<td style="text-align: left;">MONDO:0019468</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856886</td>
<td style="text-align: left;">t-cell prolymphocytic leukemia, cerebriform cell variant</td>
<td style="text-align: left;">NCIT:C36271</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant</td>
<td style="text-align: left;">A T-cell prolymphocytic leukemia characterized by the presence of neoplastic prolymphocytes with irregular or cerebriform nuclear outline.</td>
<td style="text-align: left;">MONDO:0019468</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856887</td>
<td style="text-align: left;">chronic lymphocytic leukemia with plasmacytoid differentiation</td>
<td style="text-align: left;">NCIT:C36272</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation</td>
<td style="text-align: left;">A chronic lymphocytic leukemia characterized by the presence of neoplastic lymphocytes with plasmacytoid morphology.</td>
<td style="text-align: left;">MONDO:0004948</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856891</td>
<td style="text-align: left;">prostate carcinoma metastatic in the bone</td>
<td style="text-align: left;">NCIT:C36308</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Carcinoma Metastatic in the Bone</td>
<td style="text-align: left;">A carcinoma that arises from the prostate gland and has spread to the bone.</td>
<td style="text-align: left;">MONDO:0004956,MONDO:0024884</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856897</td>
<td style="text-align: left;">oncocytic adenocarcinoma</td>
<td style="text-align: left;">NCIT:C3679</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oncocytic Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma characterized by the presence of large malignant epithelial cells with abundant granular eosinophilic cytoplasm (oncocytes). Representative examples include thyroid gland oncocytic follicular carcinoma, oncocytic breast carcinoma, and salivary gland oncocytic carcinoma.</td>
<td style="text-align: left;">MONDO:0004970,MONDO:0010795</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856900</td>
<td style="text-align: left;">carcinomatosis</td>
<td style="text-align: left;">NCIT:C3693</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Carcinomatosis</td>
<td style="text-align: left;">Carcinoma that has spread diffusely to an anatomic site or throughout the body.</td>
<td style="text-align: left;">MONDO:0024879</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856901</td>
<td style="text-align: left;">papillary fibroelastoma</td>
<td style="text-align: left;">NCIT:C3695</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Papillary Fibroelastoma</td>
<td style="text-align: left;">A rare benign neoplasm of the endocardium.  The vast majority of cases arise in the heart valves.  Histopathologic examination reveals a papilloma lined by endothelial cells with a central avascular core which contains fibroblasts and elastic fibers. Patients may be asymptomatic or present with ischemic or embolic events.</td>
<td style="text-align: left;">MONDO:0021505</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856902</td>
<td style="text-align: left;">meningiomatosis</td>
<td style="text-align: left;">NCIT:C3707</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Meningiomatosis</td>
<td style="text-align: left;">The presence of multiple meningiomas in the leptomeninges.</td>
<td style="text-align: left;">MONDO:0016642</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856905</td>
<td style="text-align: left;">chronic lymphocytic leukemia with immunoglobulin heavy chain variable-region gene somatic hypermutation</td>
<td style="text-align: left;">NCIT:C37202</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation</td>
<td style="text-align: left;">Chronic lymphocytic leukemia characterized by the presence of somatic hypermutation within the immunoglobulin heavy chain gene variable region of neoplastic clones. Patients have a better prognosis as compared to those with unmutated immunoglobulin heavy chain gene variable region rearrangements.</td>
<td style="text-align: left;">MONDO:0004948,MONDO:0004152</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856906</td>
<td style="text-align: left;">chronic lymphocytic leukemia with unmutated immunoglobulin heavy chain variable-region gene</td>
<td style="text-align: left;">NCIT:C37205</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene</td>
<td style="text-align: left;">Chronic lymphocytic leukemia characterized by the absence of somatic hypermutation within the immunoglobulin heavy chain gene variable region of neoplastic clones. Patients have a significantly worse prognosis as compared to those with mutated immunoglobulin heavy chain gene variable region rearrangements.</td>
<td style="text-align: left;">MONDO:0004478,MONDO:0004948</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856907</td>
<td style="text-align: left;">high grade b-cell lymphoma with blastoid morphologic features</td>
<td style="text-align: left;">NCIT:C37209</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">High Grade B-Cell Lymphoma with Blastoid Morphologic Features</td>
<td style="text-align: left;">A high-grade B-cell lymphoma characterized by the presence of medium-size neoplastic lymphocytes with a scant amount of cytoplasm and inconspicuous nucleoli, resembling lymphoblasts.</td>
<td style="text-align: left;">MONDO:0044889</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856911</td>
<td style="text-align: left;">benign kidney mixed epithelial and stromal tumor</td>
<td style="text-align: left;">NCIT:C37264</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Kidney Mixed Epithelial and Stromal Tumor</td>
<td style="text-align: left;">A rare, benign neoplasm that most often manifests as a multiloculated cystic renal mass. It is characterized by the presence of solid and cystic components. The solid components contain a mixture of epithelial and stromal elements.</td>
<td style="text-align: left;">MONDO:0002513,MONDO:0002386</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856912</td>
<td style="text-align: left;">atypical small acinar proliferation of the prostate gland</td>
<td style="text-align: left;">NCIT:C37268</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Small Acinar Proliferation of the Prostate Gland</td>
<td style="text-align: left;">Focal proliferation of small acinar glandular cells in the prostate gland with cytologic changes ranging from atypia to highly suggestive of malignancy.</td>
<td style="text-align: left;">MONDO:0021259</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856914</td>
<td style="text-align: left;">head and neck basaloid squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C37290</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Basaloid Squamous Cell Carcinoma</td>
<td style="text-align: left;">A high-grade, aggressive variant of squamous cell carcinoma that arises from the head and neck region.  The most common sites of origin are pyriform sinus, epiglottis, and base of tongue.  It is characterized by the presence of small malignant cells with hyperchromatic nuclei and scant amount of cytoplasm forming lobules with peripheral palisading.  Comedonecrosis may be present.</td>
<td style="text-align: left;">MONDO:0010150,MONDO:0003486</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856915</td>
<td style="text-align: left;">mixed mesodermal (mullerian) tumor</td>
<td style="text-align: left;">NCIT:C3730</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mixed Mesodermal (Mullerian) Tumor</td>
<td style="text-align: left;">A category of neoplasms characterized by the presence of epithelial and stromal elements. It includes the following clinicopathological entities: adenofibroma, adenomyoma, Mullerian adenosarcoma, and malignant mixed mesodermal (Mullerian) tumor. These neoplasms arise from the female reproductive system and extremely rarely from the peritoneum.</td>
<td style="text-align: left;">MONDO:0021043</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856917</td>
<td style="text-align: left;">abdominal (mesenteric) fibromatosis</td>
<td style="text-align: left;">NCIT:C3741</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Abdominal (Mesenteric) Fibromatosis</td>
<td style="text-align: left;">An insidious poorly circumscribed neoplasm arising from the deep soft tissues of the abdomen. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern.</td>
<td style="text-align: left;">MONDO:0007608</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856918</td>
<td style="text-align: left;">adenomatous polyp</td>
<td style="text-align: left;">NCIT:C3764</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adenomatous Polyp</td>
<td style="text-align: left;">A polypoid neoplasm that arises from the glandular epithelium of the gastrointestinal tract. There is a proliferation of glandular cells that may display dysplastic cytologic features. Representative examples include the adenomatous polyps of the colon and rectum.</td>
<td style="text-align: left;">MONDO:0006180,MONDO:0021075</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856920</td>
<td style="text-align: left;">giant cell carcinoma</td>
<td style="text-align: left;">NCIT:C3779</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Giant Cell Carcinoma</td>
<td style="text-align: left;">A malignant epithelial neoplasm composed of giant, pleomorphic cells.</td>
<td style="text-align: left;">MONDO:0005232,MONDO:0002402</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856923</td>
<td style="text-align: left;">renal cell carcinoma associated with t(x;1)(p11.2;q21)</td>
<td style="text-align: left;">NCIT:C37872</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21)</td>
<td style="text-align: left;">A renal cell carcinoma with papillary architecture comprised of clear cells. It is characterized by the t(X;1)(p11.2;q21) resulting in fusion of the PRCC and TFE3 genes.</td>
<td style="text-align: left;">MONDO:0006397</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856924</td>
<td style="text-align: left;">renal cell carcinoma associated with t(x;1)(p11.2;p34)</td>
<td style="text-align: left;">NCIT:C37874</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34)</td>
<td style="text-align: left;">A renal cell carcinoma with papillary architecture comprised of clear cells. It is characterized by the t(X;1)(p11.2;p34) resulting in fusion of the PSF and TFE3 genes.</td>
<td style="text-align: left;">MONDO:0006397</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856925</td>
<td style="text-align: left;">renal cell carcinoma associated with t(x;17)(p11.2;q25)</td>
<td style="text-align: left;">NCIT:C37876</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25)</td>
<td style="text-align: left;">A renal cell carcinoma with papillary architecture comprised of clear cells. It is characterized by the t(X;1)(p11.2;q25) resulting in fusion of the ASPL and TFE3 genes.</td>
<td style="text-align: left;">MONDO:0006397</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856927</td>
<td style="text-align: left;">angiofibroma</td>
<td style="text-align: left;">NCIT:C3799</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Angiofibroma</td>
<td style="text-align: left;">A morphologic variant of fibroma characterized by the presence of numerous dilated vascular channels.</td>
<td style="text-align: left;">MONDO:0005167</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856930</td>
<td style="text-align: left;">myoid dermatofibrosarcoma protuberans</td>
<td style="text-align: left;">NCIT:C38105</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myoid Dermatofibrosarcoma Protuberans</td>
<td style="text-align: left;">A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of areas of myofibroblastic differentiation.</td>
<td style="text-align: left;">MONDO:0011934</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856931</td>
<td style="text-align: left;">myxoid dermatofibrosarcoma protuberans</td>
<td style="text-align: left;">NCIT:C38106</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myxoid Dermatofibrosarcoma Protuberans</td>
<td style="text-align: left;">A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of multinodular growth with more than 50% of the tumor exhibiting myxoid change.</td>
<td style="text-align: left;">MONDO:0011934</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856934</td>
<td style="text-align: left;">skin basal cell carcinoma with adnexal differentiation</td>
<td style="text-align: left;">NCIT:C38109</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Basal Cell Carcinoma with Adnexal Differentiation</td>
<td style="text-align: left;">A basal cell carcinoma of the skin that is characterized by adnexal differentiation.</td>
<td style="text-align: left;">MONDO:0005341</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856938</td>
<td style="text-align: left;">clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres</td>
<td style="text-align: left;">NCIT:C38154</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Clear Cell Myomelanocytic Tumor of the Falciform Ligament/Ligamentum Teres</td>
<td style="text-align: left;">A very rare, usually benign neoplasm with perivascular epithelioid cell differentiation characterized by the presence of clear spindle cells arranged in fascicles and nests that usually affects young girls.  Patients usually present with a painful abdominal mass.</td>
<td style="text-align: left;">MONDO:0006359</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856939</td>
<td style="text-align: left;">metachronous malignant neoplasm</td>
<td style="text-align: left;">NCIT:C38156</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metachronous Malignant Neoplasm</td>
<td style="text-align: left;">A malignant tumor that arises at a site separate from another, primary malignant tumor in the same anatomic system.  It is not clear if metachronous malignant neoplasms represent new primary tumors or metastatic disease.  Examples include metachronous osteosarcoma of the bones that develops in patients with known primary bone osteosarcoma, and metachronous Wilms' tumor that affects the opposite kidney in patients with a history of Wilms' tumor.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856940</td>
<td style="text-align: left;">plasmablastic lymphoma of mucosa site</td>
<td style="text-align: left;">NCIT:C38159</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Plasmablastic Lymphoma of Mucosa Site</td>
<td style="text-align: left;">A plasmablastic lymphoma that arises from a mucosal site.</td>
<td style="text-align: left;">MONDO:0017347</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856941</td>
<td style="text-align: left;">digestive system non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C38161</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Digestive System Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A non-Hodgkin lymphoma that arises from any part of the digestive system, with the bulk of the disease localized to that site.</td>
<td style="text-align: left;">MONDO:0018908,MONDO:0004699</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856942</td>
<td style="text-align: left;">digestive system hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C38163</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Digestive System Hodgkin Lymphoma</td>
<td style="text-align: left;">A Hodgkin lymphoma that arises from any part of the digestive system, with the bulk of the disease localized to that site.</td>
<td style="text-align: left;">MONDO:0004699,MONDO:0004952</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856943</td>
<td style="text-align: left;">acute promyelocytic leukemia with stat5b-rara</td>
<td style="text-align: left;">NCIT:C38377</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Promyelocytic Leukemia with STAT5B-RARA</td>
<td style="text-align: left;">Acute promyelocytic leukemia with a variant RARA rearrangement and expression of STAT5B-RARA fusion protein.</td>
<td style="text-align: left;">MONDO:0100375</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856945</td>
<td style="text-align: left;">traditional serrated adenoma</td>
<td style="text-align: left;">NCIT:C38458</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Traditional Serrated Adenoma</td>
<td style="text-align: left;">An adenoma that arises from the large intestine and the appendix.  It is characterized by prominent serration of the glands.</td>
<td style="text-align: left;">MONDO:0006180</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856947</td>
<td style="text-align: left;">benign female breast neoplasm</td>
<td style="text-align: left;">NCIT:C3848</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Female Breast Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the breast in females and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0000620</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856948</td>
<td style="text-align: left;">aggravated malignant neoplasm</td>
<td style="text-align: left;">NCIT:C3851</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Aggravated Malignant Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that shows clinical and/or pathologic progression.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856949</td>
<td style="text-align: left;">thyroid gland sclerosing mucoepidermoid carcinoma with eosinophilia</td>
<td style="text-align: left;">NCIT:C38763</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia</td>
<td style="text-align: left;">A rare type of mucoepidermoid carcinoma of the thyroid gland, usually associated with chronic lymphocytic thyroiditis.  It exhibits a unique morphologic appearance consisting of a squamoid, nested growth pattern, dense fibrosis, and mucinous differentiation.  The histogenesis of this unusual carcinoma has been debated, and it is unclear if it arises from remnants of the ultimobranchial body or from the follicular epithelial cells.</td>
<td style="text-align: left;">MONDO:0006463</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856951</td>
<td style="text-align: left;">grade 1 meningioma</td>
<td style="text-align: left;">NCIT:C38936</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Grade 1 Meningioma</td>
<td style="text-align: left;">A slow-growing, low-grade meningioma with favorable prognosis. This category includes angiomatous meningiomas, fibrous meningiomas, lymphoplasmacyte-rich meningiomas, meningothelial meningiomas, metaplastic meningiomas, microcystic meningiomas, psammomatous meningiomas, secretory meningiomas, and transitional meningiomas. It may recur in a small minority of cases following resection.</td>
<td style="text-align: left;">MONDO:0016642</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856963</td>
<td style="text-align: left;">t-cell large granular lymphocyte leukemia, common variant</td>
<td style="text-align: left;">NCIT:C39584</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">T-Cell Large Granular Lymphocyte Leukemia, Common Variant</td>
<td style="text-align: left;">T-cell large granular lymphocyte leukemia defined by the presence of CD3-positive, CD8-positive, and T-cell receptor alpha-beta-positive cytotoxic T-cells.</td>
<td style="text-align: left;">MONDO:0019469</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856964</td>
<td style="text-align: left;">t-cell large granular lymphocyte leukemia expressing the t-cell receptor gamma-delta</td>
<td style="text-align: left;">NCIT:C39586</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta</td>
<td style="text-align: left;">An uncommon variant of T-cell large granular lymphocyte leukemia expressing the gamma-delta T-cell receptor. Approximately 60% of these cases are CD8-positive and the remainder are CD4/CD8-negative.</td>
<td style="text-align: left;">MONDO:0019469</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856966</td>
<td style="text-align: left;">anaplastic large cell lymphoma, giant cell rich subtype</td>
<td style="text-align: left;">NCIT:C39674</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype</td>
<td style="text-align: left;">An anaplastic large cell lymphoma characterized by the presence of numerous giant cells.</td>
<td style="text-align: left;">MONDO:0020325</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856967</td>
<td style="text-align: left;">anaplastic large cell lymphoma, sarcomatoid subtype</td>
<td style="text-align: left;">NCIT:C39675</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype</td>
<td style="text-align: left;">A are variant of anaplastic large cell lymphoma. It is characterized by presence of large spindle shaped cells resembling a soft tissue sarcoma.</td>
<td style="text-align: left;">MONDO:0020325</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856968</td>
<td style="text-align: left;">anaplastic large cell lymphoma, signet ring-like subtype</td>
<td style="text-align: left;">NCIT:C39676</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype</td>
<td style="text-align: left;">An anaplastic large cell lymphoma, characterized by lymphoid cells with signet ring nuclei.</td>
<td style="text-align: left;">MONDO:0020325</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856969</td>
<td style="text-align: left;">pleomorphic variant mantle cell lymphoma</td>
<td style="text-align: left;">NCIT:C39747</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pleomorphic Variant Mantle Cell Lymphoma</td>
<td style="text-align: left;">An aggressive mantle cell lymphoma characterized by the presence of pleomorphic neoplastic B-lymphocytes.</td>
<td style="text-align: left;">MONDO:0018876</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856970</td>
<td style="text-align: left;">type ii endometrial adenocarcinoma</td>
<td style="text-align: left;">NCIT:C39749</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Type II Endometrial Adenocarcinoma</td>
<td style="text-align: left;">A classification of primary endometrial adenocarcinomas that refers to clear cell adenocarcinoma, serous adenocarcinoma, and serous endometrial intraepithelial carcinoma.</td>
<td style="text-align: left;">MONDO:0005461</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856972</td>
<td style="text-align: left;">secondary glioblastoma</td>
<td style="text-align: left;">NCIT:C39751</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Secondary Glioblastoma</td>
<td style="text-align: left;">A glioblastoma arising from a lower grade astrocytoma.</td>
<td style="text-align: left;">MONDO:0018177</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856973</td>
<td style="text-align: left;">conventional ameloblastoma</td>
<td style="text-align: left;">NCIT:C39755</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conventional Ameloblastoma</td>
<td style="text-align: left;">An intraosseous ameloblastoma that arises from the jaw, usually the mandible.  It grows slowly, invades locally, and recurs frequently.  It presents with swelling of the jaw.</td>
<td style="text-align: left;">MONDO:0017795</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856974</td>
<td style="text-align: left;">unicystic ameloblastoma</td>
<td style="text-align: left;">NCIT:C39756</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Unicystic Ameloblastoma</td>
<td style="text-align: left;">An ameloblastoma that presents as a unilocular cyst.  It usually arises from the mandible.</td>
<td style="text-align: left;">MONDO:0021077,MONDO:0017795</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856975</td>
<td style="text-align: left;">renal cell carcinoma with constitutional chromosome 3 translocations</td>
<td style="text-align: left;">NCIT:C39790</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations</td>
<td style="text-align: left;">A renal cell carcinoma with constitutional chromosome 3 translocations.</td>
<td style="text-align: left;">MONDO:0003008</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856976</td>
<td style="text-align: left;">renal cell carcinoma associated with inv(x)(p11;q12)</td>
<td style="text-align: left;">NCIT:C39802</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renal Cell Carcinoma Associated with inv(X)(p11;q12)</td>
<td style="text-align: left;">A renal cell carcinoma with papillary architecture comprised of clear cells. It is characterized by the inv(X)(p11;q12) resulting in fusion of the NONO (p54nrb) and TFE3 genes.</td>
<td style="text-align: left;">MONDO:0006397</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856980</td>
<td style="text-align: left;">invasive bladder sarcomatoid urothelial carcinoma with heterologous elements</td>
<td style="text-align: left;">NCIT:C39825</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Bladder Sarcomatoid Urothelial Carcinoma with Heterologous Elements</td>
<td style="text-align: left;">Invasive bladder sarcomatoid urothelial carcinoma characterized by the presence of heterologous elements.</td>
<td style="text-align: left;">MONDO:0004278</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856981</td>
<td style="text-align: left;">invasive bladder sarcomatoid urothelial carcinoma without heterologous elements</td>
<td style="text-align: left;">NCIT:C39826</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Bladder Sarcomatoid Urothelial Carcinoma without Heterologous Elements</td>
<td style="text-align: left;">Invasive bladder sarcomatoid urothelial carcinoma characterized by the absence of heterologous elements.</td>
<td style="text-align: left;">MONDO:0004278</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856984</td>
<td style="text-align: left;">bladder adenocarcinoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C39836</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Adenocarcinoma, Not Otherwise Specified</td>
<td style="text-align: left;">An adenocarcinoma, not otherwise specified, arising from the bladder.</td>
<td style="text-align: left;">MONDO:0002751</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856986</td>
<td style="text-align: left;">human papillomavirus-related urethral squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C39862</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Human Papillomavirus-Related Urethral Squamous Cell Carcinoma</td>
<td style="text-align: left;">A rare urethral squamous cell carcinoma that is related to human papilloma virus (HPV) infection of the urinary tract.</td>
<td style="text-align: left;">MONDO:0002764,MONDO:0020657</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856987</td>
<td style="text-align: left;">bladder mucosa-associated lymphoid tissue lymphoma</td>
<td style="text-align: left;">NCIT:C39878</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Mucosa-Associated Lymphoid Tissue Lymphoma</td>
<td style="text-align: left;">A rare mucosa-associated lymphoid tissue lymphoma affecting the bladder.</td>
<td style="text-align: left;">MONDO:0001381,MONDO:0007650</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856988</td>
<td style="text-align: left;">prostate acinar adenocarcinoma, atrophic pattern</td>
<td style="text-align: left;">NCIT:C39880</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Acinar Adenocarcinoma, Atrophic Pattern</td>
<td style="text-align: left;">An unusual variant of acinar prostate adenocarcinoma characterized by the presence of neoplastic small atrophic glands that contain malignant cells with scant cytoplasm.</td>
<td style="text-align: left;">MONDO:0002493</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856989</td>
<td style="text-align: left;">prostate acinar pseudohyperplastic adenocarcinoma</td>
<td style="text-align: left;">NCIT:C39881</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Acinar Pseudohyperplastic Adenocarcinoma</td>
<td style="text-align: left;">Acinar prostate adenocarcinoma characterized by the presence of neoplastic large glands that resemble the benign, non-neoplastic prostate glands.</td>
<td style="text-align: left;">MONDO:0002493</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856991</td>
<td style="text-align: left;">prostatic duct urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C39901</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostatic Duct Urothelial Carcinoma</td>
<td style="text-align: left;">An urothelial carcinoma that arises from the urothelial lining of the prostatic ducts.</td>
<td style="text-align: left;">MONDO:0002834</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856992</td>
<td style="text-align: left;">testicular seminoma with syncytiotrophoblastic cells</td>
<td style="text-align: left;">NCIT:C39919</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Seminoma with Syncytiotrophoblastic Cells</td>
<td style="text-align: left;">A testicular seminoma characterized by the presence of syncytiotrophoblastic giant cells.</td>
<td style="text-align: left;">MONDO:0003669</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856994</td>
<td style="text-align: left;">testicular seminoma with high mitotic index</td>
<td style="text-align: left;">NCIT:C39920</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Seminoma with High Mitotic Index</td>
<td style="text-align: left;">A seminoma of the testis characterized by increased cellular pleomorphism, high mitotic activity, and a non-prominent stromal lymphocytic infiltrate.</td>
<td style="text-align: left;">MONDO:0020633,MONDO:0003669</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856995</td>
<td style="text-align: left;">testicular spermatocytic tumor with sarcoma</td>
<td style="text-align: left;">NCIT:C39922</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Spermatocytic Tumor with Sarcoma</td>
<td style="text-align: left;">A malignant germ cell tumor that arises from the testis and is characterized by the presence of a spermatocytic tumor component that is contiguous with an undifferentiated or differentiated sarcomatous component.  It usually presents as a slowly growing mass that enlarges very rapidly soon after the initial diagnosis.</td>
<td style="text-align: left;">MONDO:0020513</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856996</td>
<td style="text-align: left;">monodermal testicular teratoma</td>
<td style="text-align: left;">NCIT:C39936</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Monodermal Testicular Teratoma</td>
<td style="text-align: left;">A teratoma that arises from the testis.  It is composed exclusively of one of the following tissue types: endoderm, ectoderm, or mesoderm.</td>
<td style="text-align: left;">MONDO:0018193</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856997</td>
<td style="text-align: left;">testicular sertoli cell tumor, lipid rich variant</td>
<td style="text-align: left;">NCIT:C39943</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Sertoli Cell Tumor, Lipid Rich Variant</td>
<td style="text-align: left;">A testicular Sertoli cell tumor in which the neoplastic cells have clear and vacuolated cytoplasm due to accumulation of intracytoplasmic lipids.</td>
<td style="text-align: left;">MONDO:0020813</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856998</td>
<td style="text-align: left;">testicular large cell calcifying sertoli cell tumor</td>
<td style="text-align: left;">NCIT:C39944</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Large Cell Calcifying Sertoli Cell Tumor</td>
<td style="text-align: left;">A testicular Sertoli cell tumor characterized by the presence of large polygonal cells with eosinophilic cytoplasm in a myxoid and hyalinized stroma. Calcifications may be present in the stroma. Malignant behavior is uncommon.</td>
<td style="text-align: left;">MONDO:0020808</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0856999</td>
<td style="text-align: left;">testicular sclerosing sertoli cell tumor</td>
<td style="text-align: left;">NCIT:C39945</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Sclerosing Sertoli Cell Tumor</td>
<td style="text-align: left;">A rare testicular Sertoli cell tumor characterized by the presence of neoplastic tubules that are surrounded by a dense fibrotic stroma.</td>
<td style="text-align: left;">MONDO:0020813</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857002</td>
<td style="text-align: left;">tumor of the thecoma/fibroma group</td>
<td style="text-align: left;">NCIT:C39950</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tumor of the Thecoma/Fibroma Group</td>
<td style="text-align: left;">A sex cord-stromal tumor that arises from the ovary or the testis. Representative examples include fibroma, fibrosarcoma, and thecoma.</td>
<td style="text-align: left;">MONDO:0006055</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857004</td>
<td style="text-align: left;">moderately differentiated ovarian sertoli-leydig cell tumor</td>
<td style="text-align: left;">NCIT:C39968</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor</td>
<td style="text-align: left;">A Sertoli-Leydig cell tumor of the ovary characterized by the presence of spindle-shaped gonadal stromal cells and Sertoli cells, some of which are atypical. Leydig cells are also present forming clusters at the periphery of the cellular aggregates. Metastases have been reported in a minority of patients.</td>
<td style="text-align: left;">MONDO:0036595</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857005</td>
<td style="text-align: left;">ovarian sertoli-leydig cell tumor with heterologous elements</td>
<td style="text-align: left;">NCIT:C39970</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements</td>
<td style="text-align: left;">A Sertoli-Leydig cell tumor that arises from the ovary. It is characterized by the presence of epithelial and/or mesenchymal components and neoplasms that arise from these components.</td>
<td style="text-align: left;">MONDO:0036595</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857006</td>
<td style="text-align: left;">ovarian retiform sertoli-leydig cell tumor</td>
<td style="text-align: left;">NCIT:C39971</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Retiform Sertoli-Leydig Cell Tumor</td>
<td style="text-align: left;">A Sertoli-Leydig cell tumor of the ovary in which anastomosing, slit-like spaces resembling rete testis constitute at least 90% of the tumor elements. It may present with estrogenic and less often androgenic manifestations. It usually follows a benign clinical course.</td>
<td style="text-align: left;">MONDO:0036595</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857007</td>
<td style="text-align: left;">ovarian sertoli-leydig cell tumor with retiform elements</td>
<td style="text-align: left;">NCIT:C39974</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements</td>
<td style="text-align: left;">A Sertoli-Leydig cell tumor characterized by the presence of spaces that resemble rete testis (retiform elements).  These spaces form anastomosing patterns and comprise at least ten percent but less than ninety percent of the tumor.  When the retiform elements comprise ninety percent or more of the tumor, the term retiform Sertoli-Leydig cell tumor is used.  A minority of patients may have an aggressive clinical course.</td>
<td style="text-align: left;">MONDO:0036595</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857008</td>
<td style="text-align: left;">ovarian stromal-leydig cell tumor</td>
<td style="text-align: left;">NCIT:C39977</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Stromal-Leydig Cell Tumor</td>
<td style="text-align: left;">A rare, benign and well circumscribed stromal tumor of the ovary.  It is characterized by the presence of a fibrotic stroma with clusters of Leydig cells.  The Leydig cells contain crystals of Reinke.  Patients may present with virilization.</td>
<td style="text-align: left;">MONDO:0024387,MONDO:0020807</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857009</td>
<td style="text-align: left;">ovarian sex cord-stromal tumor, not otherwise specified</td>
<td style="text-align: left;">NCIT:C39978</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Sex Cord-Stromal Tumor, Not Otherwise Specified</td>
<td style="text-align: left;">A sex cord-stromal tumor that arises from the ovary and lacks the morphologic features that belong to the categories of granulosa-stromal tumors, Sertoli-stromal tumors, or steroid cell tumors.</td>
<td style="text-align: left;">MONDO:0021657</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857014</td>
<td style="text-align: left;">borderline ovarian serous tumor/atypical proliferative ovarian serous tumor with microinvasion</td>
<td style="text-align: left;">NCIT:C40027</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor with Microinvasion</td>
<td style="text-align: left;">A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic serous epithelial cells, atypia, and microinvasion of the ovarian stroma.</td>
<td style="text-align: left;">MONDO:0037255</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857015</td>
<td style="text-align: left;">borderline ovarian serous adenofibroma</td>
<td style="text-align: left;">NCIT:C40028</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Borderline Ovarian Serous Adenofibroma</td>
<td style="text-align: left;">A low malignant potential adenofibroma arising from the ovary. It is characterized by an atypical epithelial hyperplasia. The epithelial cells are of serous type. There is no evidence of stromal destructive invasion.</td>
<td style="text-align: left;">MONDO:0024886,MONDO:0003462,MONDO:0020662</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857016</td>
<td style="text-align: left;">borderline ovarian mucinous tumor</td>
<td style="text-align: left;">NCIT:C40036</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Borderline Ovarian Mucinous Tumor</td>
<td style="text-align: left;">A low grade mucinous epithelial neoplasm arising from the ovary.  It is characterized by an atypical proliferation of mucinous-type epithelial cells without evidence of stromal invasion.  The mucinous epithelial cells may be of intestinal or endocervical type.</td>
<td style="text-align: left;">MONDO:0003756,MONDO:0016093</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857017</td>
<td style="text-align: left;">ovarian mucinous cystic tumor with mural nodules</td>
<td style="text-align: left;">NCIT:C40042</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Mucinous Cystic Tumor with Mural Nodules</td>
<td style="text-align: left;">A mucinous cystic tumor of the ovary characterized by the presence of one or more well circumscribed solid nodules in the wall of the cysts (mural nodules) that protrude into the lumen.  The mural nodules may be benign (sarcoma-like) or malignant.  The malignant mural nodules histologically are anaplastic carcinomas, carcinosarcomas, or sarcomas.  The clinical course depends on the histology of the mural nodules.  The prognosis of mucinous cystic tumors with benign mural nodules is the same as the corresponding types of mucinous cystic tumors without the mural nodules.  Mucinous cystic tumors with malignant mural nodules may follow a malignant clinical course.</td>
<td style="text-align: left;">MONDO:0003756</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857018</td>
<td style="text-align: left;">ovarian mucinous cystic tumor associated with pseudomyxoma peritonei</td>
<td style="text-align: left;">NCIT:C40043</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei</td>
<td style="text-align: left;">The presence of abundant mucoid or gelatinous, cellular or acellular material in the pelvis and abdominal cavity (pseudomyxoma peritonei) that is associated with the presence of an ovarian mucinous cystic tumor.  In the vast majority of cases, the presence of pseudomyxoma peritonei is the result of metastasis from a primary appendiceal or gastrointestinal tumor site, and the ovarian mucinous tumor is metastatic rather than primary.</td>
<td style="text-align: left;">MONDO:0003756</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857022</td>
<td style="text-align: left;">borderline ovarian clear cell tumor</td>
<td style="text-align: left;">NCIT:C40080</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Borderline Ovarian Clear Cell Tumor</td>
<td style="text-align: left;">An epithelial neoplasm with low malignant potential affecting the ovary.  It is characterized by the presence of clear or hobnail cells.  In some cases, the cells may display nuclear atypia and prominent nucleoli.  When such cells are present, they remain confined to the glands.  There is no evidence of stromal invasion.</td>
<td style="text-align: left;">MONDO:0021144,MONDO:0016093</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857025</td>
<td style="text-align: left;">fallopian tube serous neoplasm</td>
<td style="text-align: left;">NCIT:C40102</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fallopian Tube Serous Neoplasm</td>
<td style="text-align: left;">A benign, borderline, or malignant epithelial neoplasm that arises from the fallopian tube and is characterized by the presence of neoplastic serous epithelial cells.</td>
<td style="text-align: left;">MONDO:0037256,MONDO:0021092</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857028</td>
<td style="text-align: left;">fallopian tube endometrioid polyp</td>
<td style="text-align: left;">NCIT:C40115</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fallopian Tube Endometrioid Polyp</td>
<td style="text-align: left;">An adenomatous polyp that arises from the interstitial portion of the fallopian tube and is characterized by the presence of endometrial epithelium.  It may obstruct the lumen of the fallopian tube and result in infertility or tubal pregnancy.</td>
<td style="text-align: left;">MONDO:0021075,MONDO:0021576</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857029</td>
<td style="text-align: left;">fallopian tube metaplastic papillary tumor</td>
<td style="text-align: left;">NCIT:C40116</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fallopian Tube Metaplastic Papillary Tumor</td>
<td style="text-align: left;">A rare metaplastic lesion that arises from the fallopian tube. It is characterized by the presence of an intraluminal papillary proliferation composed of atypical epithelial cells with abundant eosinophilic cytoplasm. In the vast majority of cases, it is an incidental finding during microscopic examination of a fallopian tube in the postpartum period.</td>
<td style="text-align: left;">MONDO:0021096,MONDO:0000645,MONDO:0036976</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857030</td>
<td style="text-align: left;">fallopian tube soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C40126</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fallopian Tube Soft Tissue Neoplasm</td>
<td style="text-align: left;">A benign or malignant mesenchymal neoplasm that arises from the fallopian tube.</td>
<td style="text-align: left;">MONDO:0006424,MONDO:0021092</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857031</td>
<td style="text-align: left;">type i endometrial adenocarcinoma</td>
<td style="text-align: left;">NCIT:C40145</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Type I Endometrial Adenocarcinoma</td>
<td style="text-align: left;">A classification of primary endometrial adenocarcinomas that refers to endometrioid adenocarcinoma and mucinous adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0005461</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857033</td>
<td style="text-align: left;">figo grade 1 endometrial mucinous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C40149</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">FIGO Grade 1 Endometrial Mucinous Adenocarcinoma</td>
<td style="text-align: left;">A primary mucinous adenocarcinoma of the endometrium that contains equal to or less than 5% non-squamous solid areas.</td>
<td style="text-align: left;">MONDO:0002747</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857034</td>
<td style="text-align: left;">figo grade 2 endometrial mucinous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C40150</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">FIGO Grade 2 Endometrial Mucinous Adenocarcinoma</td>
<td style="text-align: left;">A primary mucinous adenocarcinoma of the endometrium that contains 6-50% non-squamous solid areas.</td>
<td style="text-align: left;">MONDO:0002747</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857035</td>
<td style="text-align: left;">figo grade 3 endometrial mucinous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C40151</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">FIGO Grade 3 Endometrial Mucinous Adenocarcinoma</td>
<td style="text-align: left;">A primary mucinous adenocarcinoma of the endometrium that contains more than 50% non-squamous solid areas.</td>
<td style="text-align: left;">MONDO:0002747</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857036</td>
<td style="text-align: left;">uterine corpus leiomyoma, mitotically active variant</td>
<td style="text-align: left;">NCIT:C40162</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Leiomyoma, Mitotically Active Variant</td>
<td style="text-align: left;">A morphologic variant of uterine corpus leiomyoma characterized by an increased number of mitoses (up to 19 mitoses per 10 high-powered fields).</td>
<td style="text-align: left;">MONDO:0007886</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857039</td>
<td style="text-align: left;">cervical squamous neoplasm</td>
<td style="text-align: left;">NCIT:C40195</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Squamous Neoplasm</td>
<td style="text-align: left;">A benign, precancerous, or malignant neoplasm that arises from the squamous epithelium of the cervix. Representative examples include condyloma acuminatum, cervical intraepithelial neoplasia, and squamous cell carcinoma.</td>
<td style="text-align: left;">MONDO:0002532,MONDO:0021230</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857040</td>
<td style="text-align: left;">cervical glandular neoplasm</td>
<td style="text-align: left;">NCIT:C40210</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Glandular Neoplasm</td>
<td style="text-align: left;">A benign, malignant, or precancerous neoplasm that arises from the glandular epithelium of the cervix. Representative examples include endocervical polyp, cervical adenocarcinoma, and cervical glandular intraepithelial neoplasia.</td>
<td style="text-align: left;">MONDO:0024276,MONDO:0021230</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857041</td>
<td style="text-align: left;">cervical soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C40216</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Soft Tissue Neoplasm</td>
<td style="text-align: left;">A benign or malignant mesenchymal neoplasm that arises from the cervix.</td>
<td style="text-align: left;">MONDO:0006424,MONDO:0021230</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857043</td>
<td style="text-align: left;">cervical mixed epithelial and mesenchymal neoplasm</td>
<td style="text-align: left;">NCIT:C40226</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Mixed Epithelial and Mesenchymal Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that arises from the cervix and is characterized by the presence of epithelial and mesenchymal elements. This category includes adenofibroma, adenomyoma, adenosarcoma, and carcinosarcoma.</td>
<td style="text-align: left;">MONDO:0021043,MONDO:0021230</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857045</td>
<td style="text-align: left;">vaginal keratinizing squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C40243</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Keratinizing Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the vagina and is characterized by the presence of keratin pearls. Intercellular bridges and cytoplasmic keratinization are usually present.</td>
<td style="text-align: left;">MONDO:0005056,MONDO:0006490</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857046</td>
<td style="text-align: left;">vaginal basaloid squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C40245</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Basaloid Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the vagina and is characterized by the presence of nests of malignant basaloid squamous cells with scant amounts of cytoplasm.</td>
<td style="text-align: left;">MONDO:0003486,MONDO:0006490</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857048</td>
<td style="text-align: left;">vaginal mucinous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C40252</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Mucinous Adenocarcinoma</td>
<td style="text-align: left;">A rare adenocarcinoma that arises from the vagina with histologic features resembling cervical mucinous adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0020653,MONDO:0004957</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857049</td>
<td style="text-align: left;">vaginal mesonephric adenocarcinoma</td>
<td style="text-align: left;">NCIT:C40253</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Mesonephric Adenocarcinoma</td>
<td style="text-align: left;">Vaginal adenocarcinoma that derives from Wolffian duct remnants and shows mesonephric differentiation.</td>
<td style="text-align: left;">MONDO:0020653,MONDO:0005613</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857051</td>
<td style="text-align: left;">vaginal adenoid basal carcinoma</td>
<td style="text-align: left;">NCIT:C40262</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Adenoid Basal Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the vagina and is characterized by the presence of nests of basaloid cells with focal glandular formations.</td>
<td style="text-align: left;">MONDO:0015867</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857053</td>
<td style="text-align: left;">vaginal soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C40265</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Soft Tissue Neoplasm</td>
<td style="text-align: left;">A benign or malignant mesenchymal neoplasm that arises from the vagina.</td>
<td style="text-align: left;">MONDO:0021050,MONDO:0006424</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857056</td>
<td style="text-align: left;">vaginal mixed epithelial and mesenchymal neoplasm</td>
<td style="text-align: left;">NCIT:C40274</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Mixed Epithelial and Mesenchymal Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that arises from the vagina and is characterized by the presence of epithelial and mesenchymal elements.  This category includes benign mixed tumor, adenosarcoma, carcinosarcoma, and malignant mixed tumor resembling synovial sarcoma.</td>
<td style="text-align: left;">MONDO:0021043,MONDO:0021050</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857057</td>
<td style="text-align: left;">malignant vaginal mixed tumor resembling synovial sarcoma</td>
<td style="text-align: left;">NCIT:C40279</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma</td>
<td style="text-align: left;">A very rare malignant mixed epithelial and mesenchymal neoplasm that arises from the vagina and resembles synovial sarcoma.  It is characterized by a biphasic pattern and is composed of gland-like structures that are lined by epithelial cells and a cellular mesenchymal component.</td>
<td style="text-align: left;">MONDO:0037746</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857059</td>
<td style="text-align: left;">vulvar neoplasm of skin appendage origin</td>
<td style="text-align: left;">NCIT:C40303</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Neoplasm of Skin Appendage Origin</td>
<td style="text-align: left;">A benign or malignant vulvar neoplasm with differentiating characteristics towards sweat or sebaceous glands or hair follicles.  Representative examples include trichoepithelioma, syringoma, and eccrine adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0021049</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857061</td>
<td style="text-align: left;">vulvar soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C40316</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Soft Tissue Neoplasm</td>
<td style="text-align: left;">A benign or malignant mesenchymal neoplasm that arises from the vulva.</td>
<td style="text-align: left;">MONDO:0021049,MONDO:0006424</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857067</td>
<td style="text-align: left;">vulvar melanocytic neoplasm</td>
<td style="text-align: left;">NCIT:C40335</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Melanocytic Neoplasm</td>
<td style="text-align: left;">A neoplasm that originates from melanocytes and arises from the vulva. This category includes congenital and acquired melanocytic nevus, blue nevus, dysplastic melanocytic nevus, atypical melanocytic nevus of genital type, and melanoma.</td>
<td style="text-align: left;">MONDO:0021143,MONDO:0021049</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857071</td>
<td style="text-align: left;">breast carcinoma with osteoclast-like stromal giant cells</td>
<td style="text-align: left;">NCIT:C40349</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Carcinoma with Osteoclast-Like Stromal Giant Cells</td>
<td style="text-align: left;">An invasive breast adenocarcinoma characterised by the presence of non-neoplastic stromal osteoclastic giant cells.  The carcinomatous component is usually an invasive ductal carcinoma, although all other breast adenocarcinoma subtypes have also been described.  The prognosis depends on the characteristics of the adenocarcinomatous component, and is not related to the presence of the giant cells.</td>
<td style="text-align: left;">MONDO:0004953</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857072</td>
<td style="text-align: left;">breast carcinoma with choriocarcinomatous features</td>
<td style="text-align: left;">NCIT:C40350</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Carcinoma with Choriocarcinomatous Features</td>
<td style="text-align: left;">An invasive ductal breast carcinoma, not otherwise specified, characterized by increased levels of human beta-chorionic gonadotropin in the serum.  Morphologic evidence of choriocarcinomatous differentiation is rare.</td>
<td style="text-align: left;">MONDO:0004953</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857073</td>
<td style="text-align: left;">breast carcinoma with melanotic features</td>
<td style="text-align: left;">NCIT:C40351</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Carcinoma with Melanotic Features</td>
<td style="text-align: left;">A very rare primary malignant tumor of the breast, characterized by an invasive breast carcinoma that co-exists with a melanoma component.  The vast majority of melanotic tumors that affect the breast are metastatic melanomas that originate in extra-mammary sites.</td>
<td style="text-align: left;">MONDO:0004953</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857075</td>
<td style="text-align: left;">low grade breast adenosquamous carcinoma</td>
<td style="text-align: left;">NCIT:C40362</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Low Grade Breast Adenosquamous Carcinoma</td>
<td style="text-align: left;">A low-grade metaplastic carcinoma of the breast with morphologic features similar to the adenosquamous carcinoma of the skin.  In the majority of cases the prognosis is excellent.</td>
<td style="text-align: left;">MONDO:0003548</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857076</td>
<td style="text-align: left;">acute myeloid leukemia arising from previous myelodysplastic syndrome</td>
<td style="text-align: left;">NCIT:C4037</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome</td>
<td style="text-align: left;">An acute myeloid leukemia that develops in patients with a prior history of myelodysplastic syndrome.</td>
<td style="text-align: left;">MONDO:0019457</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857078</td>
<td style="text-align: left;">postradiation breast angiosarcoma</td>
<td style="text-align: left;">NCIT:C40378</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Postradiation Breast Angiosarcoma</td>
<td style="text-align: left;">A malignant vascular neoplasm arising from the skin of the breast secondary to radiation treatment for breast cancer.</td>
<td style="text-align: left;">MONDO:0003024</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857080</td>
<td style="text-align: left;">salivary gland myoepithelial tumor</td>
<td style="text-align: left;">NCIT:C40393</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Salivary Gland Myoepithelial Tumor</td>
<td style="text-align: left;">A benign or malignant tumor that arises from the salivary glands.  It is characterized by the presence of neoplastic cells with myoepithelial differentiation.  This category includes benign myoepithelioma and myoepithelial carcinoma.</td>
<td style="text-align: left;">MONDO:0002380,MONDO:0021357</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857083</td>
<td style="text-align: left;">breast soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C40406</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Soft Tissue Neoplasm</td>
<td style="text-align: left;">A benign, intermediate, or malignant mesenchymal neoplasm that arises from the breast.</td>
<td style="text-align: left;">MONDO:0006424,MONDO:0021100</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857084</td>
<td style="text-align: left;">breast pleomorphic adenoma</td>
<td style="text-align: left;">NCIT:C40408</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Pleomorphic Adenoma</td>
<td style="text-align: left;">A rare, benign and well circumscribed neoplasm that arises from the breast.  It is characterized by the proliferation of epithelial and myoepithelial cells surrounded by chondroid stroma.</td>
<td style="text-align: left;">MONDO:0008401,MONDO:0002058</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857089</td>
<td style="text-align: left;">ovarian sex cord-stromal tumor associated with peutz-jeghers syndrome</td>
<td style="text-align: left;">NCIT:C40436</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome</td>
<td style="text-align: left;">A sex cord-stromal tumor that arises from the ovary in a patient diagnosed with Peutz-Jeghers syndrome.</td>
<td style="text-align: left;">MONDO:0021657</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857091</td>
<td style="text-align: left;">esophageal polyp</td>
<td style="text-align: left;">NCIT:C4057</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Polyp</td>
<td style="text-align: left;">A benign intraluminal polypoid neoplasm of the esophagus.  It includes the squamous papilloma and the giant fibrovascular polyp.</td>
<td style="text-align: left;">MONDO:0021459,MONDO:0024292</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857095</td>
<td style="text-align: left;">polycythemia vera, polycythemic phase</td>
<td style="text-align: left;">NCIT:C41232</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Polycythemia Vera, Polycythemic Phase</td>
<td style="text-align: left;">Polycythemia vera characterized by the proliferation of the erythroid, granulocytic, and megakaryocytic lineages. The peripheral blood shows excess of red blood cells, neutrophilia, and thrombocytosis. The bone marrow is hypercellular for the patient's age.</td>
<td style="text-align: left;">MONDO:0009891</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857096</td>
<td style="text-align: left;">polycythemia vera, post-polycythemic myelofibrosis phase</td>
<td style="text-align: left;">NCIT:C41233</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase</td>
<td style="text-align: left;">Progression of polycythemia vera characterized by decreased erythropoiesis and granulopoiesis, reticulin and collagen fibrosis of the bone marrow, leucoerythroblastic reaction in the peripheral blood, poikilocytosis, tear-drop shaped red blood cells, and splenomegaly.</td>
<td style="text-align: left;">MONDO:0009891</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857097</td>
<td style="text-align: left;">overt primary myelofibrosis</td>
<td style="text-align: left;">NCIT:C41238</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Overt Primary Myelofibrosis</td>
<td style="text-align: left;">Primary myelofibrosis characterized by reticulin or collagen fibrosis in the bone marrow. The bone marrow is usually normocellular or hypocellular. Myeloblasts account for less than 10% of the bone marrow cells. Atypical megakaryocytes are present.</td>
<td style="text-align: left;">MONDO:0009692</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857098</td>
<td style="text-align: left;">metastatic adenocarcinoma</td>
<td style="text-align: left;">NCIT:C4124</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma that has spread from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0004970,MONDO:0024879</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857100</td>
<td style="text-align: left;">solid carcinoma</td>
<td style="text-align: left;">NCIT:C4137</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Solid Carcinoma</td>
<td style="text-align: left;">A carcinoma morphologically characterized by the presence of solid sheets of malignant epithelial cells in tissues.</td>
<td style="text-align: left;">MONDO:0004993</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857102</td>
<td style="text-align: left;">juxtaglomerular cell tumor</td>
<td style="text-align: left;">NCIT:C4162</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Juxtaglomerular Cell Tumor</td>
<td style="text-align: left;">A benign, well circumscribed neoplasm arising from the cortex of the kidney. It secrets renin and the patients usually present with severe hypertension and marked hypokalemia. Morphologically, it is characterized by the presence of sheets of polygonal or spindle-shaped neoplastic cells forming a hemangiopericytic pattern.</td>
<td style="text-align: left;">MONDO:0002513</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857103</td>
<td style="text-align: left;">adrenal cortical compact cell adenoma</td>
<td style="text-align: left;">NCIT:C4163</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Compact Cell Adenoma</td>
<td style="text-align: left;">An adenoma of the adrenal cortex composed of neoplastic compact cells with eosinophilic cytoplasm.</td>
<td style="text-align: left;">MONDO:0003924</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857104</td>
<td style="text-align: left;">pigmented adrenal cortical adenoma</td>
<td style="text-align: left;">NCIT:C4164</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pigmented Adrenal Cortical Adenoma</td>
<td style="text-align: left;">A usually functioning adenoma of the adrenal cortex. Grossly, it has a dark brown appearance and is characterized by the presence of neoplastic cells containing abundant intracytoplasmic lipofuscin. It may be associated with Cushing syndrome.</td>
<td style="text-align: left;">MONDO:0003924</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857105</td>
<td style="text-align: left;">adrenal cortical clear cell adenoma</td>
<td style="text-align: left;">NCIT:C4165</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Clear Cell Adenoma</td>
<td style="text-align: left;">An adenoma of the adrenal cortex composed of neoplastic clear cells containing intracytoplasmic lipid droplets.</td>
<td style="text-align: left;">MONDO:0003924,MONDO:0003426</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857106</td>
<td style="text-align: left;">adrenal cortical glomerulosa cell adenoma</td>
<td style="text-align: left;">NCIT:C4166</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Glomerulosa Cell Adenoma</td>
<td style="text-align: left;">An adenoma of the adrenal cortex composed of neoplastic cells with cytologic features of glomerulosa cells.</td>
<td style="text-align: left;">MONDO:0003924</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857107</td>
<td style="text-align: left;">adrenal cortical mixed cell adenoma</td>
<td style="text-align: left;">NCIT:C4167</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Mixed Cell Adenoma</td>
<td style="text-align: left;">An adenoma of the adrenal cortex composed of a mixed neoplastic cellular population, including varying numbers of neoplastic clear and compact cells.</td>
<td style="text-align: left;">MONDO:0003421,MONDO:0003924</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857109</td>
<td style="text-align: left;">papillary serous cystadenoma</td>
<td style="text-align: left;">NCIT:C4180</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Papillary Serous Cystadenoma</td>
<td style="text-align: left;">A serous benign or low malignant potential cystic epithelial neoplasm characterized by the presence of glandular epithelial cells forming papillary structures.</td>
<td style="text-align: left;">MONDO:0005177,MONDO:0021091</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857110</td>
<td style="text-align: left;">serous surface papillary carcinoma</td>
<td style="text-align: left;">NCIT:C4182</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Serous Surface Papillary Carcinoma</td>
<td style="text-align: left;">An invasive serous adenocarcinoma arising from the ovary and rarely the peritoneum. Morphologically, it may be a well, moderately, or poorly differentiated neoplasm. It is characterized by a papillary growth pattern often associated with the presence of psammoma bodies.</td>
<td style="text-align: left;">MONDO:0005278,MONDO:0002512</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857111</td>
<td style="text-align: left;">papillary mucinous cystadenoma</td>
<td style="text-align: left;">NCIT:C4184</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Papillary Mucinous Cystadenoma</td>
<td style="text-align: left;">A usually benign and less often low malignant potential cystic epithelial neoplasm composed of cells which contain intracytoplasmic mucin. It is characterized by the presence of papillary structures.</td>
<td style="text-align: left;">MONDO:0021091,MONDO:0006859</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857112</td>
<td style="text-align: left;">gliomatosis cerebri type i</td>
<td style="text-align: left;">NCIT:C41842</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gliomatosis Cerebri Type I</td>
<td style="text-align: left;">A classic form of gliomatosis cerebri. It is characterized by diffuse growth of neoplastic glial tissue without any focal mass.</td>
<td style="text-align: left;">MONDO:0016683</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857113</td>
<td style="text-align: left;">gliomatosis cerebri type ii</td>
<td style="text-align: left;">NCIT:C41843</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gliomatosis Cerebri Type II</td>
<td style="text-align: left;">A classic form of gliomatosis cerebri. It is characterized by diffuse growth of neoplastic glial tissue without any focal mass.</td>
<td style="text-align: left;">MONDO:0016683</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857115</td>
<td style="text-align: left;">thyroid gland medullary carcinoma with amyloid stroma</td>
<td style="text-align: left;">NCIT:C4193</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Medullary Carcinoma with Amyloid Stroma</td>
<td style="text-align: left;">A medullary thyroid gland carcinoma characterized by the presence of amyloid stroma.  The majority of medullary carcinomas of the thyroid gland are associated with amyloid deposits.  The latter are highlighted with Congo red staining method.</td>
<td style="text-align: left;">MONDO:0015277</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857117</td>
<td style="text-align: left;">acinar cell neoplasm</td>
<td style="text-align: left;">NCIT:C4197</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acinar Cell Neoplasm</td>
<td style="text-align: left;">A benign or malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. It includes the acinar cell adenoma and acinar cell carcinoma.</td>
<td style="text-align: left;">MONDO:0024276</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857118</td>
<td style="text-align: left;">ovarian luteinized thecoma</td>
<td style="text-align: left;">NCIT:C4203</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Luteinized Thecoma</td>
<td style="text-align: left;">A variant of ovarian thecoma characterized by the presence of lutein cells. It is associated with a lower frequency of estrogenic manifestations compared to typical thecomas. In a minority of cases androgenic manifestations are present.</td>
<td style="text-align: left;">MONDO:0037253</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857119</td>
<td style="text-align: left;">undifferentiated neuroblastoma</td>
<td style="text-align: left;">NCIT:C42046</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Undifferentiated Neuroblastoma</td>
<td style="text-align: left;">A neuroblastoma characterized by the absence of differentiating neuroblasts.</td>
<td style="text-align: left;">MONDO:0005072</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857120</td>
<td style="text-align: left;">poorly differentiated neuroblastoma</td>
<td style="text-align: left;">NCIT:C42047</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Poorly Differentiated Neuroblastoma</td>
<td style="text-align: left;">A neuroblastoma in which the differentiating neuroblasts constitute less than five-percent of the tumor cells.</td>
<td style="text-align: left;">MONDO:0005072</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857121</td>
<td style="text-align: left;">malignant granulosa cell tumor</td>
<td style="text-align: left;">NCIT:C4205</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Granulosa Cell Tumor</td>
<td style="text-align: left;">A granulosa cell tumor which has an aggressive clinical course and metastasizes to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0006036</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857122</td>
<td style="text-align: left;">maturing ganglioneuroma</td>
<td style="text-align: left;">NCIT:C42064</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Maturing Ganglioneuroma</td>
<td style="text-align: left;">A ganglioneuroma characterized by the presence of differentiating neuroblasts, maturing and mature ganglion cells.</td>
<td style="text-align: left;">MONDO:0005033</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857123</td>
<td style="text-align: left;">mature ganglioneuroma</td>
<td style="text-align: left;">NCIT:C42065</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mature Ganglioneuroma</td>
<td style="text-align: left;">A ganglioneuroma characterized by the presence of mature ganglion cells and a mature Schwannian stroma.</td>
<td style="text-align: left;">MONDO:0005033</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857125</td>
<td style="text-align: left;">ovarian sex cord tumor with annular tubules</td>
<td style="text-align: left;">NCIT:C4208</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Sex Cord Tumor with Annular Tubules</td>
<td style="text-align: left;">An ovarian sex cord-stromal tumor characterized by the presence of Sertoli cells forming annular tubules. It may be associated with Peutz-Jeghers syndrome. Cases associated with Peutz-Jeghers syndrome have followed a benign clinical course. Cases which are not associated with Peutz-Jeghers syndrome have been reported having a clinically malignant course.</td>
<td style="text-align: left;">MONDO:0021657</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857126</td>
<td style="text-align: left;">well differentiated ovarian sertoli-leydig cell tumor</td>
<td style="text-align: left;">NCIT:C4209</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Well Differentiated Ovarian Sertoli-Leydig Cell Tumor</td>
<td style="text-align: left;">A Sertoli-Leydig tumor of the ovary characterized by the presence of Sertoli cells in tubules without evidence of significant nuclear atypia or mitotic activity. Primitive gonadal stromal cells are not present. It usually follows a benign clinical course.</td>
<td style="text-align: left;">MONDO:0036595</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857127</td>
<td style="text-align: left;">poorly differentiated ovarian sertoli-leydig cell tumor</td>
<td style="text-align: left;">NCIT:C4210</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor</td>
<td style="text-align: left;">A Sertoli-Leydig tumor of the ovary characterized by the presence of a sarcomatoid stroma which contains primitive gonadal stromal cells. It may behave in a malignant fashion and metastasize to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0018172,MONDO:0036595</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857128</td>
<td style="text-align: left;">ovarian steroid cell tumor</td>
<td style="text-align: left;">NCIT:C4215</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Steroid Cell Tumor</td>
<td style="text-align: left;">An ovarian tumor in which the vast majority of the cells (more than 90% of the tumor cells) resemble steroid hormone-secreting cells. It usually presents with androgenic manifestations. Approximately one-third of the cases follow a malignant clinical course.</td>
<td style="text-align: left;">MONDO:0021657</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857130</td>
<td style="text-align: left;">regressing melanoma</td>
<td style="text-align: left;">NCIT:C4228</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Regressing Melanoma</td>
<td style="text-align: left;">A skin lesion characterized by the disappearance of the melanoma cells from the primary melanoma site. The disappearance of the malignant cells is associated with fibroplasia of the papillary dermis. According to some authors, complete regression of the primary melanoma may occur in 4-8% of patients.</td>
<td style="text-align: left;">MONDO:0005105</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857131</td>
<td style="text-align: left;">neuronevus</td>
<td style="text-align: left;">NCIT:C4229</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neuronevus</td>
<td style="text-align: left;">An intradermal nevus characterized by the presence of nests of atrophic nevus cells which are hyalinized and resemble nerve bundles.</td>
<td style="text-align: left;">MONDO:0006813</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857133</td>
<td style="text-align: left;">melanoma in junctional nevus</td>
<td style="text-align: left;">NCIT:C4232</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Melanoma in Junctional Nevus</td>
<td style="text-align: left;">A melanoma arising from a melanocytic nevus which involves the dermal-epidermal junction of the skin.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857134</td>
<td style="text-align: left;">type a spindle cell melanoma</td>
<td style="text-align: left;">NCIT:C4238</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Type A Spindle Cell Melanoma</td>
<td style="text-align: left;">A melanoma characterized by the presence of malignant spindle-shaped melanocytes with slender nuclei and no visible nucleoli. Representative example is the type A spindle cell uveal melanoma.</td>
<td style="text-align: left;">MONDO:0006427</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857135</td>
<td style="text-align: left;">type b spindle cell melanoma</td>
<td style="text-align: left;">NCIT:C4239</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Type B Spindle Cell Melanoma</td>
<td style="text-align: left;">A melanoma characterized by the presence of malignant spindle-shaped melanocytes with larger nuclei and distinct nucleoli. Representative example is the type B spindle cell uveal melanoma.</td>
<td style="text-align: left;">MONDO:0006427</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857136</td>
<td style="text-align: left;">melanoma arising in blue nevus</td>
<td style="text-align: left;">NCIT:C4240</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Melanoma Arising in Blue Nevus</td>
<td style="text-align: left;">A rare melanoma which develops in a pre-existing blue nevus. It occurs more frequently on the scalp, face, orbit, back, buttocks, extremities, hands, and feet.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857137</td>
<td style="text-align: left;">cellular blue nevus</td>
<td style="text-align: left;">NCIT:C4241</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cellular Blue Nevus</td>
<td style="text-align: left;">A blue nevus characterized by a multinodular cellular infiltrate with a dumb-bell architecture occupying the reticular dermis. The cellular infiltrate often extends into the subcutaneous tissue. The cellular infiltrate is composed of spindle-shaped melanocytes with pale cytoplasm alternating with bundles of pigmented spindle-shaped melanocytes. In occasional cases an increased mitotic activity, focal necrosis, and nuclear pleomorphism may be seen. Such cases with atypical features may have an uncertain malignant potential.</td>
<td style="text-align: left;">MONDO:0006680</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857138</td>
<td style="text-align: left;">fibrolipoma</td>
<td style="text-align: left;">NCIT:C4249</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fibrolipoma</td>
<td style="text-align: left;">A benign well-circumscribed tumor composed of mature adipocytes, characterized by areas of abundant fibrous tissue.</td>
<td style="text-align: left;">MONDO:0005106</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857139</td>
<td style="text-align: left;">fibromyxolipoma</td>
<td style="text-align: left;">NCIT:C4251</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fibromyxolipoma</td>
<td style="text-align: left;">A benign well-circumscribed tumor composed of mature adipocytes, characterized by areas of abundant fibrous tissue and extensive myxoid change.</td>
<td style="text-align: left;">MONDO:0005106</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857140</td>
<td style="text-align: left;">lipoblastomatosis</td>
<td style="text-align: left;">NCIT:C4255</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lipoblastomatosis</td>
<td style="text-align: left;">A neoplastic process characterized by the presence of multiple lipoblastomas.</td>
<td style="text-align: left;">MONDO:0044983</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857141</td>
<td style="text-align: left;">sporadic retinoblastoma</td>
<td style="text-align: left;">NCIT:C42596</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sporadic Retinoblastoma</td>
<td style="text-align: left;">A retinoblastoma that occurs in a patient without a family history of the disease.</td>
<td style="text-align: left;">MONDO:0008380</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857144</td>
<td style="text-align: left;">acute myelomonocytic leukemia without abnormal eosinophils</td>
<td style="text-align: left;">NCIT:C42779</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myelomonocytic Leukemia without Abnormal Eosinophils</td>
<td style="text-align: left;">Acute myelomonocytic leukemia without an abnormal eosinophilic component in the bone marrow.</td>
<td style="text-align: left;">MONDO:0018871</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857145</td>
<td style="text-align: left;">pericardial solitary fibrous tumor</td>
<td style="text-align: left;">NCIT:C4281</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pericardial Solitary Fibrous Tumor</td>
<td style="text-align: left;">A localized neoplasm of probable fibroblastic derivation, that arises from the pericardium. It is characterized by the presence of round to spindle-shaped cells, hylanized stroma formation, thin-walled branching blood vessels, and thin bands of collagen.</td>
<td style="text-align: left;">MONDO:0021381,MONDO:0016238</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857146</td>
<td style="text-align: left;">benign hemangiopericytoma</td>
<td style="text-align: left;">NCIT:C4300</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Hemangiopericytoma</td>
<td style="text-align: left;">A hemangiopericytoma without malignant morphologic or clinical characteristics.</td>
<td style="text-align: left;">MONDO:0005094</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857147</td>
<td style="text-align: left;">benign odontogenic neoplasm</td>
<td style="text-align: left;">NCIT:C4306</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Odontogenic Neoplasm</td>
<td style="text-align: left;">A benign, slow growing neoplasm arising from tooth-forming tissues. It occurs in the maxillofacial skeleton or the gingiva. Representative examples include adenomatoid odontogenic tumor, calcifying cystic odontogenic tumor, and squamous odontogenic tumor.</td>
<td style="text-align: left;">MONDO:0021445,MONDO:0021192</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857152</td>
<td style="text-align: left;">pure cutaneous mastocytosis</td>
<td style="text-align: left;">NCIT:C43277</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pure Cutaneous Mastocytosis</td>
<td style="text-align: left;">Mastocytosis that manifests with pure cutaneous involvement.</td>
<td style="text-align: left;">MONDO:0019023</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857156</td>
<td style="text-align: left;">adamantinoid trichoblastoma</td>
<td style="text-align: left;">NCIT:C43312</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adamantinoid Trichoblastoma</td>
<td style="text-align: left;">A trichoblastoma characterized by the presence of neoplastic epithelial cell forming nodules. There are palisaded basaloid cells present at the periphery and pale larger cells with vesicular nuclei, prominent nucleoli, and abundant cytoplasm present at the center of the nodules. The epithelial cells are admixed with numerous small lymphocytes and occasional large multinucleated cells that resemble Reed-Sternberg cells.</td>
<td style="text-align: left;">MONDO:0020593</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857163</td>
<td style="text-align: left;">superficial epithelioma with sebaceous differentiation</td>
<td style="text-align: left;">NCIT:C43334</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Superficial Epithelioma with Sebaceous Differentiation</td>
<td style="text-align: left;">A rare benign epithelial neoplasm characterized by the presence of a superficial and multilobular proliferation of neoplastic epithelial cells in the upper dermis with broad attachments to the basal layer of the epidermis. The tumor has well-defined borders. Sebaceous differentiation is present with mature sebocytes arranged in clusters or single cells at the periphery of the tumor.</td>
<td style="text-align: left;">MONDO:0021490</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857164</td>
<td style="text-align: left;">sebaceoma</td>
<td style="text-align: left;">NCIT:C43336</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sebaceoma</td>
<td style="text-align: left;">A benign, well circumscribed neoplasm arising from the sebaceous glands. It is characterized by the presence of predominantly basaloid cells admixed with sebaceous cells.</td>
<td style="text-align: left;">MONDO:0021490</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857165</td>
<td style="text-align: left;">extraocular sebaceous carcinoma</td>
<td style="text-align: left;">NCIT:C43341</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extraocular Sebaceous Carcinoma</td>
<td style="text-align: left;">A rare variant of sebaceous carcinoma that does not affect the ocular region.</td>
<td style="text-align: left;">MONDO:0006962</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857166</td>
<td style="text-align: left;">apocrine hidrocystoma</td>
<td style="text-align: left;">NCIT:C43342</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Apocrine Hidrocystoma</td>
<td style="text-align: left;">A slow-growing, usually solitary, dome-shaped benign sweat gland adenoma, most frequently located on the eyelid.  It is characterized by a cystic proliferation of apocrine glands. Surgical excision is curative.</td>
<td style="text-align: left;">MONDO:0002804,MONDO:0006787</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857167</td>
<td style="text-align: left;">carcinoma arising from cylindroma</td>
<td style="text-align: left;">NCIT:C43344</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Carcinoma Arising from Cylindroma</td>
<td style="text-align: left;">A carcinoma that arises from a cylindroma.</td>
<td style="text-align: left;">MONDO:0024878,MONDO:0005524</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857168</td>
<td style="text-align: left;">ductal eccrine carcinoma with spindle cell elements</td>
<td style="text-align: left;">NCIT:C43346</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ductal Eccrine Carcinoma with Spindle Cell Elements</td>
<td style="text-align: left;">A variant of ductal eccrine carcinoma characterized by the presence of malignant spindle cells.</td>
<td style="text-align: left;">MONDO:0024245</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857169</td>
<td style="text-align: left;">squamoid eccrine ductal carcinoma</td>
<td style="text-align: left;">NCIT:C43347</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Squamoid Eccrine Ductal Carcinoma</td>
<td style="text-align: left;">A variant of ductal eccrine carcinoma characterized by the presence of two components: a squamous cell carcinoma component that is usually in the superficial to mid dermis and a ductal carcinoma component in the mid to deep dermis.</td>
<td style="text-align: left;">MONDO:0024245</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857170</td>
<td style="text-align: left;">ductal eccrine carcinoma with abundant fibromyxoid stroma</td>
<td style="text-align: left;">NCIT:C43349</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma</td>
<td style="text-align: left;">A variant of ductal eccrine carcinoma characterized by the presence of abundant fibromyxoid stroma.</td>
<td style="text-align: left;">MONDO:0024245</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857171</td>
<td style="text-align: left;">sporadic cylindroma</td>
<td style="text-align: left;">NCIT:C43351</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sporadic Cylindroma</td>
<td style="text-align: left;">A cylindroma occurring as a solitary sporadic lesion.</td>
<td style="text-align: left;">MONDO:0021812</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857172</td>
<td style="text-align: left;">classic poroma</td>
<td style="text-align: left;">NCIT:C43353</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Classic Poroma</td>
<td style="text-align: left;">A poroma characterized by the presence of cords and aggregates of neoplastic cells in the superficial dermis in connection with the epidermis.</td>
<td style="text-align: left;">MONDO:0006738</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857173</td>
<td style="text-align: left;">porocarcinoma in situ</td>
<td style="text-align: left;">NCIT:C43354</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Porocarcinoma In Situ</td>
<td style="text-align: left;">A porocarcinoma that is confined to the epidermis without evidence of dermal invasion. Approximately 10% of porocarcinomas are in situ lesions.</td>
<td style="text-align: left;">MONDO:0006189</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857174</td>
<td style="text-align: left;">aleukemic lymphoid leukemia</td>
<td style="text-align: left;">NCIT:C4343</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Aleukemic Lymphoid Leukemia</td>
<td style="text-align: left;">A lymphoid leukemia characterized by the absence of leukemic cells in the peripheral blood.</td>
<td style="text-align: left;">MONDO:0003730,MONDO:0005402</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857175</td>
<td style="text-align: left;">sporadic gastric adenocarcinoma</td>
<td style="text-align: left;">NCIT:C43527</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sporadic Gastric Adenocarcinoma</td>
<td style="text-align: left;">A primary adenocarcinoma of the stomach in a patient with no family history of gastric cancer or inherited high risk mutations.</td>
<td style="text-align: left;">MONDO:0005036</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857177</td>
<td style="text-align: left;">small intestinal adenosquamous carcinoma</td>
<td style="text-align: left;">NCIT:C43535</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Adenosquamous Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the small intestine.  It is composed of malignant glandular cells and malignant squamous cells.</td>
<td style="text-align: left;">MONDO:0005522,MONDO:0006074</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857178</td>
<td style="text-align: left;">small intestinal mucinous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C43536</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Mucinous Adenocarcinoma</td>
<td style="text-align: left;">An invasive adenocarcinoma that arises from the small intestine.  It is composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation.</td>
<td style="text-align: left;">MONDO:0003198,MONDO:0004957</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857179</td>
<td style="text-align: left;">small intestinal medullary carcinoma</td>
<td style="text-align: left;">NCIT:C43537</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Medullary Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the small intestine.  It is characterized by the presence of malignant epithelial cells with vesicular nucleus, distinct nucleolus, and abundant pink cytoplasm.</td>
<td style="text-align: left;">MONDO:0005522,MONDO:0005232</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857180</td>
<td style="text-align: left;">small intestinal undifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C43538</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Undifferentiated Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the small intestine.  It is composed of malignant epithelial cells which do not display evidence of glandular, squamous, or transitional cell differentiation.</td>
<td style="text-align: left;">MONDO:0005522,MONDO:0005617</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857181</td>
<td style="text-align: left;">pituitary neuroendocrine tumor/microadenoma</td>
<td style="text-align: left;">NCIT:C43541</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pituitary Neuroendocrine Tumor/Microadenoma</td>
<td style="text-align: left;">A pituitary neuroendocrine tumor with a diameter equal or less than 10 mm.</td>
<td style="text-align: left;">MONDO:0006373</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857182</td>
<td style="text-align: left;">pituitary neuroendocrine tumor/macroadenoma</td>
<td style="text-align: left;">NCIT:C43542</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pituitary Neuroendocrine Tumor/Macroadenoma</td>
<td style="text-align: left;">A pituitary neuroendocrine tumor with a diameter greater than 10 mm. Clinical manifestations include headache, visual field disturbances, pituitary insufficiency, and mild hyperprolactinemia.</td>
<td style="text-align: left;">MONDO:0006373</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857183</td>
<td style="text-align: left;">small intestinal signet ring cell adenocarcinoma</td>
<td style="text-align: left;">NCIT:C43543</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Signet Ring Cell Adenocarcinoma</td>
<td style="text-align: left;">An invasive adenocarcinoma that arises from the small intestine.  It is characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus.</td>
<td style="text-align: left;">MONDO:0003198,MONDO:0005092</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857184</td>
<td style="text-align: left;">appendix tubular adenoma</td>
<td style="text-align: left;">NCIT:C43546</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Tubular Adenoma</td>
<td style="text-align: left;">An adenoma arising from the appendix.  It is characterized by the presence of tubular epithelial structures and it is associated with dysplasia.</td>
<td style="text-align: left;">MONDO:0006088,MONDO:0024660</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857185</td>
<td style="text-align: left;">appendix tubulovillous adenoma</td>
<td style="text-align: left;">NCIT:C43547</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Tubulovillous Adenoma</td>
<td style="text-align: left;">An adenoma arising from the appendix.  It is characterized by the presence of tubular and villous epithelial structures and it is associated with dysplasia.</td>
<td style="text-align: left;">MONDO:0006088,MONDO:0024661</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857187</td>
<td style="text-align: left;">eyelid squamous papilloma</td>
<td style="text-align: left;">NCIT:C4355</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Squamous Papilloma</td>
<td style="text-align: left;">A papilloma that arises from the eyelid. It is composed of squamous cells and is characterized by the presence of an acanthotic epithelium with hyperkeratosis and papillary projections with an inner fibrovascular core. It is the most common benign epithelial tumor of eyelid. It usually affects middle-aged or older adults.</td>
<td style="text-align: left;">MONDO:0002536,MONDO:0021605,MONDO:0001825</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857188</td>
<td style="text-align: left;">small intestinal villous adenoma</td>
<td style="text-align: left;">NCIT:C43551</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Villous Adenoma</td>
<td style="text-align: left;">A neoplasm that arises from the glandular epithelium of the small intestine. It is characterized by a villous architectural pattern. The neoplastic glandular cells have dysplastic features.</td>
<td style="text-align: left;">MONDO:0000502,MONDO:0021303</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857189</td>
<td style="text-align: left;">appendix signet ring cell adenocarcinoma</td>
<td style="text-align: left;">NCIT:C43554</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Signet Ring Cell Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma arising from the appendix, characterized by the presence of signet-ring, mucin-producing malignant cells.  The signet-ring cells constitute more than fifty-percent of the malignant cells.</td>
<td style="text-align: left;">MONDO:0005092,MONDO:0006087</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857190</td>
<td style="text-align: left;">appendix undifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C43556</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Undifferentiated Carcinoma</td>
<td style="text-align: left;">A high grade carcinoma arising from the appendix, characterized by the absence of glandular or squamous differentiation.</td>
<td style="text-align: left;">MONDO:0003196,MONDO:0005617</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857191</td>
<td style="text-align: left;">appendix mixed adenoneuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C43564</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Mixed Adenoneuroendocrine Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the appendix.  It is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.</td>
<td style="text-align: left;">MONDO:0006182,MONDO:0003196</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857192</td>
<td style="text-align: left;">appendix tubular neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C43565</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Tubular Neuroendocrine Tumor</td>
<td style="text-align: left;">A neuroendocrine tumor that arises from the appendix.  It does not show the morphologic characteristics of typical carcinoid tumors (neoplastic cells forming solid nests). In contrast, the tumor cells form small discrete tubules.</td>
<td style="text-align: left;">MONDO:0015066</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857194</td>
<td style="text-align: left;">rectosigmoid adenocarcinoma</td>
<td style="text-align: left;">NCIT:C43584</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Rectosigmoid Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma arising from the rectosigmoid area.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, rectosigmoid adenocarcinomas are divided into well, moderately, and poorly differentiated.  Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0005008,MONDO:0002424</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857195</td>
<td style="text-align: left;">colorectal mucinous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C43585</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Mucinous Adenocarcinoma</td>
<td style="text-align: left;">An invasive colorectal adenocarcinoma characterized by the presence of extracellular mucin pools that contain malignant glandular epithelial structures.  The extracellular mucin pools occupy more than 50% of the malignant lesion.</td>
<td style="text-align: left;">MONDO:0005008,MONDO:0004957</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857196</td>
<td style="text-align: left;">colorectal undifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C43591</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Undifferentiated Carcinoma</td>
<td style="text-align: left;">An invasive malignant epithelial tumor that arises from the colon or rectum.  There is no morphologic, immunophenotypic, or molecular biological evidence of glandular or squamous differentiation.</td>
<td style="text-align: left;">MONDO:0005617,MONDO:0024331</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857198</td>
<td style="text-align: left;">gallbladder adenocarcinoma, intestinal-type</td>
<td style="text-align: left;">NCIT:C43604</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Adenocarcinoma, Intestinal-Type</td>
<td style="text-align: left;">An adenocarcinoma that arises from the gallbladder.  It is characterized by the presence of neoplastic tubular glands lined by columnar cells or neoplastic glands lined by goblet cells.</td>
<td style="text-align: left;">MONDO:0006215,MONDO:0006254</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857199</td>
<td style="text-align: left;">gallbladder clear cell adenocarcinoma</td>
<td style="text-align: left;">NCIT:C43605</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Clear Cell Adenocarcinoma</td>
<td style="text-align: left;">A rare morphologic variant of gallbladder adenocarcinoma composed of malignant glandular epithelium with a predominance of glycogen rich clear cells.  The cells display hyperchromic nuclei and well-defined cytoplasmic borders.</td>
<td style="text-align: left;">MONDO:0006215,MONDO:0005004</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857200</td>
<td style="text-align: left;">gallbladder flat biliary intraepithelial neoplasia</td>
<td style="text-align: left;">NCIT:C43607</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Flat Biliary Intraepithelial Neoplasia</td>
<td style="text-align: left;">Biliary intraepithelial neoplasia that affects the gallbladder epithelium.  It is characterized by the absence of intraluminal micropapillary projections.</td>
<td style="text-align: left;">MONDO:0006218</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857201</td>
<td style="text-align: left;">gallbladder papillary biliary intraepithelial neoplasia</td>
<td style="text-align: left;">NCIT:C43609</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Papillary Biliary Intraepithelial Neoplasia</td>
<td style="text-align: left;">Biliary intraepithelial neoplasia that affects the gallbladder epithelium.  It is characterized by the presence of intraluminal micropapillary projections.</td>
<td style="text-align: left;">MONDO:0006218</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857203</td>
<td style="text-align: left;">hepatocellular sarcomatoid carcinoma</td>
<td style="text-align: left;">NCIT:C43627</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatocellular Sarcomatoid Carcinoma</td>
<td style="text-align: left;">A morphologic variant of hepatocellular carcinoma characterized by the presence of malignant spindle cells or atypical giant cells.</td>
<td style="text-align: left;">MONDO:0007256,MONDO:0006406</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857206</td>
<td style="text-align: left;">accessory urethral gland neoplasm</td>
<td style="text-align: left;">NCIT:C4378</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Accessory Urethral Gland Neoplasm</td>
<td style="text-align: left;">A benign or malignant, primary or metastatic neoplasm affecting the accessory urethral gland.</td>
<td style="text-align: left;">MONDO:0021239</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857208</td>
<td style="text-align: left;">clear cell intrahepatic cholangiocarcinoma</td>
<td style="text-align: left;">NCIT:C43848</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Clear Cell Intrahepatic Cholangiocarcinoma</td>
<td style="text-align: left;">A morphologic variant of intrahepatic cholangiocarcinoma composed of malignant glandular epithelium, an abundant fibrous stroma, and the presence of clear cells. Clinical symptoms include abdominal pain, weight loss and malaise.</td>
<td style="text-align: left;">MONDO:0005004,MONDO:0003210</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857210</td>
<td style="text-align: left;">anogenital papillomaviral intraepithelial neoplasia</td>
<td style="text-align: left;">NCIT:C4394</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anogenital Papillomaviral Intraepithelial Neoplasia</td>
<td style="text-align: left;">Intraepithelial neoplasia of the anogenital region associated with papillomavirus infection.</td>
<td style="text-align: left;">MONDO:0024475</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857211</td>
<td style="text-align: left;">posterior tongue neoplasm</td>
<td style="text-align: left;">NCIT:C4400</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Posterior Tongue Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the base of the tongue.</td>
<td style="text-align: left;">MONDO:0021240</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857212</td>
<td style="text-align: left;">pyriform fossa neoplasm</td>
<td style="text-align: left;">NCIT:C4424</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pyriform Fossa Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the pyriform sinus.</td>
<td style="text-align: left;">MONDO:0021358</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857213</td>
<td style="text-align: left;">gastric pylorus carcinoma in situ ajcc v6 and v7</td>
<td style="text-align: left;">NCIT:C4431</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Pylorus Carcinoma In Situ AJCC v6 and v7</td>
<td style="text-align: left;">Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0003971,MONDO:0004716</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857215</td>
<td style="text-align: left;">lung epithelioid hemangioendothelioma</td>
<td style="text-align: left;">NCIT:C4453</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Epithelioid Hemangioendothelioma</td>
<td style="text-align: left;">A low-grade malignant blood vessel neoplasm arising from the lung.  It is characterized by the presence of epithelioid endothelial cells.  The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma.</td>
<td style="text-align: left;">MONDO:0008903,MONDO:0015523</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857216</td>
<td style="text-align: left;">dermal duct tumor</td>
<td style="text-align: left;">NCIT:C4473</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Dermal Duct Tumor</td>
<td style="text-align: left;">A poroma characterized by the presence of small nodules of neoplastic cells in the superficial dermis without connection to the epidermis.</td>
<td style="text-align: left;">MONDO:0006738</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857217</td>
<td style="text-align: left;">skin neural neoplasm</td>
<td style="text-align: left;">NCIT:C4479</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Neural Neoplasm</td>
<td style="text-align: left;">A peripheral nervous system neoplasm that arises from the dermis.</td>
<td style="text-align: left;">MONDO:0001406,MONDO:0002300</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857219</td>
<td style="text-align: left;">malignant skin hemangiopericytoma</td>
<td style="text-align: left;">NCIT:C4493</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Skin Hemangiopericytoma</td>
<td style="text-align: left;">A malignant hemangiopericytoma arising in the skin.</td>
<td style="text-align: left;">MONDO:0021424,MONDO:0009330</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857220</td>
<td style="text-align: left;">cockade nevus</td>
<td style="text-align: left;">NCIT:C4495</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cockade Nevus</td>
<td style="text-align: left;">A rare cutaneous speckled nevus with concentric pattern of pigmentation and central papule surrounded by clear zone.</td>
<td style="text-align: left;">MONDO:0044794</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857222</td>
<td style="text-align: left;">common blue nevus</td>
<td style="text-align: left;">NCIT:C4496</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Common Blue Nevus</td>
<td style="text-align: left;">A blue nevus that is not associated with increased cellularity.</td>
<td style="text-align: left;">MONDO:0006680</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857223</td>
<td style="text-align: left;">nevus spilus</td>
<td style="text-align: left;">NCIT:C4498</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nevus Spilus</td>
<td style="text-align: left;">A cutaneous nevus that contains a variable number of darkly pigmented macules and papules.</td>
<td style="text-align: left;">MONDO:0044792</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857224</td>
<td style="text-align: left;">benign ovarian epithelial tumor</td>
<td style="text-align: left;">NCIT:C4510</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Ovarian Epithelial Tumor</td>
<td style="text-align: left;">A neoplasm that arises from the surface epithelium of the ovary and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include serous cystadenoma, mucinous cystadenoma, clear cell adenofibroma, and benign Brenner tumor.</td>
<td style="text-align: left;">MONDO:0002229,MONDO:0000646,MONDO:0036976</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857229</td>
<td style="text-align: left;">classical low grade fibromyxoid sarcoma</td>
<td style="text-align: left;">NCIT:C45210</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Classical Low Grade Fibromyxoid Sarcoma</td>
<td style="text-align: left;">A low grade fibromyxoid sarcoma that may have poorly formed collagen rosettes, but lacks prominent, well formed collagen rosettes.</td>
<td style="text-align: left;">MONDO:0006272</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857233</td>
<td style="text-align: left;">cutaneous hematopoietic and lymphoid cell neoplasm</td>
<td style="text-align: left;">NCIT:C45240</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Hematopoietic and Lymphoid Cell Neoplasm</td>
<td style="text-align: left;">A neoplasm of hematopoietic and lymphoid cell origin that affects the skin.</td>
<td style="text-align: left;">MONDO:0002531,MONDO:0044881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857240</td>
<td style="text-align: left;">lacrimal gland pleomorphic adenoma</td>
<td style="text-align: left;">NCIT:C4542</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lacrimal Gland Pleomorphic Adenoma</td>
<td style="text-align: left;">A benign, usually encapsulated neoplasm of the lacrimal gland composed of epithelial and mesenchymal cells. Pleomorphic adenomas are neoplasms that develop in the salivary glands or heterotopic salivary gland tissues. It has been suggested that myoepithelial cells play a major role in the histogenesis of these tumors. In the lacrimal gland, pleomorphic adenomas presumably develop from metaplastic myoepithelial cells.</td>
<td style="text-align: left;">MONDO:0008401,MONDO:0021488</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857244</td>
<td style="text-align: left;">orbital capillary hemangioma</td>
<td style="text-align: left;">NCIT:C4545</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Orbital Capillary Hemangioma</td>
<td style="text-align: left;">A capillary hemangioma arising from the orbit.</td>
<td style="text-align: left;">MONDO:0001974,MONDO:0002407</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857245</td>
<td style="text-align: left;">orbit hemangiopericytoma</td>
<td style="text-align: left;">NCIT:C4547</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Orbit Hemangiopericytoma</td>
<td style="text-align: left;">A benign or malignant hemangiopericytoma arising from the orbit.</td>
<td style="text-align: left;">MONDO:0005094</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857248</td>
<td style="text-align: left;">lung squamous cell carcinoma, papillary variant</td>
<td style="text-align: left;">NCIT:C45502</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Squamous Cell Carcinoma, Papillary Variant</td>
<td style="text-align: left;">A morphologic variant of squamous cell lung carcinoma characterized by the presence of papillary structures.</td>
<td style="text-align: left;">MONDO:0005056,MONDO:0002979,MONDO:0056806</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857249</td>
<td style="text-align: left;">lung squamous cell carcinoma, clear cell variant</td>
<td style="text-align: left;">NCIT:C45503</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Squamous Cell Carcinoma, Clear Cell Variant</td>
<td style="text-align: left;">A morphologic variant of squamous cell lung carcinoma characterized by the presence of clear cells.</td>
<td style="text-align: left;">MONDO:0005056,MONDO:0056806</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857250</td>
<td style="text-align: left;">lung squamous cell carcinoma, small cell variant</td>
<td style="text-align: left;">NCIT:C45504</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Squamous Cell Carcinoma, Small Cell Variant</td>
<td style="text-align: left;">A poorly differentiated morphologic variant of squamous cell lung carcinoma characterized by the presence of small tumor cells with focal squamous differentiation.</td>
<td style="text-align: left;">MONDO:0005056,MONDO:0005097</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857251</td>
<td style="text-align: left;">lung basaloid squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C45507</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Basaloid Squamous Cell Carcinoma</td>
<td style="text-align: left;">A morphologic variant of squamous cell lung carcinoma characterized by nuclear palisading.</td>
<td style="text-align: left;">MONDO:0003486,MONDO:0005097,MONDO:0005056</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857252</td>
<td style="text-align: left;">lung spindle cell carcinoma</td>
<td style="text-align: left;">NCIT:C45541</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Spindle Cell Carcinoma</td>
<td style="text-align: left;">A morphologic variant of sarcomatoid carcinoma characterized by the presence of malignant spindle cells and focal lymphoplasmacytic infiltrates.  Adenocarcinoma cells, malignant squamous cells, and giant cells are not present.</td>
<td style="text-align: left;">MONDO:0006279</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857254</td>
<td style="text-align: left;">lung carcinosarcoma</td>
<td style="text-align: left;">NCIT:C45543</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Carcinosarcoma</td>
<td style="text-align: left;">A morphologic variant of lung sarcomatoid carcinoma composed of a mixture of non-small cell lung carcinoma and a sarcomatous component.</td>
<td style="text-align: left;">MONDO:0006279,MONDO:0002928</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857256</td>
<td style="text-align: left;">lung neuroendocrine tumor g2</td>
<td style="text-align: left;">NCIT:C45551</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Neuroendocrine Tumor G2</td>
<td style="text-align: left;">A neuroendocrine tumor of the lung characterized by the presence of 2-10 mitoses per 2 mm2 and/or necrosis (usually punctate).</td>
<td style="text-align: left;">MONDO:0006041,MONDO:0006095</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857259</td>
<td style="text-align: left;">malignant ciliary body medulloepithelioma</td>
<td style="text-align: left;">NCIT:C4557</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Ciliary Body Medulloepithelioma</td>
<td style="text-align: left;">A rare malignant embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium.</td>
<td style="text-align: left;">MONDO:0002969,MONDO:0017050</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857260</td>
<td style="text-align: left;">lung squamous papilloma</td>
<td style="text-align: left;">NCIT:C45573</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Squamous Papilloma</td>
<td style="text-align: left;">A papillary neoplasm that arises endobronchially.  It is characterized by the presence of a delicate fibrovascular core lined by stratified squamous epithelium.  Squamous cell papillomas can be solitary or multiple.  Patients usually present with signs and symptoms of bronchial obstruction.  Because of the possibility of recurrence and reported cases of squamous cell carcinomas arising at the excision site of squamous cell papillomas, complete excision is indicated.</td>
<td style="text-align: left;">MONDO:0006278,MONDO:0001825</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857262</td>
<td style="text-align: left;">bronchial glandular papilloma</td>
<td style="text-align: left;">NCIT:C45601</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bronchial Glandular Papilloma</td>
<td style="text-align: left;">A benign papillary neoplasm that arises endobronchially. It is characterized by the presence of fibrovascular cores lined by columnar, cuboidal, and goblet cells. Patients usually present with signs and symptoms of bronchial obstruction. Complete resection is curative.</td>
<td style="text-align: left;">MONDO:0006278,MONDO:0021078</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857263</td>
<td style="text-align: left;">bronchial mixed squamous cell and glandular papilloma</td>
<td style="text-align: left;">NCIT:C45602</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bronchial Mixed Squamous Cell and Glandular Papilloma</td>
<td style="text-align: left;">An exceedingly rare benign endobronchial neoplasm characterized by the presence of fibrovascular cores which are lined by both squamous and glandular epithelium. Patients present with obstructive symptoms. Complete resection is curative.</td>
<td style="text-align: left;">MONDO:0021043,MONDO:0006278</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857264</td>
<td style="text-align: left;">lung pleomorphic adenoma</td>
<td style="text-align: left;">NCIT:C45603</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Pleomorphic Adenoma</td>
<td style="text-align: left;">A very rare, well circumscribed, benign epithelial neoplasm that arises from the bronchus.  It is characterized by the presence of epithelial cells, myoepithelial cells, and fibromyxoid stroma.</td>
<td style="text-align: left;">MONDO:0008401,MONDO:0003422</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857265</td>
<td style="text-align: left;">lung mucinous cystadenoma</td>
<td style="text-align: left;">NCIT:C45604</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Mucinous Cystadenoma</td>
<td style="text-align: left;">A very rare, well circumscribed, benign cystic neoplasm that arises from the lung.  It is characterized by the presence of cysts which are lined by tall mucinous epithelium and filled with mucin.</td>
<td style="text-align: left;">MONDO:0003422,MONDO:0006859</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857267</td>
<td style="text-align: left;">lung soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C45612</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Soft Tissue Neoplasm</td>
<td style="text-align: left;">A benign, intermediate, or malignant mesenchymal neoplasm that arises from the lung.</td>
<td style="text-align: left;">MONDO:0006424,MONDO:0021117</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857268</td>
<td style="text-align: left;">malignant lung and pleural neoplasm</td>
<td style="text-align: left;">NCIT:C45625</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Lung and Pleural Neoplasm</td>
<td style="text-align: left;">A primary or metastatic malignant neoplasm that affects the lung and pleura.</td>
<td style="text-align: left;">MONDO:0003274</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857270</td>
<td style="text-align: left;">lung synovial sarcoma</td>
<td style="text-align: left;">NCIT:C45631</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Synovial Sarcoma</td>
<td style="text-align: left;">A synovial sarcoma arising from the lungs.</td>
<td style="text-align: left;">MONDO:0002426,MONDO:0010434</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857273</td>
<td style="text-align: left;">intrapulmonary thymoma</td>
<td style="text-align: left;">NCIT:C45638</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intrapulmonary Thymoma</td>
<td style="text-align: left;">An epithelial neoplasm that arises from ectopic thymic tissue in the lung.  Histologically it is identical to the thymomas that arise from the mediastinum.  Signs and symptoms include cough, dyspnea, fever, and weight loss.  Surgical excision is the recommended treatment.</td>
<td style="text-align: left;">MONDO:0006456,MONDO:0021117</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857274</td>
<td style="text-align: left;">mediastinal thymoma</td>
<td style="text-align: left;">NCIT:C45639</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Thymoma</td>
<td style="text-align: left;">An invasive or non-invasive thymoma that arises from the mediastinum.  Thymomas are the most common anterior mediastinal tumors.</td>
<td style="text-align: left;">MONDO:0006456,MONDO:0021386</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857275</td>
<td style="text-align: left;">lung melanoma</td>
<td style="text-align: left;">NCIT:C45652</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Melanoma</td>
<td style="text-align: left;">A rare malignant neoplasm that derives from melanocytes and arises from the lung in a patient with no history of previous melanoma and no evidence of melanoma in another site at the time of diagnosis.  It usually presents as a solitary lesion and the prognosis is poor.</td>
<td style="text-align: left;">MONDO:0006320,MONDO:0008903</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857276</td>
<td style="text-align: left;">pleural well differentiated papillary mesothelial tumor</td>
<td style="text-align: left;">NCIT:C45660</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pleural Well Differentiated Papillary Mesothelial Tumor</td>
<td style="text-align: left;">A rare, non-invasive, localized or multifocal mesothelial neoplasm that arises from the pleura. It is characterized by the presence of papillae with myxoid fibrovascular cores, lined by a single layer of mesothelial cells.  The clinical course is usually indolent.</td>
<td style="text-align: left;">MONDO:0003308,MONDO:0003688</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857278</td>
<td style="text-align: left;">pleural non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C45687</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pleural Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A rare extranodal non-Hodgkin lymphoma that arises from the pleura with no evidence of involvement of other sites at the time of diagnosis. This category includes primary effusion lymphoma, pyothorax-associated lymphoma, and exceedingly rare cases of mucosa-associated lymphoid tissue lymphoma.</td>
<td style="text-align: left;">MONDO:0006294,MONDO:0018908</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857279</td>
<td style="text-align: left;">pleural epithelioid hemangioendothelioma</td>
<td style="text-align: left;">NCIT:C45695</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pleural Epithelioid Hemangioendothelioma</td>
<td style="text-align: left;">A low-grade malignant blood vessel neoplasm arising from the pleura. It is characterized by the presence of epithelioid endothelial cells.  The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma.</td>
<td style="text-align: left;">MONDO:0015523,MONDO:0006294</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857280</td>
<td style="text-align: left;">pleural synovial sarcoma</td>
<td style="text-align: left;">NCIT:C45696</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pleural Synovial Sarcoma</td>
<td style="text-align: left;">A synovial sarcoma arising in the pleural cavity.</td>
<td style="text-align: left;">MONDO:0006294,MONDO:0010434</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857282</td>
<td style="text-align: left;">micronodular thymoma with lymphoid stroma</td>
<td style="text-align: left;">NCIT:C45706</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Micronodular Thymoma with Lymphoid Stroma</td>
<td style="text-align: left;">A rare type of thymoma characterized by the presence of multiple, well formed epithelial nodules separated by a lymphocytic stroma that usually contains germinal centers.  Reported cases have not been associated with recurrences or metastases.</td>
<td style="text-align: left;">MONDO:0006456</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857283</td>
<td style="text-align: left;">metaplastic thymoma</td>
<td style="text-align: left;">NCIT:C45707</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metaplastic Thymoma</td>
<td style="text-align: left;">A rare type of well circumscribed or encapsulated thymoma with a biphasic architecture, consisting of epithelial cell islands and bundles of spindle cells.  The vast majority of reported cases had a benign clinical course.</td>
<td style="text-align: left;">MONDO:0006456</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857284</td>
<td style="text-align: left;">microscopic thymoma</td>
<td style="text-align: left;">NCIT:C45708</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Microscopic Thymoma</td>
<td style="text-align: left;">A rare type of thymoma, composed of multifocal epithelial proliferations less than 1 mm in diameter.  This type of thymoma usually occurs in myasthenia gravis patients without any macroscopic (gross) evidence of tumor.</td>
<td style="text-align: left;">MONDO:0006456</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857285</td>
<td style="text-align: left;">sclerosing thymoma</td>
<td style="text-align: left;">NCIT:C45709</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sclerosing Thymoma</td>
<td style="text-align: left;">A rare type of thymoma, characterized by an exuberant amount of collagen-rich stroma.</td>
<td style="text-align: left;">MONDO:0006456</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857287</td>
<td style="text-align: left;">thymus lipofibroadenoma</td>
<td style="text-align: left;">NCIT:C45710</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thymus Lipofibroadenoma</td>
<td style="text-align: left;">A benign thymic tumor morphologically resembling fibroadenoma of the breast.</td>
<td style="text-align: left;">MONDO:0021512</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857290</td>
<td style="text-align: left;">malignant skin adnexal neoplasm</td>
<td style="text-align: left;">NCIT:C4573</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Skin Adnexal Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that arises from the hair follicles, sebaceous glands, or sweat glands.</td>
<td style="text-align: left;">MONDO:0002898,MONDO:0002297</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857291</td>
<td style="text-align: left;">mediastinal germ cell tumor with somatic-type malignancy</td>
<td style="text-align: left;">NCIT:C45732</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Germ Cell Tumor with Somatic-Type Malignancy</td>
<td style="text-align: left;">A rare extragonadal germ cell tumor that arises from the mediastinum and is associated with the presence of a somatic-type malignant component.  The somatic malignancy is usually a sarcoma (e.g., embryonal rhabdomyosarcoma, angiosarcoma, or leiomyosarcoma), adenocarcinoma, squamous cell carcinoma, adenosquamous carcinoma, or primitive neuroectodermal tumor.  The prognosis is poor.</td>
<td style="text-align: left;">MONDO:0006298</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857292</td>
<td style="text-align: left;">mediastinal t lymphoblastic leukemia/lymphoma</td>
<td style="text-align: left;">NCIT:C45738</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal T Lymphoblastic Leukemia/Lymphoma</td>
<td style="text-align: left;">A precursor T-cell lymphoid neoplasm composed of small to medium-sized lymphoblasts that affects the mediastinum.</td>
<td style="text-align: left;">MONDO:0003537,MONDO:0005843</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857294</td>
<td style="text-align: left;">mediastinal myeloid sarcoma</td>
<td style="text-align: left;">NCIT:C45741</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Myeloid Sarcoma</td>
<td style="text-align: left;">A mass-forming malignant neoplasm that arises from the mediastinum and is characterized by the proliferation of myeloblasts or immature myeloid cells. It may present in association with or precede acute myeloid leukemia, or it may be the first manifestation of relapse of acute myeloid leukemia.</td>
<td style="text-align: left;">MONDO:0005843,MONDO:0006861</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857295</td>
<td style="text-align: left;">mediastinal paraganglioma</td>
<td style="text-align: left;">NCIT:C45743</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Paraganglioma</td>
<td style="text-align: left;">An extra-adrenal parasympathetic paraganglioma that arises from paraganglia in the mediastinum.  Clinical signs and symptoms include chest pain, cough, hoarseness, and dysphagia.</td>
<td style="text-align: left;">MONDO:0003098,MONDO:0021052</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857296</td>
<td style="text-align: left;">mediastinal solitary fibrous tumor</td>
<td style="text-align: left;">NCIT:C45744</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Solitary Fibrous Tumor</td>
<td style="text-align: left;">A localized neoplasm of probable fibroblastic derivation, that arises from the mediastinum.  It is characterized by the presence of round to spindle-shaped cells, hylanized stroma formation, thin-walled branching blood vessels, and thin bands of collagen.</td>
<td style="text-align: left;">MONDO:0016238,MONDO:0003512</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857297</td>
<td style="text-align: left;">adult cardiac cellular rhabdomyoma</td>
<td style="text-align: left;">NCIT:C45747</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Cardiac Cellular Rhabdomyoma</td>
<td style="text-align: left;">A rare rhabdomyoma that arises from cardiac muscle cells and occurs in adults.</td>
<td style="text-align: left;">MONDO:0006123</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857298</td>
<td style="text-align: left;">cardiac hemangioma</td>
<td style="text-align: left;">NCIT:C45749</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Hemangioma</td>
<td style="text-align: left;">A hemangioma arising from the heart.</td>
<td style="text-align: left;">MONDO:0021450,MONDO:0006500</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857300</td>
<td style="text-align: left;">cardiac inflammatory myofibroblastic tumor</td>
<td style="text-align: left;">NCIT:C45753</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Inflammatory Myofibroblastic Tumor</td>
<td style="text-align: left;">An intermediate fibroblastic neoplasm that arises from the heart and is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells.</td>
<td style="text-align: left;">MONDO:0015798,MONDO:0021209</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857301</td>
<td style="text-align: left;">cystic tumor of the atrioventricular node</td>
<td style="text-align: left;">NCIT:C45754</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cystic Tumor of the Atrioventricular Node</td>
<td style="text-align: left;">A multicystic tumor arising in the inferior interatrial septum in the region of the atrioventricular node. The vast majority of patients present with complete heart block and a minority with partial heart block. Sudden death is reported in approximately 10% of the cases. It is a morphologically benign tumor composed of cuboidal, transitional, or squamoid cells. The cells may also show sebaceous differentiation and originate from the endoderm.</td>
<td style="text-align: left;">MONDO:0021450</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857302</td>
<td style="text-align: left;">cardiac undifferentiated pleomorphic sarcoma</td>
<td style="text-align: left;">NCIT:C45755</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Undifferentiated Pleomorphic Sarcoma</td>
<td style="text-align: left;">An undifferentiated pleomorphic sarcoma usually arising from the left atrium of the heart.  It is characterized by the presence of fibrohistiocytic cells, giant cells, and spindle cells arrranged iin a storiform pattern.  Clinical presentation includes signs and symptoms associated with left atrial hemodynamic changes.</td>
<td style="text-align: left;">MONDO:0003354,MONDO:0002142</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857303</td>
<td style="text-align: left;">cardiac synovial sarcoma</td>
<td style="text-align: left;">NCIT:C45756</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Synovial Sarcoma</td>
<td style="text-align: left;">A synovial sarcoma arising from the heart.</td>
<td style="text-align: left;">MONDO:0003354,MONDO:0010434</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857305</td>
<td style="text-align: left;">cardiac rhabdomyosarcoma</td>
<td style="text-align: left;">NCIT:C45759</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Rhabdomyosarcoma</td>
<td style="text-align: left;">A rare malignant mesenchymal neoplasm that arises from cardiac muscle cells and is characterized by the presence of small round and spindle cells. Most cardiac rhabdomyosarcomas are of embryonal type and usually affect children and young adults.</td>
<td style="text-align: left;">MONDO:0003354,MONDO:0004749,MONDO:0005212</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857306</td>
<td style="text-align: left;">pericardial germ cell tumor</td>
<td style="text-align: left;">NCIT:C45761</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pericardial Germ Cell Tumor</td>
<td style="text-align: left;">A rare benign or malignant germ cell tumor that arises from the pericardium. The reported cases have been teratomas and yolk sac tumors.</td>
<td style="text-align: left;">MONDO:0021381,MONDO:0018201</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857308</td>
<td style="text-align: left;">corneal kaposi sarcoma</td>
<td style="text-align: left;">NCIT:C4579</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Corneal Kaposi Sarcoma</td>
<td style="text-align: left;">A Kaposi sarcoma arising from the cornea.</td>
<td style="text-align: left;">MONDO:0005055,MONDO:0003802</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857310</td>
<td style="text-align: left;">metastatic malignant neoplasm in the bone marrow</td>
<td style="text-align: left;">NCIT:C4582</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Bone Marrow</td>
<td style="text-align: left;">The spread of a malignant neoplasm from its original site of growth to the bone marrow.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0021138</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857311</td>
<td style="text-align: left;">pancreatic neuroendocrine microtumor</td>
<td style="text-align: left;">NCIT:C45834</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Neuroendocrine Microtumor</td>
<td style="text-align: left;">A non-functioning pancreatic neuroendocrine tumor measuring less than 0.5 cm in diameter.</td>
<td style="text-align: left;">MONDO:0004334</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857315</td>
<td style="text-align: left;">sellar gangliocytoma</td>
<td style="text-align: left;">NCIT:C45917</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sellar Gangliocytoma</td>
<td style="text-align: left;">A tumor that arises in the sellar region and is characterized by the presence of mature ganglion cells and neuronal differentiation. It is often associated with the presence of pituitary neuroendocrine tumors/adenomas.</td>
<td style="text-align: left;">MONDO:0016730,MONDO:0002720</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857316</td>
<td style="text-align: left;">hypothalamic gangliocytoma</td>
<td style="text-align: left;">NCIT:C45918</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hypothalamic Gangliocytoma</td>
<td style="text-align: left;">A tumor characterized by the presence of mature ganglion cells and neuronal differentiation, arising in the hypothalamus. It is often associated with the presence of pituitary gland adenomas. Symptoms include acromegaly and precocious puberty.</td>
<td style="text-align: left;">MONDO:0016730,MONDO:0006799</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857317</td>
<td style="text-align: left;">anterior pituitary gland neoplasm</td>
<td style="text-align: left;">NCIT:C45921</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anterior Pituitary Gland Neoplasm</td>
<td style="text-align: left;">A neoplasm arising from the anterior lobe of the pituitary gland. The vast majority are pituitary neuroendocrine tumors (formerly pituitary adenomas).</td>
<td style="text-align: left;">MONDO:0017611</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857319</td>
<td style="text-align: left;">densely granulated somatotroph pituitary neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C45925</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor</td>
<td style="text-align: left;">A growth hormone-producing pituitary neuroendocrine tumor composed of medium-sized acidophilic cells with granular cytoplasm and abundant secretory granules.</td>
<td style="text-align: left;">MONDO:0006238</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857320</td>
<td style="text-align: left;">sparsely granulated somatotroph pituitary neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C45926</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sparsely Granulated Somatotroph Pituitary Neuroendocrine Tumor</td>
<td style="text-align: left;">A growth hormone-producing pituitary neuroendocrine tumor composed of small, round cells containing fibrous bodies and scarce, small secretory granules.</td>
<td style="text-align: left;">MONDO:0006238</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857321</td>
<td style="text-align: left;">densely granulated lactotroph pituitary neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C45931</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Densely Granulated Lactotroph Pituitary Neuroendocrine Tumor</td>
<td style="text-align: left;">A rare prolactin-producing pituitary neuroendocrine tumor composed of acidophilic cells with many large secretory granules.  The endoplasmic reticulum is not as abundant as in the sparsely granulated subtype.</td>
<td style="text-align: left;">MONDO:0010911</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857322</td>
<td style="text-align: left;">sparsely granulated lactotroph pituitary neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C45932</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sparsely Granulated Lactotroph Pituitary Neuroendocrine Tumor</td>
<td style="text-align: left;">A prolactin-producing pituitary neuroendocrine tumor composed of relatively large, chromophobic or slightly acidophilic cells with well developed, abundant endoplasmic reticulum, and many immature secretory granules.  Mature secretory granules are sparse.</td>
<td style="text-align: left;">MONDO:0010911</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857324</td>
<td style="text-align: left;">benign palate neoplasm</td>
<td style="text-align: left;">NCIT:C4599</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Palate Neoplasm</td>
<td style="text-align: left;">A non-metastasizing neoplasm that arises from the hard palate, soft palate, or uvula.</td>
<td style="text-align: left;">MONDO:0005286,MONDO:0021445</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857325</td>
<td style="text-align: left;">thyroid gland oncocytic neoplasm</td>
<td style="text-align: left;">NCIT:C46068</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Oncocytic Neoplasm</td>
<td style="text-align: left;">An adenoma or carcinoma arising from the follicular cells of the thyroid gland.  It is composed of large oncocytic cells with abundant granular eosinophilic cytoplasm.</td>
<td style="text-align: left;">MONDO:0015074,MONDO:0010795</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857326</td>
<td style="text-align: left;">unilateral breast carcinoma</td>
<td style="text-align: left;">NCIT:C46073</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Unilateral Breast Carcinoma</td>
<td style="text-align: left;">Breast carcinoma of one breast, or one side of the breast.</td>
<td style="text-align: left;">MONDO:0004989</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857327</td>
<td style="text-align: left;">nonestrogen-dependent malignant neoplasm</td>
<td style="text-align: left;">NCIT:C46080</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nonestrogen-Dependent Malignant Neoplasm</td>
<td style="text-align: left;">Cancer that is not dependent upon the presence of estrogen for metastasis or growth. 2005</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857330</td>
<td style="text-align: left;">macrofollicular variant thyroid gland papillary carcinoma</td>
<td style="text-align: left;">NCIT:C46092</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Macrofollicular Variant Thyroid Gland Papillary Carcinoma</td>
<td style="text-align: left;">A morphologic variant of papillary carcinoma of the thyroid gland characterized by the predominance or the exclusive presence of macrofollicles.  Some of the malignant follicular cells display the nuclear features that characterize the papillary adenocarcinomas of the thyroid gland.</td>
<td style="text-align: left;">MONDO:0005075</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857331</td>
<td style="text-align: left;">clear cell variant thyroid gland papillary carcinoma</td>
<td style="text-align: left;">NCIT:C46094</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Clear Cell Variant Thyroid Gland Papillary Carcinoma</td>
<td style="text-align: left;">A morphologic variant of papillary carcinoma of the thyroid gland characterized by the predominance of malignant follicular clear cells.  These cells have the nuclear features that characterize the papillary carcinomas of the thyroid gland.</td>
<td style="text-align: left;">MONDO:0005075,MONDO:0005004</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857333</td>
<td style="text-align: left;">thyroid gland follicular carcinoma, clear cell variant</td>
<td style="text-align: left;">NCIT:C46096</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Follicular Carcinoma, Clear Cell Variant</td>
<td style="text-align: left;">A morphologic variant of follicular carcinoma of the thyroid gland characterized by the predominance of malignant follicular clear cells.  These cells lack the nuclear features that characterize the papillary carcinomas of the thyroid gland.</td>
<td style="text-align: left;">MONDO:0005034,MONDO:0005004</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857334</td>
<td style="text-align: left;">sporadic thyroid gland medullary carcinoma</td>
<td style="text-align: left;">NCIT:C46098</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sporadic Thyroid Gland Medullary Carcinoma</td>
<td style="text-align: left;">A non-hereditary medullary carcinoma of the thyroid gland not associated with multiple endocrine neoplasia.  The majority of thyroid gland medullary carcinomas are sporadic.</td>
<td style="text-align: left;">MONDO:0015277</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857337</td>
<td style="text-align: left;">intrathyroid thymic carcinoma</td>
<td style="text-align: left;">NCIT:C46106</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intrathyroid Thymic Carcinoma</td>
<td style="text-align: left;">A rare primary carcinoma of the thyroid gland, composed of groups of carcinoma cells with thymic epithelial differentiation.</td>
<td style="text-align: left;">MONDO:0015075</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857339</td>
<td style="text-align: left;">thyroid gland signet ring cell follicular adenoma</td>
<td style="text-align: left;">NCIT:C46115</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Signet Ring Cell Follicular Adenoma</td>
<td style="text-align: left;">A thyroid gland adenoma characterized by the presence of signet ring cells that stain positive for thyroglobulin.</td>
<td style="text-align: left;">MONDO:0005032</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857340</td>
<td style="text-align: left;">thyroid gland mucinous follicular adenoma</td>
<td style="text-align: left;">NCIT:C46116</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Mucinous Follicular Adenoma</td>
<td style="text-align: left;">A thyroid gland adenoma composed of follicles and characterized by the presence of abundant extracellular mucin.</td>
<td style="text-align: left;">MONDO:0005032</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857341</td>
<td style="text-align: left;">thyroid gland lipoadenoma</td>
<td style="text-align: left;">NCIT:C46118</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Lipoadenoma</td>
<td style="text-align: left;">A thyroid gland adenoma composed of follicular structures and mature adipocytes.</td>
<td style="text-align: left;">MONDO:0003431,MONDO:0005032</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857342</td>
<td style="text-align: left;">thyroid gland clear cell follicular adenoma</td>
<td style="text-align: left;">NCIT:C46119</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Clear Cell Follicular Adenoma</td>
<td style="text-align: left;">A thyroid gland adenoma composed of follicular cells with cytoplasmic clearing.</td>
<td style="text-align: left;">MONDO:0003426,MONDO:0005032</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857343</td>
<td style="text-align: left;">thyroid gland hyperfunctioning adenoma</td>
<td style="text-align: left;">NCIT:C46122</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Hyperfunctioning Adenoma</td>
<td style="text-align: left;">A thyroid gland adenoma producing thyroxin.  It is associated with hyperthyroidism.  Radioactive iodine scan reveals a hot nodule.</td>
<td style="text-align: left;">MONDO:0005032</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857345</td>
<td style="text-align: left;">thyroid gland paraganglioma</td>
<td style="text-align: left;">NCIT:C46125</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Paraganglioma</td>
<td style="text-align: left;">A rare, circumscribed or encapsulated neuroendocrine tumor arising from the thyroid gland. Microscopically, it is characterized by the presence of tumor cells arranged in a nesting (Zellballen) growth pattern. The reported cases have followed a benign clinical course.</td>
<td style="text-align: left;">MONDO:0006239,MONDO:0015074</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857346</td>
<td style="text-align: left;">benign skin adnexal neoplasm</td>
<td style="text-align: left;">NCIT:C4615</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Skin Adnexal Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the hair follicles, sebaceous glands, or sweat glands. It is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include cylindroma, hidrocystoma, hidradenoma, and sebaceoma.</td>
<td style="text-align: left;">MONDO:0024666,MONDO:0002297</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857349</td>
<td style="text-align: left;">pineal region germ cell tumor</td>
<td style="text-align: left;">NCIT:C4659</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pineal Region Germ Cell Tumor</td>
<td style="text-align: left;">A germ cell tumor that arises in the pineal region.  Representative examples include teratoma, germinoma, and choriocarcinoma.</td>
<td style="text-align: left;">MONDO:0021232,MONDO:0003000</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857357</td>
<td style="text-align: left;">atypical meningioma</td>
<td style="text-align: left;">NCIT:C4723</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Meningioma</td>
<td style="text-align: left;">A WHO grade II meningioma characterized by the presence of brain invasion and an increased mitotic activity, or at least three of the following morphologic features: small cells, high cellularity, prominent nucleoli, lack of architectural pattern, and necrosis.</td>
<td style="text-align: left;">MONDO:0045056</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857358</td>
<td style="text-align: left;">neoplasm by morphology</td>
<td style="text-align: left;">NCIT:C4741</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neoplasm by Morphology</td>
<td style="text-align: left;">A classification system grouping neoplasms according to their cellular characteristics.</td>
<td style="text-align: left;">MONDO:0005070</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857359</td>
<td style="text-align: left;">benign squamous cell neoplasm</td>
<td style="text-align: left;">NCIT:C4742</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Squamous Cell Neoplasm</td>
<td style="text-align: left;">A non-metastasizing neoplasm composed of squamous cells. The neoplastic cells do not display malignant features.</td>
<td style="text-align: left;">MONDO:0036976,MONDO:0002532</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857360</td>
<td style="text-align: left;">skin cavernous hemangioma</td>
<td style="text-align: left;">NCIT:C4750</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Cavernous Hemangioma</td>
<td style="text-align: left;">A cavernous hemangioma arising from the skin.</td>
<td style="text-align: left;">MONDO:0003110,MONDO:0003155</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857362</td>
<td style="text-align: left;">benign extrahepatic bile duct neoplasm</td>
<td style="text-align: left;">NCIT:C4776</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Extrahepatic Bile Duct Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the extrahepatic bile ducts and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0021385,MONDO:0000385</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857363</td>
<td style="text-align: left;">breast carcinoma with chondroid metaplasia</td>
<td style="text-align: left;">NCIT:C47847</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Carcinoma with Chondroid Metaplasia</td>
<td style="text-align: left;">An invasive carcinoma of the breast showing differentiation towards cartilaginous structures.</td>
<td style="text-align: left;">MONDO:0004274</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857364</td>
<td style="text-align: left;">breast carcinoma with osseous metaplasia</td>
<td style="text-align: left;">NCIT:C47848</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Carcinoma with Osseous Metaplasia</td>
<td style="text-align: left;">An invasive breast carcinoma showing differentiation towards bone structures.</td>
<td style="text-align: left;">MONDO:0004274</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857365</td>
<td style="text-align: left;">breast paget disease without invasive carcinoma</td>
<td style="text-align: left;">NCIT:C47858</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Paget Disease without Invasive Carcinoma</td>
<td style="text-align: left;">Paget disease involving the skin overlying the mammary gland, without accompanying invasive ductal or lobular breast carcinoma.</td>
<td style="text-align: left;">MONDO:0002648</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857366</td>
<td style="text-align: left;">breast hyperplasia</td>
<td style="text-align: left;">NCIT:C4804</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Hyperplasia</td>
<td style="text-align: left;">A general term that refers to hyperplastic proliferations of the epithelial cells in the breast parenchyma.  Examples include atypical ductal hyperplasia, usual ductal hyperplasia, columnar cell hyperplasia, and atypical lobular hyperplasia.</td>
<td style="text-align: left;">MONDO:0005043,MONDO:0021100</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857367</td>
<td style="text-align: left;">malignant odontogenic neoplasm</td>
<td style="text-align: left;">NCIT:C4812</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Odontogenic Neoplasm</td>
<td style="text-align: left;">A rare neoplasm arising from tooth-forming tissues. It occurs in the maxillofacial skeleton or the gingiva. Symptoms include swelling, pain, bleeding, mobility of affected teeth, and oral mucosa ulcerations. It may metastasize to lymph nodes and distant anatomic sites early.</td>
<td style="text-align: left;">MONDO:0021192,MONDO:0005515</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857370</td>
<td style="text-align: left;">parathyroid gland lipoadenoma</td>
<td style="text-align: left;">NCIT:C48283</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Parathyroid Gland Lipoadenoma</td>
<td style="text-align: left;">A parathyroid gland adenoma that contains mature adipocytes.</td>
<td style="text-align: left;">MONDO:0003431,MONDO:0006890</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857371</td>
<td style="text-align: left;">atypical parathyroid gland tumor</td>
<td style="text-align: left;">NCIT:C48285</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Parathyroid Gland Tumor</td>
<td style="text-align: left;">A parathyroid gland tumor that shares certain morphologic characteristics with parathyroid gland carcinomas (e.g. broad fibrous bands formation with or without hemosiderin deposition, presence of mitotic figures) but lacks unequivocal evidence of capsular or vascular invasion. It is considered a tumor of uncertain malignant potential. (WHO)</td>
<td style="text-align: left;">MONDO:0021360</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857375</td>
<td style="text-align: left;">non-metastatic paraganglioma</td>
<td style="text-align: left;">NCIT:C48314</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Metastatic Paraganglioma</td>
<td style="text-align: left;">A paraganglioma that is confined to the site of origin.</td>
<td style="text-align: left;">MONDO:0000448</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857376</td>
<td style="text-align: left;">nasopharyngeal paraganglioma</td>
<td style="text-align: left;">NCIT:C48316</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nasopharyngeal Paraganglioma</td>
<td style="text-align: left;">An extra-adrenal paraganglioma arising from the nasopharynx and nose.  Epistaxis or nasal obstruction are common presenting symptoms.</td>
<td style="text-align: left;">MONDO:0006239,MONDO:0005375</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857377</td>
<td style="text-align: left;">primary bone osteosarcoma</td>
<td style="text-align: left;">NCIT:C4834</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Bone Osteosarcoma</td>
<td style="text-align: left;">A usually aggressive malignant bone-forming mesenchymal neoplasm arising from the bone. It usually involves the long bones and predominantly affects adolescents and young adults. Pain and a palpable mass are the most frequent clinical sign and symptom. It may spread to other anatomic sites, particularly the lungs.</td>
<td style="text-align: left;">MONDO:0002629</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857378</td>
<td style="text-align: left;">adrenal cortical oncocytic adenoma</td>
<td style="text-align: left;">NCIT:C48447</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Oncocytic Adenoma</td>
<td style="text-align: left;">A usually non-functioning variant of adrenal cortex adenoma, composed of large cells with abundant granular eosinophilic cytoplasm.</td>
<td style="text-align: left;">MONDO:0003924,MONDO:0003424</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857379</td>
<td style="text-align: left;">androgen-producing adrenal cortical adenoma</td>
<td style="text-align: left;">NCIT:C48454</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Androgen-Producing Adrenal Cortical Adenoma</td>
<td style="text-align: left;">A rare adenoma of the adrenal cortex that produces androgens.  Female patients usually have symptoms related to virilism.</td>
<td style="text-align: left;">MONDO:0006408</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857380</td>
<td style="text-align: left;">estrogen-producing adrenal cortical adenoma</td>
<td style="text-align: left;">NCIT:C48456</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Estrogen-Producing Adrenal Cortical Adenoma</td>
<td style="text-align: left;">A rare adenoma of the adrenal cortex that produces estrogens.  Male patients may develop gynecomastia and impotence.</td>
<td style="text-align: left;">MONDO:0006408</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857382</td>
<td style="text-align: left;">invasive prostate carcinoma</td>
<td style="text-align: left;">NCIT:C48596</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Prostate Carcinoma</td>
<td style="text-align: left;">A carcinoma that is not confined to the prostatic epithelium but has spread to the surrounding stroma of the prostate gland.  The vast majority of invasive prostate carcinomas are adenocarcinomas.</td>
<td style="text-align: left;">MONDO:0005159,MONDO:0040677</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857383</td>
<td style="text-align: left;">minimal deviation melanoma</td>
<td style="text-align: left;">NCIT:C48612</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Minimal Deviation Melanoma</td>
<td style="text-align: left;">A melanocytic neoplasm displaying morphologic features that are intermediate between those of benign nevus and melanoma.  It is characterized by a nodular architectural growth resembling a melanoma, and a loss of nevus cell maturation.  The melanocytic cells forming the nodular growth are uniform, and they may display a high mitotic rate, but they do not show cytologic atypia.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857385</td>
<td style="text-align: left;">desmoplastic neurotropic melanoma</td>
<td style="text-align: left;">NCIT:C48614</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Desmoplastic Neurotropic Melanoma</td>
<td style="text-align: left;">A desmoplastic melanoma characterized by the presence of nerve infiltration by atypical spindled melanocytes.</td>
<td style="text-align: left;">MONDO:0044785</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857386</td>
<td style="text-align: left;">mucosal lentiginous melanoma</td>
<td style="text-align: left;">NCIT:C48622</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mucosal Lentiginous Melanoma</td>
<td style="text-align: left;">A lentiginous melanoma affecting mucosal surfaces.</td>
<td style="text-align: left;">MONDO:0000544</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857388</td>
<td style="text-align: left;">metastatic malignant neoplasm in the trachea</td>
<td style="text-align: left;">NCIT:C4887</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Trachea</td>
<td style="text-align: left;">A malignant neoplasm that has spread to the trachea from another anatomic site.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0001407</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857389</td>
<td style="text-align: left;">splenic lymphoma</td>
<td style="text-align: left;">NCIT:C48873</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Splenic Lymphoma</td>
<td style="text-align: left;">A non-Hodgkin lymphoma or rarely Hodgkin lymphoma that arises from the spleen.</td>
<td style="text-align: left;">MONDO:0017207,MONDO:0005966</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857390</td>
<td style="text-align: left;">dedifferentiated chordoma</td>
<td style="text-align: left;">NCIT:C48876</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Dedifferentiated Chordoma</td>
<td style="text-align: left;">A high-grade malignant bone tumor arising from the remnants of the notochord. It is characterized by a lobulated growth pattern, myxoid stroma formation, the presence of physaliphorous cells, and a sarcomatous component.</td>
<td style="text-align: left;">MONDO:0008978</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857391</td>
<td style="text-align: left;">benign lung hilum neoplasm</td>
<td style="text-align: left;">NCIT:C4888</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Lung Hilum Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the hilar region of lung and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0003639,MONDO:0002732</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857393</td>
<td style="text-align: left;">hiv lipodystrophy</td>
<td style="text-align: left;">NCIT:C48899</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">HIV Lipodystrophy</td>
<td style="text-align: left;">A neoplastic process characterized by a diffuse poorly circumscribed overgrowth of adipose tissue in the breast and cervical areas, and an accumulation of visceral fat.  It is associated with antiretroviral therapy.  Clinical presentation includes hyperlipidemia, insulin resistance, and fat atrophy of the face and limbs.</td>
<td style="text-align: left;">MONDO:0006573,MONDO:0006574</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857394</td>
<td style="text-align: left;">gardner fibroma</td>
<td style="text-align: left;">NCIT:C49017</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gardner Fibroma</td>
<td style="text-align: left;">An uncommon, poorly circumscribed, benign neoplasm arising in the soft tissues of infants, children and adolescents. It is characterized by the presence of haphazardly arranged spindle-shaped fibroblasts, collagenous stroma formation, and plaque-like growth pattern. There is a strong genetic component associating the neoplasm with Gardner syndrome and deep fibromatosis/desmoid tumor.</td>
<td style="text-align: left;">MONDO:0005167</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857397</td>
<td style="text-align: left;">skin fibroblastic fibrous histiocytoma</td>
<td style="text-align: left;">NCIT:C49076</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Fibroblastic Fibrous Histiocytoma</td>
<td style="text-align: left;">A variant of fibrous histiocytoma of the skin characterized by the presence of spindle-shaped fibrohistiocytic cells and associated acanthosis.</td>
<td style="text-align: left;">MONDO:0006717</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857398</td>
<td style="text-align: left;">skin histiocytic fibrous histiocytoma</td>
<td style="text-align: left;">NCIT:C49077</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Histiocytic Fibrous Histiocytoma</td>
<td style="text-align: left;">A variant of fibrous histiocytoma of the skin characterized by the presence of xanthomatous fibrohistiocytic cells, giant cells, and hemosiderin deposition.</td>
<td style="text-align: left;">MONDO:0006717</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857399</td>
<td style="text-align: left;">skin cellular fibrous histiocytoma</td>
<td style="text-align: left;">NCIT:C49078</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Cellular Fibrous Histiocytoma</td>
<td style="text-align: left;">A variant of fibrous histiocytoma of the skin characterized by the presence of spindle-shaped fibrohistiocytic cells and increased cellularity.</td>
<td style="text-align: left;">MONDO:0006717</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857401</td>
<td style="text-align: left;">solid angioleiomyoma</td>
<td style="text-align: left;">NCIT:C49110</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Solid Angioleiomyoma</td>
<td style="text-align: left;">A morphologic variant of angioleiomyoma characterized by the presence of numerous small, slit-like vascular channels.</td>
<td style="text-align: left;">MONDO:0006646</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857402</td>
<td style="text-align: left;">venous angioleiomyoma</td>
<td style="text-align: left;">NCIT:C49111</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Venous Angioleiomyoma</td>
<td style="text-align: left;">A morphologic variant of angioleiomyoma characterized by the presence of thick-walled veins.</td>
<td style="text-align: left;">MONDO:0006646</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857403</td>
<td style="text-align: left;">cavernous angioleiomyoma</td>
<td style="text-align: left;">NCIT:C49115</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cavernous Angioleiomyoma</td>
<td style="text-align: left;">A morphologic variant of angioleiomyoma characterized by the presence of markedly dilated vascular channels.</td>
<td style="text-align: left;">MONDO:0006646</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857405</td>
<td style="text-align: left;">anaplastic embryonal rhabdomyosarcoma</td>
<td style="text-align: left;">NCIT:C49204</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Embryonal Rhabdomyosarcoma</td>
<td style="text-align: left;">A morphologic variant of embryonal rhabdomyosarcoma.  It is characterized by the presence of large hyperchromatic and anaplastic cells.</td>
<td style="text-align: left;">MONDO:0009993</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857407</td>
<td style="text-align: left;">duodenal adenoma</td>
<td style="text-align: left;">NCIT:C4932</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Duodenal Adenoma</td>
<td style="text-align: left;">A circumscribed neoplasm that arises from the glandular epithelium of the duodenum. Morphologically, it is characterized by a proliferation of neoplastic glandular cells and it is associated with dysplasia. According to the growth pattern, it may be classified as tubular, villous, or tubulovillous.</td>
<td style="text-align: left;">MONDO:0021303,MONDO:0021375</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857412</td>
<td style="text-align: left;">intracranial neoplasm</td>
<td style="text-align: left;">NCIT:C4953</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intracranial Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that arises from or metastasizes to structures within the cranium.  This includes meningeal and other tumors that occur in the spaces that surround the brain, and neoplasms of the brain.</td>
<td style="text-align: left;">MONDO:0006130</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857413</td>
<td style="text-align: left;">leptomeningeal neoplasm</td>
<td style="text-align: left;">NCIT:C4958</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Leptomeningeal Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that has spread from its original site to the two innermost layers of tissue that cover the brain and spinal cord.</td>
<td style="text-align: left;">MONDO:0016743</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857415</td>
<td style="text-align: left;">benign infratentorial neoplasm</td>
<td style="text-align: left;">NCIT:C4965</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Infratentorial Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the infratentorial region and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0021451,MONDO:0037736</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857417</td>
<td style="text-align: left;">primary brain stem neoplasm</td>
<td style="text-align: left;">NCIT:C4975</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Brain Stem Neoplasm</td>
<td style="text-align: left;">A neoplasm that originates from the brain stem.</td>
<td style="text-align: left;">MONDO:0021228,MONDO:0021632</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857419</td>
<td style="text-align: left;">carcinoma unspecified site</td>
<td style="text-align: left;">NCIT:C4979</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Carcinoma Unspecified Site</td>
<td style="text-align: left;">Carcinoma in which the site of involvement is not specified.</td>
<td style="text-align: left;">MONDO:0004993</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857430</td>
<td style="text-align: left;">verrucous lesion</td>
<td style="text-align: left;">NCIT:C5028</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Verrucous Lesion</td>
<td style="text-align: left;">A papillomavirus related epithelial overgrowth. It can be located anywhere on the body though when it involves the perineal region it is generally referred to as condyloma acuminatum.</td>
<td style="text-align: left;">MONDO:0002532</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857466</td>
<td style="text-align: left;">renomedullary interstitial cell tumor</td>
<td style="text-align: left;">NCIT:C5100</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renomedullary Interstitial Cell Tumor</td>
<td style="text-align: left;">A benign, asymptomatic kidney tumor arising from renomedullary interstitial cells. It is often found incidentally at the time of nephrectomy in adults. These tumors are either single or multiple and usually measure 1-10 mm in diameter. Microscopically the tumor cells are small, stellate, or spindled cells, embedded in a faintly basophilic stroma reminiscent of renal medullary stroma. (WHO 2016)</td>
<td style="text-align: left;">MONDO:0002513</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857469</td>
<td style="text-align: left;">solid glomus tumor</td>
<td style="text-align: left;">NCIT:C51133</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Solid Glomus Tumor</td>
<td style="text-align: left;">The most common morphologic variant of glomus tumor.  It is characterized by the presence of a nest of glomus cells surrounding capillary sized vessels.</td>
<td style="text-align: left;">MONDO:0018327</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857473</td>
<td style="text-align: left;">adult central nervous system neoplasm</td>
<td style="text-align: left;">NCIT:C5131</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Central Nervous System Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm of the brain, spinal cord, or meninges occurring in adults.  Representative examples of primary neoplasms include astrocytoma, meningioma, pituitary adenoma, and neurilemoma.  Representative examples of tumor metastases from other organs to the central nervous system include lung and breast carcinoma.</td>
<td style="text-align: left;">MONDO:0006130</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857476</td>
<td style="text-align: left;">breast ductal carcinoma in situ, non-comedo type</td>
<td style="text-align: left;">NCIT:C5137</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Ductal Carcinoma In Situ, Non-Comedo Type</td>
<td style="text-align: left;">Breast ductal carcinoma in situ characterized by the presence of sheets of tumor cells without evidence of central necrosis or cell death.</td>
<td style="text-align: left;">MONDO:0005023</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857477</td>
<td style="text-align: left;">invasive breast cribriform carcinoma</td>
<td style="text-align: left;">NCIT:C5142</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Breast Cribriform Carcinoma</td>
<td style="text-align: left;">An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern.</td>
<td style="text-align: left;">MONDO:0004988,MONDO:0006256,MONDO:0006176</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857478</td>
<td style="text-align: left;">malignant breast adenomyoepithelioma</td>
<td style="text-align: left;">NCIT:C5143</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Breast Adenomyoepithelioma</td>
<td style="text-align: left;">An adenomyoepithelioma of the breast in which the epithelial, myoepithelial, or both components have undergone malignant transformation.  Such cases may follow an aggressive clinical course, including recurrences and local and distant metastases.</td>
<td style="text-align: left;">MONDO:0002066,MONDO:0007254</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857479</td>
<td style="text-align: left;">infratentorial glioblastoma</td>
<td style="text-align: left;">NCIT:C5148</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Infratentorial Glioblastoma</td>
<td style="text-align: left;">A glioblastoma that occurs in the infratentorial region.</td>
<td style="text-align: left;">MONDO:0003107,MONDO:0002501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857480</td>
<td style="text-align: left;">supratentorial glioblastoma</td>
<td style="text-align: left;">NCIT:C5149</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Supratentorial Glioblastoma</td>
<td style="text-align: left;">A glioblastoma that occurs in the supratentorial region.</td>
<td style="text-align: left;">MONDO:0002071,MONDO:0002501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857482</td>
<td style="text-align: left;">breast high grade mucoepidermoid carcinoma</td>
<td style="text-align: left;">NCIT:C5167</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast High Grade Mucoepidermoid Carcinoma</td>
<td style="text-align: left;">An aggressive mucoepidermoid carcinoma that arises from the breast. It is characterized by the presence of focal necrosis and high mitotic activity. Lymph node and distant metastases are common. The prognosis is usually poor.</td>
<td style="text-align: left;">MONDO:0003087</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857483</td>
<td style="text-align: left;">breast low grade mucoepidermoid carcinoma</td>
<td style="text-align: left;">NCIT:C5168</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Low Grade Mucoepidermoid Carcinoma</td>
<td style="text-align: left;">A slow growing mucoepidermoid carcinoma that arises from the breast. It is characterized by the presence of keratinization in the neoplastic squamous cells and lumina formation by glandular neoplastic cells. Complete excision may be curative.</td>
<td style="text-align: left;">MONDO:0003087</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857486</td>
<td style="text-align: left;">breast non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C5181</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A non-Hodgkin lymphoma that arises from the breast.  There is no history of extramammary breast non-Hodgkin lymphoma and ipsilateral axillary lymph node involvement does not exclude the diagnosis of primary breast non-Hodgkin lymphoma.  Most patients present with a painless breast lump.  The vast majority of cases are B-cell non-Hodgkin lymphomas.  Diffuse large B-cell lymphoma, follicular lymphoma, and extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue are the most common types of primary non-Hodgkin lymphoma of the breast.</td>
<td style="text-align: left;">MONDO:0018908,MONDO:0003661</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857487</td>
<td style="text-align: left;">breast complex fibroadenoma</td>
<td style="text-align: left;">NCIT:C5194</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Complex Fibroadenoma</td>
<td style="text-align: left;">A breast fibroadenoma that displays fibrocystic changes including apocrine metaplasia, sclerosing adenosis, and cyst formation.</td>
<td style="text-align: left;">MONDO:0002056</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857488</td>
<td style="text-align: left;">benign nipple neoplasm</td>
<td style="text-align: left;">NCIT:C5197</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Nipple Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the nipple and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0000620,MONDO:0002482</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857490</td>
<td style="text-align: left;">breast papillary neoplasm</td>
<td style="text-align: left;">NCIT:C5206</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Papillary Neoplasm</td>
<td style="text-align: left;">A benign or malignant papillary neoplasm that arises from the breast.  It is characterized by the presence of epithelial proliferations that are supported by fibrovascular cores.  Representative examples are intraductal papilloma and papillary carcinoma.</td>
<td style="text-align: left;">MONDO:0021100,MONDO:0021096</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857492</td>
<td style="text-align: left;">malignant nipple neoplasm</td>
<td style="text-align: left;">NCIT:C5213</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Nipple Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that affects the area of the nipple.</td>
<td style="text-align: left;">MONDO:0007254,MONDO:0002482</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857493</td>
<td style="text-align: left;">benign ovarian thecoma</td>
<td style="text-align: left;">NCIT:C5219</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Ovarian Thecoma</td>
<td style="text-align: left;">A thecoma of the ovary that does not metastasize to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0024387,MONDO:0037253</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857496</td>
<td style="text-align: left;">ovarian soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C5244</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Soft Tissue Neoplasm</td>
<td style="text-align: left;">A benign, intermediate, or malignant mesenchymal neoplasm that arises from the ovary. Representative examples include leiomyoma, myxoma, and sarcoma.</td>
<td style="text-align: left;">MONDO:0006424,MONDO:0021068</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857499</td>
<td style="text-align: left;">gastric t-cell non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C5254</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric T-Cell Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A rare, extranodal T-cell non-Hodgkin lymphoma that arises from the stomach with the bulk of the mass located in the stomach.</td>
<td style="text-align: left;">MONDO:0042493,MONDO:0015760</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857502</td>
<td style="text-align: left;">deletion of the short arm of chromosome 1 (1p) associated meningioma</td>
<td style="text-align: left;">NCIT:C5294</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Deletion of the Short Arm of Chromosome 1 (1p) Associated Meningioma</td>
<td style="text-align: left;">A meningioma that is associated with deletion of chromosomal arm 1p.</td>
<td style="text-align: left;">MONDO:0016642</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857503</td>
<td style="text-align: left;">deletion of chromosome 22 associated meningioma</td>
<td style="text-align: left;">NCIT:C5305</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Deletion of Chromosome 22 Associated Meningioma</td>
<td style="text-align: left;">A meningioma that is associated with deletion of chromosome 22.  This abnormality is the most consistent cytogenetic finding that is detected in meningiomas.</td>
<td style="text-align: left;">MONDO:0016642</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857504</td>
<td style="text-align: left;">deletion of chromosome 3p associated meningioma</td>
<td style="text-align: left;">NCIT:C5306</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Deletion of Chromosome 3p Associated Meningioma</td>
<td style="text-align: left;">A meningioma that is associated with deletion of chromosomal arm 3p.</td>
<td style="text-align: left;">MONDO:0016642</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857507</td>
<td style="text-align: left;">extra-adrenal retroperitoneal paraganglioma</td>
<td style="text-align: left;">NCIT:C5328</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extra-Adrenal Retroperitoneal Paraganglioma</td>
<td style="text-align: left;">A sympathetic paraganglioma arising from the retroperitoneum, outside the adrenal gland.</td>
<td style="text-align: left;">MONDO:0000550,MONDO:0024645</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857508</td>
<td style="text-align: left;">hereditary paraganglioma</td>
<td style="text-align: left;">NCIT:C5329</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hereditary Paraganglioma</td>
<td style="text-align: left;">A hereditary neoplasm arising from paraganglia. The majority of cases (up to 80%) are multifocal. It is caused by mutations in SDHA, SDHB, SDHC, SDHD, and SDHAF2 genes.</td>
<td style="text-align: left;">MONDO:0000448</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857513</td>
<td style="text-align: left;">great vessel neoplasm</td>
<td style="text-align: left;">NCIT:C5348</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Great Vessel Neoplasm</td>
<td style="text-align: left;">A neoplasm involving a great vessel.</td>
<td style="text-align: left;">MONDO:0024757</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857514</td>
<td style="text-align: left;">mesenchymal chondrosarcoma of bone</td>
<td style="text-align: left;">NCIT:C53493</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mesenchymal Chondrosarcoma of Bone</td>
<td style="text-align: left;">A morphologic variant of chondrosarcoma arising from the bone.  It is characterized by the presence of malignant small round cells, biphasic growth pattern, and well differentiated hyaline cartilage. Clinical presentation includes pain and swelling.  The clinical course is aggressive, with local recurrences and distant metastases.</td>
<td style="text-align: left;">MONDO:0021054,MONDO:0006853</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857518</td>
<td style="text-align: left;">cardiac schwannoma</td>
<td style="text-align: left;">NCIT:C5358</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Schwannoma</td>
<td style="text-align: left;">A benign peripheral nervous system neoplasm that is composed of well-differentiated Schwann cells and affects the heart.</td>
<td style="text-align: left;">MONDO:0021450,MONDO:0004820</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857519</td>
<td style="text-align: left;">cardiac epithelioid hemangioendothelioma</td>
<td style="text-align: left;">NCIT:C5362</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Epithelioid Hemangioendothelioma</td>
<td style="text-align: left;">A low-grade malignant blood vessel neoplasm, arising from the heart.  IIt is characterized by the presence of epithelioid endothelial cells.  The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma.</td>
<td style="text-align: left;">MONDO:0015523,MONDO:0001340</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857520</td>
<td style="text-align: left;">cardiac kaposi sarcoma</td>
<td style="text-align: left;">NCIT:C5363</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Kaposi Sarcoma</td>
<td style="text-align: left;">A Kaposi sarcoma arising from the heart.</td>
<td style="text-align: left;">MONDO:0005055,MONDO:0003354</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857524</td>
<td style="text-align: left;">cardiac myeloid sarcoma</td>
<td style="text-align: left;">NCIT:C5370</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Myeloid Sarcoma</td>
<td style="text-align: left;">A rare extramedullary myeloid tumor that arises from the heart.  It may present in association with or as a site of relapse of acute myeloid leukemia. Rare cases of myeloid sarcoma of the heart preceding acute myeloid leukemia have also been reported.</td>
<td style="text-align: left;">MONDO:0001340,MONDO:0006861</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857525</td>
<td style="text-align: left;">secondary osteosarcoma</td>
<td style="text-align: left;">NCIT:C53704</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Secondary Osteosarcoma</td>
<td style="text-align: left;">An osteosarcoma arising from a pre-existing lesion of the bone, usually Paget disease, or due to radiation therapy.</td>
<td style="text-align: left;">MONDO:0002629,MONDO:0024881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857526</td>
<td style="text-align: left;">malignant inferior vena cava neoplasm</td>
<td style="text-align: left;">NCIT:C5377</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Inferior Vena Cava Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm involving the inferior vena cava.</td>
<td style="text-align: left;">MONDO:0040676</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857527</td>
<td style="text-align: left;">malignant superior vena cava neoplasm</td>
<td style="text-align: left;">NCIT:C5379</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Superior Vena Cava Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm involving the superior vena cava.</td>
<td style="text-align: left;">MONDO:0040676</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857528</td>
<td style="text-align: left;">malignant pulmonary artery neoplasm</td>
<td style="text-align: left;">NCIT:C5380</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Pulmonary Artery Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm involving the pulmonary artery.</td>
<td style="text-align: left;">MONDO:0040676</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857529</td>
<td style="text-align: left;">malignant pulmonary vein neoplasm</td>
<td style="text-align: left;">NCIT:C5383</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Pulmonary Vein Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm involving the pulmonary vein.</td>
<td style="text-align: left;">MONDO:0040676</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857532</td>
<td style="text-align: left;">leiomyosarcoma of vessels</td>
<td style="text-align: left;">NCIT:C5387</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Leiomyosarcoma of Vessels</td>
<td style="text-align: left;">An aggressive malignant smooth muscle neoplasm, arising from the walls of the vascular system.  It is characterized by a proliferation of neoplastic spindle cells.</td>
<td style="text-align: left;">MONDO:0005058</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857533</td>
<td style="text-align: left;">benign atrial neoplasm</td>
<td style="text-align: left;">NCIT:C5389</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Atrial Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the right or left atrium and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0021450</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857535</td>
<td style="text-align: left;">solitary adult fibroma</td>
<td style="text-align: left;">NCIT:C5394</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Solitary Adult Fibroma</td>
<td style="text-align: left;">A solitary benign neoplasm arising from the fibrous soft tissues. The tumor is characterized by the presence of spindle-shaped fibroblasts.</td>
<td style="text-align: left;">MONDO:0005167</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857536</td>
<td style="text-align: left;">fibrous histiocytoma of bone</td>
<td style="text-align: left;">NCIT:C53963</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fibrous Histiocytoma of Bone</td>
<td style="text-align: left;">A rare, benign neoplasm usually arising from the non-metaphyseal regions of long bones or pelvis. It is characterized by the presence of fibroblastic spindle cells arranged in a whorled storiform pattern, osteoclast-like giant cells, foam cells, inflammatory cells, hemosiderin deposition and stromal hemorrhage.</td>
<td style="text-align: left;">MONDO:0000631,MONDO:0002989</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857537</td>
<td style="text-align: left;">bone leiomyoma</td>
<td style="text-align: left;">NCIT:C53964</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Leiomyoma</td>
<td style="text-align: left;">A rare leiomyoma affecting the bone.</td>
<td style="text-align: left;">MONDO:0006106</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857542</td>
<td style="text-align: left;">benign gastrointestinal stromal tumor</td>
<td style="text-align: left;">NCIT:C53998</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Gastrointestinal Stromal Tumor</td>
<td style="text-align: left;">A gastrointestinal stromal tumor that is characterized by a maximum diameter equal or less than 5 cm (gastric localization), or equal or less than 2 cm (intestinal localization) and no more than 5 mitotic figures per 50 high power fields.</td>
<td style="text-align: left;">MONDO:0044335,MONDO:0011719</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857543</td>
<td style="text-align: left;">malignant gastrointestinal stromal tumor</td>
<td style="text-align: left;">NCIT:C53999</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Gastrointestinal Stromal Tumor</td>
<td style="text-align: left;">A gastrointestinal stromal tumor that is characterized by large size (diameter greater than 10 cm for gastric localization and greater than 5 cm for intestinal localization) or more than 5 mitotic figures per 50 high power fields.</td>
<td style="text-align: left;">MONDO:0011719,MONDO:0044337</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857546</td>
<td style="text-align: left;">region 17p13 allelic loss associated medulloblastoma</td>
<td style="text-align: left;">NCIT:C5402</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Region 17p13 Allelic Loss Associated Medulloblastoma</td>
<td style="text-align: left;">A medulloblastoma characterized by the loss of one of the p13 regions of chromosome 17.  Loss of genetic material of chromosome arm 17p is the most common molecular genetic abnormality found in medulloblastomas.</td>
<td style="text-align: left;">MONDO:0007959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857547</td>
<td style="text-align: left;">nevoid basal cell carcinoma syndrome associated medulloblastoma</td>
<td style="text-align: left;">NCIT:C5405</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nevoid Basal Cell Carcinoma Syndrome Associated Medulloblastoma</td>
<td style="text-align: left;">A medulloblastoma developing in patients with multiple basal cell carcinomas.  It is observed in patients with nevoid basal cell carcinoma syndrome and it is associated with PTCH gene inactivation.</td>
<td style="text-align: left;">MONDO:0007959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857548</td>
<td style="text-align: left;">primary central nervous system t-cell non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C5409</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Central Nervous System T-Cell Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A T-cell non-Hodgkin lymphoma that arises from the central nervous system.</td>
<td style="text-align: left;">MONDO:0015760,MONDO:0044887</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857549</td>
<td style="text-align: left;">gastric granular cell tumor</td>
<td style="text-align: left;">NCIT:C54094</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Granular Cell Tumor</td>
<td style="text-align: left;">A benign or malignant granular cell tumor that arises from the stomach.</td>
<td style="text-align: left;">MONDO:0006235,MONDO:0021085</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857550</td>
<td style="text-align: left;">malignant central nervous system germ cell tumor</td>
<td style="text-align: left;">NCIT:C54099</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Central Nervous System Germ Cell Tumor</td>
<td style="text-align: left;">A germ cell tumor that arises from the central nervous system and is characterized by the presence of malignant morphologic characteristics. Representative examples include choriocarcinoma, embryonal carcinoma, and germinoma.</td>
<td style="text-align: left;">MONDO:0003000,MONDO:0002714,MONDO:0003113</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857552</td>
<td style="text-align: left;">breast columnar cell lesion</td>
<td style="text-align: left;">NCIT:C54180</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Columnar Cell Lesion</td>
<td style="text-align: left;">A morphologic spectrum of lesions that arise in the terminal ductal lobular units of the breast parenchyma.  These lesions are characterized by the presence of columnar epithelial cells that line dilated terminal ductal lobular units.  Cytological and architectural atypia may be absent or minimal, or significant enough to raise the possibility of atypical ductal hyperplasia or ductal carcinoma in situ.  Columnar cell lesions are frequently found in breast biopsies but their biologic significance is not known.</td>
<td style="text-align: left;">MONDO:0021100</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857556</td>
<td style="text-align: left;">head and neck keratinizing squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C54283</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Keratinizing Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the head and neck region and is characterized by prominent production of keratin.</td>
<td style="text-align: left;">MONDO:0005056,MONDO:0010150</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857559</td>
<td style="text-align: left;">metastasizing ameloblastoma</td>
<td style="text-align: left;">NCIT:C54297</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastasizing Ameloblastoma</td>
<td style="text-align: left;">A rare, well differentiated, cytologically benign ameloblastoma which paradoxically metastasizes.</td>
<td style="text-align: left;">MONDO:0024883,MONDO:0017795</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857564</td>
<td style="text-align: left;">laryngeal papillary squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C54335</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Laryngeal Papillary Squamous Cell Carcinoma</td>
<td style="text-align: left;">A variant of squamous cell carcinoma that arises from the larynx. It is characterized by exophytic and papillary growth usually in the supraglottic area. The papillae are covered by a malignant stratified squamous epithelium.</td>
<td style="text-align: left;">MONDO:0002979,MONDO:0005595</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857565</td>
<td style="text-align: left;">laryngeal spindle cell squamous carcinoma</td>
<td style="text-align: left;">NCIT:C54336</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Laryngeal Spindle Cell Squamous Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the larynx. It is characterized by the presence of a malignant spindle cell cellular component. In some cases, there is a biphasic morphology due to the presence of a well-differentiated squamous cell carcinoma component. The latter is either in situ or invasive squamous cell carcinoma.</td>
<td style="text-align: left;">MONDO:0005595,MONDO:0021663</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857566</td>
<td style="text-align: left;">laryngeal acantholytic squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C54337</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Laryngeal Acantholytic Squamous Cell Carcinoma</td>
<td style="text-align: left;">A rare variant of squamous cell carcinoma that arises from the larynx. It is characterized by acantholysis of the tumor cells that results in the formation of pseudolumina resembling glandular structures.</td>
<td style="text-align: left;">MONDO:0003487,MONDO:0005595</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857570</td>
<td style="text-align: left;">kadish stage c olfactory neuroblastoma</td>
<td style="text-align: left;">NCIT:C5435</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kadish Stage C Olfactory Neuroblastoma</td>
<td style="text-align: left;">An olfactory neuroblastoma that extends beyond the nasal cavity and paranasal sinuses.</td>
<td style="text-align: left;">MONDO:0006329</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857574</td>
<td style="text-align: left;">meningeal gliomatosis</td>
<td style="text-align: left;">NCIT:C5446</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Meningeal Gliomatosis</td>
<td style="text-align: left;">Diffuse or multifocal infiltration of the meninges by malignant glioma.</td>
<td style="text-align: left;">MONDO:0100342,MONDO:0021322</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857575</td>
<td style="text-align: left;">invasive breast apocrine carcinoma</td>
<td style="text-align: left;">NCIT:C5457</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Breast Apocrine Carcinoma</td>
<td style="text-align: left;">An invasive breast adenocarcinoma with cytological and immunophenotypic characteristics of apocrine differentiation in more than 90 percent of the malignant cells.</td>
<td style="text-align: left;">MONDO:0006256,MONDO:0003934</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857576</td>
<td style="text-align: left;">breast cutaneous nevus</td>
<td style="text-align: left;">NCIT:C54658</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Cutaneous Nevus</td>
<td style="text-align: left;">A nevus that arises from the breast skin.</td>
<td style="text-align: left;">MONDO:0044794,MONDO:0000620</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857577</td>
<td style="text-align: left;">acral nevus</td>
<td style="text-align: left;">NCIT:C54659</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acral Nevus</td>
<td style="text-align: left;">A nevus that arises from the palms, soles, and nails.</td>
<td style="text-align: left;">MONDO:0044794</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857578</td>
<td style="text-align: left;">flexural skin nevus</td>
<td style="text-align: left;">NCIT:C54660</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Flexural Skin Nevus</td>
<td style="text-align: left;">A nevus that arises from the flexural skin.</td>
<td style="text-align: left;">MONDO:0044794</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857580</td>
<td style="text-align: left;">nevoid melanoma</td>
<td style="text-align: left;">NCIT:C54662</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nevoid Melanoma</td>
<td style="text-align: left;">A rare variant of cutaneous melanoma occurring mostly in adults in their fifth decade. Morphologically it resembles an ordinary compound or dermal nevus.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857581</td>
<td style="text-align: left;">signet ring melanoma</td>
<td style="text-align: left;">NCIT:C54663</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Signet Ring Melanoma</td>
<td style="text-align: left;">A rare variant of cutaneous melanoma, characterized by the presence of malignant cells with signet-ring morphology.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857583</td>
<td style="text-align: left;">invasive breast lobular carcinoma, signet ring variant</td>
<td style="text-align: left;">NCIT:C54691</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Breast Lobular Carcinoma, Signet Ring Variant</td>
<td style="text-align: left;">An invasive lobular carcinoma characterized by the presence of malignant epithelial cells with large intracytoplasmic lumina that cause displacement of the nuclei towards one pole of the cells.</td>
<td style="text-align: left;">MONDO:0002671,MONDO:0005051</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857587</td>
<td style="text-align: left;">central nervous system dermoid cyst</td>
<td style="text-align: left;">NCIT:C5508</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Dermoid Cyst</td>
<td style="text-align: left;">A dermoid cyst arising in the central nervous system.</td>
<td style="text-align: left;">MONDO:0003733,MONDO:0002378</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857589</td>
<td style="text-align: left;">appendix mucinous cystadenoma</td>
<td style="text-align: left;">NCIT:C5510</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Mucinous Cystadenoma</td>
<td style="text-align: left;">A cystically dilated epithelial neoplasm arising from the appendix.  It is characterized by the presence of a cystic structure that is filled with mucus.</td>
<td style="text-align: left;">MONDO:0006859,MONDO:0006088</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857592</td>
<td style="text-align: left;">prostate kaposi sarcoma</td>
<td style="text-align: left;">NCIT:C5523</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Kaposi Sarcoma</td>
<td style="text-align: left;">A Kaposi sarcoma arising from the prostate.</td>
<td style="text-align: left;">MONDO:0002854,MONDO:0005055</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857593</td>
<td style="text-align: left;">prostate myeloid sarcoma</td>
<td style="text-align: left;">NCIT:C5527</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Myeloid Sarcoma</td>
<td style="text-align: left;">Myeloid sarcoma that affects the prostate gland.  It may present in association with or as a site of relapse of acute myeloid leukemia.  Cases of myeloid sarcoma of the prostate gland preceding acute myeloid leukemia have also been reported.</td>
<td style="text-align: left;">MONDO:0008315,MONDO:0006861</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857595</td>
<td style="text-align: left;">prostate non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C5534</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A rare non-Hodgkin lymphoma that arises from the prostate gland.</td>
<td style="text-align: left;">MONDO:0018908,MONDO:0000996</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857596</td>
<td style="text-align: left;">ceruminous neoplasm</td>
<td style="text-align: left;">NCIT:C5558</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ceruminous Neoplasm</td>
<td style="text-align: left;">An adenoma or carcinoma that arises from the ceruminous glands in the external auditory canal.</td>
<td style="text-align: left;">MONDO:0003686,MONDO:0021235</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857599</td>
<td style="text-align: left;">stage i skin cancer</td>
<td style="text-align: left;">NCIT:C5581</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage I Skin Cancer</td>
<td style="text-align: left;">Stage I includes: T1, N0, M0.  T1: Tumor 2 cm or less in greatest dimension with less than two high-risk features.  High-risk features for the primary tumor staging are defined as follows: depth/invasion of more than 2 mm thickness, Clark level equal or greater than IV, and perineural invasion.  Anatomic location: primary site ear and primary site non-hair-bearing lip.  Differentiation: poorly differentiated or undifferentiated.  N0: No regional lymph node metastasis.  M0: No clinical or radiographic evidence of distant metastasis.  (AJCC 7th ed.)</td>
<td style="text-align: left;">MONDO:0002656</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857600</td>
<td style="text-align: left;">stage ii skin cancer</td>
<td style="text-align: left;">NCIT:C5582</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage II Skin Cancer</td>
<td style="text-align: left;">Stage II includes: T2, N0, M0.  T2: Tumor size greater than 2 cm in greatest dimension or tumor of any size with two or more high-risk features.  High-risk features for the primary tumor staging are defined as follows: depth/invasion of more than 2 mm thickness; Clark level equal or greater than IV; and perineural invasion.  Anatomic location: primary site ear and primary site non-hair-bearing lip.  Differentiation: poorly differentiated or undifferentiated.  N0: No regional lymph node metastasis.  M0: No clinical or radiographic evidence of distant metastasis.  (AJCC 7th ed.)</td>
<td style="text-align: left;">MONDO:0002656</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857601</td>
<td style="text-align: left;">stage iii skin cancer</td>
<td style="text-align: left;">NCIT:C5583</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage III Skin Cancer</td>
<td style="text-align: left;">Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0).  T3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone.  T1: Tumor 2 cm or less in greatest dimension with less than two high-risk features.  T2: Tumor size greater than 2 cm in greatest dimension or tumor of any size with two or more high-risk features.  N0: No regional lymph node metastasis.  N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension.  M0: No clinical or radiographic evidence of distant metastasis.  (AJCC 7th Ed.)</td>
<td style="text-align: left;">MONDO:0002656</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857602</td>
<td style="text-align: left;">stage iv skin cancer</td>
<td style="text-align: left;">NCIT:C5584</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage IV Skin Cancer</td>
<td style="text-align: left;">Stage IV includes: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T Any, N3, M0); (T4, N Any, M0); (T Any, N Any, M1).  T1: Tumor 2 cm or less in greatest dimension with less than two high-risk features.  T2: Tumor size greater than 2 cm in greatest dimension or tumor of any size with two or more high-risk features.  T3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone.  T4: Tumor with invasion of skeleton or perineural invasion of skull base.  N0: No regional lymph node metastasis.  N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension.  N3: Metastasis in a lymph node, more than 6 cm in greatest dimension.  M1: Distant metastases.  (AJCC 7th Ed.)</td>
<td style="text-align: left;">MONDO:0002656</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857604</td>
<td style="text-align: left;">jugular foramen neoplasm</td>
<td style="text-align: left;">NCIT:C5589</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Jugular Foramen Neoplasm</td>
<td style="text-align: left;">A neoplasm that affects the jugular foramen.  Representative examples include paraganglioma, schwannoma, and meningioma.</td>
<td style="text-align: left;">MONDO:0021351</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857607</td>
<td style="text-align: left;">benign anal granular cell tumor</td>
<td style="text-align: left;">NCIT:C5607</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Anal Granular Cell Tumor</td>
<td style="text-align: left;">A granular cell tumor that arises from the anus and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0021469,MONDO:0003250</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857611</td>
<td style="text-align: left;">metastatic malignant neoplasm in the skin</td>
<td style="text-align: left;">NCIT:C5629</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Skin</td>
<td style="text-align: left;">The spread of a malignant neoplasm to the skin.  This may be from a primary skin malignant neoplasm, or from a malignant neoplasm at a distant site.</td>
<td style="text-align: left;">MONDO:0002898,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857613</td>
<td style="text-align: left;">occult lung carcinoma</td>
<td style="text-align: left;">NCIT:C5641</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Occult Lung Carcinoma</td>
<td style="text-align: left;">A lung carcinoma detectable by sputum cytology or bronchial washings only.  The primary tumor is undetectable radiographically or during bronchoscopy; therefore, it can not be assessed.</td>
<td style="text-align: left;">MONDO:0005138</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857614</td>
<td style="text-align: left;">endobronchial hamartoma</td>
<td style="text-align: left;">NCIT:C5662</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endobronchial Hamartoma</td>
<td style="text-align: left;">A benign neoplasm that arises endobronchially.  It is characterized by the presence of mesenchymal tissues admixed with entrapped respiratory epithelium.  It presents with signs and symptoms of bronchial obstruction.  Bronchoplastic resection is usually curative.  Recurrence is very rare.</td>
<td style="text-align: left;">MONDO:0021540</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857615</td>
<td style="text-align: left;">multiple pulmonary hamartomas</td>
<td style="text-align: left;">NCIT:C5663</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multiple Pulmonary Hamartomas</td>
<td style="text-align: left;">The presence of multiple hamartomas in the lungs.  Hamartomas are usually solitary lesions on chest-x-rays.  Multiple lung hamartomas are rare.</td>
<td style="text-align: left;">MONDO:0021540</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857619</td>
<td style="text-align: left;">colorectal adenoma with severe dysplasia</td>
<td style="text-align: left;">NCIT:C5685</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Adenoma with Severe Dysplasia</td>
<td style="text-align: left;">An adenoma that arises from the colon or rectum.  It is characterized by the presence of severe epithelial dysplasia.</td>
<td style="text-align: left;">MONDO:0005484</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857623</td>
<td style="text-align: left;">esophageal schwannoma</td>
<td style="text-align: left;">NCIT:C5703</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Schwannoma</td>
<td style="text-align: left;">A slowly growing, benign, usually encapsulated neoplasm arising from the esophagus.  Morphologically, it is composed of neoplastic differentiated Schwann cells.</td>
<td style="text-align: left;">MONDO:0021459,MONDO:0004820</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857629</td>
<td style="text-align: left;">extrahepatic bile duct undifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C5780</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrahepatic Bile Duct Undifferentiated Carcinoma</td>
<td style="text-align: left;">A carcinoma without evidence of differentiation arising from the extrahepatic bile ducts.</td>
<td style="text-align: left;">MONDO:0005617,MONDO:0003090</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857635</td>
<td style="text-align: left;">esophageal neuroendocrine neoplasm</td>
<td style="text-align: left;">NCIT:C5821</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Neuroendocrine Neoplasm</td>
<td style="text-align: left;">A neoplasm with neuroendocrine differentiation that arises from the esophagus. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms).</td>
<td style="text-align: left;">MONDO:0021355,MONDO:0024503</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857638</td>
<td style="text-align: left;">extrahepatic bile duct tubular adenoma</td>
<td style="text-align: left;">NCIT:C5850</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrahepatic Bile Duct Tubular Adenoma</td>
<td style="text-align: left;">An adenoma that arises from the extrahepatic bile ducts.  It is characterized by the presence of a tubular pattern.</td>
<td style="text-align: left;">MONDO:0003445,MONDO:0024660</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857646</td>
<td style="text-align: left;">oral cavity granular cell tumor</td>
<td style="text-align: left;">NCIT:C5912</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oral Cavity Granular Cell Tumor</td>
<td style="text-align: left;">A rare neoplasm that arises from the oral cavity, usually the tongue.  It is characterized by the presence of plump eosinophilic cells with abundant granular cytoplasm.  The neoplastic cells extend into the surrounding tissues, usually skeletal muscle.  The vast majority of cases follow a benign clinical course.  Recurrences are rare after removal of the tumor.</td>
<td style="text-align: left;">MONDO:0006235,MONDO:0021245</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857660</td>
<td style="text-align: left;">minor salivary gland mucoepidermoid carcinoma</td>
<td style="text-align: left;">NCIT:C5953</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Minor Salivary Gland Mucoepidermoid Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the minor salivary glands.  It usually presents as a firm and painless mass.  It is characterized by the presence of epidermoid cells, mucus producing cells, and cells of intermediate type.  The majority of cases have a favorable outcome.</td>
<td style="text-align: left;">MONDO:0021009,MONDO:0045069</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857661</td>
<td style="text-align: left;">minor salivary gland small cell neuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C5956</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Minor Salivary Gland Small Cell Neuroendocrine Carcinoma</td>
<td style="text-align: left;">A rare neuroendocrine carcinoma that arises from the minor salivary glands and is composed of malignant small cells. The mitotic count is more than 10 per 2 mm2 and/or the Ki-67 index is more than 20%.</td>
<td style="text-align: left;">MONDO:0006405,MONDO:0045069</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857663</td>
<td style="text-align: left;">minor salivary gland squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C5959</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Minor Salivary Gland Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that affects the minor salivary glands.</td>
<td style="text-align: left;">MONDO:0045069,MONDO:0044740</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857671</td>
<td style="text-align: left;">oropharyngeal polyp</td>
<td style="text-align: left;">NCIT:C5988</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oropharyngeal Polyp</td>
<td style="text-align: left;">A benign exophytic growth that arises from the oropharynx.</td>
<td style="text-align: left;">MONDO:0005079,MONDO:0021479</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857682</td>
<td style="text-align: left;">nasopharyngeal polyp</td>
<td style="text-align: left;">NCIT:C6034</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nasopharyngeal Polyp</td>
<td style="text-align: left;">A benign exophytic growth that arises from the nasopharynx.</td>
<td style="text-align: left;">MONDO:0005079,MONDO:0021478</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857685</td>
<td style="text-align: left;">nasopharyngeal squamous papilloma</td>
<td style="text-align: left;">NCIT:C6037</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nasopharyngeal Squamous Papilloma</td>
<td style="text-align: left;">A benign exophytic neoplasm that arises from the nasopharynx.  It is characterized by the presence of a connective tissue core covered by stratified squamous epithelium.</td>
<td style="text-align: left;">MONDO:0021478,MONDO:0001825</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857686</td>
<td style="text-align: left;">oropharyngeal squamous papilloma</td>
<td style="text-align: left;">NCIT:C6038</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oropharyngeal Squamous Papilloma</td>
<td style="text-align: left;">A benign exophytic neoplasm that arises from the oropharynx.  It is characterized by the presence of a connective tissue core covered by stratified squamous epithelium.</td>
<td style="text-align: left;">MONDO:0001825,MONDO:0021479</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857687</td>
<td style="text-align: left;">stage 0 oropharyngeal squamous cell carcinoma ajcc v6 and v7</td>
<td style="text-align: left;">NCIT:C6039</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7</td>
<td style="text-align: left;">Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0044704,MONDO:0021298</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857689</td>
<td style="text-align: left;">stage 0 hypopharyngeal squamous cell carcinoma ajcc v6, v7, and v8</td>
<td style="text-align: left;">NCIT:C6048</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8</td>
<td style="text-align: left;">Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.)</td>
<td style="text-align: left;">MONDO:0021288,MONDO:0044638</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857690</td>
<td style="text-align: left;">stage 0 oral cavity squamous cell carcinoma ajcc v6 and v7</td>
<td style="text-align: left;">NCIT:C6052</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7</td>
<td style="text-align: left;">Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0004958,MONDO:0000371,MONDO:0004693</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857692</td>
<td style="text-align: left;">anterior tongue neoplasm</td>
<td style="text-align: left;">NCIT:C6062</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anterior Tongue Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the anterior portion of the tongue.</td>
<td style="text-align: left;">MONDO:0021240</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857697</td>
<td style="text-align: left;">neck carcinoma</td>
<td style="text-align: left;">NCIT:C6077</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neck Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the anatomic structures of the neck region.</td>
<td style="text-align: left;">MONDO:0021310,MONDO:0002038</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857698</td>
<td style="text-align: left;">external ear actinic keratosis</td>
<td style="text-align: left;">NCIT:C6080</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">External Ear Actinic Keratosis</td>
<td style="text-align: left;">Actinic keratosis that develops in the skin of the external ear.</td>
<td style="text-align: left;">MONDO:0021235,MONDO:0005173</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857700</td>
<td style="text-align: left;">middle ear paraganglioma</td>
<td style="text-align: left;">NCIT:C6085</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Middle Ear Paraganglioma</td>
<td style="text-align: left;">A jugulotympanic paraganglioma arising from paraganglia in the middle ear.</td>
<td style="text-align: left;">MONDO:0021366,MONDO:0021064</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857702</td>
<td style="text-align: left;">benign uveal neoplasm</td>
<td style="text-align: left;">NCIT:C6104</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Uveal Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the uvea and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0021225,MONDO:0021454</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857703</td>
<td style="text-align: left;">stage 0 laryngeal squamous cell carcinoma ajcc v6, v7, and v8</td>
<td style="text-align: left;">NCIT:C6121</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8</td>
<td style="text-align: left;">Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.)</td>
<td style="text-align: left;">MONDO:0004693,MONDO:0005595,MONDO:0004696</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857715</td>
<td style="text-align: left;">testicular typical seminoma</td>
<td style="text-align: left;">NCIT:C61383</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Typical Seminoma</td>
<td style="text-align: left;">A testicular seminoma characterized by the presence of uniform round germ cells with glycogen-rich cytoplasm and large nuclei, and a lymphocytic infiltrate.</td>
<td style="text-align: left;">MONDO:0003669</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857719</td>
<td style="text-align: left;">ureter undifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C6159</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ureter Undifferentiated Carcinoma</td>
<td style="text-align: left;">Undifferentiated carcinoma that affects the ureter.</td>
<td style="text-align: left;">MONDO:0006481,MONDO:0005617</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857720</td>
<td style="text-align: left;">urethral undifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C6168</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Urethral Undifferentiated Carcinoma</td>
<td style="text-align: left;">An undifferentiated carcinoma arising from the urethra.</td>
<td style="text-align: left;">MONDO:0021327,MONDO:0005617</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857725</td>
<td style="text-align: left;">hard palate mucoepidermoid carcinoma</td>
<td style="text-align: left;">NCIT:C6214</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hard Palate Mucoepidermoid Carcinoma</td>
<td style="text-align: left;">A mucoepidermoid carcinoma arising from the minor salivary glands in the hard palate.</td>
<td style="text-align: left;">MONDO:0044964,MONDO:0021339</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857728</td>
<td style="text-align: left;">salivary gland clear cell carcinoma</td>
<td style="text-align: left;">NCIT:C62191</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Salivary Gland Clear Cell Carcinoma</td>
<td style="text-align: left;">A rare, low-grade carcinoma that arises from the salivary glands, most often the minor salivary glands. It is characterized by the presence of a monomorphic population of malignant epithelial cells with clear cytoplasm and the absence of morphologic features that define other primary neoplasms of the salivary glands. It usually has an indolent clinical course.</td>
<td style="text-align: left;">MONDO:0000521</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857730</td>
<td style="text-align: left;">conjunctival squamous papilloma</td>
<td style="text-align: left;">NCIT:C6224</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Squamous Papilloma</td>
<td style="text-align: left;">A papilloma that arises from the conjunctival squamous epithelium. It is usually associated with human papillomavirus infection.</td>
<td style="text-align: left;">MONDO:0001825,MONDO:0006105</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857731</td>
<td style="text-align: left;">skin nodular basal cell carcinoma</td>
<td style="text-align: left;">NCIT:C62282</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Nodular Basal Cell Carcinoma</td>
<td style="text-align: left;">A basal cell carcinoma of the skin that often appears as elevated nodules which may become ulcerated.</td>
<td style="text-align: left;">MONDO:0005341</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857732</td>
<td style="text-align: left;">superficial basal cell carcinoma</td>
<td style="text-align: left;">NCIT:C62284</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Superficial Basal Cell Carcinoma</td>
<td style="text-align: left;">A variant of basal cell carcinoma of the skin presenting as erythematous, often multiple patches.  Morphologically, it is characterized by the presence of superficial lobules of basaloid cells projecting into the dermis.  The basaloid cell lobules are surrounded by myxoid stroma and are usually confined to the papillary dermis.</td>
<td style="text-align: left;">MONDO:0005341</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857734</td>
<td style="text-align: left;">minor salivary gland acinic cell carcinoma</td>
<td style="text-align: left;">NCIT:C6243</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Minor Salivary Gland Acinic Cell Carcinoma</td>
<td style="text-align: left;">An adenocarcinoma with serous acinar cell differentiation that arises from the minor salivary glands.</td>
<td style="text-align: left;">MONDO:0006304,MONDO:0006400</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857736</td>
<td style="text-align: left;">ovarian endometrioid tumor</td>
<td style="text-align: left;">NCIT:C6257</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Endometrioid Tumor</td>
<td style="text-align: left;">A benign, borderline, or malignant epithelial tumor of the ovary characterized by the presence of glands and/or cysts lined by neoplastic cells that resemble endometrial cells.</td>
<td style="text-align: left;">MONDO:0002480,MONDO:0002229</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857738</td>
<td style="text-align: left;">childhood cerebral ependymoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C6268</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Cerebral Ependymoma, Not Otherwise Specified</td>
<td style="text-align: left;">An ependymoma, not otherwise specified that arises from the cerebral hemispheres and occurs during childhood.</td>
<td style="text-align: left;">MONDO:0004249</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857740</td>
<td style="text-align: left;">vaginal verrucous carcinoma</td>
<td style="text-align: left;">NCIT:C6325</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Verrucous Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the vagina and is characterized by a papillary growth pattern, acanthotic epithelium with minimal or absent atypia, and pushing borders.</td>
<td style="text-align: left;">MONDO:0006490,MONDO:0006006</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857743</td>
<td style="text-align: left;">benign uterine corpus mixed epithelial and mesenchymal neoplasm</td>
<td style="text-align: left;">NCIT:C6335</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm</td>
<td style="text-align: left;">A non-metastasizing neoplasm that arises from the uterine corpus and is composed of epithelial and mesenchymal elements. Representative examples include adenomyoma and adenofibroma.</td>
<td style="text-align: left;">MONDO:0021525,MONDO:0016255</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857745</td>
<td style="text-align: left;">testicular mixed embryonal carcinoma and seminoma</td>
<td style="text-align: left;">NCIT:C6350</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Mixed Embryonal Carcinoma and Seminoma</td>
<td style="text-align: left;">A malignant mixed germ cell tumor arising from the testis.  It is characterized by the presence of a mixture of embryonal carcinoma and a seminomatous component.</td>
<td style="text-align: left;">MONDO:0003120</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857746</td>
<td style="text-align: left;">testicular mixed embryonal carcinoma and teratoma</td>
<td style="text-align: left;">NCIT:C6351</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Mixed Embryonal Carcinoma and Teratoma</td>
<td style="text-align: left;">A malignant mixed germ cell tumor arising from the testis, characterized by the presence of an embryonal carcinomatous component and a teratomatous component.</td>
<td style="text-align: left;">MONDO:0003403,MONDO:0002599,MONDO:0003120</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857747</td>
<td style="text-align: left;">testicular mixed embryonal carcinoma and teratoma with seminoma</td>
<td style="text-align: left;">NCIT:C6352</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma</td>
<td style="text-align: left;">A malignant mixed germ cell tumor arising from the testis.  It is characterized by the presence of a mixture of embryonal carcinoma, a teratomatous component, and a seminomatous component.</td>
<td style="text-align: left;">MONDO:0003120</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857748</td>
<td style="text-align: left;">kidney non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C63532</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A non-Hodgkin lymphoma that arises from the kidney with no evidence of involvement of other sites at the time of diagnosis.</td>
<td style="text-align: left;">MONDO:0018908,MONDO:0002367</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857750</td>
<td style="text-align: left;">testicular mature teratoma</td>
<td style="text-align: left;">NCIT:C6355</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Mature Teratoma</td>
<td style="text-align: left;">A teratoma that arises from the testis and is composed of well differentiated, adult-type tissues.</td>
<td style="text-align: left;">MONDO:0018193,MONDO:0021447,MONDO:0003517</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857752</td>
<td style="text-align: left;">undifferentiated carcinoma with osteoclast-like giant cells</td>
<td style="text-align: left;">NCIT:C63622</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Undifferentiated Carcinoma with Osteoclast-Like Giant Cells</td>
<td style="text-align: left;">A usually aggressive carcinoma composed of malignant cells that do not display evidence of glandular or squamous differentiation, and giant cells resembling osteoclasts.</td>
<td style="text-align: left;">MONDO:0005617</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857753</td>
<td style="text-align: left;">penile kaposi sarcoma</td>
<td style="text-align: left;">NCIT:C6377</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Kaposi Sarcoma</td>
<td style="text-align: left;">A Kaposi sarcoma arising from the penis.</td>
<td style="text-align: left;">MONDO:0022293,MONDO:0005055,MONDO:0001387</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857758</td>
<td style="text-align: left;">orbital paraganglioma</td>
<td style="text-align: left;">NCIT:C6408</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Orbital Paraganglioma</td>
<td style="text-align: left;">An extra-adrenal paraganglioma arising from the orbit. Patients may present with visual disturbances or proptosis.</td>
<td style="text-align: left;">MONDO:0006239,MONDO:0024611</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857759</td>
<td style="text-align: left;">laryngeal paraganglioma</td>
<td style="text-align: left;">NCIT:C6409</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Laryngeal Paraganglioma</td>
<td style="text-align: left;">An extra-adrenal parasympathetic paraganglioma arising from paraganglia adjacent to the larynx.  Patients may present with hoarseness and dysphagia.</td>
<td style="text-align: left;">MONDO:0006239,MONDO:0015070,MONDO:0021052</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857760</td>
<td style="text-align: left;">intrathoracic paravertebral paraganglioma</td>
<td style="text-align: left;">NCIT:C6411</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intrathoracic Paravertebral Paraganglioma</td>
<td style="text-align: left;">An intrathoracic sympathetic paraganglioma arising from paravertebral paraganglia.  In functional tumors, the hypersecretion of catecholamines results in hypertension.</td>
<td style="text-align: left;">MONDO:0000550,MONDO:0021350</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857763</td>
<td style="text-align: left;">foregut neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C6421</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Foregut Neuroendocrine Tumor</td>
<td style="text-align: left;">A neuroendocrine tumor that arises from the esophagus, stomach, or duodenum.</td>
<td style="text-align: left;">MONDO:0000386</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857765</td>
<td style="text-align: left;">hindgut neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C6423</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hindgut Neuroendocrine Tumor</td>
<td style="text-align: left;">A neuroendocrine tumor that arises from the sigmoid colon, descending colon, or rectum.</td>
<td style="text-align: left;">MONDO:0000386</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857767</td>
<td style="text-align: left;">malignant mediastinal nongerminomatous germ cell tumor</td>
<td style="text-align: left;">NCIT:C6439</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Mediastinal Nongerminomatous Germ Cell Tumor</td>
<td style="text-align: left;">An extragonadal nongerminomatous malignant germ cell tumor that arises from the mediastinum.  This category includes embryonal carcinoma, yolk sac tumor, choriocarcinoma, and mixed germ cell tumors.</td>
<td style="text-align: left;">MONDO:0003578,MONDO:0006298</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857768</td>
<td style="text-align: left;">gastric germ cell tumor</td>
<td style="text-align: left;">NCIT:C6448</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Germ Cell Tumor</td>
<td style="text-align: left;">A benign or malignant germ cell tumor that arises from the stomach.  Representative examples include teratoma and choriocarcinoma.</td>
<td style="text-align: left;">MONDO:0018201,MONDO:0021085</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857770</td>
<td style="text-align: left;">invasive thymoma</td>
<td style="text-align: left;">NCIT:C6453</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Thymoma</td>
<td style="text-align: left;">A thymoma of any morphologic type that extends beyond the capsule and infiltrates the surrounding tissues.</td>
<td style="text-align: left;">MONDO:0006456</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857771</td>
<td style="text-align: left;">bone hemangioma</td>
<td style="text-align: left;">NCIT:C6477</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Hemangioma</td>
<td style="text-align: left;">A hemangioma arising in the bone.</td>
<td style="text-align: left;">MONDO:0000631,MONDO:0006500,MONDO:0024499</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857772</td>
<td style="text-align: left;">bone glomus tumor</td>
<td style="text-align: left;">NCIT:C6480</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Glomus Tumor</td>
<td style="text-align: left;">A benign or malignant glomus tumor arising from the bone.</td>
<td style="text-align: left;">MONDO:0019060,MONDO:0018327</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857773</td>
<td style="text-align: left;">extraabdominal fibromatosis</td>
<td style="text-align: left;">NCIT:C6489</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extraabdominal Fibromatosis</td>
<td style="text-align: left;">An insidious poorly circumscribed neoplasm arising from the soft tissues outside the abdomen. It is characterized by the presence of elongated spindle-shaped fibroblasts, vascular collagenous stroma formation, and an infiltrative growth pattern.</td>
<td style="text-align: left;">MONDO:0007608</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857774</td>
<td style="text-align: left;">deep lipoma</td>
<td style="text-align: left;">NCIT:C6498</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Deep Lipoma</td>
<td style="text-align: left;">A benign well-circumscribed tumor, composed of mature adipocytes, that arises within deep soft tissues.</td>
<td style="text-align: left;">MONDO:0005106</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857776</td>
<td style="text-align: left;">non-small cell carcinoma</td>
<td style="text-align: left;">NCIT:C65151</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Small Cell Carcinoma</td>
<td style="text-align: left;">A malignant epithelial neoplasm characterized by the absence of neoplastic small epithelial cells. A representative example is the lung non-small cell carcinoma.</td>
<td style="text-align: left;">MONDO:0004993</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857777</td>
<td style="text-align: left;">malignant neoplasm, uncertain whether primary or metastatic</td>
<td style="text-align: left;">NCIT:C65153</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Neoplasm, Uncertain Whether Primary or Metastatic</td>
<td style="text-align: left;">A malignant neoplasm in which the examined tissue can not be determined with certainty if it represents the primary site of tumor growth or tumor spread from another anatomic site.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857778</td>
<td style="text-align: left;">papillary carcinoma in situ</td>
<td style="text-align: left;">NCIT:C65163</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Papillary Carcinoma In Situ</td>
<td style="text-align: left;">An epithelial neoplasm with a papillary growth pattern in which the malignant cells are confined to the epithelium, without evidence of invasion.</td>
<td style="text-align: left;">MONDO:0004647,MONDO:0006509</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857779</td>
<td style="text-align: left;">non-invasive papillary squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C65164</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Invasive Papillary Squamous Cell Carcinoma</td>
<td style="text-align: left;">A well differentiated squamous cell carcinoma characterized by a papillary, exophytic growth pattern, hyperkeratosis, and absence of invasion of adjacent tissues.</td>
<td style="text-align: left;">MONDO:0002979</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857780</td>
<td style="text-align: left;">inverted squamous papilloma</td>
<td style="text-align: left;">NCIT:C65165</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Inverted Squamous Papilloma</td>
<td style="text-align: left;">A benign epithelial neoplasm characterized by an endophytic growth, papillary pattern, and proliferation of neoplastic squamous cells without morphologic evidence of malignancy.</td>
<td style="text-align: left;">MONDO:0002537,MONDO:0001825</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857783</td>
<td style="text-align: left;">squamous cell carcinoma in situ with questionable stromal invasion</td>
<td style="text-align: left;">NCIT:C65176</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Squamous Cell Carcinoma In Situ with Questionable Stromal Invasion</td>
<td style="text-align: left;">A malignant epithelial neoplasm involving all the layers of the squamous epithelium, but it is not certain if it is confined to the squamous epithelium or it has invaded the basement membrane and the underlying stroma.</td>
<td style="text-align: left;">MONDO:0005096</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857785</td>
<td style="text-align: left;">squamous cell carcinoma with horn formation</td>
<td style="text-align: left;">NCIT:C65179</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Squamous Cell Carcinoma with Horn Formation</td>
<td style="text-align: left;">A keratinizing squamous cell carcinoma characterized by the presence of horn pearls. Representative examples include squamous cell carcinomas of the face presenting as a cutaneous horn.</td>
<td style="text-align: left;">MONDO:0005056</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857786</td>
<td style="text-align: left;">squamous cell carcinoma, clear cell type</td>
<td style="text-align: left;">NCIT:C65180</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Squamous Cell Carcinoma, Clear Cell Type</td>
<td style="text-align: left;">A squamous cell carcinoma characterized by the presence of malignant cells with clear cytoplasm.</td>
<td style="text-align: left;">MONDO:0005096</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857789</td>
<td style="text-align: left;">malignant pancreatic insulinoma</td>
<td style="text-align: left;">NCIT:C65186</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Pancreatic Insulinoma</td>
<td style="text-align: left;">An insulin-producing neuroendocrine tumor arising from the beta cells of the pancreas.  Patients exhibit symptoms related to hypoglycemia due to inappropriate secretion of insulin. It displays vascular invasion and metastasizes to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0024677</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857790</td>
<td style="text-align: left;">malignant pancreatic glucagonoma</td>
<td style="text-align: left;">NCIT:C65187</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Pancreatic Glucagonoma</td>
<td style="text-align: left;">A glucagon-producing neuroendocrine tumor arising from the alpha cells of the pancreas.  It may be associated with necrolytic erythema migrans, diarrhea, diabetes, glossitis, weight loss, malabsorption, and anemia.  It displays vascular invasion and metastasizes to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0019959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857791</td>
<td style="text-align: left;">malignant gastrinoma</td>
<td style="text-align: left;">NCIT:C65188</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Gastrinoma</td>
<td style="text-align: left;">A gastrin-producing neuroendocrine tumor.  It is characterized by inappropriate secretion of gastrin and associated with Zollinger Ellison syndrome.  It displays vascular invasion and metastasizes to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0003523</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857792</td>
<td style="text-align: left;">malignant vipoma</td>
<td style="text-align: left;">NCIT:C65189</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Vipoma</td>
<td style="text-align: left;">An aggressive neuroendocrine tumor located in the pancreas or small intestine. It is composed of cells containing vasoactive intestinal peptide.  It is associated with watery diarrhea, hypokalemia, and hypochlorhydria or achlorhydria. It displays vascular invasion and metastasizes to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0019960</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857793</td>
<td style="text-align: left;">malignant somatostatinoma</td>
<td style="text-align: left;">NCIT:C65190</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Somatostatinoma</td>
<td style="text-align: left;">A neuroendocrine tumor arising from delta cells which produce somatostatin. It displays vascular invasion and metastasizes to other anatomic sites.</td>
<td style="text-align: left;">MONDO:0006976</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857794</td>
<td style="text-align: left;">flat adenoma</td>
<td style="text-align: left;">NCIT:C65193</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Flat Adenoma</td>
<td style="text-align: left;">An adenoma of the gastrointestinal tract mucosa which grossly and morphologically does not appear as an elevated or polypoid lesion.</td>
<td style="text-align: left;">MONDO:0006180</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857795</td>
<td style="text-align: left;">glandular papillomatosis</td>
<td style="text-align: left;">NCIT:C65198</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Glandular Papillomatosis</td>
<td style="text-align: left;">Multifocal neoplastic proliferations of the glandular epithelium displaying a papillary pattern.</td>
<td style="text-align: left;">MONDO:0021098</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857796</td>
<td style="text-align: left;">thyroid gland follicular carcinoma, minimally invasive</td>
<td style="text-align: left;">NCIT:C65200</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Follicular Carcinoma, Minimally Invasive</td>
<td style="text-align: left;">A follicular carcinoma of the thyroid gland showing capsular invasion only.</td>
<td style="text-align: left;">MONDO:0040677,MONDO:0005034</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857797</td>
<td style="text-align: left;">papillary mucinous cystadenocarcinoma</td>
<td style="text-align: left;">NCIT:C65204</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Papillary Mucinous Cystadenocarcinoma</td>
<td style="text-align: left;">An invasive adenocarcinoma characterized by cystic changes, papillary growth pattern, and the presence of malignant glandular cells which contain intracytoplasmic mucin.</td>
<td style="text-align: left;">MONDO:0005074,MONDO:0005858</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857798</td>
<td style="text-align: left;">malignant testicular sertoli cell tumor</td>
<td style="text-align: left;">NCIT:C6523</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Testicular Sertoli Cell Tumor</td>
<td style="text-align: left;">A Sertoli cell tumor that arises from the testis and is characterized by nuclear pleomorphism, increased mitotic activity and necrotic changes.  Metastases may be present at diagnosis.</td>
<td style="text-align: left;">MONDO:0020808,MONDO:0000378</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857799</td>
<td style="text-align: left;">malignant pericytic neoplasm</td>
<td style="text-align: left;">NCIT:C6530</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Pericytic Neoplasm</td>
<td style="text-align: left;">A malignant mesenchymal neoplasm arising from the perivascular cells of the connective and soft tissues.  It is characterized by the presence of pericytes that grow in a circumferential pattern around vessels, and cytologic atypia.</td>
<td style="text-align: left;">MONDO:0002604,MONDO:0024637</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857802</td>
<td style="text-align: left;">ancient schwannoma</td>
<td style="text-align: left;">NCIT:C6556</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ancient Schwannoma</td>
<td style="text-align: left;">A schwannoma that is characterized by degenerative changes such as hyalinization, hemorrhage, calcification and cystic change.</td>
<td style="text-align: left;">MONDO:0002546</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857803</td>
<td style="text-align: left;">extraskeletal cartilaginous and osseous neoplasm</td>
<td style="text-align: left;">NCIT:C6570</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extraskeletal Cartilaginous and Osseous Neoplasm</td>
<td style="text-align: left;">A benign or malignant mesenchymal neoplasm with cartilaginous or osseous differentiation arising from the soft tissues exclusively.  Representative examples include chondroma, osteoma, and osteosarcoma.</td>
<td style="text-align: left;">MONDO:0006424</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857804</td>
<td style="text-align: left;">intramuscular myxoma</td>
<td style="text-align: left;">NCIT:C6579</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intramuscular Myxoma</td>
<td style="text-align: left;">A benign, painless soft tissue tumor that arises in a muscle, usually in a large muscle of the thigh, buttocks, shoulder, or upper arm.  It is associated with point mutations of the GNAS gene.  Grossly it is characterized by a gelatinous and lobulated cut surface.  Morphologically it is composed of uniform spindled and stellate-shaped cells without atypia.  The cells are separated by myxoid stroma.  No recurrences have been reported.</td>
<td style="text-align: left;">MONDO:0044784</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857805</td>
<td style="text-align: left;">juxta-articular myxoma</td>
<td style="text-align: left;">NCIT:C6580</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Juxta-Articular Myxoma</td>
<td style="text-align: left;">A rare myxoma that usually arises in an area close to a large joint.  Morphologically it resembles a cellular myxoma.  In contrast to an intramuscular myxoma, it is not associated with mutations of the GNAS gene.</td>
<td style="text-align: left;">MONDO:0044784</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857806</td>
<td style="text-align: left;">peripheral neuroblastoma</td>
<td style="text-align: left;">NCIT:C6591</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Peripheral Neuroblastoma</td>
<td style="text-align: left;">A neuroblastoma arising from the peripheral nervous system.</td>
<td style="text-align: left;">MONDO:0005072,MONDO:0021089</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857807</td>
<td style="text-align: left;">benign mediastinal soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C6593</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Mediastinal Soft Tissue Neoplasm</td>
<td style="text-align: left;">A mesenchymal neoplasm that arises from the mediastinum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include lipoma, leiomyoma, and rhabdomyoma.</td>
<td style="text-align: left;">MONDO:0021521,MONDO:0003512,MONDO:0044335</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857810</td>
<td style="text-align: left;">soft tissue fibrosarcoma</td>
<td style="text-align: left;">NCIT:C6605</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Soft Tissue Fibrosarcoma</td>
<td style="text-align: left;">A usually aggressive malignant neoplasm arising from the soft tissue.  It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern.</td>
<td style="text-align: left;">MONDO:0018078,MONDO:0005164</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857811</td>
<td style="text-align: left;">mediastinal malignant peripheral nerve sheath tumor</td>
<td style="text-align: left;">NCIT:C6626</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Malignant Peripheral Nerve Sheath Tumor</td>
<td style="text-align: left;">A malignant peripheral nerve sheath tumor that arises from the mediastinum.  It may be associated with neurofibromatosis.  It often spreads to the lungs or pleura.</td>
<td style="text-align: left;">MONDO:0003098,MONDO:0002852,MONDO:0017827</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857812</td>
<td style="text-align: left;">mediastinal ganglioneuroma</td>
<td style="text-align: left;">NCIT:C6632</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Ganglioneuroma</td>
<td style="text-align: left;">A ganglioneuroma arising from the mediastinum.</td>
<td style="text-align: left;">MONDO:0021521,MONDO:0003098,MONDO:0005033</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857813</td>
<td style="text-align: left;">mediastinal hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C6634</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Hodgkin Lymphoma</td>
<td style="text-align: left;">A Hodgkin lymphoma that arises from the mediastinum.  It usually involves mediastinal lymph nodes and/or the thymus.  Signs and symptoms include fever, weight loss, fatigue, and night sweats.</td>
<td style="text-align: left;">MONDO:0004021,MONDO:0004952</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857814</td>
<td style="text-align: left;">stage 1 neuroblastoma</td>
<td style="text-align: left;">NCIT:C6638</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage 1 Neuroblastoma</td>
<td style="text-align: left;">Localized tumor with complete gross excision, with or without microscopic residual disease; representative ipsilateral lymph nodes negative for tumor microscopically. (cancer.gov)</td>
<td style="text-align: left;">MONDO:0005072</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857815</td>
<td style="text-align: left;">stage 2 neuroblastoma</td>
<td style="text-align: left;">NCIT:C6639</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage 2 Neuroblastoma</td>
<td style="text-align: left;">Stage 2 includes stage 2A and stage 2B.  Stage 2A: Localized tumor with incomplete gross excision; representative ipsilateral nonadherent lymph nodes negative for tumor microscopically. Stage 2B: Localized tumor with or without complete gross excision, with ipsilateral nonadherent lymph nodes positive for tumor. Enlarged contralateral lymph nodes must be negative microscopically. (cancer.gov)</td>
<td style="text-align: left;">MONDO:0005072</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857816</td>
<td style="text-align: left;">stage 3 neuroblastoma</td>
<td style="text-align: left;">NCIT:C6640</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage 3 Neuroblastoma</td>
<td style="text-align: left;">Unresectable unilateral tumor infiltrating across the midline, with or without regional lymph node involvement; or localized unilateral tumor with contralateral regional lymph node involvement; or midline tumor with bilateral extension by infiltration (unresectable) or by lymph node involvement. The midline is defined as the vertebral column. Tumors originating on one side and crossing the midline must infiltrate to or beyond the opposite side of the vertebral column. (cancer.gov)</td>
<td style="text-align: left;">MONDO:0005072</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857817</td>
<td style="text-align: left;">stage 4 neuroblastoma</td>
<td style="text-align: left;">NCIT:C6641</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage 4 Neuroblastoma</td>
<td style="text-align: left;">Any primary tumor with dissemination to distant lymph nodes, bone, bone marrow, liver, skin, and/or other organs, except as defined for stage 4S. (cancer.gov)</td>
<td style="text-align: left;">MONDO:0005072</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857821</td>
<td style="text-align: left;">breast atypical medullary carcinoma</td>
<td style="text-align: left;">NCIT:C66719</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Atypical Medullary Carcinoma</td>
<td style="text-align: left;">An invasive ductal breast carcinoma characterized by the presence of a predominantly syncytial architectural pattern. It may have some, but not all the strictly defined additional morphologic criteria which are necessary for the diagnosis of medullary breast carcinoma (presence of a diffuse lymphoplasmacytic infiltrate, neoplastic round cells with abundant cytoplasm and vesicular nuclei, complete histological circumscription, and absence of glandular or tubular structures). It does not have the relatively favorable outcome that characterizes medullary breast carcinoma.</td>
<td style="text-align: left;">MONDO:0004953</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857822</td>
<td style="text-align: left;">adenocarcinoma with neuroendocrine differentiation</td>
<td style="text-align: left;">NCIT:C66745</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adenocarcinoma with Neuroendocrine Differentiation</td>
<td style="text-align: left;">An invasive adenocarcinoma characterized by the presence of focal or extensive neuroendocrine differentiation.</td>
<td style="text-align: left;">MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857823</td>
<td style="text-align: left;">testicular sex cord-stromal tumor, not otherwise specified</td>
<td style="text-align: left;">NCIT:C66748</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Sex Cord-Stromal Tumor, Not Otherwise Specified</td>
<td style="text-align: left;">A sex cord-stromal tumor of the testis in which the neoplastic cells do not show specific differentiation.</td>
<td style="text-align: left;">MONDO:0003125</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857824</td>
<td style="text-align: left;">ovarian stromal tumor with minor sex cord elements</td>
<td style="text-align: left;">NCIT:C66749</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Stromal Tumor with Minor Sex Cord Elements</td>
<td style="text-align: left;">A rare, benign sex cord-stromal tumor of the ovary characterized by the presence of a fibrothecomatous stroma and scattered sex cord elements. Although it is usually hormonally inactive, cases associated with endometrial hyperplasia or adenocarcinoma have been reported.</td>
<td style="text-align: left;">MONDO:0021657</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857825</td>
<td style="text-align: left;">adult granulosa cell tumor</td>
<td style="text-align: left;">NCIT:C66750</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Granulosa Cell Tumor</td>
<td style="text-align: left;">A low-grade malignant sex cord-stromal tumor occurring in the ovary and rarely in the testis. It is composed of granulosa cells in an often fibrothecomatous stroma. The neoplastic cells may form various patterns including the microfollicular, which is characterized by the presence of Call-Exner bodies, macrofollicular, insular, trabecular, and diffuse pattern. In females, it affects middle aged to post-menopausal women. Signs and symptoms include abdominal mass, hemoperitoneum, and ascites. Estrogenic and rarely androgenic manifestations may be present. The vast majority of cases present as stage I tumors; however, all tumors have a potential for aggressive clinical course. In males, it is reported in the age range of 16-76 years and the average age at presentation is 44 years. A minority of patients have gynecomastia. Metastases have been reported in a minority of patients.</td>
<td style="text-align: left;">MONDO:0006036</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857826</td>
<td style="text-align: left;">melanoma in precancerous melanosis</td>
<td style="text-align: left;">NCIT:C66753</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Melanoma in Precancerous Melanosis</td>
<td style="text-align: left;">A melanoma arising from an atypical intraepithelial melanocytic hyperplasia.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857827</td>
<td style="text-align: left;">small cutaneous congenital nevus</td>
<td style="text-align: left;">NCIT:C66754</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Cutaneous Congenital Nevus</td>
<td style="text-align: left;">A cutaneous congenital nevus of small size, with a diameter smaller than 15 mm. It presents as a macular, papular, or plaque-like lesion.</td>
<td style="text-align: left;">MONDO:0044792</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857828</td>
<td style="text-align: left;">proliferative nodules in cutaneous congenital nevus</td>
<td style="text-align: left;">NCIT:C66755</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Proliferative Nodules in Cutaneous Congenital Nevus</td>
<td style="text-align: left;">A benign cutaneous proliferation of epithelioid or spindled melanocytes usually in the upper or mid dermis in a background of congenital nevus. It presents as a dark plaque or nodule above a giant congenital nevus.</td>
<td style="text-align: left;">MONDO:0044792</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857829</td>
<td style="text-align: left;">periosteal fibroma</td>
<td style="text-align: left;">NCIT:C66761</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Periosteal Fibroma</td>
<td style="text-align: left;">A benign fibrous neoplasm arising from the periosteal connective tissue that surrounds a bone.</td>
<td style="text-align: left;">MONDO:0000631,MONDO:0005167</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857830</td>
<td style="text-align: left;">fascial fibroma</td>
<td style="text-align: left;">NCIT:C66764</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fascial Fibroma</td>
<td style="text-align: left;">A benign fibrous tumor arising from the fascial connective tissue.</td>
<td style="text-align: left;">MONDO:0005167</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857831</td>
<td style="text-align: left;">fascial fibrosarcoma</td>
<td style="text-align: left;">NCIT:C66765</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fascial Fibrosarcoma</td>
<td style="text-align: left;">A malignant fibroblastic neoplasm arising from the fascial connective tissue.</td>
<td style="text-align: left;">MONDO:0005164</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857834</td>
<td style="text-align: left;">choriocarcinoma combined with other germ cell elements</td>
<td style="text-align: left;">NCIT:C66777</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Choriocarcinoma Combined with Other Germ Cell Elements</td>
<td style="text-align: left;">A malignant mixed germ cell tumor characterized by the presence of a choriocarcinomatous component admixed with another germ cell component (e.g. embryonal carcinoma, teratoma, or seminoma).</td>
<td style="text-align: left;">MONDO:0015864,MONDO:0005853</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857835</td>
<td style="text-align: left;">hemolymphangioma</td>
<td style="text-align: left;">NCIT:C66792</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hemolymphangioma</td>
<td style="text-align: left;">A hemorrhagic lymphatic lesion characterized by the presence of dilated lymphatic spaces, extravasation of red blood cells, hemosiderin deposition, and fibrosis.</td>
<td style="text-align: left;">MONDO:0002013</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857836</td>
<td style="text-align: left;">ganglioneuromatosis</td>
<td style="text-align: left;">NCIT:C66804</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ganglioneuromatosis</td>
<td style="text-align: left;">Extensive and diffuse infiltration of tissues by ganglioneuroma.</td>
<td style="text-align: left;">MONDO:0005033</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857837</td>
<td style="text-align: left;">benign ciliary body medulloepithelioma</td>
<td style="text-align: left;">NCIT:C66807</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Ciliary Body Medulloepithelioma</td>
<td style="text-align: left;">A rare benign embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium.</td>
<td style="text-align: left;">MONDO:0021486,MONDO:0017050</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857838</td>
<td style="text-align: left;">ciliary body teratoid medulloepithelioma</td>
<td style="text-align: left;">NCIT:C66810</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ciliary Body Teratoid Medulloepithelioma</td>
<td style="text-align: left;">A rare benign or malignant embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium and contains heterologous elements, particularly cartilage, skeletal muscle, and brain tissue.</td>
<td style="text-align: left;">MONDO:0017050</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857839</td>
<td style="text-align: left;">retinocytoma</td>
<td style="text-align: left;">NCIT:C66812</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Retinocytoma</td>
<td style="text-align: left;">A rare, unilateral or bilateral benign neoplasm that arises from the retina. There is an increased risk of malignant transformation to retinoblastoma; therefore, patients with a diagnosis of retinocytoma should be closely observed.</td>
<td style="text-align: left;">MONDO:0021453,MONDO:0024341</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857840</td>
<td style="text-align: left;">differentiated retinoblastoma</td>
<td style="text-align: left;">NCIT:C66813</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Differentiated Retinoblastoma</td>
<td style="text-align: left;">A retinoblastoma with well differentiated features. It often produces Flexner-Wintersteiner rosettes or Homer-Wright rosettes. In some cases the tumor cells form fleurettes.</td>
<td style="text-align: left;">MONDO:0008380</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857841</td>
<td style="text-align: left;">undifferentiated retinoblastoma</td>
<td style="text-align: left;">NCIT:C66814</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Undifferentiated Retinoblastoma</td>
<td style="text-align: left;">A retinoblastoma composed of small, undifferentiated cells. It is often associated with necrotic changes.</td>
<td style="text-align: left;">MONDO:0008380</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857842</td>
<td style="text-align: left;">diffuse retinoblastoma</td>
<td style="text-align: left;">NCIT:C66815</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Retinoblastoma</td>
<td style="text-align: left;">A retinoblastoma characterized by the absence of a distinct retinal mass and the presence of malignant cells diffusely infiltrating the retina. It is often confused with uveitis and endophthalmitis, resulting in delayed diagnosis of the malignancy.</td>
<td style="text-align: left;">MONDO:0008380</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857844</td>
<td style="text-align: left;">melanotic neurofibroma</td>
<td style="text-align: left;">NCIT:C66841</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Melanotic Neurofibroma</td>
<td style="text-align: left;">A rare neurofibroma characterized by the presence of melanin-laden cells and the absence of atypia.</td>
<td style="text-align: left;">MONDO:0016755</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857846</td>
<td style="text-align: left;">testicular mixed sex cord-stromal tumor</td>
<td style="text-align: left;">NCIT:C66991</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Mixed Sex Cord-Stromal Tumor</td>
<td style="text-align: left;">A sex cord-stromal tumor of the testis which may contain any combination of cell types, for example Sertoli cells, Leydig cells, and granulosa cells. Symptoms include testicular swelling and gynecomastia.</td>
<td style="text-align: left;">MONDO:0003125</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857847</td>
<td style="text-align: left;">pyriform fossa carcinoma</td>
<td style="text-align: left;">NCIT:C6700</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pyriform Fossa Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the pyriform sinus.  Patients usually present with advanced stage disease and the prognosis is poor.</td>
<td style="text-align: left;">MONDO:0005216</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857848</td>
<td style="text-align: left;">ovarian serous adenocarcinofibroma</td>
<td style="text-align: left;">NCIT:C67092</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Serous Adenocarcinofibroma</td>
<td style="text-align: left;">A malignant neoplasm of the ovary with an invasive epithelial component and a fibrotic stroma. The epithelial component is characterized by the presence of malignant epithelial cells of serous type, forming glandular, papillary, and solid patterns.</td>
<td style="text-align: left;">MONDO:0024885,MONDO:0002991</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857849</td>
<td style="text-align: left;">sternal chondromyxoid fibroma</td>
<td style="text-align: left;">NCIT:C6714</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sternal Chondromyxoid Fibroma</td>
<td style="text-align: left;">An uncommon benign cartilaginous neoplasm arising from the sternum. It is characterized by the presence of spindle-shaped or stellate chondrocytes, a lobulated growth pattern, myxoid stroma formation, and sometimes multinucleated giant cells.</td>
<td style="text-align: left;">MONDO:0021456,MONDO:0018447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857850</td>
<td style="text-align: left;">olfactory neurogenic tumor</td>
<td style="text-align: left;">NCIT:C67155</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Olfactory Neurogenic Tumor</td>
<td style="text-align: left;">A rare, benign (olfactory neurocytoma) or malignant (olfactory neuroblastoma) neuroectodermal tumor originating from olfactory receptor cells in the nasal cavity.</td>
<td style="text-align: left;">MONDO:0021193</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857852</td>
<td style="text-align: left;">nodular sclerosis classic hodgkin lymphoma, cellular phase</td>
<td style="text-align: left;">NCIT:C67171</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nodular Sclerosis Classic Hodgkin Lymphoma, Cellular Phase</td>
<td style="text-align: left;">A nodular sclerosis Hodgkin lymphoma characterized by the presence of lacunar cells, nodular growth, and the absence of fibrosis.</td>
<td style="text-align: left;">MONDO:0004665</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857853</td>
<td style="text-align: left;">sternal intraosseous schwannoma</td>
<td style="text-align: left;">NCIT:C6718</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sternal Intraosseous Schwannoma</td>
<td style="text-align: left;">A rare schwannoma that arises from the sternum.</td>
<td style="text-align: left;">MONDO:0021456,MONDO:0004820</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857854</td>
<td style="text-align: left;">peripheral primitive neuroectodermal tumor of kidney</td>
<td style="text-align: left;">NCIT:C67214</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Peripheral Primitive Neuroectodermal Tumor of Kidney</td>
<td style="text-align: left;">A small round cell tumor with neural differentiation arising from the kidney.</td>
<td style="text-align: left;">MONDO:0018271,MONDO:0002367</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857855</td>
<td style="text-align: left;">chest wall hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C6723</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chest Wall Hodgkin Lymphoma</td>
<td style="text-align: left;">A Hodgkin lymphoma that affects the structures of the chest wall.</td>
<td style="text-align: left;">MONDO:0003985,MONDO:0004952</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857858</td>
<td style="text-align: left;">benign glomus tumor</td>
<td style="text-align: left;">NCIT:C6748</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Glomus Tumor</td>
<td style="text-align: left;">A glomus tumor of small size characterized by the absence of nuclear atypia and mitotic activity.</td>
<td style="text-align: left;">MONDO:0003342,MONDO:0018327</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857859</td>
<td style="text-align: left;">malignant sex cord-stromal tumor</td>
<td style="text-align: left;">NCIT:C67561</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Sex Cord-Stromal Tumor</td>
<td style="text-align: left;">A gonadal sex cord-stromal tumor with malignant characteristics.  It includes the poorly differentiated ovarian Sertoli-Leydig cell tumor, malignant ovarian granulosa cell tumor, malignant ovarian steroid cell tumor, and malignant ovarian thecoma.</td>
<td style="text-align: left;">MONDO:0002149,MONDO:0006055</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857860</td>
<td style="text-align: left;">myxoid leiomyoma</td>
<td style="text-align: left;">NCIT:C67563</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myxoid Leiomyoma</td>
<td style="text-align: left;">A leiomyoma characterized by the presence of abundant myxoid matrix.</td>
<td style="text-align: left;">MONDO:0006106</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857862</td>
<td style="text-align: left;">stromal neoplasm</td>
<td style="text-align: left;">NCIT:C6781</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stromal Neoplasm</td>
<td style="text-align: left;">A benign or malignant mesenchymal neoplasm composed of stromal cells.  Representative examples include gastrointestinal stromal tumor, endometrial stromal sarcoma, and prostate stromal sarcoma.</td>
<td style="text-align: left;">MONDO:0002616,MONDO:0006424</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857864</td>
<td style="text-align: left;">benign apocrine neoplasm</td>
<td style="text-align: left;">NCIT:C6799</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Apocrine Neoplasm</td>
<td style="text-align: left;">An epithelial neoplasm that arises from the apocrine glands and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0021489,MONDO:0003686</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857866</td>
<td style="text-align: left;">benign external ear neoplasm</td>
<td style="text-align: left;">NCIT:C6807</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign External Ear Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the external ear and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include ceruminous adenoma, polyp, and lipoma.</td>
<td style="text-align: left;">MONDO:0021235,MONDO:0021474</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857867</td>
<td style="text-align: left;">prostate ductal adenocarcinoma</td>
<td style="text-align: left;">NCIT:C6813</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Ductal Adenocarcinoma</td>
<td style="text-align: left;">A usually aggressive invasive adenocarcinoma of the prostate gland composed of large glands containing tall columnar cells.  The columnar cells have abundant cytoplasm and are reminiscent of endometrial carcinoma.  This type of adenocarcinoma has a tendency to metastasize to the lung and penis.</td>
<td style="text-align: left;">MONDO:0005082</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857872</td>
<td style="text-align: left;">kadish stage a olfactory neuroblastoma</td>
<td style="text-align: left;">NCIT:C6853</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kadish Stage A Olfactory Neuroblastoma</td>
<td style="text-align: left;">An olfactory neuroblastoma that is confined to the nasal cavity</td>
<td style="text-align: left;">MONDO:0006329</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857873</td>
<td style="text-align: left;">kadish stage b olfactory neuroblastoma</td>
<td style="text-align: left;">NCIT:C6854</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kadish Stage B Olfactory Neuroblastoma</td>
<td style="text-align: left;">An olfactory neuroblastoma that involves the nasal cavity and paranasal sinuses.</td>
<td style="text-align: left;">MONDO:0006329</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857874</td>
<td style="text-align: left;">oropharyngeal undifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C68610</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oropharyngeal Undifferentiated Carcinoma</td>
<td style="text-align: left;">A non-keratinizing carcinoma arising from the oropharynx.  It is characterized by the presence of large malignant cells with vesicular nuclei, prominent nucleoli, syncytial growth pattern, and a lymphoplasmacytic infiltrate.</td>
<td style="text-align: left;">MONDO:0003572,MONDO:0044704</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857876</td>
<td style="text-align: left;">childhood extracranial germ cell tumor</td>
<td style="text-align: left;">NCIT:C68627</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Extracranial Germ Cell Tumor</td>
<td style="text-align: left;">A childhood benign or malignant germ cell tumor arising from an anatomic site other than the brain.</td>
<td style="text-align: left;">MONDO:0003751</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857879</td>
<td style="text-align: left;">childhood malignant extragonadal germ cell tumor</td>
<td style="text-align: left;">NCIT:C68632</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Malignant Extragonadal Germ Cell Tumor</td>
<td style="text-align: left;">A malignant germ cell tumor in children arising from an anatomic site other than the testis or ovary.</td>
<td style="text-align: left;">MONDO:0003113,MONDO:0004479</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857881</td>
<td style="text-align: left;">adrenal cortical low grade carcinoma</td>
<td style="text-align: left;">NCIT:C68635</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Low Grade Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the adrenal cortex and is characterized by the presence of twenty or less mitoses per ten square millimeters.</td>
<td style="text-align: left;">MONDO:0006639</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857882</td>
<td style="text-align: left;">adrenal cortical sarcomatoid carcinoma</td>
<td style="text-align: left;">NCIT:C68644</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Cortical Sarcomatoid Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the adrenal cortex and is characterized by the partial or complete loss of adrenal cortical differentiation.</td>
<td style="text-align: left;">MONDO:0006406,MONDO:0006639</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857884</td>
<td style="text-align: left;">hodgkin lymphoma by clinical course</td>
<td style="text-align: left;">NCIT:C68666</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hodgkin Lymphoma by Clinical Course</td>
<td style="text-align: left;">A term that refers to the classification of a Hodgkin lymphoma according to its clinical course.</td>
<td style="text-align: left;">MONDO:0004952</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857892</td>
<td style="text-align: left;">adult gliosarcoma</td>
<td style="text-align: left;">NCIT:C68701</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Gliosarcoma</td>
<td style="text-align: left;">A gliosarcoma occurring in adults.</td>
<td style="text-align: left;">MONDO:0020690,MONDO:0016681</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857893</td>
<td style="text-align: left;">adult giant cell glioblastoma</td>
<td style="text-align: left;">NCIT:C68702</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Giant Cell Glioblastoma</td>
<td style="text-align: left;">A giant cell glioblastoma occurring in adults.</td>
<td style="text-align: left;">MONDO:0016682,MONDO:0020690</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857895</td>
<td style="text-align: left;">pancreatic mixed acinar carcinoma-neuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C6878</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the pancreas and is composed of acinar carcinoma and neuroendocrine carcinoma components in both the primary tumor and the metastatic sites.</td>
<td style="text-align: left;">MONDO:0044727</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857896</td>
<td style="text-align: left;">cellular fibroma</td>
<td style="text-align: left;">NCIT:C6892</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cellular Fibroma</td>
<td style="text-align: left;">A morphologic variant of fibroma characterized by increased cellularity.</td>
<td style="text-align: left;">MONDO:0005167</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857897</td>
<td style="text-align: left;">malignant solitary fibrous tumor</td>
<td style="text-align: left;">NCIT:C6894</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Solitary Fibrous Tumor</td>
<td style="text-align: left;">A malignant neoplasm of probable fibroblastic derivation characterized by the presence of atypical round to spindle-shaped cells, increased cellularity, necrotic change, and high mitotic activity.</td>
<td style="text-align: left;">MONDO:0016238,MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857899</td>
<td style="text-align: left;">atypical burkitt/burkitt-like lymphoma</td>
<td style="text-align: left;">NCIT:C6917</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Burkitt/Burkitt-Like Lymphoma</td>
<td style="text-align: left;">A morphologic variant of Burkitt lymphoma characterized by marked nuclear pleomorphism, abundant apoptotic debris, and the presence of tangible body macrophages.</td>
<td style="text-align: left;">MONDO:0007243</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857900</td>
<td style="text-align: left;">acute myeloid leukemia with a variant kmt2a rearrangement</td>
<td style="text-align: left;">NCIT:C6924</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia with a Variant KMT2A Rearrangement</td>
<td style="text-align: left;">A term referring to acute myeloid leukemias with rearrangement of the KMT2A gene that results in translocations with various genes other than the MLLT3 (AF9) gene.</td>
<td style="text-align: left;">MONDO:0100404</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857901</td>
<td style="text-align: left;">malignant ovarian thecoma</td>
<td style="text-align: left;">NCIT:C6929</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Ovarian Thecoma</td>
<td style="text-align: left;">A thecoma of the ovary which may metastasize to another anatomic site. It is usually characterized by nuclear atypia and mitotic activity. Malignant thecomas are rare.</td>
<td style="text-align: left;">MONDO:0018172,MONDO:0037253</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857902</td>
<td style="text-align: left;">solitary plasmacytoma</td>
<td style="text-align: left;">NCIT:C6932</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Solitary Plasmacytoma</td>
<td style="text-align: left;">A localized malignant neoplasm that arises in the bony skeleton or soft tissue. It is composed of clonal (malignant) plasma cells forming a tumor mass.</td>
<td style="text-align: left;">MONDO:0005615</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857904</td>
<td style="text-align: left;">cardiac fibroma</td>
<td style="text-align: left;">NCIT:C6947</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Fibroma</td>
<td style="text-align: left;">A rare benign heart neoplasm usually occurring in young children. It is characterized by the presence of bland spindle cells and collagenous stroma formation. Clinical presentation may include cardiac arrhythmia, cyanosis, heart failure or sudden death.</td>
<td style="text-align: left;">MONDO:0005167,MONDO:0021450</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857906</td>
<td style="text-align: left;">anaplastic kidney wilms tumor</td>
<td style="text-align: left;">NCIT:C6952</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Kidney Wilms Tumor</td>
<td style="text-align: left;">Wilms tumor of the kidney characterized by the presence of nuclear anaplasia.  Anaplasia is defined by the presence of all of the following: multipolar polyploid mitotic figures, marked nuclear enlargement, and hyperchromasia.  When anaplasia is diffuse, it is associated with an unfavorable clinical outcome.</td>
<td style="text-align: left;">MONDO:0020633,MONDO:0019004</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857907</td>
<td style="text-align: left;">simple endometrial hyperplasia with atypia</td>
<td style="text-align: left;">NCIT:C6991</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Simple Endometrial Hyperplasia with Atypia</td>
<td style="text-align: left;">A proliferation of endometrial cells resulting in glandular enlargement and budding without changes in the basic structure of the endometrium. Epithelial atypia is present.</td>
<td style="text-align: left;">MONDO:0006410</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857910</td>
<td style="text-align: left;">central nervous system kaposi sarcoma</td>
<td style="text-align: left;">NCIT:C7006</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Kaposi Sarcoma</td>
<td style="text-align: left;">A Kaposi sarcoma arising from the brain, spinal cord, or meninges.</td>
<td style="text-align: left;">MONDO:0002217,MONDO:0005055</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857913</td>
<td style="text-align: left;">central nervous system inflammatory myofibroblastic tumor</td>
<td style="text-align: left;">NCIT:C7020</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Inflammatory Myofibroblastic Tumor</td>
<td style="text-align: left;">An intermediate fibroblastic neoplasm that arises from the central nervous system and is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells.</td>
<td style="text-align: left;">MONDO:0015798,MONDO:0003244</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857918</td>
<td style="text-align: left;">meningioma by site</td>
<td style="text-align: left;">NCIT:C7051</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Meningioma by Site</td>
<td style="text-align: left;">A meningioma described according to its location in the body.</td>
<td style="text-align: left;">MONDO:0016642</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857919</td>
<td style="text-align: left;">mature b-cell non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C7056</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mature B-Cell Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A non-Hodgkin lymphoma that originates from mature B lymphocytes. Representative examples include diffuse large B-cell lymphoma, follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, and small lymphocytic lymphoma.</td>
<td style="text-align: left;">MONDO:0004949,MONDO:0015759</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857921</td>
<td style="text-align: left;">neoplasm by special category</td>
<td style="text-align: left;">NCIT:C7062</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neoplasm by Special Category</td>
<td style="text-align: left;">A neoplasm defined by its unique characteristic as they apply to clinical presentation and course, morphologic patterns, frequency, and/or age distribution.</td>
<td style="text-align: left;">MONDO:0005070</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857925</td>
<td style="text-align: left;">megakaryocytic neoplasm</td>
<td style="text-align: left;">NCIT:C7066</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Megakaryocytic Neoplasm</td>
<td style="text-align: left;">A neoplasm affecting cells of the megakaryocytic lineage.</td>
<td style="text-align: left;">MONDO:0005170,MONDO:0021138</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857926</td>
<td style="text-align: left;">prostate cancer by whitmore-jewett stage</td>
<td style="text-align: left;">NCIT:C7079</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Cancer by Whitmore-Jewett Stage</td>
<td style="text-align: left;">A term that refers to the staging of prostate carcinoma according to the Whitmore-Jewett staging system.</td>
<td style="text-align: left;">MONDO:0005159</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857931</td>
<td style="text-align: left;">metastatic non-cutaneous melanoma</td>
<td style="text-align: left;">NCIT:C7092</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Non-Cutaneous Melanoma</td>
<td style="text-align: left;">A non-cutaneous melanoma that has spread from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0005191,MONDO:0006320</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857935</td>
<td style="text-align: left;">teratoid hepatoblastoma</td>
<td style="text-align: left;">NCIT:C7098</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Teratoid Hepatoblastoma</td>
<td style="text-align: left;">A mixed epithelial and mesenchymal hepatoblastoma characterized by the presence of heterologous elements. The latter include neuroectoderm, endoderm, or melanin-holding cells. Muscle, cartilage and osteoid may or may not be present.</td>
<td style="text-align: left;">MONDO:0003650</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857937</td>
<td style="text-align: left;">adult pilocytic astrocytoma</td>
<td style="text-align: left;">NCIT:C71016</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Pilocytic Astrocytoma</td>
<td style="text-align: left;">A pilocytic astrocytoma occurring in adults.</td>
<td style="text-align: left;">MONDO:0002503,MONDO:0016691</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857940</td>
<td style="text-align: left;">liver non-epithelial neoplasm</td>
<td style="text-align: left;">NCIT:C7107</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Liver Non-Epithelial Neoplasm</td>
<td style="text-align: left;">A benign or malignant non-epithelial neoplasm that affects the liver.</td>
<td style="text-align: left;">MONDO:0024477</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857943</td>
<td style="text-align: left;">stage i liver cancer</td>
<td style="text-align: left;">NCIT:C7116</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage I Liver Cancer</td>
<td style="text-align: left;">Stage I carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.</td>
<td style="text-align: left;">MONDO:0018531</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857944</td>
<td style="text-align: left;">stage ii liver cancer</td>
<td style="text-align: left;">NCIT:C7117</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage II Liver Cancer</td>
<td style="text-align: left;">Stage II carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.</td>
<td style="text-align: left;">MONDO:0018531</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857945</td>
<td style="text-align: left;">stage iii liver cancer</td>
<td style="text-align: left;">NCIT:C7118</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage III Liver Cancer</td>
<td style="text-align: left;">Stage III carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.</td>
<td style="text-align: left;">MONDO:0018531</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857946</td>
<td style="text-align: left;">stage iv liver cancer</td>
<td style="text-align: left;">NCIT:C7121</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage IV Liver Cancer</td>
<td style="text-align: left;">Stage IV carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.</td>
<td style="text-align: left;">MONDO:0018531</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857947</td>
<td style="text-align: left;">intrahepatic bile duct microcystic adenoma</td>
<td style="text-align: left;">NCIT:C7127</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intrahepatic Bile Duct Microcystic Adenoma</td>
<td style="text-align: left;">An adenoma that arises from the intrahepatic bile ducts and it is characterized by the presence of microcystic changes.</td>
<td style="text-align: left;">MONDO:0003444,MONDO:0003435</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857948</td>
<td style="text-align: left;">gallbladder benign non-epithelial neoplasm</td>
<td style="text-align: left;">NCIT:C7129</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Benign Non-Epithelial Neoplasm</td>
<td style="text-align: left;">A non-epithelial neoplasm that arises from the gallbladder and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include leiomyoma, lipoma, and neurofibroma.</td>
<td style="text-align: left;">MONDO:0021503</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857950</td>
<td style="text-align: left;">childhood grade 2 meningioma</td>
<td style="text-align: left;">NCIT:C71301</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Grade 2 Meningioma</td>
<td style="text-align: left;">A grade 2 meningioma that occurs during childhood.</td>
<td style="text-align: left;">MONDO:0045056,MONDO:0003057</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857952</td>
<td style="text-align: left;">ovarian sertoli cell tumor</td>
<td style="text-align: left;">NCIT:C7133</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Sertoli Cell Tumor</td>
<td style="text-align: left;">A rare, typically benign ovarian neoplasm composed of Sertoli cells. Patients may present with pseudoprecocity, menometrorrhagia, amenorrhea, hirsutism, and hoarseness.  Rarely it may invade the ovarian stroma and extend beyond the ovary.</td>
<td style="text-align: left;">MONDO:0002696,MONDO:0020807</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857961</td>
<td style="text-align: left;">benign fibroblastic neoplasm</td>
<td style="text-align: left;">NCIT:C7147</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Fibroblastic Neoplasm</td>
<td style="text-align: left;">A benign mesenchymal neoplasm characterized by the presence of neoplastic fibroblasts without malignant characteristics.</td>
<td style="text-align: left;">MONDO:0044335,MONDO:0006209</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857962</td>
<td style="text-align: left;">soft tissue neoplasm of uncertain differentiation</td>
<td style="text-align: left;">NCIT:C7148</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Soft Tissue Neoplasm of Uncertain Differentiation</td>
<td style="text-align: left;">A benign,intermediate, or malignant soft tissue neoplasm in which the line of differentiation is uncertain. Representative examples include neoplasm with perivascular epithelioid cell differentiation, alveolar soft part sarcoma, desmoplastic small round cell tumor, epithelioid sarcoma, extraskeletal myxoid chondrosarcoma, and synovial sarcoma.</td>
<td style="text-align: left;">MONDO:0006424</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857963</td>
<td style="text-align: left;">monoclonal immunoglobulin deposition disease</td>
<td style="text-align: left;">NCIT:C7151</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Monoclonal Immunoglobulin Deposition Disease</td>
<td style="text-align: left;">A mature B-cell neoplasm characterized by the deposition of immunoglobulin in tissues, resulting in impaired organ function. It includes the following entities: primary amyloidosis, heavy chain deposition disease, and light chain deposition disease.</td>
<td style="text-align: left;">MONDO:0004949</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857965</td>
<td style="text-align: left;">primary central chondrosarcoma</td>
<td style="text-align: left;">NCIT:C7155</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Central Chondrosarcoma</td>
<td style="text-align: left;">A chondrosarcoma arising from the central portion of bone without a benign precursor.</td>
<td style="text-align: left;">MONDO:0008977,MONDO:0021054</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857966</td>
<td style="text-align: left;">benign dermal neoplasm</td>
<td style="text-align: left;">NCIT:C7158</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Dermal Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the dermis and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0002300,MONDO:0021440</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857967</td>
<td style="text-align: left;">grade 1 nodular sclerosis classic hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C7165</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Grade 1 Nodular Sclerosis Classic Hodgkin Lymphoma</td>
<td style="text-align: left;">Nodular sclerosis Hodgkin lymphoma in which at least 75% of the tumor nodules contain scattered Reed-Sternberg cells. The background cellular infiltrate is lymphocytic, mixed, or fibrohistiocytic.</td>
<td style="text-align: left;">MONDO:0004665</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857968</td>
<td style="text-align: left;">grade 2 nodular sclerosis classic hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C7166</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma</td>
<td style="text-align: left;">Nodular sclerosis Hodgkin lymphoma in which at least 25% of the tumor nodules contain increased numbers of Reed-Sternberg cells.</td>
<td style="text-align: left;">MONDO:0004665</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857971</td>
<td style="text-align: left;">adult diffuse astrocytoma</td>
<td style="text-align: left;">NCIT:C7174</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Diffuse Astrocytoma</td>
<td style="text-align: left;">A low grade (WHO grade II) astrocytoma occurring during adulthood.  It is characterized by a high degree of cellular differentiation, slow growth, and diffuse infiltration of neighboring brain structures.</td>
<td style="text-align: left;">MONDO:0016686,MONDO:0004320</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857972</td>
<td style="text-align: left;">spindle cell/pleomorphic lipoma</td>
<td style="text-align: left;">NCIT:C7180</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Spindle Cell/Pleomorphic Lipoma</td>
<td style="text-align: left;">A benign lipomatous neoplasm characterized by the presence of an admixture of mature adipose tissue and bland spindle cells.  The pleomorphic variant contains in addition multinucleated giant cells.  It usually arises in the neck and upper trunk in older males.</td>
<td style="text-align: left;">MONDO:0005106</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857973</td>
<td style="text-align: left;">classical burkitt lymphoma</td>
<td style="text-align: left;">NCIT:C7188</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Classical Burkitt Lymphoma</td>
<td style="text-align: left;">A Burkitt lymphoma characterized by the presence of a uniform malignant lymphocytic infiltrate that is composed of medium-sized cells with round nuclei and multiple basophilic nucleoli, abundant mitotic figures, and a starry-sky pattern due to the presence of multiple tangible body macrophages.</td>
<td style="text-align: left;">MONDO:0007243</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857974</td>
<td style="text-align: left;">burkitt lymphoma with plasmacytoid differentiation</td>
<td style="text-align: left;">NCIT:C7189</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Burkitt Lymphoma with Plasmacytoid Differentiation</td>
<td style="text-align: left;">Burkitt lymphoma characterized by the presence of malignant cells with eccentric basophilic cytoplasm. The nucleoli of these cells are often single and central. This morphologic variant of Burkitt lymphoma is more often seen in patients with immunodeficiency.</td>
<td style="text-align: left;">MONDO:0007243</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857975</td>
<td style="text-align: left;">type b lymphomatoid papulosis</td>
<td style="text-align: left;">NCIT:C7198</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Type B Lymphomatoid Papulosis</td>
<td style="text-align: left;">A variant of lymphomatoid papulosis characterized by an epidermotropic infiltrate composed of small atypical cerebriform-like lymphocytes.</td>
<td style="text-align: left;">MONDO:0020326</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857976</td>
<td style="text-align: left;">lymphoepithelioid variant peripheral t-cell lymphoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C7205</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lymphoepithelioid Variant Peripheral T-Cell Lymphoma, Not Otherwise Specified</td>
<td style="text-align: left;">A variant of peripheral T-cell lymphoma, not otherwise specified. It is characterized by the presence of neoplastic small lymphocytes infiltrating the lymph nodes in a diffuse and less frequently interfollicular pattern. There is an associated proliferation of epithelioid histiocytes forming confluent clusters.</td>
<td style="text-align: left;">MONDO:0004964</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857977</td>
<td style="text-align: left;">common variant anaplastic large cell lymphoma</td>
<td style="text-align: left;">NCIT:C7206</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Common Variant Anaplastic Large Cell Lymphoma</td>
<td style="text-align: left;">An anaplastic large cell lymphoma, characterized by CD30 positive lymphoid cells.</td>
<td style="text-align: left;">MONDO:0020325</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857978</td>
<td style="text-align: left;">lymphohistiocytic variant anaplastic large cell lymphoma</td>
<td style="text-align: left;">NCIT:C7207</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma</td>
<td style="text-align: left;">A histologic variant of anaplastic large cell lymphoma characterized by the presence of a large number of histiocytes admixed with the anaplastic lymphoma cells.</td>
<td style="text-align: left;">MONDO:0020325</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857981</td>
<td style="text-align: left;">non-hodgkin lymphoma by clinical course</td>
<td style="text-align: left;">NCIT:C7215</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Hodgkin Lymphoma by Clinical Course</td>
<td style="text-align: left;">A term that refers to the classification of a non-Hodgkin lymphoma according to its clinical course.</td>
<td style="text-align: left;">MONDO:0018908</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857982</td>
<td style="text-align: left;">primary cutaneous hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C7221</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Cutaneous Hodgkin Lymphoma</td>
<td style="text-align: left;">A Hodgkin lymphoma primarily involving the skin. This diagnosis can only be made when there is no evidence of Hodgkin lymphoma in the lymph nodes or other anatomic sites. Patients usually present with papules or nodular lesions. Morphologically, primary cutaneous Hodgkin lymphoma may resemble lymphomatoid papulosis or anaplastic large cell lymphoma. Immunohistochemical tissue evaluation is essential in establishing the diagnosis.</td>
<td style="text-align: left;">MONDO:0018898,MONDO:0004952</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857984</td>
<td style="text-align: left;">blastoid variant mantle cell lymphoma</td>
<td style="text-align: left;">NCIT:C7229</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Blastoid Variant Mantle Cell Lymphoma</td>
<td style="text-align: left;">An aggressive mantle cell lymphoma characterized by the presence of neoplastic B-lymphocytes resembling lymphoblasts.</td>
<td style="text-align: left;">MONDO:0018876</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857995</td>
<td style="text-align: left;">follicular lymphoma with predominantly diffuse growth pattern</td>
<td style="text-align: left;">NCIT:C7264</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Follicular Lymphoma with Predominantly Diffuse Growth Pattern</td>
<td style="text-align: left;">A lymphoma with the morphologic and immunophenotypic features of a follicular lymphoma characterized by the presence of a diffuse growth pattern with only focal and usually small micronodular foci.</td>
<td style="text-align: left;">MONDO:0018906</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857996</td>
<td style="text-align: left;">minimally invasive lung mucinous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C7268</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Minimally Invasive Lung Mucinous Adenocarcinoma</td>
<td style="text-align: left;">A morphologic variant of minimally invasive lung adenocarcinoma characterized by tall columnar cells and mucin production.</td>
<td style="text-align: left;">MONDO:0004991</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857998</td>
<td style="text-align: left;">ovarian dermoid cyst with secondary tumor</td>
<td style="text-align: left;">NCIT:C7284</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Dermoid Cyst with Secondary Tumor</td>
<td style="text-align: left;">An adult-type tumor that has derived from an ovarian dermoid cyst.  Representative examples include dermoid cyst with secondary carcinoma, dermoid cyst with secondary sarcoma, and dermoid cyst with pituitary-type tumor.</td>
<td style="text-align: left;">MONDO:0003331</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0857999</td>
<td style="text-align: left;">ovarian granulosa-stromal cell tumor</td>
<td style="text-align: left;">NCIT:C7287</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Granulosa-Stromal Cell Tumor</td>
<td style="text-align: left;">A group of sex cord-stromal tumors that arise from the ovary.  These tumors are characterized by the presence of granulosa cells, stromal cells, and/or theca cells.  This group includes granulosa cell tumor and tumors of the thecoma/fibroma group.</td>
<td style="text-align: left;">MONDO:0021657</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858001</td>
<td style="text-align: left;">malignant splenic soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C7292</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Splenic Soft Tissue Neoplasm</td>
<td style="text-align: left;">A malignant mesenchymal neoplasm that arises from the spleen.</td>
<td style="text-align: left;">MONDO:0005966,MONDO:0024637</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858002</td>
<td style="text-align: left;">splenic manifestation of t-cell prolymphocytic leukemia</td>
<td style="text-align: left;">NCIT:C7298</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Splenic Manifestation of T-Cell Prolymphocytic Leukemia</td>
<td style="text-align: left;">Infiltration and expansion of the white and red pulp of the spleen by T-cell prolymphocytic leukemia.</td>
<td style="text-align: left;">MONDO:0002966,MONDO:0019468</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858003</td>
<td style="text-align: left;">splenic manifestation of b-cell prolymphocytic leukemia</td>
<td style="text-align: left;">NCIT:C7299</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Splenic Manifestation of B-Cell Prolymphocytic Leukemia</td>
<td style="text-align: left;">Infiltration and expansion of the white and red pulp of the spleen by B-cell prolymphocytic leukemia.</td>
<td style="text-align: left;">MONDO:0002966,MONDO:0019461</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858004</td>
<td style="text-align: left;">splenic manifestation of chronic lymphocytic leukemia</td>
<td style="text-align: left;">NCIT:C7300</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Splenic Manifestation of Chronic Lymphocytic Leukemia</td>
<td style="text-align: left;">Infiltration of the spleen by chronic lymphocytic leukemia. It primarily involves the white pulp.</td>
<td style="text-align: left;">MONDO:0004107,MONDO:0004948</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858005</td>
<td style="text-align: left;">splenic manifestation of t-cell large granular lymphocyte leukemia</td>
<td style="text-align: left;">NCIT:C7302</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia</td>
<td style="text-align: left;">Infiltration and expansion of the red pulp cords and sinusoids of the spleen by T-cell large granular lymphocyte leukemia. The white pulp of the spleen is not involved and is often hyperplastic.</td>
<td style="text-align: left;">MONDO:0004107,MONDO:0019469</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858006</td>
<td style="text-align: left;">splenic manifestation of chronic myeloid leukemia, bcr-abl1 positive</td>
<td style="text-align: left;">NCIT:C7303</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Splenic Manifestation of Chronic Myeloid Leukemia, BCR-ABL1 Positive</td>
<td style="text-align: left;">Infiltration and expansion of the red pulp and sinusoids of the spleen by chronic myeloid leukemia, BCR-ABL1 positive.</td>
<td style="text-align: left;">MONDO:0011996,MONDO:0004107</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858010</td>
<td style="text-align: left;">acute monoblastic and monocytic leukemia</td>
<td style="text-align: left;">NCIT:C7318</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Monoblastic and Monocytic Leukemia</td>
<td style="text-align: left;">Acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage, including monoblasts, promonocytes, and monocytes. Bleeding disorders are common presenting features.</td>
<td style="text-align: left;">MONDO:0015667</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858011</td>
<td style="text-align: left;">childhood chronic myeloid leukemia, bcr-abl1 positive</td>
<td style="text-align: left;">NCIT:C7320</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive</td>
<td style="text-align: left;">A chronic myeloid leukemia, BCR-ABL1 positive occurring during childhood.</td>
<td style="text-align: left;">MONDO:0011996,MONDO:0004355</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858012</td>
<td style="text-align: left;">ovarian mixed germ cell-sex cord-stromal tumor</td>
<td style="text-align: left;">NCIT:C7321</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor</td>
<td style="text-align: left;">A neoplasm that arises from the ovary and is characterized by the presence of germ cell and sex cord-stromal tissues that are intimately admixed.  If there is no malignant germ cell component present, the clinical course is benign.</td>
<td style="text-align: left;">MONDO:0021068,MONDO:0002478</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858013</td>
<td style="text-align: left;">testicular mixed germ cell-sex cord-stromal tumor</td>
<td style="text-align: left;">NCIT:C7322</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor</td>
<td style="text-align: left;">A tumor that arises from the testis and is characterized by the presence of a neoplastic germ cell component and a neoplastic sex cord-stromal component.</td>
<td style="text-align: left;">MONDO:0021348,MONDO:0002478</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858016</td>
<td style="text-align: left;">reproductive endocrine neoplasm</td>
<td style="text-align: left;">NCIT:C7335</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Reproductive Endocrine Neoplasm</td>
<td style="text-align: left;">A benign or malignant endocrine neoplasm that arises from the testis or ovary.</td>
<td style="text-align: left;">MONDO:0006054,MONDO:0002082,MONDO:0002259</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858017</td>
<td style="text-align: left;">high grade intraepithelial neoplasia</td>
<td style="text-align: left;">NCIT:C7348</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">High Grade Intraepithelial Neoplasia</td>
<td style="text-align: left;">A precancerous neoplastic process that affects the squamous, glandular, or transitional cell epithelium without evidence of invasion. According to the degree of nuclear atypia, number of mitotic figures, and presence of architectural distortion, it is classified as grade II (moderate dysplasia) or grade III (severe dysplasia).</td>
<td style="text-align: left;">MONDO:0024474</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858019</td>
<td style="text-align: left;">cerebellar glioneuronal and neuronal tumors</td>
<td style="text-align: left;">NCIT:C7372</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cerebellar Glioneuronal and Neuronal Tumors</td>
<td style="text-align: left;">Glioneuronal and neuronal tumors occurring in the cerebellum.</td>
<td style="text-align: left;">MONDO:0016729,MONDO:0002913</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858020</td>
<td style="text-align: left;">benign vascular neoplasm</td>
<td style="text-align: left;">NCIT:C7389</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Vascular Neoplasm</td>
<td style="text-align: left;">A mesenchymal neoplasm that arises from vascular tissue usually of the skin. It is characterized by the presence of vascular channel formation and endothelial cells. There is no evidence of atypical or malignant cytological and architectural features, invasive features, or metastases.</td>
<td style="text-align: left;">MONDO:0024296,MONDO:0000654</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858021</td>
<td style="text-align: left;">malignant vascular neoplasm</td>
<td style="text-align: left;">NCIT:C7390</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Vascular Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm arising from the vascular tissue.  It is characterized by vascular channel formation and malignant endothelial cells.</td>
<td style="text-align: left;">MONDO:0024296,MONDO:0002100</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858025</td>
<td style="text-align: left;">oral cavity and lip precancerous condition</td>
<td style="text-align: left;">NCIT:C7425</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oral Cavity and Lip Precancerous Condition</td>
<td style="text-align: left;">A premalignant pathologic process that affects the mucosa surface of the oral cavity or lip.  It includes leukoplakia, erythroplakia, and smoker's keratosis.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858029</td>
<td style="text-align: left;">invasive papillary adenocarcinoma</td>
<td style="text-align: left;">NCIT:C7438</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Papillary Adenocarcinoma</td>
<td style="text-align: left;">A carcinoma that has papillary growth and invades the wall and/or the surrounding tissues of the organ it originates from.</td>
<td style="text-align: left;">MONDO:0040677,MONDO:0002512</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858030</td>
<td style="text-align: left;">benign myoepithelioma</td>
<td style="text-align: left;">NCIT:C7442</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Myoepithelioma</td>
<td style="text-align: left;">A tumor with myoepithelial differentiation that lacks an infiltrative growth pattern and does not metastasize.</td>
<td style="text-align: left;">MONDO:0002380,MONDO:0044335</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858036</td>
<td style="text-align: left;">pure erythroid leukemia</td>
<td style="text-align: left;">NCIT:C7467</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pure Erythroid Leukemia</td>
<td style="text-align: left;">Acute erythroid leukemia characterized by the presence of immature erythroid cells in the bone marrow (at least 80% of the cellular component), without evidence of a significant myeloblastic cell population present.</td>
<td style="text-align: left;">MONDO:0017858</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858037</td>
<td style="text-align: left;">anal extramucosal (perianal) adenocarcinoma</td>
<td style="text-align: left;">NCIT:C7474</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anal Extramucosal (Perianal) Adenocarcinoma</td>
<td style="text-align: left;">An anal adenocarcinoma arising from the lining of an anorectal fistulous tract or the anal glands.  The overlying anal mucosa does not show evidence of neoplastic changes.  It usually presents as a submucosal tumor.</td>
<td style="text-align: left;">MONDO:0002652</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858042</td>
<td style="text-align: left;">ameloblastic carcinoma-primary type</td>
<td style="text-align: left;">NCIT:C7493</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ameloblastic Carcinoma-Primary Type</td>
<td style="text-align: left;">A rare, aggressive odontogenic malignant tumor that arises usually from the mandible and less frequently from the maxilla.  It combines the histologic features of an ameloblastoma and carcinoma.</td>
<td style="text-align: left;">MONDO:0006079</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858043</td>
<td style="text-align: left;">ameloblastic carcinoma-secondary type (dedifferentiated)</td>
<td style="text-align: left;">NCIT:C7496</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ameloblastic Carcinoma-Secondary Type (Dedifferentiated)</td>
<td style="text-align: left;">A very rare ameloblastic carcinoma that originates from a pre-existing benign ameloblastoma.</td>
<td style="text-align: left;">MONDO:0006079,MONDO:0024878</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858044</td>
<td style="text-align: left;">ameloblastic carcinoma derived from odontogenic cyst</td>
<td style="text-align: left;">NCIT:C7497</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ameloblastic Carcinoma Derived From Odontogenic Cyst</td>
<td style="text-align: left;">A rare, aggressive malignant tumor that originates from an odontogenic cyst in the maxillomandibular region.  It combines the histologic features of an ameloblastoma and carcinoma.</td>
<td style="text-align: left;">MONDO:0006079,MONDO:0024878</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858045</td>
<td style="text-align: left;">primary intraosseous carcinoma, not otherwise specified, derived from odontogenic cyst</td>
<td style="text-align: left;">NCIT:C7500</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Intraosseous Carcinoma, Not Otherwise Specified, Derived from Odontogenic Cyst</td>
<td style="text-align: left;">A rare primary intraosseous carcinoma, not otherwise specified, that arises from the lining of an odontogenic cyst.</td>
<td style="text-align: left;">MONDO:0006385</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858049</td>
<td style="text-align: left;">metastatic malignant neoplasm in the breast</td>
<td style="text-align: left;">NCIT:C7511</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Breast</td>
<td style="text-align: left;">The spread of a malignant neoplasm to the breast. This may be from a primary breast malignant neoplasm on the opposite side, or from a malignant neoplasm at a distant site.</td>
<td style="text-align: left;">MONDO:0007254,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858050</td>
<td style="text-align: left;">malignant esophageal neoplasm by anatomic region</td>
<td style="text-align: left;">NCIT:C7512</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Esophageal Neoplasm by Anatomic Region</td>
<td style="text-align: left;">A malignant neoplasm of the esophagus described according to its location in the body.</td>
<td style="text-align: left;">MONDO:0007576</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858051</td>
<td style="text-align: left;">malignant esophageal neoplasm by topographic region</td>
<td style="text-align: left;">NCIT:C7513</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Esophageal Neoplasm by Topographic Region</td>
<td style="text-align: left;">Esophageal segments used primarily in pathology, and distinct from the anatomic segments used for clinical purposes.</td>
<td style="text-align: left;">MONDO:0007576</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858052</td>
<td style="text-align: left;">kidney and ureter neoplasm</td>
<td style="text-align: left;">NCIT:C7514</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney and Ureter Neoplasm</td>
<td style="text-align: left;">A benign or malignant, primary or metastatic neoplasm affecting the kidney and ureter.</td>
<td style="text-align: left;">MONDO:0021066</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858059</td>
<td style="text-align: left;">atypical adenoma</td>
<td style="text-align: left;">NCIT:C7559</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Adenoma</td>
<td style="text-align: left;">An adenoma characterized by increased cellularity and nuclear atypia without evidence of vascular or capsular invasion. A representative example is thyroid gland atypical follicular adenoma.</td>
<td style="text-align: left;">MONDO:0004972</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858060</td>
<td style="text-align: left;">eccrine hidrocystoma</td>
<td style="text-align: left;">NCIT:C7565</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eccrine Hidrocystoma</td>
<td style="text-align: left;">A benign sweat gland cystic lesion that arises from the dermis. It is lined by a thin epithelial layer of cells with a slightly eosinophilic cytoplasm.</td>
<td style="text-align: left;">MONDO:0006787,MONDO:0024247</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858066</td>
<td style="text-align: left;">regressing cutaneous nevus</td>
<td style="text-align: left;">NCIT:C7603</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Regressing Cutaneous Nevus</td>
<td style="text-align: left;">A cutaneous nevus associated with focal regression-like changes.</td>
<td style="text-align: left;">MONDO:0044794</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858070</td>
<td style="text-align: left;">cutaneous lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C7614</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Lymphoproliferative Disorder</td>
<td style="text-align: left;">A lymphoproliferative disorder that affects the skin.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858074</td>
<td style="text-align: left;">bilateral malignant neoplasm</td>
<td style="text-align: left;">NCIT:C7627</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bilateral Malignant Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that affects both sides of an organ in a simultaneous or non-simultaneous manner.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858080</td>
<td style="text-align: left;">intermediate soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C7653</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intermediate Soft Tissue Neoplasm</td>
<td style="text-align: left;">A soft tissue neoplasm characterized by an increased risk of local recurrence and/or a low risk of metastasis.</td>
<td style="text-align: left;">MONDO:0006424</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858081</td>
<td style="text-align: left;">carcinoma in a polyp</td>
<td style="text-align: left;">NCIT:C7682</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Carcinoma in a Polyp</td>
<td style="text-align: left;">Carcinoma arising in a polyp.</td>
<td style="text-align: left;">MONDO:0004993</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858082</td>
<td style="text-align: left;">invasive breast ductal carcinoma and lobular carcinoma in situ</td>
<td style="text-align: left;">NCIT:C7689</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ</td>
<td style="text-align: left;">An invasive ductal breast carcinoma associated with an in situ lobular carcinomatous component.</td>
<td style="text-align: left;">MONDO:0005050</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858083</td>
<td style="text-align: left;">breast ductal carcinoma in situ and lobular carcinoma</td>
<td style="text-align: left;">NCIT:C7690</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Ductal Carcinoma In Situ and Lobular Carcinoma</td>
<td style="text-align: left;">A breast carcinoma characterized by the presence of a ductal carcinoma in situ component and an in situ or invasive lobular carcinomatous component.</td>
<td style="text-align: left;">MONDO:0006306</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858086</td>
<td style="text-align: left;">adult hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C7702</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Hodgkin Lymphoma</td>
<td style="text-align: left;">Hodgkin lymphoma occurring in adults.</td>
<td style="text-align: left;">MONDO:0004952,MONDO:0003660</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858087</td>
<td style="text-align: left;">adult non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C7704</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">Non-Hodgkin lymphoma occurring in adults.</td>
<td style="text-align: left;">MONDO:0018908,MONDO:0003660</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858088</td>
<td style="text-align: left;">childhood non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C7706</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">Non-Hodgkin lymphoma occurring in childhood.</td>
<td style="text-align: left;">MONDO:0003659,MONDO:0018908</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858089</td>
<td style="text-align: left;">adult soft tissue sarcoma</td>
<td style="text-align: left;">NCIT:C7707</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Soft Tissue Sarcoma</td>
<td style="text-align: left;">Soft tissue sarcoma occurring in adults.</td>
<td style="text-align: left;">MONDO:0018078</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858091</td>
<td style="text-align: left;">adult liver carcinoma</td>
<td style="text-align: left;">NCIT:C7711</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Liver Carcinoma</td>
<td style="text-align: left;">A hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood.</td>
<td style="text-align: left;">MONDO:0018531</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858092</td>
<td style="text-align: left;">childhood hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C7714</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Hodgkin Lymphoma</td>
<td style="text-align: left;">Hodgkin lymphoma occurring in childhood.</td>
<td style="text-align: left;">MONDO:0004952,MONDO:0003659</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858094</td>
<td style="text-align: left;">gingival carcinoma</td>
<td style="text-align: left;">NCIT:C7721</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gingival Carcinoma</td>
<td style="text-align: left;">A carcinoma of the oral cavity that arises from the upper or lower gingiva.</td>
<td style="text-align: left;">MONDO:0044925,MONDO:0005507</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858095</td>
<td style="text-align: left;">vaginal clear cell adenocarcinoma</td>
<td style="text-align: left;">NCIT:C7735</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Clear Cell Adenocarcinoma</td>
<td style="text-align: left;">A morphologic variant of adenocarcinoma that arises from the vagina. It is characterized by the presence of malignant glandular epithelium and clear cells containing glycogen.</td>
<td style="text-align: left;">MONDO:0020653,MONDO:0005004</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858096</td>
<td style="text-align: left;">digestive system hemangioma</td>
<td style="text-align: left;">NCIT:C7741</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Digestive System Hemangioma</td>
<td style="text-align: left;">A hemangioma arising from any part of the digestive system.</td>
<td style="text-align: left;">MONDO:0000385,MONDO:0006500</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858097</td>
<td style="text-align: left;">mucous membrane hemangioma</td>
<td style="text-align: left;">NCIT:C7744</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mucous Membrane Hemangioma</td>
<td style="text-align: left;">A hemangioma arising from the mucous membranes.</td>
<td style="text-align: left;">MONDO:0006500</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858099</td>
<td style="text-align: left;">cardiac myxoma</td>
<td style="text-align: left;">NCIT:C7748</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Myxoma</td>
<td style="text-align: left;">A myxoma arising from the endocardium.</td>
<td style="text-align: left;">MONDO:0044784,MONDO:0021505</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858100</td>
<td style="text-align: left;">malignant pericarditis</td>
<td style="text-align: left;">NCIT:C7753</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Pericarditis</td>
<td style="text-align: left;">Pericarditis caused by the infiltration of the pericardium by a malignant neoplasm.  The diagnosis is based on the cytological examination of pericardial fluid or the histologic examination of pericardial tissue.</td>
<td style="text-align: left;">MONDO:0001322,MONDO:0005904</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858108</td>
<td style="text-align: left;">adult leiomyosarcoma</td>
<td style="text-align: left;">NCIT:C7810</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Leiomyosarcoma</td>
<td style="text-align: left;">An aggressive malignant smooth muscle neoplasm, occurring in adults.  It is characterized by a proliferation of neoplastic spindle cells.</td>
<td style="text-align: left;">MONDO:0005058</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858116</td>
<td style="text-align: left;">regional neuroblastoma</td>
<td style="text-align: left;">NCIT:C7836</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Regional Neuroblastoma</td>
<td style="text-align: left;">A neuroblastoma confined to a specific anatomic region without evidence of dissemination.</td>
<td style="text-align: left;">MONDO:0005072</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858119</td>
<td style="text-align: left;">stage i kidney wilms tumor</td>
<td style="text-align: left;">NCIT:C7840</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage I Kidney Wilms Tumor</td>
<td style="text-align: left;">Wilms tumor that is found in one kidney and can be completely removed with surgery. (National Wilms Tumor Study Group Staging System)</td>
<td style="text-align: left;">MONDO:0019004</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858120</td>
<td style="text-align: left;">stage ii kidney wilms tumor</td>
<td style="text-align: left;">NCIT:C7841</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage II Kidney Wilms Tumor</td>
<td style="text-align: left;">Wilms tumor that is found in the kidney and in the fat, soft tissue, or blood vessels near the kidney. It may have spread to the renal sinus. The renal sinus is the part of the kidney where blood and fluid enter and exit the organ. The tumor can be completely removed with surgery. (National Wilms Tumor Study Group Staging System)</td>
<td style="text-align: left;">MONDO:0019004</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858121</td>
<td style="text-align: left;">stage iii kidney wilms tumor</td>
<td style="text-align: left;">NCIT:C7842</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage III Kidney Wilms Tumor</td>
<td style="text-align: left;">Wilms tumor that is found in areas near the kidney and cannot be completely removed with surgery. The tumor may have spread to nearby organs and blood vessels or throughout the abdomen and to nearby lymph nodes. Lymph nodes are tiny, bean-shaped organs that help fight infection. Stage III cancer has not spread outside the abdomen. (National Wilms Tumor Study Group Staging System)</td>
<td style="text-align: left;">MONDO:0019004</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858122</td>
<td style="text-align: left;">stage iv kidney wilms tumor</td>
<td style="text-align: left;">NCIT:C7843</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage IV Kidney Wilms Tumor</td>
<td style="text-align: left;">Wilms tumor that has spread to other more distant organs, such as the lungs, liver, bones, and brain, or to lymph nodes outside the abdomen (National Wilms Tumor Study Group Staging System)</td>
<td style="text-align: left;">MONDO:0019004</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858123</td>
<td style="text-align: left;">stage v kidney wilms tumor</td>
<td style="text-align: left;">NCIT:C7844</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage V Kidney Wilms Tumor</td>
<td style="text-align: left;">Wilms tumor that affects both kidneys at the same time. The tumor in each kidney is staged separately (National Wilms Tumor Study Group Staging System)</td>
<td style="text-align: left;">MONDO:0019004</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858126</td>
<td style="text-align: left;">limited stage lung small cell carcinoma</td>
<td style="text-align: left;">NCIT:C7853</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Limited Stage Lung Small Cell Carcinoma</td>
<td style="text-align: left;">Small cell lung carcinoma which is confined to one hemi-thorax and the regional lymph nodes.</td>
<td style="text-align: left;">MONDO:0008433</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858155</td>
<td style="text-align: left;">breast ductal carcinoma in situ, high grade</td>
<td style="text-align: left;">NCIT:C7949</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Ductal Carcinoma In Situ, High Grade</td>
<td style="text-align: left;">Breast ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells.</td>
<td style="text-align: left;">MONDO:0005023</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858156</td>
<td style="text-align: left;">breast paget disease with invasive ductal carcinoma</td>
<td style="text-align: left;">NCIT:C7951</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Paget Disease with Invasive Ductal Carcinoma</td>
<td style="text-align: left;">Paget disease involving the skin overlying the mammary gland, accompanied by invasive ductal breast carcinoma.</td>
<td style="text-align: left;">MONDO:0006256,MONDO:0002648</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858169</td>
<td style="text-align: left;">carcinoma arising from craniopharyngioma</td>
<td style="text-align: left;">NCIT:C79949</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Carcinoma Arising from Craniopharyngioma</td>
<td style="text-align: left;">A rare condition characterized by the development of a carcinoma in a pre-existing craniopharyngioma.</td>
<td style="text-align: left;">MONDO:0024878</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858170</td>
<td style="text-align: left;">testicular mixed embryonal carcinoma and yolk sac tumor</td>
<td style="text-align: left;">NCIT:C8001</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor</td>
<td style="text-align: left;">A malignant non-seminomatous germ cell tumor arising from the testis.  It is characterized by a mixture of embryonal carcinoma and yolk sac morphologic elements.  Patients may present with painless or painful testicular swelling.</td>
<td style="text-align: left;">MONDO:0003403,MONDO:0003120</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858171</td>
<td style="text-align: left;">testicular mixed yolk sac tumor and teratoma</td>
<td style="text-align: left;">NCIT:C8002</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Mixed Yolk Sac Tumor and Teratoma</td>
<td style="text-align: left;">A malignant non-seminomatous germ cell tumor arising from the testis.  It is characterized by a mixture of yolk sac and teratomatous morphologic elements.  Patients may present with painless or painful testicular swelling.</td>
<td style="text-align: left;">MONDO:0003403,MONDO:0003120</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858172</td>
<td style="text-align: left;">testicular mixed yolk sac tumor and teratoma with seminoma</td>
<td style="text-align: left;">NCIT:C8003</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma</td>
<td style="text-align: left;">A malignant germ cell tumor arising from the testis.  It is characterized by a mixture of yolk sac, teratomatous, and seminomatous morphologic elements.  Patients may present with painless or painful testicular swelling.</td>
<td style="text-align: left;">MONDO:0003120</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858173</td>
<td style="text-align: left;">pancreatic somatostatin-producing neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C8006</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Somatostatin-Producing Neuroendocrine Tumor</td>
<td style="text-align: left;">A usually malignant, somatostatin producing neuroendocrine tumor, arising from the delta cells of the pancreas.  It may or may not be associated with inappropriate secretion of somatostatin and an associated clinical syndrome.</td>
<td style="text-align: left;">MONDO:0006976,MONDO:0002994</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858174</td>
<td style="text-align: left;">salivary gland low grade carcinoma</td>
<td style="text-align: left;">NCIT:C8012</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Salivary Gland Low Grade Carcinoma</td>
<td style="text-align: left;">A salivary gland carcinoma with low-grade histopathologic features.  It includes the salivary gland polymorphous low grade adenocarcinoma, salivary gland low grade cribriform cystadenocarcinoma, and low grade salivary gland mucoepidermoid carcinoma.  It usually follows a non-aggressive clinical course.</td>
<td style="text-align: left;">MONDO:0000521</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858176</td>
<td style="text-align: left;">salivary gland intermediate grade mucoepidermoid carcinoma</td>
<td style="text-align: left;">NCIT:C8017</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Salivary Gland Intermediate Grade Mucoepidermoid Carcinoma</td>
<td style="text-align: left;">A salivary gland mucoepidermoid carcinoma with intermediate-grade histopathologic features.</td>
<td style="text-align: left;">MONDO:0021009</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858177</td>
<td style="text-align: left;">salivary gland high grade carcinoma</td>
<td style="text-align: left;">NCIT:C8018</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Salivary Gland High Grade Carcinoma</td>
<td style="text-align: left;">A usually aggressive salivary gland carcinoma with high-grade histopathologic features.  It includes the salivary duct carcinoma, salivary gland oncocytic carcinoma, and high grade salivary gland mucoepidermoid carcinoma.</td>
<td style="text-align: left;">MONDO:0000521</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858179</td>
<td style="text-align: left;">salivary gland poorly differentiated squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C8022</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Salivary Gland Poorly Differentiated Squamous Cell Carcinoma</td>
<td style="text-align: left;">A poorly differentiated squamous cell carcinoma arising from the salivary gland.</td>
<td style="text-align: left;">MONDO:0044740</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858182</td>
<td style="text-align: left;">diffuse large b-cell lymphoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C80280</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Large B-Cell Lymphoma, Not Otherwise Specified</td>
<td style="text-align: left;">A term referring to a group of diffuse large B-cell lymphomas which are biologically heterogeneous. These lymphomas have a centroblastic, immunoblastic, or anaplastic morphology.</td>
<td style="text-align: left;">MONDO:0018905</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858184</td>
<td style="text-align: left;">progressive hairy cell leukemia initial treatment</td>
<td style="text-align: left;">NCIT:C8029</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Progressive Hairy Cell Leukemia Initial Treatment</td>
<td style="text-align: left;">A hairy cell leukemia requiring initial treatment because of the presence of signs of progression.  Signs of progression include cytopenia (especially if symptomatic), increasing splenomegaly, and infectious complications.  Therapy is not necessary if the patients are asymptomatic and the blood counts are maintained in an acceptable range.</td>
<td style="text-align: left;">MONDO:0018935</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858185</td>
<td style="text-align: left;">high grade b-cell lymphoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C80291</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">High Grade B-Cell Lymphoma, Not Otherwise Specified</td>
<td style="text-align: left;">High-grade B-cell lymphoma with blastoid features or features between diffuse large B-cell lymphoma and Burkitt lymphoma that lacks MYC, BCL2, and BCL6 gene rearrangements.</td>
<td style="text-align: left;">MONDO:0044889</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858186</td>
<td style="text-align: left;">pediatric-type follicular lymphoma</td>
<td style="text-align: left;">NCIT:C80297</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pediatric-Type Follicular Lymphoma</td>
<td style="text-align: left;">A nodal follicular lymphoma with favorable prognosis. It lacks BCL-2 rearrangement and 14;18 translocation. Nearly all cases are localized. It is usually seen in the pediatric population but similar lymphomas may occur in adults.</td>
<td style="text-align: left;">MONDO:0018906</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858189</td>
<td style="text-align: left;">monoclonal b-cell lymphocytosis</td>
<td style="text-align: left;">NCIT:C80310</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Monoclonal B-Cell Lymphocytosis</td>
<td style="text-align: left;">A monoclonal expansion of B-lymphocytes with or without the characteristic immunophenotype of chronic lymphocytic leukemia. It precedes virtually all cases of chronic lymphocytic leukemia/small lymphocytic lymphoma.</td>
<td style="text-align: left;">MONDO:0004949</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858190</td>
<td style="text-align: left;">b lymphoblastic leukemia/lymphoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C80326</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified</td>
<td style="text-align: left;">B lymphoblastic leukemias/lymphomas characterized by the absence of recurrent genetic abnormalities.</td>
<td style="text-align: left;">MONDO:0004947</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858191</td>
<td style="text-align: left;">b lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); tcf3-pbx1</td>
<td style="text-align: left;">NCIT:C80341</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1</td>
<td style="text-align: left;">A precursor lymphoid neoplasm which is composed of B lymphoblasts and carries a translocation between the E2A gene on chromosome 19 and the PBX1 gene on chromosome 1.</td>
<td style="text-align: left;">MONDO:0035605</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858205</td>
<td style="text-align: left;">regional adrenal gland pheochromocytoma</td>
<td style="text-align: left;">NCIT:C8045</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Regional Adrenal Gland Pheochromocytoma</td>
<td style="text-align: left;">A pheochromocytoma that has not spread to other regions.</td>
<td style="text-align: left;">MONDO:0004974</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858211</td>
<td style="text-align: left;">stage i ovarian germ cell tumor ajcc v6 and v7</td>
<td style="text-align: left;">NCIT:C8083</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage I Ovarian Germ Cell Tumor AJCC v6 and v7</td>
<td style="text-align: left;">Stage I includes: (T1, N0, M0). T1: Tumor limited to ovaries (one or both).  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th Eds.)</td>
<td style="text-align: left;">MONDO:0018171</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858212</td>
<td style="text-align: left;">stage ii ovarian germ cell tumor ajcc v6 and v7</td>
<td style="text-align: left;">NCIT:C8084</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage II Ovarian Germ Cell Tumor AJCC v6 and v7</td>
<td style="text-align: left;">Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0018171</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858213</td>
<td style="text-align: left;">stage iii ovarian germ cell tumor ajcc v6 and v7</td>
<td style="text-align: left;">NCIT:C8085</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage III Ovarian Germ Cell Tumor AJCC v6 and v7</td>
<td style="text-align: left;">Stage III includes: T3, N0, M0. T3: Tumor involves one or both both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0018171</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858214</td>
<td style="text-align: left;">stage iv ovarian germ cell tumor ajcc v6 and v7</td>
<td style="text-align: left;">NCIT:C8086</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7</td>
<td style="text-align: left;">Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0018171</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858219</td>
<td style="text-align: left;">regional renal pelvis and ureter urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C8168</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Regional Renal Pelvis and Ureter Urothelial Carcinoma</td>
<td style="text-align: left;">Urothelial carcinoma of the renal pelvis or ureter that has spread to adjacent tissues and/or regional lymph nodes but not to distant anatomic sites.</td>
<td style="text-align: left;">MONDO:0020654</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858221</td>
<td style="text-align: left;">buccal mucosa verrucous carcinoma</td>
<td style="text-align: left;">NCIT:C8175</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Buccal Mucosa Verrucous Carcinoma</td>
<td style="text-align: left;">A verrucous carcinoma of the oral cavity that arises from the buccal mucosa.</td>
<td style="text-align: left;">MONDO:0021538,MONDO:0021431</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858224</td>
<td style="text-align: left;">disseminated juvenile xanthogranuloma</td>
<td style="text-align: left;">NCIT:C81772</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Disseminated Juvenile Xanthogranuloma</td>
<td style="text-align: left;">Juvenile xanthogranuloma disseminated to extracutaneous sites including mucosal surfaces, lung, central nervous system, pituitary, lymph nodes, eye, liver, and bone marrow. It is characterized by the presence of lipid-laden, foamy histiocytes and Touton-type giant cells forming nodules in the affected anatomic sites.</td>
<td style="text-align: left;">MONDO:0015534</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858242</td>
<td style="text-align: left;">natural killer cell lymphoblastic leukemia/lymphoma</td>
<td style="text-align: left;">NCIT:C82217</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Natural Killer Cell Lymphoblastic Leukemia/Lymphoma</td>
<td style="text-align: left;">A precursor lymphoid neoplasm that expresses CD56 and immature T-cell markers, lacks B-lymphoid and myeloid markers, and has immunoglobulin and T-cell receptor genes in the germline configuration.</td>
<td style="text-align: left;">MONDO:0003538</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858245</td>
<td style="text-align: left;">myelodysplastic/myeloproliferative neoplasm post cytotoxic therapy</td>
<td style="text-align: left;">NCIT:C82397</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic/Myeloproliferative Neoplasm Post Cytotoxic Therapy</td>
<td style="text-align: left;">A myelodysplastic/myeloproliferative neoplasm arising as a result of the mutagenic effect of chemotherapy agents and/or radiation that are used for the treatment of neoplastic or non-neoplastic disorders.</td>
<td style="text-align: left;">MONDO:0006311,MONDO:0006450</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858246</td>
<td style="text-align: left;">acute myeloid leukemia with myelodysplasia-related gene mutations</td>
<td style="text-align: left;">NCIT:C82430</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations</td>
<td style="text-align: left;">A group of acute myeloid leukemias characterized by the presence of gene mutations that are associated with myelodysplasia.</td>
<td style="text-align: left;">MONDO:0100409</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858249</td>
<td style="text-align: left;">de novo myelodysplastic syndrome</td>
<td style="text-align: left;">NCIT:C8253</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">De Novo Myelodysplastic Syndrome</td>
<td style="text-align: left;">A primary myelodysplastic syndrome that is not associated with prior radiation or chemotherapy treatment.</td>
<td style="text-align: left;">MONDO:0018881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858251</td>
<td style="text-align: left;">adult anaplastic astrocytoma</td>
<td style="text-align: left;">NCIT:C8257</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Anaplastic Astrocytoma</td>
<td style="text-align: left;">An astrocytoma occurring in adults that is characterized by the presence of high mitotic activity, cytologic atypia, and architectural distortion.</td>
<td style="text-align: left;">MONDO:0004320,MONDO:0016684</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858252</td>
<td style="text-align: left;">refractory neutropenia</td>
<td style="text-align: left;">NCIT:C82593</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Neutropenia</td>
<td style="text-align: left;">A myelodysplastic syndrome characterized by the presence of at least 10% dysplastic neutrophils in the bone marrow or the peripheral blood.</td>
<td style="text-align: left;">MONDO:0005272</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858253</td>
<td style="text-align: left;">refractory thrombocytopenia</td>
<td style="text-align: left;">NCIT:C82594</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Thrombocytopenia</td>
<td style="text-align: left;">A myelodysplastic syndrome characterized by the presence of at least 10% dysplastic megakaryocytes, found within at least 30 megakaryocytes examined in the bone marrow.</td>
<td style="text-align: left;">MONDO:0005272</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858254</td>
<td style="text-align: left;">myelodysplastic syndrome with excess blasts and fibrosis</td>
<td style="text-align: left;">NCIT:C82595</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic Syndrome with Excess Blasts and Fibrosis</td>
<td style="text-align: left;">Myelodysplastic syndrome with excess blasts associated with significant reticulin fibrosis of the bone marrow.</td>
<td style="text-align: left;">MONDO:0019454</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858256</td>
<td style="text-align: left;">myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis, not otherwise specified</td>
<td style="text-align: left;">NCIT:C82616</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified</td>
<td style="text-align: left;">A myelodysplastic/myeloproliferative neoplasm characterized by marked thrombocytosis, anemia, erythroid lineage dysplasia, presence or absence of multilineage dysplasia, 15% or more ring sideroblasts, blasts less than 5% in bone marrow and less than 1% in peripheral blood, absence of BCR/ABL fusion, absence of SF3B1 mutation, absence of genetic abnormalities associated with myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions, and no history of other myelodysplastic/myeloproliferative neoplasms or myeloproliferative neoplasms and myelodysplastic syndromes.</td>
<td style="text-align: left;">MONDO:0006311</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858257</td>
<td style="text-align: left;">adult cholangiocarcinoma</td>
<td style="text-align: left;">NCIT:C8265</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Cholangiocarcinoma</td>
<td style="text-align: left;">A cholangiocarcinoma occurring in adults.</td>
<td style="text-align: left;">MONDO:0019087</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858258</td>
<td style="text-align: left;">meyerson nevus</td>
<td style="text-align: left;">NCIT:C82862</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Meyerson Nevus</td>
<td style="text-align: left;">A nevus surrounded by eczematous changes.</td>
<td style="text-align: left;">MONDO:0044794</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858259</td>
<td style="text-align: left;">cystic oncocytic neoplasm</td>
<td style="text-align: left;">NCIT:C82890</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cystic Oncocytic Neoplasm</td>
<td style="text-align: left;">An oncocytoma with cystic degenerative changes.</td>
<td style="text-align: left;">MONDO:0010795</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858265</td>
<td style="text-align: left;">duodenal extraskeletal osteosarcoma</td>
<td style="text-align: left;">NCIT:C82972</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Duodenal Extraskeletal Osteosarcoma</td>
<td style="text-align: left;">An extraskeletal osteosarcoma affecting the duodenum.</td>
<td style="text-align: left;">MONDO:0000920,MONDO:0002621,MONDO:0003361</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858272</td>
<td style="text-align: left;">cellular pleomorphic adenoma</td>
<td style="text-align: left;">NCIT:C83174</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cellular Pleomorphic Adenoma</td>
<td style="text-align: left;">A pleomorphic adenoma with increased cellularity.</td>
<td style="text-align: left;">MONDO:0008401</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858275</td>
<td style="text-align: left;">atypical hyperplasia</td>
<td style="text-align: left;">NCIT:C8355</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Hyperplasia</td>
<td style="text-align: left;">A morphologic finding indicating the presence of atypical hyperplasia in a sample.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858277</td>
<td style="text-align: left;">low grade intraepithelial neoplasia</td>
<td style="text-align: left;">NCIT:C8367</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Low Grade Intraepithelial Neoplasia</td>
<td style="text-align: left;">A precancerous neoplastic process that affects the squamous, glandular, or transitional cell epithelium without evidence of invasion. It is characterized by the presence of mild epithelial dysplasia.</td>
<td style="text-align: left;">MONDO:0024474</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858280</td>
<td style="text-align: left;">lymphangiomatosis</td>
<td style="text-align: left;">NCIT:C8373</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lymphangiomatosis</td>
<td style="text-align: left;">A lymphangioma affecting several anatomic sites.</td>
<td style="text-align: left;">MONDO:0036870</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858283</td>
<td style="text-align: left;">fibrohistiocytic neoplasm</td>
<td style="text-align: left;">NCIT:C8402</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fibrohistiocytic Neoplasm</td>
<td style="text-align: left;">A benign, intermediate, or malignant mesenchymal neoplasm composed of fibrohistiocytic cells, spindle fibroblastic cells, and histiocytes, in a storiform pattern.</td>
<td style="text-align: left;">MONDO:0002616</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858284</td>
<td style="text-align: left;">benign supraglottis neoplasm</td>
<td style="text-align: left;">NCIT:C8414</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Supraglottis Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the supraglottis and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0004427,MONDO:0002354</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858285</td>
<td style="text-align: left;">benign bartholin gland neoplasm</td>
<td style="text-align: left;">NCIT:C8418</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Bartholin Gland Neoplasm</td>
<td style="text-align: left;">A non-metastasizing neoplasm that arises from the Bartholin gland. Representative examples include adenoma and adenomyoma.</td>
<td style="text-align: left;">MONDO:0000643,MONDO:0021114</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858286</td>
<td style="text-align: left;">diffuse malignant mesothelioma</td>
<td style="text-align: left;">NCIT:C8420</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Malignant Mesothelioma</td>
<td style="text-align: left;">A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.</td>
<td style="text-align: left;">MONDO:0006292</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858287</td>
<td style="text-align: left;">renal benign mesenchymoma</td>
<td style="text-align: left;">NCIT:C84256</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renal Benign Mesenchymoma</td>
<td style="text-align: left;">A benign mesenchymoma arising from the kidney.</td>
<td style="text-align: left;">MONDO:0002382</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858288</td>
<td style="text-align: left;">diffuse neurofibroma</td>
<td style="text-align: left;">NCIT:C8426</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Neurofibroma</td>
<td style="text-align: left;">A rare neurofibroma with an infiltrative growth pattern.  It involves the skin and subcutaneous tissue and grows in a plaque-like fashion.  Malignant transformation is rare.</td>
<td style="text-align: left;">MONDO:0016755</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858289</td>
<td style="text-align: left;">anaplastic astroblastoma, mn1-altered</td>
<td style="text-align: left;">NCIT:C84347</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Astroblastoma, MN1-Altered</td>
<td style="text-align: left;">An astroblastoma, MN1-altered, characterized by the presence of high mitotic activity, cytologic atypia, and architectural distortion.</td>
<td style="text-align: left;">MONDO:0016707</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858299</td>
<td style="text-align: left;">asbestos-related lung disorder</td>
<td style="text-align: left;">NCIT:C84472</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Asbestos-Related Lung Disorder</td>
<td style="text-align: left;">A disorder affecting the lungs due to asbestos exposure. Examples include asbestosis and lung carcinoma.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858304</td>
<td style="text-align: left;">central nervous system cavernous hemangioma</td>
<td style="text-align: left;">NCIT:C84621</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Cavernous Hemangioma</td>
<td style="text-align: left;">A cavernous hemangioma arising from the central nervous system.</td>
<td style="text-align: left;">MONDO:0003241,MONDO:0003155</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858314</td>
<td style="text-align: left;">invasive malignant neoplasm</td>
<td style="text-align: left;">NCIT:C8505</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Malignant Neoplasm</td>
<td style="text-align: left;">Cancer that has spread beyond the layer of tissue in which it developed and is growing into surrounding, healthy tissues.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858316</td>
<td style="text-align: left;">refractory carcinoma</td>
<td style="text-align: left;">NCIT:C8511</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Carcinoma</td>
<td style="text-align: left;">A carcinoma that does not respond to treatment.</td>
<td style="text-align: left;">MONDO:0036501,MONDO:0004993</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858321</td>
<td style="text-align: left;">locally advanced malignant neoplasm</td>
<td style="text-align: left;">NCIT:C8524</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Locally Advanced Malignant Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that has spread from its original site of growth to nearby tissues or lymph nodes.</td>
<td style="text-align: left;">MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858330</td>
<td style="text-align: left;">metastatic malignant neoplasm in the nervous system</td>
<td style="text-align: left;">NCIT:C8547</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Nervous System</td>
<td style="text-align: left;">The spread of a malignant neoplasm to the nervous system.  This may be from a primary nervous system malignant neoplasm, or from a malignant neoplasm at a distant site.</td>
<td style="text-align: left;">MONDO:0005872,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858334</td>
<td style="text-align: left;">metastatic malignant neoplasm in the retina</td>
<td style="text-align: left;">NCIT:C8555</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Retina</td>
<td style="text-align: left;">A malignant neoplasm that has spread to the retina from another anatomic site.</td>
<td style="text-align: left;">MONDO:0003072,MONDO:0044913</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858339</td>
<td style="text-align: left;">invasive cervical carcinoma</td>
<td style="text-align: left;">NCIT:C8577</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Cervical Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the cervix and invades into the stromal tissue.</td>
<td style="text-align: left;">MONDO:0040677,MONDO:0005131</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858341</td>
<td style="text-align: left;">precancerous polyp</td>
<td style="text-align: left;">NCIT:C8587</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Precancerous Polyp</td>
<td style="text-align: left;">A polyp with severe dysplastic features.</td>
<td style="text-align: left;">MONDO:0021075</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858342</td>
<td style="text-align: left;">leukemic phase of non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C8594</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Leukemic Phase of Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">The presence of malignant lymphocytes in the peripheral blood in a patient with non-Hodgkin lymphoma. It is usually a terminal event in the clinical course of non-Hodgkin lymphomas.</td>
<td style="text-align: left;">MONDO:0005402,MONDO:0018908</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858343</td>
<td style="text-align: left;">postcricoid carcinoma</td>
<td style="text-align: left;">NCIT:C8595</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Postcricoid Carcinoma</td>
<td style="text-align: left;">A carcinoma of the hypopharynx that arises from the postcricoid region.</td>
<td style="text-align: left;">MONDO:0005216,MONDO:0004635</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858346</td>
<td style="text-align: left;">anaplastic (malignant) spinal cord meningioma</td>
<td style="text-align: left;">NCIT:C8605</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic (Malignant) Spinal Cord Meningioma</td>
<td style="text-align: left;">An anaplastic (malignant) meningioma that arises from the spinal cord meninges.</td>
<td style="text-align: left;">MONDO:0020635,MONDO:0003544,MONDO:0001275</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858350</td>
<td style="text-align: left;">malignant hepatobiliary neoplasm</td>
<td style="text-align: left;">NCIT:C8609</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Hepatobiliary Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that affects the liver parenchyma, bile ducts, and gallbladder.  Representative examples include hepatocellular carcinoma, intrahepatic and extrahepatic cholangiocarcinoma, and gallbladder carcinoma.</td>
<td style="text-align: left;">MONDO:0002514,MONDO:0002516</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858363</td>
<td style="text-align: left;">stage i t lymphoblastic leukemia/lymphoma</td>
<td style="text-align: left;">NCIT:C8697</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage I T Lymphoblastic Leukemia/Lymphoma</td>
<td style="text-align: left;">Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (Rare in Hodgkin lymphoma).</td>
<td style="text-align: left;">MONDO:0003537</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858364</td>
<td style="text-align: left;">stage ii t lymphoblastic leukemia/lymphoma</td>
<td style="text-align: left;">NCIT:C8698</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage II T Lymphoblastic Leukemia/Lymphoma</td>
<td style="text-align: left;">Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in a with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE).</td>
<td style="text-align: left;">MONDO:0003537</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858365</td>
<td style="text-align: left;">stage iii t lymphoblastic leukemia/lymphoma</td>
<td style="text-align: left;">NCIT:C8699</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage III T Lymphoblastic Leukemia/Lymphoma</td>
<td style="text-align: left;">Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S).</td>
<td style="text-align: left;">MONDO:0003537</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858366</td>
<td style="text-align: left;">stage iv t lymphoblastic leukemia/lymphoma</td>
<td style="text-align: left;">NCIT:C8700</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage IV T Lymphoblastic Leukemia/Lymphoma</td>
<td style="text-align: left;">Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, or nodular involvement of the lungs(s).</td>
<td style="text-align: left;">MONDO:0003537</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858370</td>
<td style="text-align: left;">metastatic malignant hemangiopericytoma</td>
<td style="text-align: left;">NCIT:C8709</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Hemangiopericytoma</td>
<td style="text-align: left;">A malignant hemangiopericytoma which has spread to another anatomical site.</td>
<td style="text-align: left;">MONDO:0009330</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858371</td>
<td style="text-align: left;">primary malignant hemangiopericytoma</td>
<td style="text-align: left;">NCIT:C8710</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Malignant Hemangiopericytoma</td>
<td style="text-align: left;">A rare malignant mesenchymal neoplasm that is believed to have its origin in smooth muscle derived pericytes without evidence of metastases.</td>
<td style="text-align: left;">MONDO:0009330</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858381</td>
<td style="text-align: left;">stage i ovarian choriocarcinoma</td>
<td style="text-align: left;">NCIT:C8730</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage I Ovarian Choriocarcinoma</td>
<td style="text-align: left;">Stage I includes: T1, N0, M0. T1: Tumor limited to ovaries (one or both). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0003507</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858382</td>
<td style="text-align: left;">stage ii ovarian choriocarcinoma</td>
<td style="text-align: left;">NCIT:C8731</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage II Ovarian Choriocarcinoma</td>
<td style="text-align: left;">Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0003507</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858383</td>
<td style="text-align: left;">stage iii ovarian choriocarcinoma</td>
<td style="text-align: left;">NCIT:C8732</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage III Ovarian Choriocarcinoma</td>
<td style="text-align: left;">Stage III includes: T3, N0, M0. T3: Tumor involves one or both both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0003507</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858384</td>
<td style="text-align: left;">stage iv ovarian choriocarcinoma</td>
<td style="text-align: left;">NCIT:C8733</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage IV Ovarian Choriocarcinoma</td>
<td style="text-align: left;">Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0003507</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858395</td>
<td style="text-align: left;">stage i pharyngeal cancer</td>
<td style="text-align: left;">NCIT:C8768</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage I Pharyngeal Cancer</td>
<td style="text-align: left;">Stage I carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.</td>
<td style="text-align: left;">MONDO:0021345</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858396</td>
<td style="text-align: left;">stage ii pharyngeal cancer</td>
<td style="text-align: left;">NCIT:C8769</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage II Pharyngeal Cancer</td>
<td style="text-align: left;">Stage II carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.</td>
<td style="text-align: left;">MONDO:0021345</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858397</td>
<td style="text-align: left;">stage iii pharyngeal cancer</td>
<td style="text-align: left;">NCIT:C8770</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage III Pharyngeal Cancer</td>
<td style="text-align: left;">Stage III carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.</td>
<td style="text-align: left;">MONDO:0021345</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858398</td>
<td style="text-align: left;">stage iv pharyngeal cancer</td>
<td style="text-align: left;">NCIT:C8771</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage IV Pharyngeal Cancer</td>
<td style="text-align: left;">Stage IV carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.</td>
<td style="text-align: left;">MONDO:0021345</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858443</td>
<td style="text-align: left;">b lymphoblastic lymphoma</td>
<td style="text-align: left;">NCIT:C8868</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">B Lymphoblastic Lymphoma</td>
<td style="text-align: left;">An uncommon type of lymphoma.  It constitutes approximately 10% of cases of lymphoblastic lymphoma.  Approximately 75% of cases reported in a literature review involved patients who were less than 18 years of age.  The most commonly affected sites are the skin, bone, soft tissue, and lymph nodes.  It has a high remission rate with a median survival of approximately 60 months.  (WHO, 2001)</td>
<td style="text-align: left;">MONDO:0000873,MONDO:0017595,MONDO:0004947</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858446</td>
<td style="text-align: left;">extragonadal embryonal carcinoma</td>
<td style="text-align: left;">NCIT:C8880</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extragonadal Embryonal Carcinoma</td>
<td style="text-align: left;">An embryonal carcinoma that develops as a primary tumor in an anatomic site other than the testis or ovary.</td>
<td style="text-align: left;">MONDO:0003578,MONDO:0005440</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858459</td>
<td style="text-align: left;">pediatric disorder</td>
<td style="text-align: left;">NCIT:C89328</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pediatric Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder which occurs during infancy, childhood, or adolescence.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858464</td>
<td style="text-align: left;">fundic gland polyp</td>
<td style="text-align: left;">NCIT:C8961</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fundic Gland Polyp</td>
<td style="text-align: left;">The most common gastric polyp in the Western hemisphere.  The lesion consists of a localized hyperplasia of the deep epithelial compartment of the oxyntic mucosa, with variable degrees of cystic dilatation.  Malignant transformation is the exception.  (WHO, 2000)</td>
<td style="text-align: left;">MONDO:0006221,MONDO:0036976</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858471</td>
<td style="text-align: left;">oral neoplasm</td>
<td style="text-align: left;">NCIT:C8989</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oral Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm involving the oral cavity and/or the lips.</td>
<td style="text-align: left;">MONDO:0005586,MONDO:0006858</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858472</td>
<td style="text-align: left;">malignant mastocytosis</td>
<td style="text-align: left;">NCIT:C8991</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Mastocytosis</td>
<td style="text-align: left;">A group of malignant mast cell disorders including aggressive systemic mastocytosis, mast cell leukemia, mast cell sarcoma, and systemic mastocytosis with an associated myeloid neoplasm. Individuals with advanced systemic mastocytosis have a reduced life expectancy, with median survival measured in months to years.</td>
<td style="text-align: left;">MONDO:0004992,MONDO:0016586</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858473</td>
<td style="text-align: left;">benign adrenal cortical neoplasm</td>
<td style="text-align: left;">NCIT:C9004</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Adrenal Cortical Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the adrenal cortex and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0021511,MONDO:0036591</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858474</td>
<td style="text-align: left;">acute myelomonocytic leukemia with abnormal eosinophils</td>
<td style="text-align: left;">NCIT:C9020</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myelomonocytic Leukemia with Abnormal Eosinophils</td>
<td style="text-align: left;">Acute myelomonocytic leukemia characterized by the presence of abnormal bone marrow eosinophils. It is associated with inv(16)(p13.1;q22) or t(16;16)(p13.1;q22). It has a favorable prognosis.</td>
<td style="text-align: left;">MONDO:0018871</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858475</td>
<td style="text-align: left;">sarcoma by fnclcc grade</td>
<td style="text-align: left;">NCIT:C9023</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sarcoma by FNCLCC Grade</td>
<td style="text-align: left;">Grading of sarcomas according to the French Federation of Cancer Centers Sarcoma Group (FNCLCC). This sarcoma grading system is based on three factors: differentiation, mitotic count, and tumor necrosis. The scores for each factor are added to determine the grade (1 to 3) for the sarcoma.</td>
<td style="text-align: left;">MONDO:0005089</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858479</td>
<td style="text-align: left;">renal cell cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90343</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renal Cell Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of renal cell cancer according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0005549</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858480</td>
<td style="text-align: left;">bladder cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90344</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of bladder cancer according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0004986</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858481</td>
<td style="text-align: left;">vulvar cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90345</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of vulvar carcinoma according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0005215</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858482</td>
<td style="text-align: left;">vaginal cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90347</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of vaginal cancer according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0015867</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858483</td>
<td style="text-align: left;">adult angiosarcoma</td>
<td style="text-align: left;">NCIT:C9040</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Angiosarcoma</td>
<td style="text-align: left;">An angiosarcoma occurring in the adult population.</td>
<td style="text-align: left;">MONDO:0016982</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858485</td>
<td style="text-align: left;">extensive stage lung small cell carcinoma</td>
<td style="text-align: left;">NCIT:C9049</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extensive Stage Lung Small Cell Carcinoma</td>
<td style="text-align: left;">Small cell lung carcinoma which has spread beyond one hemi-thorax and the regional lymph nodes.</td>
<td style="text-align: left;">MONDO:0008433</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858486</td>
<td style="text-align: left;">cervical cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90493</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0005131</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858487</td>
<td style="text-align: left;">uterine corpus carcinoma or carcinosarcoma by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90494</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of uterine corpus carcinoma or carcinosarcoma according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0006003</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858488</td>
<td style="text-align: left;">fallopian tube cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90499</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fallopian Tube Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of fallopian tube carcinoma according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0006206</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858489</td>
<td style="text-align: left;">esophageal cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90500</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of esophageal carcinoma according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0019086</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858490</td>
<td style="text-align: left;">gastric cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90503</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of gastric cancer according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0004950</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858491</td>
<td style="text-align: left;">colorectal cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90506</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of colorectal carcinoma according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0024331</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858493</td>
<td style="text-align: left;">hepatocellular carcinoma by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90510</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatocellular Carcinoma by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of hepatocellular carcinoma according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0007256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858494</td>
<td style="text-align: left;">gallbladder cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90512</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of gallbladder cancer according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0003220</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858495</td>
<td style="text-align: left;">breast cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90513</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of breast cancer according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0004989</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858496</td>
<td style="text-align: left;">cutaneous melanoma by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90514</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Melanoma by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of cutaneous melanoma, following the rules of the TNM AJCC v6 classification system.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858497</td>
<td style="text-align: left;">lung cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90519</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of lung carcinoma according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0005138</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858498</td>
<td style="text-align: left;">penile cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90520</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of penile carcinoma according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0006360</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858499</td>
<td style="text-align: left;">prostate cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90521</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of prostate carcinoma according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0005159</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858502</td>
<td style="text-align: left;">pharyngeal carcinoma by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90525</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pharyngeal Carcinoma by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of pharyngeal carcinoma according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0021345</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858503</td>
<td style="text-align: left;">laryngeal cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90527</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Laryngeal Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of laryngeal carcinoma according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0002358</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858504</td>
<td style="text-align: left;">sinonasal cancer by ajcc v6 stage</td>
<td style="text-align: left;">NCIT:C90528</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sinonasal Cancer by AJCC v6 Stage</td>
<td style="text-align: left;">A term that refers to the staging of nasal cavity and paranasal sinus carcinoma according to the American Joint Committee on Cancer, 6th edition.</td>
<td style="text-align: left;">MONDO:0056819</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858510</td>
<td style="text-align: left;">kaposi sarcoma related to immunosuppressive treatment</td>
<td style="text-align: left;">NCIT:C9113</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kaposi Sarcoma Related to Immunosuppressive Treatment</td>
<td style="text-align: left;">A Kaposi sarcoma that develops after immunosuppressive treatment.</td>
<td style="text-align: left;">MONDO:0005188</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858511</td>
<td style="text-align: left;">renal cell cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91201</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renal Cell Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of renal cell cancer according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0005549</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858512</td>
<td style="text-align: left;">bladder cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91202</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bladder Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of bladder cancer according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0004986</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858513</td>
<td style="text-align: left;">vulvar cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91203</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of vulvar carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0005215</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858514</td>
<td style="text-align: left;">vaginal cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91204</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vaginal Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of vaginal cancer according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0015867</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858515</td>
<td style="text-align: left;">cervical cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91208</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0005131</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858516</td>
<td style="text-align: left;">uterine corpus carcinoma or carcinosarcoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91218</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of uterine corpus carcinoma or carcinosarcoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0006003</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858517</td>
<td style="text-align: left;">fallopian tube cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91219</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fallopian Tube Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of fallopian tube carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0006206</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858518</td>
<td style="text-align: left;">esophageal cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91221</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of esophageal carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0019086</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858519</td>
<td style="text-align: left;">gastric cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91222</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of gastric carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0004950</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858520</td>
<td style="text-align: left;">colorectal cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91223</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of colorectal carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0024331</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858522</td>
<td style="text-align: left;">hepatocellular carcinoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91228</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatocellular Carcinoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of hepatocellular carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0007256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858523</td>
<td style="text-align: left;">gallbladder cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91229</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of gallbladder cancer according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0003220</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858524</td>
<td style="text-align: left;">breast cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91230</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of breast cancer according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0004989</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858525</td>
<td style="text-align: left;">cutaneous melanoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91231</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Melanoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of cutaneous melanoma, following the rules of the TNM AJCC v7 classification system.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858526</td>
<td style="text-align: left;">lung cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91232</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of lung carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0005138</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858527</td>
<td style="text-align: left;">prostate cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91233</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of prostate carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0005159</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858528</td>
<td style="text-align: left;">penile cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91234</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of penile carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0006360</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858531</td>
<td style="text-align: left;">pharyngeal carcinoma by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91252</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pharyngeal Carcinoma by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of pharyngeal carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0021345</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858532</td>
<td style="text-align: left;">sinonasal cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91255</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sinonasal Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of nasal cavity and paranasal sinus carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0056819</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858533</td>
<td style="text-align: left;">laryngeal cancer by ajcc v7 stage</td>
<td style="text-align: left;">NCIT:C91256</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Laryngeal Cancer by AJCC v7 Stage</td>
<td style="text-align: left;">A term that refers to the staging of laryngeal carcinoma according to the American Joint Committee on Cancer, 7th edition.</td>
<td style="text-align: left;">MONDO:0002358</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858534</td>
<td style="text-align: left;">chronic myeloid leukemia, philadelphia chromosome positive, bcr-abl1 positive</td>
<td style="text-align: left;">NCIT:C9128</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive</td>
<td style="text-align: left;">A chronic myeloid leukemia characterized by the t(9;22)(q34;q11) chromosomal translocation, resulting in the presence of the Philadelphia chromosome and the BCR-ABL1 fusion gene.</td>
<td style="text-align: left;">MONDO:0024685,MONDO:0011996</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858535</td>
<td style="text-align: left;">adult rhabdomyosarcoma</td>
<td style="text-align: left;">NCIT:C9130</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Rhabdomyosarcoma</td>
<td style="text-align: left;">An aggressive malignant mesenchymal neoplasm arising from skeletal muscle in adults.</td>
<td style="text-align: left;">MONDO:0005212</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858536</td>
<td style="text-align: left;">invasive breast carcinoma of no special type with predominant intraductal component</td>
<td style="text-align: left;">NCIT:C9132</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Breast Carcinoma of No Special Type with Predominant Intraductal Component</td>
<td style="text-align: left;">An invasive breast carcinoma of no special type characterized by the presence of a predominant ductal carcinoma in situ component and a minor component of invasive carcinoma.</td>
<td style="text-align: left;">MONDO:0004953</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858537</td>
<td style="text-align: left;">invasive breast lobular carcinoma with predominant in situ component</td>
<td style="text-align: left;">NCIT:C9136</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Breast Lobular Carcinoma with Predominant In Situ Component</td>
<td style="text-align: left;">A breast carcinoma characterized by the presence of a predominant lobular carcinoma in situ component and a minor component of invasive carcinoma.</td>
<td style="text-align: left;">MONDO:0005051</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858538</td>
<td style="text-align: left;">adult acute myeloid leukemia</td>
<td style="text-align: left;">NCIT:C9154</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Acute Myeloid Leukemia</td>
<td style="text-align: left;">An acute myeloid leukemia that occurs in adults.</td>
<td style="text-align: left;">MONDO:0018874</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858543</td>
<td style="text-align: left;">testicular mixed embryonal carcinoma and yolk sac tumor with seminoma</td>
<td style="text-align: left;">NCIT:C9172</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma</td>
<td style="text-align: left;">A malignant germ cell tumor arising from the testis.  It is characterized by a mixture of embryonal carcinoma, yolk sac, and seminomatous morphologic elements.  Patients may present with painless or painful testicular swelling.</td>
<td style="text-align: left;">MONDO:0003120</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858546</td>
<td style="text-align: left;">good prognosis metastatic gestational trophoblastic tumor</td>
<td style="text-align: left;">NCIT:C9177</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Good Prognosis Metastatic Gestational Trophoblastic Tumor</td>
<td style="text-align: left;">Metastatic gestational trophoblastic tumor in which risk factors are absent.</td>
<td style="text-align: left;">MONDO:0018944</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858547</td>
<td style="text-align: left;">poor prognosis metastatic gestational trophoblastic tumor</td>
<td style="text-align: left;">NCIT:C9178</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Poor Prognosis Metastatic Gestational Trophoblastic Tumor</td>
<td style="text-align: left;">Metastatic gestational trophoblastic tumor in which risk factors are present.</td>
<td style="text-align: left;">MONDO:0018944</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858549</td>
<td style="text-align: left;">intraocular schwannoma</td>
<td style="text-align: left;">NCIT:C92182</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intraocular Schwannoma</td>
<td style="text-align: left;">A benign schwannoma occurring in the eye.</td>
<td style="text-align: left;">MONDO:0021454,MONDO:0004820</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858550</td>
<td style="text-align: left;">esophageal malignant peripheral nerve sheath tumor</td>
<td style="text-align: left;">NCIT:C92185</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Malignant Peripheral Nerve Sheath Tumor</td>
<td style="text-align: left;">A malignant peripheral nerve sheath tumor that affects the esophageal wall.</td>
<td style="text-align: left;">MONDO:0001204,MONDO:0017827</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858551</td>
<td style="text-align: left;">intraocular malignant peripheral nerve sheath tumor</td>
<td style="text-align: left;">NCIT:C92186</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intraocular Malignant Peripheral Nerve Sheath Tumor</td>
<td style="text-align: left;">A malignant peripheral nerve sheath tumor that occurs in the intraocular area.</td>
<td style="text-align: left;">MONDO:0002236,MONDO:0017827</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858558</td>
<td style="text-align: left;">non-hematologic malignancy</td>
<td style="text-align: left;">NCIT:C9226</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Hematologic Malignancy</td>
<td style="text-align: left;">A malignant neoplasm that arises from a site other than the bone marrow and lymphoid tissue.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858562</td>
<td style="text-align: left;">recurrent malignant hemangiopericytoma</td>
<td style="text-align: left;">NCIT:C9254</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Recurrent Malignant Hemangiopericytoma</td>
<td style="text-align: left;">A rare malignant mesenchymal neoplasm, believed to have its origin in smooth muscle derived pericytes, which has recurred after treatment.</td>
<td style="text-align: left;">MONDO:0009330</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858563</td>
<td style="text-align: left;">multifocal glioblastomas</td>
<td style="text-align: left;">NCIT:C92549</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multifocal Glioblastomas</td>
<td style="text-align: left;">The occurrence of multiple and independent glioblastomas that are unrelated to inherited neoplastic syndromes.</td>
<td style="text-align: left;">MONDO:0018177</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858565</td>
<td style="text-align: left;">glioneuronal tumor with neuropil-like islands</td>
<td style="text-align: left;">NCIT:C92550</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Glioneuronal Tumor with Neuropil-Like Islands</td>
<td style="text-align: left;">A rare, WHO grade II or III infiltrating astrocytoma characterized by the presence of sharply demarcated foci, composed of a neuropil-like matrix.</td>
<td style="text-align: left;">MONDO:0019781</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858569</td>
<td style="text-align: left;">anaplastic medulloblastoma</td>
<td style="text-align: left;">NCIT:C92625</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Medulloblastoma</td>
<td style="text-align: left;">A medulloblastoma characterized by marked nuclear pleomorphism, and high mitotic activity.</td>
<td style="text-align: left;">MONDO:0007959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858573</td>
<td style="text-align: left;">malignant peripheral nerve sheath tumor with mesenchymal differentiation</td>
<td style="text-align: left;">NCIT:C92647</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation</td>
<td style="text-align: left;">A malignant peripheral nerve sheath tumor characterized by the presence of mesenchymal differentiation.  Representative example is the malignant Triton tumor which contains a rhabdomyosarcomatous component.</td>
<td style="text-align: left;">MONDO:0017827</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858574</td>
<td style="text-align: left;">mycosis fungoides and sezary syndrome</td>
<td style="text-align: left;">NCIT:C9265</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mycosis Fungoides and Sezary Syndrome</td>
<td style="text-align: left;">Mature T and NK neoplasms predominantly affecting the skin and the peripheral blood.  Peripheral blood involvement by abnormal T-cells (cerebriform cells) is a late manifestation of mycosis fungoides, whereas it is the presenting finding in Sezary syndrome.</td>
<td style="text-align: left;">MONDO:0000430</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858580</td>
<td style="text-align: left;">advanced malignant neoplasm</td>
<td style="text-align: left;">NCIT:C9270</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Advanced Malignant Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that has spread extensively to other anatomic sites or is no longer responding to treatment.</td>
<td style="text-align: left;">MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858584</td>
<td style="text-align: left;">lymphocyte-depleted classic hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C9283</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lymphocyte-Depleted Classic Hodgkin Lymphoma</td>
<td style="text-align: left;">A diffuse subtype of classic Hodgkin lymphoma which is rich in Hodgkin and Reed-Sternberg cells and/or depleted in non-neoplastic lymphocytes. (WHO, 2008)</td>
<td style="text-align: left;">MONDO:0009348</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858585</td>
<td style="text-align: left;">central nervous system histiocytic and dendritic cell neoplasm</td>
<td style="text-align: left;">NCIT:C92944</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Histiocytic and Dendritic Cell Neoplasm</td>
<td style="text-align: left;">A neoplasm that originates from histiocytes and accessory cells and affects the central nervous system.  It is usually associated with the presence of identical tumors outside the central nervous system.  Representative examples include Langerhans cell histiocytosis, histiocytic sarcoma, and follicular dendritic cell sarcoma.</td>
<td style="text-align: left;">MONDO:0006247,MONDO:0003641</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858588</td>
<td style="text-align: left;">peritoneal malignant mesothelioma</td>
<td style="text-align: left;">NCIT:C9350</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Peritoneal Malignant Mesothelioma</td>
<td style="text-align: left;">An aggressive malignant mesothelioma that arises from the peritoneum.  Patients usually present with abdominal pain and ascites.</td>
<td style="text-align: left;">MONDO:0006292,MONDO:0002087,MONDO:0006362</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858597</td>
<td style="text-align: left;">well differentiated malignant hemangiopericytoma</td>
<td style="text-align: left;">NCIT:C9392</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Well Differentiated Malignant Hemangiopericytoma</td>
<td style="text-align: left;">A malignant hemangiopericytoma with well-differentiated morphological features.</td>
<td style="text-align: left;">MONDO:0009330</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858598</td>
<td style="text-align: left;">malignant hemangiopericytoma nci grade 2</td>
<td style="text-align: left;">NCIT:C9393</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Hemangiopericytoma NCI Grade 2</td>
<td style="text-align: left;"></td>
<td style="text-align: left;">MONDO:0002789</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858599</td>
<td style="text-align: left;">malignant hemangiopericytoma nci grade 3</td>
<td style="text-align: left;">NCIT:C9394</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Hemangiopericytoma NCI Grade 3</td>
<td style="text-align: left;"></td>
<td style="text-align: left;">MONDO:0002789</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858600</td>
<td style="text-align: left;">round cell liposarcoma nci grade 2</td>
<td style="text-align: left;">NCIT:C9401</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Round Cell Liposarcoma NCI Grade 2</td>
<td style="text-align: left;"></td>
<td style="text-align: left;">MONDO:0005238</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858601</td>
<td style="text-align: left;">round cell liposarcoma nci grade 3</td>
<td style="text-align: left;">NCIT:C9402</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Round Cell Liposarcoma NCI Grade 3</td>
<td style="text-align: left;"></td>
<td style="text-align: left;">MONDO:0005238</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858625</td>
<td style="text-align: left;">breast ductal carcinoma in situ, intermediate grade</td>
<td style="text-align: left;">NCIT:C9456</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Ductal Carcinoma In Situ, Intermediate Grade</td>
<td style="text-align: left;">Breast ductal carcinoma in situ characterized by the presence of monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. Intraluminal necrosis is present in some ducts. Ducts that contain neoplastic cells with occasional nucleoli and coarse chromatin may also be present.</td>
<td style="text-align: left;">MONDO:0005023</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858626</td>
<td style="text-align: left;">breast ductal carcinoma in situ, low grade</td>
<td style="text-align: left;">NCIT:C9457</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Ductal Carcinoma In Situ, Low Grade</td>
<td style="text-align: left;">Breast ductal carcinoma in situ characterized by the presence of small, monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. The nuclei are uniform and mitotic figures are rare.</td>
<td style="text-align: left;">MONDO:0005023</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858627</td>
<td style="text-align: left;">borderline ovarian brenner tumor</td>
<td style="text-align: left;">NCIT:C9459</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Borderline Ovarian Brenner Tumor</td>
<td style="text-align: left;">A neoplasm of low malignant potential arising from the ovary. It is characterized by the presence of neoplastic atypical urothelial-type cells in a fibrotic stroma without evidence of invasion.</td>
<td style="text-align: left;">MONDO:0016093,MONDO:0002370</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858628</td>
<td style="text-align: left;">systemic anaplastic large cell lymphoma</td>
<td style="text-align: left;">NCIT:C9470</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Systemic Anaplastic Large Cell Lymphoma</td>
<td style="text-align: left;">An anaplastic large cell lymphoma that is not confined to a single anatomic site and involves multiple nodal and/or extranodal sites.</td>
<td style="text-align: left;">MONDO:0020325</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858630</td>
<td style="text-align: left;">meningeal leukemia</td>
<td style="text-align: left;">NCIT:C94754</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Meningeal Leukemia</td>
<td style="text-align: left;">Infiltration of the meninges by an acute or chronic leukemia.</td>
<td style="text-align: left;">MONDO:0700219,MONDO:0001606</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858632</td>
<td style="text-align: left;">multifocal breast carcinoma</td>
<td style="text-align: left;">NCIT:C94770</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multifocal Breast Carcinoma</td>
<td style="text-align: left;">A breast carcinoma characterized by the presence of multiple cancerous tumors that originate from the same clone and are usually located in the same quadrant of the breast.</td>
<td style="text-align: left;">MONDO:0004989</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858633</td>
<td style="text-align: left;">multicentric breast carcinoma</td>
<td style="text-align: left;">NCIT:C94772</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multicentric Breast Carcinoma</td>
<td style="text-align: left;">A breast carcinoma characterized by the presence of multiple cancerous tumors that originate from different clones and are usually located in different quadrants of the breast.</td>
<td style="text-align: left;">MONDO:0004989</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858634</td>
<td style="text-align: left;">early stage breast carcinoma</td>
<td style="text-align: left;">NCIT:C94774</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early Stage Breast Carcinoma</td>
<td style="text-align: left;">Breast carcinoma that has not spread beyond the breast and the axillary lymph nodes.</td>
<td style="text-align: left;">MONDO:0004989</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858635</td>
<td style="text-align: left;">hereditary malignant neoplasm</td>
<td style="text-align: left;">NCIT:C9479</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hereditary Malignant Neoplasm</td>
<td style="text-align: left;">Malignant neoplasms occurring in families at a rate greater than that expected by chance and caused by germline mutations in a specific gene.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858637</td>
<td style="text-align: left;">stage i borderline ovarian surface epithelial-stromal tumor</td>
<td style="text-align: left;">NCIT:C94821</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor</td>
<td style="text-align: left;">Stage I includes: T1, N0, M0. T1: Tumor limited to ovaries (one or both).  N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0016093</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858638</td>
<td style="text-align: left;">stage ii borderline ovarian surface epithelial-stromal tumor</td>
<td style="text-align: left;">NCIT:C94822</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor</td>
<td style="text-align: left;">Stage II includes: T2, N0, M0.  T2: Tumor involves one or both ovaries with pelvic extension and/or implants.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0016093</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858639</td>
<td style="text-align: left;">stage iii borderline ovarian surface epithelial-stromal tumor</td>
<td style="text-align: left;">NCIT:C94824</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor</td>
<td style="text-align: left;">Stage III includes: T3, N0, M0.  T3: Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside pelvis.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0016093</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858640</td>
<td style="text-align: left;">stage iv borderline ovarian surface epithelial-stromal tumor</td>
<td style="text-align: left;">NCIT:C94825</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor</td>
<td style="text-align: left;">Stage IV includes: Any T, Any N, M1.  M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.)</td>
<td style="text-align: left;">MONDO:0016093</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858648</td>
<td style="text-align: left;">melanocytoma</td>
<td style="text-align: left;">NCIT:C9498</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Melanocytoma</td>
<td style="text-align: left;">A usually benign neoplasm that arises from the sun-exposed skin, eye, and meninges. It is composed of spindle and/or epithelioid melanocytes and melanophages. It rarely progresses to melanoma.</td>
<td style="text-align: left;">MONDO:0021143</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858649</td>
<td style="text-align: left;">myolipoma</td>
<td style="text-align: left;">NCIT:C9502</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myolipoma</td>
<td style="text-align: left;">A benign extrauterine tumor composed of mature adipocytes and smooth muscle cells.</td>
<td style="text-align: left;">MONDO:0005106</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858650</td>
<td style="text-align: left;">thymoliposarcoma</td>
<td style="text-align: left;">NCIT:C95038</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thymoliposarcoma</td>
<td style="text-align: left;">A liposarcoma that arises from the thymus gland.  It is characterized by the presence of a liposarcomatous malignant infiltrate that entraps lobules of thymic tissue.</td>
<td style="text-align: left;">MONDO:0003601,MONDO:0002586</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858651</td>
<td style="text-align: left;">ectopic cervical thymoma</td>
<td style="text-align: left;">NCIT:C95048</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ectopic Cervical Thymoma</td>
<td style="text-align: left;">A thymoma that arises in the cervical region and is not connected with the thymus gland.</td>
<td style="text-align: left;">MONDO:0006456,MONDO:0021351</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858656</td>
<td style="text-align: left;">intramucosal adenocarcinoma</td>
<td style="text-align: left;">NCIT:C95397</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intramucosal Adenocarcinoma</td>
<td style="text-align: left;">A neoplastic lesion that shows morphologic evidence of invasion into the lamina propria or muscularis mucosa.  There is no evidence of invasion into the submucosa.  Evidence of invasion may refer to stromal invasion by single cells or clusters of cells, presence of atypical and complex glandular architectural patterns beyond those that are present in normal mucosa, desmoplasia, and/or vascular invasion.</td>
<td style="text-align: left;">MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858661</td>
<td style="text-align: left;">pancreatic mixed acinar-ductal carcinoma</td>
<td style="text-align: left;">NCIT:C95458</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Mixed Acinar-Ductal Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the pancreas showing either extensive mucin accumulation and acinar neoplastic cells or a mixture of columnar or signet-ring cells and acinar neoplastic cells.</td>
<td style="text-align: left;">MONDO:0006047</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858662</td>
<td style="text-align: left;">pancreatic mixed ductal adenocarcinoma-acinar carcinoma-neuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C95460</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma</td>
<td style="text-align: left;">A very rare carcinoma that arises from the pancreas and is composed of ductal adenocarcinoma, acinar carcinoma, and neuroendocrine carcinoma components.</td>
<td style="text-align: left;">MONDO:0044727</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858663</td>
<td style="text-align: left;">pancreatic hepatoid adenocarcinoma</td>
<td style="text-align: left;">NCIT:C95465</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Hepatoid Adenocarcinoma</td>
<td style="text-align: left;">A rare adenocarcinoma that arises from the pancreas.  It is characterized by marked hepatocellular differentiation.</td>
<td style="text-align: left;">MONDO:0006243,MONDO:0005184</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858664</td>
<td style="text-align: left;">pancreatic medullary carcinoma</td>
<td style="text-align: left;">NCIT:C95466</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Medullary Carcinoma</td>
<td style="text-align: left;">A pancreatic ductal adenocarcinoma characterized by poor differentiation and a prominent syncytial growth pattern.  The prognosis is more favorable compared to conventional pancreatic ductal adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0005184</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858665</td>
<td style="text-align: left;">benign pancreatic serous neoplasm</td>
<td style="text-align: left;">NCIT:C95470</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Pancreatic Serous Neoplasm</td>
<td style="text-align: left;">A benign, non-metastasizing, usually cystic epithelial neoplasm arising from the exocrine pancreas.  It is composed of glycogen-rich epithelial cells which produce a watery fluid.  Signs and symptoms include abdominal mass, abdominal pain, nausea, vomiting, and weight loss.</td>
<td style="text-align: left;">MONDO:0021470,MONDO:0002810,MONDO:0036976</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858666</td>
<td style="text-align: left;">pancreatic intraductal neoplasm</td>
<td style="text-align: left;">NCIT:C95505</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Intraductal Neoplasm</td>
<td style="text-align: left;">A group of cystic or mass-forming epithelial neoplasms that arise from the exocrine pancreas, exhibit ductal differentiation, and grow mostly within the pancreatic ducts.  This group includes the pancreatic intraductal papillary mucinous neoplasms and the pancreatic intraductal tubulopapillary neoplasms.</td>
<td style="text-align: left;">MONDO:0024276,MONDO:0021076</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858667</td>
<td style="text-align: left;">pancreatic intraductal papillary mucinous neoplasm, gastric-type</td>
<td style="text-align: left;">NCIT:C95508</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type</td>
<td style="text-align: left;">A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that are similar to gastric foveolar epithelial cells.</td>
<td style="text-align: left;">MONDO:0004286</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858668</td>
<td style="text-align: left;">pancreatic intraductal papillary mucinous neoplasm, intestinal-type</td>
<td style="text-align: left;">NCIT:C95510</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type</td>
<td style="text-align: left;">A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that form tall papillae, similar to those that are present in colonic villous adenomas.</td>
<td style="text-align: left;">MONDO:0004286</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858669</td>
<td style="text-align: left;">pancreatic intraductal papillary mucinous neoplasm, pancreatobiliary-type</td>
<td style="text-align: left;">NCIT:C95512</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type</td>
<td style="text-align: left;">A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that form thin-branching papillae and exhibit high grade dysplasia.</td>
<td style="text-align: left;">MONDO:0004286</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858675</td>
<td style="text-align: left;">non-functioning pancreatic neuroendocrine tumor g1</td>
<td style="text-align: left;">NCIT:C95585</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Functioning Pancreatic Neuroendocrine Tumor G1</td>
<td style="text-align: left;">A pancreatic neuroendocrine tumor G1 characterized by the absence of a hormone-related clinical syndrome.</td>
<td style="text-align: left;">MONDO:0004334,MONDO:0021535</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858676</td>
<td style="text-align: left;">pancreatic vipoma</td>
<td style="text-align: left;">NCIT:C95599</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Vipoma</td>
<td style="text-align: left;">A usually malignant pancreatic neuroendocrine tumor producing vasoactive intestinal peptide (VIP).  It is associated with watery diarrhea, hypokalemia, and hypochlorhydria or achlorhydria.  One third of cases are metastatic at the time of diagnosis.</td>
<td style="text-align: left;">MONDO:0023206,MONDO:0003622</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858677</td>
<td style="text-align: left;">esophageal spindle cell carcinoma</td>
<td style="text-align: left;">NCIT:C95608</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Spindle Cell Carcinoma</td>
<td style="text-align: left;">An esophageal squamous cell carcinoma characterized by the presence of a spindle-cell carcinomatous component.  Crossly it has a polypoid appearance and usually arises from the middle or lower third of the esophagus.</td>
<td style="text-align: left;">MONDO:0005580,MONDO:0021663</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858678</td>
<td style="text-align: left;">esophageal well differentiated squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C95610</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Well Differentiated Squamous Cell Carcinoma</td>
<td style="text-align: left;">An esophageal squamous cell carcinoma characterized by the presence of prominent keratinization and low mitotic activity.</td>
<td style="text-align: left;">MONDO:0005580</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858679</td>
<td style="text-align: left;">esophageal moderately differentiated squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C95611</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Moderately Differentiated Squamous Cell Carcinoma</td>
<td style="text-align: left;">An esophageal squamous cell carcinoma characterized by the presence of variable morphologic characteristics that include areas of prominent and poor keratinization.</td>
<td style="text-align: left;">MONDO:0005580</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858680</td>
<td style="text-align: left;">esophageal poorly differentiated squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C95612</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Poorly Differentiated Squamous Cell Carcinoma</td>
<td style="text-align: left;">An esophageal squamous cell carcinoma characterized by the presence of basal-like malignant squamous cells that form nests, often associated with central necrosis.</td>
<td style="text-align: left;">MONDO:0005580</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858681</td>
<td style="text-align: left;">esophageal mixed adenoneuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C95621</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Mixed Adenoneuroendocrine Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the esophagus and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.</td>
<td style="text-align: left;">MONDO:0019086,MONDO:0006182</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858683</td>
<td style="text-align: left;">esophageal synovial sarcoma</td>
<td style="text-align: left;">NCIT:C95624</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Synovial Sarcoma</td>
<td style="text-align: left;">A synovial sarcoma that affects the esophageal wall.</td>
<td style="text-align: left;">MONDO:0001204,MONDO:0010434</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858686</td>
<td style="text-align: left;">gastric adenoma, gastric-type</td>
<td style="text-align: left;">NCIT:C95775</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Adenoma, Gastric-Type</td>
<td style="text-align: left;">A neoplastic polyp that arises from the stomach.  It is characterized by the presence of gastric epithelial differentiation.  It includes pyloric gland adenomas and foveolar-type adenomas.</td>
<td style="text-align: left;">MONDO:0006221</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858689</td>
<td style="text-align: left;">gastric mixed adenoneuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C95886</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Mixed Adenoneuroendocrine Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the stomach and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.</td>
<td style="text-align: left;">MONDO:0006182,MONDO:0004950</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858691</td>
<td style="text-align: left;">gastric schwannoma</td>
<td style="text-align: left;">NCIT:C95901</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Schwannoma</td>
<td style="text-align: left;">A rare schwannoma that arises from the stomach.  It follows a benign clinical course.</td>
<td style="text-align: left;">MONDO:0004820,MONDO:0021449</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858693</td>
<td style="text-align: left;">ampulla of vater pancreatobiliary type adenocarcinoma</td>
<td style="text-align: left;">NCIT:C95963</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ampulla of Vater Pancreatobiliary Type Adenocarcinoma</td>
<td style="text-align: left;">An invasive adenocarcinoma that arises from the ampulla of Vater. It is characterized by the presence of malignant cells that resemble the malignant cells of the pancreatic ductal or extrahepatic bile duct carcinomas.</td>
<td style="text-align: left;">MONDO:0002670</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858694</td>
<td style="text-align: left;">ampulla of vater hepatoid adenocarcinoma</td>
<td style="text-align: left;">NCIT:C95966</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ampulla of Vater Hepatoid Adenocarcinoma</td>
<td style="text-align: left;">A very rare adenocarcinoma that arises from the ampulla of Vater.  It is usually of the intestinal type and is characterized by the presence of malignant polygonal cells with abundant eosinophilic cytoplasm resembling hepatocytes.</td>
<td style="text-align: left;">MONDO:0006243,MONDO:0002670</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858695</td>
<td style="text-align: left;">ampulla of vater neuroendocrine neoplasm</td>
<td style="text-align: left;">NCIT:C95980</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ampulla of Vater Neuroendocrine Neoplasm</td>
<td style="text-align: left;">A neoplasm with neuroendocrine differentiation that arises from the ampulla of Vater and periampullary region. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms).</td>
<td style="text-align: left;">MONDO:0018510,MONDO:0000921</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858702</td>
<td style="text-align: left;">intestinal neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C96062</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intestinal Neuroendocrine Tumor</td>
<td style="text-align: left;">A well-differentiated, low-, intermediate-, or high-grade neoplasm with neuroendocrine differentiation that arises from the small or large intestine.</td>
<td style="text-align: left;">MONDO:0000386,MONDO:0002883</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858703</td>
<td style="text-align: left;">small intestinal mixed adenoneuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C96066</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Mixed Adenoneuroendocrine Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the small intestine and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.</td>
<td style="text-align: left;">MONDO:0005522,MONDO:0006182</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858705</td>
<td style="text-align: left;">colorectal neuroendocrine neoplasm</td>
<td style="text-align: left;">NCIT:C96152</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Neuroendocrine Neoplasm</td>
<td style="text-align: left;">A neoplasm with neuroendocrine differentiation that arises from the colon or rectum. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms).</td>
<td style="text-align: left;">MONDO:0002883,MONDO:0005335</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858706</td>
<td style="text-align: left;">colorectal mixed adenoneuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C96158</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Mixed Adenoneuroendocrine Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the colon or rectum and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.</td>
<td style="text-align: left;">MONDO:0006182,MONDO:0024331</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858707</td>
<td style="text-align: left;">digestive system neuroendocrine tumor g2</td>
<td style="text-align: left;">NCIT:C96166</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Digestive System Neuroendocrine Tumor G2</td>
<td style="text-align: left;">A well-differentiated, intermediate-grade neuroendocrine neoplasm that arises from the digestive system. The mitotic count is 2-20 per 2 mm2 and/or the Ki-67 index is 3 to 20%.</td>
<td style="text-align: left;">MONDO:0000386,MONDO:0006095</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858715</td>
<td style="text-align: left;">serrated lesions and polyps</td>
<td style="text-align: left;">NCIT:C96414</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Serrated Lesions and Polyps</td>
<td style="text-align: left;">Polyps that arises from the large intestine and the appendix. They are characterized by the presence of serrated glands and the absence of generalized dysplasia.</td>
<td style="text-align: left;">MONDO:0006180</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858717</td>
<td style="text-align: left;">appendix enterochromaffin cell serotonin-producing neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C96424</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor</td>
<td style="text-align: left;">A well-differentiated neuroendocrine tumor arising from the wall of the appendix.  It is characterized by the presence of neoplastic cells forming round solid nests and occasionally glandular structures.  The majority of the cases are asymptomatic, and they are found incidentally in appendectomy specimens.  The majority of the tumors are located in the distal end of the appendix and they are enterochromaffin-cell carcinoid tumors producing serotonin.  Most cases show morphologic evidence of appendiceal wall and lymphatic vessel invasion by tumor cells.  Despite the morphologic evidence of invasion, appendiceal carcinoid tumors only infrequently produce lymph node or distant metastases.</td>
<td style="text-align: left;">MONDO:0015066</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858721</td>
<td style="text-align: left;">rectal serrated lesions and polyps</td>
<td style="text-align: left;">NCIT:C96465</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Rectal Serrated Lesions and Polyps</td>
<td style="text-align: left;">Polyps that arises from the rectum. They are characterized by the presence of serrated glands and the absence of generalized dysplasia.</td>
<td style="text-align: left;">MONDO:0000530,MONDO:0006164,MONDO:0021398</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858725</td>
<td style="text-align: left;">colon serrated adenocarcinoma</td>
<td style="text-align: left;">NCIT:C96486</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colon Serrated Adenocarcinoma</td>
<td style="text-align: left;">A rare, invasive colon adenocarcinoma characterized by the presence of a malignant infiltrate with serrated glandular architecture.</td>
<td style="text-align: left;">MONDO:0006163,MONDO:0002271</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858726</td>
<td style="text-align: left;">rectal serrated adenocarcinoma</td>
<td style="text-align: left;">NCIT:C96487</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Rectal Serrated Adenocarcinoma</td>
<td style="text-align: left;">A rare, invasive rectal adenocarcinoma characterized by the presence of a malignant infiltrate with serrated glandular architecture.</td>
<td style="text-align: left;">MONDO:0006163,MONDO:0002169</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858729</td>
<td style="text-align: left;">colorectal sarcomatoid carcinoma</td>
<td style="text-align: left;">NCIT:C96494</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Sarcomatoid Carcinoma</td>
<td style="text-align: left;">A biphasic colorectal carcinoma with a spindle cell sarcomatoid component.</td>
<td style="text-align: left;">MONDO:0024331,MONDO:0006406</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858735</td>
<td style="text-align: left;">colorectal schwannoma</td>
<td style="text-align: left;">NCIT:C96512</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Schwannoma</td>
<td style="text-align: left;">A schwannoma that arises from the colon or rectum.  It may cause gastrointestinal bleeding and luminal obstruction.</td>
<td style="text-align: left;">MONDO:0021444,MONDO:0004820</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858736</td>
<td style="text-align: left;">colorectal ganglioneuroma</td>
<td style="text-align: left;">NCIT:C96514</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Ganglioneuroma</td>
<td style="text-align: left;">A ganglioneuroma that arises from the colon or rectum.  It usually presents as a small mucosal polyp.</td>
<td style="text-align: left;">MONDO:0021444,MONDO:0005033</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858737</td>
<td style="text-align: left;">benign colorectal granular cell tumor</td>
<td style="text-align: left;">NCIT:C96516</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Colorectal Granular Cell Tumor</td>
<td style="text-align: left;">A granular cell tumor that arises from the colon or rectum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0021444,MONDO:0003250</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858738</td>
<td style="text-align: left;">anal canal undifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C96529</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anal Canal Undifferentiated Carcinoma</td>
<td style="text-align: left;">A usually aggressive malignant epithelial neoplasm that arises from the anal canal.  It is composed of malignant cells which do not display evidence of glandular or squamous differentiation.</td>
<td style="text-align: left;">MONDO:0007108,MONDO:0005617</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858741</td>
<td style="text-align: left;">anal canal mixed adenoneuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C96553</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anal Canal Mixed Adenoneuroendocrine Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the anal canal.  It is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.</td>
<td style="text-align: left;">MONDO:0006182,MONDO:0007108</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858742</td>
<td style="text-align: left;">anal canal squamous papilloma</td>
<td style="text-align: left;">NCIT:C96554</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anal Canal Squamous Papilloma</td>
<td style="text-align: left;">A benign epithelial neoplasm that arises from the anal canal.  It is characterized by a papillary growth pattern and a proliferation of neoplastic squamous cells without morphologic evidence of malignancy.</td>
<td style="text-align: left;">MONDO:0021469,MONDO:0060766,MONDO:0001825</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858743</td>
<td style="text-align: left;">anal hidradenoma papilliferum</td>
<td style="text-align: left;">NCIT:C96699</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anal Hidradenoma Papilliferum</td>
<td style="text-align: left;">A benign neoplasm arising from the perianal sweat glands. It presents as a cystic nodular lesion and is characterized by the presence of cystic and papillary structures. The papillary structures contain connective tissue and are covered by two layers of epithelium.</td>
<td style="text-align: left;">MONDO:0021469,MONDO:0003446</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858745</td>
<td style="text-align: left;">hnf1alpha-inactivated hepatocellular adenoma</td>
<td style="text-align: left;">NCIT:C96758</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">HNF1alpha-Inactivated Hepatocellular Adenoma</td>
<td style="text-align: left;">A hepatocellular adenoma caused by inactivating mutations of the HNF1A gene.  It is characterized by the presence of lobulated contours, steatosis, and absence of inflammation or nuclear atypia.</td>
<td style="text-align: left;">MONDO:0018902</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858746</td>
<td style="text-align: left;">beta-catenin-activated hepatocellular adenoma</td>
<td style="text-align: left;">NCIT:C96759</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Beta-Catenin-Activated Hepatocellular Adenoma</td>
<td style="text-align: left;">A hepatocellular adenoma caused by activating mutations of beta-catenin.  It is characterized by the presence of nuclear atypia and absence of inflammation or steatosis.  There is an increased risk of malignant transformation.</td>
<td style="text-align: left;">MONDO:0018902</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858747</td>
<td style="text-align: left;">inflammatory hepatocellular adenoma</td>
<td style="text-align: left;">NCIT:C96760</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Inflammatory Hepatocellular Adenoma</td>
<td style="text-align: left;">A hepatocellular adenoma that occurs more often in women.  It is characterized by increased levels of inflammation-associated proteins.  It is usually associated with steatosis and obesity.</td>
<td style="text-align: left;">MONDO:0018902</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858748</td>
<td style="text-align: left;">unclassified hepatocellular adenoma</td>
<td style="text-align: left;">NCIT:C96761</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Unclassified Hepatocellular Adenoma</td>
<td style="text-align: left;">A hepatocellular adenoma without distinguished morphologic characteristics or known molecular abnormalities.</td>
<td style="text-align: left;">MONDO:0018902</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858750</td>
<td style="text-align: left;">liver neuroendocrine neoplasm</td>
<td style="text-align: left;">NCIT:C96786</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Liver Neuroendocrine Neoplasm</td>
<td style="text-align: left;">An extremely rare neoplasm with neuroendocrine differentiation that arises from the liver. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms).</td>
<td style="text-align: left;">MONDO:0024477,MONDO:0024503</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858751</td>
<td style="text-align: left;">hepatocellular lymphocyte-rich carcinoma</td>
<td style="text-align: left;">NCIT:C96788</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatocellular Lymphocyte-Rich Carcinoma</td>
<td style="text-align: left;">A rare type of hepatocellular carcinoma characterized by the presence of pleomorphic malignant cells that are intermixed with lymphocytes.</td>
<td style="text-align: left;">MONDO:0007256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858755</td>
<td style="text-align: left;">liver undifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C96792</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Liver Undifferentiated Carcinoma</td>
<td style="text-align: left;">A rare carcinoma that arises from the liver.  The diagnosis is made by immunohistochemical studies.  Morphologic studies alone cannot establish the diagnosis of carcinoma or further subclassify the malignant tumor.</td>
<td style="text-align: left;">MONDO:0018531,MONDO:0005617</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858756</td>
<td style="text-align: left;">small duct intrahepatic cholangiocarcinoma</td>
<td style="text-align: left;">NCIT:C96805</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Duct Intrahepatic Cholangiocarcinoma</td>
<td style="text-align: left;">An intrahepatic cholangiocarcinoma that arises from the small interlobular bile ducts.</td>
<td style="text-align: left;">MONDO:0003210</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858757</td>
<td style="text-align: left;">bile duct intraductal papillary neoplasm with an associated invasive carcinoma</td>
<td style="text-align: left;">NCIT:C96810</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma</td>
<td style="text-align: left;">An intraductal papillary neoplasm that arises from the epithelium of the intrahepatic or extrahepatic bile ducts and it is associated with an invasive carcinomatous component.</td>
<td style="text-align: left;">MONDO:0003455,MONDO:0003193</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858758</td>
<td style="text-align: left;">extrahepatic bile duct tubulopapillary adenoma</td>
<td style="text-align: left;">NCIT:C96811</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrahepatic Bile Duct Tubulopapillary Adenoma</td>
<td style="text-align: left;">An adenoma that arises from the extrahepatic bile ducts.  It is characterized by the presence of tubular and papillary growth patterns.</td>
<td style="text-align: left;">MONDO:0003445,MONDO:0024661</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858760</td>
<td style="text-align: left;">liver synovial sarcoma</td>
<td style="text-align: left;">NCIT:C96845</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Liver Synovial Sarcoma</td>
<td style="text-align: left;">A synovial sarcoma that affects the liver.</td>
<td style="text-align: left;">MONDO:0002397,MONDO:0010434</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858761</td>
<td style="text-align: left;">liver carcinosarcoma</td>
<td style="text-align: left;">NCIT:C96848</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Liver Carcinosarcoma</td>
<td style="text-align: left;">An aggressive carcinoma with a sarcomatous component that arises from the liver.  The sarcomatous component is clonally related to the more differentiated, carcinomatous component.  The prognosis is usually poor.</td>
<td style="text-align: left;">MONDO:0002928,MONDO:0018531</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858765</td>
<td style="text-align: left;">gallbladder mucinous cystic neoplasm</td>
<td style="text-align: left;">NCIT:C96881</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Mucinous Cystic Neoplasm</td>
<td style="text-align: left;">An epithelial, usually multiloculated neoplasm arising from the gallbladder. It occurs predominantly in females. Signs and symptoms include abdominal mass, abdominal pain, and jaundice. Morphologically, the cystic spaces are lined by columnar epithelium and contain mucinous or serous fluid.</td>
<td style="text-align: left;">MONDO:0021253</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858766</td>
<td style="text-align: left;">gallbladder carcinosarcoma</td>
<td style="text-align: left;">NCIT:C96888</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Carcinosarcoma</td>
<td style="text-align: left;">A carcinoma that arises from the gallbladder and it is characterized by the presence of a sarcomatous component.  The sarcomatous component may contain osteosarcoma, chondrosarcoma, or rhabdomyosarcoma elements.</td>
<td style="text-align: left;">MONDO:0003220,MONDO:0002928</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858767</td>
<td style="text-align: left;">gallbladder hepatoid adenocarcinoma</td>
<td style="text-align: left;">NCIT:C96890</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Hepatoid Adenocarcinoma</td>
<td style="text-align: left;">A rare variant of gallbladder adenocarcinoma.  It is characterized by the presence of a malignant glandular epithelial infiltrate that resembles hepatocellular carcinoma.</td>
<td style="text-align: left;">MONDO:0006215,MONDO:0006243</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858768</td>
<td style="text-align: left;">gallbladder cribriform carcinoma</td>
<td style="text-align: left;">NCIT:C96891</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Cribriform Carcinoma</td>
<td style="text-align: left;">A rare variant of gallbladder adenocarcinoma.  It is characterized by the presence of a malignant glandular epithelial infiltrate with a cribriform growth pattern.</td>
<td style="text-align: left;">MONDO:0006215,MONDO:0006176</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858769</td>
<td style="text-align: left;">gallbladder adenocarcinoma, biliary type</td>
<td style="text-align: left;">NCIT:C96915</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Adenocarcinoma, Biliary Type</td>
<td style="text-align: left;">A well or moderately differentiated adenocarcinoma that arises from the gallbladder.  It is the most common type of gallbladder carcinoma and is characterized by the presence of malignant tubular glands.  Intestinal differentiation may be present.</td>
<td style="text-align: left;">MONDO:0006215,MONDO:0005606</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858770</td>
<td style="text-align: left;">gallbladder adenocarcinoma, gastric foveolar type</td>
<td style="text-align: left;">NCIT:C96916</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Adenocarcinoma, Gastric Foveolar Type</td>
<td style="text-align: left;">An unusual, well differentiated adenocarcinoma that arises from the gallbladder.  It is characterized by the presence of tall malignant columnar cells with mucin-containing cytoplasm and basally located nuclei.</td>
<td style="text-align: left;">MONDO:0006215</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858774</td>
<td style="text-align: left;">gallbladder mixed adenoneuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C96927</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Mixed Adenoneuroendocrine Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the gallbladder and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.</td>
<td style="text-align: left;">MONDO:0003220,MONDO:0006182</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858775</td>
<td style="text-align: left;">gallbladder tubular carcinoid</td>
<td style="text-align: left;">NCIT:C96930</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Tubular Carcinoid</td>
<td style="text-align: left;">A neuroendocrine tumor that arises from the gallbladder.  It does not show the morphologic characteristics of typical carcinoid tumors (neoplastic cells forming solid nests). In contrast, the tumor cells form small discrete tubules.</td>
<td style="text-align: left;">MONDO:0015073</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858776</td>
<td style="text-align: left;">extrahepatic bile duct adenocarcinoma, biliary type</td>
<td style="text-align: left;">NCIT:C96936</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrahepatic Bile Duct Adenocarcinoma, Biliary Type</td>
<td style="text-align: left;">A well or moderately differentiated adenocarcinoma that arises from the extrahepatic bile ducts.  It is characterized by the presence of malignant tubular glands.</td>
<td style="text-align: left;">MONDO:0002665,MONDO:0005606</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858777</td>
<td style="text-align: left;">extrahepatic bile duct adenocarcinoma, gastric foveolar type</td>
<td style="text-align: left;">NCIT:C96937</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type</td>
<td style="text-align: left;">An unusual, well differentiated adenocarcinoma that arises from the extrahepatic bile ducts.  It is characterized by the presence of tall malignant columnar cells with mucin-containing cytoplasm and basally located nuclei.</td>
<td style="text-align: left;">MONDO:0002665</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858778</td>
<td style="text-align: left;">extrahepatic bile duct adenocarcinoma, intestinal type</td>
<td style="text-align: left;">NCIT:C96938</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrahepatic Bile Duct Adenocarcinoma, Intestinal Type</td>
<td style="text-align: left;">An adenocarcinoma that arises from the extrahepatic bile ducts.  It is characterized by the presence of neoplastic tubular glands lined by columnar cells or neoplastic glands lined by goblet cells.</td>
<td style="text-align: left;">MONDO:0002665</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858779</td>
<td style="text-align: left;">extrahepatic bile duct carcinosarcoma</td>
<td style="text-align: left;">NCIT:C96939</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrahepatic Bile Duct Carcinosarcoma</td>
<td style="text-align: left;">A carcinoma that arises from the extrahepatic bile ducts and it is characterized by the presence of a sarcomatous component.</td>
<td style="text-align: left;">MONDO:0003090,MONDO:0002928</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858780</td>
<td style="text-align: left;">extrahepatic bile duct mucinous cystic neoplasm with an associated invasive carcinoma</td>
<td style="text-align: left;">NCIT:C96946</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma</td>
<td style="text-align: left;">A mucinous cystic neoplasm that arises from the extrahepatic bile ducts and it is associated with an invasive carcinomatous component.</td>
<td style="text-align: left;">MONDO:0002665,MONDO:0004462,MONDO:0002868</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858781</td>
<td style="text-align: left;">intrahepatic bile duct mucinous cystic neoplasm with an associated invasive carcinoma</td>
<td style="text-align: left;">NCIT:C96947</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma</td>
<td style="text-align: left;">A mucinous cystic neoplasm that arises from the intrahepatic bile ducts and it is associated with an invasive carcinomatous component.</td>
<td style="text-align: left;">MONDO:0002868,MONDO:0018531,MONDO:0003979</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858783</td>
<td style="text-align: left;">extrahepatic bile duct lymphoma</td>
<td style="text-align: left;">NCIT:C96952</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrahepatic Bile Duct Lymphoma</td>
<td style="text-align: left;">A lymphoma that arises from the extrahepatic bile ducts, with the bulk of the disease located at this site.</td>
<td style="text-align: left;">MONDO:0021321,MONDO:0004699</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858785</td>
<td style="text-align: left;">extrahepatic bile duct neuroendocrine neoplasm</td>
<td style="text-align: left;">NCIT:C96954</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrahepatic Bile Duct Neuroendocrine Neoplasm</td>
<td style="text-align: left;">A neoplasm with neuroendocrine differentiation that arises from the extrahepatic bile ducts. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms).</td>
<td style="text-align: left;">MONDO:0021385,MONDO:0024503</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858786</td>
<td style="text-align: left;">extrahepatic bile duct mixed adenoneuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C96959</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the extrahepatic bile ducts and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.</td>
<td style="text-align: left;">MONDO:0006182,MONDO:0003090</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858788</td>
<td style="text-align: left;">invasive breast lobular carcinoma, alveolar variant</td>
<td style="text-align: left;">NCIT:C97049</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Breast Lobular Carcinoma, Alveolar Variant</td>
<td style="text-align: left;">A grade I invasive lobular carcinoma of the breast, characterized by the presence of round groups of neoplastic cells.</td>
<td style="text-align: left;">MONDO:0005051</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858789</td>
<td style="text-align: left;">invasive breast lobular carcinoma, pleomorphic variant</td>
<td style="text-align: left;">NCIT:C97051</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Breast Lobular Carcinoma, Pleomorphic Variant</td>
<td style="text-align: left;">A grade II invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells with large and atypical nuclei.</td>
<td style="text-align: left;">MONDO:0005051</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858790</td>
<td style="text-align: left;">invasive breast lobular carcinoma, solid variant</td>
<td style="text-align: left;">NCIT:C97052</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Breast Lobular Carcinoma, Solid Variant</td>
<td style="text-align: left;">A grade I invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells that form trabeculae and groups infiltrating collagen bundles.</td>
<td style="text-align: left;">MONDO:0005051</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858791</td>
<td style="text-align: left;">invasive breast lobular carcinoma, tubulolobular variant</td>
<td style="text-align: left;">NCIT:C97053</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Breast Lobular Carcinoma, Tubulolobular Variant</td>
<td style="text-align: left;">An invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells forming small tubular structures.</td>
<td style="text-align: left;">MONDO:0005051</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858792</td>
<td style="text-align: left;">mixed congenital mesoblastic nephroma</td>
<td style="text-align: left;">NCIT:C97058</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mixed Congenital Mesoblastic Nephroma</td>
<td style="text-align: left;">A congenital mesoblastic nephroma characterized by the presence of classic and cellular areas.</td>
<td style="text-align: left;">MONDO:0017043,MONDO:0005853</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0858851</td>
<td style="text-align: left;">contralateral breast carcinoma</td>
<td style="text-align: left;">NCIT:C99390</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Contralateral Breast Carcinoma</td>
<td style="text-align: left;">Breast carcinoma that develops in the opposite breast of a patient with an already diagnosed primary breast carcinoma.</td>
<td style="text-align: left;">MONDO:0003982</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0859471</td>
<td style="text-align: left;">neoplastic medium-sized lymphocyte</td>
<td style="text-align: left;">NCIT:C37004</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neoplastic Medium-Sized Lymphocyte</td>
<td style="text-align: left;"></td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0859472</td>
<td style="text-align: left;">neoplastic b-lymphocyte</td>
<td style="text-align: left;">NCIT:C38640</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neoplastic B-Lymphocyte</td>
<td style="text-align: left;"></td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0859554</td>
<td style="text-align: left;">medaka melanoma</td>
<td style="text-align: left;">NCIT:C134572</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Medaka Melanoma</td>
<td style="text-align: left;">Melanoma that occurs in Oryzias latipes.</td>
<td style="text-align: left;">MONDO:0700196</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0859555</td>
<td style="text-align: left;">xiphophorus melanoma</td>
<td style="text-align: left;">NCIT:C134575</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Xiphophorus Melanoma</td>
<td style="text-align: left;">Melanoma that occurs in Xiphophorus.</td>
<td style="text-align: left;">MONDO:0700196</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0859556</td>
<td style="text-align: left;">non-human or experimental organism neoplasm</td>
<td style="text-align: left;">NCIT:C134576</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Human or Experimental Organism Neoplasm</td>
<td style="text-align: left;">A neoplastic condition occurring in a non-human organism; this includes neoplasms occurring in organisms used in research settings.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0859560</td>
<td style="text-align: left;">tubulostromal adenoma</td>
<td style="text-align: left;">NCIT:C79953</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tubulostromal Adenoma</td>
<td style="text-align: left;">A benign ovarian epithelial tumor. It has been described in mice and rats and is rare in other animal species. Morphologically it is characterized by the presence of tubular structures and interstitial stroma.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0859561</td>
<td style="text-align: left;">tubulostromal adenocarcinoma</td>
<td style="text-align: left;">NCIT:C80356</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tubulostromal Adenocarcinoma</td>
<td style="text-align: left;">A malignant ovarian epithelial tumor. It has been described in mice and rats and is characterized by marked pleomorphism, atypia, and an infiltrative growth pattern.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860042</td>
<td style="text-align: left;">lymphoproliferative disease associated with primary immune disorder</td>
<td style="text-align: left;">NCIT:C150673</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lymphoproliferative Disease Associated with Primary Immune Disorder</td>
<td style="text-align: left;">A lymphoid proliferation that arises in the setting of immune deficiency due to a primary immunodeficiency or immunoregulatory disorder. The primary immune disorders most frequently associated with lymphoproliferative disorders are ataxia-telangiectasia, Wiskott-Aldrich syndrome, common variable immunodeficiency, severe combined immunodeficiency, X-linked lymphoproliferative disease, Nijmegen breakage syndrome, hyper-IgM syndrome, and autoimmune lymphoproliferative syndrome. (WHO 2017)</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860043</td>
<td style="text-align: left;">genitourinary system disorder</td>
<td style="text-align: left;">NCIT:C156660</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Genitourinary System Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the genitourinary system.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860044</td>
<td style="text-align: left;">recurrent hiv-related lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C157685</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Recurrent HIV-Related Lymphoproliferative Disorder</td>
<td style="text-align: left;">The reemergence of HIV-associated lymphoproliferative disorder after a period of remission.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860045</td>
<td style="text-align: left;">refractory hiv-related lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C157687</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory HIV-Related Lymphoproliferative Disorder</td>
<td style="text-align: left;">HIV-associated lymphoproliferative disorder that is resistant to treatment.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860046</td>
<td style="text-align: left;">hiv-related lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C157709</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">HIV-Related Lymphoproliferative Disorder</td>
<td style="text-align: left;">A lymphoproliferative disorder that develops in an individual with HIV infection.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860047</td>
<td style="text-align: left;">ebv-related lymphoproliferative disease with primary immunodeficiency</td>
<td style="text-align: left;">NCIT:C160150</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">EBV-Related Lymphoproliferative Disease with Primary Immunodeficiency</td>
<td style="text-align: left;">An EBV-related lymphoid proliferation that arises in the setting of immune deficiency due to a primary immunodeficiency or immunoregulatory disorder.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860048</td>
<td style="text-align: left;">recurrent ebv-related lymphoproliferative disease with primary immunodeficiency</td>
<td style="text-align: left;">NCIT:C160151</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Recurrent EBV-Related Lymphoproliferative Disease with Primary Immunodeficiency</td>
<td style="text-align: left;">The reemergence of EBV-associated lymphoproliferative disease with primary immunodeficiency after a period of remission.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860049</td>
<td style="text-align: left;">refractory ebv-related lymphoproliferative disease with primary immunodeficiency</td>
<td style="text-align: left;">NCIT:C160152</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory EBV-Related Lymphoproliferative Disease with Primary Immunodeficiency</td>
<td style="text-align: left;">EBV-associated lymphoproliferative disease with primary immunodeficiency that is resistant to treatment.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860050</td>
<td style="text-align: left;">tonsillar disorder</td>
<td style="text-align: left;">NCIT:C173797</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tonsillar Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the tonsils.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860051</td>
<td style="text-align: left;">soft tissue disorder</td>
<td style="text-align: left;">NCIT:C27042</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Soft Tissue Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the soft tissue.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860052</td>
<td style="text-align: left;">connective and soft tissue disorder</td>
<td style="text-align: left;">NCIT:C27574</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Connective and Soft Tissue Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the connective and soft tissue.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860053</td>
<td style="text-align: left;">neck disorder</td>
<td style="text-align: left;">NCIT:C27648</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neck Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the anatomic structures of the neck region.  This category includes disorders of the pharynx, larynx, thyroid gland, and parathyroid gland.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860054</td>
<td style="text-align: left;">peritoneal and retroperitoneal disorder</td>
<td style="text-align: left;">NCIT:C27664</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Peritoneal and Retroperitoneal Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the peritoneum and/or retroperitoneum.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860055</td>
<td style="text-align: left;">female reproductive system precancerous condition</td>
<td style="text-align: left;">NCIT:C27788</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Female Reproductive System Precancerous Condition</td>
<td style="text-align: left;">A pathologic process that arises from the female reproductive system and has the potential to evolve into a malignant neoplasm. Representative examples include atypical endometrial hyperplasia, endometrial intraepithelial neoplasia, and cervical intraepithelial neoplasia.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860056</td>
<td style="text-align: left;">tobacco use disorder</td>
<td style="text-align: left;">NCIT:C35074</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tobacco Use Disorder</td>
<td style="text-align: left;">Any disease or disorder that is caused by the use of tobacco.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860057</td>
<td style="text-align: left;">sternal disorder</td>
<td style="text-align: left;">NCIT:C35744</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sternal Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the sternum.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860058</td>
<td style="text-align: left;">chest wall disorder</td>
<td style="text-align: left;">NCIT:C35745</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Chest Wall Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the structures of the chest wall.  Representative examples include infection, chest wall lipoma, and chest wall lymphoma.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860059</td>
<td style="text-align: left;">axillary disorder</td>
<td style="text-align: left;">NCIT:C35746</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Axillary Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the structures of the axilla.  Representative examples include axillary lymphadenitis, axillary lipoma, and metastatic carcinoma to the axillary lymph nodes.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860060</td>
<td style="text-align: left;">hematopoietic and lymphatic system disorder</td>
<td style="text-align: left;">NCIT:C35814</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hematopoietic and Lymphatic System Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the hematopoietic and lymphatic system.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860062</td>
<td style="text-align: left;">anal precancerous condition</td>
<td style="text-align: left;">NCIT:C7407</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anal Precancerous Condition</td>
<td style="text-align: left;">A pathologic process that arises from the anus and has the potential to evolve into a malignant neoplasm.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860063</td>
<td style="text-align: left;">esophageal precancerous condition</td>
<td style="text-align: left;">NCIT:C7423</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Precancerous Condition</td>
<td style="text-align: left;">A pathologic process that arises from the esophagus and has the potential to evolve into a malignant neoplasm.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860064</td>
<td style="text-align: left;">gastric precancerous condition</td>
<td style="text-align: left;">NCIT:C7424</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Precancerous Condition</td>
<td style="text-align: left;">A pathologic process that arises from the stomach and has the potential to evolve into a malignant neoplasm.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860065</td>
<td style="text-align: left;">pulmonary precancerous condition</td>
<td style="text-align: left;">NCIT:C7435</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pulmonary Precancerous Condition</td>
<td style="text-align: left;">A pathologic process that arises from the lung and has the potential to evolve into a malignant neoplasm. This category includes bronchial intraepithelial neoplasia and atypical adenomatous hyperplasia.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860066</td>
<td style="text-align: left;">hepatobiliary precancerous condition</td>
<td style="text-align: left;">NCIT:C7655</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatobiliary Precancerous Condition</td>
<td style="text-align: left;">A pathologic process that arises from the hepatobiliary system and has the potential to evolve into a malignant neoplasm.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860067</td>
<td style="text-align: left;">intestinal precancerous condition</td>
<td style="text-align: left;">NCIT:C7657</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intestinal Precancerous Condition</td>
<td style="text-align: left;">A pathologic process that arises from the small or large intestine and has the potential to evolve into a malignant neoplasm.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860068</td>
<td style="text-align: left;">digestive system precancerous condition</td>
<td style="text-align: left;">NCIT:C7659</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Digestive System Precancerous Condition</td>
<td style="text-align: left;">A pathologic process that arises from the digestive system and has the potential to evolve into a malignant neoplasm.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860069</td>
<td style="text-align: left;">cutaneous precancerous condition</td>
<td style="text-align: left;">NCIT:C8957</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Precancerous Condition</td>
<td style="text-align: left;">A pathologic process that arises from the skin and has the potential to evolve into a malignant neoplasm. Representative examples include actinic keratosis and dysplastic nevus.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0860070</td>
<td style="text-align: left;">neonatal disorder</td>
<td style="text-align: left;">NCIT:C98996</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neonatal Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder which occurs during the neonatal period.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0955884</td>
<td style="text-align: left;">adult acute eosinophilic leukemia</td>
<td style="text-align: left;">NCIT:C7963</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Acute Eosinophilic Leukemia</td>
<td style="text-align: left;">An acute eosinophilic leukemia occurring in adults.</td>
<td style="text-align: left;">MONDO:0043881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0956044</td>
<td style="text-align: left;">acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13.3;q13.1); rbm15-mkl1</td>
<td style="text-align: left;">NCIT:C82427</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1</td>
<td style="text-align: left;">An acute myeloid leukemia associated with t(1;22)(p13.3;q13.1) resulting in the expression of RBM15-MKL1 fusion protein. It affects infants and children and usually shows megakaryocytic maturation.</td>
<td style="text-align: left;">MONDO:0017893</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0956757</td>
<td style="text-align: left;">acute myeloid leukemia with t(8;21)(q22; q22.1); runx1-runx1t1</td>
<td style="text-align: left;">NCIT:C9288</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1</td>
<td style="text-align: left;">An acute myeloid leukemia with t(8;21)(q22; q22.1) giving rise to RUNX1/RUNX1T1 fusion transcript and showing maturation in the neutrophil lineage. The bone marrow and the peripheral blood show large myeloblasts with abundant basophilic cytoplasm, often containing azurophilic granules. This type of AML is associated with good response to chemotherapy and high complete remission rate.</td>
<td style="text-align: left;">MONDO:0017893</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957624</td>
<td style="text-align: left;">indolent clonal t-cell lymphoproliferative disorder of the gastrointestinal tract</td>
<td style="text-align: left;">NCIT:C139021</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Indolent Clonal T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract</td>
<td style="text-align: left;">A clonal T-cell lymphoproliferative disorder that can involve the mucosa in all sites of the gastrointestinal tract, but is most common in the small intestine and colon. The lymphoid cells infiltrate the lamina propria but usually do not show invasion of the epithelium. The clinical course is indolent, but most patients do not respond to conventional chemotherapy. A subset of cases progress to a higher-grade T-cell lymphoma with spread beyond the gastrointestinal tract. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0005169</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957625</td>
<td style="text-align: left;">penile adenosquamous carcinoma</td>
<td style="text-align: left;">NCIT:C159248</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Adenosquamous Carcinoma</td>
<td style="text-align: left;">An extremely rare carcinoma that arises from the penis and is characterized by the presence of glandular and squamous components.</td>
<td style="text-align: left;">MONDO:0006360,MONDO:0006074</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957626</td>
<td style="text-align: left;">seminal vesicle soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C161637</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Seminal Vesicle Soft Tissue Neoplasm</td>
<td style="text-align: left;">A mesenchymal neoplasm that arises from the seminal vesicle.</td>
<td style="text-align: left;">MONDO:0002790,MONDO:0006424</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957627</td>
<td style="text-align: left;">hepatocellular malignant neoplasm, not otherwise specified</td>
<td style="text-align: left;">NCIT:C161838</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatocellular Malignant Neoplasm, Not Otherwise Specified</td>
<td style="text-align: left;">A rare childhood malignant liver neoplasm with overlapping features of hepatoblastoma and hepatocellular carcinoma.</td>
<td style="text-align: left;">MONDO:0018666</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957628</td>
<td style="text-align: left;">epididymal melanotic neuroectodermal tumor</td>
<td style="text-align: left;">NCIT:C162488</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Epididymal Melanotic Neuroectodermal Tumor</td>
<td style="text-align: left;">A rare neoplasm that arises from the epididymis and is characterized by the presence of a mixture of melanin-containing epithelial cells and smaller neuroblast-like cells. It usually occurs in infants and has a benign clinical course.</td>
<td style="text-align: left;">MONDO:0002072,MONDO:0021473</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957629</td>
<td style="text-align: left;">systemic mastocytosis with an associated germ cell tumor</td>
<td style="text-align: left;">NCIT:C186735</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Systemic Mastocytosis with an Associated Germ Cell Tumor</td>
<td style="text-align: left;">A disorder characterized by systemic infiltration of internal organs by aggregates of neoplastic mast cells and the presence of a co-occurring germ cell tumor.</td>
<td style="text-align: left;">MONDO:0016586</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957630</td>
<td style="text-align: left;">estrogen receptor-positive breast carcinoma</td>
<td style="text-align: left;">NCIT:C188366</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Estrogen Receptor-Positive Breast Carcinoma</td>
<td style="text-align: left;">Breast adenocarcinoma that is positive for estrogen receptors.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957631</td>
<td style="text-align: left;">childhood myelodysplastic syndrome with excess blasts</td>
<td style="text-align: left;">NCIT:C188449</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Myelodysplastic Syndrome with Excess Blasts</td>
<td style="text-align: left;">Myelodysplastic syndrome with excess blasts that occurs during childhood.</td>
<td style="text-align: left;">MONDO:0044873,MONDO:0019454</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957632</td>
<td style="text-align: left;">childhood acute myeloid leukemia with t(9;11)(p21.3;q23.3); mllt3-kmt2a</td>
<td style="text-align: left;">NCIT:C188451</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A</td>
<td style="text-align: left;">An acute myeloid leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A occurring in children.</td>
<td style="text-align: left;">MONDO:0004996,MONDO:0020317</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957633</td>
<td style="text-align: left;">lung small cell carcinoma neuroendocrine subtypes</td>
<td style="text-align: left;">NCIT:C188753</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Small Cell Carcinoma Neuroendocrine Subtypes</td>
<td style="text-align: left;">A header term that refers to the classification of lung small cell carcinoma based on the expression pattern of different neuroendocrine markers such as chromogranin A, synaptophysin, neural cell adhesion molecule 1, and gastrin-releasing peptide.</td>
<td style="text-align: left;">MONDO:0008433</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957634</td>
<td style="text-align: left;">lung small cell carcinoma molecular subtypes</td>
<td style="text-align: left;">NCIT:C188756</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Small Cell Carcinoma Molecular Subtypes</td>
<td style="text-align: left;">A header term that refers to the molecular classification of lung small cell carcinomas based on the relative expression of four transcription factors: achaete-scute homolog 1 (ASCL1), neurogenic differentiation factor 1 (NEUROD1), yes-associated protein 1 (YAP1), and POU class 2 homeobox 3 (POU2F3).</td>
<td style="text-align: left;">MONDO:0008433</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957635</td>
<td style="text-align: left;">adult ganglioneuroma</td>
<td style="text-align: left;">NCIT:C188947</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Ganglioneuroma</td>
<td style="text-align: left;">A ganglioneuroma that occurs in adults.</td>
<td style="text-align: left;">MONDO:0005033</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957636</td>
<td style="text-align: left;">childhood nervous system neoplasm</td>
<td style="text-align: left;">NCIT:C188950</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Nervous System Neoplasm</td>
<td style="text-align: left;">A neoplasm that affects the nervous system during childhood.</td>
<td style="text-align: left;">MONDO:0021079,MONDO:0021248</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957637</td>
<td style="text-align: left;">choroidal ganglioneuroma</td>
<td style="text-align: left;">NCIT:C188956</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Choroidal Ganglioneuroma</td>
<td style="text-align: left;">A rare ganglioneuroma that arises from the choroid.</td>
<td style="text-align: left;">MONDO:0021487,MONDO:0005033</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957638</td>
<td style="text-align: left;">childhood connective and soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C188963</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Connective and Soft Tissue Neoplasm</td>
<td style="text-align: left;">A soft tissue or bone neoplasm that occurs during childhood.</td>
<td style="text-align: left;">MONDO:0021079,MONDO:0044334</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957639</td>
<td style="text-align: left;">childhood low grade fibromyxoid sarcoma</td>
<td style="text-align: left;">NCIT:C188970</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Low Grade Fibromyxoid Sarcoma</td>
<td style="text-align: left;">A low-grade fibromyxoid sarcoma that occurs during childhood.</td>
<td style="text-align: left;">MONDO:0006272,MONDO:0002678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957641</td>
<td style="text-align: left;">testicular teratoma, postpubertal-type</td>
<td style="text-align: left;">NCIT:C189057</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Teratoma, Postpubertal-Type</td>
<td style="text-align: left;">A testicular teratoma associated with germ cell neoplasia in situ and chromosome 12p amplification.</td>
<td style="text-align: left;">MONDO:0018193,MONDO:0003510</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957642</td>
<td style="text-align: left;">kidney carcinoma molecular subtypes</td>
<td style="text-align: left;">NCIT:C189241</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Carcinoma Molecular Subtypes</td>
<td style="text-align: left;">A term that refers to the classification of kidney carcinomas based on their molecular characteristics.</td>
<td style="text-align: left;">MONDO:0005206</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957644</td>
<td style="text-align: left;">ovarian sertoli-leydig cell tumor molecular subtypes</td>
<td style="text-align: left;">NCIT:C189319</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Sertoli-Leydig Cell Tumor Molecular Subtypes</td>
<td style="text-align: left;">A term that refers to the classification of ovarian Sertoli-Leydig cell tumors based on their molecular characteristics.</td>
<td style="text-align: left;">MONDO:0036595</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957645</td>
<td style="text-align: left;">mullerian papilloma</td>
<td style="text-align: left;">NCIT:C189336</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mullerian Papilloma</td>
<td style="text-align: left;">A benign papillary neoplasm that arises from the cervix or vagina. It mostly occurs in prepubertal girls and rarely in adolescents or young adults. It is characterized by the presence of a fibrovascular core covered by cuboidal or columnar epithelial cells. Squamous metaplasia may be present. Cytologic atypia is absent.</td>
<td style="text-align: left;">MONDO:0021078</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957646</td>
<td style="text-align: left;">childhood breast neoplasm</td>
<td style="text-align: left;">NCIT:C189338</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Breast Neoplasm</td>
<td style="text-align: left;">A neoplasm that affects the breast and occurs during childhood.</td>
<td style="text-align: left;">MONDO:0021079,MONDO:0021100</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957647</td>
<td style="text-align: left;">childhood digestive system neoplasm</td>
<td style="text-align: left;">NCIT:C189869</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Digestive System Neoplasm</td>
<td style="text-align: left;">A neoplasm that affects any part of the digestive system and occurs during childhood.</td>
<td style="text-align: left;">MONDO:0021079,MONDO:0021223</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957648</td>
<td style="text-align: left;">epithelial hepatoblastoma</td>
<td style="text-align: left;">NCIT:C189923</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Epithelial Hepatoblastoma</td>
<td style="text-align: left;">A subtype of hepatoblastoma characterized by the presence of an epithelial component and absence of mesenchymal elements. It includes hepatoblastoma with pure fetal epithelial differentiation, hepatoblastoma with combined fetal and embryonal epithelial differentiation, macrotrabecular hepatoblastoma, and small cell undifferentiated hepatoblastoma (small cell undifferentiated hepatoblastoma with loss of INI1 nuclear staining should be classified as rhabdoid tumor).</td>
<td style="text-align: left;">MONDO:0018666</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957649</td>
<td style="text-align: left;">non-teratoid hepatoblastoma</td>
<td style="text-align: left;">NCIT:C189926</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Teratoid Hepatoblastoma</td>
<td style="text-align: left;">A mixed epithelial and mesenchymal hepatoblastoma characterized by the absence of heterologous elements, muscle, cartilage or osteoid.</td>
<td style="text-align: left;">MONDO:0003650</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957650</td>
<td style="text-align: left;">hepatoblastoma by pretext stage</td>
<td style="text-align: left;">NCIT:C189927</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatoblastoma by PRETEXT Stage</td>
<td style="text-align: left;">A term that refers to the staging of hepatoblastoma, following the rules of the PRETEXT (pre-treatment extent of tumor) system.</td>
<td style="text-align: left;">MONDO:0018666</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957651</td>
<td style="text-align: left;">hepatoblastoma by postsurgical stage</td>
<td style="text-align: left;">NCIT:C189929</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatoblastoma by Postsurgical Stage</td>
<td style="text-align: left;">A term that refers to the staging of hepatoblastoma according to post-operative findings.</td>
<td style="text-align: left;">MONDO:0018666</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957652</td>
<td style="text-align: left;">childhood fibrolamellar carcinoma</td>
<td style="text-align: left;">NCIT:C189932</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Fibrolamellar Carcinoma</td>
<td style="text-align: left;">A fibrolamellar carcinoma that occurs during childhood.</td>
<td style="text-align: left;">MONDO:0018055,MONDO:0006210</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957653</td>
<td style="text-align: left;">childhood endocrine neoplasm</td>
<td style="text-align: left;">NCIT:C190056</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Endocrine Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the endocrine glands during childhood.</td>
<td style="text-align: left;">MONDO:0021079,MONDO:0002082</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957654</td>
<td style="text-align: left;">childhood thoracic neoplasm</td>
<td style="text-align: left;">NCIT:C190090</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Thoracic Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that involves the tissues of the thorax during childhood.</td>
<td style="text-align: left;">MONDO:0021079,MONDO:0021350</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957655</td>
<td style="text-align: left;">childhood head and neck neoplasm</td>
<td style="text-align: left;">NCIT:C190119</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Head and Neck Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the anatomic structures of the head and neck region and occurs during childhood.</td>
<td style="text-align: left;">MONDO:0005586,MONDO:0021079</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957656</td>
<td style="text-align: left;">childhood skin neoplasm</td>
<td style="text-align: left;">NCIT:C190123</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Skin Neoplasm</td>
<td style="text-align: left;">A benign, intermediate, or malignant neoplasm that affects the skin and occurs during childhood.</td>
<td style="text-align: left;">MONDO:0002531,MONDO:0021079</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957657</td>
<td style="text-align: left;">childhood carcinoma</td>
<td style="text-align: left;">NCIT:C190275</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Carcinoma</td>
<td style="text-align: left;">A rare carcinoma that occurs during childhood.</td>
<td style="text-align: left;">MONDO:0004993,MONDO:0036491</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957658</td>
<td style="text-align: left;">refractory t/nk-cell lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C190397</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory T/NK-Cell Lymphoproliferative Disorder</td>
<td style="text-align: left;">T/NK-cell lymphoproliferative disorder that is resistant to treatment.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957659</td>
<td style="text-align: left;">recurrent t/nk-cell lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C190398</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Recurrent T/NK-Cell Lymphoproliferative Disorder</td>
<td style="text-align: left;">The reemergence of T/NK-cell lymphoproliferative disorder after a period of remission.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957660</td>
<td style="text-align: left;">ebv-related t/nk-cell lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C190402</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">EBV-Related T/NK-Cell Lymphoproliferative Disorder</td>
<td style="text-align: left;">T/NK-cell lymphoproliferative disorder that is associated with Epstein-Barr virus.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957661</td>
<td style="text-align: left;">childhood benign neoplasm</td>
<td style="text-align: left;">NCIT:C190573</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Benign Neoplasm</td>
<td style="text-align: left;">A neoplasm that occurs during childhood and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0021079,MONDO:0005165</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957662</td>
<td style="text-align: left;">benign liver neoplasm</td>
<td style="text-align: left;">NCIT:C190592</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Liver Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the liver and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0024477,MONDO:0000385</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957663</td>
<td style="text-align: left;">high grade endometrial carcinoma</td>
<td style="text-align: left;">NCIT:C190680</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">High Grade Endometrial Carcinoma</td>
<td style="text-align: left;">A group of aggressive endometrial carcinomas with high-grade histological features. It includes high grade endometrial endometrioid adenocarcinoma, endometrial clear cell adenocarcinoma, endometrial serous adenocarcinoma, and endometrial undifferentiated carcinoma.</td>
<td style="text-align: left;">MONDO:0002447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957664</td>
<td style="text-align: left;">iridociliary melanoma</td>
<td style="text-align: left;">NCIT:C190746</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Iridociliary Melanoma</td>
<td style="text-align: left;">A melanoma that affects both the iris and ciliary body.</td>
<td style="text-align: left;">MONDO:0006486</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957665</td>
<td style="text-align: left;">b acute lymphoblastic leukemia associated with down syndrome</td>
<td style="text-align: left;">NCIT:C190847</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">B Acute Lymphoblastic Leukemia Associated with Down Syndrome</td>
<td style="text-align: left;">A B acute lymphoblastic leukemia that occurs in patients with Down syndrome. It usually affects young children, but it can occur in adults as well. It has an unfavorable clinical outcome. Cases of T-acute lymphoblastic leukemia in patients with Down syndrome have not been reported.</td>
<td style="text-align: left;">MONDO:0020511</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957666</td>
<td style="text-align: left;">androgen receptor-positive breast carcinoma</td>
<td style="text-align: left;">NCIT:C190851</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Androgen Receptor-Positive Breast Carcinoma</td>
<td style="text-align: left;">Breast carcinoma that is positive for androgen receptors.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957667</td>
<td style="text-align: left;">b lymphoblastic leukemia/lymphoma with etv6-runx1-like features</td>
<td style="text-align: left;">NCIT:C190956</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">B Lymphoblastic Leukemia/Lymphoma with ETV6-RUNX1-Like Features</td>
<td style="text-align: left;">B lymphoblastic leukemia/lymphoma characterized by a gene-expression profile similar to that of ETV6-RUNX1-positive B lymphoblastic leukemia/lymphoma, absence of the pathognomonic ETV6-RUNX1 rearrangement, and rearrangements or deletions of ETV6 and IKZF1 genes.</td>
<td style="text-align: left;">MONDO:0035605</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957668</td>
<td style="text-align: left;">renal cell carcinoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C191370</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Renal Cell Carcinoma, Not Otherwise Specified</td>
<td style="text-align: left;">A renal cell carcinoma that cannot be classified into one of the established subtypes of renal cell carcinoma.</td>
<td style="text-align: left;">MONDO:0005549</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957669</td>
<td style="text-align: left;">kidney classic angiomyolipoma</td>
<td style="text-align: left;">NCIT:C191391</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Kidney Classic Angiomyolipoma</td>
<td style="text-align: left;">A benign mesenchymal tumor that arises from the kidney and is composed of mature adipose tissue, thick-walled blood vessels, and epithelioid and spindle smooth muscle cells.</td>
<td style="text-align: left;">MONDO:0002513,MONDO:0004555</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957670</td>
<td style="text-align: left;">secondary plasma cell leukemia</td>
<td style="text-align: left;">NCIT:C191432</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Secondary Plasma Cell Leukemia</td>
<td style="text-align: left;">Transformation of plasma cell myeloma to plasma cell leukemia.</td>
<td style="text-align: left;">MONDO:0018689,MONDO:0024881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957671</td>
<td style="text-align: left;">papillary urothelial neoplasm of low malignant potential</td>
<td style="text-align: left;">NCIT:C191672</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Papillary Urothelial Neoplasm of Low Malignant Potential</td>
<td style="text-align: left;">A papillary neoplasm of the urothelium. The papillary structures exhibit minimal architectural distortion and minimal atypia. Mitoses are infrequent. It usually occurs in the urinary bladder, but it can arise from other sites in the urinary tract. Patients are at an increased risk of developing new papillary lesions. Occasionally, the new lesions are urothelial carcinomas.</td>
<td style="text-align: left;">MONDO:0003755,MONDO:0003443</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957672</td>
<td style="text-align: left;">invasive lymphoepithelioma-like urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C191678</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Lymphoepithelioma-Like Urothelial Carcinoma</td>
<td style="text-align: left;">Invasive urothelial carcinoma with lymphoepithelioma-like features.</td>
<td style="text-align: left;">MONDO:0003572,MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957674</td>
<td style="text-align: left;">invasive urothelial carcinoma with glandular differentiation</td>
<td style="text-align: left;">NCIT:C191680</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Urothelial Carcinoma with Glandular Differentiation</td>
<td style="text-align: left;">An invasive urothelial carcinoma that exhibits glandular differentiation.</td>
<td style="text-align: left;">MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957675</td>
<td style="text-align: left;">invasive urothelial carcinoma with squamous differentiation</td>
<td style="text-align: left;">NCIT:C191681</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Urothelial Carcinoma with Squamous Differentiation</td>
<td style="text-align: left;">An invasive urothelial carcinoma that exhibits squamous differentiation.</td>
<td style="text-align: left;">MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957676</td>
<td style="text-align: left;">invasive urothelial carcinoma with trophoblastic differentiation</td>
<td style="text-align: left;">NCIT:C191682</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Urothelial Carcinoma with Trophoblastic Differentiation</td>
<td style="text-align: left;">An invasive urothelial carcinoma characterized by the presence of trophoblastic differentiation.</td>
<td style="text-align: left;">MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957677</td>
<td style="text-align: left;">invasive clear cell (glycogen-rich) urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C191683</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Clear Cell (Glycogen-Rich) Urothelial Carcinoma</td>
<td style="text-align: left;">An invasive urothelial carcinoma characterized by the presence of clear (glycogen-rich) cells.</td>
<td style="text-align: left;">MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957678</td>
<td style="text-align: left;">invasive lipid-rich urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C191684</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Lipid-Rich Urothelial Carcinoma</td>
<td style="text-align: left;">Invasive urothelial carcinoma characterized by the presence of lipid laden tumor cells.</td>
<td style="text-align: left;">MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957679</td>
<td style="text-align: left;">invasive microcystic urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C191685</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Microcystic Urothelial Carcinoma</td>
<td style="text-align: left;">Invasive urothelial carcinoma characterized by microcysts formation.</td>
<td style="text-align: left;">MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957680</td>
<td style="text-align: left;">invasive nested urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C191687</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Nested Urothelial Carcinoma</td>
<td style="text-align: left;">Invasive urothelial carcinoma characterized by a nested growth pattern.</td>
<td style="text-align: left;">MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957681</td>
<td style="text-align: left;">invasive plasmacytoid urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C191688</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Plasmacytoid Urothelial Carcinoma</td>
<td style="text-align: left;">Invasive urothelial carcinoma characterized by the presence of malignant cells with plasmacytoid features.</td>
<td style="text-align: left;">MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957682</td>
<td style="text-align: left;">invasive large nested urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C191725</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Large Nested Urothelial Carcinoma</td>
<td style="text-align: left;">A rare invasive urothelial carcinoma characterized by the presence of medium to large nests of malignant cells.</td>
<td style="text-align: left;">MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957683</td>
<td style="text-align: left;">invasive tubular urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C191728</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Tubular Urothelial Carcinoma</td>
<td style="text-align: left;">Invasive urothelial carcinoma characterized by the presence of a tubular growth pattern.</td>
<td style="text-align: left;">MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957684</td>
<td style="text-align: left;">invasive poorly differentiated urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C191730</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Poorly Differentiated Urothelial Carcinoma</td>
<td style="text-align: left;">Invasive urothelial carcinoma that lacks the morphological features indicating urothelial origin. Immunohistochemical studies are required to demonstrate the urothelial lineage in these tumors.</td>
<td style="text-align: left;">MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957685</td>
<td style="text-align: left;">invasive conventional urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C191734</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Invasive Conventional Urothelial Carcinoma</td>
<td style="text-align: left;">Invasive urothelial carcinoma characterized by the presence of malignant cells forming trabeculae, cords, sheets, and nests. Individual malignant cells are also present.</td>
<td style="text-align: left;">MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957686</td>
<td style="text-align: left;">prostatic intraepithelial neoplasia-like adenocarcinoma</td>
<td style="text-align: left;">NCIT:C191961</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostatic Intraepithelial Neoplasia-Like Adenocarcinoma</td>
<td style="text-align: left;">A rare subtype of prostate acinar adenocarcinoma that morphologically resembles high-grade prostatic intraepithelial neoplasia. It is characterized by the presence of large malignant glands lined with pseudostratified epithelium. It is graded as Gleason score 3+3=6.</td>
<td style="text-align: left;">MONDO:0002493</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957687</td>
<td style="text-align: left;">extrapulmonary neuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C191977</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrapulmonary Neuroendocrine Carcinoma</td>
<td style="text-align: left;">A small or large cell neuroendocrine carcinoma that arises from an anatomic site other than the lung.</td>
<td style="text-align: left;">MONDO:0002120</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957689</td>
<td style="text-align: left;">testicular yolk sac tumor, postpubertal-type</td>
<td style="text-align: left;">NCIT:C192099</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Yolk Sac Tumor, Postpubertal-Type</td>
<td style="text-align: left;">Testicular yolk sac tumor that is associated with germ cell neoplasia in situ and usually occurs as a component of mixed germ cell tumor. Pure postpubertal-type testicular yolk sac tumor is exceedingly rare.</td>
<td style="text-align: left;">MONDO:0003402</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957690</td>
<td style="text-align: left;">cystic trophoblastic tumor</td>
<td style="text-align: left;">NCIT:C192105</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cystic Trophoblastic Tumor</td>
<td style="text-align: left;">A rare trophoblastic neoplasm that arises in metastatic sites of testicular mixed germ cell tumors following chemotherapy, or is part of treated or untreated testicular mixed germ cell tumors, or is secondary to either chemotherapy-induced or spontaneous regression of testicular choriocarcinoma. It has also been described in central nervous system post-chemotherapy primary germ cell tumors. It is characterized by the presence of cysts lined by squamoid trophoblastic cells. The cysts are often compressed surrounded by other germ cell components.</td>
<td style="text-align: left;">MONDO:0021077,MONDO:0002872</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957691</td>
<td style="text-align: left;">testicular teratoma, prepubertal-type</td>
<td style="text-align: left;">NCIT:C192107</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Teratoma, Prepubertal-Type</td>
<td style="text-align: left;">A testicular teratoma that is not associated with germ cell neoplasia in situ or chromosome 12p amplification.</td>
<td style="text-align: left;">MONDO:0018193</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957692</td>
<td style="text-align: left;">gonadal myoid stromal tumor</td>
<td style="text-align: left;">NCIT:C192116</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gonadal Myoid Stromal Tumor</td>
<td style="text-align: left;">A rare, benign, well-circumscribed tumor that arises from the testis. It is characterized by the presence of fascicles of spindle cells showing muscle cell differentiation. It lacks sex cord differentiation.</td>
<td style="text-align: left;">MONDO:0021447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957693</td>
<td style="text-align: left;">penile squamous cell carcinoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C192222</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Squamous Cell Carcinoma, Not Otherwise Specified</td>
<td style="text-align: left;">A penile squamous cell carcinoma characterized by the absence of special morphologic features and lack of information on p16 immunohistochemistry and human papilloma virus testing status.</td>
<td style="text-align: left;">MONDO:0018352</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957694</td>
<td style="text-align: left;">penile mucoepidermoid carcinoma</td>
<td style="text-align: left;">NCIT:C192223</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Penile Mucoepidermoid Carcinoma</td>
<td style="text-align: left;">An extremely rare carcinoma that arises from the penis and is characterized by the presence of mucinous and squamous components.</td>
<td style="text-align: left;">MONDO:0006360,MONDO:0003036</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957696</td>
<td style="text-align: left;">benign cranial nerve neoplasm</td>
<td style="text-align: left;">NCIT:C193416</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Cranial Nerve Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from a cranial nerve and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0002633,MONDO:0000648</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957698</td>
<td style="text-align: left;">rectal gastrointestinal stromal tumor</td>
<td style="text-align: left;">NCIT:C193420</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Rectal Gastrointestinal Stromal Tumor</td>
<td style="text-align: left;">A gastrointestinal stromal tumor that arises from the rectum.</td>
<td style="text-align: left;">MONDO:0002165,MONDO:0006159</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957700</td>
<td style="text-align: left;">refractory malignant phyllodes tumor</td>
<td style="text-align: left;">NCIT:C193453</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Phyllodes Tumor</td>
<td style="text-align: left;">Malignant phyllodes tumor that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0037003,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957701</td>
<td style="text-align: left;">childhood cancer stage by toronto guidelines v2</td>
<td style="text-align: left;">NCIT:C198027</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Cancer Stage by Toronto Guidelines v2</td>
<td style="text-align: left;">A term that refers to the staging of childhood cancers following the rules of the Toronto guidelines v2, 2019. The guidelines were developed to address the lack of consistent information on childhood cancer staging in population registries and are not intended to replace staging systems in clinical use. They include a two-tiered approach that provides less detailed criteria for registries with limited resources and/or limited data access (Tier 1) and more detailed criteria for better-resourced registries (Tier 2). They apply to acute lymphoblastic leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, neuroblastoma, renal malignant tumors except renal cell carcinoma, rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, malignant bone tumors, retinoblastoma, hepatoblastoma, testicular germ cell tumors, ovarian germ cell tumors, astrocytoma, medulloblastoma and ependymoma. The following changes were noted to the original classification (v1, 2014): a staging system was no longer considered appropriate for acute myeloid leukemia; all renal tumors, with the exception of renal cell carcinomas, should use the endorsed staging systems for Wilms tumor; staging systems for osteosarcoma and Ewing sarcoma were combined into a single recommendation for all malignant bone tumors; a staging system was endorsed for astrocytomas; the S category (serum tumor markers) was confirmed as an integral part of TNM staging for testicular cancer in Tier 2 recommendations; and PRETEXT number was added to Tier 2 recommendations for hepatoblastoma. (adapted from Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)</td>
<td style="text-align: left;">MONDO:0006517</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957702</td>
<td style="text-align: left;">myeloproliferative neoplasm, bcr-abl1 negative</td>
<td style="text-align: left;">NCIT:C198555</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myeloproliferative Neoplasm, BCR-ABL1 Negative</td>
<td style="text-align: left;">A myeloproliferative neoplasm characterized by the absence of Philadelphia chromosome and BCR-ABL1 fusion gene expression. This group includes polycythemia vera, essential thrombocythemia, and primary myelofibrosis.</td>
<td style="text-align: left;">MONDO:0020076</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957703</td>
<td style="text-align: left;">myeloid/lymphoid neoplasms with flt3 rearrangement</td>
<td style="text-align: left;">NCIT:C198559</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myeloid/Lymphoid Neoplasms with FLT3 Rearrangement</td>
<td style="text-align: left;">Hematologic neoplasms characterized by the rearrangement of the FLT3 gene, most often resulting in the formation of t(12;13)(p13.2;q12.2)/ETV6-FLT3 fusion transcripts. Patients usually present with T-ALL or myeloid sarcoma.</td>
<td style="text-align: left;">MONDO:0015688</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957704</td>
<td style="text-align: left;">myeloid/lymphoid neoplasms with etv6-abl1</td>
<td style="text-align: left;">NCIT:C198565</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myeloid/Lymphoid Neoplasms with ETV6-ABL1</td>
<td style="text-align: left;">Hematologic neoplasms characterized by t(9;12)(q34.1;p13.2) that results in ETV6-ABL1 gene fusion. They have clinicopathological features of chronic myeloid leukemia with frequent eosinophilia.</td>
<td style="text-align: left;">MONDO:0015688</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957706</td>
<td style="text-align: left;">clonal monocytosis of undetermined significance</td>
<td style="text-align: left;">NCIT:C198580</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Clonal Monocytosis of Undetermined Significance</td>
<td style="text-align: left;">A myelodysplastic/myeloproliferative neoplasm characterized by the presence of persistent monocytosis, presence of at least one myeloid neoplasm-associated mutation, absence of significant dysplasia or increased blasts in the bone marrow, absence of morphologic findings suggestive of chronic myelomonocytic leukemia in the bone marrow, and absence of history of a reactive condition that would explain the persistent monocytosis.</td>
<td style="text-align: left;">MONDO:0006311</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957707</td>
<td style="text-align: left;">myelodysplastic/myeloproliferative neoplasm with sf3b1 mutation and thrombocytosis</td>
<td style="text-align: left;">NCIT:C198581</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis</td>
<td style="text-align: left;">A myelodysplastic/myeloproliferative neoplasm characterized by thrombocytosis, anemia, blasts less than 5% in bone marrow and less than 1% in peripheral blood, presence of SF3B1 gene mutation, absence of BCR/ABL fusion, absence of genetic abnormalities associated with myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions, and no history of other myelodysplastic/myeloproliferative neoplasms or myeloproliferative neoplasms and myelodysplastic syndromes.</td>
<td style="text-align: left;">MONDO:0006311</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957708</td>
<td style="text-align: left;">clonal cytopenia with monocytosis of undetermined significance</td>
<td style="text-align: left;">NCIT:C198582</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Clonal Cytopenia with Monocytosis of Undetermined Significance</td>
<td style="text-align: left;">A myelodysplastic/myeloproliferative neoplasm that fulfills the diagnostic criteria of clonal monocytosis of undetermined significance and is associated with cytopenia.</td>
<td style="text-align: left;">MONDO:0006311</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957709</td>
<td style="text-align: left;">myeloid neoplasm with mutated tp53</td>
<td style="text-align: left;">NCIT:C198593</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myeloid Neoplasm with Mutated TP53</td>
<td style="text-align: left;">Myeloid neoplasm characterized by the presence of TP53 gene mutations. This category includes myelodysplastic syndrome, myelodysplastic syndrome/acute myeloid leukemia, and acute myeloid leukemia with mutated TP53.</td>
<td style="text-align: left;">MONDO:0005170</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957710</td>
<td style="text-align: left;">myelodysplastic syndrome/acute myeloid leukemia, not otherwise specified</td>
<td style="text-align: left;">NCIT:C198597</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified</td>
<td style="text-align: left;">Myelodysplastic syndrome/acute myeloid leukemia in which there is no information on myelodysplasia-related gene mutations and cytogenetic abnormalities.</td>
<td style="text-align: left;">MONDO:0015041</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957711</td>
<td style="text-align: left;">pediatric and/or germline mutation-associated myeloid disorders</td>
<td style="text-align: left;">NCIT:C198663</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pediatric and/or Germline Mutation-Associated Myeloid Disorders</td>
<td style="text-align: left;">A group of myeloid disorders that occur in childhood and/or are associated with germline gene mutations. It includes juvenile myelomonocytic leukemia, juvenile myelomonocytic leukemia-like neoplasm, refractory cytopenia of childhood, Noonan syndrome-associated myeloproliferative disorder, and myeloid neoplasm with germline predisposition.</td>
<td style="text-align: left;">MONDO:0005170</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957712</td>
<td style="text-align: left;">b acute lymphoblastic leukemia with germline predisposition</td>
<td style="text-align: left;">NCIT:C198683</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">B Acute Lymphoblastic Leukemia with Germline Predisposition</td>
<td style="text-align: left;">B acute lymphoblastic leukemia that results from germline gene mutations. This category includes B-acute lymphoblastic leukemia with germline PAX5 mutation and B-acute lymphoblastic leukemia with germline IKZF1 mutation.</td>
<td style="text-align: left;">MONDO:0020511</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957713</td>
<td style="text-align: left;">acute promyelocytic leukemia with stat3-rara</td>
<td style="text-align: left;">NCIT:C198827</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Promyelocytic Leukemia with STAT3-RARA</td>
<td style="text-align: left;">Acute promyelocytic leukemia with a variant RARA rearrangement and expression of STAT3-RARA fusion protein.</td>
<td style="text-align: left;">MONDO:0100375</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957714</td>
<td style="text-align: left;">acute promyelocytic leukemia with t(1;17)(q42.3;q21.2); irf2bp2-rara</td>
<td style="text-align: left;">NCIT:C198831</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA</td>
<td style="text-align: left;">Acute promyelocytic leukemia with a variant RARA rearrangement associated with t(1;17)(q42.3;q21.2) that results in the expression of IRF2BP2-RARA fusion protein.</td>
<td style="text-align: left;">MONDO:0100375</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957715</td>
<td style="text-align: left;">acute promyelocytic leukemia with tbl1xr1-rara</td>
<td style="text-align: left;">NCIT:C198834</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Promyelocytic Leukemia with TBL1XR1-RARA</td>
<td style="text-align: left;">Acute promyelocytic leukemia with a variant RARA rearrangement and expression of TBL1XR1-RARA fusion protein.</td>
<td style="text-align: left;">MONDO:0100375</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957716</td>
<td style="text-align: left;">acute promyelocytic leukemia with fip1l1-rara</td>
<td style="text-align: left;">NCIT:C198839</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Promyelocytic Leukemia with FIP1L1-RARA</td>
<td style="text-align: left;">Acute promyelocytic leukemia with a variant RARA rearrangement and expression of FIP1L1-RARA fusion protein.</td>
<td style="text-align: left;">MONDO:0100375</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957717</td>
<td style="text-align: left;">acute promyelocytic leukemia with bcor-rara</td>
<td style="text-align: left;">NCIT:C198841</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Promyelocytic Leukemia with BCOR-RARA</td>
<td style="text-align: left;">Acute promyelocytic leukemia with a variant RARA rearrangement and expression of BCOR-RARA fusion protein.</td>
<td style="text-align: left;">MONDO:0100375</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957718</td>
<td style="text-align: left;">acute myeloid leukemia with in-frame bzip cebpa mutation</td>
<td style="text-align: left;">NCIT:C198891</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia with In-Frame bZIP CEBPA Mutation</td>
<td style="text-align: left;">An acute myeloid leukemia characterized by the presence of CEBPA bZIP domain mutation. It is associated with a favorable clinical outcome.</td>
<td style="text-align: left;">MONDO:0017894</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957719</td>
<td style="text-align: left;">acute myeloid leukemia with myelodysplasia-related cytogenetic abnormalities</td>
<td style="text-align: left;">NCIT:C198957</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities</td>
<td style="text-align: left;">A group of acute myeloid leukemias classified based on specific karyotype findings.</td>
<td style="text-align: left;">MONDO:0100409</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957720</td>
<td style="text-align: left;">low grade endometrioid adenocarcinoma</td>
<td style="text-align: left;">NCIT:C199146</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Low Grade Endometrioid Adenocarcinoma</td>
<td style="text-align: left;">Endometrioid adenocarcinoma exhibiting 50% or less solid non-glandular, non-squamous growth.</td>
<td style="text-align: left;">MONDO:0005026</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957721</td>
<td style="text-align: left;">high grade endometrioid adenocarcinoma</td>
<td style="text-align: left;">NCIT:C199149</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">High Grade Endometrioid Adenocarcinoma</td>
<td style="text-align: left;">Endometrioid adenocarcinoma exhibiting more than 50% solid non-glandular, non-squamous growth.</td>
<td style="text-align: left;">MONDO:0005026</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957722</td>
<td style="text-align: left;">early t precursor lymphoblastic leukemia/lymphoma</td>
<td style="text-align: left;">NCIT:C199170</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early T Precursor Lymphoblastic Leukemia/Lymphoma</td>
<td style="text-align: left;">T lymphoblastic leukemia/lymphoma in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation.</td>
<td style="text-align: left;">MONDO:0003537</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957724</td>
<td style="text-align: left;">early t precursor acute lymphoblastic leukemia, not otherwise specified</td>
<td style="text-align: left;">NCIT:C199172</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early T Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified</td>
<td style="text-align: left;">Early T precursor acute lymphoblastic leukemia in which further genetic/molecular characterization is not available.</td>
<td style="text-align: left;">MONDO:0100291</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957725</td>
<td style="text-align: left;">t lymphoblastic leukemia/lymphoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C199173</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified</td>
<td style="text-align: left;">T lymphoblastic leukemia/lymphoma in which further genetic/molecular characterization is not available.</td>
<td style="text-align: left;">MONDO:0003537</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957726</td>
<td style="text-align: left;">b acute lymphoblastic leukemia with recurrent genetic abnormalities</td>
<td style="text-align: left;">NCIT:C199202</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">B Acute Lymphoblastic Leukemia with Recurrent Genetic Abnormalities</td>
<td style="text-align: left;">B acute lymphoblastic leukemias characterized by the presence of recurring cytogenetic and/or molecular abnormalities.</td>
<td style="text-align: left;">MONDO:0020511,MONDO:0035605</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957727</td>
<td style="text-align: left;">b lymphoblastic leukemia/lymphoma with myc rearrangement</td>
<td style="text-align: left;">NCIT:C199231</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">B Lymphoblastic Leukemia/Lymphoma with MYC Rearrangement</td>
<td style="text-align: left;">B lymphoblastic leukemia/lymphoma associated with MYC gene rearrangement. The prognosis is poor.</td>
<td style="text-align: left;">MONDO:0035605</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957729</td>
<td style="text-align: left;">multiple myeloma with recurrent genetic abnormalities</td>
<td style="text-align: left;">NCIT:C199392</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multiple Myeloma with Recurrent Genetic Abnormalities</td>
<td style="text-align: left;">Multiple myelomas characterized by the presence of recurring cytogenetic abnormalities.</td>
<td style="text-align: left;">MONDO:0009693</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957730</td>
<td style="text-align: left;">multiple myeloma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C199418</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multiple Myeloma, Not Otherwise Specified</td>
<td style="text-align: left;">A category of multiple myelomas that are characterized by the absence of recurrent genetic abnormalities.</td>
<td style="text-align: left;">MONDO:0009693</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957731</td>
<td style="text-align: left;">heavy chain class-switched primary cutaneous marginal zone lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C199457</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Heavy Chain Class-Switched Primary Cutaneous Marginal Zone Lymphoproliferative Disorder</td>
<td style="text-align: left;">A primary cutaneous marginal zone lymphoproliferative disorder characterized by class-switched immunoglobulin heavy chain expression. The majority of cases are IgG-positive.</td>
<td style="text-align: left;">MONDO:0015813</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957732</td>
<td style="text-align: left;">igm-positive primary cutaneous marginal zone lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C199460</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">IgM-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder</td>
<td style="text-align: left;">A primary cutaneous marginal zone lymphoproliferative disorder characterized by expression of IgM and absence of class-switched immunoglobulin heavy chain expression.</td>
<td style="text-align: left;">MONDO:0015813</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957733</td>
<td style="text-align: left;">bcl2-r-negative, cd23-positive follicle center lymphoma</td>
<td style="text-align: left;">NCIT:C199467</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">BCL2-R-Negative, CD23-Positive Follicle Center Lymphoma</td>
<td style="text-align: left;">Follicular lymphoma characterized by the absence of BCL2 rearrangement and the presence of CD23-positive neoplastic cells. It is associated with STAT6 mutations. It presents with low-stage disease, typically in the inguinal region, and often has a predominant diffuse growth pattern.</td>
<td style="text-align: left;">MONDO:0018906</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957734</td>
<td style="text-align: left;">cyclin d1-positive mantle cell lymphoma</td>
<td style="text-align: left;">NCIT:C199481</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cyclin D1-Positive Mantle Cell Lymphoma</td>
<td style="text-align: left;">A molecular subtype of mantle cell lymphoma characterized by the presence of cyclin D1 expression and/or CCND1 rearrangement..</td>
<td style="text-align: left;">MONDO:0018876</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957735</td>
<td style="text-align: left;">hhv-8 and ebv-negative primary effusion-based lymphoma</td>
<td style="text-align: left;">NCIT:C199576</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">HHV-8 and EBV-Negative Primary Effusion-Based Lymphoma</td>
<td style="text-align: left;">An HHV-8 and EBV-negative primary effusion-based lymphoma that affects elderly, HIV-negative patients with history of medical conditions that result in fluid overload. The majority of cases have been reported in Japan. Most tumors exhibit centroblastic or immunoblastic morphology. The prognosis is good.</td>
<td style="text-align: left;">MONDO:0018905</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957736</td>
<td style="text-align: left;">classic hydroa vacciniforme lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C199676</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Classic Hydroa Vacciniforme Lymphoproliferative Disorder</td>
<td style="text-align: left;">Hydroa vacciniforme lymphoproliferative disorder characterized by the presence of self-limited papulovesicular skin lesions in sun-exposed areas. There is no involvement of internal organs. It has an indolent course and usually affects White individuals.</td>
<td style="text-align: left;">MONDO:0018224</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957737</td>
<td style="text-align: left;">systemic hydroa vacciniforme lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C199677</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Systemic Hydroa Vacciniforme Lymphoproliferative Disorder</td>
<td style="text-align: left;">Hydroa vacciniforme lymphoproliferative disorder characterized by severe clinical course and associated with fever, lymph node involvement, and involvement of internal organs by EBV-positive T-cells and NK-cells. It usually affects Asian and Latin American individuals.</td>
<td style="text-align: left;">MONDO:0018224</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957738</td>
<td style="text-align: left;">indolent nk-cell lymphoproliferative disorder of the gastrointestinal tract</td>
<td style="text-align: left;">NCIT:C200037</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract</td>
<td style="text-align: left;">An indolent lymphoproliferative disorder that affects the gastrointestinal tract. The neoplastic lymphocytes have the typical phenotype of NK-cells, are of medium to large size, show mild pleomorphism, and are EBV infection negative. Features that characterize extranodal NK/T-cell lymphomas (e.g., angioinvasion and angiodestruction) are not present.</td>
<td style="text-align: left;">MONDO:0005169</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957739</td>
<td style="text-align: left;">peripheral t-cell lymphoma-gata3</td>
<td style="text-align: left;">NCIT:C200073</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Peripheral T-Cell Lymphoma-GATA3</td>
<td style="text-align: left;">A molecular subtype of peripheral T-cell lymphoma, not otherwise specified, characterized by high expression of GATA3. It is composed of a monomorphic lymphocytic infiltrate with minimal inflammation and is associated with a poor prognosis.</td>
<td style="text-align: left;">MONDO:0004964</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957740</td>
<td style="text-align: left;">peripheral t-cell lymphoma-tbx21</td>
<td style="text-align: left;">NCIT:C200074</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Peripheral T-Cell Lymphoma-TBX21</td>
<td style="text-align: left;">A molecular subtype of peripheral T-cell lymphoma, not otherwise specified, characterized by high expression of T-box 21 (TBX21). It is composed of a polymorphic lymphocytic infiltrate admixed with abundant inflammatory cells and is associated with a better prognosis compared to peripheral T-cell lymphoma-GATA3.</td>
<td style="text-align: left;">MONDO:0004964</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957741</td>
<td style="text-align: left;">alk-positive histiocytosis</td>
<td style="text-align: left;">NCIT:C200105</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">ALK-Positive Histiocytosis</td>
<td style="text-align: left;">A rare histiocytic neoplasm associated with ALK gene rearrangement leading to activation of signaling pathways. The neoplastic cells have a mature histiocytic phenotype, and usually have a foamy cytoplasm. It is characterized by frequent neurologic involvement and responds to ALK inhibition treatments.</td>
<td style="text-align: left;">MONDO:0006247</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957744</td>
<td style="text-align: left;">myelodysplastic syndrome with low blasts</td>
<td style="text-align: left;">NCIT:C200389</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic Syndrome with Low Blasts</td>
<td style="text-align: left;">Myelodysplastic syndrome characterized by the presence of less than 5% blasts in bone marrow and less than 2% blasts in peripheral blood.</td>
<td style="text-align: left;">MONDO:0018881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957745</td>
<td style="text-align: left;">myelodysplastic syndrome with genetic abnormalities</td>
<td style="text-align: left;">NCIT:C200390</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic Syndrome with Genetic Abnormalities</td>
<td style="text-align: left;">Myelodysplastic syndrome characterized by the presence of defining genetic abnormalities.</td>
<td style="text-align: left;">MONDO:0018881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957746</td>
<td style="text-align: left;">myelodysplastic syndrome/acute myeloid leukemia with myelodysplasia-related gene mutations</td>
<td style="text-align: left;">NCIT:C200400</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations</td>
<td style="text-align: left;">Myelodysplastic syndromes/acute myeloid leukemias characterized by the presence of gene mutations that are associated with myelodysplasia.</td>
<td style="text-align: left;">MONDO:0015041</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957747</td>
<td style="text-align: left;">myelodysplastic syndrome/acute myeloid leukemia with myelodysplasia-related cytogenetic abnormalities</td>
<td style="text-align: left;">NCIT:C200402</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities</td>
<td style="text-align: left;">Myelodysplastic syndromes/acute myeloid leukemias classified based on specific karyotype findings.</td>
<td style="text-align: left;">MONDO:0015041</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957748</td>
<td style="text-align: left;">acute myeloid leukemia with mecom rearrangement</td>
<td style="text-align: left;">NCIT:C200407</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia with MECOM Rearrangement</td>
<td style="text-align: left;">Acute myeloid leukemia characterized by rearrangement of the MECOM gene with various genes.</td>
<td style="text-align: left;">MONDO:0017893</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957749</td>
<td style="text-align: left;">acute myeloid leukemia with nup98 rearrangement</td>
<td style="text-align: left;">NCIT:C200411</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia with NUP98 Rearrangement</td>
<td style="text-align: left;">Acute myeloid leukemia characterized by rearrangement of the NUP98 gene with various genes.</td>
<td style="text-align: left;">MONDO:0017893</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957750</td>
<td style="text-align: left;">acute myeloid leukemia with fus-erg</td>
<td style="text-align: left;">NCIT:C200419</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia with FUS-ERG</td>
<td style="text-align: left;">Acute myeloid leukemia associated with FUS-ERG gene fusion. The prognosis is poor.</td>
<td style="text-align: left;">MONDO:0017893</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957751</td>
<td style="text-align: left;">acute myeloid leukemia with npm1-mlf1</td>
<td style="text-align: left;">NCIT:C200420</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Myeloid Leukemia with NPM1-MLF1</td>
<td style="text-align: left;">Acute myeloid leukemia associated with NPM1-MLF1 gene fusion.</td>
<td style="text-align: left;">MONDO:0017893</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957753</td>
<td style="text-align: left;">acute leukemia of ambiguous lineage with defining genetic abnormalities</td>
<td style="text-align: left;">NCIT:C200494</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Leukemia of Ambiguous Lineage with Defining Genetic Abnormalities</td>
<td style="text-align: left;">Acute leukemia of ambiguous lineage characterized by the presence of defined genetic alterations.</td>
<td style="text-align: left;">MONDO:0019460</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957755</td>
<td style="text-align: left;">b lymphoblastic leukemia/lymphoma with tcf3-hlf rearrangement</td>
<td style="text-align: left;">NCIT:C200587</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">B Lymphoblastic Leukemia/Lymphoma with TCF3-HLF Rearrangement</td>
<td style="text-align: left;">An exceptionally rare childhood B lymphoblastic leukemia/lymphoma associated with TCF3-HLF gene rearrangement resulting in the formation of TCF3-HLF chimeric transcription factor. The prognosis is poor.</td>
<td style="text-align: left;">MONDO:0035605</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957756</td>
<td style="text-align: left;">atypical teratoid/rhabdoid tumor molecular subtypes</td>
<td style="text-align: left;">NCIT:C200597</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes</td>
<td style="text-align: left;">A term that refers to the classification of atypical teratoid/rhabdoid tumors based on their molecular characteristics.</td>
<td style="text-align: left;">MONDO:0020560</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957757</td>
<td style="text-align: left;">classic follicular lymphoma</td>
<td style="text-align: left;">NCIT:C200669</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Classic Follicular Lymphoma</td>
<td style="text-align: left;">A term that refers to follicular lymphoma grade 1, 2, and 3A.</td>
<td style="text-align: left;">MONDO:0018906</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957758</td>
<td style="text-align: left;">follicular lymphoma with unusual cytological features</td>
<td style="text-align: left;">NCIT:C200684</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Follicular Lymphoma with Unusual Cytological Features</td>
<td style="text-align: left;">An uncommon morphologic variant of follicular lymphoma characterized by the presence of predominantly medium-sized neoplastic lymphocytes with blastoid features or large neoplastic lymphocytes with cleaved nuclei.</td>
<td style="text-align: left;">MONDO:0018906</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957759</td>
<td style="text-align: left;">cyclin d1-negative mantle cell lymphoma</td>
<td style="text-align: left;">NCIT:C200685</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cyclin D1-Negative Mantle Cell Lymphoma</td>
<td style="text-align: left;">A molecular subtype of mantle cell lymphoma characterized by the absence of cyclin D1 expression and CCND1 rearrangement.</td>
<td style="text-align: left;">MONDO:0018876</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957760</td>
<td style="text-align: left;">primary large b-cell lymphoma of immune-privileged site</td>
<td style="text-align: left;">NCIT:C200687</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Large B-Cell Lymphoma of Immune-Privileged Site</td>
<td style="text-align: left;">A term that refers to diffuse large B-cell lymphomas that arise as primary tumors in the central nervous system, vitreoretina, and testis in immunocompetent patients.</td>
<td style="text-align: left;">MONDO:0018905</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957761</td>
<td style="text-align: left;">ebv-negative burkitt lymphoma</td>
<td style="text-align: left;">NCIT:C200688</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">EBV-Negative Burkitt Lymphoma</td>
<td style="text-align: left;">Burkitt lymphoma that is not associated with Epstein-Barr virus infection.</td>
<td style="text-align: left;">MONDO:0007243</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957762</td>
<td style="text-align: left;">plasma cell neoplasm with associated paraneoplastic syndrome</td>
<td style="text-align: left;">NCIT:C200738</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Plasma Cell Neoplasm with Associated Paraneoplastic Syndrome</td>
<td style="text-align: left;">A term that refers to rare paraneoplastic syndromes associated with plasma cell neoplasms. This category includes the following: POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes); TEMPI syndrome (telangiectasia, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collection, and intrapulmonary shunting); and AESOP syndrome (adenopathy and extensive skin patch overlying a plasmacytoma).</td>
<td style="text-align: left;">MONDO:0004959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957763</td>
<td style="text-align: left;">who grade 4 glioma</td>
<td style="text-align: left;">NCIT:C200758</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">WHO Grade 4 Glioma</td>
<td style="text-align: left;">A group of malignant gliomas that includes the following: glioblastoma; diffuse midline glioma; diffuse hemispheric glioma, H3 G34-mutant; astrocytoma, IDH-mutant, grade 4; and diffuse pediatric-type high grade glioma, H3-wildtype and IDH-wildtype.</td>
<td style="text-align: left;">MONDO:0100342</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957765</td>
<td style="text-align: left;">cribriform comedo-type adenocarcinoma</td>
<td style="text-align: left;">NCIT:C201124</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cribriform Comedo-Type Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma characterized by the presence of malignant cribriform glands with central necrotic changes.</td>
<td style="text-align: left;">MONDO:0003575,MONDO:0006176</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957766</td>
<td style="text-align: left;">aleukemic myeloid leukemia</td>
<td style="text-align: left;">NCIT:C201127</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Aleukemic Myeloid Leukemia</td>
<td style="text-align: left;">Myeloid leukemia presenting with leukemic infiltration of tissues and normal or decreased leukocyte count in the peripheral blood.</td>
<td style="text-align: left;">MONDO:0004643,MONDO:0003730</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957767</td>
<td style="text-align: left;">solid pseudopapillary neoplasm</td>
<td style="text-align: left;">NCIT:C201136</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Solid Pseudopapillary Neoplasm</td>
<td style="text-align: left;">A low-grade malignant neoplasm that arises from the exocrine pancreas. Rare cases arising from ectopic pancreatic tissue in the ovary have also been described. It is characterized by the presence of uniform cells that form solid and pseudopapillary patterns, cystic changes, and hemorrhage. It usually presents as an encapsulated, solitary, and lobulated mass. It occurs predominantly in young women. Complete removal of the tumor is curative in the majority of cases.</td>
<td style="text-align: left;">MONDO:0004992</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957768</td>
<td style="text-align: left;">endemic burkitt lymphoma</td>
<td style="text-align: left;">NCIT:C27122</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endemic Burkitt Lymphoma</td>
<td style="text-align: left;">A clinical variant of Burkitt lymphoma that occurs in equatorial Africa.  The Epstein-Barr virus has been detected in all patients.  It is the most common malignancy of childhood in this area.</td>
<td style="text-align: left;">MONDO:0007243</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957769</td>
<td style="text-align: left;">multicystic mesothelioma</td>
<td style="text-align: left;">NCIT:C3765</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multicystic Mesothelioma</td>
<td style="text-align: left;">A mesothelial neoplasm that arises from the peritoneum and rarely the pleura. It is characterized by the presence of multiple cysts lined by flattened or cuboidal mesothelial cells. There is no evidence of significant cytologic atypia or increased mitotic activity. It may reoccur. Rare cases of transformation to malignant mesothelioma have been reported.</td>
<td style="text-align: left;">MONDO:0006856,MONDO:0021077</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957770</td>
<td style="text-align: left;">low grade myofibroblastic sarcoma</td>
<td style="text-align: left;">NCIT:C49024</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Low Grade Myofibroblastic Sarcoma</td>
<td style="text-align: left;">A low-grade malignant neoplasm arising from the soft tissue and rarely bone. It is characterized by the presence of spindle-shaped myofibroblasts and collagenous stroma formation in a storiform growth pattern. Metastasis is very rare.</td>
<td style="text-align: left;">MONDO:0005164</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957771</td>
<td style="text-align: left;">sclerosing epithelioid fibrosarcoma</td>
<td style="text-align: left;">NCIT:C49027</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sclerosing Epithelioid Fibrosarcoma</td>
<td style="text-align: left;">A well-circumscribed malignant fibroblastic neoplasm that usually arises from the soft tissue. It is characterized by the presence of nests of malignant epithelioid fibroblasts and sclerotic collagen stroma formation.</td>
<td style="text-align: left;">MONDO:0005164</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957772</td>
<td style="text-align: left;">meningothelial cell neoplasm</td>
<td style="text-align: left;">NCIT:C6971</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Meningothelial Cell Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from meningothelial cells. This category refers to meningiomas.</td>
<td style="text-align: left;">MONDO:0002616</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957773</td>
<td style="text-align: left;">type a lymphomatoid papulosis</td>
<td style="text-align: left;">NCIT:C7197</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Type A Lymphomatoid Papulosis</td>
<td style="text-align: left;">A variant of lymphomatoid papulosis characterized by the presence of scattered anaplastic large lymphocytes, often resembling Reed-Sternberg cells, admixed with acute and chronic inflammatory cells.</td>
<td style="text-align: left;">MONDO:0020326</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957774</td>
<td style="text-align: left;">type c lymphomatoid papulosis</td>
<td style="text-align: left;">NCIT:C7199</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Type C Lymphomatoid Papulosis</td>
<td style="text-align: left;">A variant of lymphomatoid papulosis characterized clinically by regressing skin papules, and morphologically by features resembling anaplastic large cell lymphoma.</td>
<td style="text-align: left;">MONDO:0020326</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957775</td>
<td style="text-align: left;">pancreatic intraductal papillary mucinous neoplasm, oncocytic-type</td>
<td style="text-align: left;">NCIT:C95514</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type</td>
<td style="text-align: left;">A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells with abundant eosinophilic granular cytoplasm.</td>
<td style="text-align: left;">MONDO:0004286,MONDO:0010795</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957850</td>
<td style="text-align: left;">post-essential thrombocythemia myelofibrosis</td>
<td style="text-align: left;">NCIT:C126806</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Post-Essential Thrombocythemia Myelofibrosis</td>
<td style="text-align: left;">Myelofibrosis that develops in a patient with history of essential thrombocythemia.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957851</td>
<td style="text-align: left;">recurrent myelofibrosis</td>
<td style="text-align: left;">NCIT:C162424</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Recurrent Myelofibrosis</td>
<td style="text-align: left;">The reemergence of myelofibrosis after a period of remission.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957852</td>
<td style="text-align: left;">refractory myelofibrosis</td>
<td style="text-align: left;">NCIT:C162425</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Myelofibrosis</td>
<td style="text-align: left;">Myelofibrosis that is resistant to treatment.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957853</td>
<td style="text-align: left;">bone rosai-dorfman-destombes disease</td>
<td style="text-align: left;">NCIT:C178613</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Rosai-Dorfman-Destombes Disease</td>
<td style="text-align: left;">Rosai-Dorfman-Destombes disease affecting the bone.</td>
<td style="text-align: left;">MONDO:0019060,MONDO:0006412</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957854</td>
<td style="text-align: left;">stage m0 medulloblastoma</td>
<td style="text-align: left;">NCIT:C186521</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M0 Medulloblastoma</td>
<td style="text-align: left;">No evidence of subarachnoid or hematogenous metastasis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0007959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957855</td>
<td style="text-align: left;">stage m1 medulloblastoma</td>
<td style="text-align: left;">NCIT:C186522</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M1 Medulloblastoma</td>
<td style="text-align: left;">Microscopic tumor cells are detected in the cerebrospinal fluid. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0007959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957856</td>
<td style="text-align: left;">stage m2 medulloblastoma</td>
<td style="text-align: left;">NCIT:C186523</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M2 Medulloblastoma</td>
<td style="text-align: left;">Gross nodular seeding is detected in the cerebellar/cerebral subarachnoid space or in the third or lateral ventricles. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0007959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957857</td>
<td style="text-align: left;">stage m3 medulloblastoma</td>
<td style="text-align: left;">NCIT:C186524</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M3 Medulloblastoma</td>
<td style="text-align: left;">Gross nodular seeding is detected in the spinal subarachnoid space. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0007959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957858</td>
<td style="text-align: left;">stage m4 medulloblastoma</td>
<td style="text-align: left;">NCIT:C186525</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M4 Medulloblastoma</td>
<td style="text-align: left;">Metastasis outside the cerebrospinal axis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0007959</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957859</td>
<td style="text-align: left;">stage m0 atypical teratoid/rhabdoid tumor</td>
<td style="text-align: left;">NCIT:C186528</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M0 Atypical Teratoid/Rhabdoid Tumor</td>
<td style="text-align: left;">No evidence of subarachnoid or hematogenous metastasis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0020560</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957860</td>
<td style="text-align: left;">stage m1 atypical teratoid/rhabdoid tumor</td>
<td style="text-align: left;">NCIT:C186529</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M1 Atypical Teratoid/Rhabdoid Tumor</td>
<td style="text-align: left;">Microscopic tumor cells are detected in the cerebrospinal fluid. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0020560</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957861</td>
<td style="text-align: left;">stage m2 atypical teratoid/rhabdoid tumor</td>
<td style="text-align: left;">NCIT:C186530</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M2 Atypical Teratoid/Rhabdoid Tumor</td>
<td style="text-align: left;">Gross nodular seeding is detected in the cerebellar/cerebral subarachnoid space or in the third or lateral ventricles. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0020560</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957862</td>
<td style="text-align: left;">stage m3 atypical teratoid/rhabdoid tumor</td>
<td style="text-align: left;">NCIT:C186531</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M3 Atypical Teratoid/Rhabdoid Tumor</td>
<td style="text-align: left;">Gross nodular seeding is detected in the spinal subarachnoid space. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0020560</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957863</td>
<td style="text-align: left;">stage m4 atypical teratoid/rhabdoid tumor</td>
<td style="text-align: left;">NCIT:C186532</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M4 Atypical Teratoid/Rhabdoid Tumor</td>
<td style="text-align: left;">Metastasis outside the cerebrospinal axis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0020560</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957864</td>
<td style="text-align: left;">stage m0 pineoblastoma</td>
<td style="text-align: left;">NCIT:C186568</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M0 Pineoblastoma</td>
<td style="text-align: left;">No evidence of subarachnoid or hematogenous metastasis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0016722</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957865</td>
<td style="text-align: left;">stage m1 pineoblastoma</td>
<td style="text-align: left;">NCIT:C186569</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M1 Pineoblastoma</td>
<td style="text-align: left;">Microscopic tumor cells are detected in the cerebrospinal fluid. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0016722</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957866</td>
<td style="text-align: left;">stage m2 pineoblastoma</td>
<td style="text-align: left;">NCIT:C186570</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M2 Pineoblastoma</td>
<td style="text-align: left;">Gross nodular seeding is detected in the cerebellar/cerebral subarachnoid space or in the third or lateral ventricles. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0016722</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957867</td>
<td style="text-align: left;">stage m3 pineoblastoma</td>
<td style="text-align: left;">NCIT:C186571</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M3 Pineoblastoma</td>
<td style="text-align: left;">Gross nodular seeding is detected in the spinal subarachnoid space. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0016722</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0957868</td>
<td style="text-align: left;">stage m4 pineoblastoma</td>
<td style="text-align: left;">NCIT:C186572</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M4 Pineoblastoma</td>
<td style="text-align: left;">Metastasis outside the cerebrospinal axis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0016722</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0958220</td>
<td style="text-align: left;">colorectal perineurioma</td>
<td style="text-align: left;">NCIT:C96513</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Perineurioma</td>
<td style="text-align: left;">A perineurioma that arises from the colon or rectum.  It usually presents as a small sessile polyp.</td>
<td style="text-align: left;">MONDO:0015031,MONDO:0021444</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970840</td>
<td style="text-align: left;">platinum-resistant primary peritoneal carcinoma</td>
<td style="text-align: left;">NCIT:C157622</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Platinum-Resistant Primary Peritoneal Carcinoma</td>
<td style="text-align: left;">Primary peritoneal carcinoma that progresses between one and six months of completing platinum therapy.</td>
<td style="text-align: left;">MONDO:0015686</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970841</td>
<td style="text-align: left;">platinum-resistant malignant female reproductive system neoplasm</td>
<td style="text-align: left;">NCIT:C169021</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Platinum-Resistant Malignant Female Reproductive System Neoplasm</td>
<td style="text-align: left;">A malignant female reproductive system neoplasm that progresses between one and six months of completing platinum therapy.</td>
<td style="text-align: left;">MONDO:0001416</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970842</td>
<td style="text-align: left;">extracutaneous merkel cell carcinoma</td>
<td style="text-align: left;">NCIT:C173586</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extracutaneous Merkel Cell Carcinoma</td>
<td style="text-align: left;">A rare Merkel cell carcinoma that arises from extracutaneous sites, including the oral cavity, salivary glands, breast, vulva, and vaginal wall.</td>
<td style="text-align: left;">MONDO:0019210</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970844</td>
<td style="text-align: left;">swi/snf complex-deficient sinonasal carcinoma</td>
<td style="text-align: left;">NCIT:C201634</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">SWI/SNF Complex-Deficient Sinonasal Carcinoma</td>
<td style="text-align: left;">A highly aggressive, poorly to undifferentiated carcinoma that arises from the sinonasal tract. It is characterized by loss of one SWI/SNF complex subunit (either SMARCB1 or SMARCA4) and lacks histological features to allow classification into another specific entity. Most patients present with locally advanced disease.</td>
<td style="text-align: left;">MONDO:0056819</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970845</td>
<td style="text-align: left;">tracheal verrucous carcinoma</td>
<td style="text-align: left;">NCIT:C201742</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tracheal Verrucous Carcinoma</td>
<td style="text-align: left;">An exophytic, warty, well differentiated, slow growing and non-metastasizing squamous cell carcinoma arising from the trachea.</td>
<td style="text-align: left;">MONDO:0001419,MONDO:0006006</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970846</td>
<td style="text-align: left;">hypopharyngeal verrucous carcinoma</td>
<td style="text-align: left;">NCIT:C201743</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hypopharyngeal Verrucous Carcinoma</td>
<td style="text-align: left;">An exophytic, warty, well differentiated, slow growing and non-metastasizing squamous cell carcinoma arising from the hypopharynx.</td>
<td style="text-align: left;">MONDO:0044638,MONDO:0006006</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970847</td>
<td style="text-align: left;">hypopharyngeal papillary squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C201748</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hypopharyngeal Papillary Squamous Cell Carcinoma</td>
<td style="text-align: left;">A variant of squamous cell carcinoma that arises from the hypopharynx. It is characterized by exophytic and papillary growth. The papillae are covered by a malignant stratified squamous epithelium.</td>
<td style="text-align: left;">MONDO:0002979,MONDO:0044638</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970848</td>
<td style="text-align: left;">hypopharyngeal spindle cell squamous carcinoma</td>
<td style="text-align: left;">NCIT:C201749</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hypopharyngeal Spindle Cell Squamous Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the hypopharynx. It is characterized by the presence of a malignant spindle cell cellular component. In some cases, there is a biphasic morphology due to the presence of a well-differentiated squamous cell carcinoma component. The latter is either in situ or invasive squamous cell carcinoma.</td>
<td style="text-align: left;">MONDO:0044638,MONDO:0021663</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970849</td>
<td style="text-align: left;">parotid gland keratocystoma</td>
<td style="text-align: left;">NCIT:C201770</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Parotid Gland Keratocystoma</td>
<td style="text-align: left;">A benign neoplasm that arises from the parotid gland. It is characterized by the presence of multicystic formations, lined by neoplastic stratified squamous epithelium and containing keratotic lamellae. The neoplastic squamous epithelial cells have bland nuclei and abundant eosinophilic cytoplasm. Focally, solid islands of squamous cells surrounded by collagenous stroma are present.</td>
<td style="text-align: left;">MONDO:0021460</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970850</td>
<td style="text-align: left;">hyalinizing clear cell carcinoma</td>
<td style="text-align: left;">NCIT:C201821</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hyalinizing Clear Cell Carcinoma</td>
<td style="text-align: left;">A rare, slow-growing carcinoma characterized by the presence of malignant clear and eosinophilic cells in a hyalinized stroma. It has been described in the salivary glands and lung. Most cases are associated with translocation of EWSR1 and ATF1, resulting in the formation of EWSR1-ATF1 fusion gene. The prognosis is good.</td>
<td style="text-align: left;">MONDO:0004993</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970851</td>
<td style="text-align: left;">tongue verrucous carcinoma</td>
<td style="text-align: left;">NCIT:C201878</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tongue Verrucous Carcinoma</td>
<td style="text-align: left;">A well differentiated squamous cell carcinoma arising from the tongue.  It is an exophytic, warty, slow growing tumor, usually affecting older males. It is associated with the chronic use of smokeless tobacco.</td>
<td style="text-align: left;">MONDO:0021538,MONDO:0000500</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970853</td>
<td style="text-align: left;">transformed chronic lymphocytic leukemia to hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C201960</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma</td>
<td style="text-align: left;">Histologic transformation of chronic lymphocytic leukemia to Hodgkin lymphoma.</td>
<td style="text-align: left;">MONDO:0004948</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970854</td>
<td style="text-align: left;">pineoblastoma molecular subtypes</td>
<td style="text-align: left;">NCIT:C201966</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pineoblastoma Molecular Subtypes</td>
<td style="text-align: left;">A term that refers to the classification of pineoblastomas based on their molecular characteristics.</td>
<td style="text-align: left;">MONDO:0016722</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970855</td>
<td style="text-align: left;">spinal cord pilocytic astrocytoma</td>
<td style="text-align: left;">NCIT:C201976</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Spinal Cord Pilocytic Astrocytoma</td>
<td style="text-align: left;">Pilocytic astrocytoma that arises from the spinal cord.</td>
<td style="text-align: left;">MONDO:0003174,MONDO:0016691</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970856</td>
<td style="text-align: left;">brain low grade glioma</td>
<td style="text-align: left;">NCIT:C201977</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Brain Low Grade Glioma</td>
<td style="text-align: left;">A low-grade glioma that arises from the brain.</td>
<td style="text-align: left;">MONDO:0021632,MONDO:0021637</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970857</td>
<td style="text-align: left;">clear cell calcifying epithelial odontogenic tumor</td>
<td style="text-align: left;">NCIT:C202057</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Clear Cell Calcifying Epithelial Odontogenic Tumor</td>
<td style="text-align: left;">A calcifying epithelial odontogenic tumor that contains a variable proportion of clear cells containing diastase-labile PAS-positive material that is consistent with glycogen.</td>
<td style="text-align: left;">MONDO:0022057</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970858</td>
<td style="text-align: left;">cystic/microcystic calcifying epithelial odontogenic tumor</td>
<td style="text-align: left;">NCIT:C202058</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cystic/Microcystic Calcifying Epithelial Odontogenic Tumor</td>
<td style="text-align: left;">A calcifying epithelial odontogenic tumor characterized by cystic/microcystic changes.</td>
<td style="text-align: left;">MONDO:0022057</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970859</td>
<td style="text-align: left;">non-calcifying/langerhans cell-rich calcifying epithelial odontogenic tumor</td>
<td style="text-align: left;">NCIT:C202059</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Calcifying/Langerhans Cell-Rich Calcifying Epithelial Odontogenic Tumor</td>
<td style="text-align: left;">A calcifying epithelial odontogenic tumor that contains significant numbers of Langerhans cells.</td>
<td style="text-align: left;">MONDO:0022057</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970860</td>
<td style="text-align: left;">adenoid ameloblastoma</td>
<td style="text-align: left;">NCIT:C202061</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adenoid Ameloblastoma</td>
<td style="text-align: left;">A rare ameloblastoma characterized by the presence of cribriform architecture and the formation of duct-like structures. Dentinoid is usually present.</td>
<td style="text-align: left;">MONDO:0017795</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970861</td>
<td style="text-align: left;">egfr-positive lung non-small cell carcinoma</td>
<td style="text-align: left;">NCIT:C202131</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">EGFR-Positive Lung Non-Small Cell Carcinoma</td>
<td style="text-align: left;">Lung non-small cell carcinoma that is associated with EGFR gene mutation.</td>
<td style="text-align: left;">MONDO:0005233</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970862</td>
<td style="text-align: left;">juvenile trabecular ossifying fibroma</td>
<td style="text-align: left;">NCIT:C202205</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Juvenile Trabecular Ossifying Fibroma</td>
<td style="text-align: left;">A rare, benign fibro-osseous neoplasm that usually affects the jaws and predominantly arises in children and adolescents. It is characterized by prominent osteoid formation rimmed by osteoblasts in a fibrotic stroma. Patients usually present with painless jaw expansion that is associated with rapid growth and tooth displacement. Amplifications of MDM2 and RASAL1 genes have been detected in some cases. Recurrences have been reported in a minority of cases.</td>
<td style="text-align: left;">MONDO:0002119</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970863</td>
<td style="text-align: left;">psammomatoid ossifying fibroma</td>
<td style="text-align: left;">NCIT:C202209</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Psammomatoid Ossifying Fibroma</td>
<td style="text-align: left;">A rare, benign fibro-osseous neoplasm that arises from the craniofacial skeleton. It is characterized by the presence of multiple ossicles resembling psammoma bodies in a hypercellular stroma. It usually affects individuals in their second to fourth decades. Recurrences following surgical excision have been reported in a minority of cases.</td>
<td style="text-align: left;">MONDO:0002119</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970864</td>
<td style="text-align: left;">surface osteoma</td>
<td style="text-align: left;">NCIT:C202252</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Surface Osteoma</td>
<td style="text-align: left;">An osteoma that arises from the surface of the bone.</td>
<td style="text-align: left;">MONDO:0005166</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970865</td>
<td style="text-align: left;">central osteoma</td>
<td style="text-align: left;">NCIT:C202253</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Osteoma</td>
<td style="text-align: left;">An osteoma that arises from the endosteum.</td>
<td style="text-align: left;">MONDO:0005166</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970866</td>
<td style="text-align: left;">rhabdomyosarcoma with tfcp2 rearrangement</td>
<td style="text-align: left;">NCIT:C202263</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Rhabdomyosarcoma with TFCP2 Rearrangement</td>
<td style="text-align: left;">An aggressive, high-grade rhabdomyosarcoma characterized by TFCP2 rearrangement that results either in TFCP2-FUS or TFCP2-EWSR1 fusion gene formation. It affects young adults and arises from bone and less frequently soft tissue. It predominantly affects the craniofacial bones. Histologically, it usually shows a biphasic pattern with spindle and epithelioid cell areas. It is associated with poor prognosis.</td>
<td style="text-align: left;">MONDO:0005212</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970867</td>
<td style="text-align: left;">non-clear cell renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C202497</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Clear Cell Renal Cell Carcinoma</td>
<td style="text-align: left;">A group of renal cell carcinomas characterized by the absence of lipid-containing clear adenocarcinoma cells. This category includes the following morphological subtypes: papillary renal cell carcinoma; sarcomatoid renal cell carcinoma; chromophobe renal cell carcinoma; tubulocystic renal cell carcinoma; and eosinophilic solid and cystic renal cell carcinoma.</td>
<td style="text-align: left;">MONDO:0005549</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970868</td>
<td style="text-align: left;">middle ear papilloma</td>
<td style="text-align: left;">NCIT:C202582</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Middle Ear Papilloma</td>
<td style="text-align: left;">A rare papilloma that arises from the middle ear and resembles a sinonasal papilloma. Approximately half of the patients have concurrent sinonasal or nasopharyngeal papillomas.</td>
<td style="text-align: left;">MONDO:0021078,MONDO:0021482</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970869</td>
<td style="text-align: left;">external auditory canal squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C202594</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">External Auditory Canal Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the keratinizing squamous epithelium that lines the external auditory canal.</td>
<td style="text-align: left;">MONDO:0003501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970870</td>
<td style="text-align: left;">orbital solitary fibrous tumor</td>
<td style="text-align: left;">NCIT:C202620</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Orbital Solitary Fibrous Tumor</td>
<td style="text-align: left;">A solitary fibrous tumor that arises from the orbit. Most of these tumors are benign.</td>
<td style="text-align: left;">MONDO:0016238,MONDO:0024611</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970871</td>
<td style="text-align: left;">head and neck soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C202623</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Soft Tissue Neoplasm</td>
<td style="text-align: left;">A mesenchymal neoplasm that arises from the soft tissue of the head and neck.</td>
<td style="text-align: left;">MONDO:0006424,MONDO:0005586</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970872</td>
<td style="text-align: left;">proximal colon carcinoma</td>
<td style="text-align: left;">NCIT:C202633</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Proximal Colon Carcinoma</td>
<td style="text-align: left;">A colon carcinoma that arises from cecum, ascending colon, or hepatic flexure.</td>
<td style="text-align: left;">MONDO:0002032</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970873</td>
<td style="text-align: left;">distal colon carcinoma</td>
<td style="text-align: left;">NCIT:C202634</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Distal Colon Carcinoma</td>
<td style="text-align: left;">A colon carcinoma that arises from the splenic flexure, descending colon, or sigmoid colon.</td>
<td style="text-align: left;">MONDO:0002032</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970874</td>
<td style="text-align: left;">oral cavity neurofibroma</td>
<td style="text-align: left;">NCIT:C202860</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oral Cavity Neurofibroma</td>
<td style="text-align: left;">A neurofibroma that arises from the oral cavity. The tongue is the most frequently affected site.</td>
<td style="text-align: left;">MONDO:0021445,MONDO:0016755</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970875</td>
<td style="text-align: left;">oral cavity schwannoma</td>
<td style="text-align: left;">NCIT:C202876</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oral Cavity Schwannoma</td>
<td style="text-align: left;">A schwannoma that arises from the oral cavity.</td>
<td style="text-align: left;">MONDO:0021445,MONDO:0004820</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970876</td>
<td style="text-align: left;">head and neck phosphaturic mesenchymal tumor</td>
<td style="text-align: left;">NCIT:C202879</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Phosphaturic Mesenchymal Tumor</td>
<td style="text-align: left;">A phosphaturic mesenchymal tumor that arises from the head and neck. It usually affects the paranasal sinuses. The head and neck region is the most frequently involved site for phosphaturic mesenchymal tumors, following the appendicular skeleton.</td>
<td style="text-align: left;">MONDO:0006368,MONDO:0005586</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970877</td>
<td style="text-align: left;">appendicular skeleton phosphaturic mesenchymal tumor</td>
<td style="text-align: left;">NCIT:C202880</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendicular Skeleton Phosphaturic Mesenchymal Tumor</td>
<td style="text-align: left;">A phosphaturic mesenchymal tumor that arises from the appendicular skeleton. The appendicular skeleton is the most frequently involved site for phosphaturic mesenchymal tumors.</td>
<td style="text-align: left;">MONDO:0019060,MONDO:0006368</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970878</td>
<td style="text-align: left;">poorly differentiated synovial sarcoma</td>
<td style="text-align: left;">NCIT:C202883</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Poorly Differentiated Synovial Sarcoma</td>
<td style="text-align: left;">A synovial sarcoma characterized by the presence of poorly differentiated morphological features and absence of spindle cells.</td>
<td style="text-align: left;">MONDO:0010434</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970879</td>
<td style="text-align: left;">primary cd30-positive t-cell lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C202952</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary CD30-Positive T-Cell Lymphoproliferative Disorder</td>
<td style="text-align: left;">A spectrum of T-cell lymphoproliferative disorders that arise from skin, subcutaneous tissue, and head and neck mucosal sites. They are characterized by the presence of CD30-positive neoplastic lymphocytes. Cells that resemble the hallmark cells of anaplastic large cell lymphoma are often seen.</td>
<td style="text-align: left;">MONDO:0005169</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970880</td>
<td style="text-align: left;">head and neck hematopoietic and lymphoid cell neoplasm</td>
<td style="text-align: left;">NCIT:C202954</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Hematopoietic and Lymphoid Cell Neoplasm</td>
<td style="text-align: left;">A neoplasm of hematopoietic and lymphoid cell origin that affects the head and neck region.</td>
<td style="text-align: left;">MONDO:0005586,MONDO:0044881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970881</td>
<td style="text-align: left;">head and neck germ cell tumor</td>
<td style="text-align: left;">NCIT:C202977</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Germ Cell Tumor</td>
<td style="text-align: left;">An exceptionally rare benign or malignant germ cell tumor that arises from the head and neck region. It usually affects the sinonasal tract and nasopharynx.</td>
<td style="text-align: left;">MONDO:0018201,MONDO:0005586</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970882</td>
<td style="text-align: left;">cecum neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C203386</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cecum Neuroendocrine Tumor</td>
<td style="text-align: left;">A well-differentiated, low-, intermediate-, or high-grade neoplasm with neuroendocrine differentiation that arises from the cecum.</td>
<td style="text-align: left;">MONDO:0005694,MONDO:0015067</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970883</td>
<td style="text-align: left;">ascending colon neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C203387</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ascending Colon Neuroendocrine Tumor</td>
<td style="text-align: left;">A well-differentiated, low-, intermediate-, or high-grade neoplasm with neuroendocrine differentiation that arises from the ascending colon.</td>
<td style="text-align: left;">MONDO:0015067</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970884</td>
<td style="text-align: left;">descending colon neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C203388</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Descending Colon Neuroendocrine Tumor</td>
<td style="text-align: left;">A well-differentiated, low-, intermediate-, or high-grade neoplasm with neuroendocrine differentiation that arises from the descending colon.</td>
<td style="text-align: left;">MONDO:0015067</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970885</td>
<td style="text-align: left;">sigmoid colon neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C203389</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sigmoid Colon Neuroendocrine Tumor</td>
<td style="text-align: left;">A well-differentiated, low-, intermediate-, or high-grade neoplasm with neuroendocrine differentiation that arises from the sigmoid colon.</td>
<td style="text-align: left;">MONDO:0015067</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970886</td>
<td style="text-align: left;">transverse colon neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C203390</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Transverse Colon Neuroendocrine Tumor</td>
<td style="text-align: left;">A well-differentiated, low-, intermediate-, or high-grade neoplasm with neuroendocrine differentiation that arises from the transverse colon.</td>
<td style="text-align: left;">MONDO:0015067</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970887</td>
<td style="text-align: left;">histiocytic disorder</td>
<td style="text-align: left;">NCIT:C203422</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Histiocytic Disorder</td>
<td style="text-align: left;">A group of non-neoplastic and neoplastic disorders characterized by the proliferation of histiocytes. This category includes hemophagocytic lymphohistiocytosis and histiocytic and dendritic cell neoplasms.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970888</td>
<td style="text-align: left;">myelodysplastic chronic myelomonocytic leukemia</td>
<td style="text-align: left;">NCIT:C203443</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myelodysplastic Chronic Myelomonocytic Leukemia</td>
<td style="text-align: left;">Chronic myelomonocytic leukemia characterized by the absence of a markedly elevated white blood cell count in the peripheral blood.</td>
<td style="text-align: left;">MONDO:0020311</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970889</td>
<td style="text-align: left;">myeloproliferative chronic myelomonocytic leukemia</td>
<td style="text-align: left;">NCIT:C203444</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myeloproliferative Chronic Myelomonocytic Leukemia</td>
<td style="text-align: left;">Chronic myelomonocytic leukemia characterized by the presence of a markedly elevated white blood cell count in the peripheral blood.</td>
<td style="text-align: left;">MONDO:0020311</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970890</td>
<td style="text-align: left;">t acute lymphoblastic leukemia with recurrent genetic abnormalities</td>
<td style="text-align: left;">NCIT:C203469</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">T Acute Lymphoblastic Leukemia with Recurrent Genetic Abnormalities</td>
<td style="text-align: left;">T acute lymphoblastic leukemias characterized by the presence of recurring cytogenetic and/or molecular abnormalities.</td>
<td style="text-align: left;">MONDO:0004963</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970891</td>
<td style="text-align: left;">esophageal and gastroesophageal junction carcinoma</td>
<td style="text-align: left;">NCIT:C203673</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal and Gastroesophageal Junction Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the esophagus or gastroesophageal junction.</td>
<td style="text-align: left;">MONDO:0006181</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970892</td>
<td style="text-align: left;">low grade mucinous carcinoma peritonei</td>
<td style="text-align: left;">NCIT:C203946</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Low Grade Mucinous Carcinoma Peritonei</td>
<td style="text-align: left;">A low-grade mucinous adenocarcinoma that has spread to the peritoneum.</td>
<td style="text-align: left;">MONDO:0017048</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970893</td>
<td style="text-align: left;">high grade mucinous carcinoma peritonei</td>
<td style="text-align: left;">NCIT:C203948</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">High Grade Mucinous Carcinoma Peritonei</td>
<td style="text-align: left;">A high-grade mucinous adenocarcinoma that has spread to the peritoneum.</td>
<td style="text-align: left;">MONDO:0017048</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970894</td>
<td style="text-align: left;">merkel cell polyoma virus-positive merkel cell carcinoma</td>
<td style="text-align: left;">NCIT:C204383</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Merkel Cell Polyoma Virus-Positive Merkel Cell Carcinoma</td>
<td style="text-align: left;">A Merkel cell carcinoma that is associated with Merkel cell polyoma virus infection.</td>
<td style="text-align: left;">MONDO:0019210</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970895</td>
<td style="text-align: left;">merkel cell polyoma virus-negative merkel cell carcinoma</td>
<td style="text-align: left;">NCIT:C204385</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Merkel Cell Polyoma Virus-Negative Merkel Cell Carcinoma</td>
<td style="text-align: left;">A Merkel cell carcinoma that is not associated with Merkel cell polyoma virus infection.</td>
<td style="text-align: left;">MONDO:0019210</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970896</td>
<td style="text-align: left;">lentiginous nevus</td>
<td style="text-align: left;">NCIT:C204482</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lentiginous Nevus</td>
<td style="text-align: left;">A nevus characterized by an intraepidermal proliferation of nested melanocytes along the basal epidermis.</td>
<td style="text-align: left;">MONDO:0044794</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970897</td>
<td style="text-align: left;">mitf pathway-activated melanocytic tumor</td>
<td style="text-align: left;">NCIT:C204739</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">MITF Pathway-Activated Melanocytic Tumor</td>
<td style="text-align: left;">A cutaneous neoplasm associated with MITF gene rearrangement and either ACTIN-MITF translocation or MITF-CREM translocation. It is composed of large cells with clear cytoplasm that exhibit melanocytic differentiation and proliferate in the dermis. It presents as a single non-pigmented cutaneous nodule.</td>
<td style="text-align: left;">MONDO:0021583</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970898</td>
<td style="text-align: left;">dermal spitz nevus</td>
<td style="text-align: left;">NCIT:C204789</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Dermal Spitz Nevus</td>
<td style="text-align: left;">A cutaneous Spitz nevus characterized by the presence of an intradermal melanocytic component without junctional melanocytic activity.</td>
<td style="text-align: left;">MONDO:0006813,MONDO:0044793</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970899</td>
<td style="text-align: left;">cutaneous spitz tumor</td>
<td style="text-align: left;">NCIT:C204790</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Spitz Tumor</td>
<td style="text-align: left;">A term that refers to a group of cutaneous melanocytic neoplasms that are composed of epithelioid and/or spindle cells and extend from the epidermis into the reticular dermis, often in a wedge-shaped configuration. They are usually associated with oncogenic mutations that activate the MAP-kinase pathway. This category includes Spitz nevus, Spitz melanocytoma, and Spitz melanoma.</td>
<td style="text-align: left;">MONDO:0021583</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970900</td>
<td style="text-align: left;">melanoma in intermittently sun-exposed skin</td>
<td style="text-align: left;">NCIT:C204840</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Melanoma in Intermittently Sun-Exposed Skin</td>
<td style="text-align: left;">A melanoma that arises from the skin in the absence of severe actinic keratosis. It can arise from a pre-existing nevus or de novo.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970901</td>
<td style="text-align: left;">low-csd melanoma, superficial spreading melanoma subtype</td>
<td style="text-align: left;">NCIT:C204843</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Low-CSD Melanoma, Superficial Spreading Melanoma Subtype</td>
<td style="text-align: left;">A cutaneous melanoma that develops on sun exposed sites with low cumulative sun damage (CSD). It is characterized by a prominent junctional and intraepidermal component with intraepidermal proliferation of individual atypical melanocytes and formation of nests of atypical melanocytes along the dermal-epidermal junction. The dermal component is composed of atypical melanocytes that fail to mature. The atypical melanocytes have large nuclei, prominent nucleoli, and eosinophilic or lightly pigmented cytoplasm. It is the most common melanoma subtype in the Western world.</td>
<td style="text-align: left;">MONDO:0020638</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970902</td>
<td style="text-align: left;">melanoma in chronically sun-exposed skin</td>
<td style="text-align: left;">NCIT:C204864</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Melanoma in Chronically Sun-Exposed Skin</td>
<td style="text-align: left;">A melanoma that arises from a chronically sun-exposed skin area. It is associated with severe actinic keratosis.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970903</td>
<td style="text-align: left;">mucosal nevus</td>
<td style="text-align: left;">NCIT:C204907</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mucosal Nevus</td>
<td style="text-align: left;">A nevus that arises from a mucosal site.</td>
<td style="text-align: left;">MONDO:0005073</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970904</td>
<td style="text-align: left;">dendritic blue nevus</td>
<td style="text-align: left;">NCIT:C204910</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Dendritic Blue Nevus</td>
<td style="text-align: left;">A blue nevus characterized by the proliferation of dendritic melanocytes in sclerotic stromal collagen.</td>
<td style="text-align: left;">MONDO:0006680</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970905</td>
<td style="text-align: left;">cutaneous intermediate congenital nevus</td>
<td style="text-align: left;">NCIT:C204976</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Intermediate Congenital Nevus</td>
<td style="text-align: left;">A cutaneous congenital nevus measuring 15-200 mm. It is typically amenable to surgical resection.</td>
<td style="text-align: left;">MONDO:0044792</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970906</td>
<td style="text-align: left;">conjunctival melanocytic neoplasm</td>
<td style="text-align: left;">NCIT:C204977</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Melanocytic Neoplasm</td>
<td style="text-align: left;">A melanocytic neoplasm that arises from the conjunctiva. This category includes conjunctival nevi, conjunctival melanocytic intraepithelial lesions, and conjunctival melanomas.</td>
<td style="text-align: left;">MONDO:0021143,MONDO:0020204</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970907</td>
<td style="text-align: left;">uveal melanocytic neoplasm</td>
<td style="text-align: left;">NCIT:C205057</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uveal Melanocytic Neoplasm</td>
<td style="text-align: left;">A melanocytic neoplasm that arises from the iris, ciliary body, and choroid. This category includes nevi, melanocytomas, and melanomas.</td>
<td style="text-align: left;">MONDO:0021143,MONDO:0021225</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970908</td>
<td style="text-align: left;">nodular melanoma</td>
<td style="text-align: left;">NCIT:C205125</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nodular Melanoma</td>
<td style="text-align: left;">A melanoma that arises from the skin, conjunctiva, and mucosal sites. It is characterized by a vertical growth phase and lacks a significant radial growth phase. It may or may not arise from a pre-existing nevus. Morphologically, it is characterized by the presence of cohesive aggregates of neoplastic melanocytes in the dermis that often exhibit an epithelioid appearance. The overlying epidermis is often involved.</td>
<td style="text-align: left;">MONDO:0005105</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970909</td>
<td style="text-align: left;">dermal melanoma</td>
<td style="text-align: left;">NCIT:C205129</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Dermal Melanoma</td>
<td style="text-align: left;">A melanoma that is confined to the dermis and subcutaneous tissue without involvement of the epidermis.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970910</td>
<td style="text-align: left;">metastatic melanoma in the lymph nodes</td>
<td style="text-align: left;">NCIT:C205131</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Melanoma in the Lymph Nodes</td>
<td style="text-align: left;">A melanoma that has spread to the lymph nodes from a cutaneous or extracutaneous primary site.</td>
<td style="text-align: left;">MONDO:0005191,MONDO:0005438</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970911</td>
<td style="text-align: left;">platinum-sensitive endometrial carcinoma</td>
<td style="text-align: left;">NCIT:C205187</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Platinum-Sensitive Endometrial Carcinoma</td>
<td style="text-align: left;">An endometrial carcinoma that has a documented response to platinum-based chemotherapy.</td>
<td style="text-align: left;">MONDO:0002447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970912</td>
<td style="text-align: left;">early stage cervical carcinoma</td>
<td style="text-align: left;">NCIT:C205287</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early Stage Cervical Carcinoma</td>
<td style="text-align: left;">A stage term that refers to cervical carcinoma stages IA, IB, and IIA.</td>
<td style="text-align: left;">MONDO:0005131</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970913</td>
<td style="text-align: left;">early stage clear cell renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C205289</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early Stage Clear Cell Renal Cell Carcinoma</td>
<td style="text-align: left;">A stage term referring to clear cell renal cell carcinoma that presents as a small tumor and is confined to the kidney.</td>
<td style="text-align: left;">MONDO:0005005</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970914</td>
<td style="text-align: left;">early stage colorectal carcinoma</td>
<td style="text-align: left;">NCIT:C205290</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early Stage Colorectal Carcinoma</td>
<td style="text-align: left;">A stage term referring to colorectal carcinoma that is limited to the colon/rectum or local lymph nodes, without metastasis to distant anatomic sites.</td>
<td style="text-align: left;">MONDO:0024331</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970915</td>
<td style="text-align: left;">early stage endometrial carcinoma</td>
<td style="text-align: left;">NCIT:C205295</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early Stage Endometrial Carcinoma</td>
<td style="text-align: left;">A stage term referring to endometrial carcinoma that is confined to the uterus.</td>
<td style="text-align: left;">MONDO:0002447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970916</td>
<td style="text-align: left;">early stage esophageal carcinoma</td>
<td style="text-align: left;">NCIT:C205298</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early Stage Esophageal Carcinoma</td>
<td style="text-align: left;">A stage term referring to esophageal carcinoma that is confined to the esophageal mucosa or submucosa.</td>
<td style="text-align: left;">MONDO:0019086</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970917</td>
<td style="text-align: left;">early stage hepatocellular carcinoma</td>
<td style="text-align: left;">NCIT:C205301</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early Stage Hepatocellular Carcinoma</td>
<td style="text-align: left;">A stage term referring to hepatocellular carcinoma that presents as a single tumor with the largest diameter measuring 2 cm or less. The liver function is well-preserved and there is no vascular invasion or metastasis. (Barcelona Liver Cancer Classification).</td>
<td style="text-align: left;">MONDO:0007256</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970918</td>
<td style="text-align: left;">early stage lung non-small cell carcinoma</td>
<td style="text-align: left;">NCIT:C205303</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early Stage Lung Non-Small Cell Carcinoma</td>
<td style="text-align: left;">A stage term that refers to lung non-small cell carcinoma stages I, II, and IIIA.</td>
<td style="text-align: left;">MONDO:0005233</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970919</td>
<td style="text-align: left;">early stage malignant skin neoplasm</td>
<td style="text-align: left;">NCIT:C205307</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early Stage Malignant Skin Neoplasm</td>
<td style="text-align: left;">A stage term referring to a malignant neoplasm that arises from and is confined to a limited area of the skin without lymph node involvement or distant metastases.</td>
<td style="text-align: left;">MONDO:0002898</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970920</td>
<td style="text-align: left;">primary cutaneous nut adnexal carcinoma</td>
<td style="text-align: left;">NCIT:C205357</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Cutaneous NUT Adnexal Carcinoma</td>
<td style="text-align: left;">A very rare carcinoma that arises from the sweat glands. It is characterized by mutations and rearrangement of the NUT gene. It presents as a papular or nodular skin lesion and has been described in the hand, shoulder, trunk, and lower limb. Histologically, there is a proliferation of malignant epithelial cells in the dermis and/or subcutaneous tissue. The tumor cells display round nuclei with prominent single nucleoli. Features include the presence of small round ducts and foci of abrupt keratinization.</td>
<td style="text-align: left;">MONDO:0005524,MONDO:0005563</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970921</td>
<td style="text-align: left;">trichogerminoma</td>
<td style="text-align: left;">NCIT:C205371</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Trichogerminoma</td>
<td style="text-align: left;">A rare subtype of trichoblastoma characterized by the presence of lobules of basaloid cells. The lobules are separated by fibrous stroma. It is associated with the expression of recurrent FOXK1/GRHL and GPS2/GRHL gene fusions.</td>
<td style="text-align: left;">MONDO:0020593</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970922</td>
<td style="text-align: left;">apocrine cystadenoma</td>
<td style="text-align: left;">NCIT:C205459</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Apocrine Cystadenoma</td>
<td style="text-align: left;">A rare, benign cystic neoplasm that arises from the apocrine gland. It is characterized by the presence of papillary-like epithelial projections and more complex architectural patterns compared to apocrine hidrocystoma.</td>
<td style="text-align: left;">MONDO:0002804,MONDO:0002369</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970923</td>
<td style="text-align: left;">eccrine poroma</td>
<td style="text-align: left;">NCIT:C205462</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eccrine Poroma</td>
<td style="text-align: left;">A poroma with eccrine differentiation.</td>
<td style="text-align: left;">MONDO:0006738,MONDO:0024247</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970924</td>
<td style="text-align: left;">hidroacanthoma simplex</td>
<td style="text-align: left;">NCIT:C205475</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hidroacanthoma Simplex</td>
<td style="text-align: left;">A poroma characterized by the presence of aggregates of basaloid cells confined to the epidermis.</td>
<td style="text-align: left;">MONDO:0006738</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970925</td>
<td style="text-align: left;">solid cystic hidradenoma</td>
<td style="text-align: left;">NCIT:C205539</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Solid Cystic Hidradenoma</td>
<td style="text-align: left;">A hidradenoma characterized by the presence of solid lobular neoplastic cell proliferations and cystic spaces filled with homogeneous eosinophilic material.</td>
<td style="text-align: left;">MONDO:0002805</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970926</td>
<td style="text-align: left;">sialoblastoma</td>
<td style="text-align: left;">NCIT:C35837</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sialoblastoma</td>
<td style="text-align: left;">A rare, malignant primitive neoplasm that occurs in the salivary glands. Most tumors arise from the parotid gland, followed by the submandibular gland, and rarely the minor salivary glands. It is usually diagnosed during the neonatal period and presents with painless face swelling.</td>
<td style="text-align: left;">MONDO:0004669</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970927</td>
<td style="text-align: left;">cribriform trichoblastoma</td>
<td style="text-align: left;">NCIT:C43322</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cribriform Trichoblastoma</td>
<td style="text-align: left;">A trichoblastoma characterized by the presence of neoplastic epithelial cells forming cribriform patterns.</td>
<td style="text-align: left;">MONDO:0020593</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970928</td>
<td style="text-align: left;">lung neuroendocrine carcinoma</td>
<td style="text-align: left;">NCIT:C45569</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Neuroendocrine Carcinoma</td>
<td style="text-align: left;">An aggressive high-grade carcinoma with neuroendocrine differentiation that arises from the lung. It is classified as small cell lung carcinoma, large cell lung neuroendocrine carcinoma, or combined lung carcinoma.</td>
<td style="text-align: left;">MONDO:0005454,MONDO:0005138,MONDO:0002120</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970929</td>
<td style="text-align: left;">branchioma</td>
<td style="text-align: left;">NCIT:C53595</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Branchioma</td>
<td style="text-align: left;">A rare, benign, well-circumscribed or encapsulated tumor that arises from the neck and occurs in adults. It is characterized by the presence of spindle cells, epithelial islands, and adipose tissue.</td>
<td style="text-align: left;">MONDO:0021455</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970930</td>
<td style="text-align: left;">ear carcinoma</td>
<td style="text-align: left;">NCIT:C54262</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ear Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the ear.  Representative examples include ceruminous adenocarcinoma and squamous cell carcinoma of the external ear and adenocarcinoma of the middle ear.</td>
<td style="text-align: left;">MONDO:0003277,MONDO:0002038</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970931</td>
<td style="text-align: left;">intracranial melanoma</td>
<td style="text-align: left;">NCIT:C5442</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intracranial Melanoma</td>
<td style="text-align: left;">A melanoma that arises from the leptomeninges within the cranium.</td>
<td style="text-align: left;">MONDO:0021632,MONDO:0001657,MONDO:0003761</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970932</td>
<td style="text-align: left;">meckel diverticulum neuroendocrine tumor g1</td>
<td style="text-align: left;">NCIT:C6424</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Meckel Diverticulum Neuroendocrine Tumor G1</td>
<td style="text-align: left;">A well-differentiated, low-grade neuroendocrine neoplasm that arises in a Meckel diverticulum. The mitotic count is less than 2 per 2 mm2 and the Ki-67 index is less than 3%.</td>
<td style="text-align: left;">MONDO:0021533</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970933</td>
<td style="text-align: left;">duodenal neuroendocrine tumor g1</td>
<td style="text-align: left;">NCIT:C6425</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Duodenal Neuroendocrine Tumor G1</td>
<td style="text-align: left;">A well-differentiated, low-grade neuroendocrine neoplasm that arises from the duodenum. The mitotic count is less than 2 per 2 mm2 and the Ki-67 index is less than 3%.</td>
<td style="text-align: left;">MONDO:0015063,MONDO:0000540</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970934</td>
<td style="text-align: left;">intracranial myeloid sarcoma</td>
<td style="text-align: left;">NCIT:C7008</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intracranial Myeloid Sarcoma</td>
<td style="text-align: left;">A myeloid sarcoma that affects the meninges or the cerebral hemispheres.</td>
<td style="text-align: left;">MONDO:0001657,MONDO:0003641,MONDO:0021632,MONDO:0006861</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970936</td>
<td style="text-align: left;">well differentiated fibrosarcoma</td>
<td style="text-align: left;">NCIT:C9025</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Well Differentiated Fibrosarcoma</td>
<td style="text-align: left;">A well-differentiated malignant neoplasm arising from the deep soft tissues.  It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern.</td>
<td style="text-align: left;">MONDO:0005164</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970937</td>
<td style="text-align: left;">poorly differentiated angiosarcoma</td>
<td style="text-align: left;">NCIT:C9031</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Poorly Differentiated Angiosarcoma</td>
<td style="text-align: left;">An angiosarcoma characterized by the presence of significant cytologic atypia, necrosis and high mitotic activity.</td>
<td style="text-align: left;">MONDO:0016982</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970938</td>
<td style="text-align: left;">well differentiated leiomyosarcoma</td>
<td style="text-align: left;">NCIT:C9389</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Well Differentiated Leiomyosarcoma</td>
<td style="text-align: left;">Grade I malignant smooth muscle neoplasm.  It is characterized by a proliferation of neoplastic spindle cells.</td>
<td style="text-align: left;">MONDO:0005058</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970939</td>
<td style="text-align: left;">poorly differentiated fibrosarcoma</td>
<td style="text-align: left;">NCIT:C9404</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Poorly Differentiated Fibrosarcoma</td>
<td style="text-align: left;">A usually aggressive malignant neoplasm arising from the deep soft tissue.  It is characterized by the presence of poorly-differentiated spindle-shaped fibroblasts, collagenous stroma formation and increased mitotic activity.</td>
<td style="text-align: left;">MONDO:0005164</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970940</td>
<td style="text-align: left;">low grade sarcoma</td>
<td style="text-align: left;">NCIT:C9417</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Low Grade Sarcoma</td>
<td style="text-align: left;">A sarcoma with the morphologic features of a low-grade tumor and presence of cellular differentiation.</td>
<td style="text-align: left;">MONDO:0005089</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0970941</td>
<td style="text-align: left;">high grade sarcoma</td>
<td style="text-align: left;">NCIT:C9418</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">High Grade Sarcoma</td>
<td style="text-align: left;">A sarcoma with the morphologic features of a high-grade tumor and lack of cellular differentiation.</td>
<td style="text-align: left;">MONDO:0005089</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976015</td>
<td style="text-align: left;">infiltrating intramuscular lipoma</td>
<td style="text-align: left;">NCIT:C121131</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Infiltrating Intramuscular Lipoma</td>
<td style="text-align: left;">An infiltrating lipoma that affects skeletal muscle.  It has a higher rate of local recurrence.</td>
<td style="text-align: left;">MONDO:0004075,MONDO:0004075</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976016</td>
<td style="text-align: left;">fsh-producing pituitary neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C121152</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">FSH-Producing Pituitary Neuroendocrine Tumor</td>
<td style="text-align: left;">A pituitary neuroendocrine tumor that produces follicle-stimulating hormone (FSH).</td>
<td style="text-align: left;">MONDO:0019612</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976017</td>
<td style="text-align: left;">lh-producing pituitary neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C121153</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">LH-Producing Pituitary Neuroendocrine Tumor</td>
<td style="text-align: left;">A pituitary neuroendocrine tumor that produces luteinizing hormone (LH).</td>
<td style="text-align: left;">MONDO:0019612</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976018</td>
<td style="text-align: left;">small cell glioblastoma</td>
<td style="text-align: left;">NCIT:C125890</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Cell Glioblastoma</td>
<td style="text-align: left;">A morphologic variant of glioblastoma characterized by the presence of a highly proliferative and monotonous population of malignant small glial cells.</td>
<td style="text-align: left;">MONDO:0850335</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976019</td>
<td style="text-align: left;">vulvar yolk sac tumor</td>
<td style="text-align: left;">NCIT:C128295</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Yolk Sac Tumor</td>
<td style="text-align: left;">A rare yolk sac tumor that arises from the vulva.</td>
<td style="text-align: left;">MONDO:0001528,MONDO:0005744,MONDO:0020650</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976020</td>
<td style="text-align: left;">gemistocytic astrocytoma, idh-mutant</td>
<td style="text-align: left;">NCIT:C129272</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gemistocytic Astrocytoma, IDH-Mutant</td>
<td style="text-align: left;">Gemistocytic astrocytoma carrying IDH mutations.</td>
<td style="text-align: left;">MONDO:0016689,MONDO:0956994</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976021</td>
<td style="text-align: left;">epithelioid glioblastoma</td>
<td style="text-align: left;">NCIT:C129293</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Epithelioid Glioblastoma</td>
<td style="text-align: left;">An IDH-wildtype glioblastoma characterized by the presence of large epithelioid cells with abundant eosinophilic cytoplasm, vesicular chromatin, and prominent nucleoli.</td>
<td style="text-align: left;">MONDO:0850335</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976022</td>
<td style="text-align: left;">glioblastoma with primitive neuronal component</td>
<td style="text-align: left;">NCIT:C129296</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Glioblastoma with Primitive Neuronal Component</td>
<td style="text-align: left;">A glioblastoma characterized by the presence of well-demarcated nodules which contain primitive cells exhibiting neuronal differentiation.</td>
<td style="text-align: left;">MONDO:0850335</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976023</td>
<td style="text-align: left;">embryonal tumor with multilayered rosettes without c19mc alteration</td>
<td style="text-align: left;">NCIT:C129499</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Embryonal Tumor with Multilayered Rosettes without C19MC Alteration</td>
<td style="text-align: left;">An embryonal tumor with multilayered rosettes characterized by the absence of C19MC amplification. Approximately half of embryonal tumors with multilayered rosettes that lack a C19MC alteration carry DICER1 mutations.</td>
<td style="text-align: left;">MONDO:0958119</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976024</td>
<td style="text-align: left;">unknown primary tumor (except for ebv-related and hpv-related tumors) and metastatic cervical adenopathy by ajcc v8 stage</td>
<td style="text-align: left;">NCIT:C132676</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage</td>
<td style="text-align: left;">A term that refers to the staging of unknown primary tumor (except for EBV-related and HPV-related tumors) and metastatic cervical adenopathy according to the American Joint Committee on Cancer, 8th edition.</td>
<td style="text-align: left;">MONDO:0858997</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976025</td>
<td style="text-align: left;">mgmt-unmethylated glioblastoma</td>
<td style="text-align: left;">NCIT:C132902</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">MGMT-Unmethylated Glioblastoma</td>
<td style="text-align: left;">A glioblastoma characterized by the absence of DNA methylation in the promoter region of the MGMT gene. It is associated with a poor outcome.</td>
<td style="text-align: left;">MONDO:0850335</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976027</td>
<td style="text-align: left;">cardiac teratoma</td>
<td style="text-align: left;">NCIT:C147007</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Teratoma</td>
<td style="text-align: left;">A teratoma that arises within the myocardium or cardiac chambers.</td>
<td style="text-align: left;">MONDO:0019500,MONDO:0020589</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976028</td>
<td style="text-align: left;">refractory malignant thymoma</td>
<td style="text-align: left;">NCIT:C148099</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Thymoma</td>
<td style="text-align: left;">Malignant thymoma that does not respond to treatment.</td>
<td style="text-align: left;">MONDO:0006451,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976029</td>
<td style="text-align: left;">fibrin-associated diffuse large b-cell lymphoma</td>
<td style="text-align: left;">NCIT:C150396</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fibrin-Associated Diffuse Large B-Cell Lymphoma</td>
<td style="text-align: left;">An unusual form of diffuse large B-cell lymphoma. It is not mass-forming and does not directly produce symptoms, but it is discovered incidentally on histological examination of surgical pathology specimens, excised for various pathologies other than lymphoma. The specimens typically contain fibrinous materials. Single and small aggregates of large lymphoma cells are found in only small foci within the fibrinous or amorphous material. EBV is positive, with type III latency. The clinical outcome is highly favorable, even with surgical excision alone. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0017601</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976030</td>
<td style="text-align: left;">mgmt-methylated glioblastoma</td>
<td style="text-align: left;">NCIT:C154335</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">MGMT-Methylated Glioblastoma</td>
<td style="text-align: left;">A glioblastoma characterized by the presence of DNA methylation in the promoter region of the MGMT gene. It is associated with improved survival.</td>
<td style="text-align: left;">MONDO:0850335</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976031</td>
<td style="text-align: left;">melanoma of unknown primary</td>
<td style="text-align: left;">NCIT:C154473</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Melanoma of Unknown Primary</td>
<td style="text-align: left;">A melanoma which has metastasized from an unknown primary anatomic site.</td>
<td style="text-align: left;">MONDO:0005191,MONDO:0858997</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976032</td>
<td style="text-align: left;">frontal lobe anaplastic oligodendroglioma</td>
<td style="text-align: left;">NCIT:C156120</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Frontal Lobe Anaplastic Oligodendroglioma</td>
<td style="text-align: left;">An anaplastic oligodendroglioma occurring in the frontal lobe.</td>
<td style="text-align: left;">MONDO:0016696,MONDO:0005499</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976033</td>
<td style="text-align: left;">grade 1 teratoma</td>
<td style="text-align: left;">NCIT:C156411</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Grade 1 Teratoma</td>
<td style="text-align: left;">A teratoma that contains mature tissue elements and a limited amount of immature tissue elements.</td>
<td style="text-align: left;">MONDO:0956962</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976035</td>
<td style="text-align: left;">metanephric stromal tumor</td>
<td style="text-align: left;">NCIT:C157749</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metanephric Stromal Tumor</td>
<td style="text-align: left;">A rare benign renal neoplasm composed of moderately cellular spindle cells. It occurs mostly in infancy and childhood.</td>
<td style="text-align: left;">MONDO:0018738</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976037</td>
<td style="text-align: left;">cic-dux4 sarcoma</td>
<td style="text-align: left;">NCIT:C165663</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">CIC-DUX4 Sarcoma</td>
<td style="text-align: left;">An undifferentiated, high grade small round cell sarcoma affecting predominantly young adults. It is characterized by a recurrent translocation involving the CIC gene on chromosome 19 and DUX4 gene on chromosome 4. The translocation results in CIC-DUX4, t(4;19)(q35;q13) fusions.</td>
<td style="text-align: left;">MONDO:0956989</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976038</td>
<td style="text-align: left;">cic-dux4l sarcoma</td>
<td style="text-align: left;">NCIT:C165665</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">CIC-DUX4L Sarcoma</td>
<td style="text-align: left;">An undifferentiated, high grade small round cell sarcoma affecting predominantly young adults. It is characterized by a recurrent translocation involving the CIC gene on chromosome 19 and DUX4L gene on chromosome 10. The translocation results in CIC-DUX4L, t(10;19)(q26;q13) fusions.</td>
<td style="text-align: left;">MONDO:0956989</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976041</td>
<td style="text-align: left;">lacrimal drainage system melanoma</td>
<td style="text-align: left;">NCIT:C175345</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lacrimal Drainage System Melanoma</td>
<td style="text-align: left;">An extremely rare melanoma that arises from the lacrimal drainage system.</td>
<td style="text-align: left;">MONDO:0006320,MONDO:0001580</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976045</td>
<td style="text-align: left;">breast neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C175610</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Breast Neuroendocrine Tumor</td>
<td style="text-align: left;">A well-differentiated neuroendocrine neoplasm that arises from the breast. It may be classified as G1 (low grade) or G2 (intermediate grade) neuroendocrine tumor.</td>
<td style="text-align: left;">MONDO:0002485,MONDO:0019496</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976046</td>
<td style="text-align: left;">round cell sarcoma with ewsr1-nfatc2 gene fusion</td>
<td style="text-align: left;">NCIT:C178460</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Round Cell Sarcoma with EWSR1-NFATC2 Gene Fusion</td>
<td style="text-align: left;">A group of rare round and spindle cell sarcomas characterized by the presence of EWSR1-NFATC2 gene fusion.</td>
<td style="text-align: left;">MONDO:0958160</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976047</td>
<td style="text-align: left;">round cell sarcoma with ewsr1-patz1 gene fusion</td>
<td style="text-align: left;">NCIT:C178461</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Round Cell Sarcoma with EWSR1-PATZ1 Gene Fusion</td>
<td style="text-align: left;">A group of rare round and spindle cell sarcomas characterized by the presence of EWSR1-PATZ1 gene fusion.</td>
<td style="text-align: left;">MONDO:0958160</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976048</td>
<td style="text-align: left;">round cell sarcoma with fus-nfatc2 gene fusion</td>
<td style="text-align: left;">NCIT:C178462</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Round Cell Sarcoma with FUS-NFATC2 Gene Fusion</td>
<td style="text-align: left;">A group of rare round and spindle cell sarcomas characterized by the presence of FUS-NFATC2 gene fusion.</td>
<td style="text-align: left;">MONDO:0958160</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976049</td>
<td style="text-align: left;">bcor-ccnb3 sarcoma</td>
<td style="text-align: left;">NCIT:C178466</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">BCOR-CCNB3 Sarcoma</td>
<td style="text-align: left;">A group of rare primitive round cell sarcomas characterized by the presence of BCOR-CCNB3 fusion gene.</td>
<td style="text-align: left;">MONDO:0958159</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976050</td>
<td style="text-align: left;">bcor itd sarcoma</td>
<td style="text-align: left;">NCIT:C178468</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">BCOR ITD Sarcoma</td>
<td style="text-align: left;">A group of rare primitive round cell sarcomas characterized by the presence of BCOR internal tandem duplication. This genetic alteration has been described in infantile undifferentiated round cell sarcomas and primitive myxoid mesenchymal tumors of infancy.</td>
<td style="text-align: left;">MONDO:0958159</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976051</td>
<td style="text-align: left;">myxoid glioneuronal tumor of the septum pellucidum</td>
<td style="text-align: left;">NCIT:C179230</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myxoid Glioneuronal Tumor of the Septum Pellucidum</td>
<td style="text-align: left;">A myxoid glioneuronal tumor that arises from the septum pellucidum.</td>
<td style="text-align: left;">MONDO:0858944</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976052</td>
<td style="text-align: left;">broad ligament leiomyosarcoma</td>
<td style="text-align: left;">NCIT:C179926</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Broad Ligament Leiomyosarcoma</td>
<td style="text-align: left;">A rare leiomyosarcoma that arises from the broad ligament.</td>
<td style="text-align: left;">MONDO:0005058,MONDO:0001108</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976053</td>
<td style="text-align: left;">uterine corpus inflammatory myofibroblastic tumor</td>
<td style="text-align: left;">NCIT:C180545</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Inflammatory Myofibroblastic Tumor</td>
<td style="text-align: left;">A rare inflammatory myofibroblastic tumor that arises from the uterine corpus.</td>
<td style="text-align: left;">MONDO:0015798,MONDO:0004526</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976054</td>
<td style="text-align: left;">jejunal carcinoma</td>
<td style="text-align: left;">NCIT:C181157</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Jejunal Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the jejunum.</td>
<td style="text-align: left;">MONDO:0005522,MONDO:0006815</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976055</td>
<td style="text-align: left;">tongue mucoepidermoid carcinoma</td>
<td style="text-align: left;">NCIT:C181160</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tongue Mucoepidermoid Carcinoma</td>
<td style="text-align: left;">A mucoepidermoid carcinoma that arises from the tongue.</td>
<td style="text-align: left;">MONDO:0044964,MONDO:0850154</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976056</td>
<td style="text-align: left;">granular cell glioblastoma</td>
<td style="text-align: left;">NCIT:C185178</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Granular Cell Glioblastoma</td>
<td style="text-align: left;">A glioblastoma characterized by the presence of large numbers of neoplastic cells with granular, PAS-positive cytoplasm. It is associated with an aggressive clinical course.</td>
<td style="text-align: left;">MONDO:0850335</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976057</td>
<td style="text-align: left;">lipidized glioblastoma</td>
<td style="text-align: left;">NCIT:C185180</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lipidized Glioblastoma</td>
<td style="text-align: left;">A rare glioblastoma characterized by the presence of a predominant population of neoplastic cells with foamy cytoplasm.</td>
<td style="text-align: left;">MONDO:0850335</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976058</td>
<td style="text-align: left;">diffuse low grade glioma, fgfr1 tyrosine kinase domain-duplicated</td>
<td style="text-align: left;">NCIT:C185219</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Low Grade Glioma, FGFR1 Tyrosine Kinase Domain-Duplicated</td>
<td style="text-align: left;">Diffuse low-grade glioma characterized by internal tandem duplications of the sequences in the FGFR1 gene encoding the tyrosine kinase domain.</td>
<td style="text-align: left;">MONDO:0859614</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976059</td>
<td style="text-align: left;">diffuse low grade glioma, fgfr1-mutant</td>
<td style="text-align: left;">NCIT:C185220</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Low Grade Glioma, FGFR1-Mutant</td>
<td style="text-align: left;">Diffuse low-grade glioma characterized by FGFR1 gene mutations, an internal tandem duplication within the FGFR1 gene or the presence of an FGFR1 fusion gene.</td>
<td style="text-align: left;">MONDO:0859614</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976060</td>
<td style="text-align: left;">diffuse low grade glioma, braf p.v600e-mutant</td>
<td style="text-align: left;">NCIT:C185221</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Low Grade Glioma, BRAF p.V600E-Mutant</td>
<td style="text-align: left;">Diffuse low-grade glioma characterized by the presence of BRAF gene mutations encoding a p.V600E substitution mutation.</td>
<td style="text-align: left;">MONDO:0859614</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976061</td>
<td style="text-align: left;">diffuse pediatric-type high grade glioma rtk2</td>
<td style="text-align: left;">NCIT:C185468</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Pediatric-Type High Grade Glioma RTK2</td>
<td style="text-align: left;">An aggressive, WHO grade 4 diffuse glioma usually affecting children, adolescents, or young adults. It is characterized by receptor tyrosine kinase type 2 (RTK2) alterations.</td>
<td style="text-align: left;">MONDO:0858939</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976062</td>
<td style="text-align: left;">diffuse pediatric-type high grade glioma rtk1</td>
<td style="text-align: left;">NCIT:C185469</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Pediatric-Type High Grade Glioma RTK1</td>
<td style="text-align: left;">An aggressive, WHO grade 4 diffuse glioma usually affecting children, adolescents, or young adults. It is characterized by receptor tyrosine kinase type 1 (RTK1) alterations.</td>
<td style="text-align: left;">MONDO:0858939</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976063</td>
<td style="text-align: left;">diffuse pediatric-type high grade glioma mycn</td>
<td style="text-align: left;">NCIT:C185470</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Pediatric-Type High Grade Glioma MYCN</td>
<td style="text-align: left;">An aggressive, WHO grade 4 diffuse glioma usually affecting children, adolescents, or young adults. It is characterized by the expression of MYCN molecular signature.</td>
<td style="text-align: left;">MONDO:0858939</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976064</td>
<td style="text-align: left;">infant-type hemispheric glioma, ntrk-altered</td>
<td style="text-align: left;">NCIT:C185472</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Infant-Type Hemispheric Glioma, NTRK-Altered</td>
<td style="text-align: left;">A high-grade cellular astrocytoma that arises in the cerebral hemisphere and occurs in early childhood. It is characterized by receptor tyrosine kinase fusions in the NTRK family.</td>
<td style="text-align: left;">MONDO:0858940</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976065</td>
<td style="text-align: left;">infant-type hemispheric glioma, ros1-altered</td>
<td style="text-align: left;">NCIT:C185473</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Infant-Type Hemispheric Glioma, ROS1-Altered</td>
<td style="text-align: left;">A high-grade cellular astrocytoma that arises in the cerebral hemisphere and occurs in early childhood. It is characterized by receptor tyrosine kinase fusions in the ROS1 gene.</td>
<td style="text-align: left;">MONDO:0858940</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976066</td>
<td style="text-align: left;">infant-type hemispheric glioma, alk-altered</td>
<td style="text-align: left;">NCIT:C185474</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Infant-Type Hemispheric Glioma, ALK-Altered</td>
<td style="text-align: left;">A high-grade cellular astrocytoma that arises in the cerebral hemisphere and occurs in early childhood. It is characterized by receptor tyrosine kinase fusions in the ALK gene.</td>
<td style="text-align: left;">MONDO:0858940</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976067</td>
<td style="text-align: left;">infant-type hemispheric glioma, met-altered</td>
<td style="text-align: left;">NCIT:C185475</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Infant-Type Hemispheric Glioma, MET-Altered</td>
<td style="text-align: left;">A high-grade cellular astrocytoma that arises in the cerebral hemisphere and occurs in early childhood. It is characterized by receptor tyrosine kinase fusions in the MET gene.</td>
<td style="text-align: left;">MONDO:0858940</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976068</td>
<td style="text-align: left;">supratentorial ependymoma, not elsewhere classified</td>
<td style="text-align: left;">NCIT:C186348</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Supratentorial Ependymoma, Not Elsewhere Classified</td>
<td style="text-align: left;">A circumscribed ependymoma that arises from the supratentorial region of the brain, characterized by the absence of a fusion gene involving ZFTA or YAP1 genes.</td>
<td style="text-align: left;">MONDO:0850340</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976069</td>
<td style="text-align: left;">supratentorial ependymoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C186349</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Supratentorial Ependymoma, Not Otherwise Specified</td>
<td style="text-align: left;">A circumscribed ependymoma that arises from the supratentorial region of the brain in which the genetic analysis for fusion genes involving ZFTA or YAP1 genes was unsuccessful or not reported.</td>
<td style="text-align: left;">MONDO:0850340</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976070</td>
<td style="text-align: left;">posterior fossa ependymoma, not elsewhere classified</td>
<td style="text-align: left;">NCIT:C186448</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Posterior Fossa Ependymoma, Not Elsewhere Classified</td>
<td style="text-align: left;">A circumscribed ependymoma that arises in the posterior fossa in which molecular analysis for DNA methylation profiling cannot assign a molecular group.</td>
<td style="text-align: left;">MONDO:0850339</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976071</td>
<td style="text-align: left;">posterior fossa ependymoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C186449</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Posterior Fossa Ependymoma, Not Otherwise Specified</td>
<td style="text-align: left;">A circumscribed ependymoma that arises in the posterior fossa in which molecular analysis for DNA methylation profiling was unsuccessful or not reported.</td>
<td style="text-align: left;">MONDO:0850339</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976072</td>
<td style="text-align: left;">embryonal tumor with multilayered rosettes, dicer1-mutated</td>
<td style="text-align: left;">NCIT:C186535</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated</td>
<td style="text-align: left;">An embryonal tumor with multilayered rosettes characterized by the presence of DICER1 mutation. Approximately half of embryonal tumors with multilayered rosettes that lack a C19MC alteration carry DICER1 mutations.</td>
<td style="text-align: left;">MONDO:0958119</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976073</td>
<td style="text-align: left;">stage m0 embryonal tumor with multilayered rosettes</td>
<td style="text-align: left;">NCIT:C186537</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M0 Embryonal Tumor with Multilayered Rosettes</td>
<td style="text-align: left;">No evidence of subarachnoid or hematogenous metastasis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0958119</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976074</td>
<td style="text-align: left;">stage m1 embryonal tumor with multilayered rosettes</td>
<td style="text-align: left;">NCIT:C186538</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M1 Embryonal Tumor with Multilayered Rosettes</td>
<td style="text-align: left;">Microscopic tumor cells are detected in the cerebrospinal fluid. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0958119</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976075</td>
<td style="text-align: left;">stage m2 embryonal tumor with multilayered rosettes</td>
<td style="text-align: left;">NCIT:C186539</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M2 Embryonal Tumor with Multilayered Rosettes</td>
<td style="text-align: left;">Gross nodular seeding is detected in the cerebellar/cerebral subarachnoid space or in the third or lateral ventricles. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0958119</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976076</td>
<td style="text-align: left;">stage m3 embryonal tumor with multilayered rosettes</td>
<td style="text-align: left;">NCIT:C186540</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M3 Embryonal Tumor with Multilayered Rosettes</td>
<td style="text-align: left;">Gross nodular seeding is detected in the spinal subarachnoid space. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0958119</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976077</td>
<td style="text-align: left;">stage m4 embryonal tumor with multilayered rosettes</td>
<td style="text-align: left;">NCIT:C186541</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Stage M4 Embryonal Tumor with Multilayered Rosettes</td>
<td style="text-align: left;">Metastasis outside the cerebrospinal axis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)</td>
<td style="text-align: left;">MONDO:0958119</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976078</td>
<td style="text-align: left;">elp1-associated medulloblastoma</td>
<td style="text-align: left;">NCIT:C186591</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">ELP1-Associated Medulloblastoma</td>
<td style="text-align: left;">An SHH-activated, TP53-wildtype medulloblastoma caused by germline ELP1 gene variations and develops during childhood.</td>
<td style="text-align: left;">MONDO:0956965</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976079</td>
<td style="text-align: left;">central nervous system cic-rearranged sarcoma</td>
<td style="text-align: left;">NCIT:C186607</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System CIC-Rearranged Sarcoma</td>
<td style="text-align: left;">A rare, undifferentiated, high grade small round cell sarcoma that arises from the central nervous system. It is characterized by a recurrent translocation involving the CIC gene on chromosome 19 resulting in CIC gene fusion with different gene partners.</td>
<td style="text-align: left;">MONDO:0002217,MONDO:0956989</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976080</td>
<td style="text-align: left;">smoldering systemic mastocytosis with an associated myeloid neoplasm</td>
<td style="text-align: left;">NCIT:C188041</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Smoldering Systemic Mastocytosis with an Associated Myeloid Neoplasm</td>
<td style="text-align: left;">Smoldering systemic mastocytosis associated with the presence of a clonal non-mast cell myeloid neoplasm (e.g., myelodysplastic syndrome,  myeloproliferative neoplasm, and acute myeloid leukemia).</td>
<td style="text-align: left;">MONDO:0020332,MONDO:0015557</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976081</td>
<td style="text-align: left;">jejunal melanoma</td>
<td style="text-align: left;">NCIT:C188067</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Jejunal Melanoma</td>
<td style="text-align: left;">A melanoma that arises from the jejunum.</td>
<td style="text-align: left;">MONDO:0045070,MONDO:0006815</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976082</td>
<td style="text-align: left;">composite gangliocytoma/neuroma and neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C188229</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor</td>
<td style="text-align: left;">A usually indolent neuroendocrine neoplasm that almost exclusively arises in the second part of the duodenum. Rare sites of involvement include jejunum, pylorus, appendix, thymus, and lung. It is a triphasic tumor consisting of a mixture of epithelioid neuroendocrine cells, Schwann-like cells, and ganglion cells.</td>
<td style="text-align: left;">MONDO:0019496</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976083</td>
<td style="text-align: left;">adult posterior fossa ependymoma</td>
<td style="text-align: left;">NCIT:C188945</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Posterior Fossa Ependymoma</td>
<td style="text-align: left;">A posterior fossa ependymoma that occurs in adults.</td>
<td style="text-align: left;">MONDO:0004352,MONDO:0850339</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976084</td>
<td style="text-align: left;">childhood renal cell carcinoma with mit translocations</td>
<td style="text-align: left;">NCIT:C189242</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Renal Cell Carcinoma with MiT Translocations</td>
<td style="text-align: left;">A TFE3 or TFEB-rearranged renal cell carcinoma that occurs during childhood.</td>
<td style="text-align: left;">MONDO:0003007,MONDO:0017886</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976085</td>
<td style="text-align: left;">hereditary primary localized cutaneous amyloidosis-1</td>
<td style="text-align: left;">NCIT:C189282</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hereditary Primary Localized Cutaneous Amyloidosis-1</td>
<td style="text-align: left;">An autosomal dominant condition caused by mutation(s) in the OSMR gene, encoding oncostatin-M-specific receptor subunit beta. It is characterized by localized cutaneous amyloidosis.</td>
<td style="text-align: left;">MONDO:0018634,MONDO:0015301</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976086</td>
<td style="text-align: left;">medulloblastoma, shh-1</td>
<td style="text-align: left;">NCIT:C189841</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Medulloblastoma, SHH-1</td>
<td style="text-align: left;">Medulloblastoma, SHH-activated, characterized by SUFU gene mutations and chromosome 2 gain. It affects mostly infants.</td>
<td style="text-align: left;">MONDO:0850197</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976087</td>
<td style="text-align: left;">medulloblastoma, shh-2</td>
<td style="text-align: left;">NCIT:C189844</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Medulloblastoma, SHH-2</td>
<td style="text-align: left;">Medulloblastoma, SHH-activated, characterized by chromosome 9q loss and nodular morphology. It affects mostly infants.</td>
<td style="text-align: left;">MONDO:0850197</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976088</td>
<td style="text-align: left;">medulloblastoma, shh-3</td>
<td style="text-align: left;">NCIT:C189845</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Medulloblastoma, SHH-3</td>
<td style="text-align: left;">Medulloblastoma, SHH-activated, characterized by mutations of TP53 and ELP1 genes. It affects older individuals.</td>
<td style="text-align: left;">MONDO:0850197</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976089</td>
<td style="text-align: left;">medulloblastoma, shh-4</td>
<td style="text-align: left;">NCIT:C189846</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Medulloblastoma, SHH-4</td>
<td style="text-align: left;">Medulloblastoma, SHH-activated, characterized by mutations of U1-snRNA and TERT genes. Mutations of PTCH1 or SMO genes are usually also present. It affects mostly adults.</td>
<td style="text-align: left;">MONDO:0850197</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976090</td>
<td style="text-align: left;">squamous papilloma of the urinary tract</td>
<td style="text-align: left;">NCIT:C191740</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Squamous Papilloma of the Urinary Tract</td>
<td style="text-align: left;">A rare papillary neoplastic growth that arises from the urothelial mucosa. It is characterized by the presence of fibrovascular cores lined by benign keratinizing squamous epithelium. There is no evidence of architectural or cytologic atypia. It usually occurs in elderly people and is found in the bladder and urethra.</td>
<td style="text-align: left;">MONDO:0001825,MONDO:0004180</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976092</td>
<td style="text-align: left;">embryonal tumor with multilayered rosettes of the fourth ventricle</td>
<td style="text-align: left;">NCIT:C202010</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Embryonal Tumor with Multilayered Rosettes of the Fourth Ventricle</td>
<td style="text-align: left;">An embryonal tumor with multilayered rosettes that arises from the fourth ventricle.</td>
<td style="text-align: left;">MONDO:0958119</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976093</td>
<td style="text-align: left;">neuroendocrine tumor g1</td>
<td style="text-align: left;">NCIT:C203250</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neuroendocrine Tumor G1</td>
<td style="text-align: left;">A well-differentiated, low-grade neuroendocrine neoplasm. It arises from multiple sites, including the digestive system, lung, and head and neck.</td>
<td style="text-align: left;">MONDO:0019496</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976094</td>
<td style="text-align: left;">neuroendocrine tumor g3</td>
<td style="text-align: left;">NCIT:C203251</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neuroendocrine Tumor G3</td>
<td style="text-align: left;">A well-differentiated, high-grade epithelial neoplasm with neuroendocrine differentiation. It usually arises from the digestive system.</td>
<td style="text-align: left;">MONDO:0019496</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976095</td>
<td style="text-align: left;">multiple lobular capillary hemangiomas</td>
<td style="text-align: left;">NCIT:C27552</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multiple Lobular Capillary Hemangiomas</td>
<td style="text-align: left;">A lobular hemangioma present in multiple anatomic sites.</td>
<td style="text-align: left;">MONDO:0022096</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976096</td>
<td style="text-align: left;">skin lobular capillary hemangioma</td>
<td style="text-align: left;">NCIT:C34967</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Lobular Capillary Hemangioma</td>
<td style="text-align: left;">A skin hemangioma characterized by the proliferation of capillaries with a lobular architecture. It most often affects the fingers and manifests as a rapidly growing, polypoid, hemorrhagic, red or blue nodule that is frequently ulcerated.</td>
<td style="text-align: left;">MONDO:0003110,MONDO:0022096</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976097</td>
<td style="text-align: left;">tfeb-rearranged renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C37210</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">TFEB-Rearranged Renal Cell Carcinoma</td>
<td style="text-align: left;">A rare renal cell carcinoma affecting young patients. It is characterized by the presence of the chromosomal translocation t(6;11) which fuses the TFEB transcription factor gene, located on chromosome 6, with the MALAT1 gene, located on chromosome 11.</td>
<td style="text-align: left;">MONDO:0017886</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976098</td>
<td style="text-align: left;">aids-related kaposi sarcoma</td>
<td style="text-align: left;">NCIT:C3992</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">AIDS-Related Kaposi Sarcoma</td>
<td style="text-align: left;">The most aggressive form of Kaposi sarcoma. It presents in patients who are infected with the human immunodeficiency virus. It can affect the skin and internal organs.</td>
<td style="text-align: left;">MONDO:0005055,MONDO:0018628</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976099</td>
<td style="text-align: left;">uterine corpus smooth muscle neoplasm</td>
<td style="text-align: left;">NCIT:C40176</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Smooth Muscle Neoplasm</td>
<td style="text-align: left;">A benign, intermediate, or malignant neoplasm that arises from the uterine corpus and is composed of neoplastic cells with smooth muscle differentiation.</td>
<td style="text-align: left;">MONDO:0004526,MONDO:0006975</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976100</td>
<td style="text-align: left;">uterine corpus endometrial stromal and related neoplasms</td>
<td style="text-align: left;">NCIT:C40217</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Uterine Corpus Endometrial Stromal and Related Neoplasms</td>
<td style="text-align: left;">A category of benign or malignant mesenchymal neoplasms that arises from the uterine corpus. This category includes the endometrial stromal nodule which is benign and non-invasive, the endometrial stromal sarcoma, and the undifferentiated uterine sarcoma. The endometrial stromal sarcoma is an invasive malignant neoplasm, further subdivided into low grade and high grade endometrial stromal sarcoma. Undifferentiated uterine sarcoma was previously also known as high grade endometrial stromal sarcoma. In 2014, high grade endometrial stromal sarcoma was reclassified and is currently considered a distinct and rare neoplasm. It appears to have a prognosis that falls between low grade endometrial stromal sarcoma and undifferentiated sarcoma.</td>
<td style="text-align: left;">MONDO:0037742,MONDO:0004526</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976101</td>
<td style="text-align: left;">melanoma arising in giant congenital nevus</td>
<td style="text-align: left;">NCIT:C4235</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Melanoma Arising in Giant Congenital Nevus</td>
<td style="text-align: left;">A melanoma arising in a giant congenital melanocytic nevus. The risk of developing a melanoma in a giant congenital melanocytic nevus has been reported to be between 5% and 50%. The incidence of developing melanoma is higher before the age of 10 and in adult life.</td>
<td style="text-align: left;">MONDO:0850110</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976102</td>
<td style="text-align: left;">benign ovarian germ cell tumor</td>
<td style="text-align: left;">NCIT:C4516</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Ovarian Germ Cell Tumor</td>
<td style="text-align: left;">A germ cell tumor that arises from the ovary. There is no evidence of atypia or metastases. The vast majority of cases are benign dermoid cysts.</td>
<td style="text-align: left;">MONDO:0000646,MONDO:0850144,MONDO:0011366</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976103</td>
<td style="text-align: left;">primary cutaneous diffuse large b-cell lymphoma</td>
<td style="text-align: left;">NCIT:C45193</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Cutaneous Diffuse Large B-Cell Lymphoma</td>
<td style="text-align: left;">A diffuse large B-cell lymphoma that arises from the skin. Representative examples include primary cutaneous intravascular large B-cell lymphoma, primary cutaneous T-cell/histiocyte-rich large B-cell lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg type.</td>
<td style="text-align: left;">MONDO:0018905,MONDO:0015820</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976104</td>
<td style="text-align: left;">lung teratoma</td>
<td style="text-align: left;">NCIT:C45637</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Teratoma</td>
<td style="text-align: left;">A teratoma that arises from the lung.</td>
<td style="text-align: left;">MONDO:0037105,MONDO:0019500</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976105</td>
<td style="text-align: left;">thymus neuroendocrine tumor g2</td>
<td style="text-align: left;">NCIT:C45719</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thymus Neuroendocrine Tumor G2</td>
<td style="text-align: left;">A neuroendocrine tumor of the thymus characterized by the presence of 2-10 mitoses per 2 mm2 and/or necrosis (usually punctate).</td>
<td style="text-align: left;">MONDO:0019964,MONDO:0006095</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976106</td>
<td style="text-align: left;">prostate neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C5024</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prostate Neuroendocrine Tumor</td>
<td style="text-align: left;">An extremely rare, slow-growing well-differentiated neuroendocrine neoplasm that affects the prostate gland.</td>
<td style="text-align: left;">MONDO:0002477,MONDO:0019496</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976107</td>
<td style="text-align: left;">aids-related malignant anal neoplasm</td>
<td style="text-align: left;">NCIT:C5047</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">AIDS-Related Malignant Anal Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm arising from the anus and occurring in HIV-positive patients.  Representative examples include squamous cell carcinoma and non-Hodgkin lymphoma.  Homosexual HIV-positive men have an increased risk of developing such malignancies in comparison to the general male population.</td>
<td style="text-align: left;">MONDO:0018628,MONDO:0001879</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976108</td>
<td style="text-align: left;">aids-related malignant cervical neoplasm</td>
<td style="text-align: left;">NCIT:C5052</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">AIDS-Related Malignant Cervical Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that arises from the cervix in a patient with acquired immunodeficiency syndrome. This category includes cervical carcinoma, Kaposi sarcoma, and non-Hodgkin lymphoma.</td>
<td style="text-align: left;">MONDO:0018628,MONDO:0002974</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976109</td>
<td style="text-align: left;">hemispheric anaplastic astrocytoma</td>
<td style="text-align: left;">NCIT:C5123</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hemispheric Anaplastic Astrocytoma</td>
<td style="text-align: left;">An anaplastic astrocytoma that arises from the cerebral hemispheres.</td>
<td style="text-align: left;">MONDO:0021633,MONDO:0005499,MONDO:0016684,MONDO:0002731</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976110</td>
<td style="text-align: left;">anaplastic diencephalic astrocytoma</td>
<td style="text-align: left;">NCIT:C5124</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Diencephalic Astrocytoma</td>
<td style="text-align: left;">An anaplastic astrocytoma that arises from the diencephalon.</td>
<td style="text-align: left;">MONDO:0003169,MONDO:0005499,MONDO:0002786,MONDO:0016684</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976111</td>
<td style="text-align: left;">ovarian neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C5229</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ovarian Neuroendocrine Tumor</td>
<td style="text-align: left;">A rare, well-differentiated neuroendocrine neoplasm that arises from the ovary.</td>
<td style="text-align: left;">MONDO:0019496,MONDO:0002481</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976112</td>
<td style="text-align: left;">secondary supratentorial anaplastic astrocytoma</td>
<td style="text-align: left;">NCIT:C5416</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Secondary Supratentorial Anaplastic Astrocytoma</td>
<td style="text-align: left;">An anaplastic astrocytoma occurring in the supratentorial area secondary to a preexisting tumor.</td>
<td style="text-align: left;">MONDO:0005499,MONDO:0016684,MONDO:0021631,MONDO:0024881,MONDO:0002071</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976113</td>
<td style="text-align: left;">testicular neuroendocrine tumor, prepubertal-type</td>
<td style="text-align: left;">NCIT:C6360</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Testicular Neuroendocrine Tumor, Prepubertal-Type</td>
<td style="text-align: left;">A rare, usually well-differentiated neuroendocrine neoplasm that arises from the testis. It usually affects adults, and a minority of patients have carcinoid syndrome. It may occur in isolation or, less frequently, be associated with testicular teratoma. The majority of cases are not associated with isochromosome 12p or germ cell neoplasia in situ. The clinical course is usually benign.</td>
<td style="text-align: left;">MONDO:0019496,MONDO:0021348</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976114</td>
<td style="text-align: left;">benign extragonadal germ cell tumor</td>
<td style="text-align: left;">NCIT:C6751</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Extragonadal Germ Cell Tumor</td>
<td style="text-align: left;">A germ cell tumor that arises from an anatomic site other than the testis or ovary. There is no evidence of atypia or metastases.</td>
<td style="text-align: left;">MONDO:0850144,MONDO:0018201</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976115</td>
<td style="text-align: left;">benign central nervous system mesenchymal, non-meningothelial neoplasm</td>
<td style="text-align: left;">NCIT:C6757</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm</td>
<td style="text-align: left;">A mesenchymal, non-meningothelial neoplasm that arises from the central nervous system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0003244,MONDO:0000628,MONDO:0044335</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976116</td>
<td style="text-align: left;">malignant type b2 thymoma</td>
<td style="text-align: left;">NCIT:C6889</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Type B2 Thymoma</td>
<td style="text-align: left;">A type B2 thymoma which is characterized by an aggressive clinical course (capsular invasion, infiltration of the surrounding tissues) and can metastasize.</td>
<td style="text-align: left;">MONDO:0006451,MONDO:0003915</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976118</td>
<td style="text-align: left;">anaplastic brain stem glioma</td>
<td style="text-align: left;">NCIT:C7446</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anaplastic Brain Stem Glioma</td>
<td style="text-align: left;">An anaplastic glioma that arises from the brain stem.</td>
<td style="text-align: left;">MONDO:0020633,MONDO:0005499,MONDO:0002912,MONDO:0002911,MONDO:0021640</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976119</td>
<td style="text-align: left;">malignant type b1 thymoma</td>
<td style="text-align: left;">NCIT:C7996</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Type B1 Thymoma</td>
<td style="text-align: left;">A type B1 thymoma which is characterized by an aggressive clinical course (capsular invasion, infiltration of the surrounding tissues) and can metastasize.</td>
<td style="text-align: left;">MONDO:0006451,MONDO:0006459</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976120</td>
<td style="text-align: left;">submandibular gland carcinoma</td>
<td style="text-align: left;">NCIT:C8396</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Submandibular Gland Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the submandibular gland.  Representative examples include mucoepidermoid carcinoma, adenoid cystic carcinoma, and carcinoma ex pleomorphic adenoma.</td>
<td style="text-align: left;">MONDO:0004724,MONDO:0006284</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0976121</td>
<td style="text-align: left;">pancreatic teratoma</td>
<td style="text-align: left;">NCIT:C95558</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Teratoma</td>
<td style="text-align: left;">A teratoma that arises from the pancreas.</td>
<td style="text-align: left;">MONDO:0021040,MONDO:0019500</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979601</td>
<td style="text-align: left;">nodular lymphocyte predominant b-cell lymphoma by ann arbor stage</td>
<td style="text-align: left;">NCIT:C141225</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nodular Lymphocyte Predominant B-Cell Lymphoma by Ann Arbor Stage</td>
<td style="text-align: left;">An anatomic stage for nodular lymphocyte predominant B-cell lymphoma based on the Ann Arbor classification criteria.</td>
<td style="text-align: left;">MONDO:0044778</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979602</td>
<td style="text-align: left;">refractory hepatoblastoma</td>
<td style="text-align: left;">NCIT:C142854</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Hepatoblastoma</td>
<td style="text-align: left;">Hepatoblastoma that does not respond to treatment.</td>
<td style="text-align: left;">MONDO:0018666,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979603</td>
<td style="text-align: left;">cardiac amyloidosis</td>
<td style="text-align: left;">NCIT:C153217</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac Amyloidosis</td>
<td style="text-align: left;">The accumulation of amyloid protein in the heart. Cardiac amyloidosis is irreversible and may lead to conductive dysfunction as well as heart failure secondary to restrictive cardiomyopathy.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979604</td>
<td style="text-align: left;">refractory hemophagocytic lymphohistiocytosis</td>
<td style="text-align: left;">NCIT:C153297</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Hemophagocytic Lymphohistiocytosis</td>
<td style="text-align: left;">Hemophagocytic lymphohistiocytosis that is resistant to treatment.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979605</td>
<td style="text-align: left;">sellar neurocytoma</td>
<td style="text-align: left;">NCIT:C155768</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sellar Neurocytoma</td>
<td style="text-align: left;">A rare extraventricular neurocytoma (WHO grade 2) of the hypothalamic-pituitary area. (WHO 2017)</td>
<td style="text-align: left;">MONDO:0002720</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979606</td>
<td style="text-align: left;">sellar olfactory neuroblastoma</td>
<td style="text-align: left;">NCIT:C155772</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sellar Olfactory Neuroblastoma</td>
<td style="text-align: left;">An extremely rare ectopic olfactory neuroblastoma that arises from the sellar region.</td>
<td style="text-align: left;">MONDO:0002720,MONDO:0001657,MONDO:0006329</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979607</td>
<td style="text-align: left;">sellar schwannoma</td>
<td style="text-align: left;">NCIT:C155780</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sellar Schwannoma</td>
<td style="text-align: left;">An extremely rare schwannoma that arises from the sellar region.</td>
<td style="text-align: left;">MONDO:0002720,MONDO:0002546</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979608</td>
<td style="text-align: left;">sellar chordoma</td>
<td style="text-align: left;">NCIT:C155781</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sellar Chordoma</td>
<td style="text-align: left;">A chordoma that arises from the sellar region.</td>
<td style="text-align: left;">MONDO:0002720,MONDO:0001657,MONDO:0008978</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979609</td>
<td style="text-align: left;">malignant skull base neoplasm</td>
<td style="text-align: left;">NCIT:C155791</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Skull Base Neoplasm</td>
<td style="text-align: left;">A primary or metastatic malignant neoplasm that affects the skull base.</td>
<td style="text-align: left;">MONDO:0002785,MONDO:0002132</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979610</td>
<td style="text-align: left;">benign skull neoplasm</td>
<td style="text-align: left;">NCIT:C155792</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Skull Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the bones and structures of skull and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0000631,MONDO:0024653</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979611</td>
<td style="text-align: left;">sellar germ cell tumor</td>
<td style="text-align: left;">NCIT:C155801</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sellar Germ Cell Tumor</td>
<td style="text-align: left;">A germ cell tumor that arises from or adjacent to the sellar region.</td>
<td style="text-align: left;">MONDO:0003000,MONDO:0002720</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979612</td>
<td style="text-align: left;">primary peritoneal carcinosarcoma</td>
<td style="text-align: left;">NCIT:C159507</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Peritoneal Carcinosarcoma</td>
<td style="text-align: left;">An extremely rare and highly aggressive malignant neoplasm arising from the peritoneum.  Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements.</td>
<td style="text-align: left;">MONDO:0002087,MONDO:0002928</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979613</td>
<td style="text-align: left;">progressive thyroid gland carcinoma</td>
<td style="text-align: left;">NCIT:C161765</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Progressive Thyroid Gland Carcinoma</td>
<td style="text-align: left;">A thyroid gland carcinoma that is worsening in terms of extent or severity.</td>
<td style="text-align: left;">MONDO:0015075</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979614</td>
<td style="text-align: left;">refractory chordoma</td>
<td style="text-align: left;">NCIT:C162721</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Chordoma</td>
<td style="text-align: left;">A chordoma that does not respond to treatment.</td>
<td style="text-align: left;">MONDO:0008978,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979615</td>
<td style="text-align: left;">gastrointestinal tract adenoma, intestinal-type</td>
<td style="text-align: left;">NCIT:C164253</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastrointestinal Tract Adenoma, Intestinal-Type</td>
<td style="text-align: left;">An adenoma that arises from the glandular epithelium of the gastrointestinal tract and is associated with intestinal-type differentiation.</td>
<td style="text-align: left;">MONDO:0006180</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979616</td>
<td style="text-align: left;">cardiac attr amyloidosis</td>
<td style="text-align: left;">NCIT:C165484</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cardiac ATTR Amyloidosis</td>
<td style="text-align: left;">The accumulation of ATTR amyloid deposits in the heart.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979617</td>
<td style="text-align: left;">hereditary cardiac attr amyloidosis</td>
<td style="text-align: left;">NCIT:C165489</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hereditary Cardiac ATTR Amyloidosis</td>
<td style="text-align: left;">The accumulation of ATTR amyloid deposits in the heart due to mutations in the TTR gene.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979618</td>
<td style="text-align: left;">ebv-positive inflammatory follicular dendritic cell/fibroblastic reticular cell tumor</td>
<td style="text-align: left;">NCIT:C172847</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">EBV-Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor</td>
<td style="text-align: left;">A rare, Epstein-Barr virus-associated variant of follicular dendritic cell sarcoma. It usually arises from the liver or spleen and has a favorable prognosis. The name of this entity has been changed from "sarcoma" to "tumor" because of its indolent nature.</td>
<td style="text-align: left;">MONDO:0005764</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979619</td>
<td style="text-align: left;">primary cutaneous non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C188114</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Primary Cutaneous Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A B-or T-cell non-Hodgkin lymphoma that arises from the skin.</td>
<td style="text-align: left;">MONDO:0018898,MONDO:0018908</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979620</td>
<td style="text-align: left;">childhood chordoma</td>
<td style="text-align: left;">NCIT:C189032</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Chordoma</td>
<td style="text-align: left;">A rare chordoma that occurs during childhood.</td>
<td style="text-align: left;">MONDO:0006517,MONDO:0008978</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979621</td>
<td style="text-align: left;">reactive b-cell rich lymphoid proliferations that can mimic lymphoma</td>
<td style="text-align: left;">NCIT:C200590</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Reactive B-Cell Rich Lymphoid Proliferations that Can Mimic Lymphoma</td>
<td style="text-align: left;">A term that refers to non-neoplastic, dense B-cell lymphoproliferations in nodal or extranodal sites that resemble B-cell lymphoma.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979622</td>
<td style="text-align: left;">refractory post-essential thrombocythemia myelofibrosis</td>
<td style="text-align: left;">NCIT:C200606</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Post-Essential Thrombocythemia Myelofibrosis</td>
<td style="text-align: left;">Post-essential thrombocythemia myelofibrosis that is resistant to treatment.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979623</td>
<td style="text-align: left;">early stage bladder urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C205286</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Early Stage Bladder Urothelial Carcinoma</td>
<td style="text-align: left;">Bladder urothelial carcinoma confined to the lining of the bladder.</td>
<td style="text-align: left;">MONDO:0005611</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979624</td>
<td style="text-align: left;">attr amyloidosis</td>
<td style="text-align: left;">NCIT:C205628</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">ATTR Amyloidosis</td>
<td style="text-align: left;">A disorder caused by changes in the structure of transthyretin protein, affecting its ability to form tetramers. The tetramers break down and form strands of amyloid fibrils. The fibrils clump together and form amyloid deposits in tissues, causing irreversible damage. It can be hereditary, caused by mutations in the TTR gene or age-related.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979625</td>
<td style="text-align: left;">hereditary attr amyloidosis</td>
<td style="text-align: left;">NCIT:C205629</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hereditary ATTR Amyloidosis</td>
<td style="text-align: left;">An autosomal dominant hereditary disorder caused by mutations in the TTR gene. These mutations alter the structure of transthyretin protein, affecting its ability to form tetramers. The tetramers break down and form strands of amyloid fibrils. The fibrils clump together and form amyloid deposits in tissues, causing irreversible damage. Forms of ATTR amyloidosis include neuropathic, cardiac, and leptomeningeal, which primarily affects the central nervous system.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979626</td>
<td style="text-align: left;">canine nk cell neoplasm</td>
<td style="text-align: left;">NCIT:C205646</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Canine NK Cell Neoplasm</td>
<td style="text-align: left;">A group of neoplasms composed of NK cells occurring in a dog.</td>
<td style="text-align: left;">MONDO:0700139</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979627</td>
<td style="text-align: left;">thalamic germinoma</td>
<td style="text-align: left;">NCIT:C205746</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thalamic Germinoma</td>
<td style="text-align: left;">A germinoma that arises from the thalamus.</td>
<td style="text-align: left;">MONDO:0002214,MONDO:0003766</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979628</td>
<td style="text-align: left;">recurrent post-essential thrombocythemia myelofibrosis</td>
<td style="text-align: left;">NCIT:C206089</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Recurrent Post-Essential Thrombocythemia Myelofibrosis</td>
<td style="text-align: left;">The reemergence of post-essential thrombocythemia myelofibrosis after a period of remission.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979629</td>
<td style="text-align: left;">atypical proliferating trichilemmal tumor</td>
<td style="text-align: left;">NCIT:C206109</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Proliferating Trichilemmal Tumor</td>
<td style="text-align: left;">A proliferating trichilemmal tumor with atypical morphological characteristics and absence of metastatic potential.</td>
<td style="text-align: left;">MONDO:0018850</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979630</td>
<td style="text-align: left;">non-brca hereditary breast carcinoma</td>
<td style="text-align: left;">NCIT:C206118</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-BRCA Hereditary Breast Carcinoma</td>
<td style="text-align: left;">Hereditary breast carcinoma that is associated with a mutation in a gene other than the BRCA genes.</td>
<td style="text-align: left;">MONDO:0016419</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979631</td>
<td style="text-align: left;">periocular sebaceous carcinoma</td>
<td style="text-align: left;">NCIT:C206119</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Periocular Sebaceous Carcinoma</td>
<td style="text-align: left;">A sebaceous carcinoma that arises from the periocular region.</td>
<td style="text-align: left;">MONDO:0006962</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979632</td>
<td style="text-align: left;">nail bed epithelial neoplasm</td>
<td style="text-align: left;">NCIT:C206153</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nail Bed Epithelial Neoplasm</td>
<td style="text-align: left;">A benign or malignant epithelial neoplasm that arises from the nail bed.</td>
<td style="text-align: left;">MONDO:0021634</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979633</td>
<td style="text-align: left;">cervical non-squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C206192</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cervical Non-Squamous Cell Carcinoma</td>
<td style="text-align: left;">A term that refers to carcinomas that arise from the cervix, excluding squamous cell carcinomas. This category includes adenocarcinomas, adenoid basal carcinomas, adenoid cystic carcinomas, mucoepidermoid carcinomas, neuroendocrine carcinomas, and undifferentiated carcinomas.</td>
<td style="text-align: left;">MONDO:0005131</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979634</td>
<td style="text-align: left;">mucinous adenocarcinoma with signet ring cell differentiation</td>
<td style="text-align: left;">NCIT:C206212</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mucinous Adenocarcinoma with Signet Ring Cell Differentiation</td>
<td style="text-align: left;">An adenocarcinoma characterized by the presence of extracellular mucin and signet ring cells.</td>
<td style="text-align: left;">MONDO:0004957</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979635</td>
<td style="text-align: left;">endometrial cancer by figo stage 2023</td>
<td style="text-align: left;">NCIT:C206217</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endometrial Cancer by FIGO Stage 2023</td>
<td style="text-align: left;">A term that refers to the staging of endometrial carcinoma according to the International Federation of Gynecology and Obstetrics (FIGO) staging, 2023.</td>
<td style="text-align: left;">MONDO:0002447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979636</td>
<td style="text-align: left;">endometrial carcinoma molecular subtypes</td>
<td style="text-align: left;">NCIT:C206278</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endometrial Carcinoma Molecular Subtypes</td>
<td style="text-align: left;">A term that refers to the classification of endometrial carcinomas based on their molecular characteristics.</td>
<td style="text-align: left;">MONDO:0002447</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979637</td>
<td style="text-align: left;">cutaneous reactive b-cell rich lymphoid proliferation</td>
<td style="text-align: left;">NCIT:C206289</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Reactive B-Cell Rich Lymphoid Proliferation</td>
<td style="text-align: left;">A reactive, dense dermal nodular or nodular and diffuse lymphocytic infiltrate that is predominantly composed of B-cells. It may extend to subcutaneous tissue. In some cases, the histological and clinical characteristics can resemble cutaneous B-cell lymphomas.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979638</td>
<td style="text-align: left;">skin atypical fibrous histiocytoma</td>
<td style="text-align: left;">NCIT:C206447</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Atypical Fibrous Histiocytoma</td>
<td style="text-align: left;">A variant of fibrous histiocytoma of the skin characterized by the presence of scattered atypical and pleomorphic neoplastic cells. Necrotic changes and atypical mitoses may be present.</td>
<td style="text-align: left;">MONDO:0006717</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979639</td>
<td style="text-align: left;">skin aneurysmal fibrous histiocytoma</td>
<td style="text-align: left;">NCIT:C206448</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Aneurysmal Fibrous Histiocytoma</td>
<td style="text-align: left;">A variant of fibrous histiocytoma of the skin characterized by the presence of blood-filled spaces, hemosiderin deposition, and spindle-shaped neoplastic cells in the dermis. There is peripheral entrapment of collagen bundles, and the overlying epidermis is hyperplastic.</td>
<td style="text-align: left;">MONDO:0006717</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979640</td>
<td style="text-align: left;">skin classic fibrous histiocytoma</td>
<td style="text-align: left;">NCIT:C206450</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Skin Classic Fibrous Histiocytoma</td>
<td style="text-align: left;">A variant of fibrous histiocytoma of the skin characterized by the presence of spindle-shaped neoplastic cells that are surrounded by dendrocytes and macrophages in the dermis. The neoplastic cellular infiltrate may exhibit a storiform growth pattern. The overlying epidermis is usually hyperplastic with elongated hyperpigmented rete ridges.</td>
<td style="text-align: left;">MONDO:0006717</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979641</td>
<td style="text-align: left;">classic inclusion body fibromatosis</td>
<td style="text-align: left;">NCIT:C206471</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Classic Inclusion Body Fibromatosis</td>
<td style="text-align: left;">Inclusion body fibromatosis that affects the soft tissue of the digits.</td>
<td style="text-align: left;">MONDO:0016039</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979642</td>
<td style="text-align: left;">non-classic inclusion body fibromatosis</td>
<td style="text-align: left;">NCIT:C206472</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Classic Inclusion Body Fibromatosis</td>
<td style="text-align: left;">Inclusion body fibromatosis that affects extradigital areas, including the extremities, breasts, and tongue.</td>
<td style="text-align: left;">MONDO:0016039</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979643</td>
<td style="text-align: left;">microvenular hemangioma</td>
<td style="text-align: left;">NCIT:C206679</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Microvenular Hemangioma</td>
<td style="text-align: left;">A rare hemangioma that affects the reticular dermis and consists of small vascular channels that resemble venules.</td>
<td style="text-align: left;">MONDO:0003110</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979644</td>
<td style="text-align: left;">papillary hemangioma</td>
<td style="text-align: left;">NCIT:C206681</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Papillary Hemangioma</td>
<td style="text-align: left;">A hemangioma characterized by the presence of dilated vascular channels with prominent intraluminal papillary projections in the dermis. It usually affects adult males and manifests as a solitary bluish-red papule almost always on the head and neck.</td>
<td style="text-align: left;">MONDO:0003110</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979645</td>
<td style="text-align: left;">progressive nervous system neoplasm</td>
<td style="text-align: left;">NCIT:C206692</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Progressive Nervous System Neoplasm</td>
<td style="text-align: left;">A nervous system neoplasm that is worsening in terms of extent or severity.</td>
<td style="text-align: left;">MONDO:0021248</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979646</td>
<td style="text-align: left;">poikilodermatous plaque-like hemangioma</td>
<td style="text-align: left;">NCIT:C206693</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Poikilodermatous Plaque-Like Hemangioma</td>
<td style="text-align: left;">A skin hemangioma characterized by the proliferation of small blood vessels in the superficial dermis and loss or reduction of elastic fibers. It manifests with erythematous or violet color plaques described as poikilodermatous. Almost all lesions arise in the lower extremities in elderly males.</td>
<td style="text-align: left;">MONDO:0003110</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979647</td>
<td style="text-align: left;">acquired elastotic hemangioma</td>
<td style="text-align: left;">NCIT:C206695</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acquired Elastotic Hemangioma</td>
<td style="text-align: left;">A rare skin hemangioma characterized by the presence of a band-like proliferation of small blood vessels in the upper reticular dermis. It is associated with solar elastosis and manifests with a small papule or plaque in sun-exposed areas with chronic sun damage.</td>
<td style="text-align: left;">MONDO:0003110,MONDO:0003206</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979648</td>
<td style="text-align: left;">neuroendocrine composite hemangioendothelioma</td>
<td style="text-align: left;">NCIT:C207030</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neuroendocrine Composite Hemangioendothelioma</td>
<td style="text-align: left;">A composite hemangioendothelioma characterized by aberrant neuroendocrine markers expression. It more often involves deep locations and has a more aggressive behavior as compared to conventional composite hemangioendotheliomas.</td>
<td style="text-align: left;">MONDO:0018712</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979649</td>
<td style="text-align: left;">dermal clear cell sarcoma</td>
<td style="text-align: left;">NCIT:C207033</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Dermal Clear Cell Sarcoma</td>
<td style="text-align: left;">A clear cell sarcoma that arises from the dermis. It usually affects the extremities, most often distal extremities, and manifests with small amelanotic nodules.</td>
<td style="text-align: left;">MONDO:0006414,MONDO:0002926</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979650</td>
<td style="text-align: left;">hereditary glomus tumor</td>
<td style="text-align: left;">NCIT:C207041</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hereditary Glomus Tumor</td>
<td style="text-align: left;">Glomus tumor inherited in an autosomal dominant pattern and caused by mutations in the GLMN gene encoding glomulin.</td>
<td style="text-align: left;">MONDO:0018327</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979651</td>
<td style="text-align: left;">sporadic glomus tumor</td>
<td style="text-align: left;">NCIT:C207042</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sporadic Glomus Tumor</td>
<td style="text-align: left;">A glomus tumor that is not caused by inherited genetic mutations.</td>
<td style="text-align: left;">MONDO:0018327</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979652</td>
<td style="text-align: left;">intravascular myopericytoma</td>
<td style="text-align: left;">NCIT:C207045</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intravascular Myopericytoma</td>
<td style="text-align: left;">An extremely rare myopericytoma that develops within vessels.</td>
<td style="text-align: left;">MONDO:0017349</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979653</td>
<td style="text-align: left;">myopericytomatosis</td>
<td style="text-align: left;">NCIT:C207046</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myopericytomatosis</td>
<td style="text-align: left;">A myopericytoma characterized by the presence of a diffuse plexiform growth.</td>
<td style="text-align: left;">MONDO:0017349</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979654</td>
<td style="text-align: left;">multicentric myofibromatosis</td>
<td style="text-align: left;">NCIT:C207047</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multicentric Myofibromatosis</td>
<td style="text-align: left;">Myofibromatosis that manifests with multiple tumors in the skin or subcutaneous tissue without visceral involvement.</td>
<td style="text-align: left;">MONDO:0016824</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979655</td>
<td style="text-align: left;">generalized myofibromatosis</td>
<td style="text-align: left;">NCIT:C207048</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Generalized Myofibromatosis</td>
<td style="text-align: left;">Myofibromatosis that manifests with multiple tumors in the skin or subcutaneous tissue with concomitant visceral involvement.</td>
<td style="text-align: left;">MONDO:0016824</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979656</td>
<td style="text-align: left;">reticular perineurioma</td>
<td style="text-align: left;">NCIT:C207064</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Reticular Perineurioma</td>
<td style="text-align: left;">A morphologic subtype of perineurioma characterized by the presence of anastomosing cords of elongated spindle cells that form a reticular pattern.</td>
<td style="text-align: left;">MONDO:0019404</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979657</td>
<td style="text-align: left;">sclerosing perineurioma</td>
<td style="text-align: left;">NCIT:C207065</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sclerosing Perineurioma</td>
<td style="text-align: left;">A morphologic subtype of perineurioma characterized by the presence of strands of small epithelioid to spindle cells in a collagenous stroma.</td>
<td style="text-align: left;">MONDO:0019404</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979658</td>
<td style="text-align: left;">malignant perineurioma</td>
<td style="text-align: left;">NCIT:C207066</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Perineurioma</td>
<td style="text-align: left;">A morphologic subtype of perineurioma characterized by the presence of high mitotic activity, hypercellularity, hyperchromasia, and pleomorphism.</td>
<td style="text-align: left;">MONDO:0019404,MONDO:0021089</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979659</td>
<td style="text-align: left;">solitary neurofibroma</td>
<td style="text-align: left;">NCIT:C207078</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Solitary Neurofibroma</td>
<td style="text-align: left;">A neurofibroma that manifests as a single mass.</td>
<td style="text-align: left;">MONDO:0016755</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979660</td>
<td style="text-align: left;">neuroblastoma-like schwannoma</td>
<td style="text-align: left;">NCIT:C207079</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Neuroblastoma-Like Schwannoma</td>
<td style="text-align: left;">A rare schwannoma characterized by the presence of large rosette-like structures that are surrounded by small, round, hyperchromatic Schwann cells.</td>
<td style="text-align: left;">MONDO:0002546</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979661</td>
<td style="text-align: left;">hereditary melanoma with cdk4 mutation</td>
<td style="text-align: left;">NCIT:C207624</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hereditary Melanoma with CDK4 Mutation</td>
<td style="text-align: left;">A hereditary cutaneous melanoma caused by germline mutation(s) in the CDK4 gene.</td>
<td style="text-align: left;">MONDO:0018961</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979662</td>
<td style="text-align: left;">vulvar cancer by ajcc v9 stage</td>
<td style="text-align: left;">NCIT:C207662</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Vulvar Cancer by AJCC v9 Stage</td>
<td style="text-align: left;">A term that refers to the staging of vulvar cancer according to the American Joint Committee on Cancer, 9th edition. This staging system applies to carcinomas. It does not apply to sarcomas, hematopoietic neoplasms, melanomas, and Merkel cell carcinomas. (from AJCC 9th Ed.)</td>
<td style="text-align: left;">MONDO:0005215</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979663</td>
<td style="text-align: left;">appendix carcinoma by ajcc v9 stage</td>
<td style="text-align: left;">NCIT:C207705</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Carcinoma by AJCC v9 Stage</td>
<td style="text-align: left;">A term that refers to the staging of appendix carcinoma according to the American Joint Committee on Cancer, 9th edition. This staging system applies to adenocarcinomas, mucinous neoplasms (low-grade mucinous neoplasms and high-grade mucinous neoplasms), poorly differentiated neuroendocrine carcinomas, mixed neuroendocrine-nonneuroendocrine neoplasms (mixed adenocarcinoma-neuroendocrine carcinoma), and goblet cell adenocarcinomas (formerly termed goblet cell carcinoids). Well-differentiated neuroendocrine tumors (carcinoids) are staged according to the classification for neuroendocrine tumors of the appendix. (from AJCC 9th Ed.)</td>
<td style="text-align: left;">MONDO:0003196</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979664</td>
<td style="text-align: left;">thyroid-like follicular renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C207787</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid-Like Follicular Renal Cell Carcinoma</td>
<td style="text-align: left;">An extremely rare type of renal cell carcinoma that histologically resembles thyroid follicular neoplasms. It is a well-circumscribed mass, characterized by the presence of thyroid-like follicles that contain eosinophilic, colloid-like material. It is negative for thyroid transcription factor 1 (TTF-1) and thyroglobulin. The majority of the reported cases have a low-grade malignant potential. Rare cases with lymph nodes involvement and distant metastases have also been described.</td>
<td style="text-align: left;">MONDO:0005549</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979665</td>
<td style="text-align: left;">anal cancer by ajcc v9 stage</td>
<td style="text-align: left;">NCIT:C207789</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anal Cancer by AJCC v9 Stage</td>
<td style="text-align: left;">A term that refers to the staging of anal cancer according to the American Joint Committee on Cancer, 9th edition. This staging system applies to all carcinomas arising in the anal canal, including high-grade neuroendocrine carcinomas (small cell neuroendocrine carcinoma and large cell neuroendocrine carcinoma), carcinomas that arise within anorectal fistulas, and those arising in the perianal area. This staging system does not apply to sarcomas (they are staged according to the classification for soft tissue sarcomas of the abdomen and thoracic visceral organs), mucosal melanomas of the anus (no AJCC staging system), and well-differentiated neuroendocrine tumors (no AJCC staging system). Premalignant lesions [i.e., LSIL, HSIL, anal intraepithelial neoplasia (AIN), Paget's disease, Bowen's disease] are not part of the AJCC system. (from AJCC 9th Ed.)</td>
<td style="text-align: left;">MONDO:0003199</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979666</td>
<td style="text-align: left;">refractory secondary hemophagocytic lymphohistiocytosis</td>
<td style="text-align: left;">NCIT:C207802</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Secondary Hemophagocytic Lymphohistiocytosis</td>
<td style="text-align: left;">Secondary hemophagocytic lymphohistiocytosis that is resistant to treatment.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979667</td>
<td style="text-align: left;">duodenal and ampulla of vater neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C207852</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Duodenal and Ampulla of Vater Neuroendocrine Tumor</td>
<td style="text-align: left;">A well-differentiated, low-, intermediate-, or high-grade neoplasm with neuroendocrine differentiation that arises from the duodenum or ampulla of Vater.</td>
<td style="text-align: left;">MONDO:0002995</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979668</td>
<td style="text-align: left;">appendix neuroendocrine tumor by ajcc v9 stage</td>
<td style="text-align: left;">NCIT:C207999</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Appendix Neuroendocrine Tumor by AJCC v9 Stage</td>
<td style="text-align: left;">A term that refers to the staging of appendix neuroendocrine tumors, based on the American Joint Committee on Cancer (AJCC) v9 staging guidelines. This staging system applies only to well-differentiated neuroendocrine tumors of the appendix (NET G1, G2, and G3). It does not apply to high-grade neuroendocrine carcinoma (NEC), goblet cell adenocarcinoma, and mixed adenocarcinoma-NET/NEC of the appendix. (from AJCC 9th Ed.)</td>
<td style="text-align: left;">MONDO:0015066</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979669</td>
<td style="text-align: left;">extrahepatic cholangiocarcinoma</td>
<td style="text-align: left;">NCIT:C208025</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extrahepatic Cholangiocarcinoma</td>
<td style="text-align: left;">A cholangiocarcinoma that arises from the extrahepatic bile ducts. It includes hilar (perihilar) cholangiocarcinoma and distal cholangiocarcinoma (distal bile duct adenocarcinoma).</td>
<td style="text-align: left;">MONDO:0002665,MONDO:0019087</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979670</td>
<td style="text-align: left;">jejunal and ileal neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C208152</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Jejunal and Ileal Neuroendocrine Tumor</td>
<td style="text-align: left;">A well-differentiated, low-, intermediate-, or high-grade neoplasm with neuroendocrine differentiation that arises from the jejunum or ileum.</td>
<td style="text-align: left;">MONDO:0002995</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979671</td>
<td style="text-align: left;">pancreatic neuroendocrine tumor by ajcc v9 stage</td>
<td style="text-align: left;">NCIT:C208221</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Neuroendocrine Tumor by AJCC v9 Stage</td>
<td style="text-align: left;">A term that refers to the staging of pancreatic neuroendocrine tumor, based on the American Joint Committee on Cancer (AJCC) v9 staging guidelines. This staging system applies only to well-differentiated neuroendocrine tumors of the pancreas (NET G1, G2, and G3). It does not apply to carcinomas of the pancreas, including poorly differentiated neuroendocrine carcinoma (NEC) and mixed neuroendocrine non-neuroendocrine (MiNEN) neoplasms of the pancreas. (from AJCC 9th Ed.)</td>
<td style="text-align: left;">MONDO:0019954</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979672</td>
<td style="text-align: left;">cold agglutinin disease</td>
<td style="text-align: left;">NCIT:C208228</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cold Agglutinin Disease</td>
<td style="text-align: left;">A rare disorder that manifests with autoimmune hemolytic anemia and is caused by cold-reacting autoantibodies. It may be a primary clonal B-cell lymphoproliferative disorder or a secondary disorder, resulting from infection or malignancy.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979673</td>
<td style="text-align: left;">childhood hematopoietic and lymphatic system neoplasm</td>
<td style="text-align: left;">NCIT:C208293</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Hematopoietic and Lymphatic System Neoplasm</td>
<td style="text-align: left;">A benign or malignant (primary or metastatic) neoplasm that affects the hematopoietic and lymphatic system and occurs during childhood.</td>
<td style="text-align: left;">MONDO:0021079,MONDO:0002334</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979674</td>
<td style="text-align: left;">gastric neuroendocrine tumor by ajcc v9 stage</td>
<td style="text-align: left;">NCIT:C208301</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Neuroendocrine Tumor by AJCC v9 Stage</td>
<td style="text-align: left;">A term that refers to the staging of gastric neuroendocrine tumors, based on the American Joint Committee on Cancer (AJCC) v9 staging guidelines. This staging system applies only to well-differentiated neuroendocrine tumors of the stomach (NET G1, G2, and G3). It does not apply to carcinoma of the stomach including neuroendocrine carcinoma (NEC), mixed adenocarcinoma-NEC and mixed adenocarcinoma-NET. (from AJCC 9th Ed.)</td>
<td style="text-align: left;">MONDO:0015062</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979675</td>
<td style="text-align: left;">childhood who grade 3 glioma</td>
<td style="text-align: left;">NCIT:C208306</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood WHO Grade 3 Glioma</td>
<td style="text-align: left;">A WHO grade 3 glioma that occurs during childhood.</td>
<td style="text-align: left;">MONDO:1010030,MONDO:0021640</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979676</td>
<td style="text-align: left;">cutaneous blue nevus</td>
<td style="text-align: left;">NCIT:C208328</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cutaneous Blue Nevus</td>
<td style="text-align: left;">An intradermal nevus characterized by the presence of benign pigmented dendritic spindle-shaped melanocytes. It most frequently occurs in the skin of the distal upper extremities, followed by the lower extremities, scalp, face, and buttocks. It usually presents as a single blue or blue-black papular lesion that is less than 1cm in diameter. Simple excision is usually curative.</td>
<td style="text-align: left;">MONDO:0006680,MONDO:0006813</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979677</td>
<td style="text-align: left;">childhood melanocytic neoplasm</td>
<td style="text-align: left;">NCIT:C208332</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Melanocytic Neoplasm</td>
<td style="text-align: left;">A benign, atypical, or malignant neoplasm that arises from and is composed of melanocytes and occurs during childhood.</td>
<td style="text-align: left;">MONDO:0021143,MONDO:0021079</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979678</td>
<td style="text-align: left;">acute promyelocytic leukemia</td>
<td style="text-align: left;">NCIT:C208352</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Acute Promyelocytic Leukemia</td>
<td style="text-align: left;">An acute myeloid leukemia characterized by the predominance of abnormal promyelocytes and translocations involving the retinoic acid receptor- (RARA) gene. Over 95% of cases are characterized by the presence of the reciprocal balanced translocation t(15;17)(q24.1;q21.2) that results in the fusion of the promyelocytic leukemia (PML) gene and RARA gene. The remainder of the cases show variant RARA gene translocations with other genes including NUMA1, ZBTB16, STAT5B, and NPM1.</td>
<td style="text-align: left;">MONDO:0017893</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979679</td>
<td style="text-align: left;">periorbital neoplasm</td>
<td style="text-align: left;">NCIT:C208455</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Periorbital Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the periorbital soft tissue.</td>
<td style="text-align: left;">MONDO:0024611</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979680</td>
<td style="text-align: left;">orbital squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C208484</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Orbital Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that affects the orbital region. In the majority of cases, the lesions represent metastatic involvement of the orbital structures by cutaneous squamous cell carcinoma. Primary squamous cell carcinomas in the orbital region are exceedingly rare.</td>
<td style="text-align: left;">MONDO:0010150,MONDO:0002889</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979681</td>
<td style="text-align: left;">tubular adenoma</td>
<td style="text-align: left;">NCIT:C209283</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tubular Adenoma</td>
<td style="text-align: left;">An adenoma characterized by the presence of a tubular architectural pattern. The vast majority of cases occur in the gastrointestinal tract.</td>
<td style="text-align: left;">MONDO:0004972</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979682</td>
<td style="text-align: left;">villous adenoma</td>
<td style="text-align: left;">NCIT:C209284</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Villous Adenoma</td>
<td style="text-align: left;">An adenoma characterized by the presence of a villous architectural pattern. The vast majority of cases occur in the gastrointestinal tract.</td>
<td style="text-align: left;">MONDO:0004972</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979683</td>
<td style="text-align: left;">tubulovillous adenoma</td>
<td style="text-align: left;">NCIT:C209285</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tubulovillous Adenoma</td>
<td style="text-align: left;">An adenoma characterized by the presence of a tubular and a villous architectural pattern. The vast majority of cases occur in the gastrointestinal tract.</td>
<td style="text-align: left;">MONDO:0004972</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979684</td>
<td style="text-align: left;">secondary acute myeloid leukemia in acquired aplastic anemia</td>
<td style="text-align: left;">NCIT:C209345</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Secondary Acute Myeloid Leukemia in Acquired Aplastic Anemia</td>
<td style="text-align: left;">An acute myeloid leukemia developing in patients with a prior history of acquired aplastic anemia.</td>
<td style="text-align: left;">MONDO:0019457</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979685</td>
<td style="text-align: left;">thyroid gland low grade medullary carcinoma</td>
<td style="text-align: left;">NCIT:C210125</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland Low Grade Medullary Carcinoma</td>
<td style="text-align: left;">A thyroid gland medullary carcinoma with no necrosis, less than 5 mitoses per 2 mm2, and a Ki-67 index less than 5%.</td>
<td style="text-align: left;">MONDO:0015277</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979686</td>
<td style="text-align: left;">thyroid gland high grade medullary carcinoma</td>
<td style="text-align: left;">NCIT:C210129</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Thyroid Gland High Grade Medullary Carcinoma</td>
<td style="text-align: left;">A thyroid gland medullary carcinoma with at least one of the following characteristics: necrosis, 5 or more mitoses per 2 mm2, and/or a Ki-67 index equal to or greater than 5%.</td>
<td style="text-align: left;">MONDO:0015277</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979687</td>
<td style="text-align: left;">digestive system adenocarcinoma</td>
<td style="text-align: left;">NCIT:C210140</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Digestive System Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma that arises from any part of the digestive system.</td>
<td style="text-align: left;">MONDO:0006181,MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979688</td>
<td style="text-align: left;">amphicrine carcinoma</td>
<td style="text-align: left;">NCIT:C210709</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Amphicrine Carcinoma</td>
<td style="text-align: left;">A carcinoma that shows both neuroendocrine and non-neuroendocrine differentiation in the same malignant cells. It has been described in the digestive system and extra-digestive sites. It is distinct from mixed neuroendocrine non-neuroendocrine neoplasms as it does not contain two distinct neoplastic components, one neuroendocrine and one non-neuroendocrine.</td>
<td style="text-align: left;">MONDO:0004993</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979689</td>
<td style="text-align: left;">canine oligodendroglioma</td>
<td style="text-align: left;">NCIT:C210818</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Canine Oligodendroglioma</td>
<td style="text-align: left;">Oligodendroglioma occurring in a dog.</td>
<td style="text-align: left;">MONDO:0700151</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979690</td>
<td style="text-align: left;">canine astrocytoma</td>
<td style="text-align: left;">NCIT:C210824</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Canine Astrocytoma</td>
<td style="text-align: left;">Astrocytoma occurring in a dog.</td>
<td style="text-align: left;">MONDO:0700151</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979691</td>
<td style="text-align: left;">nonmetastatic castration-resistant prostate carcinoma</td>
<td style="text-align: left;">NCIT:C210980</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nonmetastatic Castration-Resistant Prostate Carcinoma</td>
<td style="text-align: left;">A prostate carcinoma that is confined to the prostate gland and shows rising prostate-specific antigen concentration despite castration therapy. It progresses to metastatic disease.</td>
<td style="text-align: left;">MONDO:0850353</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979692</td>
<td style="text-align: left;">metastatic castration-resistant prostate carcinoma</td>
<td style="text-align: left;">NCIT:C210981</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Castration-Resistant Prostate Carcinoma</td>
<td style="text-align: left;">A prostate carcinoma that has spread to other sites and is resistant to castration therapy.</td>
<td style="text-align: left;">MONDO:0004956,MONDO:0850353</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979693</td>
<td style="text-align: left;">bronchial papillomatosis</td>
<td style="text-align: left;">NCIT:C211514</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bronchial Papillomatosis</td>
<td style="text-align: left;">Recurrent respiratory papillomatosis that affects the bronchi.</td>
<td style="text-align: left;">MONDO:0018955,MONDO:0021117</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979694</td>
<td style="text-align: left;">tracheal papillomatosis</td>
<td style="text-align: left;">NCIT:C211515</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Tracheal Papillomatosis</td>
<td style="text-align: left;">Recurrent respiratory papillomatosis that affects the trachea.</td>
<td style="text-align: left;">MONDO:0021210,MONDO:0018955</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979695</td>
<td style="text-align: left;">non-keratinizing squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C211551</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Keratinizing Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma composed of malignant cells without morphologic evidence of keratin production.</td>
<td style="text-align: left;">MONDO:0005096</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979696</td>
<td style="text-align: left;">ebv-related nasopharyngeal squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C211843</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">EBV-Related Nasopharyngeal Squamous Cell Carcinoma</td>
<td style="text-align: left;">A nasopharyngeal squamous cell carcinoma that is caused by Epstein-Barr virus infection. The vast majority of nasopharyngeal non-keratinizing squamous cell carcinomas (differentiated or type II and undifferentiated or type III nasopharyngeal squamous cell carcinomas) and a small minority of nasopharyngeal keratinizing squamous cell carcinomas (type I nasopharyngeal squamous cell carcinomas) are associated with Epstein-Barr virus infection.</td>
<td style="text-align: left;">MONDO:0006060,MONDO:0017344</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979697</td>
<td style="text-align: left;">type ir pleuropulmonary blastoma</td>
<td style="text-align: left;">NCIT:C211861</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Type Ir Pleuropulmonary Blastoma</td>
<td style="text-align: left;">A subtype of type I pleuropulmonary blastoma characterized by the presence of cysts without the presence of primitive malignant small cells.</td>
<td style="text-align: left;">MONDO:0020555</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979698</td>
<td style="text-align: left;">gastrointestinal stromal tumor with kit gene mutation</td>
<td style="text-align: left;">NCIT:C211871</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastrointestinal Stromal Tumor with KIT Gene Mutation</td>
<td style="text-align: left;">A gastrointestinal stromal tumor characterized by the presence of KIT gene mutations.</td>
<td style="text-align: left;">MONDO:0011719</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979699</td>
<td style="text-align: left;">gastrointestinal stromal tumor with pdgfra gene mutation</td>
<td style="text-align: left;">NCIT:C211872</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastrointestinal Stromal Tumor with PDGFRA Gene Mutation</td>
<td style="text-align: left;">A gastrointestinal stromal tumor characterized by the presence of PDGFRA gene mutations.</td>
<td style="text-align: left;">MONDO:0011719</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979700</td>
<td style="text-align: left;">succinate dehydrogenase-deficient gastrointestinal stromal tumor</td>
<td style="text-align: left;">NCIT:C211873</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor</td>
<td style="text-align: left;">A gastrointestinal stromal tumor characterized by the presence of mutations in the SDH genes and absence of mutations in the KIT and PDGFRA genes. It has an epithelioid morphology and a multinodular growth pattern.</td>
<td style="text-align: left;">MONDO:0011719</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979701</td>
<td style="text-align: left;">central nervous system lymphoma</td>
<td style="text-align: left;">NCIT:C212063</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Lymphoma</td>
<td style="text-align: left;">A non-Hodgkin or Hodgkin lymphoma that either arises in the central nervous system or has spread to the central nervous system following the initial presentation in another nodal or extranodal site.</td>
<td style="text-align: left;">MONDO:0017207,MONDO:0003641,MONDO:0002714</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979702</td>
<td style="text-align: left;">conjunctival hereditary benign intraepithelial dyskeratosis</td>
<td style="text-align: left;">NCIT:C212097</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Hereditary Benign Intraepithelial Dyskeratosis</td>
<td style="text-align: left;">A rare autosomal dominant disorder with high penetrance that affects the limbal conjunctiva. It is almost exclusively encountered in Native Americans belonging to the Haliwa-Saponi tribe of northeastern North Carolina and is caused by a duplication in chromosome 4q35. It is characterized by the presence of frequently bilateral, elevated epithelial dyskeratotic plaques in the limbal conjunctiva. There is prominent inflammation in substantia propria. Epithelial dysplasia is absent.</td>
<td style="text-align: left;">MONDO:0007486,MONDO:0006105</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979703</td>
<td style="text-align: left;">oral mucosa hereditary benign intraepithelial dyskeratosis</td>
<td style="text-align: left;">NCIT:C212098</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oral Mucosa Hereditary Benign Intraepithelial Dyskeratosis</td>
<td style="text-align: left;">A rare autosomal dominant disorder with high penetrance that affects the oral mucosa. It is almost exclusively encountered in Native Americans belonging to the Haliwa-Saponi tribe of northeastern North Carolina and is caused by a duplication in chromosome 4q35. It is characterized by the presence of elevated epithelial dyskeratotic plaques in the oral mucosa. Epithelial dysplasia is absent.</td>
<td style="text-align: left;">MONDO:0021445,MONDO:0007486</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979704</td>
<td style="text-align: left;">urticaria pigmentosa/maculopapular cutaneous mastocytosis, monomorphic variant</td>
<td style="text-align: left;">NCIT:C212102</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Urticaria Pigmentosa/Maculopapular Cutaneous Mastocytosis, Monomorphic Variant</td>
<td style="text-align: left;">A variant of urticaria pigmentosa/maculopapular cutaneous mastocytosis characterized by the presence of multiple small, roundish maculopapular skin lesions.</td>
<td style="text-align: left;">MONDO:0019316</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979705</td>
<td style="text-align: left;">urticaria pigmentosa/maculopapular cutaneous mastocytosis, polymorphic variant</td>
<td style="text-align: left;">NCIT:C212103</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Urticaria Pigmentosa/Maculopapular Cutaneous Mastocytosis, Polymorphic Variant</td>
<td style="text-align: left;">A variant of urticaria pigmentosa/maculopapular cutaneous mastocytosis characterized by the presence of larger skin lesions of variable size compared to the monomorphic variant.</td>
<td style="text-align: left;">MONDO:0019316</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979706</td>
<td style="text-align: left;">multiple mastocytomas of the skin</td>
<td style="text-align: left;">NCIT:C212107</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Multiple Mastocytomas of the Skin</td>
<td style="text-align: left;">Multiple distinct mastocytomas that arise from the skin.</td>
<td style="text-align: left;">MONDO:0021048</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979707</td>
<td style="text-align: left;">conjunctival conventional squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C212110</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Conventional Squamous Cell Carcinoma</td>
<td style="text-align: left;">A conjunctival squamous cell carcinoma characterized by the presence of various degrees of keratinization.</td>
<td style="text-align: left;">MONDO:0006173</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979708</td>
<td style="text-align: left;">conjunctival basaloid squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C212111</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Basaloid Squamous Cell Carcinoma</td>
<td style="text-align: left;">A conjunctival poorly differentiated squamous cell carcinoma characterized by the presence of malignant cells with scant basophilic cytoplasm, a high nuclear to cytoplasmic ratio, and oval to spindle hyperchromatic nuclei without prominent nucleoli. Apoptosis and tumor cell necrosis are present.</td>
<td style="text-align: left;">MONDO:0003486,MONDO:0006173</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979709</td>
<td style="text-align: left;">conjunctival squamous cell carcinoma with mucinous differentiation</td>
<td style="text-align: left;">NCIT:C212112</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Squamous Cell Carcinoma with Mucinous Differentiation</td>
<td style="text-align: left;">A conjunctival squamous cell carcinoma characterized by the presence of focal intracytoplasmic mucin.</td>
<td style="text-align: left;">MONDO:0006173</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979710</td>
<td style="text-align: left;">conjunctival acantholytic squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C212113</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Acantholytic Squamous Cell Carcinoma</td>
<td style="text-align: left;">A conjunctival squamous cell carcinoma characterized by the presence of acantholysis of the tumor cells that results in the formation of pseudolumina resembling glandular structures.</td>
<td style="text-align: left;">MONDO:0006173,MONDO:0003487</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979711</td>
<td style="text-align: left;">conjunctival pigmented squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C212114</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Pigmented Squamous Cell Carcinoma</td>
<td style="text-align: left;">A conjunctival squamous cell carcinoma that occurs in patients with Fitzpatrick skin types IV-VI and is characterized by the presence of dendritic melanocytic hyperplasia among the tumor cells.</td>
<td style="text-align: left;">MONDO:0006173</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979712</td>
<td style="text-align: left;">malignant histiocytic and dendritic cell neoplasm</td>
<td style="text-align: left;">NCIT:C212210</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Histiocytic and Dendritic Cell Neoplasm</td>
<td style="text-align: left;">A hematopoietic and lymphoid tissue neoplasm that arises from histiocytic and dendritic cells and is characterized by malignant cytological and architectural features, and presence of invasive features or metastatic potential. This category includes histiocytic sarcoma, fibroblastic reticular cell sarcoma, follicular dendritic cell sarcoma, interdigitating dendritic cell sarcoma, Langerhans cell sarcoma, and plasmacytoid dendritic cell neoplasm.</td>
<td style="text-align: left;">MONDO:0004992,MONDO:0006247</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979713</td>
<td style="text-align: left;">pigmented conjunctival squamous intraepithelial neoplasia</td>
<td style="text-align: left;">NCIT:C212836</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pigmented Conjunctival Squamous Intraepithelial Neoplasia</td>
<td style="text-align: left;">A conjunctival squamous intraepithelial neoplasia that occurs in patients with Fitzpatrick skin types IV-VI and is characterized by the presence of dendritic melanocytic hyperplasia among the dysplastic cells.</td>
<td style="text-align: left;">MONDO:0003453</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979714</td>
<td style="text-align: left;">conjunctival squamous intraepithelial neoplasia with mucinous differentiation</td>
<td style="text-align: left;">NCIT:C212841</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Squamous Intraepithelial Neoplasia with Mucinous Differentiation</td>
<td style="text-align: left;">A conjunctival squamous intraepithelial neoplasia characterized by the presence of dysplastic squamous cells with intracytoplasmic mucin.</td>
<td style="text-align: left;">MONDO:0003453</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979715</td>
<td style="text-align: left;">conjunctival squamous intraepithelial neoplasia 2</td>
<td style="text-align: left;">NCIT:C212845</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Squamous Intraepithelial Neoplasia 2</td>
<td style="text-align: left;">A conjunctival squamous intraepithelial neoplasia characterized by the presence of dysplasia that involves the lower two-thirds of epithelial thickness.</td>
<td style="text-align: left;">MONDO:0003453</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979716</td>
<td style="text-align: left;">conjunctival squamous cell carcinoma in situ</td>
<td style="text-align: left;">NCIT:C212849</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Squamous Cell Carcinoma In Situ</td>
<td style="text-align: left;">A conjunctival squamous cell neoplasm characterized by the presence of dysplasia that involves the entire epithelium (full thickness) without surface epithelial maturation. The basement membrane is intact.</td>
<td style="text-align: left;">MONDO:0006173,MONDO:0004693</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979717</td>
<td style="text-align: left;">keratoacanthoma</td>
<td style="text-align: left;">NCIT:C212871</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Keratoacanthoma</td>
<td style="text-align: left;">A dome-shaped, rapidly growing neoplasm composed of well differentiated squamous cells. It almost always affects the skin and usually occurs on sun-exposed areas of the body, most often the head, neck, and limbs. Rare cases have been reported in extracutaneous sites including the conjunctiva, subungual space, and vulva. It is considered a variant of well-differentiated squamous cell carcinoma with distinct clinical behavior.</td>
<td style="text-align: left;">MONDO:0005096</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979718</td>
<td style="text-align: left;">essential thrombocythemia with recurrent thrombosis</td>
<td style="text-align: left;">NCIT:C212978</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Essential Thrombocythemia with Recurrent Thrombosis</td>
<td style="text-align: left;">Essential thrombocythemia associated with the repeated formation of blood clots due to the underlying disorder.</td>
<td style="text-align: left;">MONDO:0005029</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979719</td>
<td style="text-align: left;">von hippel lindau syndrome-associated clear cell renal cell carcinoma</td>
<td style="text-align: left;">NCIT:C213036</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Von Hippel Lindau Syndrome-Associated Clear Cell Renal Cell Carcinoma</td>
<td style="text-align: left;">A clear cell renal cell carcinoma that develops in a patient with Von Hippel Lindau syndrome. Renal involvement in Von Hippel Lindau syndrome is characterized by multiple, bilateral, and recurring tumors.</td>
<td style="text-align: left;">MONDO:0018492</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979720</td>
<td style="text-align: left;">von hippel lindau syndrome-associated pancreatic neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C213039</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Von Hippel Lindau Syndrome-Associated Pancreatic Neuroendocrine Tumor</td>
<td style="text-align: left;">A pancreatic neuroendocrine tumor that develops in a patient with Von Hippel Lindau syndrome. Most often, there are multiple non-functional tumors.</td>
<td style="text-align: left;">MONDO:0019954</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979721</td>
<td style="text-align: left;">refractory malignant neoplasm of unknown primary</td>
<td style="text-align: left;">NCIT:C213042</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Refractory Malignant Neoplasm of Unknown Primary</td>
<td style="text-align: left;">A metastatic malignant neoplasm of unknown primary that is resistant to treatment.</td>
<td style="text-align: left;">MONDO:0858997,MONDO:0036501</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979722</td>
<td style="text-align: left;">men1-associated pancreatic neuroendocrine tumor</td>
<td style="text-align: left;">NCIT:C213055</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">MEN1-Associated Pancreatic Neuroendocrine Tumor</td>
<td style="text-align: left;">A pancreatic neuroendocrine tumor that develops in a patient with multiple endocrine neoplasia type 1 (MEN1). The incidence of pancreatic neuroendocrine tumors in patients with MEN1 ranges between 30-80% in various studies.</td>
<td style="text-align: left;">MONDO:0019954</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979723</td>
<td style="text-align: left;">compound nevus</td>
<td style="text-align: left;">NCIT:C213114</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Compound Nevus</td>
<td style="text-align: left;">A nevus that arises from the skin or conjunctiva and is characterized by the presence of nevus cells within the epithelium and in the dermis (skin) or substantia propria (conjunctiva).</td>
<td style="text-align: left;">MONDO:0005073</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979724</td>
<td style="text-align: left;">balloon cell nevus</td>
<td style="text-align: left;">NCIT:C213115</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Balloon Cell Nevus</td>
<td style="text-align: left;">A melanocytic nevus that arises from the skin or conjunctiva and is characterized by the presence of large melanocytes with clear, foamy, or finely vacuolated cytoplasm.</td>
<td style="text-align: left;">MONDO:0005073</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979725</td>
<td style="text-align: left;">spitz nevus</td>
<td style="text-align: left;">NCIT:C213118</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Spitz Nevus</td>
<td style="text-align: left;">A benign melanocytic neoplasm that occurs in the skin and rarely the conjunctiva and is characterized by a proliferation of large epithelioid and/or spindled melanocytes.</td>
<td style="text-align: left;">MONDO:0005073</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979726</td>
<td style="text-align: left;">dysplastic nevus</td>
<td style="text-align: left;">NCIT:C213198</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Dysplastic Nevus</td>
<td style="text-align: left;">A slightly raised pigmented melanocytic lesion with irregular borders characterized by the presence of atypical melanocytes. The differential diagnosis from melanoma may be difficult and patients are at an increased risk for the development of melanoma.</td>
<td style="text-align: left;">MONDO:0005073</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979727</td>
<td style="text-align: left;">junctional nevus</td>
<td style="text-align: left;">NCIT:C213199</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Junctional Nevus</td>
<td style="text-align: left;">A melanocytic nevus that arises from the skin or conjunctiva. In the skin, it is characterized by the presence of a junctional proliferation of nevus cells without involvement of the dermis. In the conjunctiva, it is characterized by an intraepithelial proliferation of nevus cells.</td>
<td style="text-align: left;">MONDO:0005073</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979728</td>
<td style="text-align: left;">conjunctival amelanotic melanoma</td>
<td style="text-align: left;">NCIT:C213201</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Amelanotic Melanoma</td>
<td style="text-align: left;">A melanoma that arises from the conjunctiva and is characterized by the absence of melanin pigment in the melanoma cells.</td>
<td style="text-align: left;">MONDO:0002096,MONDO:0002971</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979729</td>
<td style="text-align: left;">conjunctival mixed epithelioid and spindle cell melanoma</td>
<td style="text-align: left;">NCIT:C213202</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Mixed Epithelioid and Spindle Cell Melanoma</td>
<td style="text-align: left;">A melanoma that arises from the conjunctiva and is characterized by the presence of malignant large epithelioid melanocytes and malignant spindle-shaped melanocytes.</td>
<td style="text-align: left;">MONDO:0006749,MONDO:0002096</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979730</td>
<td style="text-align: left;">metastatic carcinoma in the lymph nodes</td>
<td style="text-align: left;">NCIT:C213275</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Carcinoma in the Lymph Nodes</td>
<td style="text-align: left;">A carcinoma that has spread to the lymph nodes.</td>
<td style="text-align: left;">MONDO:0005438,MONDO:0024879</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979731</td>
<td style="text-align: left;">metastatic carcinoma in the colon</td>
<td style="text-align: left;">NCIT:C213276</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Carcinoma in the Colon</td>
<td style="text-align: left;">A carcinoma that has spread to the colon from another anatomic site.</td>
<td style="text-align: left;">MONDO:0041447,MONDO:0024879</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979732</td>
<td style="text-align: left;">sigmoid colon neoplasm</td>
<td style="text-align: left;">NCIT:C213279</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Sigmoid Colon Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the sigmoid colon.</td>
<td style="text-align: left;">MONDO:0005401</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979733</td>
<td style="text-align: left;">papillary urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C213296</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Papillary Urothelial Carcinoma</td>
<td style="text-align: left;">An invasive or non-invasive urothelial carcinoma exhibiting papillary growth.</td>
<td style="text-align: left;">MONDO:0040679,MONDO:0006509,MONDO:0003443</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979734</td>
<td style="text-align: left;">border of tongue squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C213305</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Border of Tongue Squamous Cell Carcinoma</td>
<td style="text-align: left;">A squamous cell carcinoma that arises from the border of the tongue.</td>
<td style="text-align: left;">MONDO:0000500</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979735</td>
<td style="text-align: left;">nasopharyngeal squamous cell carcinoma in situ</td>
<td style="text-align: left;">NCIT:C213307</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Nasopharyngeal Squamous Cell Carcinoma In Situ</td>
<td style="text-align: left;">A non-invasive intraepithelial squamous cell carcinoma that arises from the nasopharynx.</td>
<td style="text-align: left;">MONDO:0021297,MONDO:0004693,MONDO:0006060</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979736</td>
<td style="text-align: left;">eyelid squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C213312</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Squamous Cell Carcinoma</td>
<td style="text-align: left;">An uncommon squamous cell carcinoma that arises from the eyelid.</td>
<td style="text-align: left;">MONDO:0003876,MONDO:0002529</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979737</td>
<td style="text-align: left;">lung acantholytic squamous cell carcinoma</td>
<td style="text-align: left;">NCIT:C213321</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Acantholytic Squamous Cell Carcinoma</td>
<td style="text-align: left;">A rare variant of squamous cell carcinoma of the lung characterized by cellular discohesion of the tumor cells that results in the formation of pseudolumina resembling glandular structures.</td>
<td style="text-align: left;">MONDO:0003487,MONDO:0005097</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979738</td>
<td style="text-align: left;">head and neck cutaneous carcinoma</td>
<td style="text-align: left;">NCIT:C213333</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Cutaneous Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the skin of the head and neck.</td>
<td style="text-align: left;">MONDO:0002656,MONDO:0002038</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979739</td>
<td style="text-align: left;">adult hepatoblastoma</td>
<td style="text-align: left;">NCIT:C213350</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adult Hepatoblastoma</td>
<td style="text-align: left;">A rare hepatoblastoma that occurs during adulthood.</td>
<td style="text-align: left;">MONDO:0018666</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979740</td>
<td style="text-align: left;">hepatic flexure neoplasm</td>
<td style="text-align: left;">NCIT:C213372</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatic Flexure Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that affects the hepatic flexure.</td>
<td style="text-align: left;">MONDO:0005401</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979741</td>
<td style="text-align: left;">pancreatic ductal intestinal-type adenocarcinoma</td>
<td style="text-align: left;">NCIT:C213375</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Ductal Intestinal-Type Adenocarcinoma</td>
<td style="text-align: left;">A rare pancreatic ductal adenocarcinoma characterized by the presence of intestinal-type malignant epithelial cells resembling colonic adenocarcinoma.</td>
<td style="text-align: left;">MONDO:0005184,MONDO:0006254</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979742</td>
<td style="text-align: left;">high grade serous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C213446</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">High Grade Serous Adenocarcinoma</td>
<td style="text-align: left;">A rapidly growing serous adenocarcinoma that arises from the ovary, fallopian tube, or peritoneum. It is characterized by the presence of high-grade cytologic features and frequent mitotic figures.</td>
<td style="text-align: left;">MONDO:0005278</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979743</td>
<td style="text-align: left;">low grade serous adenocarcinoma</td>
<td style="text-align: left;">NCIT:C213448</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Low Grade Serous Adenocarcinoma</td>
<td style="text-align: left;">A serous adenocarcinoma that arises from the ovary or the peritoneum and is characterized by low-grade histopathologic features.</td>
<td style="text-align: left;">MONDO:0005278</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979744</td>
<td style="text-align: left;">intraductal carcinoma</td>
<td style="text-align: left;">NCIT:C213452</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intraductal Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the epithelial lining of a duct and has not invaded the surrounding stroma.</td>
<td style="text-align: left;">MONDO:0004993</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979745</td>
<td style="text-align: left;">head and neck adenosquamous carcinoma</td>
<td style="text-align: left;">NCIT:C213477</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Adenosquamous Carcinoma</td>
<td style="text-align: left;">An adenosquamous carcinoma that arises from the head and neck region.</td>
<td style="text-align: left;">MONDO:0006074,MONDO:0002038</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979746</td>
<td style="text-align: left;">colorectal hepatoid adenocarcinoma</td>
<td style="text-align: left;">NCIT:C213479</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Hepatoid Adenocarcinoma</td>
<td style="text-align: left;">A rare and aggressive extrahepatic carcinoma that morphologically and immunophenotypically resembles hepatocellular carcinoma and arises from the colon or rectum.</td>
<td style="text-align: left;">MONDO:0006243,MONDO:0005008</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979747</td>
<td style="text-align: left;">mediastinal melanoma</td>
<td style="text-align: left;">NCIT:C213491</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mediastinal Melanoma</td>
<td style="text-align: left;">An exceedingly rare melanoma that arises from the mediastinum.</td>
<td style="text-align: left;">MONDO:0006320,MONDO:0005843</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979748</td>
<td style="text-align: left;">temporal bone paraganglioma</td>
<td style="text-align: left;">NCIT:C213492</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Temporal Bone Paraganglioma</td>
<td style="text-align: left;">A paraganglioma that arises from the temporal bone.</td>
<td style="text-align: left;">MONDO:0006239</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979749</td>
<td style="text-align: left;">maxillary bone paraganglioma</td>
<td style="text-align: left;">NCIT:C213493</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Maxillary Bone Paraganglioma</td>
<td style="text-align: left;">A paraganglioma that arises from the maxillary bone.</td>
<td style="text-align: left;">MONDO:0006239</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979750</td>
<td style="text-align: left;">parotid gland melanoma</td>
<td style="text-align: left;">NCIT:C213517</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Parotid Gland Melanoma</td>
<td style="text-align: left;">An exceedingly rare melanoma that arises from the parotid gland. The vast majority of melanomas affecting the parotid gland are metastatic lesions.</td>
<td style="text-align: left;">MONDO:0006320,MONDO:0004700</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979751</td>
<td style="text-align: left;">lung undifferentiated pleomorphic sarcoma</td>
<td style="text-align: left;">NCIT:C213523</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Undifferentiated Pleomorphic Sarcoma</td>
<td style="text-align: left;">An exceedingly rare undifferentiated pleomorphic sarcoma that arises from the lung. In the vast majority of cases lung involvement is due to metastasis from another anatomic site.</td>
<td style="text-align: left;">MONDO:0002426,MONDO:0002142</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979752</td>
<td style="text-align: left;">lung desmoplastic small round cell tumor</td>
<td style="text-align: left;">NCIT:C213527</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Desmoplastic Small Round Cell Tumor</td>
<td style="text-align: left;">An exceedingly rare desmoplastic small round cell tumor that arises from the lung.</td>
<td style="text-align: left;">MONDO:0019373,MONDO:0002426</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979753</td>
<td style="text-align: left;">lung liposarcoma</td>
<td style="text-align: left;">NCIT:C213538</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Liposarcoma</td>
<td style="text-align: left;">An exceedingly rare liposarcoma that arises from the lung.</td>
<td style="text-align: left;">MONDO:0002426,MONDO:0005060</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979754</td>
<td style="text-align: left;">retroperitoneal liposarcoma</td>
<td style="text-align: left;">NCIT:C213540</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Retroperitoneal Liposarcoma</td>
<td style="text-align: left;">A liposarcoma that arises from the retroperitoneum. It is the most common soft tissue sarcoma of the retroperitoneum.</td>
<td style="text-align: left;">MONDO:0001501,MONDO:0005060</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979755</td>
<td style="text-align: left;">liver liposarcoma</td>
<td style="text-align: left;">NCIT:C213546</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Liver Liposarcoma</td>
<td style="text-align: left;">An exceedingly rare liposarcoma that arises from the liver.</td>
<td style="text-align: left;">MONDO:0002397,MONDO:0005060</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979756</td>
<td style="text-align: left;">colon gastrointestinal stromal tumor</td>
<td style="text-align: left;">NCIT:C213590</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colon Gastrointestinal Stromal Tumor</td>
<td style="text-align: left;">A gastrointestinal stromal tumor that arises from the colon.</td>
<td style="text-align: left;">MONDO:0005401,MONDO:0006159</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979757</td>
<td style="text-align: left;">synovial sarcoma of nerve</td>
<td style="text-align: left;">NCIT:C213591</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Synovial Sarcoma of Nerve</td>
<td style="text-align: left;">A rare synovial sarcoma that arises from a nerve.</td>
<td style="text-align: left;">MONDO:0021089,MONDO:0010434</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979758</td>
<td style="text-align: left;">lung ewing sarcoma</td>
<td style="text-align: left;">NCIT:C213633</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Ewing Sarcoma</td>
<td style="text-align: left;">An exceedingly rare Ewing sarcoma that arises from the lung.</td>
<td style="text-align: left;">MONDO:0018270,MONDO:0002426</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979759</td>
<td style="text-align: left;">female reproductive system lymphoma</td>
<td style="text-align: left;">NCIT:C213738</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Female Reproductive System Lymphoma</td>
<td style="text-align: left;">A rare lymphoma that arises from the female reproductive system. It usually affects the ovaries and less commonly the cervix, whereas primary lymphoma involving the endometrium or fallopian tube is exceedingly rare.</td>
<td style="text-align: left;">MONDO:0017207,MONDO:0001416</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979760</td>
<td style="text-align: left;">intestinal lymphoma</td>
<td style="text-align: left;">NCIT:C213745</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intestinal Lymphoma</td>
<td style="text-align: left;">A non-Hodgkin or rarely a Hodgkin lymphoma that arises from the intestine.</td>
<td style="text-align: left;">MONDO:0005814,MONDO:0004699</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979761</td>
<td style="text-align: left;">retroperitoneal non-hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C213753</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Retroperitoneal Non-Hodgkin Lymphoma</td>
<td style="text-align: left;">A rare non-Hodgkin lymphoma that arises from the retroperitoneum.</td>
<td style="text-align: left;">MONDO:0001499,MONDO:0018908</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979762</td>
<td style="text-align: left;">retroperitoneal hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C213755</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Retroperitoneal Hodgkin Lymphoma</td>
<td style="text-align: left;">A rare Hodgkin lymphoma that arises from the retroperitoneum.</td>
<td style="text-align: left;">MONDO:0004952,MONDO:0001499</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979763</td>
<td style="text-align: left;">metastatic malignant neoplasm in the retroperitoneum</td>
<td style="text-align: left;">NCIT:C213768</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Retroperitoneum</td>
<td style="text-align: left;">A malignant neoplasm that has spread to the retroperitoneum from another (primary) anatomic site.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0005941</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979764</td>
<td style="text-align: left;">non-sun exposed skin melanoma</td>
<td style="text-align: left;">NCIT:C213774</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Sun Exposed Skin Melanoma</td>
<td style="text-align: left;">A melanoma that develops in an area of the skin that is not exposed to sunlight.</td>
<td style="text-align: left;">MONDO:0005012</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979765</td>
<td style="text-align: left;">gastrointestinal tract post-transplant lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C213824</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastrointestinal Tract Post-Transplant Lymphoproliferative Disorder</td>
<td style="text-align: left;">A post-transplant lymphoproliferative disorder that arises from the gastrointestinal tract. The most common sites of involvement are the stomach and small intestine.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979766</td>
<td style="text-align: left;">gastric post-transplant lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C213840</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gastric Post-Transplant Lymphoproliferative Disorder</td>
<td style="text-align: left;">A post-transplant lymphoproliferative disorder that arises from the stomach.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979767</td>
<td style="text-align: left;">intestinal post-transplant lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C213842</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Intestinal Post-Transplant Lymphoproliferative Disorder</td>
<td style="text-align: left;">A post-transplant lymphoproliferative disorder that arises from the intestine.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979768</td>
<td style="text-align: left;">small intestinal post-transplant lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C213846</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Post-Transplant Lymphoproliferative Disorder</td>
<td style="text-align: left;">A post-transplant lymphoproliferative disorder that arises from the small intestine.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979769</td>
<td style="text-align: left;">colorectal post-transplant lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C213847</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Post-Transplant Lymphoproliferative Disorder</td>
<td style="text-align: left;">A post-transplant lymphoproliferative disorder that arises from the colon or rectum.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979770</td>
<td style="text-align: left;">colon post-transplant lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C213848</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colon Post-Transplant Lymphoproliferative Disorder</td>
<td style="text-align: left;">A post-transplant lymphoproliferative disorder that arises from the colon.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979771</td>
<td style="text-align: left;">lung post-transplant lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C213849</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Post-Transplant Lymphoproliferative Disorder</td>
<td style="text-align: left;">A post-transplant lymphoproliferative disorder that arises from the lung.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979772</td>
<td style="text-align: left;">central nervous system post-transplant lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C213850</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Central Nervous System Post-Transplant Lymphoproliferative Disorder</td>
<td style="text-align: left;">A post-transplant lymphoproliferative disorder that arises from the central nervous system.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979773</td>
<td style="text-align: left;">brain post-transplant lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C213851</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Brain Post-Transplant Lymphoproliferative Disorder</td>
<td style="text-align: left;">A post-transplant lymphoproliferative disorder that arises from the brain.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979774</td>
<td style="text-align: left;">adrenal gland post-transplant lymphoproliferative disorder</td>
<td style="text-align: left;">NCIT:C213853</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Gland Post-Transplant Lymphoproliferative Disorder</td>
<td style="text-align: left;">An exceedingly rare post-transplant lymphoproliferative disorder that arises from the adrenal gland.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979775</td>
<td style="text-align: left;">benign peripheral nervous system neoplasm</td>
<td style="text-align: left;">NCIT:C213862</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Peripheral Nervous System Neoplasm</td>
<td style="text-align: left;">A neoplasm that arises from the peripheral nervous system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.</td>
<td style="text-align: left;">MONDO:0000648,MONDO:0001406</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979776</td>
<td style="text-align: left;">digestive system hematopoietic and lymphoid cell neoplasm</td>
<td style="text-align: left;">NCIT:C213901</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Digestive System Hematopoietic and Lymphoid Cell Neoplasm</td>
<td style="text-align: left;">A neoplasm of hematopoietic and lymphoid cell origin that affects any part of the digestive system.</td>
<td style="text-align: left;">MONDO:0021223,MONDO:0044881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979777</td>
<td style="text-align: left;">lung hematopoietic and lymphoid cell neoplasm</td>
<td style="text-align: left;">NCIT:C213902</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lung Hematopoietic and Lymphoid Cell Neoplasm</td>
<td style="text-align: left;">A neoplasm of hematopoietic and lymphoid cell origin that affects the lung.</td>
<td style="text-align: left;">MONDO:0021117,MONDO:0044881</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979778</td>
<td style="text-align: left;">eyelid verruca vulgaris</td>
<td style="text-align: left;">NCIT:C214774</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Verruca Vulgaris</td>
<td style="text-align: left;">Verruca vulgaris that affects the eyelid. It presents with papules, nodules, and keratotic plaques, and resolves spontaneously after a period of time.</td>
<td style="text-align: left;">MONDO:0021605,MONDO:0001209</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979779</td>
<td style="text-align: left;">eyelid inverted follicular keratosis</td>
<td style="text-align: left;">NCIT:C214775</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Inverted Follicular Keratosis</td>
<td style="text-align: left;">A benign eyelid tumor that presents with asymptomatic papules and is characterized by the proliferation of squamous and basaloid cells of the follicular infundibulum.</td>
<td style="text-align: left;">MONDO:0006563,MONDO:0021607</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979780</td>
<td style="text-align: left;">muscle disorder</td>
<td style="text-align: left;">NCIT:C214794</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Muscle Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the muscle.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979781</td>
<td style="text-align: left;">bone disorder</td>
<td style="text-align: left;">NCIT:C214795</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the bone.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979782</td>
<td style="text-align: left;">myomatous neoplasm</td>
<td style="text-align: left;">NCIT:C214799</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myomatous Neoplasm</td>
<td style="text-align: left;">A benign, intermediate, or malignant mesenchymal neoplasm that arises from smooth, skeletal, or cardiac muscle cells.</td>
<td style="text-align: left;">MONDO:0002616,MONDO:0021545</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979783</td>
<td style="text-align: left;">extracardiac rhabdomyosarcoma</td>
<td style="text-align: left;">NCIT:C214845</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extracardiac Rhabdomyosarcoma</td>
<td style="text-align: left;">A rare aggressive malignant mesenchymal neoplasm that arises from skeletal muscle cells.</td>
<td style="text-align: left;">MONDO:0002847,MONDO:0005212</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979784</td>
<td style="text-align: left;">jaw disorder</td>
<td style="text-align: left;">NCIT:C214883</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Jaw Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the maxilla or mandible.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979785</td>
<td style="text-align: left;">oropharyngeal disorder</td>
<td style="text-align: left;">NCIT:C214900</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Oropharyngeal Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the oropharynx.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979786</td>
<td style="text-align: left;">malignant head and neck mucosal neoplasm</td>
<td style="text-align: left;">NCIT:C214952</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Malignant Head and Neck Mucosal Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm that arises from the mucosa of the nasal cavity, paranasal sinuses, oral cavity, oropharynx, nasopharynx, hypopharynx, and larynx.</td>
<td style="text-align: left;">MONDO:0005627</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979787</td>
<td style="text-align: left;">eyelid actinic keratosis</td>
<td style="text-align: left;">NCIT:C214968</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Actinic Keratosis</td>
<td style="text-align: left;">Actinic keratosis that develops in the skin of the eyelid.</td>
<td style="text-align: left;">MONDO:0005173,MONDO:0002235</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979788</td>
<td style="text-align: left;">eyelid adnexal neoplasm</td>
<td style="text-align: left;">NCIT:C214969</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Adnexal Neoplasm</td>
<td style="text-align: left;">A benign or malignant neoplasm that arises from the adnexal structures of the eyelid. Examples include sebaceous adenoma, mixed tumor, sebaceous carcinoma, and apocrine carcinoma.</td>
<td style="text-align: left;">MONDO:0002297,MONDO:0002235</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979789</td>
<td style="text-align: left;">hepatopancreatobiliary carcinoma</td>
<td style="text-align: left;">NCIT:C214986</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Hepatopancreatobiliary Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the liver, pancreas, bile ducts, or gallbladder.</td>
<td style="text-align: left;">MONDO:0006181</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979790</td>
<td style="text-align: left;">head and neck adenoid cystic carcinoma</td>
<td style="text-align: left;">NCIT:C214991</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Adenoid Cystic Carcinoma</td>
<td style="text-align: left;">An adenoid cystic carcinoma that arises from the head and neck region. Sites of involvement include the salivary glands, lip, oral cavity, paranasal sinuses, pharynx, and larynx.</td>
<td style="text-align: left;">MONDO:0002038,MONDO:0004971</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979791</td>
<td style="text-align: left;">her2-positive lung non-small cell carcinoma</td>
<td style="text-align: left;">NCIT:C215011</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">HER2-Positive Lung Non-Small Cell Carcinoma</td>
<td style="text-align: left;">A lung non-small cell carcinoma characterized by activation of the HER2 gene through gene mutation, amplification, or protein overexpression.</td>
<td style="text-align: left;">MONDO:0005233</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979792</td>
<td style="text-align: left;">eyelid melanocytic neoplasm</td>
<td style="text-align: left;">NCIT:C215032</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Melanocytic Neoplasm</td>
<td style="text-align: left;">A melanocytic neoplasm that arises from the eyelid. This category includes nevi and melanomas.</td>
<td style="text-align: left;">MONDO:0021583,MONDO:0002235</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979793</td>
<td style="text-align: left;">bone chordoma</td>
<td style="text-align: left;">NCIT:C215033</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Bone Chordoma</td>
<td style="text-align: left;">A chordoma that arises from the axial skeleton (skull or spine) and very rarely the appendicular skeleton. Soft tissue involvement as a primary site is extremely rare.</td>
<td style="text-align: left;">MONDO:0002129,MONDO:0008978</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979794</td>
<td style="text-align: left;">extra-axial chordoma</td>
<td style="text-align: left;">NCIT:C215036</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Extra-Axial Chordoma</td>
<td style="text-align: left;">An extremely rare neoplasm with identical histological features to chordoma that arises outside the axial skeleton in the appendicular skeleton and soft tissue.</td>
<td style="text-align: left;">MONDO:0008978</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979795</td>
<td style="text-align: left;">melanoma in situ</td>
<td style="text-align: left;">NCIT:C215044</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Melanoma In Situ</td>
<td style="text-align: left;">A term that refers to a cutaneous melanoma that is confined to the epidermis and lacks evidence of dermal invasion or mucosal melanoma that is confined to the epithelium and lacks evidence of subepithelial stromal invasion.</td>
<td style="text-align: left;">MONDO:0005105</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979796</td>
<td style="text-align: left;">eyelid spitz nevus</td>
<td style="text-align: left;">NCIT:C215046</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Spitz Nevus</td>
<td style="text-align: left;">A rare benign melanocytic neoplasm that arises from the eyelid and is characterized by a proliferation of large epithelioid and/or spindled melanocytes.</td>
<td style="text-align: left;">MONDO:0020179,MONDO:0044793</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979797</td>
<td style="text-align: left;">optic nerve pilocytic astrocytoma</td>
<td style="text-align: left;">NCIT:C215125</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Optic Nerve Pilocytic Astrocytoma</td>
<td style="text-align: left;">A pilocytic astrocytoma that arises from the optic nerve.</td>
<td style="text-align: left;">MONDO:0003234,MONDO:0016691</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979798</td>
<td style="text-align: left;">optic nerve pilomyxoid astrocytoma</td>
<td style="text-align: left;">NCIT:C215126</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Optic Nerve Pilomyxoid Astrocytoma</td>
<td style="text-align: left;">A pilomyxoid astrocytoma that arises from the optic nerve.</td>
<td style="text-align: left;">MONDO:0003234,MONDO:0016692</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979799</td>
<td style="text-align: left;">spinal cord glioblastoma</td>
<td style="text-align: left;">NCIT:C215130</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Spinal Cord Glioblastoma</td>
<td style="text-align: left;">A rare glioblastoma that arises from the spinal cord.</td>
<td style="text-align: left;">MONDO:0002542,MONDO:0003544,MONDO:0018177</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979800</td>
<td style="text-align: left;">optic chiasm disorder</td>
<td style="text-align: left;">NCIT:C215170</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Optic Chiasm Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the optic chiasm.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979801</td>
<td style="text-align: left;">anorectal disorder</td>
<td style="text-align: left;">NCIT:C215171</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anorectal Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the anus and rectum.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979802</td>
<td style="text-align: left;">rectal disorder</td>
<td style="text-align: left;">NCIT:C215173</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Rectal Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the rectum.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979803</td>
<td style="text-align: left;">small intestinal disorder</td>
<td style="text-align: left;">NCIT:C215175</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Small Intestinal Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the small intestine.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979804</td>
<td style="text-align: left;">colorectal disorder</td>
<td style="text-align: left;">NCIT:C215180</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colorectal Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the colon and rectum.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979805</td>
<td style="text-align: left;">colon disorder</td>
<td style="text-align: left;">NCIT:C215181</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Colon Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the colon.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979806</td>
<td style="text-align: left;">spinal disorder</td>
<td style="text-align: left;">NCIT:C215182</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Spinal Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the vertebrae and/or vertebral canal.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979807</td>
<td style="text-align: left;">prepuce disorder</td>
<td style="text-align: left;">NCIT:C215188</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Prepuce Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the fold of skin that covers the head of the penis or clitoris.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979808</td>
<td style="text-align: left;">large intestinal disorder</td>
<td style="text-align: left;">NCIT:C215199</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Large Intestinal Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the large intestine.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979809</td>
<td style="text-align: left;">recurrent castleman disease</td>
<td style="text-align: left;">NCIT:C215241</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Recurrent Castleman Disease</td>
<td style="text-align: left;">The reemergence of Castleman disease after a period of remission.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979810</td>
<td style="text-align: left;">recurrent multicentric castleman disease</td>
<td style="text-align: left;">NCIT:C215298</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Recurrent Multicentric Castleman Disease</td>
<td style="text-align: left;">The reemergence of multicentric Castleman disease after a period of remission.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979811</td>
<td style="text-align: left;">alk-positive lung non-small cell carcinoma</td>
<td style="text-align: left;">NCIT:C215346</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">ALK-Positive Lung Non-Small Cell Carcinoma</td>
<td style="text-align: left;">A lung non-small cell carcinoma (NSCLC) characterized by the presence of rearrangements of the ALK gene that lead to activation of ALK kinase and ALK driven tumor formation. These rearrangements were initially identified as EML4-ALK fusions, but a variety of other ALK gene fusions were subsequently identified. Approximately 5% of patients with NSCLC carry ALK rearrangements and are highly sensitive to treatment with ALK inhibitors.</td>
<td style="text-align: left;">MONDO:0005233</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979812</td>
<td style="text-align: left;">myocardial lipoma</td>
<td style="text-align: left;">NCIT:C215383</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Myocardial Lipoma</td>
<td style="text-align: left;">A lipoma that arises from the myocardium.</td>
<td style="text-align: left;">MONDO:0003841,MONDO:0021509</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979813</td>
<td style="text-align: left;">head and neck adenocarcinoma</td>
<td style="text-align: left;">NCIT:C215426</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Adenocarcinoma</td>
<td style="text-align: left;">An adenocarcinoma that arises from the head and neck region.</td>
<td style="text-align: left;">MONDO:0002038,MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979814</td>
<td style="text-align: left;">head and neck undifferentiated carcinoma</td>
<td style="text-align: left;">NCIT:C215427</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Head and Neck Undifferentiated Carcinoma</td>
<td style="text-align: left;">An undifferentiated carcinoma that arises from the head and neck region.</td>
<td style="text-align: left;">MONDO:0005617,MONDO:0002038</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979815</td>
<td style="text-align: left;">benign muscle neoplasm</td>
<td style="text-align: left;">NCIT:C215429</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Benign Muscle Neoplasm</td>
<td style="text-align: left;">A non-metastasizing neoplasm without atypical or malignant histopathological features that arises from the smooth muscle, skeletal muscle, or myocardium.</td>
<td style="text-align: left;">MONDO:0021545,MONDO:0000636</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979816</td>
<td style="text-align: left;">metastatic malignant neoplasm in the endocrine glands</td>
<td style="text-align: left;">NCIT:C215678</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Neoplasm in the Endocrine Glands</td>
<td style="text-align: left;">A malignant neoplasm that has spread from its original site of growth to an endocrine gland. Representative examples include metastases to pituitary and adrenal glands that result in diabetes insipidus and adrenal insufficiency, respectively. Representative examples of primary tumors metastasizing to endocrine glands include breast carcinomas, lung carcinomas, and melanomas.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0021069</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979817</td>
<td style="text-align: left;">endocrine carcinoma</td>
<td style="text-align: left;">NCIT:C215715</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Endocrine Carcinoma</td>
<td style="text-align: left;">A carcinoma that arises from the endocrine glands. Representative examples include thyroid gland carcinomas, parathyroid gland carcinomas, adrenal cortex carcinomas, and neuroendocrine carcinomas.</td>
<td style="text-align: left;">MONDO:0021069,MONDO:0004993</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979818</td>
<td style="text-align: left;">metastatic malignant endocrine neoplasm</td>
<td style="text-align: left;">NCIT:C215797</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Endocrine Neoplasm</td>
<td style="text-align: left;">A malignant endocrine neoplasm that has spread from its original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0024880,MONDO:0021069</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979819</td>
<td style="text-align: left;">lacrimal gland primary ductal adenocarcinoma</td>
<td style="text-align: left;">NCIT:C215836</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lacrimal Gland Primary Ductal Adenocarcinoma</td>
<td style="text-align: left;">A rare high-grade adenocarcinoma that arises from the lacrimal gland and resembles breast invasive ductal carcinoma.</td>
<td style="text-align: left;">MONDO:0002475</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979820</td>
<td style="text-align: left;">lacrimal gland secretory carcinoma</td>
<td style="text-align: left;">NCIT:C215878</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lacrimal Gland Secretory Carcinoma</td>
<td style="text-align: left;">A rare, low-grade carcinoma that arises from the lacrimal gland and shares histopathologic features and molecular characteristics (ETV6 gene rearrangement) with secretory breast carcinoma. It has a favorable clinical outcome.</td>
<td style="text-align: left;">MONDO:0002475</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979821</td>
<td style="text-align: left;">lacrimal gland adenocarcinoma, not otherwise specified</td>
<td style="text-align: left;">NCIT:C215880</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Lacrimal Gland Adenocarcinoma, Not Otherwise Specified</td>
<td style="text-align: left;">An adenocarcinoma that arises from the lacrimal gland and is characterized by the absence of the histopathological features that define other types of lacrimal gland carcinomas.</td>
<td style="text-align: left;">MONDO:0002475</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979822</td>
<td style="text-align: left;">orbital disorder</td>
<td style="text-align: left;">NCIT:C216244</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Orbital Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the orbital structures.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979823</td>
<td style="text-align: left;">advanced phase myeloproliferative neoplasm</td>
<td style="text-align: left;">NCIT:C216260</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Advanced Phase Myeloproliferative Neoplasm</td>
<td style="text-align: left;">A myeloproliferative neoplasm in accelerated phase or blast phase.</td>
<td style="text-align: left;">MONDO:0020076</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979824</td>
<td style="text-align: left;">ocular adnexal disorder</td>
<td style="text-align: left;">NCIT:C216962</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ocular Adnexal Disorder</td>
<td style="text-align: left;">A non-neoplastic or neoplastic disorder that affects the conjunctiva, eyelid, or lacrimal system.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979825</td>
<td style="text-align: left;">ocular surface fibroma</td>
<td style="text-align: left;">NCIT:C217092</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Ocular Surface Fibroma</td>
<td style="text-align: left;">A benign tumor that arises from the bulbar conjunctiva and less frequently the palpebral conjunctiva and is composed of collagen-rich stroma, spindle cells, and scattered mast cells.</td>
<td style="text-align: left;">MONDO:0006105,MONDO:0005167</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979826</td>
<td style="text-align: left;">luminal androgen receptor breast carcinoma</td>
<td style="text-align: left;">NCIT:C217270</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Luminal Androgen Receptor Breast Carcinoma</td>
<td style="text-align: left;">A subtype of triple-negative breast carcinoma (TNBC) with a unique gene expression profile compared to other TNBC subtypes, characterized by androgen receptor (AR) protein expression.</td>
<td style="text-align: left;">MONDO:0005494</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979827</td>
<td style="text-align: left;">peritoneal adenosarcoma</td>
<td style="text-align: left;">NCIT:C217655</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Peritoneal Adenosarcoma</td>
<td style="text-align: left;">An extremely rare adenosarcoma that arises from the peritoneum.</td>
<td style="text-align: left;">MONDO:0005636,MONDO:0002087</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979828</td>
<td style="text-align: left;">esophageal submucosal gland duct adenoma</td>
<td style="text-align: left;">NCIT:C217665</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Esophageal Submucosal Gland Duct Adenoma</td>
<td style="text-align: left;">A very rare benign tumor that arises from the submucosal glands of the esophagus. It is characterized by the presence of glandular cysts, multilayered epithelium, and inflammation. It is not related to Barrett esophagus.</td>
<td style="text-align: left;">MONDO:0006180,MONDO:0021459</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979829</td>
<td style="text-align: left;">muscle invasive urethral urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C217731</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Muscle Invasive Urethral Urothelial Carcinoma</td>
<td style="text-align: left;">A urethral urothelial carcinoma invading into the muscle of the urethral wall.</td>
<td style="text-align: left;">MONDO:0002836,MONDO:0040678</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979830</td>
<td style="text-align: left;">muscle invasive ureter urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C217732</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Muscle Invasive Ureter Urothelial Carcinoma</td>
<td style="text-align: left;">A ureter urothelial carcinoma invading into the muscle of the ureteral wall.</td>
<td style="text-align: left;">MONDO:0004030,MONDO:0004010</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979831</td>
<td style="text-align: left;">muscle invasive renal pelvis urothelial carcinoma</td>
<td style="text-align: left;">NCIT:C217733</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Muscle Invasive Renal Pelvis Urothelial Carcinoma</td>
<td style="text-align: left;">A renal pelvis urothelial carcinoma invading into the muscle of the renal pelvis.</td>
<td style="text-align: left;">MONDO:0005221,MONDO:0004010</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979832</td>
<td style="text-align: left;">eyelid fibrous histiocytoma</td>
<td style="text-align: left;">NCIT:C217739</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Fibrous Histiocytoma</td>
<td style="text-align: left;">A benign fibrous histiocytoma that arises from the skin of the eyelid.</td>
<td style="text-align: left;">MONDO:0006717,MONDO:0021605</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979833</td>
<td style="text-align: left;">conjunctival fibrous histiocytoma</td>
<td style="text-align: left;">NCIT:C217740</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Conjunctival Fibrous Histiocytoma</td>
<td style="text-align: left;">A rare benign fibrous histiocytoma that arises from the conjunctiva.</td>
<td style="text-align: left;">MONDO:0002989,MONDO:0006105</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979834</td>
<td style="text-align: left;">eyelid lipoma</td>
<td style="text-align: left;">NCIT:C217741</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Eyelid Lipoma</td>
<td style="text-align: left;">A rare lipoma that arises from the eyelid.</td>
<td style="text-align: left;">MONDO:0000964,MONDO:0021605</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979835</td>
<td style="text-align: left;">mismatch repair proficient colorectal carcinoma</td>
<td style="text-align: left;">NCIT:C218464</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Mismatch Repair Proficient Colorectal Carcinoma</td>
<td style="text-align: left;">A colorectal carcinoma in which the mismatch repair system is functional.</td>
<td style="text-align: left;">MONDO:0024331</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979836</td>
<td style="text-align: left;">metastatic malignant soft tissue neoplasm</td>
<td style="text-align: left;">NCIT:C219038</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Metastatic Malignant Soft Tissue Neoplasm</td>
<td style="text-align: left;">A malignant soft tissue neoplasm that has spread from the original site of growth to another anatomic site.</td>
<td style="text-align: left;">MONDO:0024637,MONDO:0024880</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979837</td>
<td style="text-align: left;">fibrosarcomatous dermatofibrosarcoma protuberans</td>
<td style="text-align: left;">NCIT:C27547</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Fibrosarcomatous Dermatofibrosarcoma Protuberans</td>
<td style="text-align: left;">A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of a fibrosarcomatous component.</td>
<td style="text-align: left;">MONDO:0011934</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979838</td>
<td style="text-align: left;">non-neoplastic skin disorder</td>
<td style="text-align: left;">NCIT:C27555</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Neoplastic Skin Disorder</td>
<td style="text-align: left;">A non-neoplastic disorder that affects the skin.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979839</td>
<td style="text-align: left;">non-neoplastic adrenal gland disorder</td>
<td style="text-align: left;">NCIT:C27569</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Non-Neoplastic Adrenal Gland Disorder</td>
<td style="text-align: left;">A non-neoplastic disorder that affects the adrenal glands.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979840</td>
<td style="text-align: left;">adrenal hyperplasia</td>
<td style="text-align: left;">NCIT:C35408</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adrenal Hyperplasia</td>
<td style="text-align: left;">A congenital or acquired hyperplasia of the cells of the adrenal cortex or medulla.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979841</td>
<td style="text-align: left;">grade 3 malignant neoplasm</td>
<td style="text-align: left;">NCIT:C36042</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Grade 3 Malignant Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm with poorly differentiated morphological features.</td>
<td style="text-align: left;">MONDO:0020665</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979842</td>
<td style="text-align: left;">grade 4 malignant neoplasm</td>
<td style="text-align: left;">NCIT:C36045</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Grade 4 Malignant Neoplasm</td>
<td style="text-align: left;">A malignant neoplasm with undifferentiated and/or anaplastic morphological features.</td>
<td style="text-align: left;">MONDO:0020665</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979843</td>
<td style="text-align: left;">carcinoma of unknown primary</td>
<td style="text-align: left;">NCIT:C3812</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Carcinoma of Unknown Primary</td>
<td style="text-align: left;">A carcinoma that has spread to other regions from an unknown primary anatomic site.</td>
<td style="text-align: left;">MONDO:0024879,MONDO:0858997</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979844</td>
<td style="text-align: left;">male reproductive system precancerous condition</td>
<td style="text-align: left;">NCIT:C38164</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Male Reproductive System Precancerous Condition</td>
<td style="text-align: left;">A pathologic process that arises from the male reproductive system and has the potential to evolve into a malignant neoplasm. Representative examples include prostatic intraepithelial neoplasia, giant condyloma acuminatum of the penis, and penile intraepithelial neoplasia.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979845</td>
<td style="text-align: left;">urothelial carcinoma in situ</td>
<td style="text-align: left;">NCIT:C4116</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Urothelial Carcinoma In Situ</td>
<td style="text-align: left;">A neoplastic lesion in which the urothelium of the bladder, renal pelvis and/or ureter displays cells with malignant cytological characteristics and abnormal architectural features without evidence of stromal invasion.</td>
<td style="text-align: left;">MONDO:0003755,MONDO:0004647,MONDO:0040679</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979846</td>
<td style="text-align: left;">adenocarcinoma in villous adenoma</td>
<td style="text-align: left;">NCIT:C4141</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adenocarcinoma in Villous Adenoma</td>
<td style="text-align: left;">An adenocarcinoma that arises from a villous adenoma.</td>
<td style="text-align: left;">MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979847</td>
<td style="text-align: left;">adenocarcinoma in tubulovillous adenoma</td>
<td style="text-align: left;">NCIT:C4145</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adenocarcinoma in Tubulovillous Adenoma</td>
<td style="text-align: left;">An adenocarcinoma that arises from a tubulovillous adenoma.</td>
<td style="text-align: left;">MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979848</td>
<td style="text-align: left;">pilar leiomyoma</td>
<td style="text-align: left;">NCIT:C43332</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pilar Leiomyoma</td>
<td style="text-align: left;">A cutaneous leiomyoma arising from the erector muscle of the hair.</td>
<td style="text-align: left;">MONDO:0003291</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979849</td>
<td style="text-align: left;">giant cell fibroblastoma</td>
<td style="text-align: left;">NCIT:C4700</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Giant Cell Fibroblastoma</td>
<td style="text-align: left;">A morphologic variant of dermatofibrosarcoma protuberans that is most often seen in childhood and is characterized by the presence of spindle-shaped fibroblastic cells, a storiform growth pattern, numerous multinucleated giant cells, wide vessel-like spaces, and extensive myxoid change.</td>
<td style="text-align: left;">MONDO:0011934</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979850</td>
<td style="text-align: left;">classic dermatofibrosarcoma protuberans</td>
<td style="text-align: left;">NCIT:C49104</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Classic Dermatofibrosarcoma Protuberans</td>
<td style="text-align: left;">A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of spindle-shaped fibroblastic cells, histiocytic cells, and a storiform growth pattern.</td>
<td style="text-align: left;">MONDO:0011934</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979851</td>
<td style="text-align: left;">cerebral hodgkin lymphoma</td>
<td style="text-align: left;">NCIT:C5055</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Cerebral Hodgkin Lymphoma</td>
<td style="text-align: left;">A Hodgkin lymphoma that affects the cerebrum.</td>
<td style="text-align: left;">MONDO:0003655,MONDO:0004952</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979852</td>
<td style="text-align: left;">laryngeal lymphoepithelial carcinoma</td>
<td style="text-align: left;">NCIT:C54341</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Laryngeal Lymphoepithelial Carcinoma</td>
<td style="text-align: left;">A rare and aggressive carcinoma that arises from the larynx.  It is characterized by the presence of an undifferentiated carcinoma accompanied by a prominent reactive lymphoplasmacytic infiltrate.</td>
<td style="text-align: left;">MONDO:0002358,MONDO:0003572</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979853</td>
<td style="text-align: left;">gallbladder sarcomatoid carcinoma</td>
<td style="text-align: left;">NCIT:C5838</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Gallbladder Sarcomatoid Carcinoma</td>
<td style="text-align: left;">A rare aggressive carcinoma that arises from the gallbladder. It is characterized by the presence of poorly differentiated pleomorphic carcinoma cells admixed with malignant spindle-shaped cells that express epithelial immunohistochemical markers.</td>
<td style="text-align: left;">MONDO:0006406,MONDO:0003220</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979854</td>
<td style="text-align: left;">parotid gland warthin tumor</td>
<td style="text-align: left;">NCIT:C66865</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Parotid Gland Warthin Tumor</td>
<td style="text-align: left;">An adenoma that arises from the parotid gland. It is characterized by an oncocytic, often papillary, epithelial component, dense lymphoid stroma, and cystic spaces. A strong association with smoking has been reported. It typically presents as a painless swelling in the lower portion of the parotid gland.</td>
<td style="text-align: left;">MONDO:0006493,MONDO:0021494</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979855</td>
<td style="text-align: left;">pancreatic precancerous condition</td>
<td style="text-align: left;">NCIT:C7412</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Precancerous Condition</td>
<td style="text-align: left;">A pathologic process that arises from the pancreas and has the potential to evolve into a malignant neoplasm.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979856</td>
<td style="text-align: left;">adenocarcinoma in tubular adenoma</td>
<td style="text-align: left;">NCIT:C7677</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Adenocarcinoma in Tubular Adenoma</td>
<td style="text-align: left;">An adenocarcinoma that arises from a tubular adenoma.</td>
<td style="text-align: left;">MONDO:0004970</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979857</td>
<td style="text-align: left;">childhood nodular lymphocyte predominant b-cell lymphoma</td>
<td style="text-align: left;">NCIT:C8060</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma</td>
<td style="text-align: left;">A nodular lymphocyte predominant B-cell lymphoma occurring in children.</td>
<td style="text-align: left;">MONDO:0044778,MONDO:0003659</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979858</td>
<td style="text-align: left;">atypical glandular hyperplasia</td>
<td style="text-align: left;">NCIT:C8356</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Atypical Glandular Hyperplasia</td>
<td style="text-align: left;">Proliferation of glandular epithelial cells associated with the presence of cytologic atypia and architectural growth pattern changes.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979859</td>
<td style="text-align: left;">inherited bone marrow failure syndrome</td>
<td style="text-align: left;">NCIT:C94810</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Inherited Bone Marrow Failure Syndrome</td>
<td style="text-align: left;">A group of inherited genetic hematopoietic stem cell disorders characterized by bone marrow failure that involves one or more cell lines. Representative examples include Fanconi anemia, Diamond-Blackfan anemia, and Shwachman-Diamond syndrome.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979860</td>
<td style="text-align: left;">pancreatic serous macrocystic cystadenoma</td>
<td style="text-align: left;">NCIT:C95471</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Pancreatic Serous Macrocystic Cystadenoma</td>
<td style="text-align: left;">A benign, non-metastasizing epithelial neoplasm arising from the exocrine pancreas.  It is characterized by the presence of a few large cysts and is composed of glycogen-rich epithelial cells which produce a watery fluid.</td>
<td style="text-align: left;">MONDO:0002808</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979861</td>
<td style="text-align: left;">preinvasive neoplasm of the ampullary region</td>
<td style="text-align: left;">NCIT:C95909</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Preinvasive Neoplasm of the Ampullary Region</td>
<td style="text-align: left;">A premalignant neoplastic and dysplastic lesion that arises from the ampulla of Vater.  It is characterized by the absence of invasion.  This category includes intestinal-type adenomas, noninvasive papillary neoplasms of pancreatobiliary type, and flat intraepithelial neoplasia.</td>
<td style="text-align: left;">MONDO:0024276,MONDO:0000921</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979862</td>
<td style="text-align: left;">anal canal neuroendocrine tumor g1</td>
<td style="text-align: left;">NCIT:C96543</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Anal Canal Neuroendocrine Tumor G1</td>
<td style="text-align: left;">A well-differentiated, low-grade neuroendocrine neoplasm that arises from the anal canal. The mitotic count is less than 2 per 2 mm2 and the Ki-67 index is less than 3%.</td>
<td style="text-align: left;">MONDO:0015069,MONDO:0021533</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979863</td>
<td style="text-align: left;">congenital skin disorder</td>
<td style="text-align: left;">NCIT:C97174</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Congenital Skin Disorder</td>
<td style="text-align: left;">A skin abnormality that is present at birth or detected in the neonatal period.</td>
<td style="text-align: left;"></td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979894</td>
<td style="text-align: left;">diffuse midline glioma, egfr-mutant</td>
<td style="text-align: left;">NCIT:C185369</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Midline Glioma, EGFR-Mutant</td>
<td style="text-align: left;">A diffuse midline glioma, H3 K27-altered, characterized by the presence of EGFR gene mutation.</td>
<td style="text-align: left;">MONDO:1060171</td>
</tr>
<tr>
<td style="text-align: left;">MONDO:0979895</td>
<td style="text-align: left;">diffuse midline glioma with ezhip overexpression</td>
<td style="text-align: left;">NCIT:C185370</td>
<td style="text-align: left;">MONDO:equivalentTo</td>
<td style="text-align: left;">Diffuse Midline Glioma with EZHIP Overexpression</td>
<td style="text-align: left;">A diffuse midline glioma, H3 K27-altered, characterized by the presence of EZHIP overexpression.</td>
<td style="text-align: left;">MONDO:1060171</td>
</tr>
</tbody>
</table>












                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "../..", "features": [], "search": "../../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    
      <script src="../../assets/javascripts/bundle.1e8ae164.min.js"></script>
      
    
  </body>
</html>